data_1bwy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bwy _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.92 54.05 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.526 2.731 . . . . 0.0 111.833 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.38 -56.52 0.08 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.81 1.644 . . . . 0.0 106.65 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -47.18 -44.52 22.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.266 1.826 . . . . 0.0 111.93 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -35.52 102.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.037 2.135 . . . . 0.0 112.093 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.43 -156.63 26.28 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.162 0.892 . . . . 0.0 112.906 165.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 m -116.32 127.09 54.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.632 1.173 . . . . 0.0 109.019 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -112.04 156.93 21.39 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.531 1.132 . . . . 0.0 110.463 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 25.7 ttpp -119.31 130.65 55.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.503 2.321 . . . . 0.0 107.355 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.93 137.35 58.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.15 -71.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.156 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -111.42 139.78 46.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.958 0.799 . . . . 0.0 109.448 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -163.45 160.28 23.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.771 0.828 . . . . 0.0 108.779 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 171.66 19.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.808 2.043 . . . . 0.0 107.678 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 m120 64.5 12.98 7.84 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.508 1.523 . . . . 0.0 113.78 166.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.91 -39.94 93.76 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 120.426 -1.421 . . . . 0.0 109.895 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.25 -71.75 0.06 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 109.619 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -37.88 -57.74 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.698 1.999 . . . . 0.0 111.971 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.54 -40.65 75.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.971 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -33.04 44.38 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.523 -0.735 . . . . 0.0 111.004 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -72.01 46.76 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 0.0 110.436 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p 179.04 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.303 1.841 . . . . 0.0 107.229 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -64.5 -27.88 69.28 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.97 44.31 37.29 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -113.29 43.79 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.82 -72.84 0.28 Allowed Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.75 20.49 3.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.104 0.961 . . . . 0.0 111.984 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 171.32 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 126.613 1.965 . . . . 0.0 107.456 -168.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -53.79 -43.84 69.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.232 1.013 . . . . 0.0 111.416 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -65.86 -12.25 52.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.271 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -60.2 -23.24 63.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.331 1.423 . . . . 0.0 112.056 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.95 -39.53 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 110.269 167.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.03 47.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.199 -0.938 . . . . 0.0 113.735 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -57.77 -47.15 83.34 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.413 1.485 . . . . 0.0 109.731 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.6 ttt -92.3 -42.31 9.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.884 1.274 . . . . 0.0 110.394 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -74.45 66.26 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 0.0 112.604 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -149.26 58.57 3.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.871 1.268 . . . . 0.0 110.084 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.3 -44.67 8.67 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.685 2.923 . . . . 0.0 111.869 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.7 m -107.16 157.07 18.15 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.663 0.744 . . . . 0.0 109.217 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 m -148.02 116.83 6.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 162.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 83.1 mt -80.59 137.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.7 mm -130.96 91.19 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.556 1.543 . . . . 0.0 106.992 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.84 105.63 17.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.79 140.79 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -125.05 165.57 17.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.499 1.519 . . . . 0.0 107.912 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -25.12 -66.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.613 2.054 . . . . 0.0 115.121 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -118.36 15.05 13.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.792 2.037 . . . . 0.0 110.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.09 179.69 7.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.065 1.746 . . . . 0.0 109.727 -151.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.9 150.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.86 127.61 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.4 tt -94.64 138.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -127.74 99.02 5.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.539 1.536 . . . . 0.0 108.587 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.5 m -72.94 83.89 1.24 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -83.74 113.11 20.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.966 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -139.01 -172.64 3.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.93 1.292 . . . . 0.0 108.372 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -82.86 -80.69 0.17 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -84.06 116.53 22.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 109.662 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 81.29 133.04 0.06 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.586 1.954 . . . . 0.0 108.904 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.12 155.75 49.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 p -150.48 153.45 35.91 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.29 143.23 17.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.989 171.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mm -153.61 142.67 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.688 1.195 . . . . 0.0 108.791 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -89.69 136.87 32.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.779 2.032 . . . . 0.0 109.391 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.1 144.59 38.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.991 0.917 . . . . 0.0 110.345 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 106.23 16.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.55 1.54 . . . . 0.0 107.309 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.82 105.01 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.959 0.504 . . . . 0.0 111.076 168.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.97 30.42 2.98 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.688 2.09 . . . . 0.0 112.698 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.3 t -146.95 159.88 9.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 107.986 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.76 137.35 49.81 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 111.605 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -135.43 135.74 40.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.84 1.256 . . . . 0.0 109.512 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.15 114.98 27.62 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.565 1.546 . . . . 0.0 108.281 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.54 159.15 38.28 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.209 0.459 . . . . 0.0 110.32 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 t -122.38 98.76 6.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.641 1.577 . . . . 0.0 112.063 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -83.78 142.95 30.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.39 -40.91 27.33 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.053 0.941 . . . . 0.0 110.869 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -102.45 42.19 1.17 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.874 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.58 -37.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.213 1.005 . . . . 0.0 110.079 154.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 86.55 -172.24 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.949 2.5 . . . . 0.0 107.093 -163.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -72.71 123.95 24.32 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.738 0.699 . . . . 0.0 110.193 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.93 147.86 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.216 1.406 . . . . 0.0 108.172 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -93.94 101.6 13.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 122.095 0.95 . . . . 0.0 109.932 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.5 m -83.81 116.15 22.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.015 1.326 . . . . 0.0 109.787 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.26 125.23 54.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 166.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.34 138.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -155.24 -176.66 6.05 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 164.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -132.44 105.58 7.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.865 1.266 . . . . 0.0 108.439 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.27 120.57 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.71 -80.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.722 0.677 . . . . 0.0 111.964 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.14 17.7 1.54 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.195 1.379 . . . . 0.0 111.587 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.5 117.06 30.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 108.342 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 tp -80.1 98.56 7.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.0 m -87.95 107.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -98.25 100.99 12.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.83 141.82 13.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -133.53 99.67 4.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -108.63 114.95 29.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.58 1.952 . . . . 0.0 108.502 -163.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.409 ' HE1' ' NE2' ' A' ' 100' ' ' GLN . 14.1 p90 -107.74 -67.25 0.97 Allowed 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.572 0.624 . . . . 0.0 110.99 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -172.11 -81.32 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.322 0.51 . . . . 0.0 111.734 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.96 80.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.409 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -142.68 -172.82 3.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -131.39 -178.99 5.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.118 1.767 . . . . 0.0 107.274 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.5 t -143.56 177.64 8.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.7 p -138.05 136.75 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.669 1.188 . . . . 0.0 108.264 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -129.87 71.33 1.44 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.139 2.176 . . . . 0.0 106.259 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.92 124.92 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.822 -0.549 . . . . 0.0 109.819 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.13 139.42 49.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.784 1.634 . . . . 0.0 110.348 -171.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -156.44 144.29 19.46 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -110.61 120.4 42.28 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 162.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.45 167.4 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 156.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.85 -124.44 2.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.13 13.63 7.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.945 1.26 . . . . 0.0 111.93 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -122.93 127.02 48.35 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.389 1.095 . . . . 0.0 109.333 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.65 103.02 4.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 165.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 pt -85.95 127.73 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.5 tp -115.1 111.3 20.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.67 1.588 . . . . 0.0 106.785 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -88.85 115.35 26.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -102.93 109.78 21.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 m -132.17 131.15 41.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.279 1.031 . . . . 0.0 110.548 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.49 169.14 12.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.814 1.646 . . . . 0.0 108.921 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.44 83.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 166.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 85.52 140.22 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.186 2.594 . . . . 0.0 109.585 -166.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 77.55 145.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 112.346 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -137.05 153.61 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.434 1.893 . . . . 0.0 107.29 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.6 137.64 32.04 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.821 -1.175 . . . . 0.0 108.559 161.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -85.37 128.09 34.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 161.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -125.94 113.96 17.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 p -113.31 136.77 52.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.333 0.97 . . . . 0.0 110.386 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.41 146.17 47.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.925 1.69 . . . . 0.0 108.646 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 40.8 tt0 -130.09 125.04 34.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.056 2.143 . . . . 0.0 106.77 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -66.05 116.6 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.417 1.008 . . . . 0.0 110.146 -171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -91.23 -30.12 16.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.645 0.378 . . . . 0.0 111.048 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.503 0.592 . . . . 0.0 111.138 173.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 63.9 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.078 2.951 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.94 -44.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.873 1.669 . . . . 0.0 107.956 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -61.7 -44.82 96.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -37.04 105.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.992 2.117 . . . . 0.0 111.676 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.91 -163.76 25.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.499 0.571 . . . . 0.0 112.41 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 m -108.94 122.66 47.7 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 110.481 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -103.09 162.37 13.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.462 1.905 . . . . 0.0 110.624 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -129.34 132.86 47.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.455 2.302 . . . . 0.0 108.139 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.63 131.38 45.87 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.281 0.633 . . . . 0.0 110.121 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.33 31.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.247 0.619 . . . . 0.0 110.918 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.76 159.49 8.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.401 1.48 . . . . 0.0 108.175 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 177.07 102.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.442 1.897 . . . . 0.0 107.868 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -135.94 148.71 48.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.179 0.445 . . . . 0.0 110.385 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.34 35.49 20.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.544 1.538 . . . . 0.0 110.807 174.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.35 -19.14 27.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.78 1.276 . . . . 0.0 109.948 -177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -52.99 4.84 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 129.494 3.118 . . . . 0.0 106.146 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -49.68 -40.76 41.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.895 1.278 . . . . 0.0 111.148 166.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.89 -50.6 34.23 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.576 0.75 . . . . 0.0 111.165 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 -37.51 84.69 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.425 -0.797 . . . . 0.0 111.652 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -70.42 61.65 0.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 110.063 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m 168.6 -58.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 129.165 2.986 . . . . 0.0 106.795 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.73 -34.78 24.8 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 52.61 42.65 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -170.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.31 -52.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.195 0.998 . . . . 0.0 110.611 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.89 -65.6 3.21 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.873 -0.404 . . . . 0.0 113.579 -163.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.45 101.46 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.779 1.632 . . . . 0.0 112.454 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 135.16 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.707 3.203 . . . . 0.0 109.461 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -113.19 -26.5 8.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.929 1.692 . . . . 0.0 111.343 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -66.46 -41.95 88.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.83 1.195 . . . . 0.0 110.888 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -53.21 -36.67 61.26 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.287 1.035 . . . . 0.0 111.197 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.0 t -39.42 -50.86 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.401 1.88 . . . . 0.0 110.329 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.06 54.56 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.643 0.64 . . . . 0.0 113.075 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.45 24.97 10.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.85 1.26 . . . . 0.0 111.198 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.5 ttt -152.62 -2.57 0.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.0 m -158.3 169.96 23.32 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.793 -1.192 . . . . 0.0 109.602 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -117.08 73.02 6.53 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.204 1.402 . . . . 0.0 108.977 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.22 158.2 58.58 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.431 2.087 . . . . 0.0 109.809 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -100.83 164.54 11.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.74 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.95 113.1 11.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 163.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.37 127.66 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mm -120.79 110.84 29.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.57 115.95 29.44 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.3 85.87 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -50.41 154.64 1.22 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.521 0.728 . . . . 0.0 110.171 170.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -23.79 -59.28 0.04 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.317 1.913 . . . . 0.0 115.352 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.11 13.35 9.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.944 1.298 . . . . 0.0 111.805 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.89 -170.37 3.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.937 1.695 . . . . 0.0 108.767 -158.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.29 149.1 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 120.72 -1.238 . . . . 0.0 110.53 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.67 140.75 47.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.88 1.272 . . . . 0.0 109.17 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 tt -129.43 145.5 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.454 1.901 . . . . 0.0 109.371 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.0 152.75 51.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.952 2.101 . . . . 0.0 107.842 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 m -111.61 62.95 0.62 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.032 1.287 . . . . 0.0 107.717 159.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.07 108.15 0.84 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.488 -0.758 . . . . 0.0 110.794 -173.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -116.24 102.1 9.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.334 1.454 . . . . 0.0 108.55 -168.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m 63.92 -75.7 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.155 1.382 . . . . 0.0 111.451 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.33 27.85 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.119 0.968 . . . . 0.0 110.865 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 96.99 2.71 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.862 -0.524 . . . . 0.0 110.989 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -161.61 163.77 29.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.516 -0.74 . . . . 0.0 111.157 161.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -94.72 175.03 6.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.97 3.308 . . . . 0.0 109.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 152.25 47.98 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.065 1.346 . . . . 0.0 107.976 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.73 137.79 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 p -126.24 147.33 49.7 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.556 0.743 . . . . 0.0 109.399 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -160.82 163.25 32.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.056 0.931 . . . . 0.0 113.124 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -98.83 133.71 42.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.56 64.64 2.25 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.83 -0.544 . . . . 0.0 110.161 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.82 57.92 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.21 159.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.4 1.1 . . . . 0.0 111.119 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -88.89 151.61 22.23 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.072 1.349 . . . . 0.0 109.56 160.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.48 150.1 21.16 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.377 0.671 . . . . 0.0 109.265 164.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.44 141.24 32.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.4 156.86 47.2 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.193 0.997 . . . . 0.0 108.946 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -149.71 118.77 6.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.686 0.394 . . . . 0.0 110.178 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -147.35 143.45 28.02 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.88 78.94 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.531 0.732 . . . . 0.0 111.912 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -94.83 19.71 9.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.17 1.788 . . . . 0.0 112.511 -171.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.25 -42.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.782 0.833 . . . . 0.0 110.721 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 114.69 -160.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 131.383 3.873 . . . . 0.0 108.89 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -85.71 118.4 25.19 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.26 142.04 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.263 1.025 . . . . 0.0 108.527 -167.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -80.82 126.8 31.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -97.36 143.77 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.894 0.878 . . . . 0.0 108.714 168.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 tt -136.4 127.62 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.6 139.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.0 m -158.98 173.82 15.91 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.379 2.672 . . . . 0.0 104.657 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.45 153.76 43.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.425 1.466 . . . . 0.0 111.977 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.77 143.27 49.47 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.414 1.486 . . . . 0.0 108.421 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 -77.13 0.04 OUTLIER Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.24 0.924 . . . . 0.0 111.118 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.17 21.27 0.19 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.115 1.341 . . . . 0.0 111.918 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.42 134.21 54.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.119 1.368 . . . . 0.0 108.204 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.06 122.27 29.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.78 109.11 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -94.92 90.96 6.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 166.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.84 146.58 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -147.06 121.43 9.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -159.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -127.51 127.72 44.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.342 1.457 . . . . 0.0 108.748 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -100.12 -55.01 2.74 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -163.66 -85.1 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.973 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.31 71.8 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.225 0.466 . . . . 0.0 112.458 -170.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 177.31 10.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.922 0.889 . . . . 0.0 109.073 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.51 163.92 30.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 109.741 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -126.84 152.6 46.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.553 1.541 . . . . 0.0 108.453 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -111.0 124.94 53.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.409 1.483 . . . . 0.0 109.377 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.44 106.71 17.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.182 1.793 . . . . 0.0 106.771 171.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.35 131.58 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -138.64 142.37 39.06 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -159.11 155.81 27.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.284 2.233 . . . . 0.0 106.024 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -106.17 122.63 46.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 160.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.15 162.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 155.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.75 -129.66 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -166.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.01 0.33 24.16 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.526 1.536 . . . . 0.0 111.672 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.44 136.4 50.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.971 0.908 . . . . 0.0 108.982 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.67 112.25 24.14 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.31 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.4 tp -87.51 131.28 34.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.4 m -126.47 135.46 51.38 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.37 114.87 29.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 128.986 2.914 . . . . 0.0 106.71 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.1 m -120.95 130.34 53.8 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -124.22 159.21 30.66 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.88 -35.35 12.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.658 0.647 . . . . 0.0 112.291 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -124.31 123.87 41.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 92.14 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.042 2.137 . . . . 0.0 112.147 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.14 139.58 27.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.344 1.457 . . . . 0.0 107.293 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.3 t -150.75 128.24 11.44 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.986 0.914 . . . . 0.0 110.457 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 p -81.69 155.22 25.66 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -144.87 68.19 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.08 141.37 58.79 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.604 -0.685 . . . . 0.0 111.225 176.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.75 165.43 19.28 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 126.021 1.728 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.23 151.22 51.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.168 1.387 . . . . 0.0 109.681 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -86.65 128.5 35.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.908 1.283 . . . . 0.0 109.938 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.86 -15.43 14.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.961 0.8 . . . . 0.0 113.119 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.115 0 C-N-CA 123.193 0.597 . . . . 0.0 110.401 -177.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.26 -22.31 11.43 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.979 2.512 . . . . 0.0 112.857 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.95 -34.2 33.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.917 0.887 . . . . 0.0 111.272 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -48.19 56.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.23 108.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.477 1.511 . . . . 0.0 112.211 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.29 -157.46 21.28 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.25 0.477 . . . . 0.0 112.522 171.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.1 m -97.67 113.54 25.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.12 1.368 . . . . 0.0 110.791 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.416 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 16.6 m0 -84.77 113.07 21.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.579 1.552 . . . . 0.0 107.753 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.69 129.8 51.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.49 143.93 55.94 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.286 -0.884 . . . . 0.0 110.996 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.34 -42.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 120.706 -1.246 . . . . 0.0 111.854 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -138.33 162.58 34.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 t -171.49 126.47 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.67 133.17 45.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.18 29.97 5.92 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.347 1.859 . . . . 0.0 111.06 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -75.41 -53.33 8.87 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.45 -0.782 . . . . 0.0 109.671 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.56 -30.62 67.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.391 -0.193 . . . . 0.0 110.962 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.5 -48.72 62.82 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.22 -0.3 . . . . 0.0 110.56 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -56.82 -61.71 2.25 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 0.0 111.507 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -35.1 66.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 63.97 0.23 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.941 0.897 . . . . 0.0 109.874 167.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t 162.77 -56.96 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.963 2.505 . . . . 0.0 106.978 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -26.96 68.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.683 0.793 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 -19.81 15.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.885 0.755 . . . . 0.0 113.769 168.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.6 m -40.59 -32.43 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 128.21 2.604 . . . . 0.0 113.951 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.11 73.23 0.17 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -45.21 -58.66 3.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.576 1.15 . . . . 0.0 111.236 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.77 -29.54 11.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.641 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.2 p -81.87 -65.87 0.96 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.973 0.909 . . . . 0.0 111.092 -167.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -54.0 -33.1 56.16 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.829 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.9 -27.65 65.43 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.79 1.177 . . . . 0.0 113.9 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.1 t -85.53 -49.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.78 45.65 1.64 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.097 0.856 . . . . 0.0 113.684 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -160.41 -42.38 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 110.555 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtm -60.07 -26.53 66.24 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.793 0.724 . . . . 0.0 110.763 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 m -67.06 66.53 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.107 1.763 . . . . 0.0 112.367 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 44.24 72.57 1.16 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.412 1.885 . . . . 0.0 112.228 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.32 147.79 37.65 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.69 1.593 . . . . 0.0 111.904 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -152.7 160.5 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 108.175 -169.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -154.31 144.86 22.29 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pt -110.32 148.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.225 0.92 . . . . 0.0 108.772 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.416 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 30.5 mm -129.68 130.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.734 1.214 . . . . 0.0 108.761 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.17 114.88 20.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.507 1.523 . . . . 0.0 109.25 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.87 70.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.9 0.857 . . . . 0.0 110.259 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.89 149.87 43.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.571 -0.706 . . . . 0.0 109.976 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -19.89 -67.84 0.01 OUTLIER Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.494 1.997 . . . . 0.0 116.309 -171.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -113.52 14.35 18.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.599 1.559 . . . . 0.0 111.791 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.31 179.75 7.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.606 1.563 . . . . 0.0 109.0 -158.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -139.79 101.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.05 143.99 12.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.56 144.14 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -128.62 101.95 6.38 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -76.33 145.95 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.32 66.75 1.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.08 1.352 . . . . 0.0 108.591 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 m -72.17 -44.81 62.49 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -150.7 -109.51 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -113.93 -49.52 2.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.677 1.126 . . . . 0.0 111.566 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -77.77 66.72 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -101.41 -171.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.079 1.751 . . . . 0.0 109.402 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.9 p -152.77 171.95 17.44 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.664 1.186 . . . . 0.0 110.047 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -145.34 135.87 24.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.916 1.686 . . . . 0.0 108.21 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -145.26 147.81 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.227 1.011 . . . . 0.0 108.577 -172.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.5 p -99.7 97.41 8.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.608 1.563 . . . . 0.0 110.322 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -72.27 148.89 45.01 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.58 20.38 14.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.41 1.084 . . . . 0.0 113.845 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 37.04 32.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.602 1.961 . . . . 0.0 115.934 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.87 47.74 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.307 -0.718 . . . . 0.0 112.006 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -174.7 168.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.394 1.097 . . . . 0.0 109.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -104.86 143.47 33.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.621 0.768 . . . . 0.0 111.682 170.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -139.23 156.26 47.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 107.316 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.64 138.62 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.61 62.57 1.59 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -52.46 100.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.873 0.869 . . . . 0.0 110.379 163.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 t -117.66 136.05 53.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.261 0.553 . . . . 0.0 110.032 165.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.48 49.64 1.03 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.794 1.237 . . . . 0.0 111.374 -171.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -172.04 -58.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.565 2.346 . . . . 0.0 107.96 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.77 5.1 26.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.84 0.856 . . . . 0.0 113.22 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 83.4 -169.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 163.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -97.88 80.39 2.75 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 109.968 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.74 167.73 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.14 0.976 . . . . 0.0 109.377 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -127.33 97.12 4.79 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.5 t -113.48 114.86 27.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -157.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.3 119.11 29.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.878 1.671 . . . . 0.0 109.007 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.02 140.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 123.675 0.79 . . . . 0.0 110.031 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 p -136.81 166.71 22.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.777 1.631 . . . . 0.0 107.346 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.05 108.76 10.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.65 121.81 45.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.538 0.608 . . . . 0.0 109.835 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.52 -77.73 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.498 1.047 . . . . 0.0 111.344 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.85 21.47 0.69 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.995 1.283 . . . . 0.0 111.173 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -116.43 123.56 47.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.23 110.26 18.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.2 t -95.28 116.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -113.05 117.79 32.98 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.1 t -102.79 119.15 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -104.27 85.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 108.713 -169.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.42 143.14 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.349 1.86 . . . . 0.0 108.396 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -125.74 -59.19 1.37 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.51 166.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -167.2 -87.32 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.353 0.524 . . . . 0.0 111.311 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.72 -23.31 77.92 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.47 175.61 9.42 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.807 0.843 . . . . 0.0 108.728 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -134.45 176.04 8.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.918 2.087 . . . . 0.0 106.455 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -138.14 165.59 26.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 162.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 77.4 p -117.9 138.7 51.96 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.155 0.582 . . . . 0.0 110.282 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 98.0 4.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.032 1.733 . . . . 0.0 107.387 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.37 142.26 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -130.99 105.0 7.45 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.774 1.629 . . . . 0.0 108.668 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -131.98 142.93 49.76 Favored 'General case' 0 C--O 1.228 -0.042 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -116.67 124.5 49.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 164.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.57 -177.39 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.7 t70 52.36 -111.74 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.55 33.43 1.31 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -139.89 140.59 36.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -98.44 105.65 17.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.287 1.035 . . . . 0.0 108.412 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.22 105.16 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.32 95.25 9.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -81.92 115.22 21.0 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.67 105.39 13.25 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.129 1.372 . . . . 0.0 107.466 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 t -135.56 137.4 41.97 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.369 0.532 . . . . 0.0 111.35 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -109.73 -35.17 6.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.148 1.379 . . . . 0.0 111.293 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 -100.65 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 -172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 34.9 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.681 1.192 . . . . 0.0 112.749 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.34 126.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.124 2.169 . . . . 0.0 106.443 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.36 134.44 63.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 126.562 1.945 . . . . 0.0 107.016 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.47 154.27 49.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.897 0.879 . . . . 0.0 109.813 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.6 t -119.14 139.23 52.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 157.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -117.15 95.62 5.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.94 101.1 11.46 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -91.43 165.85 13.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.704 1.602 . . . . 0.0 111.028 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -139.31 109.23 6.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -66.06 98.3 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.36 -45.72 65.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 110.459 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 C-N-CA 126.057 1.743 . . . . 0.0 107.597 -176.386 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.46 65.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.11 2.964 . . . . 0.0 111.491 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.72 -49.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.03 2.132 . . . . 0.0 106.203 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -76.22 44.87 0.35 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.496 2.318 . . . . 0.0 111.421 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.1 96.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.53 -157.94 25.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -132.17 140.44 48.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.597 0.759 . . . . 0.0 110.185 -168.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -126.22 161.65 27.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.398 1.479 . . . . 0.0 109.548 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -127.65 139.01 52.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.513 1.125 . . . . 0.0 108.359 174.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.73 145.4 54.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.277 0.49 . . . . 0.0 111.007 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.5 -32.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 0.0 113.474 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 14' ' ' LYS . 18.9 t0 -133.06 154.06 50.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.97 1.259 . . . . 0.0 108.683 170.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -163.51 27.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.507 2.323 . . . . 0.0 110.879 -164.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 4.3 ptpp? -57.44 146.99 27.66 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.892 -1.13 . . . . 0.0 110.435 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 66.95 5.36 4.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 114.19 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.73 -39.08 76.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.467 1.485 . . . . 0.0 111.466 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.83 -69.69 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.0 110.24 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -30.9 -57.52 0.22 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.94 2.496 . . . . 0.0 111.146 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.51 -54.45 7.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 112.66 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -40.41 75.2 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.883 -0.51 . . . . 0.0 110.227 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -73.88 45.81 0.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.52 1.528 . . . . 0.0 110.75 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -171.35 -48.21 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.517 1.927 . . . . 0.0 109.053 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.54 -34.31 70.86 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.885 -0.509 . . . . 0.0 110.914 168.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.85 44.81 3.27 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.92 -30.02 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.376 1.47 . . . . 0.0 108.058 162.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -21.29 114.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.996 0 C-N-CA 127.688 2.566 . . . . 0.0 114.86 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -162.73 -177.13 5.36 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.114 1.366 . . . . 0.0 108.985 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.99 65.24 9.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.22 0.608 . . . . 0.0 109.89 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 m -154.57 -51.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.415 0.686 . . . . 0.0 109.624 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -43.81 -34.85 1.7 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 0.0 113.529 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.01 -30.54 68.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.042 0.937 . . . . 0.0 112.724 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.74 -37.77 9.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.8 65.3 0.07 OUTLIER Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.239 2.352 . . . . 0.0 112.788 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -179.07 -37.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.462 2.705 . . . . 0.0 108.336 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.44 -30.22 17.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.227 1.011 . . . . 0.0 110.65 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -64.15 -179.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.374 0.607 . . . . 0.0 111.108 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.44 80.8 2.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.738 1.215 . . . . 0.0 110.054 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 140.98 73.05 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.471 1.447 . . . . 0.0 110.642 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -121.79 146.53 46.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.155 1.782 . . . . 0.0 107.521 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.2 m -145.49 118.91 9.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.646 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.1 mt -92.76 128.84 44.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.88 110.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.11 104.5 10.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.445 1.098 . . . . 0.0 108.504 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.18 110.0 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.693 0.759 . . . . 0.0 109.122 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.72 60.21 5.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.11 -81.45 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.022 1.296 . . . . 0.0 112.3 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -36.81 20.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.056 1.342 . . . . 0.0 110.242 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -177.84 3.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.579 1.952 . . . . 0.0 108.225 -173.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.53 143.81 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -124.4 132.8 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 122.94 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -101.47 102.45 13.22 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.16 70.32 1.1 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.973 1.309 . . . . 0.0 107.67 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -78.22 128.62 34.01 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.499 -0.75 . . . . 0.0 110.103 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 t 74.87 -55.52 0.65 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.898 1.679 . . . . 0.0 110.291 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -39.93 81.68 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.603 3.161 . . . . 0.0 114.101 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 66.0 52.98 1.14 Allowed 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.999 1.719 . . . . 0.0 109.852 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 78.22 157.96 0.18 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.094 1.758 . . . . 0.0 107.709 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -71.01 104.76 3.09 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -124.86 177.28 6.1 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.267 1.027 . . . . 0.0 109.089 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -158.61 145.05 17.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -172.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 mt -135.4 120.05 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.484 1.114 . . . . 0.0 108.144 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.0 p -89.29 132.86 34.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.499 1.52 . . . . 0.0 108.805 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -146.39 157.55 43.79 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.71 0.686 . . . . 0.0 110.701 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -124.6 112.29 16.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.03 110.16 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.272 0.229 . . . . 0.0 110.676 170.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.31 37.76 2.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 0.0 111.682 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.5 t -147.14 151.7 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.787 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.12 136.95 46.93 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.742 1.617 . . . . 0.0 107.764 163.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.96 -173.5 3.48 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.964 0.905 . . . . 0.0 109.43 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -110.64 124.19 51.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.408 1.483 . . . . 0.0 108.858 -172.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -112.83 158.8 19.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.536 1.534 . . . . 0.0 109.209 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -147.02 101.55 3.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.71 154.46 36.86 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.1 0.96 . . . . 0.0 110.4 -171.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.19 72.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.83 -4.7 59.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.198 -171.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.76 2.79 0.21 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.62 -148.13 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.921 -1.737 . . . . 0.0 109.736 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.32 128.04 32.83 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.642 1.177 . . . . 0.0 109.388 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.62 139.33 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -83.27 125.05 31.18 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.8 t -125.16 147.17 49.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.69 0.677 . . . . 0.0 110.647 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.57 136.56 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.44 141.73 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 t -161.36 -171.4 2.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.714 1.206 . . . . 0.0 108.243 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 pp -127.66 135.43 50.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.045 0.938 . . . . 0.0 111.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -108.37 91.06 3.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.909 1.683 . . . . 0.0 108.186 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.64 -70.76 0.9 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.74 0.686 . . . . 0.0 111.771 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 14.87 1.19 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -115.48 165.94 12.45 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.5 tt -117.43 115.45 25.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 m -91.16 119.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -113.27 110.97 21.25 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 167.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.52 133.34 60.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -132.12 106.43 7.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.668 0.787 . . . . 0.0 108.948 -158.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -106.23 151.31 24.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.59 2.356 . . . . 0.0 109.529 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -130.32 -62.93 0.91 Allowed 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.624 -0.673 . . . . 0.0 109.601 163.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -159.31 -87.54 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 119.41 -0.329 . . . . 0.0 111.375 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.76 -25.28 76.01 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.929 0.786 . . . . 0.0 112.016 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 -177.39 5.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.138 0.975 . . . . 0.0 109.025 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -159.38 -176.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.288 1.435 . . . . 0.0 109.56 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.4 t -144.63 153.43 41.75 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 111.129 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -83.89 155.29 22.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 162.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -142.01 65.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.125 1.77 . . . . 0.0 107.26 161.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.58 141.41 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -124.74 128.41 48.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.322 1.049 . . . . 0.0 109.589 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -141.51 141.3 33.6 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.88 103.23 13.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 166.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.71 172.88 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 154.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 48.83 -122.58 1.68 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -166.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.44 29.91 4.64 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.438 1.494 . . . . 0.0 109.813 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -128.35 126.48 40.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.278 0.631 . . . . 0.0 110.889 -167.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.72 109.42 17.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.01 120.39 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -104.37 89.5 3.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.247 1.419 . . . . 0.0 108.026 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 m -76.91 82.81 3.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.222 0.534 . . . . 0.0 109.752 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.57 101.36 6.49 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 108.54 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.39 112.64 20.26 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -110.93 148.52 32.3 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.751 1.22 . . . . 0.0 108.714 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.28 84.68 0.01 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 169.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t 126.82 -2.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 131.631 3.972 . . . . 0.0 113.217 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.63 140.67 18.37 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.856 1.207 . . . . 0.0 109.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.54 130.41 69.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 124.466 1.106 . . . . 0.0 108.141 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.55 110.87 7.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.542 0.737 . . . . 0.0 109.808 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 76.5 p -70.27 79.63 0.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -64.46 136.65 57.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 158.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 t -156.81 147.28 21.41 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.051 -1.031 . . . . 0.0 108.909 169.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.78 159.95 33.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.836 1.255 . . . . 0.0 110.751 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.411 ' OE2' ' NZ ' ' A' ' 9' ' ' LYS . 36.1 tt0 -121.49 130.76 53.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.565 2.346 . . . . 0.0 106.231 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -69.89 120.01 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.719 0.69 . . . . 0.0 109.623 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -94.76 -31.41 13.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.478 0.711 . . . . 0.0 111.24 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.154 0 CA-C-N 118.428 0.558 . . . . 0.0 110.712 177.682 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.07 53.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.638 2.775 . . . . 0.0 111.393 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.36 -37.04 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.346 1.459 . . . . 0.0 109.133 -159.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.3 -47.46 6.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.965 0.906 . . . . 0.0 109.448 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -48.28 114.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.664 0.785 . . . . 0.0 112.404 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.75 -172.84 21.78 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.521 0.582 . . . . 0.0 112.311 162.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -102.75 123.62 46.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.283 0.633 . . . . 0.0 109.585 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -118.87 154.78 32.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.461 1.104 . . . . 0.0 108.975 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -128.6 136.8 51.2 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.41 1.084 . . . . 0.0 108.082 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.08 140.31 58.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.87 -2.6 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.6 145.07 38.09 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.472 1.033 . . . . 0.0 108.511 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -162.53 148.33 12.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.223 1.409 . . . . 0.0 108.765 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -159.46 154.14 24.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.709 1.203 . . . . 0.0 107.816 163.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 44.06 29.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.883 1.273 . . . . 0.0 110.649 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -56.26 4.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.778 0.799 . . . . 0.0 109.844 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -54.67 43.91 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.183 2.193 . . . . 0.0 108.902 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.68 -46.2 74.03 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.254 1.022 . . . . 0.0 112.286 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -55.67 -50.17 70.98 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.4 mtt -61.89 -36.61 81.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.219 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.62 46.9 0.05 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.808 1.643 . . . . 0.0 111.653 172.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.0 p -165.02 -41.02 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.857 1.263 . . . . 0.0 109.129 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.95 -32.46 74.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 19.98 35.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.194 0.426 . . . . 0.0 112.495 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -38.85 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 162.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.92 -138.32 6.42 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -165.98 -71.35 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -46.57 4.21 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.499 1.52 . . . . 0.0 113.1 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -36.77 -35.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.579 2.352 . . . . 0.0 114.01 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -25.37 40.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.148 -0.97 . . . . 0.0 112.436 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -45.12 -35.85 3.37 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.144 0.884 . . . . 0.0 112.711 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.73 -45.41 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.38 -3.55 62.17 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.23 -1.317 . . . . 0.0 115.824 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -110.53 1.37 18.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.645 1.578 . . . . 0.0 111.06 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 ttm -120.42 -59.26 1.78 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.908 0.883 . . . . 0.0 109.503 -162.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.5 m -78.31 76.16 4.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.989 -0.444 . . . . 0.0 109.98 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 5.68 77.96 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 128.846 2.858 . . . . 0.0 113.379 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.79 122.4 11.67 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.691 1.594 . . . . 0.0 109.655 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.0 m -88.21 155.21 19.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 m -147.48 87.95 1.68 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -171.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.9 mt -72.5 119.87 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.81 103.26 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.05 146.82 23.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.52 1.528 . . . . 0.0 108.69 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.19 141.81 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.5 165.27 21.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.79 -69.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.627 2.06 . . . . 0.0 115.04 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -131.63 35.05 3.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.393 1.477 . . . . 0.0 110.015 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -147.62 162.97 38.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.81 153.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 165.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.22 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 135.14 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -110.54 105.19 14.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.118 0.967 . . . . 0.0 110.387 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -70.24 107.84 3.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 168.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -122.69 112.75 18.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.554 0.742 . . . . 0.0 110.932 -166.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -149.82 170.24 19.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 110.251 168.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -79.41 38.01 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.792 1.237 . . . . 0.0 113.621 -160.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -161.96 -43.4 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.444 -0.785 . . . . 0.0 110.064 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -135.19 130.91 36.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.23 121.57 36.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -136.5 128.91 30.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.567 0.621 . . . . 0.0 110.232 -171.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 134.13 41.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.138 1.375 . . . . 0.0 109.147 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.13 123.1 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 p -80.7 160.04 25.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.263 1.025 . . . . 0.0 109.417 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -140.83 86.22 2.03 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.333 1.453 . . . . 0.0 108.591 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -79.99 93.97 5.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 110.79 0.59 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.395 0.678 . . . . 0.0 112.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.32 28.15 8.25 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.683 1.135 . . . . 0.0 112.016 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.0 t -150.46 159.35 4.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.667 1.187 . . . . 0.0 108.165 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -108.89 140.83 41.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.107 0.963 . . . . 0.0 110.189 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -154.78 157.53 38.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 148.07 47.3 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.096 0.407 . . . . 0.0 110.73 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.66 86.97 2.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.934 2.094 . . . . 0.0 105.795 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.8 m -90.55 96.76 10.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 t -121.16 137.99 54.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.581 0.753 . . . . 0.0 110.634 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.44 49.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.059 0.944 . . . . 0.0 113.436 -168.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.66 -75.13 0.51 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -87.35 17.28 4.53 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -162.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 mtm-85 80.54 -163.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.295 1.838 . . . . 0.0 110.969 165.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.4 109.37 19.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.192 0.997 . . . . 0.0 108.553 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.07 168.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -108.3 135.36 49.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 t -105.03 87.88 2.74 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.196 1.798 . . . . 0.0 109.624 -168.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -80.52 104.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.85 135.78 41.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.4 t -152.48 -162.7 1.56 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 161.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.47 154.83 41.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.308 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.13 146.61 28.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.08 0.952 . . . . 0.0 109.33 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.52 -82.42 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.105 0.859 . . . . 0.0 111.25 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.73 15.5 0.62 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.105 1.336 . . . . 0.0 111.721 171.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.34 127.49 55.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.543 1.537 . . . . 0.0 108.008 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.18 113.02 25.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.44 132.67 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.99 0.916 . . . . 0.0 109.442 -167.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -115.47 99.3 7.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.18 1.792 . . . . 0.0 106.655 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.08 103.99 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 169.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -96.36 96.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -105.37 121.96 44.98 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.612 1.565 . . . . 0.0 109.434 -171.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -104.23 -75.87 0.61 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.243 0.474 . . . . 0.0 109.852 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.31 139.04 6.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.25 -34.88 1.31 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.031 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.08 -175.37 5.3 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.072 0.949 . . . . 0.0 110.459 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -133.93 177.15 7.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.133 1.773 . . . . 0.0 108.271 165.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.4 143.0 50.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 159.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.72 125.19 50.2 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.173 0.589 . . . . 0.0 109.502 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.46 120.02 32.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.951 1.3 . . . . 0.0 107.646 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -114.4 118.33 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.558 0.617 . . . . 0.0 110.78 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -102.0 136.77 41.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.187 1.395 . . . . 0.0 110.824 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -160.38 156.67 26.53 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.514 1.126 . . . . 0.0 108.081 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -134.78 130.8 36.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 166.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.15 159.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.52 -72.18 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.699 1.6 . . . . 0.0 112.61 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.28 68.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 mttt 174.02 164.77 0.2 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 129.307 3.043 . . . . 0.0 106.057 160.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.32 117.4 33.03 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.23 140.16 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.6 0.76 . . . . 0.0 110.304 -172.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.15 118.8 25.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.182 1.393 . . . . 0.0 107.757 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.1 m -100.46 121.35 41.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 161.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.52 117.46 34.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -118.39 146.51 44.36 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.979 0.809 . . . . 0.0 109.384 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -127.09 170.82 11.95 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.225 1.81 . . . . 0.0 106.545 175.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.83 55.99 3.04 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.472 -0.626 . . . . 0.0 111.765 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t 160.57 -63.51 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.09 2.956 . . . . 0.0 108.414 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.05 143.22 34.21 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.825 0.45 . . . . 0.0 110.362 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.45 136.93 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.4 t -151.46 133.94 15.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.011 0.524 . . . . 0.0 110.679 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 p -85.77 158.46 20.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.229 0.611 . . . . 0.0 110.14 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -134.84 142.8 46.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 153.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 137.43 38.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.152 0.887 . . . . 0.0 108.924 164.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.06 162.54 21.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.093 1.757 . . . . 0.0 109.579 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.17 153.19 51.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 165.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -67.73 121.19 15.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.42 1.488 . . . . 0.0 108.468 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.27 -25.28 39.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.408 0.549 . . . . 0.0 112.041 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.846 0.858 . . . . 0.0 109.183 176.258 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -74.65 60.11 0.89 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.251 1.82 . . . . 0.0 110.154 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 -53.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -164.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.16 -45.62 10.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.529 0.732 . . . . 0.0 111.437 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -47.41 120.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.325 0.65 . . . . 0.0 112.276 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.86 -163.07 12.18 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.778 1.18 . . . . 0.0 112.294 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -84.98 139.95 31.42 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.456 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -119.93 155.18 33.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.778 1.631 . . . . 0.0 108.343 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 137.57 54.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.51 0.724 . . . . 0.0 109.766 163.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.17 147.07 53.88 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.22 0.608 . . . . 0.0 110.289 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.69 42.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.179 0.514 . . . . 0.0 110.935 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.89 153.96 3.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.721 2.009 . . . . 0.0 106.792 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.5 t -159.18 25.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.589 0.756 . . . . 0.0 111.72 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 122.53 16.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.586 1.085 . . . . 0.0 110.048 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 68.11 62.67 0.38 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.097 1.759 . . . . 0.0 110.996 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -83.0 -63.92 1.27 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.35 -0.844 . . . . 0.0 111.486 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.82 -34.52 62.36 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.435 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -36.61 -54.3 0.88 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.754 1.221 . . . . 0.0 110.087 165.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.93 -51.0 65.19 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.407 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -38.41 76.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.634 0.774 . . . . 0.0 111.421 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -73.13 63.25 0.69 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.457 1.903 . . . . 0.0 111.509 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 158.34 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 130.061 3.344 . . . . 0.0 107.368 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.19 -27.13 68.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.665 0.386 . . . . 0.0 111.588 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.43 -53.88 0.61 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.843 1.211 . . . . 0.0 110.309 169.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t 1.23 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 129.001 2.92 . . . . 0.0 115.284 -170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.1 110.47 0.27 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.992 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -65.74 173.27 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.137 0.468 . . . . 0.0 110.261 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.4 -68.99 0.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.134 1.774 . . . . 0.0 111.902 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.4 m -55.77 -54.74 40.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -65.38 -42.49 92.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.047 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.7 -7.92 48.26 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.12 -43.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 118.675 0.67 . . . . 0.0 109.804 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.36 -25.79 67.19 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.07 0.843 . . . . 0.0 112.847 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -66.95 -24.85 66.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.09 0.956 . . . . 0.0 112.239 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.0 tpt -83.97 -39.3 19.89 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.746 -0.596 . . . . 0.0 110.668 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -63.25 -57.43 10.49 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -177.25 88.61 0.25 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.162 0.985 . . . . 0.0 110.463 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -75.25 92.47 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.562 2.175 . . . . 0.0 108.833 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 m -87.94 163.18 16.47 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -142.78 152.33 42.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -130.28 128.47 64.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.8 125.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 165.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 128.21 54.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 169.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.31 75.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -58.81 153.19 17.51 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.5 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -39.56 -52.0 3.05 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.365 0.983 . . . . 0.0 114.257 -167.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -112.0 0.62 16.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.523 1.529 . . . . 0.0 112.008 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -147.6 -171.48 3.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.809 1.186 . . . . 0.0 109.819 -161.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.63 130.69 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 166.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.02 150.25 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 165.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 118.62 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -108.15 131.08 55.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.79 0.836 . . . . 0.0 109.753 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.74 27.3 4.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.213 1.405 . . . . 0.0 111.265 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -49.83 97.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.843 1.657 . . . . 0.0 114.166 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.451 ' H ' ' ND2' ' A' ' 59' ' ' ASN . 3.7 t -138.53 126.9 23.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 128.212 2.605 . . . . 0.0 104.453 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t 55.45 -171.68 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.541 1.937 . . . . 0.0 114.729 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -83.66 18.98 1.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.395 1.478 . . . . 0.0 112.776 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -159.3 115.42 2.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' A' ' 55' ' ' SER . 2.0 t-20 -165.31 -176.73 4.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.271 0.487 . . . . 0.0 110.8 -169.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 p -142.84 171.1 14.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.36 1.464 . . . . 0.0 108.681 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.7 150.22 38.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.4 mt -134.47 164.44 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.806 1.642 . . . . 0.0 106.596 -170.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.8 p -139.19 161.95 36.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.76 167.53 22.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.335 0.654 . . . . 0.0 110.091 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -109.31 131.14 55.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 166.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 84.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 165.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.56 42.33 0.14 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.628 1.585 . . . . 0.0 111.725 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -153.46 152.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.195 0.998 . . . . 0.0 109.066 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -111.95 140.92 46.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.213 1.005 . . . . 0.0 109.891 163.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -161.07 158.32 27.56 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.16 134.43 50.51 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -118.57 129.91 55.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -124.23 98.54 5.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 t -122.94 145.61 48.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.949 0.795 . . . . 0.0 111.012 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.44 48.85 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.399 1.079 . . . . 0.0 111.003 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.0 -83.47 0.05 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.918 1.687 . . . . 0.0 106.929 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -75.77 16.24 0.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 76.25 -147.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.03 1.332 . . . . 0.0 109.505 166.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -101.04 136.81 40.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 m -151.54 175.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.254 1.822 . . . . 0.0 107.257 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -103.24 132.08 49.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 155.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -92.82 109.54 20.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 mt -104.38 103.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.8 139.23 47.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 122.25 0.22 . . . . 0.0 110.759 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -151.87 156.29 39.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.546 1.139 . . . . 0.0 108.362 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.45 145.08 33.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -164.45 -146.76 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.874 1.67 . . . . 0.0 106.708 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.78 48.61 2.99 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.331 0.969 . . . . 0.0 110.864 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.93 27.6 0.2 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.234 0.921 . . . . 0.0 111.663 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 74.76 163.85 0.27 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.647 1.579 . . . . 0.0 111.475 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -79.18 101.53 8.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.86 106.34 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -93.88 95.51 9.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 162.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.77 122.28 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -117.16 99.44 7.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -168.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -119.58 115.11 23.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.513 1.125 . . . . 0.0 111.448 -161.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -96.51 -66.04 0.93 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.333 0.515 . . . . 0.0 109.847 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -169.03 -78.31 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 117.751 0.251 . . . . 0.0 111.649 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.58 -30.19 74.66 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 173.45 11.59 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.25 142.27 30.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.199 1.8 . . . . 0.0 106.277 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.86 148.39 30.68 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.85 0.86 . . . . 0.0 109.565 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 p -104.0 112.75 25.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mt -95.47 92.07 6.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 164.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 126.05 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.16 137.38 48.97 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.754 1.222 . . . . 0.0 110.627 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -161.81 151.52 16.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.957 1.303 . . . . 0.0 107.716 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -107.14 120.53 42.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.766 0.826 . . . . 0.0 109.261 170.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.21 -171.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 163.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.15 -111.15 0.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.02 21.02 3.55 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 126.046 1.784 . . . . 0.0 109.792 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -145.02 147.31 32.48 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.345 1.072 . . . . 0.0 111.112 -166.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tt -102.51 106.73 17.5 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.74 1.216 . . . . 0.0 108.116 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.82 96.17 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.16 106.73 17.48 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -96.42 134.62 39.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.0 tp -131.43 94.1 3.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -117.79 125.04 49.86 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.429 0.692 . . . . 0.0 110.816 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -103.38 -49.38 3.73 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.235 1.014 . . . . 0.0 110.491 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.22 120.57 2.2 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 106.939 -2.465 . . . . 0.0 106.939 -166.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m 65.65 -68.54 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.962 1.305 . . . . 0.0 109.317 -165.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.96 134.27 45.86 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -146.83 138.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 106.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.73 136.98 31.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.624 0.77 . . . . 0.0 110.125 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 149.42 22.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 164.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -140.42 73.39 1.42 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 161.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.22 123.2 14.49 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.625 -0.672 . . . . 0.0 109.522 171.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -109.63 157.11 19.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.044 1.738 . . . . 0.0 109.38 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.38 118.82 24.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -85.4 104.38 15.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 110.536 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -77.35 -20.2 55.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.479 1.036 . . . . 0.0 111.516 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 124.305 1.042 . . . . 0.0 110.124 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.237 0.412 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 64.01 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.872 2.469 . . . . 0.0 110.398 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.13 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.282 1.433 . . . . 0.0 107.147 -155.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.99 -46.51 8.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.891 1.276 . . . . 0.0 110.733 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.4 t -48.99 97.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.893 1.677 . . . . 0.0 112.526 -172.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.31 -161.74 27.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.131 0.872 . . . . 0.0 111.318 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -96.89 128.06 43.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.66 0.784 . . . . 0.0 109.99 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -98.83 132.74 43.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -110.2 125.69 53.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.897 0.771 . . . . 0.0 109.324 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.51 148.54 48.14 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.754 0.422 . . . . 0.0 110.131 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.251 4.6 p -137.8 -68.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.011 171.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' OD2' ' NZ ' ' A' ' 112' ' ' LYS . 27.4 m-20 -103.93 123.45 47.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.052 0.842 . . . . 0.0 110.313 -169.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -167.82 148.76 5.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.088 0.555 . . . . 0.0 109.937 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -163.91 174.25 11.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.814 1.245 . . . . 0.0 109.165 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.32 38.1 4.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.744 1.618 . . . . 0.0 111.642 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.75 -40.46 5.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.011 0.925 . . . . 0.0 108.601 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -23.97 -77.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.212 1.805 . . . . 0.0 111.88 147.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.55 -44.49 56.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.297 1.439 . . . . 0.0 112.167 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -55.5 -55.53 30.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.318 0.647 . . . . 0.0 111.107 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 tpt -52.92 -47.02 68.29 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.809 0.844 . . . . 0.0 109.44 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -67.86 62.0 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.627 1.571 . . . . 0.0 110.444 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m 160.65 -57.32 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 129.564 3.145 . . . . 0.0 106.833 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.17 -26.14 33.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -167.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.83 91.29 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.055 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -121.76 -58.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.799 1.239 . . . . 0.0 108.844 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.41 -162.54 7.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.3 t80 118.21 130.65 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.531 3.132 . . . . 0.0 107.328 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 62.0 8.2 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 -164.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 p -95.6 -62.49 1.29 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.411 1.484 . . . . 0.0 109.65 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -53.62 -52.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.642 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -60.39 -23.74 64.57 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.383 1.473 . . . . 0.0 113.179 -169.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.02 -52.46 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.69 26.96 1.93 Allowed Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.983 -0.898 . . . . 0.0 114.471 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -141.23 21.51 2.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.468 1.507 . . . . 0.0 109.562 164.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.3 ttm -143.24 -54.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -166.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -92.83 176.4 6.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 156.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.55 82.87 16.24 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.07 156.29 67.0 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.089 1.859 . . . . 0.0 110.36 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -110.8 158.34 18.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.736 0.814 . . . . 0.0 108.935 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 m -138.1 126.87 23.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mm -85.52 126.74 40.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.03 112.85 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.18 134.74 54.59 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.89 0.876 . . . . 0.0 109.945 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.13 79.69 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.856 0.836 . . . . 0.0 109.407 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -54.3 154.76 4.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.605 167.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.54 -75.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.465 2.459 . . . . 0.0 115.956 -168.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.79 10.34 19.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.826 1.65 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -168.27 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.966 2.106 . . . . 0.0 107.644 -151.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.67 147.23 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 161.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -122.14 136.15 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 123.387 0.675 . . . . 0.0 109.253 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mt -112.57 138.57 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.267 1.427 . . . . 0.0 108.051 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -135.48 117.95 15.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.473 2.309 . . . . 0.0 108.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -91.07 100.96 13.72 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.842 1.201 . . . . 0.0 112.596 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 72.12 10.2 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.581 -1.325 . . . . 0.0 108.671 169.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -88.65 -178.56 5.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 153.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -103.41 37.67 1.95 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.046 0.938 . . . . 0.0 111.553 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.07 82.63 0.86 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -102.53 102.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 156.26 46.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.674 1.99 . . . . 0.0 106.316 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -152.77 144.6 23.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 129.88 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 p -99.31 127.42 45.32 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.023 2.129 . . . . 0.0 109.214 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.09 156.62 46.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.128 0.876 . . . . 0.0 111.901 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.45 115.74 31.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.92 71.19 0.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.473 0.709 . . . . 0.0 111.363 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.26 38.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.635 1.112 . . . . 0.0 111.847 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 t -152.05 154.8 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.566 1.183 . . . . 0.0 109.199 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -106.83 123.57 48.35 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.739 2.016 . . . . 0.0 108.616 166.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -165.36 164.74 19.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.097 0.959 . . . . 0.0 109.924 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.77 144.13 55.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.916 0.78 . . . . 0.0 111.56 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -132.64 72.11 1.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.405 2.282 . . . . 0.0 107.166 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.8 m -71.25 108.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.437 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.1 t -140.57 144.67 35.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.138 0.575 . . . . 0.0 110.679 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.5 57.59 2.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.045 1.338 . . . . 0.0 111.948 -167.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.48 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.755 1.622 . . . . 0.0 108.512 -170.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -73.79 -15.94 61.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.71 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 90.9 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.587 2.755 . . . . 0.0 109.334 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -78.86 59.11 2.51 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.626 -0.672 . . . . 0.0 109.274 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.83 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.399 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -111.17 126.24 54.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.715 0.689 . . . . 0.0 109.655 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 p -78.26 108.49 11.63 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -102.14 110.22 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 155.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.06 145.37 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.9 t -155.38 -165.76 2.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.2 1.8 . . . . 0.0 107.112 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.82 145.12 39.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.2 0.27 46.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -166.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.92 -39.18 2.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -160.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.92 -63.11 0.09 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.7 1.143 . . . . 0.0 111.126 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 142.54 38.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -169.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.1 tt -79.85 114.7 18.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.88 105.08 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.62 1.168 . . . . 0.0 108.241 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.34 107.81 19.75 Favored 'General case' 0 CA--C 1.524 -0.054 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.43 101.93 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 167.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -89.92 102.42 15.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.752 1.221 . . . . 0.0 107.782 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -116.85 127.34 54.2 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.126 0.57 . . . . 0.0 110.987 -165.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -97.72 -107.15 0.18 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.48 136.14 29.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.679 1.592 . . . . 0.0 108.642 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.8 -45.68 3.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.65 177.41 8.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.585 0.692 . . . . 0.0 111.552 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.01 176.79 11.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.532 1.933 . . . . 0.0 108.69 -172.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -132.7 138.42 47.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.954 1.301 . . . . 0.0 109.868 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.6 p -76.22 136.64 39.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 168.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.69 76.87 1.69 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 164.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.31 120.97 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.0 133.15 56.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.1 1.76 . . . . 0.0 109.868 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.33 146.66 29.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.704 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -124.55 107.28 10.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.288 1.435 . . . . 0.0 108.926 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.99 179.95 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 168.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.36 -98.32 0.08 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 0.0 109.664 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.16 32.79 0.5 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.458 1.028 . . . . 0.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 23.3 mttt -150.73 159.13 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.25 122.31 47.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.85 118.86 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.31 116.4 29.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 m -96.19 124.35 40.16 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.24 93.28 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.68 1.192 . . . . 0.0 108.276 -171.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -143.47 153.42 42.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 0.0 111.354 -165.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.69 138.6 9.64 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 122.738 0.415 . . . . 0.0 110.96 166.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 47.95 -119.01 4.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.857 0.741 . . . . 0.0 111.428 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -73.72 -30.96 63.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.019 0.528 . . . . 0.0 112.193 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 126.3 42.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.365 0.53 . . . . 0.0 109.861 -166.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.69 144.17 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.025 0 C-N-CA 125.602 1.561 . . . . 0.0 109.168 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.25 151.42 32.96 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.6 -1.313 . . . . 0.0 110.826 172.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.5 p -114.89 142.44 46.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.937 1.695 . . . . 0.0 107.384 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -139.73 82.21 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.83 142.16 31.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.774 0.797 . . . . 0.0 109.707 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -119.88 169.0 10.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.711 1.604 . . . . 0.0 108.509 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -116.45 117.45 29.94 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 163.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -75.69 108.67 8.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -78.95 -31.51 45.12 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 118.352 0.524 . . . . 0.0 111.672 -170.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.485 0.179 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.68 59.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.758 3.223 . . . . 0.0 111.959 -168.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.98 -50.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.284 1.834 . . . . 0.0 107.26 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.86 -40.49 87.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.813 1.245 . . . . 0.0 110.639 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.25 116.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.123 1.369 . . . . 0.0 111.259 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -129.56 4.28 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.834 1.207 . . . . 0.0 111.199 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 m -148.67 121.9 8.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.77 -0.841 . . . . 0.0 109.837 -171.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -115.15 130.09 56.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.761 1.624 . . . . 0.0 110.484 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -114.0 141.8 46.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.883 0.873 . . . . 0.0 109.483 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.8 144.01 29.13 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 123.399 0.437 . . . . 0.0 110.199 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 -73.99 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.513 0.725 . . . . 0.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -108.92 149.58 28.97 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.368 0.985 . . . . 0.0 110.102 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 t -170.89 -175.58 1.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.054 1.742 . . . . 0.0 107.805 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 pttt 177.14 154.16 0.25 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.366 2.666 . . . . 0.0 107.336 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.04 34.08 21.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.675 0.79 . . . . 0.0 109.743 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -95.76 -50.68 4.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -21.45 -74.98 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.719 2.408 . . . . 0.0 113.433 148.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.14 -57.55 8.44 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.988 0.813 . . . . 0.0 111.03 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.59 -48.16 19.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.331 0.586 . . . . 0.0 112.178 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -28.06 69.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -74.97 47.07 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.52 1.928 . . . . 0.0 110.514 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.1 t -174.89 -51.86 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.939 1.695 . . . . 0.0 106.887 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.58 -35.71 80.38 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.974 0.51 . . . . 0.0 111.073 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.32 -45.71 1.28 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -37.61 -26.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.508 2.323 . . . . 0.0 114.327 171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -27.75 -68.64 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.807 1.67 . . . . 0.0 112.96 159.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.58 155.83 38.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.959 0.38 . . . . 0.0 110.111 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 71.89 -52.07 0.69 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.969 1.708 . . . . 0.0 113.786 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.6 m -105.25 -67.37 0.92 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.424 1.089 . . . . 0.0 110.647 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -68.38 -17.42 64.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.282 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -41.22 -49.7 3.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.651 0.78 . . . . 0.0 111.972 163.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -94.33 -38.93 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.09 -40.79 59.56 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.075 0.845 . . . . 0.0 113.165 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -79.31 -12.42 59.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.273 1.037 . . . . 0.0 112.381 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -61.5 1.44 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.253 3.8 t -83.74 79.29 9.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.627 0.727 . . . . 0.0 109.656 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt 12.85 76.44 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 128.766 2.826 . . . . 0.0 113.91 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.25 150.17 76.38 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.998 2.465 . . . . 0.0 113.229 -161.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 m -102.53 159.1 15.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.055 1.742 . . . . 0.0 108.75 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 119.35 12.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -87.49 126.71 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.92 114.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.06 140.33 53.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.337 0.517 . . . . 0.0 110.302 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 79.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -62.42 74.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.597 1.559 . . . . 0.0 112.11 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.34 -92.73 0.06 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.486 1.041 . . . . 0.0 111.749 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.37 -30.09 19.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.409 1.083 . . . . 0.0 110.745 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.05 -175.54 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.493 2.317 . . . . 0.0 109.161 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.13 138.04 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -114.94 131.48 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.509 1.123 . . . . 0.0 108.732 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -120.68 120.45 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.718 2.407 . . . . 0.0 106.346 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -128.88 99.92 5.49 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 t -82.41 43.21 0.8 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.778 -172.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 124.03 18.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.959 1.704 . . . . 0.0 112.669 -175.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -123.8 -166.54 1.5 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 162.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -46.9 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.941 0.896 . . . . 0.0 111.459 -166.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.1 p90 38.66 34.29 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.081 2.152 . . . . 0.0 114.464 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -156.26 162.87 40.09 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.663 0.665 . . . . 0.0 110.634 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 96.71 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 129.547 3.139 . . . . 0.0 110.491 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 p -110.43 174.54 5.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.481 1.512 . . . . 0.0 112.385 -156.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.98 122.17 37.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.593 2.357 . . . . 0.0 106.583 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -129.38 136.73 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 p -141.48 122.23 14.36 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 119.183 0.901 . . . . 0.0 110.316 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -147.54 165.86 29.05 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.095 0.861 . . . . 0.0 111.915 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -101.1 138.34 38.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 166.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.0 59.06 0.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.113 0.565 . . . . 0.0 110.506 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 157.31 60.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -166.85 172.55 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.855 0.828 . . . . 0.0 109.041 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -131.35 152.07 50.94 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.859 0.864 . . . . 0.0 110.793 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.92 160.17 14.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 109.478 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.74 129.03 36.42 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -123.93 123.71 41.02 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -116.1 95.53 5.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 t -113.01 140.63 47.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.065 0.946 . . . . 0.0 109.899 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.71 48.54 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.481 1.112 . . . . 0.0 112.217 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -163.42 -62.45 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.729 1.612 . . . . 0.0 109.392 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -87.12 -3.64 59.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.75 0.82 . . . . 0.0 111.631 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 83.33 -157.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.837 1.655 . . . . 0.0 109.696 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -74.62 116.34 15.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 168.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.63 154.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -81.29 138.18 35.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 150.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -100.6 119.74 39.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 161.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tt -121.02 123.36 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.02 144.68 32.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.562 0.345 . . . . 0.0 110.944 -167.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -157.54 144.15 17.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.55 1.14 . . . . 0.0 109.317 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -85.15 109.11 18.05 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 90' ' ' LYS . 26.7 p-10 -78.58 29.2 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.325 0.65 . . . . 0.0 112.625 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.4 -36.47 1.56 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.597 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 -24.94 5.91 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.097 1.449 . . . . 0.0 113.087 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -163.3 159.97 23.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.733 1.267 . . . . 0.0 109.855 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 100.3 8.03 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.16 118.33 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -114.97 108.38 16.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.41 132.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -129.68 99.67 5.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -161.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HZ1' ' CD ' ' A' ' 101' ' ' GLU . 39.1 tttp -113.89 110.63 20.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.941 0.896 . . . . 0.0 111.648 -159.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -96.56 -27.31 14.9 Favored 'General case' 0 C--O 1.228 -0.048 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -155.68 -143.79 0.13 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.683 0.674 . . . . 0.0 109.897 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -42.74 -41.18 4.27 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.205 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -97.03 175.35 6.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 112.283 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.465 ' CD ' ' HZ1' ' A' ' 96' ' ' LYS . 2.3 pm0 -143.71 167.11 23.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.988 2.115 . . . . 0.0 108.301 173.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -98.59 148.14 24.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 148.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -119.31 137.11 53.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.94 138.13 19.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.207 0.458 . . . . 0.0 111.138 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.7 m -130.69 117.3 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.663 1.185 . . . . 0.0 110.203 -164.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -102.77 139.64 38.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.873 0.76 . . . . 0.0 109.573 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.71 155.63 36.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 153.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 19.8 ttt -91.83 119.36 31.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.857 0.863 . . . . 0.0 108.994 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.46 170.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 166.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.73 -85.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.627 1.171 . . . . 0.0 109.616 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.3 26.19 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.04 1.305 . . . . 0.0 110.467 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.48 154.54 47.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.89 117.42 16.71 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.95 120.77 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 168.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.93 104.81 9.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.8 m -94.25 131.93 39.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.93 130.37 53.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 t -141.19 131.99 25.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.546 0.689 . . . . 0.0 110.211 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -119.51 165.37 14.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.169 2.587 . . . . 0.0 105.838 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.78 65.09 1.47 Allowed Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.092 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t 156.45 -59.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 130.105 3.362 . . . . 0.0 108.432 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.15 137.24 35.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.197 0.599 . . . . 0.0 109.931 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.12 134.02 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 127.53 7.32 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.197 0.908 . . . . 0.0 112.98 -176.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.6 p -78.48 153.57 31.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.958 0.903 . . . . 0.0 109.072 168.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.69 140.13 19.64 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.2 p -133.36 160.34 37.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.945 0.793 . . . . 0.0 109.363 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -145.37 144.99 31.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.576 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -128.39 134.2 48.78 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -79.68 111.81 16.34 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.26 -39.08 82.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.71 -45.06 6.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.386 2.274 . . . . 0.0 111.731 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.87 -21.6 8.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.581 1.952 . . . . 0.0 112.511 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -120.22 17.65 12.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.915 1.286 . . . . 0.0 111.314 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -99.56 94.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.539 0.736 . . . . 0.0 110.954 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.66 -165.92 23.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.824 0.726 . . . . 0.0 113.486 159.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -83.64 143.05 30.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.503 0.721 . . . . 0.0 110.125 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -133.26 141.41 48.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.963 1.305 . . . . 0.0 108.513 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 133.01 36.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 165.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.11 144.56 56.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 166.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 -57.69 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.492 0.717 . . . . 0.0 111.483 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -78.98 160.08 27.37 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.815 1.189 . . . . 0.0 109.605 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -170.42 56.72 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.779 1.632 . . . . 0.0 108.302 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.38 127.18 35.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 66.97 27.92 8.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.995 1.718 . . . . 0.0 109.876 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.6 -51.34 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 120.033 -1.667 . . . . 0.0 108.089 -171.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -17.9 -77.39 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.835 2.054 . . . . 0.0 112.485 144.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -37.12 -57.45 0.85 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 111.12 175.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' SG ' ' A' ' 124' ' ' CYS . 0.8 OUTLIER -50.9 -50.18 57.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -166.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.72 81.43 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.528 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -77.08 49.52 0.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.535 1.934 . . . . 0.0 109.185 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -178.98 -55.99 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.368 1.867 . . . . 0.0 106.955 -168.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.69 -41.9 95.7 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.92 -44.16 0.87 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.5 42.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.979 1.312 . . . . 0.0 111.327 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.3 146.06 17.97 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.871 1.224 . . . . 0.0 112.406 -166.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.1 162.2 1.98 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.014 1.726 . . . . 0.0 107.175 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -18.73 65.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -47.9 -40.01 20.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 112.432 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -31.53 63.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.759 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -62.42 -23.94 67.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.117 0.871 . . . . 0.0 111.729 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.3 t -91.1 -47.94 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.79 -58.75 3.49 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.137 1.351 . . . . 0.0 112.884 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -55.66 -41.94 74.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.774 0.787 . . . . 0.0 110.913 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.359 1.064 . . . . 0.0 112.205 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -86.13 -132.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -145.61 76.53 12.91 Favored Pre-proline 0 C--O 1.234 0.274 0 O-C-N 121.086 -1.009 . . . . 0.0 109.085 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 82.7 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.344 2.696 . . . . 0.0 108.761 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -83.03 148.21 27.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.299 1.84 . . . . 0.0 107.902 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m -140.58 122.31 15.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.183 -0.323 . . . . 0.0 110.282 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -77.77 127.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mt -124.29 117.76 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.29 129.6 49.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.79 96.94 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -78.18 69.82 4.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.37 -89.25 0.05 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.759 1.171 . . . . 0.0 111.531 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -24.67 16.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.52 . . . . 0.0 110.747 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.48 9.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.165 1.786 . . . . 0.0 106.866 -172.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.98 141.7 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.96 133.31 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.762 0.825 . . . . 0.0 108.899 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.9 tt -110.35 132.32 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.754 1.222 . . . . 0.0 107.713 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -133.95 95.96 3.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 107.328 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.71 138.48 31.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -132.77 116.38 16.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.841 1.656 . . . . 0.0 110.903 -162.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -161.56 151.27 16.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.784 2.034 . . . . 0.0 106.314 161.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -56.73 -49.38 75.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.416 0.687 . . . . 0.0 109.502 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -48.87 -38.16 21.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.704 1.201 . . . . 0.0 112.755 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.59 136.27 0.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.922 0.889 . . . . 0.0 109.848 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -141.87 151.07 42.35 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.654 1.582 . . . . 0.0 108.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p -156.34 148.18 22.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.46 0.704 . . . . 0.0 109.351 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -128.04 117.79 22.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.071 2.149 . . . . 0.0 108.284 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.96 143.3 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.692 0.797 . . . . 0.0 109.287 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 p -108.19 150.06 27.74 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.472 1.509 . . . . 0.0 110.814 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -159.61 175.58 13.05 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.909 1.283 . . . . 0.0 108.91 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -134.79 143.64 47.2 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.999 0.92 . . . . 0.0 108.943 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 53.05 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.302 1.041 . . . . 0.0 112.027 -175.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.12 40.13 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.24 151.18 12.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.1 138.88 35.57 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.926 1.291 . . . . 0.0 109.469 166.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -142.19 158.35 43.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.381 1.472 . . . . 0.0 108.177 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.27 134.55 36.64 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -134.37 151.67 51.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -139.82 166.87 23.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.955 -0.466 . . . . 0.0 109.833 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 t -136.85 -177.27 4.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.162 0.985 . . . . 0.0 109.371 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.78 -25.02 62.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -156.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -95.22 15.02 20.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.233 1.413 . . . . 0.0 111.633 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t0 49.76 41.02 21.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.359 2.264 . . . . 0.0 112.969 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -66.76 87.44 0.13 Allowed 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -77.87 92.86 4.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.607 1.563 . . . . 0.0 109.464 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.41 171.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.778 1.231 . . . . 0.0 110.079 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.64 135.85 41.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 m -124.57 123.73 40.72 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 107.857 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.93 126.21 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -110.24 145.32 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.6 m -148.7 164.32 34.69 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -113.39 113.44 25.21 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.83 107.98 20.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.833 1.253 . . . . 0.0 108.012 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.35 -80.94 0.06 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.318 0.961 . . . . 0.0 112.106 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.67 4.18 3.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.495 1.521 . . . . 0.0 112.344 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -105.17 120.99 42.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 107.203 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.87 106.17 10.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 m -95.32 111.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -99.4 106.76 18.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.65 133.73 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.9 112.31 12.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -162.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -127.98 125.82 40.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.375 1.87 . . . . 0.0 108.688 -157.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -108.86 -81.55 0.57 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -162.19 150.76 15.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.96 -44.47 1.55 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.419 0.533 . . . . 0.0 112.044 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.58 -164.91 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.554 1.542 . . . . 0.0 109.196 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.77 -170.36 3.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.613 1.565 . . . . 0.0 109.334 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 t -136.14 150.72 49.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.623 1.569 . . . . 0.0 107.991 162.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.4 p -98.56 138.47 35.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 163.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.1 mt -131.64 96.83 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.401 1.88 . . . . 0.0 105.939 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.71 131.83 42.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.07 124.84 53.09 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.199 1.4 . . . . 0.0 108.27 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -141.91 122.42 14.13 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -106.74 115.89 30.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.09 -173.3 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 156.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 52.08 -108.91 0.42 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.48 28.76 2.05 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.859 1.695 . . . . 0.0 109.615 171.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -137.45 122.09 18.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.674 0.737 . . . . 0.0 110.128 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.24 92.73 5.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.8 mt -73.1 138.53 21.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.57 105.09 4.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.098 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.0 m -95.33 136.0 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.81 119.9 38.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -126.28 125.2 41.95 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.942 0.337 . . . . 0.0 110.309 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -129.5 165.01 22.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.54 1.536 . . . . 0.0 107.095 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.33 126.07 18.37 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 168.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.99 -58.84 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 112.146 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.78 133.15 34.34 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.694 -0.629 . . . . 0.0 111.862 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.21 130.3 69.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.773 1.629 . . . . 0.0 107.26 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' TYR . 4.4 m -146.99 158.76 44.02 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 121.379 -0.826 . . . . 0.0 109.174 -170.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.7 p -134.35 151.81 51.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.101 0.409 . . . . 0.0 110.738 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -145.2 167.26 23.21 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 156.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 p -136.47 146.43 46.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.22 129.68 52.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.551 1.54 . . . . 0.0 108.779 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -106.18 136.79 45.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.907 1.283 . . . . 0.0 108.422 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -65.25 139.0 58.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.358 0.263 . . . . 0.0 110.728 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -123.81 -6.0 7.99 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 111.722 159.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.144 0 C-N-CA 124.616 1.167 . . . . 0.0 110.922 172.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.236 0.378 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.41 67.9 0.02 OUTLIER 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.53 2.332 . . . . 0.0 111.091 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.37 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 107.09 -163.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -86.71 -45.67 10.75 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.914 1.286 . . . . 0.0 110.69 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -46.11 108.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.385 1.474 . . . . 0.0 111.645 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.83 -166.46 13.02 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.416 1.008 . . . . 0.0 112.37 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -84.2 138.84 32.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.131 0.973 . . . . 0.0 111.324 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.6 141.17 43.27 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.474 0.709 . . . . 0.0 110.314 167.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -107.87 153.84 22.43 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.463 1.105 . . . . 0.0 109.867 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.96 148.64 16.87 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 167.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.41 -54.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.867 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.49 147.24 39.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.631 1.105 . . . . 0.0 109.01 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -160.47 153.86 22.06 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.234 -0.916 . . . . 0.0 110.73 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -158.13 155.88 29.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.499 1.12 . . . . 0.0 108.541 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 m120 63.71 -10.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.36 -41.52 9.08 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.264 1.025 . . . . 0.0 110.869 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -71.76 -24.78 61.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.19 -46.44 56.26 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 165.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.88 -51.36 61.4 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.972 0.909 . . . . 0.0 112.327 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -57.68 -42.65 84.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.294 0.638 . . . . 0.0 109.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.94 57.71 1.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.448 1.499 . . . . 0.0 109.22 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t 179.63 -52.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.712 2.405 . . . . 0.0 107.028 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.27 -27.6 68.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.679 0.392 . . . . 0.0 111.575 172.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 -47.14 3.69 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p 0.28 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 130.324 3.45 . . . . 0.0 116.074 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.05 58.24 0.38 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -31.56 -61.42 0.22 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 128.003 2.521 . . . . 0.0 111.484 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.21 57.94 1.29 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.318 1.047 . . . . 0.0 108.202 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -149.67 -52.54 0.15 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.859 -0.526 . . . . 0.0 109.802 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -59.23 -22.99 61.93 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.453 -1.261 . . . . 0.0 110.863 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -41.57 -35.52 0.75 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.218 1.007 . . . . 0.0 112.696 169.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.82 -67.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.05 45.21 2.23 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.443 1.02 . . . . 0.0 113.817 -173.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -154.03 -34.61 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.958 1.703 . . . . 0.0 110.886 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.2 ttm -92.22 -21.12 20.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.89 1.676 . . . . 0.0 110.307 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -65.71 -165.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.409 0.623 . . . . 0.0 109.995 159.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -107.37 78.97 0.7 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.597 1.159 . . . . 0.0 109.411 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.65 145.11 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.113 1.875 . . . . 0.0 110.344 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 m -104.26 126.18 51.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.505 1.122 . . . . 0.0 108.039 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -109.19 99.42 8.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.34 121.22 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.16 128.6 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -107.1 141.56 38.15 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.04 71.39 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.151 0.98 . . . . 0.0 108.695 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -55.05 139.69 40.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.882 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.46 -75.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.9 2.191 . . . . 0.0 116.457 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -111.18 18.45 19.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.519 1.928 . . . . 0.0 111.03 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.26 -162.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.954 1.301 . . . . 0.0 108.253 -155.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.89 142.74 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.8 tt -124.98 117.68 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.67 135.79 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -115.3 107.55 15.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.944 2.098 . . . . 0.0 105.746 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -88.25 102.64 15.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.59 138.48 43.74 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.034 0.834 . . . . 0.0 111.008 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -169.81 54.86 0.04 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.196 1.398 . . . . 0.0 108.748 -173.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 m 65.71 -75.13 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.653 1.581 . . . . 0.0 111.637 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.33 -51.79 4.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.062 0.945 . . . . 0.0 109.2 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -77.07 76.9 3.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.58 59.84 0.61 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.575 1.15 . . . . 0.0 110.537 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.14 163.62 18.64 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.936 1.294 . . . . 0.0 111.123 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -123.58 156.62 35.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.908 0.883 . . . . 0.0 110.067 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mp -133.53 101.16 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.6 122.6 36.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.811 2.044 . . . . 0.0 108.926 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.58 168.81 22.49 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.097 0.862 . . . . 0.0 112.61 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.58 108.79 13.53 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.539 1.535 . . . . 0.0 107.812 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 96.78 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 122.051 -0.406 . . . . 0.0 110.017 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.14 33.3 0.2 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.365 1.936 . . . . 0.0 111.832 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.72 149.39 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.835 1.317 . . . . 0.0 109.32 -171.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.85 121.95 44.74 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.268 1.427 . . . . 0.0 107.612 161.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.37 155.02 23.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.821 0.737 . . . . 0.0 111.366 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.88 120.11 13.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.203 0.601 . . . . 0.0 110.237 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.76 95.43 5.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 m -103.77 102.6 12.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 t -131.28 146.79 52.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.013 0.925 . . . . 0.0 109.405 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.2 43.92 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.588 1.155 . . . . 0.0 112.066 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -149.98 -68.39 0.2 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.771 1.628 . . . . 0.0 108.264 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.99 -12.79 61.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.242 0.928 . . . . 0.0 111.525 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.12 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.256 2.222 . . . . 0.0 108.566 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -80.91 112.37 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 166.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.52 138.21 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -80.41 109.54 15.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.9 p -74.57 149.64 40.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 tt -137.36 107.75 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 163.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.18 139.92 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.184 -170.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -156.99 176.96 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.731 2.013 . . . . 0.0 107.206 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -132.17 122.08 24.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 159.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 176.11 167.51 0.43 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.109 2.564 . . . . 0.0 105.32 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.44 -64.56 1.06 Allowed Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.49 104.93 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 91.83 162.3 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.706 2.402 . . . . 0.0 110.05 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 121.09 26.28 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.24 86.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.992 1.717 . . . . 0.0 108.484 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -81.57 81.13 7.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.5 149.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -153.34 106.17 2.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -158.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -116.13 100.98 8.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.062 2.145 . . . . 0.0 108.121 -160.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -90.61 -62.36 1.47 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.592 1.087 . . . . 0.0 110.48 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -170.13 -85.27 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.157 0.435 . . . . 0.0 111.465 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.82 -20.81 79.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.44 170.02 16.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -133.22 175.48 9.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.945 1.698 . . . . 0.0 107.429 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.3 t -143.02 160.88 39.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.174 0.99 . . . . 0.0 109.218 168.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -127.53 116.8 20.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 108.126 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.32 105.7 15.2 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.194 0.998 . . . . 0.0 108.536 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.46 114.82 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.268 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -109.75 139.62 44.58 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.97 0.908 . . . . 0.0 109.075 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -161.28 151.09 17.0 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.087 0.403 . . . . 0.0 110.907 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -113.57 107.59 16.0 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.008 0.923 . . . . 0.0 109.756 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.28 -176.97 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 159.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.0 t70 52.21 -113.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -148.29 34.41 1.19 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.559 1.076 . . . . 0.0 110.777 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -144.47 148.45 34.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.39 98.04 10.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.5 128.21 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -131.51 122.85 26.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -119.48 132.28 55.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.3 123.33 45.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.7 m -124.73 132.98 53.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.053 1.341 . . . . 0.0 109.411 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.31 170.02 16.79 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.451 0.569 . . . . 0.0 110.565 169.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -45.31 106.82 0.13 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 60.04 45.48 11.96 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.959 1.304 . . . . 0.0 112.556 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -173.01 140.87 0.93 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 144.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.6 144.16 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.542 1.937 . . . . 0.0 106.67 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -149.85 126.44 10.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.186 0.448 . . . . 0.0 111.172 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -76.49 138.06 40.04 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.868 1.267 . . . . 0.0 108.311 163.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -150.75 100.84 2.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 161.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.3 m -97.0 138.44 34.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.889 0.852 . . . . 0.0 109.421 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -114.87 171.2 7.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.063 1.745 . . . . 0.0 108.976 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.02 142.07 47.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.109 1.763 . . . . 0.0 106.257 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -101.23 121.38 41.75 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.129 0.572 . . . . 0.0 110.577 -167.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -126.43 61.77 1.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.275 1.43 . . . . 0.0 109.366 -172.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 C-N-CA 123.696 0.799 . . . . 0.0 109.123 168.453 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.52 -37.6 50.08 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.571 1.948 . . . . 0.0 111.492 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.96 -16.5 63.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.392 1.877 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -119.04 -54.01 2.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.739 1.216 . . . . 0.0 110.426 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -52.56 109.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.6 1.16 . . . . 0.0 111.36 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.85 -177.21 31.46 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 123.849 0.737 . . . . 0.0 112.617 167.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -91.02 129.84 36.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.651 1.58 . . . . 0.0 108.991 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.402 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 36.6 m95 -126.59 142.18 51.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 109.536 -177.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -110.23 140.77 44.02 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.215 1.006 . . . . 0.0 109.551 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.4 tt -70.78 117.74 12.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 p -141.73 53.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 122.245 1.021 . . . . 0.0 108.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t0 163.59 156.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 130.347 3.459 . . . . 0.0 106.039 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 t 164.46 135.71 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.541 2.736 . . . . 0.0 108.138 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -106.38 159.07 16.42 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.05 48.19 8.84 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.584 0.707 . . . . 0.0 111.949 161.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -56.53 18.34 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.787 0.803 . . . . 0.0 109.718 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.63 -23.38 31.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.847 -166.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -44.25 -60.64 1.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.854 0.835 . . . . 0.0 109.688 161.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.51 -50.68 67.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.663 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.2 ttp -49.38 -47.16 47.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.353 1.061 . . . . 0.0 111.04 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -73.74 56.0 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.467 1.107 . . . . 0.0 111.201 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 m 175.17 -54.71 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.296 2.238 . . . . 0.0 107.374 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -38.92 91.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.621 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.18 86.96 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.91 -34.35 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 117.163 0.481 . . . . 0.0 110.979 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.16 102.36 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -48.95 -59.45 3.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.306 1.042 . . . . 0.0 110.512 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -55.75 19.98 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.236 0.541 . . . . 0.0 109.834 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -47.67 14.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.16 1.784 . . . . 0.0 112.874 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -61.08 -32.08 71.74 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.046 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.18 -55.79 19.29 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.149 0.886 . . . . 0.0 109.204 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.07 -46.83 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.08 45.27 1.4 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.259 1.409 . . . . 0.0 113.557 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -158.07 -41.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.419 1.887 . . . . 0.0 108.838 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -34.96 75.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.642 167.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.6 t -69.88 22.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 35.13 64.66 1.88 Allowed Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.2 1.8 . . . . 0.0 112.692 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.84 156.97 50.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.082 2.522 . . . . 0.0 112.706 -166.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.1 p -119.33 161.27 20.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 109.42 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -149.35 155.45 40.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.8 147.47 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 160.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.59 121.25 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -137.05 110.85 8.14 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.593 0.633 . . . . 0.0 109.765 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 95.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.345 1.058 . . . . 0.0 108.353 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -77.35 61.09 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.649 1.179 . . . . 0.0 108.691 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.16 -86.0 0.1 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.742 -0.599 . . . . 0.0 111.766 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -83.31 -43.46 15.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.136 0.969 . . . . 0.0 109.239 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.93 162.07 17.1 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.955 1.702 . . . . 0.0 109.554 -172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.39 118.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 103.568 -2.752 . . . . 0.0 103.568 169.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.1 tt -93.42 136.46 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.18 149.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 141.02 38.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.076 0.853 . . . . 0.0 110.721 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -103.46 44.52 1.01 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.851 1.26 . . . . 0.0 110.82 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.13 116.97 3.09 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.529 1.131 . . . . 0.0 113.409 -157.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 t -102.89 -172.43 2.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.653 1.181 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -28.8 61.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.311 1.444 . . . . 0.0 112.322 -167.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.28 51.84 2.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 109.555 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.8 tttt 68.76 173.41 0.29 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.972 0.909 . . . . 0.0 109.087 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -152.41 -173.92 4.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 164.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.4 p -64.99 164.75 12.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.735 0.778 . . . . 0.0 111.536 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.69 136.15 54.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 165.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.3 mt -132.2 146.62 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.01 2.524 . . . . 0.0 106.232 -161.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -146.48 91.27 2.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.716 1.144 . . . . 0.0 111.617 -161.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -118.12 161.89 19.11 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 110.149 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 130.18 52.32 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.51 60.49 3.9 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.743 0.817 . . . . 0.0 112.286 -162.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.07 49.28 0.05 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -171.68 160.9 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.974 . . . . 0.0 110.082 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.92 147.87 36.18 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.356 1.062 . . . . 0.0 109.798 162.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.74 161.36 15.51 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.93 133.31 44.3 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -124.32 128.97 49.91 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.1 m -124.74 108.17 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -132.5 137.44 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.413 1.085 . . . . 0.0 109.897 -172.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.78 39.96 0.23 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.275 -0.891 . . . . 0.0 113.043 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -145.88 -54.37 0.27 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.855 1.662 . . . . 0.0 108.191 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.87 1.99 44.6 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -150.08 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.556 1.542 . . . . 0.0 111.089 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -99.07 118.85 36.75 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.097 1.759 . . . . 0.0 108.156 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.98 144.98 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -173.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -70.79 127.7 33.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 153.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -108.28 99.81 9.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.244 1.418 . . . . 0.0 107.275 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.17 103.82 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.998 1.319 . . . . 0.0 107.93 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.88 139.25 45.77 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 117.882 0.31 . . . . 0.0 110.461 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 p -151.93 -168.43 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.32 2.248 . . . . 0.0 106.971 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -140.82 156.33 46.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 163.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -123.41 134.98 53.9 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.043 1.337 . . . . 0.0 107.514 171.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.86 -82.96 0.02 OUTLIER Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.678 0.656 . . . . 0.0 112.289 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.66 33.76 0.63 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 110.059 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -126.98 123.28 36.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.771 2.028 . . . . 0.0 106.301 -171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.4 tt -82.99 123.5 29.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -170.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.06 134.15 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 125.416 1.487 . . . . 0.0 108.63 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -132.81 103.63 6.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.17 140.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 166.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -144.8 114.67 7.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.014 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -127.65 119.36 25.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.751 0.821 . . . . 0.0 110.228 -160.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -102.09 -62.64 1.24 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.801 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -163.44 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.56 0.618 . . . . 0.0 112.375 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.58 70.03 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 118.948 0.795 . . . . 0.0 111.713 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -179.75 7.49 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.705 1.202 . . . . 0.0 107.804 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -144.68 -178.82 6.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.76 2.024 . . . . 0.0 107.775 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 t -140.93 160.79 39.32 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.176 0.991 . . . . 0.0 108.351 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -137.13 137.54 39.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.58 154.59 47.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.11 141.92 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -126.64 133.33 51.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.838 1.255 . . . . 0.0 109.865 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -149.85 141.69 23.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -110.53 116.02 30.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 161.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.28 -176.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 161.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.3 t70 51.55 -109.11 0.42 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.27 30.99 1.85 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.322 1.439 . . . . 0.0 110.47 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -147.61 150.15 33.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.169 0.985 . . . . 0.0 110.404 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -89.67 97.93 11.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.35 112.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tp -121.84 109.73 15.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.412 1.085 . . . . 0.0 108.346 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.7 p -102.55 127.26 49.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.18 118.71 37.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.375 1.47 . . . . 0.0 107.762 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.6 p -121.15 125.64 47.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.528 1.131 . . . . 0.0 110.579 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -129.75 71.28 1.44 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.323 1.449 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 -90.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.085 1.326 . . . . 0.0 111.941 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 t -84.15 -38.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.07 0.948 . . . . 0.0 110.346 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.05 141.76 32.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.96 115.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 O-C-N 122.211 -0.306 . . . . 0.0 110.57 -162.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.4 t -131.78 105.06 7.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.099 0.96 . . . . 0.0 110.669 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.4 p -62.85 145.57 54.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 157.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -152.37 119.58 5.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.791 0.836 . . . . 0.0 110.149 161.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 81.8 p -92.89 97.32 10.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.764 -1.21 . . . . 0.0 109.382 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -67.65 164.41 19.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.863 . . . . 0.0 109.611 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.04 140.01 34.2 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.612 0.765 . . . . 0.0 109.598 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -73.17 109.0 6.37 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -90.39 -27.88 19.04 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.76 0.255 . . . . 0.0 110.778 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 123.231 0.613 . . . . 0.0 110.999 -175.682 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.73 60.84 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.64 1.976 . . . . 0.0 111.662 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.26 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.189 1.396 . . . . 0.0 107.494 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -59.04 -54.71 44.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 110.935 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -11.96 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 129.668 3.187 . . . . 0.0 113.613 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.19 -125.47 4.88 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 118.72 0.691 . . . . 0.0 112.172 168.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -129.88 121.49 26.78 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.7 0.8 . . . . 0.0 110.591 -159.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -106.17 132.07 52.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.496 1.118 . . . . 0.0 108.773 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -105.42 125.39 50.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.576 1.55 . . . . 0.0 108.371 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.77 144.91 45.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.542 0.61 . . . . 0.0 110.928 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.15 69.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 118.352 0.523 . . . . 0.0 111.92 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -164.38 178.75 7.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.212 1.405 . . . . 0.0 107.957 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -162.0 59.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.554 1.07 . . . . 0.0 112.453 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.64 114.62 21.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.229 0.612 . . . . 0.0 110.877 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 52.23 28.26 5.43 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.394 2.277 . . . . 0.0 113.065 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -81.52 -43.43 18.78 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.74 -1.225 . . . . 0.0 111.386 -167.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -71.32 -55.31 8.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -36.17 -63.17 0.4 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.086 1.354 . . . . 0.0 112.499 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -48.55 -49.93 34.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.372 1.069 . . . . 0.0 110.702 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.1 mtp -68.04 -35.57 78.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.91 0.484 . . . . 0.0 110.903 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -83.31 40.83 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.662 1.985 . . . . 0.0 109.98 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 p -169.66 -42.44 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.999 2.12 . . . . 0.0 107.146 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.24 -45.75 68.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.276 -0.265 . . . . 0.0 111.292 162.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.98 0.4 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.121 1.343 . . . . 0.0 111.354 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.71 -5.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.45 51.6 4.23 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 119.379 -2.076 . . . . 0.0 112.961 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -50.49 -60.43 3.02 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.192 1.397 . . . . 0.0 112.999 -159.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.83 -31.81 27.91 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.504 -170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m 64.52 122.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.239 1.816 . . . . 0.0 112.513 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 52.86 35.99 20.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 112.243 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.06 -51.7 0.1 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.445 1.098 . . . . 0.0 108.482 170.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -35.25 -41.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 128.424 2.69 . . . . 0.0 114.576 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.85 46.34 1.04 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-O 119.194 -0.781 . . . . 0.0 111.268 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -164.11 -37.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.591 0.757 . . . . 0.0 112.139 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.22 -56.35 4.64 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -64.1 -29.18 70.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.198 0.999 . . . . 0.0 112.539 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 73.33 83.41 0.13 Allowed Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.663 1.585 . . . . 0.0 110.007 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.49 134.96 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.441 1.427 . . . . 0.0 109.244 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 m -118.27 144.48 45.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.1 m -126.44 107.21 10.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -83.34 117.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.98 111.08 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 148.45 42.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 123.701 0.626 . . . . 0.0 109.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.23 111.46 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.961 0.904 . . . . 0.0 109.52 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.82 56.77 3.54 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.07 -83.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.946 0.784 . . . . 0.0 112.231 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.38 -36.44 16.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.763 1.225 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 177.02 5.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.962 2.105 . . . . 0.0 107.913 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 p -152.45 138.45 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 tt -119.98 127.05 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.627 0.771 . . . . 0.0 109.573 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 138.81 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 125.007 1.323 . . . . 0.0 108.751 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -130.09 119.69 23.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.451 1.5 . . . . 0.0 109.085 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -80.96 96.95 7.24 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.374 1.469 . . . . 0.0 108.656 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -79.21 106.76 11.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.857 0.837 . . . . 0.0 109.301 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -131.76 -176.97 4.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.945 2.498 . . . . 0.0 107.812 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 m -145.18 64.26 1.27 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -169.86 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.493 1.517 . . . . 0.0 108.569 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -158.73 131.59 7.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -126.09 156.8 39.45 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -150.29 154.29 37.62 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -150.53 139.15 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.216 0.606 . . . . 0.0 110.113 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -150.78 145.37 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.343 1.057 . . . . 0.0 108.712 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -97.21 145.85 25.65 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 109.67 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.04 179.45 8.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.15 0.98 . . . . 0.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.81 146.5 28.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.838 0.855 . . . . 0.0 109.264 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.41 69.17 0.38 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.066 1.346 . . . . 0.0 111.151 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 51.87 0.04 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -146.97 140.58 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.849 0.824 . . . . 0.0 109.152 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 129.55 53.38 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 166.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.43 168.42 20.31 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.53 136.14 36.81 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.291 0.636 . . . . 0.0 110.264 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.34 90.63 3.26 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.607 2.363 . . . . 0.0 106.132 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -86.46 110.69 19.92 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -143.58 160.93 39.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.408 0.683 . . . . 0.0 110.783 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.41 -10.68 53.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.695 0.798 . . . . 0.0 113.139 -168.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -92.64 -57.72 2.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.679 1.592 . . . . 0.0 108.652 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HA ' ' NH1' ' A' ' 78' ' ' ARG 0.416 0.7 OUTLIER -97.76 10.6 39.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.31 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' NH1' ' HA ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 67.03 -154.24 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.836 1.255 . . . . 0.0 109.163 172.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.45 114.18 21.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.56 154.92 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -86.62 127.27 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.084 0.856 . . . . 0.0 110.262 167.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -83.83 114.57 21.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.29 1.836 . . . . 0.0 107.636 167.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.31 94.64 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.94 138.85 46.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 O-C-N 122.124 -0.36 . . . . 0.0 111.177 -165.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -156.8 173.62 16.71 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.963 2.105 . . . . 0.0 106.55 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.55 135.23 48.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.594 1.088 . . . . 0.0 110.612 161.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -88.87 61.86 6.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -168.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.25 -35.32 0.66 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.485 -0.619 . . . . 0.0 113.827 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.24 59.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt 171.61 125.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.375 2.27 . . . . 0.0 107.91 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -83.95 127.01 33.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.842 0.746 . . . . 0.0 110.038 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.14 110.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.649 1.579 . . . . 0.0 106.961 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -98.82 89.27 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 170.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.0 t -74.5 139.56 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -130.96 94.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -159.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.31 114.86 24.2 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.489 0.715 . . . . 0.0 111.243 -167.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.64 -56.73 2.8 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.147 0.43 . . . . 0.0 110.153 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -167.9 -87.07 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.964 0.347 . . . . 0.0 111.425 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.83 -24.69 76.79 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -173.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 172.42 12.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.8 167.56 20.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.49 2.316 . . . . 0.0 107.14 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.0 p -133.82 157.54 45.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.448 0.699 . . . . 0.0 109.499 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 p -88.52 138.18 31.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.1 mt -125.09 84.32 2.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 159.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -106.23 144.59 15.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.437 0.695 . . . . 0.0 110.105 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 158.0 43.61 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.926 0.491 . . . . 0.0 111.56 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -165.09 153.84 12.23 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.738 1.215 . . . . 0.0 109.132 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.9 ttp -114.98 124.83 52.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.163 1.385 . . . . 0.0 109.902 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.88 179.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 157.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.01 -112.65 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -172.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.62 30.08 1.56 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.512 1.053 . . . . 0.0 110.988 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -141.61 156.71 45.66 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.2 108.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.477 1.111 . . . . 0.0 108.373 -170.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.11 141.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 0.0 109.548 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.9 tp -128.0 85.85 2.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.464 1.106 . . . . 0.0 110.037 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -95.85 111.69 23.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt -113.17 120.35 40.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.8 m -119.24 125.44 49.16 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.776 0.716 . . . . 0.0 109.435 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -123.23 146.15 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 106.844 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -36.24 -52.55 1.29 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.191 0.901 . . . . 0.0 113.469 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -34.05 57.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.05 133.1 29.49 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.188 0.595 . . . . 0.0 110.362 -159.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.08 121.38 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.68 1.192 . . . . 0.0 108.336 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.86 109.4 14.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.673 1.189 . . . . 0.0 109.298 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.86 104.21 12.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.917 1.287 . . . . 0.0 108.217 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -122.43 -177.91 3.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.711 0.804 . . . . 0.0 109.985 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -145.6 155.33 42.97 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.151 0.58 . . . . 0.0 109.835 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -115.87 164.95 13.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.588 1.955 . . . . 0.0 108.99 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.17 136.99 49.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -75.53 109.69 9.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.835 -0.541 . . . . 0.0 110.086 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.31 -23.65 23.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.544 0.338 . . . . 0.0 111.542 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 111.508 -178.44 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.48 63.22 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.75 2.82 . . . . 0.0 111.725 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.09 -48.14 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.802 2.041 . . . . 0.0 107.099 -171.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -54.82 -43.02 72.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.742 1.617 . . . . 0.0 111.566 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.4 t -41.4 109.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.754 1.622 . . . . 0.0 112.487 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.17 -168.45 23.73 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.436 1.017 . . . . 0.0 113.758 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -91.04 122.43 33.69 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.4 1.48 . . . . 0.0 110.451 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -108.32 156.52 19.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.673 1.589 . . . . 0.0 110.415 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 135.74 31.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.35 148.05 49.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.994 0.918 . . . . 0.0 111.873 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.65 -15.12 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.233 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' CG ' ' HZ3' ' A' ' 14' ' ' LYS . 48.0 t0 -145.86 155.83 43.16 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.145 1.339 . . . . 0.0 110.52 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -173.98 134.52 0.46 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 127.678 2.391 . . . . 0.0 109.095 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HZ3' ' CG ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -152.82 166.73 31.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 163.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 63.4 12.3 6.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.267 1.827 . . . . 0.0 112.394 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.02 -52.25 30.71 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.028 -1.045 . . . . 0.0 109.885 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.06 -50.7 63.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.051 2.14 . . . . 0.0 110.101 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -61.69 -39.58 91.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.834 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -47.35 -49.55 24.14 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.316 0.646 . . . . 0.0 110.864 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.67 -28.62 70.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.678 -0.677 . . . . 0.0 112.029 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -73.78 58.96 0.65 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.711 1.204 . . . . 0.0 110.511 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 p 168.24 -48.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.945 3.298 . . . . 0.0 106.691 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.04 -35.27 79.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 112.088 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.39 -15.46 63.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.297 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -76.21 42.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -161.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.42 96.7 0.05 OUTLIER Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.063 -1.023 . . . . 0.0 113.538 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -62.66 -17.97 61.45 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.851 -1.381 . . . . 0.0 112.786 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.63 -53.73 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.308 1.043 . . . . 0.0 111.679 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 m -66.2 -31.01 71.59 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.994 -0.441 . . . . 0.0 110.896 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -38.96 86.18 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -58.61 -58.12 9.96 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.101 0.864 . . . . 0.0 108.976 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -45.82 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.31 -14.07 71.22 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.453 -1.748 . . . . 0.0 114.937 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -103.12 -38.0 7.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.63 . . . . 0.0 110.744 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.54 -47.42 7.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.866 0.866 . . . . 0.0 111.875 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 m -99.15 90.9 4.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 118.861 -0.59 . . . . 0.0 109.722 -161.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 6.35 75.01 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 127.384 2.274 . . . . 0.0 113.415 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.17 93.64 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.363 2.042 . . . . 0.0 109.366 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.0 m -89.19 150.97 22.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.848 1.259 . . . . 0.0 107.889 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.2 m -140.91 140.89 34.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.73 -1.231 . . . . 0.0 108.674 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.0 132.75 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.0 mt -128.14 107.57 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.88 107.03 15.91 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.116 1.767 . . . . 0.0 109.274 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.97 109.31 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -93.79 65.49 3.6 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.17 -87.69 0.09 OUTLIER Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.299 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.15 -6.11 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.501 1.12 . . . . 0.0 112.302 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -102.2 169.43 8.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.26 117.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 mt -88.32 132.96 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tt -116.44 133.57 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -122.2 137.07 54.96 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.406 1.083 . . . . 0.0 109.043 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 p -105.73 16.83 24.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.04 1.336 . . . . 0.0 113.007 -166.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.13 109.05 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.259 1.423 . . . . 0.0 114.418 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -66.81 -41.47 87.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 171.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -149.62 -75.85 0.16 Allowed 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -71.68 -54.56 9.95 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.115 -0.366 . . . . 0.0 110.453 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -174.58 156.36 2.39 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.52 -79.02 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -142.52 157.94 44.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.297 1.039 . . . . 0.0 109.29 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.06 133.69 54.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 166.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.72 117.52 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 p -106.54 81.45 1.59 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.181 1.792 . . . . 0.0 110.537 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -72.23 143.18 48.9 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.396 -0.815 . . . . 0.0 111.637 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -121.54 112.56 18.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.65 102.98 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.785 0.834 . . . . 0.0 111.665 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.54 54.79 1.3 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.44 170.64 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.51 149.02 43.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.934 0.494 . . . . 0.0 110.387 163.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -141.83 153.44 44.5 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.366 1.066 . . . . 0.0 109.254 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.69 144.53 56.95 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.84 158.21 43.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.815 1.246 . . . . 0.0 108.672 -168.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 t -137.53 146.58 44.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.574 0.75 . . . . 0.0 109.639 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -128.19 170.36 13.09 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.42 -15.46 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -156.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -95.37 13.52 25.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.374 1.47 . . . . 0.0 111.551 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.25 38.2 t0 31.15 57.17 0.25 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.016 2.126 . . . . 0.0 113.658 -156.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -61.63 123.93 19.28 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 116.282 -2.167 . . . . 0.0 106.546 149.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -78.72 112.71 16.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.27 172.47 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -108.99 130.38 55.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -88.89 102.17 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.929 1.291 . . . . 0.0 107.636 164.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.75 134.5 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 166.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.01 139.54 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.651 0.659 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -151.76 -172.15 4.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.101 1.361 . . . . 0.0 107.668 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 tt -137.51 113.21 9.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.806 1.642 . . . . 0.0 108.376 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -115.06 105.88 13.47 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.58 1.181 . . . . 0.0 110.843 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.87 -62.14 3.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.141 0.877 . . . . 0.0 111.774 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.04 69.88 0.08 OUTLIER Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 pttm 173.5 142.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 106.527 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.302 0.0 OUTLIER -88.81 136.81 32.81 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -115.69 97.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.95 104.03 13.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.25 126.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -116.19 105.51 12.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.64 126.69 55.29 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.233 1.013 . . . . 0.0 110.417 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -99.62 -62.53 1.23 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.931 0.492 . . . . 0.0 109.732 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.92 -92.85 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.31 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.77 -12.61 83.74 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.938 0.79 . . . . 0.0 112.265 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -137.84 164.3 29.28 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -142.11 152.07 42.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 167.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -116.55 148.03 41.25 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -107.66 134.45 50.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.013 0.525 . . . . 0.0 109.931 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.08 90.05 3.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.346 1.859 . . . . 0.0 106.733 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.15 139.41 17.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 148.42 43.15 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.059 0.544 . . . . 0.0 111.324 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -164.09 155.0 15.59 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.656 1.582 . . . . 0.0 108.06 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.7 ttp -105.08 118.37 36.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.616 0.767 . . . . 0.0 109.086 161.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.24 170.41 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 154.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 52.05 -124.28 2.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -165.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.75 21.75 4.68 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.906 1.241 . . . . 0.0 111.58 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 65.2 mttm -137.28 140.77 41.79 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.117 0.958 . . . . 0.0 108.779 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.61 121.56 31.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.38 150.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.7 118.0 13.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.8 m -111.89 100.03 8.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.8 115.84 18.75 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.2 m -118.38 114.2 22.55 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.002 0.921 . . . . 0.0 109.98 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 -27.84 14.42 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.471 1.508 . . . . 0.0 109.827 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.39 -92.87 0.2 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 t -58.72 -44.33 90.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.81 141.5 29.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.091 0.557 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.28 129.21 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 126.109 1.763 . . . . 0.0 107.086 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.9 t -116.52 104.74 11.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 108.973 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.4 p -70.37 143.84 51.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 163.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.88 153.9 28.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 t -146.68 155.7 42.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.734 0.697 . . . . 0.0 110.984 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.03 154.25 51.26 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.032 2.133 . . . . 0.0 109.395 -165.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 112' ' ' LYS . 42.5 tt0 -129.22 134.23 47.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.945 1.298 . . . . 0.0 107.843 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -78.22 119.52 21.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -104.11 -29.69 10.71 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.656 0.782 . . . . 0.0 110.978 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.379 0.672 . . . . 0.0 110.968 -178.374 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.237 0.418 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.41 55.87 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.979 2.512 . . . . 0.0 111.625 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.65 -38.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.766 1.626 . . . . 0.0 108.849 -161.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -96.55 -34.84 11.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.732 1.213 . . . . 0.0 110.758 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.43 105.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.88 176.93 27.67 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.912 0.778 . . . . 0.0 113.081 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 m -102.49 118.24 36.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -114.66 134.67 54.89 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.417 1.487 . . . . 0.0 107.659 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -112.09 121.12 44.08 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.99 131.89 52.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.266 0.939 . . . . 0.0 108.793 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.51 -64.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 125.068 1.48 . . . . 0.0 110.288 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.21 158.18 17.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.078 0.854 . . . . 0.0 110.171 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -175.08 165.02 3.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 107.709 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -149.31 153.94 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 166.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.39 42.49 32.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.217 1.007 . . . . 0.0 110.633 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.8 -55.48 26.04 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.179 -0.951 . . . . 0.0 109.278 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.522 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -25.93 -60.27 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.542 1.537 . . . . 0.0 112.822 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -51.08 -59.9 3.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.131 0.972 . . . . 0.0 112.695 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.2 ptp -63.43 -29.7 70.95 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.674 -0.641 . . . . 0.0 112.403 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp -78.73 45.74 0.62 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.764 2.026 . . . . 0.0 111.379 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m 177.29 -46.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 128.061 2.544 . . . . 0.0 107.396 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -54.34 -31.47 54.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.472 0.709 . . . . 0.0 110.39 173.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 45.6 0.59 Allowed Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 160.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -139.01 -36.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 109.179 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.66 68.46 2.17 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.279 -0.888 . . . . 0.0 112.28 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.73 70.7 0.72 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 109.92 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.8 -60.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.947 2.099 . . . . 0.0 112.55 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -33.08 -46.07 0.15 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.092 2.957 . . . . 0.0 112.801 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -112.47 23.71 13.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.798 . . . . 0.0 112.575 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.86 -23.33 15.4 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.962 1.705 . . . . 0.0 110.053 157.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.67 -46.05 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.32 61.02 2.32 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.296 0.951 . . . . 0.0 113.708 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -178.02 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.033 1.733 . . . . 0.0 108.922 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.1 ttm -54.36 -35.48 62.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.291 0.636 . . . . 0.0 109.946 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 m -65.19 76.54 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.274 0.63 . . . . 0.0 109.852 161.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -20.08 95.04 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.943 2.897 . . . . 0.0 112.562 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.64 165.18 26.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.998 -167.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.5 m -131.46 149.5 52.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.463 -0.79 . . . . 0.0 108.888 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -138.34 95.05 2.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.057 -161.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.46 127.91 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.9 mt -126.49 109.39 20.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.92 135.99 49.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.102 0.961 . . . . 0.0 109.743 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.08 84.84 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.732 0.813 . . . . 0.0 108.817 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.63 71.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.109 1.764 . . . . 0.0 111.177 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.78 -105.01 0.58 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -34.67 55.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.351 0.66 . . . . 0.0 110.414 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -179.01 4.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.755 2.022 . . . . 0.0 107.236 -167.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.68 146.55 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.98 132.73 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 133.29 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.391 1.076 . . . . 0.0 108.441 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -114.4 114.5 25.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.859 1.263 . . . . 0.0 108.579 170.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 p -82.21 120.84 25.87 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -117.3 139.49 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.591 1.156 . . . . 0.0 110.818 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 t -167.0 -165.88 0.76 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.829 1.652 . . . . 0.0 109.207 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -62.82 93.61 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.276 1.431 . . . . 0.0 111.837 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 58.49 18.0 5.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.515 1.526 . . . . 0.0 112.463 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -134.04 77.11 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -115.99 127.28 54.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -173.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.68 159.78 43.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -152.29 158.12 42.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -140.99 121.65 13.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -84.41 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 165.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -156.75 144.39 19.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.393 -0.817 . . . . 0.0 111.402 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.56 105.58 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.85 109.13 0.25 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.413 0.285 . . . . 0.0 111.051 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.65 39.9 1.68 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -154.8 157.26 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.79 145.1 37.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.692 0.797 . . . . 0.0 110.474 161.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.65 148.72 24.52 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.77 143.17 40.05 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.0 156.08 44.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.552 1.541 . . . . 0.0 107.845 -173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.1 m -141.12 82.23 1.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.232 1.013 . . . . 0.0 109.09 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -98.32 130.9 44.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.3 -35.49 27.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.962 0.905 . . . . 0.0 112.404 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -96.77 16.6 18.68 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.172 1.789 . . . . 0.0 112.766 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -150.15 2.25 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 163.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 79.76 -164.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.383 1.473 . . . . 0.0 109.003 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -73.81 126.48 30.47 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.12 143.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.679 1.592 . . . . 0.0 108.043 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -83.27 127.1 33.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 166.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.2 m -94.63 114.83 26.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.98 123.78 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 166.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 p -132.78 136.9 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -158.2 158.93 35.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 pp -105.98 137.82 43.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.337 0.972 . . . . 0.0 108.813 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -84.03 -11.51 56.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.282 0.633 . . . . 0.0 111.65 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.29 -32.92 5.67 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.22 -39.66 3.45 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.173 1.368 . . . . 0.0 110.905 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -142.05 167.62 21.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.65 1.18 . . . . 0.0 111.424 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tt -96.94 114.99 26.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.198 0.999 . . . . 0.0 108.519 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.55 112.2 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.099 1.76 . . . . 0.0 108.76 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -103.99 108.94 20.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.56 126.07 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -110.63 117.22 32.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -131.71 120.38 22.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.79 1.236 . . . . 0.0 109.909 -164.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -56.75 2.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -161.8 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.07 -16.26 78.5 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 118.629 0.65 . . . . 0.0 112.592 -171.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.29 173.24 15.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.474 1.11 . . . . 0.0 108.403 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.49 154.83 33.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.962 1.705 . . . . 0.0 108.186 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.9 p -109.4 145.75 35.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 110.018 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.09 121.22 36.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.85 98.51 6.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.437 1.495 . . . . 0.0 107.554 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.94 118.74 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.05 145.91 38.86 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.963 0.905 . . . . 0.0 109.376 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -160.72 156.7 25.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 164.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -121.46 121.88 38.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.117 0.967 . . . . 0.0 109.29 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.39 -177.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 160.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t70 53.23 -108.53 0.42 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.97 29.65 1.38 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.678 1.132 . . . . 0.0 111.336 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -140.18 145.22 37.18 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.968 0.884 . . . . 0.0 109.158 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -90.48 110.82 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.07 139.86 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tp -142.44 106.1 4.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 m -98.43 121.59 40.55 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 133.5 45.15 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -155.12 156.22 35.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.809 0.731 . . . . 0.0 111.483 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -160.08 168.23 26.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 107.234 165.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.59 -35.39 7.35 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 118.847 0.749 . . . . 0.0 112.44 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 m -46.23 -49.73 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.577 1.551 . . . . 0.0 113.026 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 175.89 169.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.135 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.41 144.94 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 125.404 1.481 . . . . 0.0 108.533 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 16.7 t -158.5 116.32 2.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.581 0.628 . . . . 0.0 111.633 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -73.12 151.09 41.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.239 0.616 . . . . 0.0 109.551 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -140.5 154.46 46.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.597 1.959 . . . . 0.0 106.266 156.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 t -151.84 148.6 28.02 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.67 0.668 . . . . 0.0 110.697 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -129.77 139.04 51.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.606 1.562 . . . . 0.0 108.553 -167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -110.92 138.8 46.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.373 1.069 . . . . 0.0 108.899 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -73.02 84.04 1.27 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.607 0.363 . . . . 0.0 111.081 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -59.28 -35.95 74.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.749 0.309 . . . . 0.0 110.726 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 O-C-N 121.842 -0.536 . . . . 0.0 109.735 173.274 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.27 66.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 129.992 3.317 . . . . 0.0 111.311 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.19 -61.35 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.04 48.62 0.87 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.855 2.062 . . . . 0.0 111.282 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -142.77 78.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.771 2.028 . . . . 0.0 106.558 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.8 -160.35 23.21 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.668 0.652 . . . . 0.0 113.108 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -87.73 138.65 31.28 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 111.752 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -118.9 158.38 25.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.166 1.386 . . . . 0.0 109.084 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 155.96 46.89 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.403 0.44 . . . . 0.0 110.668 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.95 145.26 55.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.588 1.555 . . . . 0.0 111.051 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.83 -56.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 164.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.39 141.98 47.66 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -167.79 152.78 6.85 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -173.19 159.23 3.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.505 1.522 . . . . 0.0 107.497 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 72.02 -4.74 1.89 Allowed 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.148 1.779 . . . . 0.0 111.49 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -41.71 83.52 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -34.92 -69.01 0.1 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.696 1.998 . . . . 0.0 111.916 160.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.36 -47.89 80.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.536 1.062 . . . . 0.0 111.611 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.71 -52.5 10.83 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 111.235 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -31.42 72.48 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -64.46 -62.79 1.38 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -54.72 -46.64 74.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.079 1.351 . . . . 0.0 111.69 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.57 -9.6 57.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.702 1.201 . . . . 0.0 112.247 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.44 51.49 42.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.92 -40.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 109.797 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -45.18 -64.24 2.32 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 125.928 1.727 . . . . 0.0 113.562 -171.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 36.11 -122.7 0.15 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.374 1.87 . . . . 0.0 110.754 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.19 48.57 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 m -151.32 -73.32 0.15 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.692 -0.63 . . . . 0.0 110.84 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -70.45 -14.38 62.51 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -55.08 -39.55 69.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.426 0.557 . . . . 0.0 111.341 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.22 -56.18 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.2 -49.77 4.47 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.128 1.347 . . . . 0.0 113.826 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -80.53 -14.78 57.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.21 2.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 163.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.255 1.2 t -72.24 83.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.682 1.229 . . . . 0.0 111.261 -164.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 84.05 0.98 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 125.826 1.65 . . . . 0.0 107.749 159.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.95 -48.68 1.77 Allowed 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.629 1.553 . . . . 0.0 108.44 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -87.7 141.06 28.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.914 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -147.72 117.43 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.057 -1.027 . . . . 0.0 108.534 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.43 140.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.78 111.52 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -130.15 125.74 35.78 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.345 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.16 99.84 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 122.029 0.919 . . . . 0.0 110.686 172.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -74.52 65.15 1.24 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.63 -82.63 0.02 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.396 0.998 . . . . 0.0 112.973 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -99.78 -6.59 26.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 0.0 112.259 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.36 166.33 17.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.223 1.809 . . . . 0.0 107.217 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.98 109.24 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 tt -90.02 129.36 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.48 134.3 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -124.98 105.9 9.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 109.962 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 m -70.09 113.12 6.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.857 2.063 . . . . 0.0 108.083 170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -120.01 135.25 54.99 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.336 0.516 . . . . 0.0 111.243 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -139.69 17.92 2.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.068 0.947 . . . . 0.0 111.256 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t 39.97 38.06 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 111.426 -164.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -174.3 95.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -166.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? 54.85 54.95 8.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.709 0.804 . . . . 0.0 110.146 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -63.08 162.65 11.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.906 1.283 . . . . 0.0 109.893 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.88 164.12 31.11 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.998 0.919 . . . . 0.0 108.756 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -156.04 151.94 27.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.922 0.489 . . . . 0.0 109.994 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.4 144.57 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 p -106.86 88.17 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.908 0.883 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.87 148.37 47.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -132.26 117.41 18.16 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 166.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 96.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.612 1.165 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.34 51.9 1.19 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.35 0.976 . . . . 0.0 111.148 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.38 162.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.0 0.9 . . . . 0.0 110.939 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -101.97 136.48 41.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.436 1.894 . . . . 0.0 107.863 167.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.44 149.84 38.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.734 0.814 . . . . 0.0 109.191 170.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.32 136.83 37.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.29 153.6 47.8 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.82 1.248 . . . . 0.0 109.144 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -130.66 68.58 1.47 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.875 1.67 . . . . 0.0 110.016 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -83.76 143.73 29.79 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.09 40.23 0.33 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.618 1.167 . . . . 0.0 112.851 -167.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -161.02 -75.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.569 1.548 . . . . 0.0 107.859 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -27.64 65.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.69 0.796 . . . . 0.0 111.729 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 98.8 -155.63 0.0 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 128.628 2.771 . . . . 0.0 107.971 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -81.4 116.33 21.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.13 177.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.474 1.51 . . . . 0.0 107.709 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -107.42 128.25 54.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.768 0.713 . . . . 0.0 110.176 164.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.93 126.08 35.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.44 125.26 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.63 145.37 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 160.51 41.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.5 2.72 . . . . 0.0 105.811 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tt -140.93 73.62 1.43 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 p30 176.4 164.18 0.42 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -156.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 -69.17 0.9 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.21 56.91 0.65 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 56.94 -130.66 1.65 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.007 0.923 . . . . 0.0 109.208 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp -81.88 79.29 8.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 109.834 -170.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.39 111.5 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.846 0.858 . . . . 0.0 109.984 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -117.95 115.8 25.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.798 1.239 . . . . 0.0 109.639 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.19 150.74 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 170.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -131.81 95.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 106.354 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -112.64 117.14 31.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -89.56 -111.0 0.08 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -122.87 -74.01 0.63 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.761 1.224 . . . . 0.0 111.488 -173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.74 61.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.569 0.622 . . . . 0.0 111.722 -170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -179.91 6.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -149.29 156.85 42.74 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.371 1.869 . . . . 0.0 106.291 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.6 t -127.8 155.9 43.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.536 0.684 . . . . 0.0 109.254 160.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.1 p -96.17 150.7 20.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 164.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 pp -151.94 101.63 2.75 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 164.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.91 128.85 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.043 0.537 . . . . 0.0 109.601 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -94.26 99.23 11.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 108.318 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.94 143.67 28.29 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -137.11 120.01 16.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.09 -168.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 51.91 -116.93 1.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.35 23.58 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 126.137 1.827 . . . . 0.0 109.485 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -134.26 129.55 35.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.401 0.681 . . . . 0.0 109.461 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -87.68 105.09 17.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.6 mt -82.05 103.22 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.88 101.23 13.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.4 t -99.27 130.92 45.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.65 126.36 43.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.296 1.439 . . . . 0.0 109.775 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.7 m -131.88 114.0 14.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -97.62 146.63 25.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.764 2.026 . . . . 0.0 107.456 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.01 92.06 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 167.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 m 135.2 -28.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 131.402 3.881 . . . . 0.0 111.851 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.27 153.62 37.82 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.28 1.4 . . . . 0.0 112.46 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.9 t -124.79 143.73 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.093 1.757 . . . . 0.0 107.964 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 t -158.6 158.54 34.08 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 t -126.24 158.06 36.67 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.672 -0.642 . . . . 0.0 109.942 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -119.59 130.89 55.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 150.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -108.79 124.94 51.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -112.89 154.54 26.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.005 1.722 . . . . 0.0 109.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -122.01 137.07 54.94 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.756 1.622 . . . . 0.0 107.395 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -75.37 125.38 28.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.23 -4.06 17.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.033 0.533 . . . . 0.0 111.336 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 C-N-CA 124.778 1.231 . . . . 0.0 110.864 174.111 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 58.38 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 129.345 3.058 . . . . 0.0 111.894 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.27 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.153 1.781 . . . . 0.0 107.516 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -59.27 -42.88 92.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.495 1.118 . . . . 0.0 111.221 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.1 t -40.62 101.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.197 1.799 . . . . 0.0 111.814 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.29 -154.69 25.92 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.188 0.899 . . . . 0.0 112.196 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -118.25 119.71 35.49 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.502 1.521 . . . . 0.0 109.656 -170.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -109.29 141.93 40.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.521 1.128 . . . . 0.0 110.177 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -115.11 137.71 51.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -77.75 128.34 33.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.94 -45.64 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -128.92 151.14 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 110.008 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -170.14 150.55 3.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.596 2.358 . . . . 0.0 108.719 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -138.87 148.74 44.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m120 62.68 43.86 7.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.222 1.409 . . . . 0.0 111.452 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -70.53 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.804 -0.56 . . . . 0.0 109.75 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.57 -49.66 72.13 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -30.03 -53.88 0.16 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.702 2.001 . . . . 0.0 112.547 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -51.93 -51.93 53.57 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.752 -0.593 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.0 ptp -74.23 -33.12 63.25 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.434 -0.791 . . . . 0.0 111.793 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -40.96 75.97 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.473 -0.767 . . . . 0.0 111.166 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -82.09 -41.18 20.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.494 1.117 . . . . 0.0 110.219 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.1 -39.13 74.44 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.199 0.454 . . . . 0.0 111.844 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 55.14 0.81 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.78 -9.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.64 1.176 . . . . 0.0 111.678 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.48 78.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.105 -0.997 . . . . 0.0 114.248 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -48.81 139.26 10.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.911 1.285 . . . . 0.0 109.039 156.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.95 62.76 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.22 1.008 . . . . 0.0 111.01 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 m -147.9 -37.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.814 -1.179 . . . . 0.0 111.272 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.8 tpt85 -56.69 -37.83 71.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.229 0.922 . . . . 0.0 109.678 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -43.01 -32.96 0.72 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.386 2.675 . . . . 0.0 115.074 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 34' ' ' ASN . 13.6 p -110.29 -35.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.007 0.821 . . . . 0.0 111.347 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 26.85 0.65 Allowed Glycine 0 CA--C 1.539 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 113.973 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 32' ' ' VAL . 24.2 p-10 -122.96 -39.21 2.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.062 3.345 . . . . 0.0 109.54 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -42.6 70.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.733 1.213 . . . . 0.0 108.731 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -60.12 116.26 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 156.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.66 114.44 14.53 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.983 -168.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.85 156.57 56.53 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 120.246 1.124 . . . . 0.0 109.667 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.6 m -130.99 153.98 48.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.298 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -147.51 117.42 7.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.82 144.13 11.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 166.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.53 111.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.39 143.75 51.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 0.701 . . . . 0.0 110.993 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 80.5 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 122.46 1.124 . . . . 0.0 110.133 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -65.42 78.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.008 0.923 . . . . 0.0 111.398 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.04 -114.0 6.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -86.6 -12.55 48.27 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.431 0.615 . . . . 0.0 111.296 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -102.05 179.32 4.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.449 1.1 . . . . 0.0 108.36 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.82 138.94 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 166.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.6 tt -112.55 134.25 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.59 143.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 O-C-N 123.98 0.8 . . . . 0.0 109.137 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -131.94 111.7 11.77 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 m -104.12 128.33 51.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.728 1.611 . . . . 0.0 110.104 -167.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -105.38 125.1 50.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.697 1.999 . . . . 0.0 109.121 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -148.92 68.61 1.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 p 48.3 96.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.157 2.183 . . . . 0.0 114.194 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.6 t80 71.02 -64.98 0.36 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.302 1.841 . . . . 0.0 109.615 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.31 134.76 45.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.05 156.34 39.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.14 158.18 43.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.82 132.23 13.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -147.52 127.68 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 p -88.94 133.68 34.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.859 1.264 . . . . 0.0 108.469 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.75 160.65 42.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 127.56 43.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 86.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 169.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.07 41.98 0.19 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.095 1.807 . . . . 0.0 111.474 168.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.5 t -147.71 153.05 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.368 1.084 . . . . 0.0 109.575 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -113.04 133.98 54.73 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 126.724 2.01 . . . . 0.0 107.463 167.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -163.21 -179.34 6.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.268 0.94 . . . . 0.0 111.136 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.5 121.53 29.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 109.225 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 107.52 15.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.453 1.901 . . . . 0.0 106.255 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.3 53.85 0.76 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.095 0.558 . . . . 0.0 111.233 -164.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 146.8 50.42 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.456 -0.777 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.02 63.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.009 0.923 . . . . 0.0 112.267 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -94.81 -50.41 5.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.836 1.654 . . . . 0.0 110.299 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -56.44 -25.62 51.17 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.182 0.446 . . . . 0.0 111.802 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 77.64 -166.05 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.889 2.075 . . . . 0.0 109.021 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.33 89.32 2.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.93 149.93 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.917 0.887 . . . . 0.0 109.747 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -85.08 116.9 23.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -80.63 146.87 30.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -139.57 125.74 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 157.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.93 143.92 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -166.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -155.57 -172.82 4.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.51 1.924 . . . . 0.0 108.232 -176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.63 113.02 10.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.12 125.97 43.36 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.84 -78.95 0.01 OUTLIER Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.342 0.973 . . . . 0.0 113.465 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.34 26.49 1.1 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.524 1.535 . . . . 0.0 111.742 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 130.53 48.9 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.084 1.354 . . . . 0.0 109.182 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.6 112.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.318 1.447 . . . . 0.0 107.36 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.01 126.62 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.376 1.07 . . . . 0.0 108.258 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -135.07 102.44 5.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.516 0.727 . . . . 0.0 109.891 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.87 147.2 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -141.8 99.39 3.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -119.74 108.81 14.87 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.441 1.897 . . . . 0.0 109.655 -160.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -60.2 1.68 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.322 0.51 . . . . 0.0 110.557 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -165.01 -81.51 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.235 0.47 . . . . 0.0 112.217 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.93 -26.16 74.46 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.786 0.721 . . . . 0.0 111.58 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 173.37 16.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.14 1.376 . . . . 0.0 107.725 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -131.21 140.29 49.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.968 2.107 . . . . 0.0 107.956 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 t -98.05 174.8 6.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.7 p -155.82 155.04 32.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 153.93 39.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.739 172.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.65 139.56 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -128.18 140.37 51.95 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.381 1.072 . . . . 0.0 109.51 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.08 133.74 16.7 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.416 0.686 . . . . 0.0 109.228 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -103.98 119.49 39.04 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.2 176.51 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 153.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.31 -118.1 1.26 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -170.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.92 21.22 3.75 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.188 1.375 . . . . 0.0 110.873 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -124.6 127.42 47.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.794 0.838 . . . . 0.0 108.764 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 tt -91.75 91.1 7.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.06 143.28 13.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.72 141.51 22.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.701 0.763 . . . . 0.0 112.712 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.9 m -106.81 124.73 50.04 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 125.109 1.364 . . . . 0.0 107.992 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.47 75.7 1.04 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.087 1.755 . . . . 0.0 107.192 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -128.13 138.81 52.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.281 0.562 . . . . 0.0 110.365 -165.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -160.18 155.64 25.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.62 -34.55 6.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.026 0.822 . . . . 0.0 113.121 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 t -51.75 -41.83 61.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.377 1.071 . . . . 0.0 111.852 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.87 127.15 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.678 1.591 . . . . 0.0 110.063 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.04 136.81 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -150.66 156.0 40.47 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.349 -1.469 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -143.5 163.37 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.648 0.779 . . . . 0.0 109.321 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -167.27 168.74 13.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.302 1.041 . . . . 0.0 111.069 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -136.8 136.49 38.89 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.957 0.884 . . . . 0.0 109.591 163.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -89.02 155.81 19.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.736 164.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.6 146.58 44.16 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.771 1.228 . . . . 0.0 107.867 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -81.79 114.53 20.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -90.82 -26.64 19.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.031 0.378 . . . . 0.0 111.697 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.161 0 CA-C-N 118.39 0.541 . . . . 0.0 110.781 174.471 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.238 0.47 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.6 61.42 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.932 2.093 . . . . 0.0 110.576 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.08 -40.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.028 1.731 . . . . 0.0 108.298 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -95.11 -47.73 6.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.859 1.264 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.5 t -45.37 117.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.435 1.094 . . . . 0.0 112.81 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.65 -120.77 3.42 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.851 0.739 . . . . 0.0 111.277 158.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -152.05 140.57 20.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.869 -0.783 . . . . 0.0 109.176 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -138.41 162.85 33.39 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.699 1.6 . . . . 0.0 107.166 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 23.5 pttm -135.69 142.37 45.08 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.792 1.237 . . . . 0.0 108.953 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 141.57 55.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.774 0.715 . . . . 0.0 110.974 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.76 -35.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 118.451 -0.785 . . . . 0.0 112.338 169.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.08 151.24 51.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.554 1.07 . . . . 0.0 110.749 169.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -168.24 165.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.065 2.546 . . . . 0.0 106.532 167.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -146.58 178.13 8.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.586 1.554 . . . . 0.0 107.138 169.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 m120 58.55 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.36 1.064 . . . . 0.0 110.834 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -57.11 14.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.58 0.752 . . . . 0.0 110.286 -172.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.56 -52.87 18.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.141 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -35.06 -57.96 0.55 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.0 112.222 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -57.79 -45.97 85.26 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.61 -0.681 . . . . 0.0 112.141 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -68.83 -30.17 68.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.838 . . . . 0.0 111.994 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -72.83 58.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.873 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m 175.59 -55.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.764 2.426 . . . . 0.0 107.143 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.15 -37.76 75.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.781 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.41 32.91 68.02 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.28 -31.35 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.694 0.747 . . . . 0.0 110.442 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.4 71.15 0.03 OUTLIER Glycine 0 C--N 1.336 0.572 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.413 ' C ' ' H ' ' A' ' 29' ' ' THR . 45.3 t80 -54.33 146.59 15.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.33 -12.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.627 1.571 . . . . 0.0 114.636 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 27' ' ' PHE . 11.1 m -102.16 -61.86 1.34 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 108.586 -168.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -70.71 7.33 1.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.104 -0.998 . . . . 0.0 113.382 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.59 -46.48 85.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.206 -0.934 . . . . 0.0 108.993 159.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -44.7 96.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.66 43.15 1.84 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.327 0.965 . . . . 0.0 112.98 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -163.72 -32.52 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.222 1.809 . . . . 0.0 109.588 167.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 90.2 mmm -53.26 -45.0 68.64 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 159.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -64.05 108.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -35.15 104.97 0.27 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.463 1.905 . . . . 0.0 112.302 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.77 123.93 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.734 1.622 . . . . 0.0 109.42 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.8 m -79.96 179.94 7.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -152.09 88.71 1.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -79.03 128.36 38.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mt -127.98 101.73 7.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -109.24 115.59 30.29 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.825 1.25 . . . . 0.0 108.653 -171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.1 t -78.74 103.58 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -77.81 65.08 3.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.867 1.267 . . . . 0.0 108.764 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.53 -88.14 0.05 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.665 0.65 . . . . 0.0 111.752 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.38 17.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.132 0.973 . . . . 0.0 110.081 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.42 173.12 7.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.77 2.028 . . . . 0.0 108.093 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.41 130.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.81 131.52 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.9 tt -114.37 128.15 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -135.04 131.38 36.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.805 0.442 . . . . 0.0 111.002 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -29.52 39.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.609 1.563 . . . . 0.0 112.951 -159.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 33.72 56.96 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.215 1.806 . . . . 0.0 113.691 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -66.07 -60.5 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -114.23 62.03 0.66 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 69.22 -21.16 0.16 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.92 88.4 1.67 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 0.0 108.078 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.49 55.88 1.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.58 0.752 . . . . 0.0 109.776 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 58.59 175.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.892 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -151.11 155.63 39.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.834 0.454 . . . . 0.0 110.811 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.0 mt -128.87 143.0 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.2 p -149.46 97.78 2.69 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -149.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.26 176.93 8.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.939 0.496 . . . . 0.0 110.905 -160.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -151.88 122.43 7.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -175.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.93 103.76 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 109.871 171.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.5 40.48 1.35 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.556 2.027 . . . . 0.0 111.802 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -148.02 149.86 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.024 1.33 . . . . 0.0 107.641 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -115.01 146.89 40.78 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.614 1.166 . . . . 0.0 109.194 162.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.27 161.98 12.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.474 0.309 . . . . 0.0 110.666 -168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -76.37 112.79 13.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -100.8 110.22 22.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -113.71 121.83 45.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 t -145.45 145.62 31.18 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.79 44.07 0.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.204 1.001 . . . . 0.0 111.942 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -152.93 -63.91 0.16 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.43 1.892 . . . . 0.0 106.963 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -79.64 1.37 26.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.331 0.652 . . . . 0.0 111.599 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 78.28 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.059 1.344 . . . . 0.0 108.671 169.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -92.25 124.42 36.31 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.81 139.09 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 20.3 ttmt -78.99 131.38 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 162.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 p -130.42 161.92 30.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.0 0.364 . . . . 0.0 110.673 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.6 tt -129.53 142.42 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.327 1.851 . . . . 0.0 106.485 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.7 144.93 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -150.89 -170.62 3.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 164.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tt -135.4 124.85 24.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 107.355 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.22 145.13 51.4 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.811 0.844 . . . . 0.0 109.461 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.85 -78.93 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.632 1.11 . . . . 0.0 111.548 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.82 26.97 0.26 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.037 1.303 . . . . 0.0 110.932 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.69 136.32 52.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.377 1.471 . . . . 0.0 107.341 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 tt -92.21 118.61 31.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.84 121.36 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.705 0.802 . . . . 0.0 109.377 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -105.53 123.11 47.36 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.92 1.688 . . . . 0.0 106.453 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.33 129.7 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -148.08 112.65 5.34 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.629 -151.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -130.61 163.84 26.26 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.749 1.22 . . . . 0.0 112.245 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -136.83 -65.85 0.54 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.33 143.71 10.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.19 -7.5 5.91 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.128 -0.818 . . . . 0.0 114.206 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 165.08 14.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.935 1.367 . . . . 0.0 110.423 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -142.07 125.56 16.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.33 1.852 . . . . 0.0 106.948 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.33 153.54 24.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 110.482 164.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -123.12 136.9 54.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.913 1.285 . . . . 0.0 107.581 172.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 110.12 7.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.19 129.8 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -122.21 124.71 44.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 127.063 2.145 . . . . 0.0 107.801 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -143.6 144.21 31.82 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -115.57 123.46 48.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 161.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.03 -179.73 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 159.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 52.16 -113.83 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.1 28.39 2.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.897 1.237 . . . . 0.0 110.075 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -127.59 127.31 43.64 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 tt -83.8 93.99 8.09 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.9 mt -73.44 111.96 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.8 135.5 44.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 163.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.6 m -128.36 124.19 35.79 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.77 125.82 51.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.599 0.76 . . . . 0.0 109.235 -178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.8 m -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.195 1.798 . . . . 0.0 108.994 -172.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -97.34 161.88 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.01 63.84 1.61 Allowed Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.646 -0.659 . . . . 0.0 111.802 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.8 t 161.13 -60.44 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.544 3.138 . . . . 0.0 108.265 172.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.71 137.74 33.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.429 0.692 . . . . 0.0 110.391 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.84 123.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.496 1.118 . . . . 0.0 108.712 -173.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.1 t -133.37 111.67 10.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.416 0.687 . . . . 0.0 109.903 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -63.82 153.53 36.37 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 160.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -159.54 83.57 0.76 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.344 0.657 . . . . 0.0 109.3 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -88.46 126.88 35.45 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.459 -0.776 . . . . 0.0 109.973 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -102.61 144.37 31.1 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.695 1.198 . . . . 0.0 109.169 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 43.3 tt0 -119.86 133.72 55.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.209 2.204 . . . . 0.0 106.864 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -58.8 141.27 53.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.058 0.845 . . . . 0.0 110.839 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -31.25 67.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.953 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.657 1.183 . . . . 0.0 108.488 179.461 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.572 0.225 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.54 54.36 0.45 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.695 2.798 . . . . 0.0 111.578 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.71 -51.44 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.573 1.149 . . . . 0.0 108.279 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -57.64 -46.83 83.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.436 1.095 . . . . 0.0 110.96 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 p -38.23 110.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.412 1.885 . . . . 0.0 111.908 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.83 -146.48 18.42 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -130.78 134.74 47.12 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.639 0.775 . . . . 0.0 110.708 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -118.58 162.28 18.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.799 1.64 . . . . 0.0 109.744 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -136.8 132.96 35.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.604 1.162 . . . . 0.0 108.643 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.14 147.86 42.59 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.98 -70.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 122.856 0.463 . . . . 0.0 111.284 164.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -93.47 144.14 25.64 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -171.93 43.34 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.66 155.36 33.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.053 0.842 . . . . 0.0 112.381 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.99 25.52 13.92 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.519 1.528 . . . . 0.0 111.991 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -75.18 -49.82 18.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.124 -0.985 . . . . 0.0 109.898 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.91 -61.38 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.466 0.65 . . . . 0.0 110.093 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 17.9 t70 -45.56 -48.56 14.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.559 1.944 . . . . 0.0 112.065 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -55.24 -44.62 75.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.262 1.025 . . . . 0.0 111.257 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.25 -33.2 59.17 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.679 -0.638 . . . . 0.0 111.088 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.7 ttpm? -73.41 51.89 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.473 1.509 . . . . 0.0 109.358 170.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 m -178.59 -60.17 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 128.372 2.669 . . . . 0.0 107.058 -173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.55 -20.26 62.05 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.91 -22.16 32.85 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.78 -1.011 . . . . 0.0 112.62 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -66.15 66.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.664 1.986 . . . . 0.0 114.776 -162.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.87 44.23 3.15 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.92 2.2 . . . . 0.0 110.438 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -36.17 -43.77 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.183 2.193 . . . . 0.0 114.027 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.29 44.48 2.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.489 1.116 . . . . 0.0 110.799 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.9 t -152.04 -44.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.65 . . . . 0.0 111.177 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -27.48 45.0 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.928 -1.107 . . . . 0.0 110.022 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.24 -20.14 64.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.361 1.464 . . . . 0.0 112.522 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.35 -30.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.15 0.58 . . . . 0.0 110.293 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.22 63.61 0.77 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.155 0.883 . . . . 0.0 111.925 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -162.3 -51.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.721 1.608 . . . . 0.0 110.455 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.4 mtt -57.21 -47.54 81.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.035 1.334 . . . . 0.0 109.983 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -68.16 66.85 0.11 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.148 2.179 . . . . 0.0 110.412 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -18.66 91.73 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 128.032 2.533 . . . . 0.0 113.549 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.27 136.89 67.16 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.125 1.216 . . . . 0.0 110.806 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.71 141.74 28.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 m -130.91 102.28 5.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.22 131.2 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.1 mt -126.2 103.41 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.12 134.57 40.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.77 119.34 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -95.13 168.78 10.55 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.253 1.021 . . . . 0.0 108.585 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -29.54 -60.38 0.18 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.886 1.707 . . . . 0.0 114.645 -170.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -126.47 22.19 7.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.867 1.667 . . . . 0.0 109.919 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.96 -178.67 6.61 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.834 0.854 . . . . 0.0 109.455 -153.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.45 150.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 121.122 -0.986 . . . . 0.0 108.96 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.4 tt -133.65 126.66 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -93.19 127.06 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -133.51 91.55 2.87 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -80.79 131.5 35.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.024 1.33 . . . . 0.0 109.17 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 114.13 23.51 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.559 0.744 . . . . 0.0 109.479 169.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.8 t -140.97 54.1 1.57 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t 39.67 -118.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.735 1.214 . . . . 0.0 110.045 -168.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -57.59 -9.37 1.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.889 1.676 . . . . 0.0 115.125 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -118.03 32.24 6.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.608 1.095 . . . . 0.0 111.129 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -63.21 159.76 17.02 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.65 -0.656 . . . . 0.0 110.653 162.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 160.16 23.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.807 1.243 . . . . 0.0 108.203 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.54 120.08 6.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.286 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mt -143.65 124.26 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.001 0.92 . . . . 0.0 109.928 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 p -91.2 142.19 27.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.955 2.102 . . . . 0.0 110.071 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -156.68 -175.68 5.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.436 1.094 . . . . 0.0 109.213 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -124.7 145.51 49.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 54.55 0.59 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.881 1.273 . . . . 0.0 110.154 174.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.42 58.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 p -164.99 162.33 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.49 148.16 23.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.778 0.674 . . . . 0.0 109.751 165.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.88 145.84 22.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.742 0.817 . . . . 0.0 110.263 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.68 133.59 48.65 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.697 1.599 . . . . 0.0 108.347 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -143.51 131.25 21.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 t -103.07 121.66 43.05 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.74 0.816 . . . . 0.0 108.857 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 171.72 8.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.43 -7.96 11.74 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -155.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -105.41 11.03 33.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.275 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t0 43.84 46.98 6.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.202 2.201 . . . . 0.0 113.222 -162.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 117.219 -1.792 . . . . 0.0 106.359 148.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.25 84.07 7.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -82.67 178.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.839 1.256 . . . . 0.0 109.536 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -124.44 119.36 28.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -100.74 157.68 16.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.852 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 120.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.6 t -107.57 131.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p -126.06 119.96 29.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.348 1.059 . . . . 0.0 108.352 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.87 103.99 15.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -86.25 -167.53 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.941 0.401 . . . . 0.0 110.16 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.2 55.02 2.75 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.585 -0.697 . . . . 0.0 111.798 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 -57.49 0.27 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.93 152.28 47.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.334 0.654 . . . . 0.0 111.116 -162.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.66 102.71 15.13 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -80.32 96.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.05 99.95 12.83 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.96 142.09 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 167.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -131.43 100.19 5.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.242 1.417 . . . . 0.0 107.76 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -114.55 157.01 23.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.609 1.164 . . . . 0.0 108.567 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -140.71 -62.5 0.49 Allowed 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.714 -0.617 . . . . 0.0 110.916 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -166.75 -82.58 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.075 0.398 . . . . 0.0 110.9 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.45 -17.02 80.28 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.84 -0.538 . . . . 0.0 112.099 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.79 163.49 30.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.88 151.45 50.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.646 1.978 . . . . 0.0 106.213 173.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.8 p -137.06 166.9 22.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.011 0.924 . . . . 0.0 109.206 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 p -133.59 154.73 50.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.2 68.97 1.1 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.01 132.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.937 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -123.08 153.32 40.06 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.483 0.583 . . . . 0.0 110.756 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 90' ' ' LYS . 45.4 tt0 -157.54 159.6 37.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.75 120.9 35.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 160.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.72 172.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 155.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.23 -120.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -165.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.63 21.71 3.56 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.828 1.204 . . . . 0.0 111.357 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -122.26 134.55 54.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.81 0.805 . . . . 0.0 109.454 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.94 79.82 1.66 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mt -64.27 132.55 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.187 0.995 . . . . 0.0 108.347 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.69 158.25 43.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 165.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 t -126.18 127.07 45.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 166.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tt -109.34 106.75 16.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.691 1.996 . . . . 0.0 105.782 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 p -124.76 138.53 54.28 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.695 1.198 . . . . 0.0 110.941 -162.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -134.19 141.28 47.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 107.859 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.4 91.22 0.02 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 165.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m 136.19 -27.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 131.28 3.832 . . . . 0.0 111.337 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.83 152.23 36.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.007 1.276 . . . . 0.0 111.206 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.16 135.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.727 0.811 . . . . 0.0 109.35 -170.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.0 t -141.32 106.85 5.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.442 0.697 . . . . 0.0 110.887 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.1 p -58.28 143.81 43.36 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 159.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -156.01 154.84 31.7 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.322 0.964 . . . . 0.0 108.978 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.6 t -157.57 156.59 32.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.26 150.6 52.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.832 1.653 . . . . 0.0 107.956 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.61 136.22 52.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.053 1.341 . . . . 0.0 108.151 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -67.01 121.9 16.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -86.86 -38.43 16.78 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.133 0 C-N-CA 122.985 0.514 . . . . 0.0 109.879 -178.112 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.48 50.76 0.43 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.11 2.564 . . . . 0.0 111.84 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.01 -55.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.57 -46.71 66.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 111.421 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.01 104.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.416 1.487 . . . . 0.0 112.066 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.62 -169.68 29.15 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -109.93 132.74 53.89 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.73 0.812 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.405 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 53.0 m95 -115.71 140.88 48.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.384 1.074 . . . . 0.0 109.568 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -95.93 132.35 41.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.72 141.48 57.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.51 -52.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.719 -0.657 . . . . 0.0 110.584 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.58 137.69 49.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.941 0.791 . . . . 0.0 108.995 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -155.36 144.57 20.94 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.931 1.692 . . . . 0.0 108.074 -169.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -170.62 159.46 6.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.786 0.835 . . . . 0.0 111.787 163.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 t30 62.16 34.42 16.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.361 1.864 . . . . 0.0 112.756 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -74.78 -43.66 53.63 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.78 -48.22 75.7 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 117.493 0.133 . . . . 0.0 111.01 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -50.36 -46.87 56.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.942 0.897 . . . . 0.0 111.568 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.15 -55.52 33.6 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -36.64 31.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.757 1.223 . . . . 0.0 112.333 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -74.72 55.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.484 1.914 . . . . 0.0 109.611 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.4 p -178.88 -48.59 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.859 2.464 . . . . 0.0 107.065 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.15 -28.07 59.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.373 0.669 . . . . 0.0 112.322 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.78 29.35 72.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.688 0.661 . . . . 0.0 113.259 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.14 -51.62 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.588 1.155 . . . . 0.0 110.986 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.39 -65.52 2.31 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -155.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 25.5 -96.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.564 1.946 . . . . 0.0 114.788 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.78 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.488 0.715 . . . . 0.0 110.954 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 m -57.87 -36.97 73.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.753 1.621 . . . . 0.0 110.456 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -51.22 63.42 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.414 0.686 . . . . 0.0 111.003 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.275 4.9 pp0? -63.78 -46.33 85.69 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.717 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.02 -49.38 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.216 0.462 . . . . 0.0 109.837 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.06 -23.68 1.2 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 128.239 2.828 . . . . 0.0 115.087 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -137.96 39.38 2.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.422 0.689 . . . . 0.0 110.34 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.0 ttt -156.86 -56.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.622 0.369 . . . . 0.0 111.684 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -115.13 56.93 0.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.084 0.553 . . . . 0.0 111.446 -157.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 33.38 61.61 1.66 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.989 1.716 . . . . 0.0 113.823 172.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.13 116.31 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.241 2.628 . . . . 0.0 109.187 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.33 157.75 19.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.371 1.068 . . . . 0.0 108.273 -170.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 m -148.09 101.55 3.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.508 -0.745 . . . . 0.0 110.865 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.79 126.47 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 107.995 161.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.3 mm -123.85 110.07 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.418 1.487 . . . . 0.0 107.558 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -112.02 115.94 29.73 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.203 1.001 . . . . 0.0 109.128 -168.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.09 123.3 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.05 164.9 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.855 1.262 . . . . 0.0 108.288 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -36.41 -53.7 1.33 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.028 1.299 . . . . 0.0 113.381 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -106.79 -42.19 5.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.651 1.581 . . . . 0.0 111.292 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -101.36 -170.65 1.86 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.754 2.021 . . . . 0.0 110.645 -162.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.76 133.55 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 162.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 133.11 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -101.32 124.91 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.63 103.23 10.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.493 1.917 . . . . 0.0 106.804 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -80.58 124.42 28.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.147 0.579 . . . . 0.0 109.895 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -93.78 119.69 33.08 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -136.65 36.99 2.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.898 0.479 . . . . 0.0 110.212 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.7 m 61.22 101.26 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.318 1.447 . . . . 0.0 112.129 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 t80 72.4 -62.13 0.47 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.611 1.164 . . . . 0.0 109.359 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 145.97 46.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.156 0.979 . . . . 0.0 109.081 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.93 178.26 7.09 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 163.6 38.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 161.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.66 149.71 40.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -140.37 133.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.4 p -96.74 124.71 40.8 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.825 1.65 . . . . 0.0 108.425 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.62 159.5 41.95 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 119.704 1.138 . . . . 0.0 111.056 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.14 135.58 50.04 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 66.74 0.37 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.299 0.5 . . . . 0.0 110.545 169.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.35 63.4 0.03 OUTLIER Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.181 0.896 . . . . 0.0 111.127 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -170.77 169.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.227 1.011 . . . . 0.0 108.347 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.99 157.35 40.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.292 0.637 . . . . 0.0 109.948 165.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -167.57 152.3 6.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.178 0.591 . . . . 0.0 111.205 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -72.34 133.06 44.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.755 1.622 . . . . 0.0 107.075 170.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -140.63 155.82 46.43 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.402 1.081 . . . . 0.0 108.729 -165.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -154.22 145.22 22.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.705 -0.622 . . . . 0.0 110.509 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.3 t -157.97 151.6 23.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.348 0.594 . . . . 0.0 111.865 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.75 65.56 3.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.822 1.649 . . . . 0.0 110.515 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 p30 171.49 -64.76 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 129.132 2.973 . . . . 0.0 108.015 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.274 9.3 t70 -78.1 -1.65 33.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 73.73 -156.74 0.07 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.964 1.306 . . . . 0.0 109.191 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -79.98 140.24 36.7 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 164.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.69 166.84 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.01 126.13 55.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 167.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -90.21 135.06 33.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 tt -129.2 115.77 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.08 134.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.92 0.888 . . . . 0.0 108.952 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -160.12 150.88 18.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.71 151.9 21.61 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.654 0.661 . . . . 0.0 111.2 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.21 178.97 4.74 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 161.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -19.07 -47.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 128.0 2.714 . . . . 0.0 115.363 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.42 62.09 0.28 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.305 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -172.73 149.9 2.08 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 108.893 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -86.95 131.51 34.07 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.35 108.44 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -94.83 107.5 19.52 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.08 131.39 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -122.15 101.93 7.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 107.108 -163.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -115.62 114.49 24.98 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.611 1.564 . . . . 0.0 110.905 -163.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -104.79 -62.5 1.33 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.599 0.636 . . . . 0.0 111.599 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.81 106.27 1.84 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.758 0.708 . . . . 0.0 112.597 -171.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.95 25.25 65.77 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.939 0.781 . . . . 0.0 112.177 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -175.15 167.66 3.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.368 1.467 . . . . 0.0 107.045 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -157.3 160.91 39.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.9 p -124.15 149.43 46.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.138 0.575 . . . . 0.0 109.824 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.9 p -88.45 135.11 33.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.945 0.898 . . . . 0.0 109.123 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.94 87.72 2.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 161.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.21 129.92 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.0 138.11 51.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.445 1.098 . . . . 0.0 110.944 -171.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.02 155.34 32.51 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.743 0.652 . . . . 0.0 109.287 154.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -96.59 112.39 24.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.14 0.976 . . . . 0.0 109.188 165.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.6 -171.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.8 t70 51.07 -110.27 0.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.14 29.64 2.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.646 1.593 . . . . 0.0 109.678 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -150.01 146.12 26.81 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.99 0.895 . . . . 0.0 109.732 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 5.2 tt -85.09 113.19 21.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.4 mt -89.33 105.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.41 117.44 29.12 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 166.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.0 m -103.43 133.95 47.62 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.67 86.78 2.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.475 1.11 . . . . 0.0 108.199 -161.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -115.59 133.03 56.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.414 0.552 . . . . 0.0 110.65 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -134.45 138.38 44.72 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.166 2.187 . . . . 0.0 107.783 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.58 108.01 0.72 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 165.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 m 121.8 -37.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 130.001 3.32 . . . . 0.0 112.174 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.63 162.64 38.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.098 1.317 . . . . 0.0 112.122 -168.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.87 151.74 20.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.699 0.799 . . . . 0.0 109.86 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.5 m -143.72 159.52 42.35 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.162 -0.961 . . . . 0.0 108.776 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.35 145.43 37.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 159.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -142.34 101.91 3.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -103.05 123.68 47.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -108.86 149.23 29.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.23 1.812 . . . . 0.0 110.101 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -124.35 127.36 47.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.512 1.525 . . . . 0.0 107.798 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -68.64 119.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.28 -29.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.244 0.618 . . . . 0.0 111.451 -173.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.138 0 CA-C-N 118.403 0.547 . . . . 0.0 109.907 170.384 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.25 -36.72 32.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.02 1.728 . . . . 0.0 111.438 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.64 -15.32 62.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.715 1.606 . . . . 0.0 112.016 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.75 -52.41 2.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.563 1.145 . . . . 0.0 110.098 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.11 114.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.422 1.489 . . . . 0.0 111.603 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.99 -178.66 22.64 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 121.722 0.624 . . . . 0.0 112.84 164.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -96.39 127.41 42.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 169.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -117.61 157.34 26.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.323 1.049 . . . . 0.0 108.355 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -120.33 149.92 41.55 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 162.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.16 148.36 31.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.47 -56.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 118.25 0.477 . . . . 0.0 111.42 168.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 148.82 27.65 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -166.07 154.24 10.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.768 0.827 . . . . 0.0 109.129 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -148.57 145.93 28.04 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.425 1.09 . . . . 0.0 108.701 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 66.77 17.8 10.61 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.32 1.848 . . . . 0.0 113.147 168.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -59.58 -38.88 82.34 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.753 -1.217 . . . . 0.0 109.341 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.94 -41.78 96.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 111.194 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -58.53 -48.0 82.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.326 0.65 . . . . 0.0 109.558 173.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -51.97 -56.27 15.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -48.85 -50.52 34.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.436 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -77.38 53.58 1.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.086 1.754 . . . . 0.0 110.056 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.3 p -177.92 -50.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.266 2.227 . . . . 0.0 106.592 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.94 -32.45 74.17 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.54 23.87 74.22 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.675 0.655 . . . . 0.0 112.064 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.82 53.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.518 -0.99 . . . . 0.0 110.417 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.25 109.14 0.05 OUTLIER Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.717 0.675 . . . . 0.0 112.256 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.78 -64.91 0.76 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 120.776 -1.426 . . . . 0.0 111.049 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.28 65.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.101 0.56 . . . . 0.0 110.736 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -51.3 -51.75 51.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.211 1.404 . . . . 0.0 110.98 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -72.77 -42.19 64.25 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.468 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.32 -56.91 7.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.842 1.201 . . . . 0.0 110.248 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.01 -52.13 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 42.54 2.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.84 0.733 . . . . 0.0 113.514 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -157.71 -37.16 0.07 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.712 2.005 . . . . 0.0 109.91 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.9 ttt -76.77 -33.98 58.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.881 0.472 . . . . 0.0 109.942 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -66.24 166.68 11.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.539 166.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.29 80.59 3.46 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.719 0.808 . . . . 0.0 109.223 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.61 158.81 46.93 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.784 2.323 . . . . 0.0 112.338 -168.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 164.54 25.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.348 166.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -145.43 121.93 11.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 155.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mt -90.91 135.58 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -133.44 104.4 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -109.88 109.15 19.69 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.81 88.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -50.53 157.67 0.71 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.481 1.112 . . . . 0.0 110.854 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -26.0 -59.72 0.07 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.202 1.858 . . . . 0.0 115.182 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.75 13.63 9.29 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.718 1.207 . . . . 0.0 111.524 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.18 -172.16 4.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.557 1.543 . . . . 0.0 108.264 -157.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.06 149.56 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 120.766 -1.209 . . . . 0.0 109.974 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.49 128.9 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.11 125.01 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -115.09 106.04 13.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.568 1.547 . . . . 0.0 108.976 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -83.59 63.02 7.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.749 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -71.31 144.63 49.88 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 122.14 0.971 . . . . 0.0 112.957 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -158.53 168.11 27.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 168.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -80.81 56.72 2.78 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -172.7 -51.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -172.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -138.3 146.01 41.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -148.34 49.62 1.03 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.489 0.715 . . . . 0.0 110.138 -163.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.9 p -85.61 151.4 23.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.592 0.357 . . . . 0.0 110.443 -172.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -121.55 142.93 49.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 0.0 110.292 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.34 93.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -172.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 p -104.36 125.32 50.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.97 1.708 . . . . 0.0 110.113 -174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -161.27 170.55 20.01 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -93.77 127.46 39.51 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 165.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.06 64.73 1.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 110.867 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.46 55.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -169.61 173.5 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.26 1.024 . . . . 0.0 108.274 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -107.16 148.56 28.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.458 160.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.67 169.34 22.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.363 1.465 . . . . 0.0 108.469 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -92.2 121.85 34.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -116.65 138.17 51.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.413 1.485 . . . . 0.0 107.226 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -138.65 108.37 6.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -128.64 129.57 46.04 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 44.56 0.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.944 -1.097 . . . . 0.0 113.934 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.27 48.9 p30 -147.36 -52.32 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.975 0.91 . . . . 0.0 109.382 156.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -6.07 47.6 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 82.72 -159.53 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.433 2.293 . . . . 0.0 111.9 165.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -83.76 127.98 34.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.263 1.425 . . . . 0.0 107.835 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 143.98 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.925 1.29 . . . . 0.0 107.641 -174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -81.35 114.39 20.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 166.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -96.58 119.49 35.16 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.312 1.045 . . . . 0.0 108.846 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.59 126.5 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.67 134.93 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.1 m -142.59 170.33 15.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.4 133.53 55.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 165.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -82.08 -23.01 36.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.747 0.419 . . . . 0.0 111.378 -174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.01 -32.55 3.96 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.021 1.296 . . . . 0.0 110.298 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.19 -23.96 8.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.643 1.592 . . . . 0.0 111.985 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -150.25 161.26 42.78 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.233 1.413 . . . . 0.0 111.522 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.29 124.55 31.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 163.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.21 128.74 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.302 1.041 . . . . 0.0 109.424 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -114.64 95.85 5.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.438 2.295 . . . . 0.0 106.78 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.65 96.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -97.9 107.9 20.49 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.326 1.45 . . . . 0.0 108.486 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -121.42 155.71 34.27 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.525 0.602 . . . . 0.0 111.954 -171.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -130.71 -60.94 0.97 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.406 -0.331 . . . . 0.0 110.788 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -160.63 -76.62 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 118.346 0.521 . . . . 0.0 111.962 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.8 -11.8 85.1 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.592 0.633 . . . . 0.0 113.094 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -173.13 175.87 3.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.6 1.56 . . . . 0.0 107.649 -172.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -154.06 158.96 41.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.294 1.437 . . . . 0.0 109.417 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.13 121.31 44.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.715 2.006 . . . . 0.0 108.814 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.17 99.16 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.536 1.134 . . . . 0.0 108.32 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.66 146.48 25.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.91 146.57 31.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -136.23 140.78 43.75 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.539 1.536 . . . . 0.0 108.248 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -163.96 153.18 14.02 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.437 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -111.66 118.74 36.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.477 0.58 . . . . 0.0 109.799 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 -174.43 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 t70 52.73 -107.09 0.32 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.67 29.62 1.43 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.036 1.303 . . . . 0.0 110.544 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -143.35 144.03 31.91 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.134 0.967 . . . . 0.0 109.875 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.84 93.59 6.29 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 171.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.5 mt -70.34 129.57 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -144.95 142.73 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.89 113.68 14.94 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -171.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 p -117.88 129.0 55.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 108.842 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -125.15 169.92 11.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.261 1.424 . . . . 0.0 107.191 173.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.09 118.57 2.39 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 161.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.285 0.5 OUTLIER 67.91 -58.25 0.45 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.6 2.36 . . . . 0.0 113.281 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.55 112.21 12.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.527 -0.733 . . . . 0.0 111.26 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.73 125.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 126.201 1.8 . . . . 0.0 106.573 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 3.9 m -144.8 167.42 22.62 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.926 -1.109 . . . . 0.0 110.281 -174.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.8 p -136.4 144.41 44.5 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.927 0.491 . . . . 0.0 111.249 -170.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -138.04 151.09 47.52 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 166.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.24 139.67 47.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -115.66 156.53 25.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.615 1.166 . . . . 0.0 109.568 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.1 127.45 26.49 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.509 1.124 . . . . 0.0 108.41 -168.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -64.24 119.54 10.46 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.198 0.999 . . . . 0.0 108.96 -173.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -82.01 -50.93 8.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 C-N-CA 123.795 0.838 . . . . 0.0 109.088 176.755 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.6 48.02 0.19 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.25 2.62 . . . . 0.0 112.483 -175.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.32 -60.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -172.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -61.67 -33.65 74.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.271 1.028 . . . . 0.0 110.716 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.63 78.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.724 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.94 -166.86 26.51 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 160.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 m -76.97 124.05 27.21 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.196 1.398 . . . . 0.0 110.984 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -104.16 149.42 25.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.841 1.256 . . . . 0.0 109.002 169.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.2 134.94 54.69 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.992 0.917 . . . . 0.0 108.888 162.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.31 144.77 56.38 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.4 -25.71 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.667 177.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.08 157.08 47.05 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.61 1.096 . . . . 0.0 110.124 173.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 t 176.72 86.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.414 1.886 . . . . 0.0 109.903 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -116.1 160.89 19.71 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.088 0.555 . . . . 0.0 110.925 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 58.33 8.05 0.77 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.329 1.852 . . . . 0.0 112.89 -177.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -31.15 64.46 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.878 -1.139 . . . . 0.0 109.397 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.57 -65.4 0.62 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -44.13 -52.06 7.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.1 1.76 . . . . 0.0 112.229 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -46.43 -50.38 16.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.032 1.333 . . . . 0.0 112.035 176.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.8 mtp -76.9 -34.5 57.73 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.728 -0.607 . . . . 0.0 110.291 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 43.64 0.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.515 2.326 . . . . 0.0 110.313 171.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -171.23 -54.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.2 -27.68 68.6 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 172.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.29 -18.72 55.69 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 119.28 0.945 . . . . 0.0 113.103 171.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 m -41.12 -47.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 127.133 2.173 . . . . 0.0 113.453 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.25 72.27 0.2 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -172.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.85 158.36 2.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 110.605 172.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.13 -78.06 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.438 1.495 . . . . 0.0 110.478 -170.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.7 p -35.24 -44.68 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.756 2.823 . . . . 0.0 113.992 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -34.9 -40.11 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 170.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -50.54 -34.88 27.09 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.007 1.723 . . . . 0.0 113.361 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.72 -44.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.31 18.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.071 0.843 . . . . 0.0 113.109 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -55.57 -53.81 51.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.895 . . . . 0.0 111.978 174.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.4 mtt -81.08 -21.7 39.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.477 1.511 . . . . 0.0 111.511 -172.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -70.44 60.66 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.802 0.728 . . . . 0.0 110.903 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -147.8 48.51 0.65 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.234 2.614 . . . . 0.0 109.043 172.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 -41.58 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.138 2.559 . . . . 0.0 112.311 -167.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -119.62 142.61 48.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 m -146.09 105.19 3.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.769 -0.582 . . . . 0.0 109.592 177.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.4 mt -77.11 113.47 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 170.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -101.41 138.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 163.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -142.99 109.8 5.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -166.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.64 81.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -54.62 156.77 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.286 171.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.0 -72.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.419 2.438 . . . . 0.0 115.604 -171.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -116.42 10.0 14.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.898 1.679 . . . . 0.0 111.132 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.83 -166.48 2.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.296 1.838 . . . . 0.0 108.197 -157.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.28 136.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -112.16 133.58 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 tt -93.62 137.65 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 169.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -138.79 88.11 2.27 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.92 1.688 . . . . 0.0 107.398 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -77.91 129.94 35.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.804 1.642 . . . . 0.0 108.636 178.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.31 143.61 51.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.707 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -158.99 -173.0 4.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.213 1.005 . . . . 0.0 109.461 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -82.18 116.48 21.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.3 t80 59.98 27.25 16.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.093 0.957 . . . . 0.0 112.665 173.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -163.66 75.07 0.35 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.264 -0.898 . . . . 0.0 109.661 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -105.91 139.86 39.82 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 p -150.77 148.81 28.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.85 142.9 24.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.252 0.478 . . . . 0.0 110.989 179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.9 mt -149.96 136.14 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.784 1.234 . . . . 0.0 109.095 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 p -90.22 133.78 34.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.923 1.689 . . . . 0.0 110.075 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.67 177.81 8.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.034 0.934 . . . . 0.0 111.009 176.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -125.58 139.33 53.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 107.042 -176.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 57.14 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.465 0.706 . . . . 0.0 109.65 169.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.07 57.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -167.44 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 96' ' ' LYS . 13.0 pt-20 -122.4 142.69 50.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.558 0.536 . . . . 0.0 111.174 161.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -133.78 150.53 51.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.498 1.519 . . . . 0.0 107.556 -174.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -72.22 131.09 42.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -125.65 131.14 52.69 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 t -126.97 145.35 50.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -146.0 172.32 13.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.56 0.695 . . . . 0.0 110.275 174.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.88 30.73 0.25 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.972 1.309 . . . . 0.0 113.433 -158.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -126.18 11.85 7.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.12 2.568 . . . . 0.0 109.85 165.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t0 63.05 29.33 16.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.492 2.317 . . . . 0.0 112.751 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.81 74.67 1.6 Allowed 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.247 -1.533 . . . . 0.0 109.674 164.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.81 68.86 1.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.196 1.398 . . . . 0.0 109.092 170.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.81 -168.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 110.415 -174.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -135.38 134.67 39.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -122.36 122.6 39.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.285 1.034 . . . . 0.0 109.703 -163.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.39 132.02 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.07 132.19 68.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.275 0.63 . . . . 0.0 109.663 -176.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.05 103.06 2.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.552 1.541 . . . . 0.0 107.661 -178.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.83 130.81 40.09 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.907 -1.12 . . . . 0.0 110.563 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.64 27.59 0.21 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -164.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.81 -38.74 3.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.607 -1.107 . . . . 0.0 111.081 -158.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.54 -64.77 0.17 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.309 1.554 . . . . 0.0 112.544 -175.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 135.82 34.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -174.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.28 89.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.78 113.6 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -115.05 117.97 32.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -117.08 140.46 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -128.6 97.98 4.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -157.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 16.1 ptpt -90.93 162.56 14.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 109.133 -174.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -138.52 -56.15 0.63 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.642 -0.661 . . . . 0.0 110.789 166.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -163.88 -76.11 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.805 0.275 . . . . 0.0 111.11 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.63 -21.76 59.37 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.569 -0.573 . . . . 0.0 111.773 -177.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.73 174.71 11.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.792 . . . . 0.0 109.348 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -133.02 176.17 8.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.845 2.458 . . . . 0.0 109.069 177.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.7 t -133.59 153.77 51.4 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.49 1.116 . . . . 0.0 109.454 165.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.7 m -109.78 134.03 52.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.953 0.901 . . . . 0.0 108.879 -176.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.67 80.4 1.28 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.801 0.81 . . . . 0.0 109.658 -176.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.95 148.72 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -126.12 110.05 13.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -132.54 147.73 52.36 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.243 -177.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.0 ttt -118.09 134.3 55.11 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.21 1.404 . . . . 0.0 108.541 171.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -148.91 177.68 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 54.67 -103.78 0.19 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.35 26.24 1.54 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.123 1.344 . . . . 0.0 109.869 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -140.37 169.08 18.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.756 0.822 . . . . 0.0 109.194 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.62 128.37 45.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -171.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.5 mt -111.82 130.77 64.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -112.7 114.67 27.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.989 0.916 . . . . 0.0 108.693 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.6 p -94.63 76.16 3.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.18 101.45 3.97 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.6 t -128.71 128.33 43.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.471 0.578 . . . . 0.0 110.846 -176.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -173.38 143.69 1.1 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.769 1.227 . . . . 0.0 109.336 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.31 54.74 32.29 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 167.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 m 73.98 -44.96 0.58 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.8 1.24 . . . . 0.0 112.11 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.05 115.98 4.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.67 0.788 . . . . 0.0 111.279 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.09 99.19 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.297 1.439 . . . . 0.0 107.497 172.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.9 t -100.36 105.66 17.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.229 1.012 . . . . 0.0 110.479 175.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -65.29 138.48 58.23 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 155.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -115.51 155.88 26.72 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 144.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.84 137.84 46.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 165.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.81 166.03 11.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.284 2.234 . . . . 0.0 108.77 174.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.37 114.11 15.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -75.35 73.82 2.43 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.382 0.611 . . . . 0.0 109.538 -171.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -45.06 62.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.611 1.564 . . . . 0.0 111.526 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.007 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.93 51.07 0.21 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 131.02 3.728 . . . . 0.0 111.329 -166.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.3 -53.87 0.05 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -158.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.93 47.67 0.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.454 1.102 . . . . 0.0 109.494 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 49.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.847 1.259 . . . . 0.0 108.593 -174.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.3 -165.04 35.28 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.627 -0.671 . . . . 0.0 112.793 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m -87.83 136.39 32.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.499 1.12 . . . . 0.0 111.17 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -115.8 154.5 29.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.912 1.685 . . . . 0.0 108.824 172.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -121.19 152.92 38.23 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 167.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.05 134.65 34.2 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.005 1.322 . . . . 0.0 109.635 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.65 -41.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.451 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -144.48 158.25 43.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.135 0.879 . . . . 0.0 109.192 170.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -174.35 111.93 0.16 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.929 2.092 . . . . 0.0 109.422 -163.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.3 145.26 24.47 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m120 77.11 -5.9 2.1 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.484 2.313 . . . . 0.0 111.476 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -76.21 -41.95 47.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.604 1.562 . . . . 0.0 107.678 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -32.21 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.032 1.733 . . . . 0.0 111.995 151.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -56.49 -40.15 74.46 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.346 0.521 . . . . 0.0 112.381 -173.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -36.04 -58.91 0.63 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.832 1.253 . . . . 0.0 112.826 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.29 65.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.103 -174.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -76.79 51.99 0.81 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.226 1.01 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -168.28 -44.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.372 2.269 . . . . 0.0 107.428 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.44 -12.19 13.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.69 63.07 1.72 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -166.16 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.826 1.65 . . . . 0.0 110.205 -176.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.04 149.45 20.36 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.88 62.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.97 1.308 . . . . 0.0 108.362 -178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 65.59 -19.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.157 1.783 . . . . 0.0 115.255 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 m -99.77 -54.48 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.291 1.436 . . . . 0.0 109.072 -170.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -63.65 -10.94 21.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -56.11 -43.53 78.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.265 0.939 . . . . 0.0 110.884 165.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -50.96 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.19 39.94 1.22 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.116 1.341 . . . . 0.0 113.376 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.1 -25.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.245 1.018 . . . . 0.0 112.227 171.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.86 -36.93 85.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 162.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -63.13 82.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.151 0.977 . . . . 0.0 109.873 167.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -144.47 60.6 7.82 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.792 1.637 . . . . 0.0 108.732 164.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.72 -21.18 25.52 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.381 2.721 . . . . 0.0 110.87 -174.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.3 m -142.87 152.06 41.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.494 -0.754 . . . . 0.0 109.244 -177.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.3 m -154.86 125.99 7.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.0 mt -78.26 134.0 29.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 166.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.9 105.36 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 166.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.1 108.31 12.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.866 0.866 . . . . 0.0 110.224 -170.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.96 114.97 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 169.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -99.74 169.38 9.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.303 1.441 . . . . 0.0 108.495 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -22.49 -65.24 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.433 1.968 . . . . 0.0 114.913 -172.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -116.88 5.06 12.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.097 1.359 . . . . 0.0 111.865 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.8 -172.73 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.717 1.607 . . . . 0.0 109.96 -154.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.11 136.08 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 166.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 tt -104.0 140.21 22.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 tt -124.96 125.68 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.614 1.565 . . . . 0.0 108.456 177.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -134.73 105.9 6.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.84 0.856 . . . . 0.0 109.397 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.82 38.73 0.72 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.609 1.163 . . . . 0.0 113.274 -159.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -44.05 121.52 2.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 113.943 -164.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -141.63 62.87 1.44 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.277 0.631 . . . . 0.0 110.004 -176.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 m 73.03 125.66 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.137 1.375 . . . . 0.0 109.96 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 72.9 -53.68 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.99 1.316 . . . . 0.0 111.911 -178.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.77 -163.73 0.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -169.28 -168.49 0.83 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 p -54.58 147.59 14.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.256 1.423 . . . . 0.0 110.959 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -134.78 122.71 22.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.704 1.601 . . . . 0.0 106.832 176.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.49 158.41 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -129.64 159.72 35.53 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 165.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.13 179.55 8.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.919 0.888 . . . . 0.0 108.717 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -145.75 128.11 15.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 76.03 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.133 0.973 . . . . 0.0 110.052 171.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.54 59.3 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.274 1.416 . . . . 0.0 111.084 174.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -168.32 168.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.103 0.952 . . . . 0.0 109.148 174.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.18 152.56 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 110.774 168.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -172.62 163.81 5.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.539 1.136 . . . . 0.0 109.622 -172.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.5 132.78 44.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.738 0.415 . . . . 0.0 110.115 177.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -123.08 87.02 2.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.58 1.952 . . . . 0.0 107.11 -176.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.7 m -89.4 109.07 20.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.436 0.694 . . . . 0.0 109.514 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -131.88 157.7 43.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.523 0.677 . . . . 0.0 112.256 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.76 49.27 1.03 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.506 1.522 . . . . 0.0 111.727 -173.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -172.01 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.342 1.457 . . . . 0.0 107.346 -173.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.268 5.6 m-20 -74.43 9.47 1.71 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 70.12 -154.9 0.13 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 109.108 162.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.96 81.61 3.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -96.68 165.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -108.19 128.03 54.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.165 -0.959 . . . . 0.0 109.127 171.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 134.55 36.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 tt -129.1 115.52 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 153.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.698 0.799 . . . . 0.0 110.254 -166.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -156.29 173.7 16.48 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.546 1.539 . . . . 0.0 106.934 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.27 148.14 49.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.448 1.022 . . . . 0.0 109.886 161.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -116.89 108.83 16.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.519 1.127 . . . . 0.0 108.151 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.67 -68.01 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.637 1.113 . . . . 0.0 111.715 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.8 60.82 0.16 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.679 -2.169 . . . . 0.0 107.679 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.07 113.58 1.22 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 -177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.09 120.63 31.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.04 129.93 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.693 1.597 . . . . 0.0 108.116 -174.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -113.09 106.18 14.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 171.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -82.17 125.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 164.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -126.09 92.26 3.55 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -163.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -110.0 113.97 27.13 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.267 1.427 . . . . 0.0 108.658 -162.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.45 -55.27 3.35 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.192 0.905 . . . . 0.0 110.677 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -169.46 -90.96 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 117.901 0.319 . . . . 0.0 110.76 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.63 -23.53 77.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -175.35 4.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.613 0.765 . . . . 0.0 109.646 176.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.75 166.54 26.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.286 2.234 . . . . 0.0 106.624 -171.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 t -130.24 153.83 48.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 156.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 p -116.82 137.99 51.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.16 156.64 44.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.71 152.19 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.114 0.566 . . . . 0.0 110.236 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -123.6 138.13 54.61 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.915 1.286 . . . . 0.0 108.641 168.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -156.16 146.69 21.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.733 2.013 . . . . 0.0 106.471 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.09 122.22 22.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.624 0.77 . . . . 0.0 109.133 169.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.46 176.41 4.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 159.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.3 t70 51.76 -117.58 1.15 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -129.7 15.25 5.72 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.234 1.397 . . . . 0.0 110.588 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -123.81 134.22 53.66 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.759 0.78 . . . . 0.0 110.453 -167.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 tp -97.66 116.35 29.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.814 1.645 . . . . 0.0 108.311 -171.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.7 mm -86.29 120.94 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.76 113.34 26.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 167.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -111.46 127.78 55.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 170.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 108.53 6.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.347 1.459 . . . . 0.0 107.689 -166.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -131.48 138.65 49.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.885 0.85 . . . . 0.0 112.211 -170.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -139.72 92.05 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.62 -118.37 12.58 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -61.85 -43.46 98.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.697 1.199 . . . . 0.0 111.323 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.64 68.07 5.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.218 -167.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.9 136.42 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.62 160.7 41.29 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.361 -1.462 . . . . 0.0 109.929 177.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -142.07 154.61 45.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.362 0.414 . . . . 0.0 110.783 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -132.95 169.29 17.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 151.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 119.07 11.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 -176.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -112.24 163.69 14.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.983 1.713 . . . . 0.0 109.283 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -133.56 123.8 25.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 127.364 2.266 . . . . 0.0 107.934 -174.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.97 111.15 3.19 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.13 -34.04 10.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 110.636 -173.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 C-N-CA 123.878 0.871 . . . . 0.0 109.936 174.63 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.53 60.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 129.304 3.042 . . . . 0.0 112.096 -169.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.53 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.159 1.784 . . . . 0.0 107.754 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -58.52 -36.6 74.09 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.752 1.221 . . . . 0.0 111.404 -176.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.5 104.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.14 0.976 . . . . 0.0 111.773 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.58 -177.26 27.87 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.349 1.452 . . . . 0.0 113.347 169.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -85.45 108.45 17.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.147 1.779 . . . . 0.0 111.075 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -97.01 155.86 16.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 174.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -123.97 129.67 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.161 1.784 . . . . 0.0 106.555 174.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.86 131.2 35.82 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.51 -42.75 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.439 0.563 . . . . 0.0 110.781 172.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 66.86 151.55 0.07 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.898 2.079 . . . . 0.0 111.953 -173.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -166.88 30.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.675 163.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -166.91 87.34 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.249 -0.907 . . . . 0.0 110.851 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 63.05 50.98 2.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.44 1.096 . . . . 0.0 110.787 161.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -82.46 -60.65 2.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.212 0.605 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -43.17 -66.34 0.39 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.124 2.169 . . . . 0.0 109.647 171.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.47 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.7 OUTLIER -20.48 -60.55 0.02 OUTLIER 'General case' 0 C--N 1.34 0.175 0 C-N-CA 127.732 2.413 . . . . 0.0 113.039 164.122 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -63.84 -48.97 74.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.234 -171.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 mtt -62.16 -45.13 94.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.981 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -57.06 -31.34 65.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.125 2.57 . . . . 0.0 111.988 177.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -85.95 -57.27 3.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.598 1.159 . . . . 0.0 110.033 178.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.29 -25.25 68.23 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.191 0.596 . . . . 0.0 112.568 -173.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.16 21.61 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.99 -27.74 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.12 -109.3 0.01 OUTLIER Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.176 1.846 . . . . 0.0 113.631 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 27.94 54.25 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.081 2.553 . . . . 0.0 114.36 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 138.87 -61.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.602 2.761 . . . . 0.0 107.743 -172.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 p -66.23 -48.59 70.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -173.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -49.49 -18.92 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.401 1.88 . . . . 0.0 115.74 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -107.16 -13.6 15.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.787 0.835 . . . . 0.0 113.034 -177.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -143.23 -68.61 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.894 0.77 . . . . 0.0 109.169 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.39 60.45 1.53 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.777 1.656 . . . . 0.0 111.223 -176.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.9 -48.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.978 2.111 . . . . 0.0 107.643 -174.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.5 ttm -99.91 -16.9 17.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.321 1.048 . . . . 0.0 111.482 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 t -69.43 72.06 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.825 0.85 . . . . 0.0 111.327 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 45.51 66.62 5.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 111.947 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.16 105.16 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.005 2.47 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -108.82 139.37 43.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.793 1.237 . . . . 0.0 108.48 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.5 m -126.3 106.84 9.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -71.43 130.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 164.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -121.89 133.27 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 165.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.2 139.57 37.54 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 119.145 0.884 . . . . 0.0 109.421 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.72 138.62 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.32 164.26 19.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.0 108.173 175.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.81 -71.8 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.934 2.207 . . . . 0.0 115.521 -175.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -123.98 23.48 8.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.998 1.719 . . . . 0.0 110.319 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.85 -178.75 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.273 1.029 . . . . 0.0 108.681 -152.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.04 134.25 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 172.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.2 tt -99.1 141.31 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.078 0.951 . . . . 0.0 108.554 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 133.52 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.689 1.596 . . . . 0.0 107.422 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -127.32 95.75 4.37 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.811 1.244 . . . . 0.0 109.071 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.28 82.7 7.68 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.677 0.791 . . . . 0.0 109.685 -174.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -74.92 72.9 2.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.627 0.771 . . . . 0.0 109.018 173.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.9 t -142.99 -68.55 0.35 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.067 1.747 . . . . 0.0 106.977 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 m -60.3 144.38 50.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.113 0.965 . . . . 0.0 110.279 175.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -48.55 135.69 14.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.944 0.498 . . . . 0.0 110.115 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 73.39 -4.73 2.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 0.0 113.458 -178.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.6 72.49 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 111.821 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 150.01 38.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.623 -174.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -139.02 135.67 34.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.879 1.672 . . . . 0.0 107.863 -174.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 tp -159.45 159.42 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.535 0.607 . . . . 0.0 109.961 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.7 p -110.59 129.59 55.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.867 . . . . 0.0 109.834 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -131.16 179.87 5.75 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 110.225 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -139.59 147.16 40.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.901 1.28 . . . . 0.0 107.864 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.54 68.7 1.64 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.007 0.523 . . . . 0.0 109.603 174.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.38 69.72 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.11 165.79 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.827 0.851 . . . . 0.0 108.908 175.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -156.85 166.95 31.92 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.771 0.829 . . . . 0.0 109.005 174.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -74.47 124.11 25.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.91 58.93 0.73 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 107.433 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -57.61 106.14 0.31 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 165.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 t -147.64 134.6 20.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.895 0.478 . . . . 0.0 110.393 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.36 -36.19 41.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.13 . . . . 0.0 113.367 -174.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.43 1.07 23.36 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.669 1.188 . . . . 0.0 113.21 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -132.4 -57.05 0.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 109.7 174.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 128.64 -147.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 1 C-N-CA 132.553 4.341 . . . . 0.0 107.255 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -86.69 117.11 25.23 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.85 148.0 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -169.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -95.61 141.1 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.8 p -121.06 87.76 2.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.513 1.125 . . . . 0.0 109.622 -166.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.1 105.34 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 175.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.59 139.92 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.835 0.854 . . . . 0.0 110.913 -172.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.35 171.0 19.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.23 1.812 . . . . 0.0 107.423 -152.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -142.16 131.53 23.65 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -136.7 150.81 48.66 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.182 0.993 . . . . 0.0 109.181 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.46 -80.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.61 1.1 . . . . 0.0 111.66 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.25 30.61 0.27 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.111 1.339 . . . . 0.0 110.651 171.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -132.1 141.55 49.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.111 1.364 . . . . 0.0 108.013 -176.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tt -96.78 112.32 24.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.632 1.173 . . . . 0.0 108.203 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.91 118.33 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 109.335 -174.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -111.35 99.43 8.23 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.601 2.36 . . . . 0.0 106.771 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 132.76 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 170.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -135.19 98.4 3.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -156.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -116.08 118.48 32.99 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.225 1.01 . . . . 0.0 111.232 -163.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -109.4 -26.16 10.15 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.235 0.614 . . . . 0.0 112.5 -176.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -144.61 -135.53 0.09 Allowed 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.54 66.85 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.287 0.949 . . . . 0.0 111.058 170.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -94.6 166.28 12.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.843 0.857 . . . . 0.0 111.643 -174.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 172.76 12.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.681 1.992 . . . . 0.0 110.597 173.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 t -113.67 154.2 27.66 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 153.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 p -112.9 106.52 14.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.652 1.181 . . . . 0.0 108.753 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mp -102.74 109.65 21.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.72 116.45 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.33 0.652 . . . . 0.0 109.403 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -95.93 131.58 42.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.836 1.654 . . . . 0.0 108.752 177.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -144.51 143.1 30.68 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -118.22 119.83 35.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -125.32 -169.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 159.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.26 -113.81 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.035 0.534 . . . . 0.0 109.649 176.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.32 20.68 3.15 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.095 1.807 . . . . 0.0 110.172 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -140.31 143.03 35.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.978 0.889 . . . . 0.0 109.895 -172.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.4 tt -97.01 99.61 11.14 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.23 125.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -115.95 103.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -92.6 125.55 37.29 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.45 85.05 2.26 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.682 1.193 . . . . 0.0 108.383 -174.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.58 124.19 30.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -145.26 145.47 31.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 160.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.64 -36.07 4.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.1 1.333 . . . . 0.0 113.898 -175.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -54.8 -41.21 70.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.388 0.594 . . . . 0.0 111.623 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -171.2 128.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.196 0.599 . . . . 0.0 110.33 -175.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.82 128.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 166.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.47 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 24.2 m -145.1 153.07 41.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.086 -1.009 . . . . 0.0 108.436 -177.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.3 p -140.94 123.67 16.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.154 0.888 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -95.9 102.89 14.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.358 1.863 . . . . 0.0 107.559 175.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 110.04 18.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -92.92 147.99 22.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.54 0.686 . . . . 0.0 111.334 176.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -134.38 123.27 23.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.311 2.244 . . . . 0.0 107.148 -172.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -75.49 130.54 39.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.771 0.714 . . . . 0.0 109.782 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.84 -21.42 11.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.137 0.426 . . . . 0.0 112.011 164.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 118.333 0.515 . . . . 0.0 111.171 -179.455 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.758 0.313 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.86 60.28 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 130.5 3.52 . . . . 0.0 111.174 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.07 -44.83 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.074 1.75 . . . . 0.0 107.884 -169.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -61.59 -39.86 92.71 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.534 0.734 . . . . 0.0 111.391 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -38.26 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.906 1.682 . . . . 0.0 111.753 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.19 -172.41 23.21 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.271 0.928 . . . . 0.0 113.172 170.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -84.24 116.98 23.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.64 1.576 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -99.99 161.21 13.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 166.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.17 135.42 22.82 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.85 135.42 52.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.981 -0.45 . . . . 0.0 109.846 -173.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.33 -39.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 175.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -141.6 162.72 34.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.8 t -174.38 148.89 1.29 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 171.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -121.68 164.43 17.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.33 -22.86 0.21 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 166.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.09 -43.2 20.13 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -166.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -67.35 -61.82 1.72 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.245 0.93 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -40.8 -50.17 3.15 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.868 1.267 . . . . 0.0 111.92 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -50.36 -49.15 55.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.855 1.662 . . . . 0.0 111.876 177.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -37.17 70.76 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.501 -0.75 . . . . 0.0 110.256 176.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.95 48.82 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.914 2.486 . . . . 0.0 109.073 -169.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 p -172.96 -49.26 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.865 1.666 . . . . 0.0 107.26 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -66.16 33.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.226 1.411 . . . . 0.0 114.339 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.87 2.87 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 120.09 -1.631 . . . . 0.0 111.754 -178.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.61 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.299 2.64 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.82 145.39 17.84 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.916 1.246 . . . . 0.0 110.054 172.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -175.19 171.98 2.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.926 1.69 . . . . 0.0 106.568 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.25 44.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.845 0.748 . . . . 0.0 112.999 -175.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 -52.17 11.01 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.32 -0.863 . . . . 0.0 112.896 -167.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -63.87 -40.09 95.73 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -157.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -36.63 -43.31 0.4 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.686 1.595 . . . . 0.0 113.764 163.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.86 -50.04 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.75 -31.79 5.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.042 2.258 . . . . 0.0 115.702 -176.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -85.5 -37.51 19.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.36 1.08 . . . . 0.0 110.463 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -32.7 66.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.975 0.91 . . . . 0.0 109.885 -174.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -76.17 52.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.399 1.08 . . . . 0.0 111.763 -177.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 30.56 58.45 0.94 Allowed Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 127.599 2.36 . . . . 0.0 114.116 172.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.67 142.0 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.444 1.429 . . . . 0.0 112.023 -166.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.26 175.11 4.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.924 1.289 . . . . 0.0 109.825 172.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -159.29 112.15 2.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.486 1.914 . . . . 0.0 106.146 151.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.41 136.58 22.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 174.007 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.4 114.82 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 173.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -118.79 128.81 54.82 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.08 96.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -77.81 65.13 3.2 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.27 -87.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.453 1.502 . . . . 0.0 112.572 -179.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.42 -15.94 18.56 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.956 1.703 . . . . 0.0 111.621 -175.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.1 p -108.11 157.18 18.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.75 118.11 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 tt -101.35 137.89 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.794 0.837 . . . . 0.0 108.99 -174.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mp -117.44 131.72 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.416 1.487 . . . . 0.0 107.165 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -124.54 115.92 21.64 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -64.89 -46.79 80.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.274 0.23 . . . . 0.0 110.475 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 56.5 78.52 0.21 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.59 0.756 . . . . 0.0 112.538 169.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -148.06 149.37 31.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 162.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.7 p -11.41 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 129.129 2.972 . . . . 0.0 114.363 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -118.24 46.48 1.78 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.98 1.312 . . . . 0.0 108.085 177.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -158.96 55.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -110.57 139.66 45.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.748 1.619 . . . . 0.0 108.892 177.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 p -146.41 160.83 41.55 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 173.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -138.99 128.14 23.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -144.12 132.67 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.596 0.758 . . . . 0.0 109.439 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.1 p -106.14 99.5 9.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.547 1.539 . . . . 0.0 109.98 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -84.91 110.22 18.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.424 0.556 . . . . 0.0 110.218 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -76.84 97.99 4.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 161.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.05 110.5 0.61 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 170.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.09 22.55 6.17 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.09 1.805 . . . . 0.0 113.11 175.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -149.11 159.95 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.905 1.352 . . . . 0.0 109.388 -177.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.14 121.81 42.94 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.593 1.557 . . . . 0.0 108.371 166.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -132.52 155.77 48.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.959 1.303 . . . . 0.0 109.401 -177.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.57 148.39 51.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.057 0.543 . . . . 0.0 109.867 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -141.39 158.01 44.43 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.044 1.337 . . . . 0.0 108.786 -167.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -130.18 119.42 22.93 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.969 0.508 . . . . 0.0 110.945 -175.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.82 150.44 20.41 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.68 14.68 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -166.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -106.41 11.58 30.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.569 1.948 . . . . 0.0 110.094 164.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 t0 58.96 26.26 14.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.26 1.824 . . . . 0.0 111.909 -170.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -68.75 100.88 1.22 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 156.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.92 125.59 19.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 151.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.45 -165.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -139.42 144.32 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.458 1.027 . . . . 0.0 110.935 171.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -110.16 118.5 36.53 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.701 2.0 . . . . 0.0 108.71 -175.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.7 tt -96.57 125.47 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 164.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.5 139.69 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 m -144.94 161.84 38.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 170.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -123.33 115.02 20.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.03 130.73 53.89 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.88 -82.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.091 0.853 . . . . 0.0 113.705 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.35 25.45 1.1 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.353 1.454 . . . . 0.0 111.683 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -117.99 126.14 51.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 107.222 177.071 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.38 106.02 17.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 170.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.8 109.08 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -107.81 123.42 48.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -115.94 140.38 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.26 110.08 12.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.858 1.663 . . . . 0.0 107.907 -169.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.99 132.55 56.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.724 2.01 . . . . 0.0 108.233 -164.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -119.72 -65.01 1.2 Allowed 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.825 0.284 . . . . 0.0 111.443 177.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.49 -84.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.183 0.447 . . . . 0.0 111.11 -173.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.45 -30.22 74.91 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -175.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -171.75 3.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.557 0.694 . . . . 0.0 109.251 173.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.23 168.36 20.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.817 2.847 . . . . 0.0 104.767 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.5 t -144.26 147.79 34.02 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.9 m -109.74 143.99 38.77 Favored 'General case' 0 C--O 1.228 -0.075 0 C-N-CA 123.289 0.635 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.24 63.85 1.57 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.044 2.138 . . . . 0.0 107.322 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 p -74.02 128.94 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -110.82 114.64 28.15 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.904 1.282 . . . . 0.0 108.068 174.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 44.9 tt0 -121.74 144.49 48.76 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 165.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.71 127.8 54.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.929 1.292 . . . . 0.0 108.393 169.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.59 -178.59 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.4 -110.78 0.58 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.3 21.0 2.25 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.866 1.698 . . . . 0.0 110.695 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -140.2 156.74 46.39 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -173.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.06 137.9 54.82 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.375 0.534 . . . . 0.0 109.776 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.63 106.97 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -176.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.12 103.72 16.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 170.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 m -85.91 93.66 8.99 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.84 95.63 9.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -121.07 131.61 54.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.66 0.784 . . . . 0.0 111.538 -174.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -113.97 -39.28 3.99 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.539 1.536 . . . . 0.0 110.224 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.84 -80.29 0.26 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 174.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.2 t -58.24 -39.86 80.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.45 141.38 40.4 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 108.766 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -146.22 112.02 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.634 1.574 . . . . 0.0 107.798 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.12 101.46 8.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.245 1.418 . . . . 0.0 110.33 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -56.59 129.83 42.58 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 150.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.94 108.55 10.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.1 113.55 26.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.893 1.277 . . . . 0.0 108.721 -156.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.56 147.57 35.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.946 1.298 . . . . 0.0 112.245 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -124.51 124.22 41.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.219 2.207 . . . . 0.0 106.501 -171.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -75.86 124.7 27.76 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -107.02 -28.51 9.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.387 0.275 . . . . 0.0 111.218 173.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 123.2 0.6 . . . . 0.0 110.705 -177.345 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.764 -0.16 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.97 63.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.084 2.154 . . . . 0.0 110.53 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.18 -43.02 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.88 1.672 . . . . 0.0 108.084 -163.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.15 -43.66 21.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.257 0.623 . . . . 0.0 111.309 -177.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -43.97 102.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.75 1.62 . . . . 0.0 112.949 -169.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.86 -167.52 25.34 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.345 0.974 . . . . 0.0 113.224 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -76.34 110.58 10.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.301 1.441 . . . . 0.0 110.229 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -83.57 113.82 21.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.435 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 13.4 tttm -96.74 125.15 41.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.211 1.004 . . . . 0.0 109.073 174.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.52 141.64 58.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.491 0.587 . . . . 0.0 111.339 -175.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.81 25.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -161.41 158.11 26.26 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.856 1.662 . . . . 0.0 107.506 163.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 t -177.96 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.357 1.463 . . . . 0.0 109.7 -168.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -96.25 138.92 33.15 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 167.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 62.86 -3.69 0.3 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 167.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -59.16 -31.0 68.59 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.542 -1.348 . . . . 0.0 112.106 -173.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.72 -71.18 0.22 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -27.41 -61.24 0.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.458 2.303 . . . . 0.0 111.761 170.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.27 -61.12 1.43 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.912 1.285 . . . . 0.0 111.365 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.8 ptp -74.44 -31.56 62.32 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.859 -0.526 . . . . 0.0 111.718 -176.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.28 47.06 0.35 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.869 2.467 . . . . 0.0 109.29 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m 177.47 -45.65 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 128.061 2.545 . . . . 0.0 107.691 -172.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.6 -45.09 66.39 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.204 -0.31 . . . . 0.0 110.93 172.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.95 -84.22 0.13 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -9.01 -68.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.522 2.329 . . . . 0.0 115.549 167.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 38.04 39.61 0.7 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.418 1.009 . . . . 0.0 115.067 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 150.66 44.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 72.86 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.463 1.105 . . . . 0.0 108.929 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -162.65 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.993 1.317 . . . . 0.0 109.454 -176.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -44.2 63.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.194 0.598 . . . . 0.0 110.651 -172.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -34.79 -41.26 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.637 2.375 . . . . 0.0 114.789 168.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.84 -30.24 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.307 1.443 . . . . 0.0 110.448 177.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.37 59.21 0.63 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.1 2.286 . . . . 0.0 111.668 174.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.93 -69.01 0.07 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.516 3.526 . . . . 0.0 104.886 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -61.53 -36.23 79.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.101 1.36 . . . . 0.0 110.457 -179.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -75.52 14.44 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.64 56.24 12.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.928 1.24 . . . . 0.0 111.773 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.61 153.24 73.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.581 2.188 . . . . 0.0 111.802 -165.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -109.48 165.45 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.216 1.006 . . . . 0.0 109.058 -176.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 m -151.55 106.69 3.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.14 121.07 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mm -111.1 123.08 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 164.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.79 145.53 48.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.9 m -105.15 110.33 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.7 56.97 3.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.06 -85.55 0.02 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.925 0.774 . . . . 0.0 112.33 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.12 -29.65 21.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.893 1.277 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 173.52 6.29 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.015 1.726 . . . . 0.0 107.95 -177.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.83 148.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -177.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.8 tt -129.84 129.29 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.639 0.776 . . . . 0.0 110.167 -173.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.62 135.9 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 125.354 1.461 . . . . 0.0 107.164 172.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -127.13 119.89 27.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.086 0.954 . . . . 0.0 109.361 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -94.25 84.11 4.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 111.46 -166.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -88.07 95.7 10.24 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.442 1.019 . . . . 0.0 112.778 -168.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.9 p -108.12 154.34 21.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 164.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -76.17 61.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -177.93 -49.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.731 0.812 . . . . 0.0 110.148 -170.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -146.13 135.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -173.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -134.31 123.32 23.98 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.2 p -134.42 167.06 21.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.52 149.52 33.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.096 0.407 . . . . 0.0 110.544 168.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 pt -146.38 140.75 20.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.321 1.049 . . . . 0.0 109.106 177.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 p -105.03 153.97 20.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 110.335 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -158.9 160.62 36.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.345 0.658 . . . . 0.0 110.167 -178.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -84.48 131.87 34.61 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.94 54.89 1.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.079 0.854 . . . . 0.0 109.954 167.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.78 57.74 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.001 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -173.12 162.57 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.351 1.076 . . . . 0.0 111.037 169.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -100.44 126.22 46.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.063 2.545 . . . . 0.0 109.385 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.32 157.42 35.67 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.603 -0.685 . . . . 0.0 110.603 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -70.57 150.7 45.8 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.512 0.725 . . . . 0.0 109.626 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -163.65 177.01 9.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.167 1.387 . . . . 0.0 107.276 -164.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.4 m -160.46 99.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 120.168 -1.583 . . . . 0.0 108.255 -163.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 t -82.62 174.76 10.74 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.354 -178.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.17 21.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.204 1.802 . . . . 0.0 115.585 -163.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -139.8 15.6 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.119 2.168 . . . . 0.0 111.37 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.34 40.12 21.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 111.576 -169.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -68.2 111.08 4.32 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 149.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -74.58 71.54 1.88 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.03 154.42 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.802 -175.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.35 120.43 32.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 159.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.18 125.14 30.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 167.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.89 107.35 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.301 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.27 135.51 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 -169.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.7 p -145.85 -168.93 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 107.413 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.59 135.52 38.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 167.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.0 24.67 0.23 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.603 1.092 . . . . 0.0 112.602 -167.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -32.21 3.17 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.337 -163.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.36 -46.83 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.108 1.337 . . . . 0.0 113.143 -172.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -127.21 155.92 42.67 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.382 1.873 . . . . 0.0 109.039 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tt -81.49 121.56 26.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.85 104.57 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.893 1.277 . . . . 0.0 107.675 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -99.6 104.26 16.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.42 143.06 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 169.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.03 108.74 10.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -117.86 139.66 50.8 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.712 1.605 . . . . 0.0 107.66 -170.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.63 -78.76 0.58 Allowed 'General case' 0 C--N 1.337 0.064 0 CA-C-N 119.565 1.075 . . . . 0.0 110.717 172.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.23 -60.04 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.57 0.07 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.402 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 153.36 38.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -125.79 170.15 11.89 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 108.233 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -143.57 149.75 37.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 110.269 165.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 p -109.57 138.03 46.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.512 1.125 . . . . 0.0 108.255 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.54 69.03 1.44 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.124 1.369 . . . . 0.0 107.997 -177.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.21 146.35 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.566 -174.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.99 136.94 35.9 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.723 1.209 . . . . 0.0 110.254 176.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -161.25 147.71 14.59 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 157.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -93.0 102.6 14.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.478 1.511 . . . . 0.0 109.09 167.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.49 -173.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 158.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 50.99 -110.82 0.5 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.79 25.03 2.11 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.072 1.32 . . . . 0.0 110.803 174.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -150.74 153.45 35.54 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.3 1.05 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.7 120.62 31.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -89.0 133.52 30.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.58 121.6 36.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.6 m -110.99 109.61 19.81 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.49 124.79 35.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 168.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.3 m -141.57 135.14 29.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.684 0.675 . . . . 0.0 110.723 173.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -137.71 154.7 49.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.376 2.27 . . . . 0.0 108.001 -177.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -30.6 -48.22 0.16 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.569 2.033 . . . . 0.0 115.627 -178.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 t -135.27 41.28 2.81 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.805 0.803 . . . . 0.0 110.6 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.6 126.07 4.44 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.325 -0.86 . . . . 0.0 109.202 169.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 p -118.09 132.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.732 1.213 . . . . 0.0 107.774 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -139.24 112.56 8.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 p -67.12 143.48 56.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 158.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -139.14 162.28 35.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 160.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.73 145.64 26.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 170.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -125.48 162.82 24.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.416 1.486 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.435 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 30.6 tt0 -124.87 103.22 7.94 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.045 2.138 . . . . 0.0 105.485 -175.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.53 108.71 12.11 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 -55.98 26.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.865 -173.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 O-C-N 121.93 -0.481 . . . . 0.0 110.939 -171.712 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.92 54.05 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.526 2.731 . . . . 0.0 111.833 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.38 -56.52 0.08 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.81 1.644 . . . . 0.0 106.65 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -47.18 -44.52 22.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.266 1.826 . . . . 0.0 111.93 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -35.52 102.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.037 2.135 . . . . 0.0 112.093 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.43 -156.63 26.28 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.162 0.892 . . . . 0.0 112.906 165.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 m -116.32 127.09 54.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.632 1.173 . . . . 0.0 109.019 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -112.04 156.93 21.39 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.531 1.132 . . . . 0.0 110.463 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 25.7 ttpp -119.31 130.65 55.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.503 2.321 . . . . 0.0 107.355 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.93 137.35 58.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.15 -71.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.156 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -111.42 139.78 46.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.958 0.799 . . . . 0.0 109.448 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -163.45 160.28 23.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.771 0.828 . . . . 0.0 108.779 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 171.66 19.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.808 2.043 . . . . 0.0 107.678 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 m120 64.5 12.98 7.84 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.508 1.523 . . . . 0.0 113.78 166.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.91 -39.94 93.76 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 120.426 -1.421 . . . . 0.0 109.895 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.25 -71.75 0.06 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 109.619 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -37.88 -57.74 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.698 1.999 . . . . 0.0 111.971 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.54 -40.65 75.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.971 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -33.04 44.38 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.523 -0.735 . . . . 0.0 111.004 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -72.01 46.76 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 0.0 110.436 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p 179.04 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.303 1.841 . . . . 0.0 107.229 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -64.5 -27.88 69.28 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.97 44.31 37.29 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -113.29 43.79 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.82 -72.84 0.28 Allowed Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.75 20.49 3.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.104 0.961 . . . . 0.0 111.984 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 171.32 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 126.613 1.965 . . . . 0.0 107.456 -168.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -53.79 -43.84 69.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.232 1.013 . . . . 0.0 111.416 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -65.86 -12.25 52.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.271 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -60.2 -23.24 63.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.331 1.423 . . . . 0.0 112.056 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.95 -39.53 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 110.269 167.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.03 47.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.199 -0.938 . . . . 0.0 113.735 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -57.77 -47.15 83.34 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.413 1.485 . . . . 0.0 109.731 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.6 ttt -92.3 -42.31 9.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.884 1.274 . . . . 0.0 110.394 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -74.45 66.26 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 0.0 112.604 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -149.26 58.57 3.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.871 1.268 . . . . 0.0 110.084 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.3 -44.67 8.67 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.685 2.923 . . . . 0.0 111.869 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.7 m -107.16 157.07 18.15 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.663 0.744 . . . . 0.0 109.217 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 m -148.02 116.83 6.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 162.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 83.1 mt -80.59 137.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.7 mm -130.96 91.19 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.556 1.543 . . . . 0.0 106.992 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.84 105.63 17.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.79 140.79 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -125.05 165.57 17.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.499 1.519 . . . . 0.0 107.912 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -25.12 -66.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.613 2.054 . . . . 0.0 115.121 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -118.36 15.05 13.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.792 2.037 . . . . 0.0 110.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.09 179.69 7.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.065 1.746 . . . . 0.0 109.727 -151.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.9 150.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.86 127.61 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.4 tt -94.64 138.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -127.74 99.02 5.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.539 1.536 . . . . 0.0 108.587 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.5 m -72.94 83.89 1.24 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -83.74 113.11 20.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.966 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -139.01 -172.64 3.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.93 1.292 . . . . 0.0 108.372 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -82.86 -80.69 0.17 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -84.06 116.53 22.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 109.662 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 81.29 133.04 0.06 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.586 1.954 . . . . 0.0 108.904 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.12 155.75 49.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 p -150.48 153.45 35.91 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.29 143.23 17.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.989 171.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mm -153.61 142.67 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.688 1.195 . . . . 0.0 108.791 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -89.69 136.87 32.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.779 2.032 . . . . 0.0 109.391 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.1 144.59 38.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.991 0.917 . . . . 0.0 110.345 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 106.23 16.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.55 1.54 . . . . 0.0 107.309 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.82 105.01 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.959 0.504 . . . . 0.0 111.076 168.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.97 30.42 2.98 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.688 2.09 . . . . 0.0 112.698 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.3 t -146.95 159.88 9.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 107.986 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.76 137.35 49.81 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 111.605 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -135.43 135.74 40.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.84 1.256 . . . . 0.0 109.512 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.15 114.98 27.62 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.565 1.546 . . . . 0.0 108.281 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.54 159.15 38.28 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.209 0.459 . . . . 0.0 110.32 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 t -122.38 98.76 6.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.641 1.577 . . . . 0.0 112.063 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -83.78 142.95 30.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.39 -40.91 27.33 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.053 0.941 . . . . 0.0 110.869 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -102.45 42.19 1.17 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.874 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.58 -37.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.213 1.005 . . . . 0.0 110.079 154.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 86.55 -172.24 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.949 2.5 . . . . 0.0 107.093 -163.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -72.71 123.95 24.32 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.738 0.699 . . . . 0.0 110.193 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.93 147.86 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.216 1.406 . . . . 0.0 108.172 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -93.94 101.6 13.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 122.095 0.95 . . . . 0.0 109.932 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.5 m -83.81 116.15 22.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.015 1.326 . . . . 0.0 109.787 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.26 125.23 54.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 166.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.34 138.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -155.24 -176.66 6.05 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 164.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -132.44 105.58 7.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.865 1.266 . . . . 0.0 108.439 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.27 120.57 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.71 -80.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.722 0.677 . . . . 0.0 111.964 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.14 17.7 1.54 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.195 1.379 . . . . 0.0 111.587 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.5 117.06 30.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 108.342 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 tp -80.1 98.56 7.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.0 m -87.95 107.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -98.25 100.99 12.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.83 141.82 13.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -133.53 99.67 4.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -108.63 114.95 29.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.58 1.952 . . . . 0.0 108.502 -163.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.409 ' HE1' ' NE2' ' A' ' 100' ' ' GLN . 14.1 p90 -107.74 -67.25 0.97 Allowed 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.572 0.624 . . . . 0.0 110.99 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -172.11 -81.32 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.322 0.51 . . . . 0.0 111.734 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.96 80.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -142.68 -172.82 3.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -131.39 -178.99 5.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.118 1.767 . . . . 0.0 107.274 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.5 t -143.56 177.64 8.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.7 p -138.05 136.75 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.669 1.188 . . . . 0.0 108.264 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -129.87 71.33 1.44 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.139 2.176 . . . . 0.0 106.259 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.92 124.92 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.822 -0.549 . . . . 0.0 109.819 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.13 139.42 49.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.784 1.634 . . . . 0.0 110.348 -171.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -156.44 144.29 19.46 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -110.61 120.4 42.28 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 162.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.45 167.4 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 156.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.85 -124.44 2.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.13 13.63 7.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.945 1.26 . . . . 0.0 111.93 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -122.93 127.02 48.35 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.389 1.095 . . . . 0.0 109.333 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.65 103.02 4.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 165.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 pt -85.95 127.73 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.5 tp -115.1 111.3 20.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.67 1.588 . . . . 0.0 106.785 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -88.85 115.35 26.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -102.93 109.78 21.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 m -132.17 131.15 41.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.279 1.031 . . . . 0.0 110.548 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.49 169.14 12.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.814 1.646 . . . . 0.0 108.921 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.44 83.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 166.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 85.52 140.22 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.186 2.594 . . . . 0.0 109.585 -166.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 77.55 145.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 112.346 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -137.05 153.61 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.434 1.893 . . . . 0.0 107.29 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.6 137.64 32.04 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.821 -1.175 . . . . 0.0 108.559 161.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -85.37 128.09 34.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 161.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -125.94 113.96 17.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 p -113.31 136.77 52.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.333 0.97 . . . . 0.0 110.386 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.41 146.17 47.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.925 1.69 . . . . 0.0 108.646 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 40.8 tt0 -130.09 125.04 34.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.056 2.143 . . . . 0.0 106.77 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -66.05 116.6 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.417 1.008 . . . . 0.0 110.146 -171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -91.23 -30.12 16.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.645 0.378 . . . . 0.0 111.048 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.503 0.592 . . . . 0.0 111.138 173.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 63.9 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.078 2.951 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.94 -44.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.873 1.669 . . . . 0.0 107.956 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -61.7 -44.82 96.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -37.04 105.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.992 2.117 . . . . 0.0 111.676 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.91 -163.76 25.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.499 0.571 . . . . 0.0 112.41 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 m -108.94 122.66 47.7 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 110.481 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -103.09 162.37 13.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.462 1.905 . . . . 0.0 110.624 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -129.34 132.86 47.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.455 2.302 . . . . 0.0 108.139 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.63 131.38 45.87 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.281 0.633 . . . . 0.0 110.121 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.33 31.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.247 0.619 . . . . 0.0 110.918 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.76 159.49 8.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.401 1.48 . . . . 0.0 108.175 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 177.07 102.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.442 1.897 . . . . 0.0 107.868 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -135.94 148.71 48.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.179 0.445 . . . . 0.0 110.385 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.34 35.49 20.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.544 1.538 . . . . 0.0 110.807 174.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.35 -19.14 27.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.78 1.276 . . . . 0.0 109.948 -177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -52.99 4.84 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 129.494 3.118 . . . . 0.0 106.146 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -49.68 -40.76 41.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.895 1.278 . . . . 0.0 111.148 166.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.89 -50.6 34.23 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.576 0.75 . . . . 0.0 111.165 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 -37.51 84.69 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.425 -0.797 . . . . 0.0 111.652 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -70.42 61.65 0.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 110.063 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m 168.6 -58.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 129.165 2.986 . . . . 0.0 106.795 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.73 -34.78 24.8 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 52.61 42.65 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -170.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.31 -52.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.195 0.998 . . . . 0.0 110.611 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.89 -65.6 3.21 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.873 -0.404 . . . . 0.0 113.579 -163.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.45 101.46 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.779 1.632 . . . . 0.0 112.454 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 135.16 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.707 3.203 . . . . 0.0 109.461 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -113.19 -26.5 8.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.929 1.692 . . . . 0.0 111.343 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -66.46 -41.95 88.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.83 1.195 . . . . 0.0 110.888 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -53.21 -36.67 61.26 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.287 1.035 . . . . 0.0 111.197 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.0 t -39.42 -50.86 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.401 1.88 . . . . 0.0 110.329 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.06 54.56 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.643 0.64 . . . . 0.0 113.075 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.45 24.97 10.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.85 1.26 . . . . 0.0 111.198 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.5 ttt -152.62 -2.57 0.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.0 m -158.3 169.96 23.32 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.793 -1.192 . . . . 0.0 109.602 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -117.08 73.02 6.53 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.204 1.402 . . . . 0.0 108.977 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.22 158.2 58.58 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.431 2.087 . . . . 0.0 109.809 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -100.83 164.54 11.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.74 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.95 113.1 11.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 163.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.37 127.66 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mm -120.79 110.84 29.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.57 115.95 29.44 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.3 85.87 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -50.41 154.64 1.22 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.521 0.728 . . . . 0.0 110.171 170.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -23.79 -59.28 0.04 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.317 1.913 . . . . 0.0 115.352 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.11 13.35 9.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.944 1.298 . . . . 0.0 111.805 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.89 -170.37 3.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.937 1.695 . . . . 0.0 108.767 -158.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.29 149.1 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 120.72 -1.238 . . . . 0.0 110.53 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.67 140.75 47.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.88 1.272 . . . . 0.0 109.17 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 tt -129.43 145.5 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.454 1.901 . . . . 0.0 109.371 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.0 152.75 51.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.952 2.101 . . . . 0.0 107.842 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 m -111.61 62.95 0.62 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.032 1.287 . . . . 0.0 107.717 159.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.07 108.15 0.84 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.488 -0.758 . . . . 0.0 110.794 -173.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -116.24 102.1 9.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.334 1.454 . . . . 0.0 108.55 -168.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m 63.92 -75.7 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.155 1.382 . . . . 0.0 111.451 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.33 27.85 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.119 0.968 . . . . 0.0 110.865 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 96.99 2.71 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.862 -0.524 . . . . 0.0 110.989 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -161.61 163.77 29.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.516 -0.74 . . . . 0.0 111.157 161.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -94.72 175.03 6.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.97 3.308 . . . . 0.0 109.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 152.25 47.98 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.065 1.346 . . . . 0.0 107.976 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.73 137.79 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 p -126.24 147.33 49.7 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.556 0.743 . . . . 0.0 109.399 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -160.82 163.25 32.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.056 0.931 . . . . 0.0 113.124 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -98.83 133.71 42.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.56 64.64 2.25 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.83 -0.544 . . . . 0.0 110.161 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.82 57.92 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.21 159.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.4 1.1 . . . . 0.0 111.119 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -88.89 151.61 22.23 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.072 1.349 . . . . 0.0 109.56 160.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.48 150.1 21.16 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.377 0.671 . . . . 0.0 109.265 164.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.44 141.24 32.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.4 156.86 47.2 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.193 0.997 . . . . 0.0 108.946 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -149.71 118.77 6.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.686 0.394 . . . . 0.0 110.178 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -147.35 143.45 28.02 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.88 78.94 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.531 0.732 . . . . 0.0 111.912 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -94.83 19.71 9.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.17 1.788 . . . . 0.0 112.511 -171.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.25 -42.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.782 0.833 . . . . 0.0 110.721 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 114.69 -160.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 131.383 3.873 . . . . 0.0 108.89 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -85.71 118.4 25.19 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.26 142.04 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.263 1.025 . . . . 0.0 108.527 -167.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -80.82 126.8 31.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -97.36 143.77 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.894 0.878 . . . . 0.0 108.714 168.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 tt -136.4 127.62 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.6 139.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.0 m -158.98 173.82 15.91 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.379 2.672 . . . . 0.0 104.657 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.45 153.76 43.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.425 1.466 . . . . 0.0 111.977 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.77 143.27 49.47 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.414 1.486 . . . . 0.0 108.421 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 -77.13 0.04 OUTLIER Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.24 0.924 . . . . 0.0 111.118 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.17 21.27 0.19 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.115 1.341 . . . . 0.0 111.918 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.42 134.21 54.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.119 1.368 . . . . 0.0 108.204 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.06 122.27 29.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.78 109.11 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -94.92 90.96 6.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 166.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.84 146.58 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -147.06 121.43 9.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -159.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -127.51 127.72 44.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.342 1.457 . . . . 0.0 108.748 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -100.12 -55.01 2.74 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -163.66 -85.1 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.973 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.31 71.8 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.225 0.466 . . . . 0.0 112.458 -170.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 177.31 10.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.922 0.889 . . . . 0.0 109.073 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.51 163.92 30.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 109.741 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -126.84 152.6 46.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.553 1.541 . . . . 0.0 108.453 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -111.0 124.94 53.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.409 1.483 . . . . 0.0 109.377 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.44 106.71 17.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.182 1.793 . . . . 0.0 106.771 171.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.35 131.58 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -138.64 142.37 39.06 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -159.11 155.81 27.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.284 2.233 . . . . 0.0 106.024 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -106.17 122.63 46.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 160.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.15 162.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 155.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.75 -129.66 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -166.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.01 0.33 24.16 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.526 1.536 . . . . 0.0 111.672 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.44 136.4 50.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.971 0.908 . . . . 0.0 108.982 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.67 112.25 24.14 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.31 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.4 tp -87.51 131.28 34.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.4 m -126.47 135.46 51.38 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.37 114.87 29.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 128.986 2.914 . . . . 0.0 106.71 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.1 m -120.95 130.34 53.8 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -124.22 159.21 30.66 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.88 -35.35 12.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.658 0.647 . . . . 0.0 112.291 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -124.31 123.87 41.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 92.14 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.042 2.137 . . . . 0.0 112.147 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.14 139.58 27.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.344 1.457 . . . . 0.0 107.293 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.3 t -150.75 128.24 11.44 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.986 0.914 . . . . 0.0 110.457 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 p -81.69 155.22 25.66 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -144.87 68.19 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.08 141.37 58.79 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.604 -0.685 . . . . 0.0 111.225 176.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.75 165.43 19.28 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 126.021 1.728 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.23 151.22 51.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.168 1.387 . . . . 0.0 109.681 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -86.65 128.5 35.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.908 1.283 . . . . 0.0 109.938 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.86 -15.43 14.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.961 0.8 . . . . 0.0 113.119 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.115 0 C-N-CA 123.193 0.597 . . . . 0.0 110.401 -177.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.26 -22.31 11.43 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.979 2.512 . . . . 0.0 112.857 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.95 -34.2 33.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.917 0.887 . . . . 0.0 111.272 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -48.19 56.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.23 108.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.477 1.511 . . . . 0.0 112.211 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.29 -157.46 21.28 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.25 0.477 . . . . 0.0 112.522 171.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.1 m -97.67 113.54 25.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.12 1.368 . . . . 0.0 110.791 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.416 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 16.6 m0 -84.77 113.07 21.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.579 1.552 . . . . 0.0 107.753 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.69 129.8 51.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.49 143.93 55.94 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.286 -0.884 . . . . 0.0 110.996 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.34 -42.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 120.706 -1.246 . . . . 0.0 111.854 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -138.33 162.58 34.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 t -171.49 126.47 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.67 133.17 45.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.18 29.97 5.92 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.347 1.859 . . . . 0.0 111.06 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -75.41 -53.33 8.87 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.45 -0.782 . . . . 0.0 109.671 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.56 -30.62 67.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.391 -0.193 . . . . 0.0 110.962 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.5 -48.72 62.82 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.22 -0.3 . . . . 0.0 110.56 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -56.82 -61.71 2.25 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 0.0 111.507 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -35.1 66.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 63.97 0.23 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.941 0.897 . . . . 0.0 109.874 167.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t 162.77 -56.96 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.963 2.505 . . . . 0.0 106.978 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -26.96 68.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.683 0.793 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 -19.81 15.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.885 0.755 . . . . 0.0 113.769 168.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.6 m -40.59 -32.43 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 128.21 2.604 . . . . 0.0 113.951 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.11 73.23 0.17 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -45.21 -58.66 3.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.576 1.15 . . . . 0.0 111.236 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.77 -29.54 11.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.641 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.2 p -81.87 -65.87 0.96 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.973 0.909 . . . . 0.0 111.092 -167.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -54.0 -33.1 56.16 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.829 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.9 -27.65 65.43 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.79 1.177 . . . . 0.0 113.9 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.1 t -85.53 -49.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.78 45.65 1.64 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.097 0.856 . . . . 0.0 113.684 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -160.41 -42.38 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 110.555 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtm -60.07 -26.53 66.24 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.793 0.724 . . . . 0.0 110.763 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 m -67.06 66.53 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.107 1.763 . . . . 0.0 112.367 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 44.24 72.57 1.16 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.412 1.885 . . . . 0.0 112.228 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.32 147.79 37.65 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.69 1.593 . . . . 0.0 111.904 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -152.7 160.5 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 108.175 -169.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -154.31 144.86 22.29 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pt -110.32 148.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.225 0.92 . . . . 0.0 108.772 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.416 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 30.5 mm -129.68 130.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.734 1.214 . . . . 0.0 108.761 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.17 114.88 20.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.507 1.523 . . . . 0.0 109.25 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.87 70.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.9 0.857 . . . . 0.0 110.259 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.89 149.87 43.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.571 -0.706 . . . . 0.0 109.976 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -19.89 -67.84 0.01 OUTLIER Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.494 1.997 . . . . 0.0 116.309 -171.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -113.52 14.35 18.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.599 1.559 . . . . 0.0 111.791 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.31 179.75 7.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.606 1.563 . . . . 0.0 109.0 -158.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -139.79 101.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.05 143.99 12.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.56 144.14 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -128.62 101.95 6.38 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -76.33 145.95 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.32 66.75 1.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.08 1.352 . . . . 0.0 108.591 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 m -72.17 -44.81 62.49 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -150.7 -109.51 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -113.93 -49.52 2.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.677 1.126 . . . . 0.0 111.566 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -77.77 66.72 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -101.41 -171.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.079 1.751 . . . . 0.0 109.402 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.9 p -152.77 171.95 17.44 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.664 1.186 . . . . 0.0 110.047 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -145.34 135.87 24.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.916 1.686 . . . . 0.0 108.21 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -145.26 147.81 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.227 1.011 . . . . 0.0 108.577 -172.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.5 p -99.7 97.41 8.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.608 1.563 . . . . 0.0 110.322 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -72.27 148.89 45.01 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.58 20.38 14.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.41 1.084 . . . . 0.0 113.845 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 37.04 32.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.602 1.961 . . . . 0.0 115.934 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.87 47.74 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.307 -0.718 . . . . 0.0 112.006 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -174.7 168.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.394 1.097 . . . . 0.0 109.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -104.86 143.47 33.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.621 0.768 . . . . 0.0 111.682 170.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -139.23 156.26 47.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 107.316 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.64 138.62 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.61 62.57 1.59 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -52.46 100.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.873 0.869 . . . . 0.0 110.379 163.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 t -117.66 136.05 53.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.261 0.553 . . . . 0.0 110.032 165.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.48 49.64 1.03 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.794 1.237 . . . . 0.0 111.374 -171.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -172.04 -58.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.565 2.346 . . . . 0.0 107.96 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.77 5.1 26.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.84 0.856 . . . . 0.0 113.22 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 83.4 -169.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 163.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -97.88 80.39 2.75 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 109.968 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.74 167.73 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.14 0.976 . . . . 0.0 109.377 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -127.33 97.12 4.79 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.5 t -113.48 114.86 27.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -157.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.3 119.11 29.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.878 1.671 . . . . 0.0 109.007 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.02 140.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 123.675 0.79 . . . . 0.0 110.031 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 p -136.81 166.71 22.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.777 1.631 . . . . 0.0 107.346 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.05 108.76 10.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.65 121.81 45.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.538 0.608 . . . . 0.0 109.835 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.52 -77.73 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.498 1.047 . . . . 0.0 111.344 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.85 21.47 0.69 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.995 1.283 . . . . 0.0 111.173 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -116.43 123.56 47.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.23 110.26 18.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.2 t -95.28 116.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -113.05 117.79 32.98 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.1 t -102.79 119.15 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -104.27 85.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 108.713 -169.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.42 143.14 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.349 1.86 . . . . 0.0 108.396 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -125.74 -59.19 1.37 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.51 166.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -167.2 -87.32 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.353 0.524 . . . . 0.0 111.311 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.72 -23.31 77.92 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.47 175.61 9.42 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.807 0.843 . . . . 0.0 108.728 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -134.45 176.04 8.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.918 2.087 . . . . 0.0 106.455 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -138.14 165.59 26.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 162.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 77.4 p -117.9 138.7 51.96 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.155 0.582 . . . . 0.0 110.282 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 98.0 4.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.032 1.733 . . . . 0.0 107.387 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.37 142.26 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -130.99 105.0 7.45 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.774 1.629 . . . . 0.0 108.668 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -131.98 142.93 49.76 Favored 'General case' 0 C--O 1.228 -0.042 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -116.67 124.5 49.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 164.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.57 -177.39 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.7 t70 52.36 -111.74 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.55 33.43 1.31 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -139.89 140.59 36.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -98.44 105.65 17.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.287 1.035 . . . . 0.0 108.412 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.22 105.16 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.32 95.25 9.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -81.92 115.22 21.0 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.67 105.39 13.25 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.129 1.372 . . . . 0.0 107.466 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 t -135.56 137.4 41.97 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.369 0.532 . . . . 0.0 111.35 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -109.73 -35.17 6.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.148 1.379 . . . . 0.0 111.293 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 -100.65 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 -172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 34.9 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.681 1.192 . . . . 0.0 112.749 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.34 126.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.124 2.169 . . . . 0.0 106.443 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.36 134.44 63.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 126.562 1.945 . . . . 0.0 107.016 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.47 154.27 49.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.897 0.879 . . . . 0.0 109.813 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.6 t -119.14 139.23 52.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 157.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -117.15 95.62 5.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.94 101.1 11.46 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -91.43 165.85 13.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.704 1.602 . . . . 0.0 111.028 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -139.31 109.23 6.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -66.06 98.3 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.36 -45.72 65.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 110.459 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 C-N-CA 126.057 1.743 . . . . 0.0 107.597 -176.386 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.46 65.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.11 2.964 . . . . 0.0 111.491 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.72 -49.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.03 2.132 . . . . 0.0 106.203 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -76.22 44.87 0.35 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.496 2.318 . . . . 0.0 111.421 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.1 96.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.53 -157.94 25.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -132.17 140.44 48.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.597 0.759 . . . . 0.0 110.185 -168.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -126.22 161.65 27.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.398 1.479 . . . . 0.0 109.548 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -127.65 139.01 52.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.513 1.125 . . . . 0.0 108.359 174.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.73 145.4 54.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.277 0.49 . . . . 0.0 111.007 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.5 -32.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 0.0 113.474 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 14' ' ' LYS . 18.9 t0 -133.06 154.06 50.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.97 1.259 . . . . 0.0 108.683 170.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -163.51 27.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.507 2.323 . . . . 0.0 110.879 -164.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 4.3 ptpp? -57.44 146.99 27.66 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.892 -1.13 . . . . 0.0 110.435 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 66.95 5.36 4.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 114.19 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.73 -39.08 76.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.467 1.485 . . . . 0.0 111.466 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.83 -69.69 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.0 110.24 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -30.9 -57.52 0.22 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.94 2.496 . . . . 0.0 111.146 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.51 -54.45 7.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 112.66 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -40.41 75.2 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.883 -0.51 . . . . 0.0 110.227 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -73.88 45.81 0.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.52 1.528 . . . . 0.0 110.75 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -171.35 -48.21 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.517 1.927 . . . . 0.0 109.053 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.54 -34.31 70.86 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.885 -0.509 . . . . 0.0 110.914 168.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.85 44.81 3.27 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.92 -30.02 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.376 1.47 . . . . 0.0 108.058 162.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -21.29 114.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.996 0 C-N-CA 127.688 2.566 . . . . 0.0 114.86 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -162.73 -177.13 5.36 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.114 1.366 . . . . 0.0 108.985 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.99 65.24 9.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.22 0.608 . . . . 0.0 109.89 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 m -154.57 -51.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.415 0.686 . . . . 0.0 109.624 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -43.81 -34.85 1.7 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 0.0 113.529 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.01 -30.54 68.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.042 0.937 . . . . 0.0 112.724 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.74 -37.77 9.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.8 65.3 0.07 OUTLIER Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.239 2.352 . . . . 0.0 112.788 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -179.07 -37.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.462 2.705 . . . . 0.0 108.336 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.44 -30.22 17.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.227 1.011 . . . . 0.0 110.65 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -64.15 -179.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.374 0.607 . . . . 0.0 111.108 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.44 80.8 2.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.738 1.215 . . . . 0.0 110.054 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 140.98 73.05 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.471 1.447 . . . . 0.0 110.642 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -121.79 146.53 46.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.155 1.782 . . . . 0.0 107.521 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.2 m -145.49 118.91 9.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.646 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.1 mt -92.76 128.84 44.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.88 110.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.11 104.5 10.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.445 1.098 . . . . 0.0 108.504 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.18 110.0 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.693 0.759 . . . . 0.0 109.122 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.72 60.21 5.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.11 -81.45 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.022 1.296 . . . . 0.0 112.3 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -36.81 20.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.056 1.342 . . . . 0.0 110.242 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -177.84 3.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.579 1.952 . . . . 0.0 108.225 -173.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.53 143.81 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -124.4 132.8 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 122.94 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -101.47 102.45 13.22 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.16 70.32 1.1 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.973 1.309 . . . . 0.0 107.67 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -78.22 128.62 34.01 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.499 -0.75 . . . . 0.0 110.103 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 t 74.87 -55.52 0.65 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.898 1.679 . . . . 0.0 110.291 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -39.93 81.68 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.603 3.161 . . . . 0.0 114.101 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 66.0 52.98 1.14 Allowed 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.999 1.719 . . . . 0.0 109.852 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 78.22 157.96 0.18 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.094 1.758 . . . . 0.0 107.709 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -71.01 104.76 3.09 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -124.86 177.28 6.1 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.267 1.027 . . . . 0.0 109.089 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -158.61 145.05 17.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -172.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 mt -135.4 120.05 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.484 1.114 . . . . 0.0 108.144 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.0 p -89.29 132.86 34.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.499 1.52 . . . . 0.0 108.805 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -146.39 157.55 43.79 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.71 0.686 . . . . 0.0 110.701 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -124.6 112.29 16.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.03 110.16 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.272 0.229 . . . . 0.0 110.676 170.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.31 37.76 2.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 0.0 111.682 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.5 t -147.14 151.7 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.787 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.12 136.95 46.93 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.742 1.617 . . . . 0.0 107.764 163.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.96 -173.5 3.48 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.964 0.905 . . . . 0.0 109.43 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -110.64 124.19 51.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.408 1.483 . . . . 0.0 108.858 -172.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -112.83 158.8 19.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.536 1.534 . . . . 0.0 109.209 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -147.02 101.55 3.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.71 154.46 36.86 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.1 0.96 . . . . 0.0 110.4 -171.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.19 72.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.83 -4.7 59.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.198 -171.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.76 2.79 0.21 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.62 -148.13 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.921 -1.737 . . . . 0.0 109.736 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -79.32 128.04 32.83 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.642 1.177 . . . . 0.0 109.388 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.62 139.33 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -83.27 125.05 31.18 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.8 t -125.16 147.17 49.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.69 0.677 . . . . 0.0 110.647 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.57 136.56 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.44 141.73 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 t -161.36 -171.4 2.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.714 1.206 . . . . 0.0 108.243 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 pp -127.66 135.43 50.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.045 0.938 . . . . 0.0 111.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -108.37 91.06 3.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.909 1.683 . . . . 0.0 108.186 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.64 -70.76 0.9 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.74 0.686 . . . . 0.0 111.771 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 14.87 1.19 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -115.48 165.94 12.45 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.5 tt -117.43 115.45 25.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 m -91.16 119.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -113.27 110.97 21.25 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 167.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.52 133.34 60.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -132.12 106.43 7.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.668 0.787 . . . . 0.0 108.948 -158.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -106.23 151.31 24.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.59 2.356 . . . . 0.0 109.529 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -130.32 -62.93 0.91 Allowed 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.624 -0.673 . . . . 0.0 109.601 163.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -159.31 -87.54 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 119.41 -0.329 . . . . 0.0 111.375 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.76 -25.28 76.01 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.929 0.786 . . . . 0.0 112.016 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 -177.39 5.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.138 0.975 . . . . 0.0 109.025 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -159.38 -176.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.288 1.435 . . . . 0.0 109.56 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.4 t -144.63 153.43 41.75 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 111.129 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -83.89 155.29 22.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 162.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -142.01 65.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.125 1.77 . . . . 0.0 107.26 161.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.58 141.41 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -124.74 128.41 48.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.322 1.049 . . . . 0.0 109.589 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -141.51 141.3 33.6 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.88 103.23 13.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 166.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.71 172.88 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 154.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 48.83 -122.58 1.68 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -166.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.44 29.91 4.64 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.438 1.494 . . . . 0.0 109.813 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -128.35 126.48 40.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.278 0.631 . . . . 0.0 110.889 -167.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.72 109.42 17.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.01 120.39 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -104.37 89.5 3.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.247 1.419 . . . . 0.0 108.026 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 m -76.91 82.81 3.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.222 0.534 . . . . 0.0 109.752 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.57 101.36 6.49 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 108.54 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.39 112.64 20.26 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -110.93 148.52 32.3 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.751 1.22 . . . . 0.0 108.714 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.28 84.68 0.01 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 169.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t 126.82 -2.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 131.631 3.972 . . . . 0.0 113.217 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.63 140.67 18.37 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.856 1.207 . . . . 0.0 109.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.54 130.41 69.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 124.466 1.106 . . . . 0.0 108.141 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.55 110.87 7.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.542 0.737 . . . . 0.0 109.808 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 76.5 p -70.27 79.63 0.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -64.46 136.65 57.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 158.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 t -156.81 147.28 21.41 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.051 -1.031 . . . . 0.0 108.909 169.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.78 159.95 33.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.836 1.255 . . . . 0.0 110.751 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.411 ' OE2' ' NZ ' ' A' ' 9' ' ' LYS . 36.1 tt0 -121.49 130.76 53.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.565 2.346 . . . . 0.0 106.231 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -69.89 120.01 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.719 0.69 . . . . 0.0 109.623 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -94.76 -31.41 13.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.478 0.711 . . . . 0.0 111.24 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.154 0 CA-C-N 118.428 0.558 . . . . 0.0 110.712 177.682 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.07 53.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.638 2.775 . . . . 0.0 111.393 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.36 -37.04 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.346 1.459 . . . . 0.0 109.133 -159.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.3 -47.46 6.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.965 0.906 . . . . 0.0 109.448 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -48.28 114.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.664 0.785 . . . . 0.0 112.404 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.75 -172.84 21.78 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.521 0.582 . . . . 0.0 112.311 162.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -102.75 123.62 46.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.283 0.633 . . . . 0.0 109.585 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -118.87 154.78 32.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.461 1.104 . . . . 0.0 108.975 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -128.6 136.8 51.2 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.41 1.084 . . . . 0.0 108.082 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.08 140.31 58.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.87 -2.6 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.6 145.07 38.09 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.472 1.033 . . . . 0.0 108.511 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -162.53 148.33 12.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.223 1.409 . . . . 0.0 108.765 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -159.46 154.14 24.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.709 1.203 . . . . 0.0 107.816 163.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 44.06 29.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.883 1.273 . . . . 0.0 110.649 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -56.26 4.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.778 0.799 . . . . 0.0 109.844 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -54.67 43.91 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.183 2.193 . . . . 0.0 108.902 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.68 -46.2 74.03 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.254 1.022 . . . . 0.0 112.286 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -55.67 -50.17 70.98 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.4 mtt -61.89 -36.61 81.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.219 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.62 46.9 0.05 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.808 1.643 . . . . 0.0 111.653 172.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.0 p -165.02 -41.02 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.857 1.263 . . . . 0.0 109.129 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.95 -32.46 74.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 19.98 35.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.194 0.426 . . . . 0.0 112.495 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -38.85 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 162.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.92 -138.32 6.42 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -165.98 -71.35 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -46.57 4.21 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.499 1.52 . . . . 0.0 113.1 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -36.77 -35.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.579 2.352 . . . . 0.0 114.01 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -25.37 40.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.148 -0.97 . . . . 0.0 112.436 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -45.12 -35.85 3.37 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.144 0.884 . . . . 0.0 112.711 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.73 -45.41 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.38 -3.55 62.17 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.23 -1.317 . . . . 0.0 115.824 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -110.53 1.37 18.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.645 1.578 . . . . 0.0 111.06 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 ttm -120.42 -59.26 1.78 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.908 0.883 . . . . 0.0 109.503 -162.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.5 m -78.31 76.16 4.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.989 -0.444 . . . . 0.0 109.98 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 5.68 77.96 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 128.846 2.858 . . . . 0.0 113.379 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.79 122.4 11.67 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.691 1.594 . . . . 0.0 109.655 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.0 m -88.21 155.21 19.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 m -147.48 87.95 1.68 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -171.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.9 mt -72.5 119.87 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.81 103.26 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.05 146.82 23.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.52 1.528 . . . . 0.0 108.69 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.19 141.81 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.5 165.27 21.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.79 -69.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.627 2.06 . . . . 0.0 115.04 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -131.63 35.05 3.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.393 1.477 . . . . 0.0 110.015 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -147.62 162.97 38.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.81 153.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 165.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.22 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 135.14 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -110.54 105.19 14.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.118 0.967 . . . . 0.0 110.387 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -70.24 107.84 3.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 168.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -122.69 112.75 18.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.554 0.742 . . . . 0.0 110.932 -166.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -149.82 170.24 19.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 110.251 168.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -79.41 38.01 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.792 1.237 . . . . 0.0 113.621 -160.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -161.96 -43.4 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.444 -0.785 . . . . 0.0 110.064 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -135.19 130.91 36.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.23 121.57 36.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -136.5 128.91 30.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.567 0.621 . . . . 0.0 110.232 -171.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 134.13 41.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.138 1.375 . . . . 0.0 109.147 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.13 123.1 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 p -80.7 160.04 25.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.263 1.025 . . . . 0.0 109.417 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -140.83 86.22 2.03 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.333 1.453 . . . . 0.0 108.591 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -79.99 93.97 5.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 110.79 0.59 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.395 0.678 . . . . 0.0 112.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.32 28.15 8.25 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.683 1.135 . . . . 0.0 112.016 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.0 t -150.46 159.35 4.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.667 1.187 . . . . 0.0 108.165 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -108.89 140.83 41.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.107 0.963 . . . . 0.0 110.189 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -154.78 157.53 38.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 148.07 47.3 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.096 0.407 . . . . 0.0 110.73 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.66 86.97 2.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.934 2.094 . . . . 0.0 105.795 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.8 m -90.55 96.76 10.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 t -121.16 137.99 54.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.581 0.753 . . . . 0.0 110.634 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.44 49.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.059 0.944 . . . . 0.0 113.436 -168.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.66 -75.13 0.51 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -87.35 17.28 4.53 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -162.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 mtm-85 80.54 -163.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.295 1.838 . . . . 0.0 110.969 165.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.4 109.37 19.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.192 0.997 . . . . 0.0 108.553 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.07 168.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -108.3 135.36 49.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 t -105.03 87.88 2.74 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.196 1.798 . . . . 0.0 109.624 -168.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -80.52 104.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.85 135.78 41.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.4 t -152.48 -162.7 1.56 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 161.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.47 154.83 41.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.308 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.13 146.61 28.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.08 0.952 . . . . 0.0 109.33 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.52 -82.42 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.105 0.859 . . . . 0.0 111.25 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.73 15.5 0.62 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.105 1.336 . . . . 0.0 111.721 171.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.34 127.49 55.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.543 1.537 . . . . 0.0 108.008 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.18 113.02 25.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.44 132.67 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.99 0.916 . . . . 0.0 109.442 -167.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -115.47 99.3 7.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.18 1.792 . . . . 0.0 106.655 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.08 103.99 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 169.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -96.36 96.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -105.37 121.96 44.98 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.612 1.565 . . . . 0.0 109.434 -171.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -104.23 -75.87 0.61 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.243 0.474 . . . . 0.0 109.852 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.31 139.04 6.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.25 -34.88 1.31 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.031 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.08 -175.37 5.3 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.072 0.949 . . . . 0.0 110.459 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -133.93 177.15 7.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.133 1.773 . . . . 0.0 108.271 165.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.4 143.0 50.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 159.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.72 125.19 50.2 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.173 0.589 . . . . 0.0 109.502 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.46 120.02 32.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.951 1.3 . . . . 0.0 107.646 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -114.4 118.33 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.558 0.617 . . . . 0.0 110.78 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -102.0 136.77 41.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.187 1.395 . . . . 0.0 110.824 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -160.38 156.67 26.53 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.514 1.126 . . . . 0.0 108.081 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -134.78 130.8 36.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 166.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.15 159.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.52 -72.18 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.699 1.6 . . . . 0.0 112.61 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.28 68.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 mttt 174.02 164.77 0.2 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 129.307 3.043 . . . . 0.0 106.057 160.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.32 117.4 33.03 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.23 140.16 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.6 0.76 . . . . 0.0 110.304 -172.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.15 118.8 25.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.182 1.393 . . . . 0.0 107.757 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.1 m -100.46 121.35 41.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 161.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.52 117.46 34.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -118.39 146.51 44.36 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.979 0.809 . . . . 0.0 109.384 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -127.09 170.82 11.95 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.225 1.81 . . . . 0.0 106.545 175.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.83 55.99 3.04 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.472 -0.626 . . . . 0.0 111.765 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t 160.57 -63.51 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.09 2.956 . . . . 0.0 108.414 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.05 143.22 34.21 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.825 0.45 . . . . 0.0 110.362 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.45 136.93 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.4 t -151.46 133.94 15.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.011 0.524 . . . . 0.0 110.679 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 p -85.77 158.46 20.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.229 0.611 . . . . 0.0 110.14 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -134.84 142.8 46.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 153.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 137.43 38.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.152 0.887 . . . . 0.0 108.924 164.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.06 162.54 21.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.093 1.757 . . . . 0.0 109.579 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.17 153.19 51.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 165.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -67.73 121.19 15.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.42 1.488 . . . . 0.0 108.468 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.27 -25.28 39.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.408 0.549 . . . . 0.0 112.041 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.846 0.858 . . . . 0.0 109.183 176.258 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -74.65 60.11 0.89 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.251 1.82 . . . . 0.0 110.154 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 -53.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -164.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.16 -45.62 10.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.529 0.732 . . . . 0.0 111.437 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -47.41 120.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.325 0.65 . . . . 0.0 112.276 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.86 -163.07 12.18 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.778 1.18 . . . . 0.0 112.294 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -84.98 139.95 31.42 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.456 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -119.93 155.18 33.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.778 1.631 . . . . 0.0 108.343 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 137.57 54.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.51 0.724 . . . . 0.0 109.766 163.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.17 147.07 53.88 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.22 0.608 . . . . 0.0 110.289 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.69 42.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.179 0.514 . . . . 0.0 110.935 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.89 153.96 3.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.721 2.009 . . . . 0.0 106.792 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.5 t -159.18 25.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.589 0.756 . . . . 0.0 111.72 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 122.53 16.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.586 1.085 . . . . 0.0 110.048 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 68.11 62.67 0.38 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.097 1.759 . . . . 0.0 110.996 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -83.0 -63.92 1.27 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.35 -0.844 . . . . 0.0 111.486 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.82 -34.52 62.36 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.435 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -36.61 -54.3 0.88 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.754 1.221 . . . . 0.0 110.087 165.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.93 -51.0 65.19 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.407 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -38.41 76.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.634 0.774 . . . . 0.0 111.421 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -73.13 63.25 0.69 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.457 1.903 . . . . 0.0 111.509 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 158.34 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 130.061 3.344 . . . . 0.0 107.368 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.19 -27.13 68.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.665 0.386 . . . . 0.0 111.588 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.43 -53.88 0.61 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.843 1.211 . . . . 0.0 110.309 169.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t 1.23 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 129.001 2.92 . . . . 0.0 115.284 -170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.1 110.47 0.27 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.992 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -65.74 173.27 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.137 0.468 . . . . 0.0 110.261 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.4 -68.99 0.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.134 1.774 . . . . 0.0 111.902 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.4 m -55.77 -54.74 40.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -65.38 -42.49 92.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.047 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.7 -7.92 48.26 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.12 -43.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 118.675 0.67 . . . . 0.0 109.804 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.36 -25.79 67.19 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.07 0.843 . . . . 0.0 112.847 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -66.95 -24.85 66.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.09 0.956 . . . . 0.0 112.239 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.0 tpt -83.97 -39.3 19.89 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.746 -0.596 . . . . 0.0 110.668 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -63.25 -57.43 10.49 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -177.25 88.61 0.25 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.162 0.985 . . . . 0.0 110.463 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -75.25 92.47 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.562 2.175 . . . . 0.0 108.833 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 m -87.94 163.18 16.47 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -142.78 152.33 42.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -130.28 128.47 64.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.8 125.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 165.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 128.21 54.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 169.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.31 75.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -58.81 153.19 17.51 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.5 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -39.56 -52.0 3.05 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.365 0.983 . . . . 0.0 114.257 -167.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -112.0 0.62 16.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.523 1.529 . . . . 0.0 112.008 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -147.6 -171.48 3.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.809 1.186 . . . . 0.0 109.819 -161.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.63 130.69 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 166.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.02 150.25 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 165.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 118.62 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -108.15 131.08 55.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.79 0.836 . . . . 0.0 109.753 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.74 27.3 4.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.213 1.405 . . . . 0.0 111.265 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -49.83 97.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.843 1.657 . . . . 0.0 114.166 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.451 ' H ' ' ND2' ' A' ' 59' ' ' ASN . 3.7 t -138.53 126.9 23.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 128.212 2.605 . . . . 0.0 104.453 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t 55.45 -171.68 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.541 1.937 . . . . 0.0 114.729 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -83.66 18.98 1.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.395 1.478 . . . . 0.0 112.776 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -159.3 115.42 2.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' A' ' 55' ' ' SER . 2.0 t-20 -165.31 -176.73 4.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.271 0.487 . . . . 0.0 110.8 -169.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 p -142.84 171.1 14.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.36 1.464 . . . . 0.0 108.681 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.7 150.22 38.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.4 mt -134.47 164.44 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.806 1.642 . . . . 0.0 106.596 -170.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.8 p -139.19 161.95 36.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.76 167.53 22.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.335 0.654 . . . . 0.0 110.091 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -109.31 131.14 55.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 166.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 84.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 165.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.56 42.33 0.14 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.628 1.585 . . . . 0.0 111.725 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -153.46 152.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.195 0.998 . . . . 0.0 109.066 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -111.95 140.92 46.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.213 1.005 . . . . 0.0 109.891 163.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -161.07 158.32 27.56 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.16 134.43 50.51 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -118.57 129.91 55.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -124.23 98.54 5.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 t -122.94 145.61 48.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.949 0.795 . . . . 0.0 111.012 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.44 48.85 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.399 1.079 . . . . 0.0 111.003 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.0 -83.47 0.05 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.918 1.687 . . . . 0.0 106.929 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -75.77 16.24 0.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 76.25 -147.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.03 1.332 . . . . 0.0 109.505 166.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -101.04 136.81 40.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 m -151.54 175.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.254 1.822 . . . . 0.0 107.257 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -103.24 132.08 49.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 155.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -92.82 109.54 20.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 mt -104.38 103.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.8 139.23 47.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 122.25 0.22 . . . . 0.0 110.759 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -151.87 156.29 39.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.546 1.139 . . . . 0.0 108.362 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.45 145.08 33.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -164.45 -146.76 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.874 1.67 . . . . 0.0 106.708 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.78 48.61 2.99 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.331 0.969 . . . . 0.0 110.864 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.93 27.6 0.2 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.234 0.921 . . . . 0.0 111.663 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 74.76 163.85 0.27 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.647 1.579 . . . . 0.0 111.475 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -79.18 101.53 8.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.86 106.34 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -93.88 95.51 9.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 162.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.77 122.28 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -117.16 99.44 7.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -168.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -119.58 115.11 23.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.513 1.125 . . . . 0.0 111.448 -161.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -96.51 -66.04 0.93 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.333 0.515 . . . . 0.0 109.847 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -169.03 -78.31 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 117.751 0.251 . . . . 0.0 111.649 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.58 -30.19 74.66 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 173.45 11.59 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.25 142.27 30.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.199 1.8 . . . . 0.0 106.277 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.86 148.39 30.68 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.85 0.86 . . . . 0.0 109.565 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 p -104.0 112.75 25.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mt -95.47 92.07 6.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 164.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 126.05 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.16 137.38 48.97 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.754 1.222 . . . . 0.0 110.627 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -161.81 151.52 16.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.957 1.303 . . . . 0.0 107.716 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -107.14 120.53 42.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.766 0.826 . . . . 0.0 109.261 170.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.21 -171.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 163.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.15 -111.15 0.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.02 21.02 3.55 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 126.046 1.784 . . . . 0.0 109.792 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -145.02 147.31 32.48 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.345 1.072 . . . . 0.0 111.112 -166.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tt -102.51 106.73 17.5 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.74 1.216 . . . . 0.0 108.116 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.82 96.17 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.16 106.73 17.48 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -96.42 134.62 39.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.0 tp -131.43 94.1 3.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -117.79 125.04 49.86 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.429 0.692 . . . . 0.0 110.816 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -103.38 -49.38 3.73 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.235 1.014 . . . . 0.0 110.491 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.22 120.57 2.2 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 106.939 -2.465 . . . . 0.0 106.939 -166.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m 65.65 -68.54 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.962 1.305 . . . . 0.0 109.317 -165.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.96 134.27 45.86 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -146.83 138.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 106.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.73 136.98 31.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.624 0.77 . . . . 0.0 110.125 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 149.42 22.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 164.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -140.42 73.39 1.42 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 161.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.22 123.2 14.49 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.625 -0.672 . . . . 0.0 109.522 171.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -109.63 157.11 19.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.044 1.738 . . . . 0.0 109.38 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.38 118.82 24.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -85.4 104.38 15.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 110.536 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -77.35 -20.2 55.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.479 1.036 . . . . 0.0 111.516 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 124.305 1.042 . . . . 0.0 110.124 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.237 0.412 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 64.01 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.872 2.469 . . . . 0.0 110.398 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.13 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.282 1.433 . . . . 0.0 107.147 -155.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.99 -46.51 8.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.891 1.276 . . . . 0.0 110.733 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.4 t -48.99 97.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.893 1.677 . . . . 0.0 112.526 -172.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.31 -161.74 27.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.131 0.872 . . . . 0.0 111.318 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -96.89 128.06 43.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.66 0.784 . . . . 0.0 109.99 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -98.83 132.74 43.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -110.2 125.69 53.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.897 0.771 . . . . 0.0 109.324 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.51 148.54 48.14 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.754 0.422 . . . . 0.0 110.131 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.251 4.6 p -137.8 -68.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.011 171.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' OD2' ' NZ ' ' A' ' 112' ' ' LYS . 27.4 m-20 -103.93 123.45 47.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.052 0.842 . . . . 0.0 110.313 -169.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -167.82 148.76 5.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.088 0.555 . . . . 0.0 109.937 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -163.91 174.25 11.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.814 1.245 . . . . 0.0 109.165 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.32 38.1 4.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.744 1.618 . . . . 0.0 111.642 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.75 -40.46 5.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.011 0.925 . . . . 0.0 108.601 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -23.97 -77.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.212 1.805 . . . . 0.0 111.88 147.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.55 -44.49 56.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.297 1.439 . . . . 0.0 112.167 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -55.5 -55.53 30.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.318 0.647 . . . . 0.0 111.107 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 tpt -52.92 -47.02 68.29 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.809 0.844 . . . . 0.0 109.44 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -67.86 62.0 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.627 1.571 . . . . 0.0 110.444 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m 160.65 -57.32 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 129.564 3.145 . . . . 0.0 106.833 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.17 -26.14 33.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -167.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.83 91.29 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.055 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -121.76 -58.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.799 1.239 . . . . 0.0 108.844 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.41 -162.54 7.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.3 t80 118.21 130.65 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.531 3.132 . . . . 0.0 107.328 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 62.0 8.2 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 -164.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 p -95.6 -62.49 1.29 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.411 1.484 . . . . 0.0 109.65 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -53.62 -52.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.642 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -60.39 -23.74 64.57 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.383 1.473 . . . . 0.0 113.179 -169.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.02 -52.46 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.69 26.96 1.93 Allowed Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.983 -0.898 . . . . 0.0 114.471 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -141.23 21.51 2.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.468 1.507 . . . . 0.0 109.562 164.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.3 ttm -143.24 -54.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -166.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -92.83 176.4 6.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 156.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.55 82.87 16.24 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.07 156.29 67.0 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.089 1.859 . . . . 0.0 110.36 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -110.8 158.34 18.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.736 0.814 . . . . 0.0 108.935 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 m -138.1 126.87 23.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mm -85.52 126.74 40.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.03 112.85 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.18 134.74 54.59 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.89 0.876 . . . . 0.0 109.945 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.13 79.69 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.856 0.836 . . . . 0.0 109.407 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -54.3 154.76 4.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.605 167.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.54 -75.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.465 2.459 . . . . 0.0 115.956 -168.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.79 10.34 19.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.826 1.65 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -168.27 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.966 2.106 . . . . 0.0 107.644 -151.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.67 147.23 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 161.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -122.14 136.15 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 123.387 0.675 . . . . 0.0 109.253 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mt -112.57 138.57 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.267 1.427 . . . . 0.0 108.051 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -135.48 117.95 15.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.473 2.309 . . . . 0.0 108.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -91.07 100.96 13.72 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.842 1.201 . . . . 0.0 112.596 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 72.12 10.2 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.581 -1.325 . . . . 0.0 108.671 169.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -88.65 -178.56 5.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 153.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -103.41 37.67 1.95 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.046 0.938 . . . . 0.0 111.553 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.07 82.63 0.86 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -102.53 102.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 156.26 46.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.674 1.99 . . . . 0.0 106.316 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -152.77 144.6 23.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 129.88 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 p -99.31 127.42 45.32 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.023 2.129 . . . . 0.0 109.214 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.09 156.62 46.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.128 0.876 . . . . 0.0 111.901 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.45 115.74 31.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.92 71.19 0.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.473 0.709 . . . . 0.0 111.363 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.26 38.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.635 1.112 . . . . 0.0 111.847 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 t -152.05 154.8 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.566 1.183 . . . . 0.0 109.199 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -106.83 123.57 48.35 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.739 2.016 . . . . 0.0 108.616 166.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -165.36 164.74 19.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.097 0.959 . . . . 0.0 109.924 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.77 144.13 55.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.916 0.78 . . . . 0.0 111.56 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -132.64 72.11 1.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.405 2.282 . . . . 0.0 107.166 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.8 m -71.25 108.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.437 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.1 t -140.57 144.67 35.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.138 0.575 . . . . 0.0 110.679 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.5 57.59 2.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.045 1.338 . . . . 0.0 111.948 -167.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.48 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.755 1.622 . . . . 0.0 108.512 -170.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -73.79 -15.94 61.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.71 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 90.9 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.587 2.755 . . . . 0.0 109.334 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -78.86 59.11 2.51 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.626 -0.672 . . . . 0.0 109.274 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.83 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.399 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -111.17 126.24 54.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.715 0.689 . . . . 0.0 109.655 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 p -78.26 108.49 11.63 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -102.14 110.22 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 155.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.06 145.37 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.9 t -155.38 -165.76 2.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.2 1.8 . . . . 0.0 107.112 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.82 145.12 39.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.2 0.27 46.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -166.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.92 -39.18 2.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -160.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.92 -63.11 0.09 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.7 1.143 . . . . 0.0 111.126 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 142.54 38.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -169.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.1 tt -79.85 114.7 18.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.88 105.08 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.62 1.168 . . . . 0.0 108.241 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.34 107.81 19.75 Favored 'General case' 0 CA--C 1.524 -0.054 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.43 101.93 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 167.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -89.92 102.42 15.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.752 1.221 . . . . 0.0 107.782 -166.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -116.85 127.34 54.2 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.126 0.57 . . . . 0.0 110.987 -165.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -97.72 -107.15 0.18 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.48 136.14 29.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.679 1.592 . . . . 0.0 108.642 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.8 -45.68 3.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.65 177.41 8.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.585 0.692 . . . . 0.0 111.552 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.01 176.79 11.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.532 1.933 . . . . 0.0 108.69 -172.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -132.7 138.42 47.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.954 1.301 . . . . 0.0 109.868 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.6 p -76.22 136.64 39.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 168.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.69 76.87 1.69 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 164.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.31 120.97 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.0 133.15 56.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.1 1.76 . . . . 0.0 109.868 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.33 146.66 29.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.704 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -124.55 107.28 10.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.288 1.435 . . . . 0.0 108.926 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.99 179.95 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 168.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.36 -98.32 0.08 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 0.0 109.664 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.16 32.79 0.5 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.458 1.028 . . . . 0.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 23.3 mttt -150.73 159.13 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.25 122.31 47.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.85 118.86 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.31 116.4 29.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 m -96.19 124.35 40.16 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.24 93.28 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.68 1.192 . . . . 0.0 108.276 -171.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -143.47 153.42 42.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 0.0 111.354 -165.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.69 138.6 9.64 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 122.738 0.415 . . . . 0.0 110.96 166.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 47.95 -119.01 4.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.857 0.741 . . . . 0.0 111.428 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -73.72 -30.96 63.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.019 0.528 . . . . 0.0 112.193 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 126.3 42.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.365 0.53 . . . . 0.0 109.861 -166.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.69 144.17 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.025 0 C-N-CA 125.602 1.561 . . . . 0.0 109.168 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.25 151.42 32.96 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.6 -1.313 . . . . 0.0 110.826 172.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.5 p -114.89 142.44 46.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.937 1.695 . . . . 0.0 107.384 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -139.73 82.21 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.83 142.16 31.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.774 0.797 . . . . 0.0 109.707 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -119.88 169.0 10.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.711 1.604 . . . . 0.0 108.509 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -116.45 117.45 29.94 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 163.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -75.69 108.67 8.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -78.95 -31.51 45.12 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 118.352 0.524 . . . . 0.0 111.672 -170.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.485 0.179 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.68 59.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.758 3.223 . . . . 0.0 111.959 -168.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.98 -50.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.284 1.834 . . . . 0.0 107.26 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.86 -40.49 87.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.813 1.245 . . . . 0.0 110.639 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.25 116.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.123 1.369 . . . . 0.0 111.259 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -129.56 4.28 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.834 1.207 . . . . 0.0 111.199 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 m -148.67 121.9 8.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.77 -0.841 . . . . 0.0 109.837 -171.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -115.15 130.09 56.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.761 1.624 . . . . 0.0 110.484 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -114.0 141.8 46.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.883 0.873 . . . . 0.0 109.483 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.8 144.01 29.13 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 123.399 0.437 . . . . 0.0 110.199 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 -73.99 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.513 0.725 . . . . 0.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -108.92 149.58 28.97 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.368 0.985 . . . . 0.0 110.102 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 t -170.89 -175.58 1.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.054 1.742 . . . . 0.0 107.805 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 pttt 177.14 154.16 0.25 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.366 2.666 . . . . 0.0 107.336 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.04 34.08 21.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.675 0.79 . . . . 0.0 109.743 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -95.76 -50.68 4.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -21.45 -74.98 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.719 2.408 . . . . 0.0 113.433 148.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.14 -57.55 8.44 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.988 0.813 . . . . 0.0 111.03 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.59 -48.16 19.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.331 0.586 . . . . 0.0 112.178 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -28.06 69.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -74.97 47.07 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.52 1.928 . . . . 0.0 110.514 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.1 t -174.89 -51.86 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.939 1.695 . . . . 0.0 106.887 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.58 -35.71 80.38 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.974 0.51 . . . . 0.0 111.073 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.32 -45.71 1.28 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -37.61 -26.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.508 2.323 . . . . 0.0 114.327 171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -27.75 -68.64 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.807 1.67 . . . . 0.0 112.96 159.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.58 155.83 38.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.959 0.38 . . . . 0.0 110.111 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 71.89 -52.07 0.69 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.969 1.708 . . . . 0.0 113.786 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.6 m -105.25 -67.37 0.92 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.424 1.089 . . . . 0.0 110.647 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -68.38 -17.42 64.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.282 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -41.22 -49.7 3.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.651 0.78 . . . . 0.0 111.972 163.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -94.33 -38.93 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.09 -40.79 59.56 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.075 0.845 . . . . 0.0 113.165 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -79.31 -12.42 59.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.273 1.037 . . . . 0.0 112.381 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -61.5 1.44 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.253 3.8 t -83.74 79.29 9.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.627 0.727 . . . . 0.0 109.656 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt 12.85 76.44 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 128.766 2.826 . . . . 0.0 113.91 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.25 150.17 76.38 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.998 2.465 . . . . 0.0 113.229 -161.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 m -102.53 159.1 15.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.055 1.742 . . . . 0.0 108.75 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 119.35 12.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -87.49 126.71 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.92 114.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.06 140.33 53.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.337 0.517 . . . . 0.0 110.302 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 79.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -62.42 74.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.597 1.559 . . . . 0.0 112.11 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.34 -92.73 0.06 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.486 1.041 . . . . 0.0 111.749 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.37 -30.09 19.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.409 1.083 . . . . 0.0 110.745 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.05 -175.54 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.493 2.317 . . . . 0.0 109.161 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.13 138.04 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -114.94 131.48 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.509 1.123 . . . . 0.0 108.732 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -120.68 120.45 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.718 2.407 . . . . 0.0 106.346 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -128.88 99.92 5.49 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 t -82.41 43.21 0.8 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.778 -172.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 124.03 18.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.959 1.704 . . . . 0.0 112.669 -175.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -123.8 -166.54 1.5 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 162.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -46.9 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.941 0.896 . . . . 0.0 111.459 -166.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.1 p90 38.66 34.29 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.081 2.152 . . . . 0.0 114.464 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -156.26 162.87 40.09 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.663 0.665 . . . . 0.0 110.634 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 96.71 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 129.547 3.139 . . . . 0.0 110.491 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 p -110.43 174.54 5.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.481 1.512 . . . . 0.0 112.385 -156.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.98 122.17 37.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.593 2.357 . . . . 0.0 106.583 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -129.38 136.73 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 p -141.48 122.23 14.36 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 119.183 0.901 . . . . 0.0 110.316 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -147.54 165.86 29.05 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.095 0.861 . . . . 0.0 111.915 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -101.1 138.34 38.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 166.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.0 59.06 0.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.113 0.565 . . . . 0.0 110.506 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 157.31 60.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -166.85 172.55 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.855 0.828 . . . . 0.0 109.041 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -131.35 152.07 50.94 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.859 0.864 . . . . 0.0 110.793 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.92 160.17 14.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 109.478 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.74 129.03 36.42 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -123.93 123.71 41.02 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -116.1 95.53 5.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 t -113.01 140.63 47.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.065 0.946 . . . . 0.0 109.899 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.71 48.54 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.481 1.112 . . . . 0.0 112.217 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -163.42 -62.45 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.729 1.612 . . . . 0.0 109.392 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -87.12 -3.64 59.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.75 0.82 . . . . 0.0 111.631 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 83.33 -157.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.837 1.655 . . . . 0.0 109.696 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -74.62 116.34 15.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 168.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.63 154.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -81.29 138.18 35.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 150.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -100.6 119.74 39.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 161.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tt -121.02 123.36 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.02 144.68 32.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.562 0.345 . . . . 0.0 110.944 -167.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -157.54 144.15 17.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.55 1.14 . . . . 0.0 109.317 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -85.15 109.11 18.05 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 90' ' ' LYS . 26.7 p-10 -78.58 29.2 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.325 0.65 . . . . 0.0 112.625 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.4 -36.47 1.56 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.597 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 -24.94 5.91 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.097 1.449 . . . . 0.0 113.087 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -163.3 159.97 23.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.733 1.267 . . . . 0.0 109.855 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 100.3 8.03 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.16 118.33 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -114.97 108.38 16.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.41 132.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -129.68 99.67 5.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -161.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HZ1' ' CD ' ' A' ' 101' ' ' GLU . 39.1 tttp -113.89 110.63 20.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.941 0.896 . . . . 0.0 111.648 -159.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -96.56 -27.31 14.9 Favored 'General case' 0 C--O 1.228 -0.048 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -155.68 -143.79 0.13 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.683 0.674 . . . . 0.0 109.897 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -42.74 -41.18 4.27 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.205 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -97.03 175.35 6.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 112.283 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.465 ' CD ' ' HZ1' ' A' ' 96' ' ' LYS . 2.3 pm0 -143.71 167.11 23.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.988 2.115 . . . . 0.0 108.301 173.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -98.59 148.14 24.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 148.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -119.31 137.11 53.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.94 138.13 19.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.207 0.458 . . . . 0.0 111.138 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.7 m -130.69 117.3 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.663 1.185 . . . . 0.0 110.203 -164.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -102.77 139.64 38.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.873 0.76 . . . . 0.0 109.573 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.71 155.63 36.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 153.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 19.8 ttt -91.83 119.36 31.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.857 0.863 . . . . 0.0 108.994 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.46 170.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 166.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.73 -85.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.627 1.171 . . . . 0.0 109.616 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.3 26.19 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.04 1.305 . . . . 0.0 110.467 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.48 154.54 47.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.89 117.42 16.71 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.95 120.77 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 168.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.93 104.81 9.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.8 m -94.25 131.93 39.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.93 130.37 53.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 t -141.19 131.99 25.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.546 0.689 . . . . 0.0 110.211 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -119.51 165.37 14.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.169 2.587 . . . . 0.0 105.838 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.78 65.09 1.47 Allowed Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.092 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t 156.45 -59.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 130.105 3.362 . . . . 0.0 108.432 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.15 137.24 35.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.197 0.599 . . . . 0.0 109.931 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.12 134.02 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 127.53 7.32 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.197 0.908 . . . . 0.0 112.98 -176.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.6 p -78.48 153.57 31.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.958 0.903 . . . . 0.0 109.072 168.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.69 140.13 19.64 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.2 p -133.36 160.34 37.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.945 0.793 . . . . 0.0 109.363 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -145.37 144.99 31.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.576 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -128.39 134.2 48.78 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -79.68 111.81 16.34 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.26 -39.08 82.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.71 -45.06 6.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.386 2.274 . . . . 0.0 111.731 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.87 -21.6 8.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.581 1.952 . . . . 0.0 112.511 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -120.22 17.65 12.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.915 1.286 . . . . 0.0 111.314 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -99.56 94.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.539 0.736 . . . . 0.0 110.954 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.66 -165.92 23.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.824 0.726 . . . . 0.0 113.486 159.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -83.64 143.05 30.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.503 0.721 . . . . 0.0 110.125 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -133.26 141.41 48.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.963 1.305 . . . . 0.0 108.513 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 133.01 36.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 165.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.11 144.56 56.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 166.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 -57.69 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.492 0.717 . . . . 0.0 111.483 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -78.98 160.08 27.37 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.815 1.189 . . . . 0.0 109.605 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -170.42 56.72 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.779 1.632 . . . . 0.0 108.302 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.38 127.18 35.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 66.97 27.92 8.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.995 1.718 . . . . 0.0 109.876 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.6 -51.34 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 120.033 -1.667 . . . . 0.0 108.089 -171.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -17.9 -77.39 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.835 2.054 . . . . 0.0 112.485 144.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -37.12 -57.45 0.85 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 111.12 175.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' SG ' ' A' ' 124' ' ' CYS . 0.8 OUTLIER -50.9 -50.18 57.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -166.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.72 81.43 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.528 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -77.08 49.52 0.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.535 1.934 . . . . 0.0 109.185 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -178.98 -55.99 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.368 1.867 . . . . 0.0 106.955 -168.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.69 -41.9 95.7 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.92 -44.16 0.87 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.5 42.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.979 1.312 . . . . 0.0 111.327 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.3 146.06 17.97 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.871 1.224 . . . . 0.0 112.406 -166.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.1 162.2 1.98 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.014 1.726 . . . . 0.0 107.175 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -18.73 65.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -47.9 -40.01 20.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 112.432 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -31.53 63.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.759 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -62.42 -23.94 67.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.117 0.871 . . . . 0.0 111.729 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.3 t -91.1 -47.94 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.79 -58.75 3.49 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.137 1.351 . . . . 0.0 112.884 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -55.66 -41.94 74.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.774 0.787 . . . . 0.0 110.913 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.359 1.064 . . . . 0.0 112.205 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -86.13 -132.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -145.61 76.53 12.91 Favored Pre-proline 0 C--O 1.234 0.274 0 O-C-N 121.086 -1.009 . . . . 0.0 109.085 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 82.7 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.344 2.696 . . . . 0.0 108.761 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -83.03 148.21 27.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.299 1.84 . . . . 0.0 107.902 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m -140.58 122.31 15.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.183 -0.323 . . . . 0.0 110.282 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -77.77 127.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mt -124.29 117.76 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.29 129.6 49.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.79 96.94 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -78.18 69.82 4.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.37 -89.25 0.05 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.759 1.171 . . . . 0.0 111.531 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -24.67 16.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.52 . . . . 0.0 110.747 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.48 9.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.165 1.786 . . . . 0.0 106.866 -172.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.98 141.7 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.96 133.31 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.762 0.825 . . . . 0.0 108.899 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.9 tt -110.35 132.32 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.754 1.222 . . . . 0.0 107.713 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -133.95 95.96 3.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 107.328 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.71 138.48 31.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -132.77 116.38 16.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.841 1.656 . . . . 0.0 110.903 -162.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -161.56 151.27 16.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.784 2.034 . . . . 0.0 106.314 161.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -56.73 -49.38 75.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.416 0.687 . . . . 0.0 109.502 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -48.87 -38.16 21.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.704 1.201 . . . . 0.0 112.755 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.59 136.27 0.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.922 0.889 . . . . 0.0 109.848 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -141.87 151.07 42.35 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.654 1.582 . . . . 0.0 108.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p -156.34 148.18 22.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.46 0.704 . . . . 0.0 109.351 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -128.04 117.79 22.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.071 2.149 . . . . 0.0 108.284 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.96 143.3 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.692 0.797 . . . . 0.0 109.287 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 p -108.19 150.06 27.74 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.472 1.509 . . . . 0.0 110.814 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -159.61 175.58 13.05 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.909 1.283 . . . . 0.0 108.91 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -134.79 143.64 47.2 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.999 0.92 . . . . 0.0 108.943 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 53.05 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.302 1.041 . . . . 0.0 112.027 -175.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.12 40.13 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.24 151.18 12.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.1 138.88 35.57 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.926 1.291 . . . . 0.0 109.469 166.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -142.19 158.35 43.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.381 1.472 . . . . 0.0 108.177 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.27 134.55 36.64 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -134.37 151.67 51.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -139.82 166.87 23.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.955 -0.466 . . . . 0.0 109.833 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 t -136.85 -177.27 4.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.162 0.985 . . . . 0.0 109.371 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.78 -25.02 62.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -156.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -95.22 15.02 20.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.233 1.413 . . . . 0.0 111.633 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t0 49.76 41.02 21.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.359 2.264 . . . . 0.0 112.969 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -66.76 87.44 0.13 Allowed 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -77.87 92.86 4.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.607 1.563 . . . . 0.0 109.464 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.41 171.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.778 1.231 . . . . 0.0 110.079 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.64 135.85 41.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 m -124.57 123.73 40.72 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 107.857 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.93 126.21 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -110.24 145.32 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.6 m -148.7 164.32 34.69 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -113.39 113.44 25.21 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.83 107.98 20.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.833 1.253 . . . . 0.0 108.012 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.35 -80.94 0.06 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.318 0.961 . . . . 0.0 112.106 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.67 4.18 3.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.495 1.521 . . . . 0.0 112.344 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -105.17 120.99 42.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 107.203 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.87 106.17 10.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 m -95.32 111.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -99.4 106.76 18.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.65 133.73 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.9 112.31 12.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -162.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -127.98 125.82 40.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.375 1.87 . . . . 0.0 108.688 -157.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -108.86 -81.55 0.57 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -162.19 150.76 15.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.96 -44.47 1.55 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.419 0.533 . . . . 0.0 112.044 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.58 -164.91 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.554 1.542 . . . . 0.0 109.196 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.77 -170.36 3.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.613 1.565 . . . . 0.0 109.334 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 t -136.14 150.72 49.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.623 1.569 . . . . 0.0 107.991 162.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.4 p -98.56 138.47 35.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 163.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.1 mt -131.64 96.83 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.401 1.88 . . . . 0.0 105.939 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.71 131.83 42.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.07 124.84 53.09 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.199 1.4 . . . . 0.0 108.27 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -141.91 122.42 14.13 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -106.74 115.89 30.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.09 -173.3 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 156.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 52.08 -108.91 0.42 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.48 28.76 2.05 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.859 1.695 . . . . 0.0 109.615 171.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -137.45 122.09 18.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.674 0.737 . . . . 0.0 110.128 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.24 92.73 5.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.8 mt -73.1 138.53 21.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.57 105.09 4.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.098 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.0 m -95.33 136.0 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.81 119.9 38.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -126.28 125.2 41.95 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.942 0.337 . . . . 0.0 110.309 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -129.5 165.01 22.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.54 1.536 . . . . 0.0 107.095 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.33 126.07 18.37 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 168.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.99 -58.84 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 112.146 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.78 133.15 34.34 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.694 -0.629 . . . . 0.0 111.862 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.21 130.3 69.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.773 1.629 . . . . 0.0 107.26 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' TYR . 4.4 m -146.99 158.76 44.02 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 121.379 -0.826 . . . . 0.0 109.174 -170.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.7 p -134.35 151.81 51.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.101 0.409 . . . . 0.0 110.738 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -145.2 167.26 23.21 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 156.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 p -136.47 146.43 46.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.22 129.68 52.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.551 1.54 . . . . 0.0 108.779 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -106.18 136.79 45.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.907 1.283 . . . . 0.0 108.422 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -65.25 139.0 58.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.358 0.263 . . . . 0.0 110.728 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -123.81 -6.0 7.99 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 111.722 159.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.144 0 C-N-CA 124.616 1.167 . . . . 0.0 110.922 172.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.236 0.378 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.41 67.9 0.02 OUTLIER 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.53 2.332 . . . . 0.0 111.091 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.37 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 107.09 -163.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -86.71 -45.67 10.75 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.914 1.286 . . . . 0.0 110.69 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -46.11 108.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.385 1.474 . . . . 0.0 111.645 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.83 -166.46 13.02 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.416 1.008 . . . . 0.0 112.37 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -84.2 138.84 32.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.131 0.973 . . . . 0.0 111.324 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.6 141.17 43.27 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.474 0.709 . . . . 0.0 110.314 167.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -107.87 153.84 22.43 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.463 1.105 . . . . 0.0 109.867 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.96 148.64 16.87 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 167.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.41 -54.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.867 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.49 147.24 39.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.631 1.105 . . . . 0.0 109.01 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -160.47 153.86 22.06 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.234 -0.916 . . . . 0.0 110.73 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -158.13 155.88 29.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.499 1.12 . . . . 0.0 108.541 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 m120 63.71 -10.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.36 -41.52 9.08 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.264 1.025 . . . . 0.0 110.869 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -71.76 -24.78 61.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.19 -46.44 56.26 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 165.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.88 -51.36 61.4 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.972 0.909 . . . . 0.0 112.327 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -57.68 -42.65 84.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.294 0.638 . . . . 0.0 109.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.94 57.71 1.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.448 1.499 . . . . 0.0 109.22 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t 179.63 -52.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.712 2.405 . . . . 0.0 107.028 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.27 -27.6 68.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.679 0.392 . . . . 0.0 111.575 172.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 -47.14 3.69 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p 0.28 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 130.324 3.45 . . . . 0.0 116.074 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.05 58.24 0.38 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -31.56 -61.42 0.22 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 128.003 2.521 . . . . 0.0 111.484 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.21 57.94 1.29 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.318 1.047 . . . . 0.0 108.202 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -149.67 -52.54 0.15 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.859 -0.526 . . . . 0.0 109.802 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -59.23 -22.99 61.93 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.453 -1.261 . . . . 0.0 110.863 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -41.57 -35.52 0.75 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.218 1.007 . . . . 0.0 112.696 169.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.82 -67.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.05 45.21 2.23 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.443 1.02 . . . . 0.0 113.817 -173.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -154.03 -34.61 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.958 1.703 . . . . 0.0 110.886 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.2 ttm -92.22 -21.12 20.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.89 1.676 . . . . 0.0 110.307 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -65.71 -165.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.409 0.623 . . . . 0.0 109.995 159.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -107.37 78.97 0.7 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.597 1.159 . . . . 0.0 109.411 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.65 145.11 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.113 1.875 . . . . 0.0 110.344 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 m -104.26 126.18 51.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.505 1.122 . . . . 0.0 108.039 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -109.19 99.42 8.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.34 121.22 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.16 128.6 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -107.1 141.56 38.15 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.04 71.39 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.151 0.98 . . . . 0.0 108.695 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -55.05 139.69 40.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.882 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.46 -75.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.9 2.191 . . . . 0.0 116.457 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -111.18 18.45 19.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.519 1.928 . . . . 0.0 111.03 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.26 -162.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.954 1.301 . . . . 0.0 108.253 -155.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.89 142.74 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.8 tt -124.98 117.68 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.67 135.79 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -115.3 107.55 15.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.944 2.098 . . . . 0.0 105.746 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -88.25 102.64 15.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.59 138.48 43.74 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.034 0.834 . . . . 0.0 111.008 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -169.81 54.86 0.04 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.196 1.398 . . . . 0.0 108.748 -173.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 m 65.71 -75.13 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.653 1.581 . . . . 0.0 111.637 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.33 -51.79 4.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.062 0.945 . . . . 0.0 109.2 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -77.07 76.9 3.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.58 59.84 0.61 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.575 1.15 . . . . 0.0 110.537 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.14 163.62 18.64 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.936 1.294 . . . . 0.0 111.123 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -123.58 156.62 35.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.908 0.883 . . . . 0.0 110.067 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mp -133.53 101.16 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.6 122.6 36.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.811 2.044 . . . . 0.0 108.926 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.58 168.81 22.49 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.097 0.862 . . . . 0.0 112.61 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.58 108.79 13.53 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.539 1.535 . . . . 0.0 107.812 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 96.78 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 122.051 -0.406 . . . . 0.0 110.017 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.14 33.3 0.2 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.365 1.936 . . . . 0.0 111.832 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.72 149.39 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.835 1.317 . . . . 0.0 109.32 -171.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.85 121.95 44.74 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.268 1.427 . . . . 0.0 107.612 161.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.37 155.02 23.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.821 0.737 . . . . 0.0 111.366 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.88 120.11 13.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.203 0.601 . . . . 0.0 110.237 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.76 95.43 5.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 m -103.77 102.6 12.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 t -131.28 146.79 52.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.013 0.925 . . . . 0.0 109.405 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.2 43.92 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.588 1.155 . . . . 0.0 112.066 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -149.98 -68.39 0.2 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.771 1.628 . . . . 0.0 108.264 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.99 -12.79 61.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.242 0.928 . . . . 0.0 111.525 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.12 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.256 2.222 . . . . 0.0 108.566 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -80.91 112.37 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 166.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.52 138.21 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -80.41 109.54 15.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.9 p -74.57 149.64 40.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 tt -137.36 107.75 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 163.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.18 139.92 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.184 -170.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -156.99 176.96 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.731 2.013 . . . . 0.0 107.206 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -132.17 122.08 24.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 159.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 176.11 167.51 0.43 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.109 2.564 . . . . 0.0 105.32 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.44 -64.56 1.06 Allowed Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.49 104.93 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 91.83 162.3 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.706 2.402 . . . . 0.0 110.05 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 121.09 26.28 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.24 86.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.992 1.717 . . . . 0.0 108.484 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -81.57 81.13 7.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.5 149.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -153.34 106.17 2.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -158.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -116.13 100.98 8.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.062 2.145 . . . . 0.0 108.121 -160.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -90.61 -62.36 1.47 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.592 1.087 . . . . 0.0 110.48 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -170.13 -85.27 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.157 0.435 . . . . 0.0 111.465 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.82 -20.81 79.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.44 170.02 16.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -133.22 175.48 9.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.945 1.698 . . . . 0.0 107.429 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.3 t -143.02 160.88 39.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.174 0.99 . . . . 0.0 109.218 168.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -127.53 116.8 20.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 108.126 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.32 105.7 15.2 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.194 0.998 . . . . 0.0 108.536 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.46 114.82 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.268 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -109.75 139.62 44.58 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.97 0.908 . . . . 0.0 109.075 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -161.28 151.09 17.0 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.087 0.403 . . . . 0.0 110.907 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -113.57 107.59 16.0 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.008 0.923 . . . . 0.0 109.756 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.28 -176.97 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 159.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.0 t70 52.21 -113.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -148.29 34.41 1.19 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.559 1.076 . . . . 0.0 110.777 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -144.47 148.45 34.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.39 98.04 10.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.5 128.21 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -131.51 122.85 26.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -119.48 132.28 55.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.3 123.33 45.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.7 m -124.73 132.98 53.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.053 1.341 . . . . 0.0 109.411 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.31 170.02 16.79 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.451 0.569 . . . . 0.0 110.565 169.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -45.31 106.82 0.13 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 60.04 45.48 11.96 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.959 1.304 . . . . 0.0 112.556 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -173.01 140.87 0.93 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 144.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.6 144.16 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.542 1.937 . . . . 0.0 106.67 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -149.85 126.44 10.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.186 0.448 . . . . 0.0 111.172 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -76.49 138.06 40.04 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.868 1.267 . . . . 0.0 108.311 163.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -150.75 100.84 2.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 161.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.3 m -97.0 138.44 34.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.889 0.852 . . . . 0.0 109.421 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -114.87 171.2 7.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.063 1.745 . . . . 0.0 108.976 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.02 142.07 47.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.109 1.763 . . . . 0.0 106.257 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -101.23 121.38 41.75 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.129 0.572 . . . . 0.0 110.577 -167.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -126.43 61.77 1.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.275 1.43 . . . . 0.0 109.366 -172.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 C-N-CA 123.696 0.799 . . . . 0.0 109.123 168.453 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.52 -37.6 50.08 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.571 1.948 . . . . 0.0 111.492 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.96 -16.5 63.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.392 1.877 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -119.04 -54.01 2.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.739 1.216 . . . . 0.0 110.426 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -52.56 109.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.6 1.16 . . . . 0.0 111.36 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.85 -177.21 31.46 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 123.849 0.737 . . . . 0.0 112.617 167.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -91.02 129.84 36.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.651 1.58 . . . . 0.0 108.991 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.402 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 36.6 m95 -126.59 142.18 51.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 109.536 -177.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -110.23 140.77 44.02 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.215 1.006 . . . . 0.0 109.551 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.4 tt -70.78 117.74 12.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 p -141.73 53.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 122.245 1.021 . . . . 0.0 108.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t0 163.59 156.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 130.347 3.459 . . . . 0.0 106.039 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 t 164.46 135.71 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.541 2.736 . . . . 0.0 108.138 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -106.38 159.07 16.42 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.05 48.19 8.84 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.584 0.707 . . . . 0.0 111.949 161.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -56.53 18.34 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.787 0.803 . . . . 0.0 109.718 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.63 -23.38 31.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.847 -166.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -44.25 -60.64 1.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.854 0.835 . . . . 0.0 109.688 161.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.51 -50.68 67.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.663 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.2 ttp -49.38 -47.16 47.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.353 1.061 . . . . 0.0 111.04 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -73.74 56.0 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.467 1.107 . . . . 0.0 111.201 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 m 175.17 -54.71 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.296 2.238 . . . . 0.0 107.374 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.48 -38.92 91.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.621 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.18 86.96 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.91 -34.35 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 117.163 0.481 . . . . 0.0 110.979 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.16 102.36 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -48.95 -59.45 3.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.306 1.042 . . . . 0.0 110.512 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -55.75 19.98 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.236 0.541 . . . . 0.0 109.834 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -47.67 14.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.16 1.784 . . . . 0.0 112.874 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -61.08 -32.08 71.74 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.046 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.18 -55.79 19.29 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.149 0.886 . . . . 0.0 109.204 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.07 -46.83 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.08 45.27 1.4 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.259 1.409 . . . . 0.0 113.557 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -158.07 -41.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.419 1.887 . . . . 0.0 108.838 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -34.96 75.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.642 167.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.6 t -69.88 22.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 35.13 64.66 1.88 Allowed Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.2 1.8 . . . . 0.0 112.692 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.84 156.97 50.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.082 2.522 . . . . 0.0 112.706 -166.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.1 p -119.33 161.27 20.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 109.42 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -149.35 155.45 40.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.8 147.47 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 160.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.59 121.25 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -137.05 110.85 8.14 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.593 0.633 . . . . 0.0 109.765 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 95.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.345 1.058 . . . . 0.0 108.353 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -77.35 61.09 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.649 1.179 . . . . 0.0 108.691 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.16 -86.0 0.1 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.742 -0.599 . . . . 0.0 111.766 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -83.31 -43.46 15.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.136 0.969 . . . . 0.0 109.239 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.93 162.07 17.1 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.955 1.702 . . . . 0.0 109.554 -172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.39 118.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 103.568 -2.752 . . . . 0.0 103.568 169.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.1 tt -93.42 136.46 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.18 149.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 141.02 38.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.076 0.853 . . . . 0.0 110.721 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -103.46 44.52 1.01 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.851 1.26 . . . . 0.0 110.82 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.13 116.97 3.09 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.529 1.131 . . . . 0.0 113.409 -157.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 t -102.89 -172.43 2.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.653 1.181 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -28.8 61.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.311 1.444 . . . . 0.0 112.322 -167.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.28 51.84 2.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 109.555 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.8 tttt 68.76 173.41 0.29 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.972 0.909 . . . . 0.0 109.087 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -152.41 -173.92 4.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 164.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.4 p -64.99 164.75 12.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.735 0.778 . . . . 0.0 111.536 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.69 136.15 54.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 165.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.3 mt -132.2 146.62 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.01 2.524 . . . . 0.0 106.232 -161.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -146.48 91.27 2.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.716 1.144 . . . . 0.0 111.617 -161.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -118.12 161.89 19.11 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 110.149 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 130.18 52.32 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.51 60.49 3.9 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.743 0.817 . . . . 0.0 112.286 -162.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.07 49.28 0.05 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -171.68 160.9 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.974 . . . . 0.0 110.082 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.92 147.87 36.18 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.356 1.062 . . . . 0.0 109.798 162.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.74 161.36 15.51 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.93 133.31 44.3 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -124.32 128.97 49.91 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.1 m -124.74 108.17 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -132.5 137.44 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.413 1.085 . . . . 0.0 109.897 -172.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.78 39.96 0.23 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.275 -0.891 . . . . 0.0 113.043 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -145.88 -54.37 0.27 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.855 1.662 . . . . 0.0 108.191 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.87 1.99 44.6 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -150.08 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.556 1.542 . . . . 0.0 111.089 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -99.07 118.85 36.75 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.097 1.759 . . . . 0.0 108.156 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.98 144.98 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -173.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -70.79 127.7 33.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 153.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -108.28 99.81 9.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.244 1.418 . . . . 0.0 107.275 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.17 103.82 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.998 1.319 . . . . 0.0 107.93 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.88 139.25 45.77 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 117.882 0.31 . . . . 0.0 110.461 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 p -151.93 -168.43 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.32 2.248 . . . . 0.0 106.971 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -140.82 156.33 46.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 163.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -123.41 134.98 53.9 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.043 1.337 . . . . 0.0 107.514 171.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.86 -82.96 0.02 OUTLIER Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.678 0.656 . . . . 0.0 112.289 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.66 33.76 0.63 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 110.059 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -126.98 123.28 36.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.771 2.028 . . . . 0.0 106.301 -171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.4 tt -82.99 123.5 29.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -170.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.06 134.15 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 125.416 1.487 . . . . 0.0 108.63 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -132.81 103.63 6.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.17 140.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 166.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -144.8 114.67 7.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.014 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -127.65 119.36 25.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.751 0.821 . . . . 0.0 110.228 -160.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -102.09 -62.64 1.24 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.801 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -163.44 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.56 0.618 . . . . 0.0 112.375 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.58 70.03 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 118.948 0.795 . . . . 0.0 111.713 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -179.75 7.49 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.705 1.202 . . . . 0.0 107.804 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -144.68 -178.82 6.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.76 2.024 . . . . 0.0 107.775 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 t -140.93 160.79 39.32 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.176 0.991 . . . . 0.0 108.351 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -137.13 137.54 39.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.58 154.59 47.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.11 141.92 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -126.64 133.33 51.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.838 1.255 . . . . 0.0 109.865 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -149.85 141.69 23.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -110.53 116.02 30.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 161.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.28 -176.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 161.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.3 t70 51.55 -109.11 0.42 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.27 30.99 1.85 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.322 1.439 . . . . 0.0 110.47 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -147.61 150.15 33.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.169 0.985 . . . . 0.0 110.404 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -89.67 97.93 11.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.35 112.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tp -121.84 109.73 15.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.412 1.085 . . . . 0.0 108.346 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.7 p -102.55 127.26 49.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.18 118.71 37.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.375 1.47 . . . . 0.0 107.762 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.6 p -121.15 125.64 47.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.528 1.131 . . . . 0.0 110.579 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -129.75 71.28 1.44 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.323 1.449 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 -90.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.085 1.326 . . . . 0.0 111.941 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 t -84.15 -38.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.07 0.948 . . . . 0.0 110.346 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.05 141.76 32.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.96 115.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 O-C-N 122.211 -0.306 . . . . 0.0 110.57 -162.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.4 t -131.78 105.06 7.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.099 0.96 . . . . 0.0 110.669 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.4 p -62.85 145.57 54.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 157.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -152.37 119.58 5.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.791 0.836 . . . . 0.0 110.149 161.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 81.8 p -92.89 97.32 10.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.764 -1.21 . . . . 0.0 109.382 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -67.65 164.41 19.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.863 . . . . 0.0 109.611 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.04 140.01 34.2 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.612 0.765 . . . . 0.0 109.598 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -73.17 109.0 6.37 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -90.39 -27.88 19.04 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.76 0.255 . . . . 0.0 110.778 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 123.231 0.613 . . . . 0.0 110.999 -175.682 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.73 60.84 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.64 1.976 . . . . 0.0 111.662 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.26 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.189 1.396 . . . . 0.0 107.494 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -59.04 -54.71 44.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 110.935 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -11.96 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 129.668 3.187 . . . . 0.0 113.613 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.19 -125.47 4.88 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 118.72 0.691 . . . . 0.0 112.172 168.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -129.88 121.49 26.78 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.7 0.8 . . . . 0.0 110.591 -159.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -106.17 132.07 52.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.496 1.118 . . . . 0.0 108.773 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -105.42 125.39 50.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.576 1.55 . . . . 0.0 108.371 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.77 144.91 45.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.542 0.61 . . . . 0.0 110.928 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.15 69.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 118.352 0.523 . . . . 0.0 111.92 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -164.38 178.75 7.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.212 1.405 . . . . 0.0 107.957 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -162.0 59.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.554 1.07 . . . . 0.0 112.453 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.64 114.62 21.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.229 0.612 . . . . 0.0 110.877 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 52.23 28.26 5.43 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.394 2.277 . . . . 0.0 113.065 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -81.52 -43.43 18.78 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.74 -1.225 . . . . 0.0 111.386 -167.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -71.32 -55.31 8.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -36.17 -63.17 0.4 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.086 1.354 . . . . 0.0 112.499 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -48.55 -49.93 34.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.372 1.069 . . . . 0.0 110.702 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.1 mtp -68.04 -35.57 78.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.91 0.484 . . . . 0.0 110.903 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -83.31 40.83 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.662 1.985 . . . . 0.0 109.98 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 p -169.66 -42.44 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.999 2.12 . . . . 0.0 107.146 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.24 -45.75 68.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.276 -0.265 . . . . 0.0 111.292 162.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.98 0.4 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.121 1.343 . . . . 0.0 111.354 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.71 -5.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.45 51.6 4.23 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 119.379 -2.076 . . . . 0.0 112.961 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -50.49 -60.43 3.02 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.192 1.397 . . . . 0.0 112.999 -159.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.83 -31.81 27.91 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.504 -170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m 64.52 122.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.239 1.816 . . . . 0.0 112.513 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 52.86 35.99 20.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 112.243 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.06 -51.7 0.1 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.445 1.098 . . . . 0.0 108.482 170.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -35.25 -41.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 128.424 2.69 . . . . 0.0 114.576 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.85 46.34 1.04 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-O 119.194 -0.781 . . . . 0.0 111.268 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -164.11 -37.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.591 0.757 . . . . 0.0 112.139 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.22 -56.35 4.64 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -64.1 -29.18 70.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.198 0.999 . . . . 0.0 112.539 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 73.33 83.41 0.13 Allowed Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.663 1.585 . . . . 0.0 110.007 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.49 134.96 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.441 1.427 . . . . 0.0 109.244 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 m -118.27 144.48 45.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.1 m -126.44 107.21 10.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -83.34 117.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.98 111.08 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 148.45 42.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 123.701 0.626 . . . . 0.0 109.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.23 111.46 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.961 0.904 . . . . 0.0 109.52 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.82 56.77 3.54 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.07 -83.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.946 0.784 . . . . 0.0 112.231 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.38 -36.44 16.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.763 1.225 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 177.02 5.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.962 2.105 . . . . 0.0 107.913 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 p -152.45 138.45 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 tt -119.98 127.05 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.627 0.771 . . . . 0.0 109.573 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 138.81 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 125.007 1.323 . . . . 0.0 108.751 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -130.09 119.69 23.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.451 1.5 . . . . 0.0 109.085 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -80.96 96.95 7.24 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.374 1.469 . . . . 0.0 108.656 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -79.21 106.76 11.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.857 0.837 . . . . 0.0 109.301 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -131.76 -176.97 4.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.945 2.498 . . . . 0.0 107.812 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 m -145.18 64.26 1.27 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -169.86 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.493 1.517 . . . . 0.0 108.569 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -158.73 131.59 7.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -126.09 156.8 39.45 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -150.29 154.29 37.62 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -150.53 139.15 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.216 0.606 . . . . 0.0 110.113 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -150.78 145.37 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.343 1.057 . . . . 0.0 108.712 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -97.21 145.85 25.65 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 109.67 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.04 179.45 8.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.15 0.98 . . . . 0.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.81 146.5 28.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.838 0.855 . . . . 0.0 109.264 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.41 69.17 0.38 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.066 1.346 . . . . 0.0 111.151 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 51.87 0.04 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -146.97 140.58 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.849 0.824 . . . . 0.0 109.152 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 129.55 53.38 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 166.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.43 168.42 20.31 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.53 136.14 36.81 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.291 0.636 . . . . 0.0 110.264 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.34 90.63 3.26 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.607 2.363 . . . . 0.0 106.132 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -86.46 110.69 19.92 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -143.58 160.93 39.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.408 0.683 . . . . 0.0 110.783 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.41 -10.68 53.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.695 0.798 . . . . 0.0 113.139 -168.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -92.64 -57.72 2.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.679 1.592 . . . . 0.0 108.652 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HA ' ' NH1' ' A' ' 78' ' ' ARG 0.416 0.7 OUTLIER -97.76 10.6 39.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.31 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' NH1' ' HA ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 67.03 -154.24 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.836 1.255 . . . . 0.0 109.163 172.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.45 114.18 21.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.56 154.92 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -86.62 127.27 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.084 0.856 . . . . 0.0 110.262 167.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -83.83 114.57 21.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.29 1.836 . . . . 0.0 107.636 167.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.31 94.64 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.94 138.85 46.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 O-C-N 122.124 -0.36 . . . . 0.0 111.177 -165.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -156.8 173.62 16.71 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.963 2.105 . . . . 0.0 106.55 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.55 135.23 48.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.594 1.088 . . . . 0.0 110.612 161.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -88.87 61.86 6.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -168.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.25 -35.32 0.66 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.485 -0.619 . . . . 0.0 113.827 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.24 59.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt 171.61 125.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.375 2.27 . . . . 0.0 107.91 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -83.95 127.01 33.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.842 0.746 . . . . 0.0 110.038 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.14 110.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.649 1.579 . . . . 0.0 106.961 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -98.82 89.27 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 170.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.0 t -74.5 139.56 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -130.96 94.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -159.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.31 114.86 24.2 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.489 0.715 . . . . 0.0 111.243 -167.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.64 -56.73 2.8 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.147 0.43 . . . . 0.0 110.153 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -167.9 -87.07 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.964 0.347 . . . . 0.0 111.425 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.83 -24.69 76.79 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -173.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 172.42 12.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.8 167.56 20.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.49 2.316 . . . . 0.0 107.14 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.0 p -133.82 157.54 45.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.448 0.699 . . . . 0.0 109.499 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 p -88.52 138.18 31.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.1 mt -125.09 84.32 2.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 159.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -106.23 144.59 15.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.437 0.695 . . . . 0.0 110.105 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 158.0 43.61 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.926 0.491 . . . . 0.0 111.56 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -165.09 153.84 12.23 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.738 1.215 . . . . 0.0 109.132 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.9 ttp -114.98 124.83 52.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.163 1.385 . . . . 0.0 109.902 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.88 179.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 157.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.01 -112.65 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -172.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.62 30.08 1.56 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.512 1.053 . . . . 0.0 110.988 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -141.61 156.71 45.66 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.2 108.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.477 1.111 . . . . 0.0 108.373 -170.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.11 141.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 0.0 109.548 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.9 tp -128.0 85.85 2.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.464 1.106 . . . . 0.0 110.037 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -95.85 111.69 23.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt -113.17 120.35 40.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.8 m -119.24 125.44 49.16 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.776 0.716 . . . . 0.0 109.435 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -123.23 146.15 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 106.844 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -36.24 -52.55 1.29 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.191 0.901 . . . . 0.0 113.469 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -34.05 57.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.05 133.1 29.49 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.188 0.595 . . . . 0.0 110.362 -159.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.08 121.38 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.68 1.192 . . . . 0.0 108.336 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.86 109.4 14.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.673 1.189 . . . . 0.0 109.298 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.86 104.21 12.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.917 1.287 . . . . 0.0 108.217 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -122.43 -177.91 3.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.711 0.804 . . . . 0.0 109.985 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -145.6 155.33 42.97 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.151 0.58 . . . . 0.0 109.835 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -115.87 164.95 13.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.588 1.955 . . . . 0.0 108.99 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.17 136.99 49.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -75.53 109.69 9.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.835 -0.541 . . . . 0.0 110.086 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.31 -23.65 23.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.544 0.338 . . . . 0.0 111.542 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 111.508 -178.44 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.48 63.22 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.75 2.82 . . . . 0.0 111.725 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.09 -48.14 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.802 2.041 . . . . 0.0 107.099 -171.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -54.82 -43.02 72.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.742 1.617 . . . . 0.0 111.566 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.4 t -41.4 109.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.754 1.622 . . . . 0.0 112.487 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.17 -168.45 23.73 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.436 1.017 . . . . 0.0 113.758 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -91.04 122.43 33.69 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.4 1.48 . . . . 0.0 110.451 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -108.32 156.52 19.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.673 1.589 . . . . 0.0 110.415 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 135.74 31.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.35 148.05 49.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.994 0.918 . . . . 0.0 111.873 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.65 -15.12 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.233 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' CG ' ' HZ3' ' A' ' 14' ' ' LYS . 48.0 t0 -145.86 155.83 43.16 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.145 1.339 . . . . 0.0 110.52 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -173.98 134.52 0.46 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 127.678 2.391 . . . . 0.0 109.095 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HZ3' ' CG ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -152.82 166.73 31.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 163.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 63.4 12.3 6.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.267 1.827 . . . . 0.0 112.394 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.02 -52.25 30.71 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.028 -1.045 . . . . 0.0 109.885 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.06 -50.7 63.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.051 2.14 . . . . 0.0 110.101 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -61.69 -39.58 91.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.834 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -47.35 -49.55 24.14 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.316 0.646 . . . . 0.0 110.864 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.67 -28.62 70.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.678 -0.677 . . . . 0.0 112.029 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -73.78 58.96 0.65 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.711 1.204 . . . . 0.0 110.511 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 p 168.24 -48.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.945 3.298 . . . . 0.0 106.691 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.04 -35.27 79.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 112.088 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.39 -15.46 63.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.297 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -76.21 42.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -161.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.42 96.7 0.05 OUTLIER Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.063 -1.023 . . . . 0.0 113.538 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -62.66 -17.97 61.45 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.851 -1.381 . . . . 0.0 112.786 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.63 -53.73 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.308 1.043 . . . . 0.0 111.679 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 m -66.2 -31.01 71.59 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.994 -0.441 . . . . 0.0 110.896 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -38.96 86.18 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -58.61 -58.12 9.96 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.101 0.864 . . . . 0.0 108.976 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -45.82 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.31 -14.07 71.22 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.453 -1.748 . . . . 0.0 114.937 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -103.12 -38.0 7.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.63 . . . . 0.0 110.744 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.54 -47.42 7.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.866 0.866 . . . . 0.0 111.875 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 m -99.15 90.9 4.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 118.861 -0.59 . . . . 0.0 109.722 -161.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 6.35 75.01 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 127.384 2.274 . . . . 0.0 113.415 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.17 93.64 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.363 2.042 . . . . 0.0 109.366 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.0 m -89.19 150.97 22.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.848 1.259 . . . . 0.0 107.889 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.2 m -140.91 140.89 34.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.73 -1.231 . . . . 0.0 108.674 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.0 132.75 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.0 mt -128.14 107.57 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.88 107.03 15.91 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.116 1.767 . . . . 0.0 109.274 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.97 109.31 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -93.79 65.49 3.6 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.17 -87.69 0.09 OUTLIER Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.299 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.15 -6.11 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.501 1.12 . . . . 0.0 112.302 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -102.2 169.43 8.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.26 117.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 mt -88.32 132.96 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tt -116.44 133.57 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -122.2 137.07 54.96 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.406 1.083 . . . . 0.0 109.043 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 p -105.73 16.83 24.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.04 1.336 . . . . 0.0 113.007 -166.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.13 109.05 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.259 1.423 . . . . 0.0 114.418 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -66.81 -41.47 87.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 171.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -149.62 -75.85 0.16 Allowed 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -71.68 -54.56 9.95 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.115 -0.366 . . . . 0.0 110.453 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -174.58 156.36 2.39 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.52 -79.02 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -142.52 157.94 44.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.297 1.039 . . . . 0.0 109.29 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.06 133.69 54.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 166.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.72 117.52 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 p -106.54 81.45 1.59 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.181 1.792 . . . . 0.0 110.537 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -72.23 143.18 48.9 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.396 -0.815 . . . . 0.0 111.637 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -121.54 112.56 18.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.65 102.98 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.785 0.834 . . . . 0.0 111.665 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.54 54.79 1.3 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.44 170.64 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.51 149.02 43.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.934 0.494 . . . . 0.0 110.387 163.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -141.83 153.44 44.5 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.366 1.066 . . . . 0.0 109.254 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.69 144.53 56.95 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.84 158.21 43.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.815 1.246 . . . . 0.0 108.672 -168.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 t -137.53 146.58 44.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.574 0.75 . . . . 0.0 109.639 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -128.19 170.36 13.09 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.42 -15.46 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -156.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -95.37 13.52 25.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.374 1.47 . . . . 0.0 111.551 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.25 38.2 t0 31.15 57.17 0.25 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.016 2.126 . . . . 0.0 113.658 -156.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -61.63 123.93 19.28 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 116.282 -2.167 . . . . 0.0 106.546 149.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -78.72 112.71 16.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.27 172.47 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -108.99 130.38 55.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -88.89 102.17 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.929 1.291 . . . . 0.0 107.636 164.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.75 134.5 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 166.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.01 139.54 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.651 0.659 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -151.76 -172.15 4.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.101 1.361 . . . . 0.0 107.668 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 tt -137.51 113.21 9.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.806 1.642 . . . . 0.0 108.376 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -115.06 105.88 13.47 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.58 1.181 . . . . 0.0 110.843 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.87 -62.14 3.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.141 0.877 . . . . 0.0 111.774 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.04 69.88 0.08 OUTLIER Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 pttm 173.5 142.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 106.527 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.302 0.0 OUTLIER -88.81 136.81 32.81 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -115.69 97.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.95 104.03 13.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.25 126.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -116.19 105.51 12.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.64 126.69 55.29 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.233 1.013 . . . . 0.0 110.417 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -99.62 -62.53 1.23 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.931 0.492 . . . . 0.0 109.732 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.92 -92.85 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.31 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.77 -12.61 83.74 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.938 0.79 . . . . 0.0 112.265 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -137.84 164.3 29.28 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -142.11 152.07 42.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 167.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -116.55 148.03 41.25 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -107.66 134.45 50.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.013 0.525 . . . . 0.0 109.931 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.08 90.05 3.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.346 1.859 . . . . 0.0 106.733 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.5 m -90.15 139.41 17.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 148.42 43.15 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.059 0.544 . . . . 0.0 111.324 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -164.09 155.0 15.59 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.656 1.582 . . . . 0.0 108.06 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.7 ttp -105.08 118.37 36.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.616 0.767 . . . . 0.0 109.086 161.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.24 170.41 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 154.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 52.05 -124.28 2.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -165.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.75 21.75 4.68 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.906 1.241 . . . . 0.0 111.58 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 65.2 mttm -137.28 140.77 41.79 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.117 0.958 . . . . 0.0 108.779 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.61 121.56 31.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.38 150.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.7 118.0 13.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.8 m -111.89 100.03 8.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.8 115.84 18.75 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.2 m -118.38 114.2 22.55 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.002 0.921 . . . . 0.0 109.98 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 -27.84 14.42 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.471 1.508 . . . . 0.0 109.827 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.39 -92.87 0.2 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 t -58.72 -44.33 90.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.81 141.5 29.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.091 0.557 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.28 129.21 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 126.109 1.763 . . . . 0.0 107.086 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.9 t -116.52 104.74 11.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 108.973 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.4 p -70.37 143.84 51.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 163.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.88 153.9 28.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 t -146.68 155.7 42.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.734 0.697 . . . . 0.0 110.984 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.03 154.25 51.26 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.032 2.133 . . . . 0.0 109.395 -165.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 112' ' ' LYS . 42.5 tt0 -129.22 134.23 47.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.945 1.298 . . . . 0.0 107.843 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -78.22 119.52 21.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -104.11 -29.69 10.71 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.656 0.782 . . . . 0.0 110.978 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.379 0.672 . . . . 0.0 110.968 -178.374 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.237 0.418 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.41 55.87 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.979 2.512 . . . . 0.0 111.625 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.65 -38.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.766 1.626 . . . . 0.0 108.849 -161.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -96.55 -34.84 11.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.732 1.213 . . . . 0.0 110.758 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.43 105.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.88 176.93 27.67 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.912 0.778 . . . . 0.0 113.081 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 m -102.49 118.24 36.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -114.66 134.67 54.89 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.417 1.487 . . . . 0.0 107.659 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -112.09 121.12 44.08 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.99 131.89 52.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.266 0.939 . . . . 0.0 108.793 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.51 -64.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 125.068 1.48 . . . . 0.0 110.288 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.21 158.18 17.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.078 0.854 . . . . 0.0 110.171 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -175.08 165.02 3.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 107.709 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -149.31 153.94 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 166.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.39 42.49 32.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.217 1.007 . . . . 0.0 110.633 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.8 -55.48 26.04 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.179 -0.951 . . . . 0.0 109.278 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.522 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -25.93 -60.27 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.542 1.537 . . . . 0.0 112.822 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -51.08 -59.9 3.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.131 0.972 . . . . 0.0 112.695 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.2 ptp -63.43 -29.7 70.95 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.674 -0.641 . . . . 0.0 112.403 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp -78.73 45.74 0.62 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.764 2.026 . . . . 0.0 111.379 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m 177.29 -46.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 128.061 2.544 . . . . 0.0 107.396 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -54.34 -31.47 54.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.472 0.709 . . . . 0.0 110.39 173.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 45.6 0.59 Allowed Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 160.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -139.01 -36.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 109.179 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.66 68.46 2.17 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.279 -0.888 . . . . 0.0 112.28 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.73 70.7 0.72 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 109.92 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.8 -60.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.947 2.099 . . . . 0.0 112.55 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -33.08 -46.07 0.15 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.092 2.957 . . . . 0.0 112.801 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -112.47 23.71 13.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.798 . . . . 0.0 112.575 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.86 -23.33 15.4 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.962 1.705 . . . . 0.0 110.053 157.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.67 -46.05 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.32 61.02 2.32 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.296 0.951 . . . . 0.0 113.708 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -178.02 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.033 1.733 . . . . 0.0 108.922 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.1 ttm -54.36 -35.48 62.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.291 0.636 . . . . 0.0 109.946 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 m -65.19 76.54 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.274 0.63 . . . . 0.0 109.852 161.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -20.08 95.04 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.943 2.897 . . . . 0.0 112.562 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.64 165.18 26.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.998 -167.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.5 m -131.46 149.5 52.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.463 -0.79 . . . . 0.0 108.888 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -138.34 95.05 2.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.057 -161.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.46 127.91 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.9 mt -126.49 109.39 20.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.92 135.99 49.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.102 0.961 . . . . 0.0 109.743 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.08 84.84 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.732 0.813 . . . . 0.0 108.817 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.63 71.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.109 1.764 . . . . 0.0 111.177 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.78 -105.01 0.58 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -34.67 55.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.351 0.66 . . . . 0.0 110.414 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -179.01 4.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.755 2.022 . . . . 0.0 107.236 -167.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.68 146.55 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.98 132.73 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 133.29 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.391 1.076 . . . . 0.0 108.441 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -114.4 114.5 25.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.859 1.263 . . . . 0.0 108.579 170.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 p -82.21 120.84 25.87 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -117.3 139.49 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.591 1.156 . . . . 0.0 110.818 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 t -167.0 -165.88 0.76 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.829 1.652 . . . . 0.0 109.207 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -62.82 93.61 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.276 1.431 . . . . 0.0 111.837 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 58.49 18.0 5.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.515 1.526 . . . . 0.0 112.463 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -134.04 77.11 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -115.99 127.28 54.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -173.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.68 159.78 43.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -152.29 158.12 42.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -140.99 121.65 13.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -84.41 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 165.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -156.75 144.39 19.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.393 -0.817 . . . . 0.0 111.402 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.56 105.58 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.85 109.13 0.25 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.413 0.285 . . . . 0.0 111.051 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.65 39.9 1.68 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -154.8 157.26 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.79 145.1 37.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.692 0.797 . . . . 0.0 110.474 161.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.65 148.72 24.52 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.77 143.17 40.05 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.0 156.08 44.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.552 1.541 . . . . 0.0 107.845 -173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.1 m -141.12 82.23 1.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.232 1.013 . . . . 0.0 109.09 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -98.32 130.9 44.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.3 -35.49 27.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.962 0.905 . . . . 0.0 112.404 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -96.77 16.6 18.68 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.172 1.789 . . . . 0.0 112.766 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -150.15 2.25 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 163.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 79.76 -164.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.383 1.473 . . . . 0.0 109.003 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -73.81 126.48 30.47 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.12 143.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.679 1.592 . . . . 0.0 108.043 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -83.27 127.1 33.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 166.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.2 m -94.63 114.83 26.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.98 123.78 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 166.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 p -132.78 136.9 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -158.2 158.93 35.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 pp -105.98 137.82 43.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.337 0.972 . . . . 0.0 108.813 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -84.03 -11.51 56.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.282 0.633 . . . . 0.0 111.65 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.29 -32.92 5.67 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.22 -39.66 3.45 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.173 1.368 . . . . 0.0 110.905 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -142.05 167.62 21.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.65 1.18 . . . . 0.0 111.424 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tt -96.94 114.99 26.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.198 0.999 . . . . 0.0 108.519 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.55 112.2 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.099 1.76 . . . . 0.0 108.76 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -103.99 108.94 20.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.56 126.07 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -110.63 117.22 32.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -131.71 120.38 22.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.79 1.236 . . . . 0.0 109.909 -164.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -56.75 2.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -161.8 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.07 -16.26 78.5 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 118.629 0.65 . . . . 0.0 112.592 -171.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.29 173.24 15.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.474 1.11 . . . . 0.0 108.403 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.49 154.83 33.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.962 1.705 . . . . 0.0 108.186 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.9 p -109.4 145.75 35.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 110.018 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.09 121.22 36.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.85 98.51 6.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.437 1.495 . . . . 0.0 107.554 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.94 118.74 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.05 145.91 38.86 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.963 0.905 . . . . 0.0 109.376 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -160.72 156.7 25.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 164.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -121.46 121.88 38.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.117 0.967 . . . . 0.0 109.29 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.39 -177.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 160.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t70 53.23 -108.53 0.42 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.97 29.65 1.38 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.678 1.132 . . . . 0.0 111.336 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -140.18 145.22 37.18 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.968 0.884 . . . . 0.0 109.158 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -90.48 110.82 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.07 139.86 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tp -142.44 106.1 4.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 m -98.43 121.59 40.55 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 133.5 45.15 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -155.12 156.22 35.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.809 0.731 . . . . 0.0 111.483 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -160.08 168.23 26.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 107.234 165.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.59 -35.39 7.35 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 118.847 0.749 . . . . 0.0 112.44 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 m -46.23 -49.73 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.577 1.551 . . . . 0.0 113.026 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 175.89 169.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.135 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.41 144.94 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 125.404 1.481 . . . . 0.0 108.533 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 16.7 t -158.5 116.32 2.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.581 0.628 . . . . 0.0 111.633 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -73.12 151.09 41.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.239 0.616 . . . . 0.0 109.551 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -140.5 154.46 46.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.597 1.959 . . . . 0.0 106.266 156.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 t -151.84 148.6 28.02 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.67 0.668 . . . . 0.0 110.697 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -129.77 139.04 51.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.606 1.562 . . . . 0.0 108.553 -167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -110.92 138.8 46.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.373 1.069 . . . . 0.0 108.899 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -73.02 84.04 1.27 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.607 0.363 . . . . 0.0 111.081 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -59.28 -35.95 74.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.749 0.309 . . . . 0.0 110.726 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 O-C-N 121.842 -0.536 . . . . 0.0 109.735 173.274 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.27 66.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 129.992 3.317 . . . . 0.0 111.311 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.19 -61.35 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.04 48.62 0.87 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.855 2.062 . . . . 0.0 111.282 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -142.77 78.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.771 2.028 . . . . 0.0 106.558 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.8 -160.35 23.21 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.668 0.652 . . . . 0.0 113.108 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -87.73 138.65 31.28 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 111.752 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -118.9 158.38 25.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.166 1.386 . . . . 0.0 109.084 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 155.96 46.89 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.403 0.44 . . . . 0.0 110.668 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.95 145.26 55.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.588 1.555 . . . . 0.0 111.051 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.83 -56.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 164.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.39 141.98 47.66 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -167.79 152.78 6.85 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -173.19 159.23 3.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.505 1.522 . . . . 0.0 107.497 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 72.02 -4.74 1.89 Allowed 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.148 1.779 . . . . 0.0 111.49 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -41.71 83.52 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -34.92 -69.01 0.1 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.696 1.998 . . . . 0.0 111.916 160.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.36 -47.89 80.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.536 1.062 . . . . 0.0 111.611 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.71 -52.5 10.83 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 111.235 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -31.42 72.48 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -64.46 -62.79 1.38 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -54.72 -46.64 74.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.079 1.351 . . . . 0.0 111.69 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.57 -9.6 57.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.702 1.201 . . . . 0.0 112.247 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.44 51.49 42.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.92 -40.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 109.797 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -45.18 -64.24 2.32 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 125.928 1.727 . . . . 0.0 113.562 -171.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 36.11 -122.7 0.15 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.374 1.87 . . . . 0.0 110.754 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.19 48.57 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 m -151.32 -73.32 0.15 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.692 -0.63 . . . . 0.0 110.84 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -70.45 -14.38 62.51 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -55.08 -39.55 69.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.426 0.557 . . . . 0.0 111.341 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.22 -56.18 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.2 -49.77 4.47 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.128 1.347 . . . . 0.0 113.826 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -80.53 -14.78 57.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.21 2.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 163.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.255 1.2 t -72.24 83.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.682 1.229 . . . . 0.0 111.261 -164.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 84.05 0.98 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 125.826 1.65 . . . . 0.0 107.749 159.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.95 -48.68 1.77 Allowed 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.629 1.553 . . . . 0.0 108.44 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -87.7 141.06 28.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.914 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -147.72 117.43 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.057 -1.027 . . . . 0.0 108.534 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.43 140.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.78 111.52 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -130.15 125.74 35.78 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.345 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.16 99.84 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 122.029 0.919 . . . . 0.0 110.686 172.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -74.52 65.15 1.24 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.63 -82.63 0.02 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.396 0.998 . . . . 0.0 112.973 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -99.78 -6.59 26.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 0.0 112.259 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.36 166.33 17.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.223 1.809 . . . . 0.0 107.217 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.98 109.24 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 tt -90.02 129.36 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.48 134.3 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -124.98 105.9 9.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 109.962 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 m -70.09 113.12 6.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.857 2.063 . . . . 0.0 108.083 170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -120.01 135.25 54.99 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.336 0.516 . . . . 0.0 111.243 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -139.69 17.92 2.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.068 0.947 . . . . 0.0 111.256 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t 39.97 38.06 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 111.426 -164.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -174.3 95.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -166.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? 54.85 54.95 8.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.709 0.804 . . . . 0.0 110.146 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -63.08 162.65 11.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.906 1.283 . . . . 0.0 109.893 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.88 164.12 31.11 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.998 0.919 . . . . 0.0 108.756 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -156.04 151.94 27.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.922 0.489 . . . . 0.0 109.994 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.4 144.57 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 p -106.86 88.17 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.908 0.883 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.87 148.37 47.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -132.26 117.41 18.16 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 166.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 96.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.612 1.165 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.34 51.9 1.19 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.35 0.976 . . . . 0.0 111.148 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.38 162.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.0 0.9 . . . . 0.0 110.939 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -101.97 136.48 41.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.436 1.894 . . . . 0.0 107.863 167.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.44 149.84 38.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.734 0.814 . . . . 0.0 109.191 170.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.32 136.83 37.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.29 153.6 47.8 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.82 1.248 . . . . 0.0 109.144 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -130.66 68.58 1.47 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.875 1.67 . . . . 0.0 110.016 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -83.76 143.73 29.79 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.09 40.23 0.33 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.618 1.167 . . . . 0.0 112.851 -167.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -161.02 -75.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.569 1.548 . . . . 0.0 107.859 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -27.64 65.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.69 0.796 . . . . 0.0 111.729 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 98.8 -155.63 0.0 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 128.628 2.771 . . . . 0.0 107.971 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -81.4 116.33 21.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.13 177.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.474 1.51 . . . . 0.0 107.709 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -107.42 128.25 54.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.768 0.713 . . . . 0.0 110.176 164.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.93 126.08 35.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.44 125.26 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.63 145.37 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 160.51 41.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.5 2.72 . . . . 0.0 105.811 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tt -140.93 73.62 1.43 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 p30 176.4 164.18 0.42 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -156.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 -69.17 0.9 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.21 56.91 0.65 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 56.94 -130.66 1.65 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.007 0.923 . . . . 0.0 109.208 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp -81.88 79.29 8.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 109.834 -170.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.39 111.5 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.846 0.858 . . . . 0.0 109.984 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -117.95 115.8 25.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.798 1.239 . . . . 0.0 109.639 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.19 150.74 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 170.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -131.81 95.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 106.354 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -112.64 117.14 31.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -89.56 -111.0 0.08 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -122.87 -74.01 0.63 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.761 1.224 . . . . 0.0 111.488 -173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.74 61.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.569 0.622 . . . . 0.0 111.722 -170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -179.91 6.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -149.29 156.85 42.74 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.371 1.869 . . . . 0.0 106.291 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.6 t -127.8 155.9 43.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.536 0.684 . . . . 0.0 109.254 160.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.1 p -96.17 150.7 20.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 164.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 pp -151.94 101.63 2.75 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 164.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.91 128.85 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.043 0.537 . . . . 0.0 109.601 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -94.26 99.23 11.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 108.318 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.94 143.67 28.29 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -137.11 120.01 16.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.09 -168.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 51.91 -116.93 1.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.35 23.58 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 126.137 1.827 . . . . 0.0 109.485 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -134.26 129.55 35.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.401 0.681 . . . . 0.0 109.461 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -87.68 105.09 17.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.6 mt -82.05 103.22 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.88 101.23 13.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.4 t -99.27 130.92 45.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.65 126.36 43.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.296 1.439 . . . . 0.0 109.775 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.7 m -131.88 114.0 14.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -97.62 146.63 25.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.764 2.026 . . . . 0.0 107.456 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.01 92.06 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 167.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 m 135.2 -28.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 131.402 3.881 . . . . 0.0 111.851 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.27 153.62 37.82 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.28 1.4 . . . . 0.0 112.46 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.9 t -124.79 143.73 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.093 1.757 . . . . 0.0 107.964 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 t -158.6 158.54 34.08 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 t -126.24 158.06 36.67 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.672 -0.642 . . . . 0.0 109.942 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -119.59 130.89 55.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 150.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -108.79 124.94 51.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -112.89 154.54 26.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.005 1.722 . . . . 0.0 109.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -122.01 137.07 54.94 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.756 1.622 . . . . 0.0 107.395 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -75.37 125.38 28.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.23 -4.06 17.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.033 0.533 . . . . 0.0 111.336 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 C-N-CA 124.778 1.231 . . . . 0.0 110.864 174.111 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 58.38 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 129.345 3.058 . . . . 0.0 111.894 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.27 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.153 1.781 . . . . 0.0 107.516 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -59.27 -42.88 92.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.495 1.118 . . . . 0.0 111.221 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.1 t -40.62 101.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.197 1.799 . . . . 0.0 111.814 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.29 -154.69 25.92 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.188 0.899 . . . . 0.0 112.196 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -118.25 119.71 35.49 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.502 1.521 . . . . 0.0 109.656 -170.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -109.29 141.93 40.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.521 1.128 . . . . 0.0 110.177 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -115.11 137.71 51.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -77.75 128.34 33.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.94 -45.64 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -128.92 151.14 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 110.008 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -170.14 150.55 3.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.596 2.358 . . . . 0.0 108.719 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -138.87 148.74 44.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m120 62.68 43.86 7.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.222 1.409 . . . . 0.0 111.452 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -70.53 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.804 -0.56 . . . . 0.0 109.75 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.57 -49.66 72.13 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -30.03 -53.88 0.16 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.702 2.001 . . . . 0.0 112.547 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -51.93 -51.93 53.57 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.752 -0.593 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.0 ptp -74.23 -33.12 63.25 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.434 -0.791 . . . . 0.0 111.793 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -40.96 75.97 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.473 -0.767 . . . . 0.0 111.166 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -82.09 -41.18 20.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.494 1.117 . . . . 0.0 110.219 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.1 -39.13 74.44 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.199 0.454 . . . . 0.0 111.844 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 55.14 0.81 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.78 -9.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.64 1.176 . . . . 0.0 111.678 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.48 78.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.105 -0.997 . . . . 0.0 114.248 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -48.81 139.26 10.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.911 1.285 . . . . 0.0 109.039 156.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.95 62.76 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.22 1.008 . . . . 0.0 111.01 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 m -147.9 -37.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.814 -1.179 . . . . 0.0 111.272 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.8 tpt85 -56.69 -37.83 71.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.229 0.922 . . . . 0.0 109.678 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -43.01 -32.96 0.72 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.386 2.675 . . . . 0.0 115.074 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 34' ' ' ASN . 13.6 p -110.29 -35.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.007 0.821 . . . . 0.0 111.347 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 26.85 0.65 Allowed Glycine 0 CA--C 1.539 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 113.973 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 32' ' ' VAL . 24.2 p-10 -122.96 -39.21 2.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.062 3.345 . . . . 0.0 109.54 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -42.6 70.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.733 1.213 . . . . 0.0 108.731 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -60.12 116.26 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 156.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.66 114.44 14.53 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.983 -168.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.85 156.57 56.53 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 120.246 1.124 . . . . 0.0 109.667 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.6 m -130.99 153.98 48.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.298 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -147.51 117.42 7.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.82 144.13 11.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 166.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.53 111.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.39 143.75 51.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 0.701 . . . . 0.0 110.993 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 80.5 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 122.46 1.124 . . . . 0.0 110.133 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -65.42 78.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.008 0.923 . . . . 0.0 111.398 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.04 -114.0 6.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -86.6 -12.55 48.27 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.431 0.615 . . . . 0.0 111.296 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -102.05 179.32 4.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.449 1.1 . . . . 0.0 108.36 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.82 138.94 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 166.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.6 tt -112.55 134.25 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.59 143.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 O-C-N 123.98 0.8 . . . . 0.0 109.137 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -131.94 111.7 11.77 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 m -104.12 128.33 51.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.728 1.611 . . . . 0.0 110.104 -167.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -105.38 125.1 50.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.697 1.999 . . . . 0.0 109.121 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -148.92 68.61 1.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 p 48.3 96.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.157 2.183 . . . . 0.0 114.194 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.6 t80 71.02 -64.98 0.36 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.302 1.841 . . . . 0.0 109.615 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.31 134.76 45.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.05 156.34 39.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.14 158.18 43.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.82 132.23 13.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -147.52 127.68 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 p -88.94 133.68 34.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.859 1.264 . . . . 0.0 108.469 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.75 160.65 42.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 127.56 43.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 86.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 169.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.07 41.98 0.19 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.095 1.807 . . . . 0.0 111.474 168.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.5 t -147.71 153.05 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.368 1.084 . . . . 0.0 109.575 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -113.04 133.98 54.73 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 126.724 2.01 . . . . 0.0 107.463 167.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -163.21 -179.34 6.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.268 0.94 . . . . 0.0 111.136 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.5 121.53 29.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 109.225 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 107.52 15.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.453 1.901 . . . . 0.0 106.255 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.3 53.85 0.76 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.095 0.558 . . . . 0.0 111.233 -164.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 146.8 50.42 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.456 -0.777 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.02 63.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.009 0.923 . . . . 0.0 112.267 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -94.81 -50.41 5.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.836 1.654 . . . . 0.0 110.299 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -56.44 -25.62 51.17 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.182 0.446 . . . . 0.0 111.802 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 77.64 -166.05 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.889 2.075 . . . . 0.0 109.021 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.33 89.32 2.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.93 149.93 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.917 0.887 . . . . 0.0 109.747 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -85.08 116.9 23.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -80.63 146.87 30.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -139.57 125.74 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 157.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.93 143.92 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -166.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -155.57 -172.82 4.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.51 1.924 . . . . 0.0 108.232 -176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.63 113.02 10.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.12 125.97 43.36 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.84 -78.95 0.01 OUTLIER Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.342 0.973 . . . . 0.0 113.465 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.34 26.49 1.1 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.524 1.535 . . . . 0.0 111.742 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 130.53 48.9 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.084 1.354 . . . . 0.0 109.182 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.6 112.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.318 1.447 . . . . 0.0 107.36 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.01 126.62 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.376 1.07 . . . . 0.0 108.258 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -135.07 102.44 5.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.516 0.727 . . . . 0.0 109.891 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.87 147.2 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -141.8 99.39 3.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -119.74 108.81 14.87 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.441 1.897 . . . . 0.0 109.655 -160.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -60.2 1.68 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.322 0.51 . . . . 0.0 110.557 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -165.01 -81.51 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.235 0.47 . . . . 0.0 112.217 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.93 -26.16 74.46 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.786 0.721 . . . . 0.0 111.58 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 173.37 16.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.14 1.376 . . . . 0.0 107.725 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -131.21 140.29 49.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.968 2.107 . . . . 0.0 107.956 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 t -98.05 174.8 6.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.7 p -155.82 155.04 32.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 153.93 39.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.739 172.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.65 139.56 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -128.18 140.37 51.95 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.381 1.072 . . . . 0.0 109.51 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.08 133.74 16.7 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.416 0.686 . . . . 0.0 109.228 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -103.98 119.49 39.04 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.2 176.51 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 153.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.31 -118.1 1.26 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -170.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.92 21.22 3.75 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.188 1.375 . . . . 0.0 110.873 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -124.6 127.42 47.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.794 0.838 . . . . 0.0 108.764 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 tt -91.75 91.1 7.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.06 143.28 13.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.72 141.51 22.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.701 0.763 . . . . 0.0 112.712 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.9 m -106.81 124.73 50.04 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 125.109 1.364 . . . . 0.0 107.992 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.47 75.7 1.04 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.087 1.755 . . . . 0.0 107.192 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -128.13 138.81 52.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.281 0.562 . . . . 0.0 110.365 -165.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -160.18 155.64 25.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.62 -34.55 6.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.026 0.822 . . . . 0.0 113.121 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 t -51.75 -41.83 61.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.377 1.071 . . . . 0.0 111.852 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.87 127.15 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.678 1.591 . . . . 0.0 110.063 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.04 136.81 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -150.66 156.0 40.47 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.349 -1.469 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -143.5 163.37 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.648 0.779 . . . . 0.0 109.321 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -167.27 168.74 13.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.302 1.041 . . . . 0.0 111.069 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -136.8 136.49 38.89 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.957 0.884 . . . . 0.0 109.591 163.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -89.02 155.81 19.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.736 164.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.6 146.58 44.16 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.771 1.228 . . . . 0.0 107.867 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -81.79 114.53 20.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -90.82 -26.64 19.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.031 0.378 . . . . 0.0 111.697 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.161 0 CA-C-N 118.39 0.541 . . . . 0.0 110.781 174.471 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.238 0.47 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.6 61.42 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.932 2.093 . . . . 0.0 110.576 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.08 -40.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.028 1.731 . . . . 0.0 108.298 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -95.11 -47.73 6.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.859 1.264 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.5 t -45.37 117.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.435 1.094 . . . . 0.0 112.81 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.65 -120.77 3.42 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.851 0.739 . . . . 0.0 111.277 158.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -152.05 140.57 20.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.869 -0.783 . . . . 0.0 109.176 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -138.41 162.85 33.39 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.699 1.6 . . . . 0.0 107.166 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 23.5 pttm -135.69 142.37 45.08 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.792 1.237 . . . . 0.0 108.953 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 141.57 55.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.774 0.715 . . . . 0.0 110.974 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.76 -35.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 118.451 -0.785 . . . . 0.0 112.338 169.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.08 151.24 51.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.554 1.07 . . . . 0.0 110.749 169.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -168.24 165.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.065 2.546 . . . . 0.0 106.532 167.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -146.58 178.13 8.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.586 1.554 . . . . 0.0 107.138 169.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 m120 58.55 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.36 1.064 . . . . 0.0 110.834 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -57.11 14.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.58 0.752 . . . . 0.0 110.286 -172.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.56 -52.87 18.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.141 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -35.06 -57.96 0.55 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.0 112.222 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -57.79 -45.97 85.26 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.61 -0.681 . . . . 0.0 112.141 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -68.83 -30.17 68.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.838 . . . . 0.0 111.994 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -72.83 58.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.873 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m 175.59 -55.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.764 2.426 . . . . 0.0 107.143 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.15 -37.76 75.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.781 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.41 32.91 68.02 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.28 -31.35 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.694 0.747 . . . . 0.0 110.442 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.4 71.15 0.03 OUTLIER Glycine 0 C--N 1.336 0.572 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.413 ' C ' ' H ' ' A' ' 29' ' ' THR . 45.3 t80 -54.33 146.59 15.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.33 -12.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.627 1.571 . . . . 0.0 114.636 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 27' ' ' PHE . 11.1 m -102.16 -61.86 1.34 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 108.586 -168.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -70.71 7.33 1.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.104 -0.998 . . . . 0.0 113.382 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.59 -46.48 85.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.206 -0.934 . . . . 0.0 108.993 159.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -44.7 96.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.66 43.15 1.84 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.327 0.965 . . . . 0.0 112.98 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -163.72 -32.52 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.222 1.809 . . . . 0.0 109.588 167.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 90.2 mmm -53.26 -45.0 68.64 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 159.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -64.05 108.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -35.15 104.97 0.27 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.463 1.905 . . . . 0.0 112.302 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.77 123.93 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.734 1.622 . . . . 0.0 109.42 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.8 m -79.96 179.94 7.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -152.09 88.71 1.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -79.03 128.36 38.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mt -127.98 101.73 7.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -109.24 115.59 30.29 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.825 1.25 . . . . 0.0 108.653 -171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.1 t -78.74 103.58 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -77.81 65.08 3.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.867 1.267 . . . . 0.0 108.764 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.53 -88.14 0.05 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.665 0.65 . . . . 0.0 111.752 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.38 17.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.132 0.973 . . . . 0.0 110.081 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.42 173.12 7.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.77 2.028 . . . . 0.0 108.093 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.41 130.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.81 131.52 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.9 tt -114.37 128.15 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -135.04 131.38 36.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.805 0.442 . . . . 0.0 111.002 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -29.52 39.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.609 1.563 . . . . 0.0 112.951 -159.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 33.72 56.96 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.215 1.806 . . . . 0.0 113.691 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -66.07 -60.5 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -114.23 62.03 0.66 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 69.22 -21.16 0.16 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.92 88.4 1.67 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 0.0 108.078 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.49 55.88 1.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.58 0.752 . . . . 0.0 109.776 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 58.59 175.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.892 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -151.11 155.63 39.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.834 0.454 . . . . 0.0 110.811 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.0 mt -128.87 143.0 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.2 p -149.46 97.78 2.69 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -149.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.26 176.93 8.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.939 0.496 . . . . 0.0 110.905 -160.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -151.88 122.43 7.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -175.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.93 103.76 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 109.871 171.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.5 40.48 1.35 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.556 2.027 . . . . 0.0 111.802 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -148.02 149.86 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.024 1.33 . . . . 0.0 107.641 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -115.01 146.89 40.78 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.614 1.166 . . . . 0.0 109.194 162.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.27 161.98 12.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.474 0.309 . . . . 0.0 110.666 -168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -76.37 112.79 13.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -100.8 110.22 22.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -113.71 121.83 45.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 t -145.45 145.62 31.18 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.79 44.07 0.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.204 1.001 . . . . 0.0 111.942 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -152.93 -63.91 0.16 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.43 1.892 . . . . 0.0 106.963 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -79.64 1.37 26.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.331 0.652 . . . . 0.0 111.599 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 78.28 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.059 1.344 . . . . 0.0 108.671 169.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -92.25 124.42 36.31 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.81 139.09 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 20.3 ttmt -78.99 131.38 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 162.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 p -130.42 161.92 30.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.0 0.364 . . . . 0.0 110.673 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.6 tt -129.53 142.42 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.327 1.851 . . . . 0.0 106.485 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.7 144.93 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -150.89 -170.62 3.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 164.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tt -135.4 124.85 24.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 107.355 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.22 145.13 51.4 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.811 0.844 . . . . 0.0 109.461 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.85 -78.93 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.632 1.11 . . . . 0.0 111.548 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.82 26.97 0.26 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.037 1.303 . . . . 0.0 110.932 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.69 136.32 52.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.377 1.471 . . . . 0.0 107.341 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.1 tt -92.21 118.61 31.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.84 121.36 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.705 0.802 . . . . 0.0 109.377 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -105.53 123.11 47.36 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.92 1.688 . . . . 0.0 106.453 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.33 129.7 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -148.08 112.65 5.34 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.629 -151.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -130.61 163.84 26.26 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.749 1.22 . . . . 0.0 112.245 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -136.83 -65.85 0.54 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.33 143.71 10.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.19 -7.5 5.91 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.128 -0.818 . . . . 0.0 114.206 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 165.08 14.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.935 1.367 . . . . 0.0 110.423 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -142.07 125.56 16.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.33 1.852 . . . . 0.0 106.948 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.33 153.54 24.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 110.482 164.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -123.12 136.9 54.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.913 1.285 . . . . 0.0 107.581 172.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 110.12 7.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.19 129.8 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -122.21 124.71 44.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 127.063 2.145 . . . . 0.0 107.801 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -143.6 144.21 31.82 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -115.57 123.46 48.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 161.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.03 -179.73 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 159.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 52.16 -113.83 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.1 28.39 2.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.897 1.237 . . . . 0.0 110.075 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -127.59 127.31 43.64 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 tt -83.8 93.99 8.09 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.9 mt -73.44 111.96 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.8 135.5 44.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 163.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.6 m -128.36 124.19 35.79 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.77 125.82 51.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.599 0.76 . . . . 0.0 109.235 -178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.8 m -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.195 1.798 . . . . 0.0 108.994 -172.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -97.34 161.88 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.01 63.84 1.61 Allowed Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.646 -0.659 . . . . 0.0 111.802 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.8 t 161.13 -60.44 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.544 3.138 . . . . 0.0 108.265 172.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.71 137.74 33.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.429 0.692 . . . . 0.0 110.391 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.84 123.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.496 1.118 . . . . 0.0 108.712 -173.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.1 t -133.37 111.67 10.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.416 0.687 . . . . 0.0 109.903 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -63.82 153.53 36.37 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 160.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -159.54 83.57 0.76 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.344 0.657 . . . . 0.0 109.3 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -88.46 126.88 35.45 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.459 -0.776 . . . . 0.0 109.973 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -102.61 144.37 31.1 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.695 1.198 . . . . 0.0 109.169 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 43.3 tt0 -119.86 133.72 55.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.209 2.204 . . . . 0.0 106.864 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -58.8 141.27 53.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.058 0.845 . . . . 0.0 110.839 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -31.25 67.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.953 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.657 1.183 . . . . 0.0 108.488 179.461 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.572 0.225 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.54 54.36 0.45 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.695 2.798 . . . . 0.0 111.578 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.71 -51.44 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.573 1.149 . . . . 0.0 108.279 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -57.64 -46.83 83.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.436 1.095 . . . . 0.0 110.96 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 p -38.23 110.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.412 1.885 . . . . 0.0 111.908 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.83 -146.48 18.42 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -130.78 134.74 47.12 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.639 0.775 . . . . 0.0 110.708 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -118.58 162.28 18.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.799 1.64 . . . . 0.0 109.744 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -136.8 132.96 35.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.604 1.162 . . . . 0.0 108.643 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.14 147.86 42.59 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.98 -70.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 122.856 0.463 . . . . 0.0 111.284 164.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -93.47 144.14 25.64 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -171.93 43.34 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.66 155.36 33.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.053 0.842 . . . . 0.0 112.381 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.99 25.52 13.92 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.519 1.528 . . . . 0.0 111.991 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -75.18 -49.82 18.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.124 -0.985 . . . . 0.0 109.898 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.91 -61.38 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.466 0.65 . . . . 0.0 110.093 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 17.9 t70 -45.56 -48.56 14.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.559 1.944 . . . . 0.0 112.065 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -55.24 -44.62 75.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.262 1.025 . . . . 0.0 111.257 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.25 -33.2 59.17 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.679 -0.638 . . . . 0.0 111.088 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.7 ttpm? -73.41 51.89 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.473 1.509 . . . . 0.0 109.358 170.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 m -178.59 -60.17 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 128.372 2.669 . . . . 0.0 107.058 -173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.55 -20.26 62.05 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.91 -22.16 32.85 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.78 -1.011 . . . . 0.0 112.62 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -66.15 66.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.664 1.986 . . . . 0.0 114.776 -162.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.87 44.23 3.15 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.92 2.2 . . . . 0.0 110.438 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -36.17 -43.77 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.183 2.193 . . . . 0.0 114.027 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.29 44.48 2.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.489 1.116 . . . . 0.0 110.799 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.9 t -152.04 -44.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.65 . . . . 0.0 111.177 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -27.48 45.0 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.928 -1.107 . . . . 0.0 110.022 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.24 -20.14 64.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.361 1.464 . . . . 0.0 112.522 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.35 -30.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.15 0.58 . . . . 0.0 110.293 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.22 63.61 0.77 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.155 0.883 . . . . 0.0 111.925 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -162.3 -51.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.721 1.608 . . . . 0.0 110.455 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.4 mtt -57.21 -47.54 81.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.035 1.334 . . . . 0.0 109.983 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -68.16 66.85 0.11 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.148 2.179 . . . . 0.0 110.412 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -18.66 91.73 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 128.032 2.533 . . . . 0.0 113.549 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.27 136.89 67.16 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.125 1.216 . . . . 0.0 110.806 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.71 141.74 28.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 m -130.91 102.28 5.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.22 131.2 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.1 mt -126.2 103.41 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.12 134.57 40.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.77 119.34 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -95.13 168.78 10.55 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.253 1.021 . . . . 0.0 108.585 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -29.54 -60.38 0.18 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.886 1.707 . . . . 0.0 114.645 -170.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -126.47 22.19 7.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.867 1.667 . . . . 0.0 109.919 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.96 -178.67 6.61 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.834 0.854 . . . . 0.0 109.455 -153.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.45 150.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 121.122 -0.986 . . . . 0.0 108.96 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.4 tt -133.65 126.66 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -93.19 127.06 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -133.51 91.55 2.87 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -80.79 131.5 35.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.024 1.33 . . . . 0.0 109.17 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 114.13 23.51 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.559 0.744 . . . . 0.0 109.479 169.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.8 t -140.97 54.1 1.57 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t 39.67 -118.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.735 1.214 . . . . 0.0 110.045 -168.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -57.59 -9.37 1.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.889 1.676 . . . . 0.0 115.125 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -118.03 32.24 6.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.608 1.095 . . . . 0.0 111.129 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -63.21 159.76 17.02 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.65 -0.656 . . . . 0.0 110.653 162.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 160.16 23.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.807 1.243 . . . . 0.0 108.203 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.54 120.08 6.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.286 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mt -143.65 124.26 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.001 0.92 . . . . 0.0 109.928 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 p -91.2 142.19 27.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.955 2.102 . . . . 0.0 110.071 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -156.68 -175.68 5.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.436 1.094 . . . . 0.0 109.213 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -124.7 145.51 49.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 54.55 0.59 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.881 1.273 . . . . 0.0 110.154 174.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.42 58.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 p -164.99 162.33 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.49 148.16 23.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.778 0.674 . . . . 0.0 109.751 165.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.88 145.84 22.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.742 0.817 . . . . 0.0 110.263 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.68 133.59 48.65 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.697 1.599 . . . . 0.0 108.347 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -143.51 131.25 21.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 t -103.07 121.66 43.05 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.74 0.816 . . . . 0.0 108.857 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 171.72 8.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.43 -7.96 11.74 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -155.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -105.41 11.03 33.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.275 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t0 43.84 46.98 6.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.202 2.201 . . . . 0.0 113.222 -162.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 117.219 -1.792 . . . . 0.0 106.359 148.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.25 84.07 7.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -82.67 178.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.839 1.256 . . . . 0.0 109.536 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -124.44 119.36 28.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -100.74 157.68 16.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.852 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 120.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.6 t -107.57 131.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p -126.06 119.96 29.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.348 1.059 . . . . 0.0 108.352 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.87 103.99 15.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -86.25 -167.53 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.941 0.401 . . . . 0.0 110.16 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.2 55.02 2.75 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.585 -0.697 . . . . 0.0 111.798 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 -57.49 0.27 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.93 152.28 47.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.334 0.654 . . . . 0.0 111.116 -162.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.66 102.71 15.13 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -80.32 96.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.05 99.95 12.83 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.96 142.09 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 167.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -131.43 100.19 5.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.242 1.417 . . . . 0.0 107.76 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -114.55 157.01 23.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.609 1.164 . . . . 0.0 108.567 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -140.71 -62.5 0.49 Allowed 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.714 -0.617 . . . . 0.0 110.916 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -166.75 -82.58 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.075 0.398 . . . . 0.0 110.9 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.45 -17.02 80.28 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.84 -0.538 . . . . 0.0 112.099 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.79 163.49 30.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.88 151.45 50.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.646 1.978 . . . . 0.0 106.213 173.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.8 p -137.06 166.9 22.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.011 0.924 . . . . 0.0 109.206 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 p -133.59 154.73 50.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.2 68.97 1.1 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.01 132.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.937 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -123.08 153.32 40.06 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.483 0.583 . . . . 0.0 110.756 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 90' ' ' LYS . 45.4 tt0 -157.54 159.6 37.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.75 120.9 35.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 160.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.72 172.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 155.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.23 -120.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -165.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.63 21.71 3.56 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.828 1.204 . . . . 0.0 111.357 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -122.26 134.55 54.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.81 0.805 . . . . 0.0 109.454 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.94 79.82 1.66 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mt -64.27 132.55 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.187 0.995 . . . . 0.0 108.347 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.69 158.25 43.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 165.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 t -126.18 127.07 45.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 166.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tt -109.34 106.75 16.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.691 1.996 . . . . 0.0 105.782 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 p -124.76 138.53 54.28 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.695 1.198 . . . . 0.0 110.941 -162.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -134.19 141.28 47.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 107.859 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.4 91.22 0.02 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 165.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m 136.19 -27.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 131.28 3.832 . . . . 0.0 111.337 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.83 152.23 36.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.007 1.276 . . . . 0.0 111.206 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.16 135.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.727 0.811 . . . . 0.0 109.35 -170.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.0 t -141.32 106.85 5.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.442 0.697 . . . . 0.0 110.887 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.1 p -58.28 143.81 43.36 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 159.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -156.01 154.84 31.7 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.322 0.964 . . . . 0.0 108.978 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.6 t -157.57 156.59 32.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.26 150.6 52.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.832 1.653 . . . . 0.0 107.956 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.61 136.22 52.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.053 1.341 . . . . 0.0 108.151 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -67.01 121.9 16.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -86.86 -38.43 16.78 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.133 0 C-N-CA 122.985 0.514 . . . . 0.0 109.879 -178.112 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.48 50.76 0.43 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.11 2.564 . . . . 0.0 111.84 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.01 -55.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.57 -46.71 66.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 111.421 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.01 104.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.416 1.487 . . . . 0.0 112.066 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.62 -169.68 29.15 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -109.93 132.74 53.89 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.73 0.812 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.405 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 53.0 m95 -115.71 140.88 48.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.384 1.074 . . . . 0.0 109.568 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -95.93 132.35 41.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.72 141.48 57.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.51 -52.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.719 -0.657 . . . . 0.0 110.584 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.58 137.69 49.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.941 0.791 . . . . 0.0 108.995 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -155.36 144.57 20.94 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.931 1.692 . . . . 0.0 108.074 -169.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -170.62 159.46 6.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.786 0.835 . . . . 0.0 111.787 163.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 t30 62.16 34.42 16.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.361 1.864 . . . . 0.0 112.756 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -74.78 -43.66 53.63 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.78 -48.22 75.7 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 117.493 0.133 . . . . 0.0 111.01 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -50.36 -46.87 56.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.942 0.897 . . . . 0.0 111.568 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.15 -55.52 33.6 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -36.64 31.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.757 1.223 . . . . 0.0 112.333 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -74.72 55.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.484 1.914 . . . . 0.0 109.611 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.4 p -178.88 -48.59 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.859 2.464 . . . . 0.0 107.065 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.15 -28.07 59.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.373 0.669 . . . . 0.0 112.322 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.78 29.35 72.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.688 0.661 . . . . 0.0 113.259 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.14 -51.62 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.588 1.155 . . . . 0.0 110.986 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.39 -65.52 2.31 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -155.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 25.5 -96.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.564 1.946 . . . . 0.0 114.788 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.78 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.488 0.715 . . . . 0.0 110.954 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 m -57.87 -36.97 73.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.753 1.621 . . . . 0.0 110.456 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -51.22 63.42 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.414 0.686 . . . . 0.0 111.003 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.275 4.9 pp0? -63.78 -46.33 85.69 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.717 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.02 -49.38 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.216 0.462 . . . . 0.0 109.837 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.06 -23.68 1.2 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 128.239 2.828 . . . . 0.0 115.087 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -137.96 39.38 2.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.422 0.689 . . . . 0.0 110.34 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.0 ttt -156.86 -56.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.622 0.369 . . . . 0.0 111.684 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -115.13 56.93 0.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.084 0.553 . . . . 0.0 111.446 -157.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 33.38 61.61 1.66 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.989 1.716 . . . . 0.0 113.823 172.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.13 116.31 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.241 2.628 . . . . 0.0 109.187 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.33 157.75 19.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.371 1.068 . . . . 0.0 108.273 -170.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 m -148.09 101.55 3.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.508 -0.745 . . . . 0.0 110.865 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.79 126.47 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 107.995 161.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.3 mm -123.85 110.07 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.418 1.487 . . . . 0.0 107.558 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -112.02 115.94 29.73 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.203 1.001 . . . . 0.0 109.128 -168.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.09 123.3 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.05 164.9 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.855 1.262 . . . . 0.0 108.288 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -36.41 -53.7 1.33 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.028 1.299 . . . . 0.0 113.381 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -106.79 -42.19 5.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.651 1.581 . . . . 0.0 111.292 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -101.36 -170.65 1.86 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.754 2.021 . . . . 0.0 110.645 -162.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.76 133.55 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 162.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 133.11 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -101.32 124.91 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.63 103.23 10.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.493 1.917 . . . . 0.0 106.804 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -80.58 124.42 28.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.147 0.579 . . . . 0.0 109.895 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -93.78 119.69 33.08 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -136.65 36.99 2.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.898 0.479 . . . . 0.0 110.212 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.7 m 61.22 101.26 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.318 1.447 . . . . 0.0 112.129 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 t80 72.4 -62.13 0.47 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.611 1.164 . . . . 0.0 109.359 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 145.97 46.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.156 0.979 . . . . 0.0 109.081 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.93 178.26 7.09 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 163.6 38.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 161.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.66 149.71 40.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -140.37 133.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.4 p -96.74 124.71 40.8 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.825 1.65 . . . . 0.0 108.425 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.62 159.5 41.95 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 119.704 1.138 . . . . 0.0 111.056 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.14 135.58 50.04 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 66.74 0.37 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.299 0.5 . . . . 0.0 110.545 169.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.35 63.4 0.03 OUTLIER Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.181 0.896 . . . . 0.0 111.127 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -170.77 169.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.227 1.011 . . . . 0.0 108.347 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.99 157.35 40.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.292 0.637 . . . . 0.0 109.948 165.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -167.57 152.3 6.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.178 0.591 . . . . 0.0 111.205 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -72.34 133.06 44.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.755 1.622 . . . . 0.0 107.075 170.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -140.63 155.82 46.43 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.402 1.081 . . . . 0.0 108.729 -165.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -154.22 145.22 22.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.705 -0.622 . . . . 0.0 110.509 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.3 t -157.97 151.6 23.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.348 0.594 . . . . 0.0 111.865 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.75 65.56 3.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.822 1.649 . . . . 0.0 110.515 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 p30 171.49 -64.76 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 129.132 2.973 . . . . 0.0 108.015 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.274 9.3 t70 -78.1 -1.65 33.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 73.73 -156.74 0.07 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.964 1.306 . . . . 0.0 109.191 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -79.98 140.24 36.7 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 164.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.69 166.84 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.01 126.13 55.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 167.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -90.21 135.06 33.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 tt -129.2 115.77 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.08 134.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.92 0.888 . . . . 0.0 108.952 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -160.12 150.88 18.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.71 151.9 21.61 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.654 0.661 . . . . 0.0 111.2 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.21 178.97 4.74 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 161.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -19.07 -47.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 128.0 2.714 . . . . 0.0 115.363 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.42 62.09 0.28 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.305 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -172.73 149.9 2.08 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 108.893 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -86.95 131.51 34.07 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.35 108.44 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -94.83 107.5 19.52 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.08 131.39 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -122.15 101.93 7.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 107.108 -163.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -115.62 114.49 24.98 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.611 1.564 . . . . 0.0 110.905 -163.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -104.79 -62.5 1.33 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.599 0.636 . . . . 0.0 111.599 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.81 106.27 1.84 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.758 0.708 . . . . 0.0 112.597 -171.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.95 25.25 65.77 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.939 0.781 . . . . 0.0 112.177 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -175.15 167.66 3.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.368 1.467 . . . . 0.0 107.045 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -157.3 160.91 39.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.9 p -124.15 149.43 46.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.138 0.575 . . . . 0.0 109.824 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.9 p -88.45 135.11 33.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.945 0.898 . . . . 0.0 109.123 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.94 87.72 2.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 161.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.21 129.92 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.0 138.11 51.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.445 1.098 . . . . 0.0 110.944 -171.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.02 155.34 32.51 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.743 0.652 . . . . 0.0 109.287 154.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -96.59 112.39 24.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.14 0.976 . . . . 0.0 109.188 165.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.6 -171.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.8 t70 51.07 -110.27 0.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.14 29.64 2.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.646 1.593 . . . . 0.0 109.678 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -150.01 146.12 26.81 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.99 0.895 . . . . 0.0 109.732 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 5.2 tt -85.09 113.19 21.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.4 mt -89.33 105.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.41 117.44 29.12 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 166.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.0 m -103.43 133.95 47.62 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.67 86.78 2.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.475 1.11 . . . . 0.0 108.199 -161.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -115.59 133.03 56.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.414 0.552 . . . . 0.0 110.65 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -134.45 138.38 44.72 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.166 2.187 . . . . 0.0 107.783 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.58 108.01 0.72 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 165.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 m 121.8 -37.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 130.001 3.32 . . . . 0.0 112.174 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.63 162.64 38.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.098 1.317 . . . . 0.0 112.122 -168.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.87 151.74 20.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.699 0.799 . . . . 0.0 109.86 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.5 m -143.72 159.52 42.35 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.162 -0.961 . . . . 0.0 108.776 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.35 145.43 37.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 159.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -142.34 101.91 3.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -103.05 123.68 47.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -108.86 149.23 29.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.23 1.812 . . . . 0.0 110.101 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -124.35 127.36 47.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.512 1.525 . . . . 0.0 107.798 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -68.64 119.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.28 -29.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.244 0.618 . . . . 0.0 111.451 -173.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.138 0 CA-C-N 118.403 0.547 . . . . 0.0 109.907 170.384 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.25 -36.72 32.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.02 1.728 . . . . 0.0 111.438 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.64 -15.32 62.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.715 1.606 . . . . 0.0 112.016 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.75 -52.41 2.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.563 1.145 . . . . 0.0 110.098 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.11 114.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.422 1.489 . . . . 0.0 111.603 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.99 -178.66 22.64 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 121.722 0.624 . . . . 0.0 112.84 164.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -96.39 127.41 42.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 169.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -117.61 157.34 26.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.323 1.049 . . . . 0.0 108.355 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -120.33 149.92 41.55 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 162.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.16 148.36 31.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.47 -56.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 118.25 0.477 . . . . 0.0 111.42 168.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 148.82 27.65 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -166.07 154.24 10.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.768 0.827 . . . . 0.0 109.129 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -148.57 145.93 28.04 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.425 1.09 . . . . 0.0 108.701 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 66.77 17.8 10.61 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.32 1.848 . . . . 0.0 113.147 168.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -59.58 -38.88 82.34 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.753 -1.217 . . . . 0.0 109.341 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.94 -41.78 96.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 111.194 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -58.53 -48.0 82.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.326 0.65 . . . . 0.0 109.558 173.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -51.97 -56.27 15.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -48.85 -50.52 34.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.436 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -77.38 53.58 1.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.086 1.754 . . . . 0.0 110.056 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.3 p -177.92 -50.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.266 2.227 . . . . 0.0 106.592 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.94 -32.45 74.17 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.54 23.87 74.22 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.675 0.655 . . . . 0.0 112.064 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.82 53.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.518 -0.99 . . . . 0.0 110.417 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.25 109.14 0.05 OUTLIER Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.717 0.675 . . . . 0.0 112.256 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.78 -64.91 0.76 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 120.776 -1.426 . . . . 0.0 111.049 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.28 65.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.101 0.56 . . . . 0.0 110.736 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -51.3 -51.75 51.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.211 1.404 . . . . 0.0 110.98 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -72.77 -42.19 64.25 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.468 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.32 -56.91 7.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.842 1.201 . . . . 0.0 110.248 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.01 -52.13 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 42.54 2.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.84 0.733 . . . . 0.0 113.514 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -157.71 -37.16 0.07 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.712 2.005 . . . . 0.0 109.91 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.9 ttt -76.77 -33.98 58.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.881 0.472 . . . . 0.0 109.942 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -66.24 166.68 11.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.539 166.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.29 80.59 3.46 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.719 0.808 . . . . 0.0 109.223 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.61 158.81 46.93 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.784 2.323 . . . . 0.0 112.338 -168.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 164.54 25.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.348 166.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -145.43 121.93 11.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 155.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mt -90.91 135.58 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -133.44 104.4 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -109.88 109.15 19.69 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.81 88.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -50.53 157.67 0.71 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.481 1.112 . . . . 0.0 110.854 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -26.0 -59.72 0.07 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.202 1.858 . . . . 0.0 115.182 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.75 13.63 9.29 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.718 1.207 . . . . 0.0 111.524 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.18 -172.16 4.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.557 1.543 . . . . 0.0 108.264 -157.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.06 149.56 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 120.766 -1.209 . . . . 0.0 109.974 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.49 128.9 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.11 125.01 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -115.09 106.04 13.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.568 1.547 . . . . 0.0 108.976 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -83.59 63.02 7.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.749 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -71.31 144.63 49.88 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 122.14 0.971 . . . . 0.0 112.957 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -158.53 168.11 27.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 168.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -80.81 56.72 2.78 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -172.7 -51.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -172.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -138.3 146.01 41.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -148.34 49.62 1.03 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.489 0.715 . . . . 0.0 110.138 -163.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.9 p -85.61 151.4 23.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.592 0.357 . . . . 0.0 110.443 -172.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -121.55 142.93 49.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 0.0 110.292 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.34 93.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -172.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 p -104.36 125.32 50.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.97 1.708 . . . . 0.0 110.113 -174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -161.27 170.55 20.01 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -93.77 127.46 39.51 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 165.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.06 64.73 1.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 110.867 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.46 55.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -169.61 173.5 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.26 1.024 . . . . 0.0 108.274 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -107.16 148.56 28.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.458 160.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.67 169.34 22.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.363 1.465 . . . . 0.0 108.469 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -92.2 121.85 34.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -116.65 138.17 51.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.413 1.485 . . . . 0.0 107.226 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -138.65 108.37 6.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -128.64 129.57 46.04 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 44.56 0.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.944 -1.097 . . . . 0.0 113.934 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.27 48.9 p30 -147.36 -52.32 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.975 0.91 . . . . 0.0 109.382 156.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -6.07 47.6 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 82.72 -159.53 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.433 2.293 . . . . 0.0 111.9 165.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -83.76 127.98 34.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.263 1.425 . . . . 0.0 107.835 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 143.98 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.925 1.29 . . . . 0.0 107.641 -174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -81.35 114.39 20.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 166.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -96.58 119.49 35.16 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.312 1.045 . . . . 0.0 108.846 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.59 126.5 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.67 134.93 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.1 m -142.59 170.33 15.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.4 133.53 55.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 165.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -82.08 -23.01 36.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.747 0.419 . . . . 0.0 111.378 -174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.01 -32.55 3.96 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.021 1.296 . . . . 0.0 110.298 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.19 -23.96 8.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.643 1.592 . . . . 0.0 111.985 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -150.25 161.26 42.78 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.233 1.413 . . . . 0.0 111.522 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.29 124.55 31.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 163.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.21 128.74 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.302 1.041 . . . . 0.0 109.424 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -114.64 95.85 5.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.438 2.295 . . . . 0.0 106.78 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.65 96.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -97.9 107.9 20.49 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.326 1.45 . . . . 0.0 108.486 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -121.42 155.71 34.27 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.525 0.602 . . . . 0.0 111.954 -171.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -130.71 -60.94 0.97 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.406 -0.331 . . . . 0.0 110.788 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -160.63 -76.62 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 118.346 0.521 . . . . 0.0 111.962 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.8 -11.8 85.1 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.592 0.633 . . . . 0.0 113.094 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -173.13 175.87 3.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.6 1.56 . . . . 0.0 107.649 -172.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -154.06 158.96 41.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.294 1.437 . . . . 0.0 109.417 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.13 121.31 44.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.715 2.006 . . . . 0.0 108.814 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.17 99.16 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.536 1.134 . . . . 0.0 108.32 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.66 146.48 25.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.91 146.57 31.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -136.23 140.78 43.75 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.539 1.536 . . . . 0.0 108.248 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -163.96 153.18 14.02 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.437 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -111.66 118.74 36.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.477 0.58 . . . . 0.0 109.799 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 -174.43 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 t70 52.73 -107.09 0.32 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.67 29.62 1.43 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.036 1.303 . . . . 0.0 110.544 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -143.35 144.03 31.91 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.134 0.967 . . . . 0.0 109.875 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.84 93.59 6.29 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 171.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.5 mt -70.34 129.57 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -144.95 142.73 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.89 113.68 14.94 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -171.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 p -117.88 129.0 55.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 108.842 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -125.15 169.92 11.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.261 1.424 . . . . 0.0 107.191 173.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.09 118.57 2.39 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 161.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.285 0.5 OUTLIER 67.91 -58.25 0.45 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.6 2.36 . . . . 0.0 113.281 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.55 112.21 12.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.527 -0.733 . . . . 0.0 111.26 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.73 125.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 126.201 1.8 . . . . 0.0 106.573 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 3.9 m -144.8 167.42 22.62 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.926 -1.109 . . . . 0.0 110.281 -174.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.8 p -136.4 144.41 44.5 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.927 0.491 . . . . 0.0 111.249 -170.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -138.04 151.09 47.52 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 166.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.24 139.67 47.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -115.66 156.53 25.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.615 1.166 . . . . 0.0 109.568 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.1 127.45 26.49 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.509 1.124 . . . . 0.0 108.41 -168.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -64.24 119.54 10.46 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.198 0.999 . . . . 0.0 108.96 -173.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -82.01 -50.93 8.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 C-N-CA 123.795 0.838 . . . . 0.0 109.088 176.755 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.6 48.02 0.19 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.25 2.62 . . . . 0.0 112.483 -175.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.32 -60.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -172.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -61.67 -33.65 74.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.271 1.028 . . . . 0.0 110.716 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.63 78.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.724 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.94 -166.86 26.51 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 160.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 m -76.97 124.05 27.21 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.196 1.398 . . . . 0.0 110.984 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -104.16 149.42 25.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.841 1.256 . . . . 0.0 109.002 169.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.2 134.94 54.69 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.992 0.917 . . . . 0.0 108.888 162.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.31 144.77 56.38 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.4 -25.71 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.667 177.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.08 157.08 47.05 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.61 1.096 . . . . 0.0 110.124 173.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 t 176.72 86.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.414 1.886 . . . . 0.0 109.903 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -116.1 160.89 19.71 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.088 0.555 . . . . 0.0 110.925 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 58.33 8.05 0.77 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.329 1.852 . . . . 0.0 112.89 -177.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -31.15 64.46 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.878 -1.139 . . . . 0.0 109.397 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.57 -65.4 0.62 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -44.13 -52.06 7.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.1 1.76 . . . . 0.0 112.229 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -46.43 -50.38 16.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.032 1.333 . . . . 0.0 112.035 176.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.8 mtp -76.9 -34.5 57.73 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.728 -0.607 . . . . 0.0 110.291 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 43.64 0.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.515 2.326 . . . . 0.0 110.313 171.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -171.23 -54.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.2 -27.68 68.6 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 172.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.29 -18.72 55.69 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 119.28 0.945 . . . . 0.0 113.103 171.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 m -41.12 -47.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 127.133 2.173 . . . . 0.0 113.453 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.25 72.27 0.2 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -172.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.85 158.36 2.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 110.605 172.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.13 -78.06 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.438 1.495 . . . . 0.0 110.478 -170.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.7 p -35.24 -44.68 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.756 2.823 . . . . 0.0 113.992 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -34.9 -40.11 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 170.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -50.54 -34.88 27.09 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.007 1.723 . . . . 0.0 113.361 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.72 -44.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.31 18.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.071 0.843 . . . . 0.0 113.109 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -55.57 -53.81 51.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.895 . . . . 0.0 111.978 174.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.4 mtt -81.08 -21.7 39.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.477 1.511 . . . . 0.0 111.511 -172.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -70.44 60.66 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.802 0.728 . . . . 0.0 110.903 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -147.8 48.51 0.65 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.234 2.614 . . . . 0.0 109.043 172.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 -41.58 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.138 2.559 . . . . 0.0 112.311 -167.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -119.62 142.61 48.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 m -146.09 105.19 3.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.769 -0.582 . . . . 0.0 109.592 177.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.4 mt -77.11 113.47 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 170.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -101.41 138.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 163.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -142.99 109.8 5.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -166.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.64 81.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -54.62 156.77 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.286 171.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.0 -72.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.419 2.438 . . . . 0.0 115.604 -171.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -116.42 10.0 14.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.898 1.679 . . . . 0.0 111.132 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.83 -166.48 2.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.296 1.838 . . . . 0.0 108.197 -157.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.28 136.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -112.16 133.58 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 tt -93.62 137.65 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 169.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -138.79 88.11 2.27 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.92 1.688 . . . . 0.0 107.398 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -77.91 129.94 35.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.804 1.642 . . . . 0.0 108.636 178.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.31 143.61 51.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.707 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -158.99 -173.0 4.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.213 1.005 . . . . 0.0 109.461 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -82.18 116.48 21.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.3 t80 59.98 27.25 16.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.093 0.957 . . . . 0.0 112.665 173.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -163.66 75.07 0.35 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.264 -0.898 . . . . 0.0 109.661 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -105.91 139.86 39.82 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 p -150.77 148.81 28.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.85 142.9 24.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.252 0.478 . . . . 0.0 110.989 179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.9 mt -149.96 136.14 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.784 1.234 . . . . 0.0 109.095 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 p -90.22 133.78 34.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.923 1.689 . . . . 0.0 110.075 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.67 177.81 8.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.034 0.934 . . . . 0.0 111.009 176.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -125.58 139.33 53.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 107.042 -176.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 57.14 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.465 0.706 . . . . 0.0 109.65 169.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.07 57.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -167.44 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 96' ' ' LYS . 13.0 pt-20 -122.4 142.69 50.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.558 0.536 . . . . 0.0 111.174 161.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -133.78 150.53 51.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.498 1.519 . . . . 0.0 107.556 -174.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -72.22 131.09 42.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -125.65 131.14 52.69 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 t -126.97 145.35 50.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -146.0 172.32 13.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.56 0.695 . . . . 0.0 110.275 174.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.88 30.73 0.25 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.972 1.309 . . . . 0.0 113.433 -158.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -126.18 11.85 7.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.12 2.568 . . . . 0.0 109.85 165.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t0 63.05 29.33 16.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.492 2.317 . . . . 0.0 112.751 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.81 74.67 1.6 Allowed 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.247 -1.533 . . . . 0.0 109.674 164.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.81 68.86 1.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.196 1.398 . . . . 0.0 109.092 170.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.81 -168.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 110.415 -174.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -135.38 134.67 39.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -122.36 122.6 39.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.285 1.034 . . . . 0.0 109.703 -163.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.39 132.02 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.07 132.19 68.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.275 0.63 . . . . 0.0 109.663 -176.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.05 103.06 2.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.552 1.541 . . . . 0.0 107.661 -178.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.83 130.81 40.09 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.907 -1.12 . . . . 0.0 110.563 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.64 27.59 0.21 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -164.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.81 -38.74 3.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.607 -1.107 . . . . 0.0 111.081 -158.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.54 -64.77 0.17 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.309 1.554 . . . . 0.0 112.544 -175.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 135.82 34.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -174.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.28 89.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.78 113.6 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -115.05 117.97 32.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -117.08 140.46 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -128.6 97.98 4.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -157.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 16.1 ptpt -90.93 162.56 14.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 109.133 -174.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -138.52 -56.15 0.63 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.642 -0.661 . . . . 0.0 110.789 166.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -163.88 -76.11 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.805 0.275 . . . . 0.0 111.11 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.63 -21.76 59.37 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.569 -0.573 . . . . 0.0 111.773 -177.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.73 174.71 11.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.792 . . . . 0.0 109.348 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -133.02 176.17 8.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.845 2.458 . . . . 0.0 109.069 177.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.7 t -133.59 153.77 51.4 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.49 1.116 . . . . 0.0 109.454 165.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.7 m -109.78 134.03 52.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.953 0.901 . . . . 0.0 108.879 -176.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.67 80.4 1.28 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.801 0.81 . . . . 0.0 109.658 -176.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.95 148.72 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -126.12 110.05 13.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -132.54 147.73 52.36 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.243 -177.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.0 ttt -118.09 134.3 55.11 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.21 1.404 . . . . 0.0 108.541 171.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -148.91 177.68 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 54.67 -103.78 0.19 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.35 26.24 1.54 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.123 1.344 . . . . 0.0 109.869 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -140.37 169.08 18.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.756 0.822 . . . . 0.0 109.194 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.62 128.37 45.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -171.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.5 mt -111.82 130.77 64.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -112.7 114.67 27.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.989 0.916 . . . . 0.0 108.693 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.6 p -94.63 76.16 3.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.18 101.45 3.97 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.6 t -128.71 128.33 43.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.471 0.578 . . . . 0.0 110.846 -176.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -173.38 143.69 1.1 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.769 1.227 . . . . 0.0 109.336 175.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.31 54.74 32.29 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 167.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 m 73.98 -44.96 0.58 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.8 1.24 . . . . 0.0 112.11 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.05 115.98 4.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.67 0.788 . . . . 0.0 111.279 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.09 99.19 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.297 1.439 . . . . 0.0 107.497 172.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.9 t -100.36 105.66 17.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.229 1.012 . . . . 0.0 110.479 175.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -65.29 138.48 58.23 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 155.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -115.51 155.88 26.72 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 144.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.84 137.84 46.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 165.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.81 166.03 11.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.284 2.234 . . . . 0.0 108.77 174.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.37 114.11 15.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -75.35 73.82 2.43 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.382 0.611 . . . . 0.0 109.538 -171.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -45.06 62.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.611 1.564 . . . . 0.0 111.526 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.007 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.93 51.07 0.21 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 131.02 3.728 . . . . 0.0 111.329 -166.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.3 -53.87 0.05 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -158.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.93 47.67 0.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.454 1.102 . . . . 0.0 109.494 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 49.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.847 1.259 . . . . 0.0 108.593 -174.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.3 -165.04 35.28 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.627 -0.671 . . . . 0.0 112.793 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m -87.83 136.39 32.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.499 1.12 . . . . 0.0 111.17 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -115.8 154.5 29.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.912 1.685 . . . . 0.0 108.824 172.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -121.19 152.92 38.23 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 167.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.05 134.65 34.2 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.005 1.322 . . . . 0.0 109.635 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.65 -41.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.451 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -144.48 158.25 43.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.135 0.879 . . . . 0.0 109.192 170.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -174.35 111.93 0.16 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.929 2.092 . . . . 0.0 109.422 -163.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.3 145.26 24.47 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m120 77.11 -5.9 2.1 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.484 2.313 . . . . 0.0 111.476 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -76.21 -41.95 47.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.604 1.562 . . . . 0.0 107.678 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -32.21 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.032 1.733 . . . . 0.0 111.995 151.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -56.49 -40.15 74.46 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.346 0.521 . . . . 0.0 112.381 -173.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -36.04 -58.91 0.63 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.832 1.253 . . . . 0.0 112.826 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.29 65.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.103 -174.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -76.79 51.99 0.81 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.226 1.01 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -168.28 -44.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.372 2.269 . . . . 0.0 107.428 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.44 -12.19 13.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.69 63.07 1.72 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -166.16 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.826 1.65 . . . . 0.0 110.205 -176.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.04 149.45 20.36 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.88 62.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.97 1.308 . . . . 0.0 108.362 -178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 65.59 -19.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.157 1.783 . . . . 0.0 115.255 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 m -99.77 -54.48 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.291 1.436 . . . . 0.0 109.072 -170.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -63.65 -10.94 21.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -56.11 -43.53 78.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.265 0.939 . . . . 0.0 110.884 165.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -50.96 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.19 39.94 1.22 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.116 1.341 . . . . 0.0 113.376 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.1 -25.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.245 1.018 . . . . 0.0 112.227 171.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.86 -36.93 85.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 162.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -63.13 82.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.151 0.977 . . . . 0.0 109.873 167.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -144.47 60.6 7.82 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.792 1.637 . . . . 0.0 108.732 164.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.72 -21.18 25.52 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.381 2.721 . . . . 0.0 110.87 -174.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.3 m -142.87 152.06 41.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.494 -0.754 . . . . 0.0 109.244 -177.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.3 m -154.86 125.99 7.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.0 mt -78.26 134.0 29.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 166.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.9 105.36 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 166.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.1 108.31 12.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.866 0.866 . . . . 0.0 110.224 -170.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.96 114.97 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 169.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -99.74 169.38 9.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.303 1.441 . . . . 0.0 108.495 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -22.49 -65.24 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.433 1.968 . . . . 0.0 114.913 -172.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -116.88 5.06 12.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.097 1.359 . . . . 0.0 111.865 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.8 -172.73 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.717 1.607 . . . . 0.0 109.96 -154.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.11 136.08 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 166.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 tt -104.0 140.21 22.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 tt -124.96 125.68 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.614 1.565 . . . . 0.0 108.456 177.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -134.73 105.9 6.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.84 0.856 . . . . 0.0 109.397 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.82 38.73 0.72 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.609 1.163 . . . . 0.0 113.274 -159.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -44.05 121.52 2.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 113.943 -164.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -141.63 62.87 1.44 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.277 0.631 . . . . 0.0 110.004 -176.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 m 73.03 125.66 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.137 1.375 . . . . 0.0 109.96 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 72.9 -53.68 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.99 1.316 . . . . 0.0 111.911 -178.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.77 -163.73 0.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -169.28 -168.49 0.83 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 p -54.58 147.59 14.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.256 1.423 . . . . 0.0 110.959 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -134.78 122.71 22.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.704 1.601 . . . . 0.0 106.832 176.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.49 158.41 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -129.64 159.72 35.53 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 165.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.13 179.55 8.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.919 0.888 . . . . 0.0 108.717 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -145.75 128.11 15.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 76.03 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.133 0.973 . . . . 0.0 110.052 171.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.54 59.3 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.274 1.416 . . . . 0.0 111.084 174.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -168.32 168.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.103 0.952 . . . . 0.0 109.148 174.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.18 152.56 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 110.774 168.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -172.62 163.81 5.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.539 1.136 . . . . 0.0 109.622 -172.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.5 132.78 44.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.738 0.415 . . . . 0.0 110.115 177.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -123.08 87.02 2.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.58 1.952 . . . . 0.0 107.11 -176.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.7 m -89.4 109.07 20.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.436 0.694 . . . . 0.0 109.514 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -131.88 157.7 43.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.523 0.677 . . . . 0.0 112.256 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.76 49.27 1.03 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.506 1.522 . . . . 0.0 111.727 -173.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -172.01 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.342 1.457 . . . . 0.0 107.346 -173.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.268 5.6 m-20 -74.43 9.47 1.71 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 70.12 -154.9 0.13 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 109.108 162.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.96 81.61 3.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -96.68 165.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -108.19 128.03 54.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.165 -0.959 . . . . 0.0 109.127 171.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 134.55 36.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 tt -129.1 115.52 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 153.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.698 0.799 . . . . 0.0 110.254 -166.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -156.29 173.7 16.48 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.546 1.539 . . . . 0.0 106.934 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.27 148.14 49.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.448 1.022 . . . . 0.0 109.886 161.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -116.89 108.83 16.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.519 1.127 . . . . 0.0 108.151 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.67 -68.01 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.637 1.113 . . . . 0.0 111.715 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.8 60.82 0.16 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.679 -2.169 . . . . 0.0 107.679 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.07 113.58 1.22 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 -177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.09 120.63 31.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.04 129.93 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.693 1.597 . . . . 0.0 108.116 -174.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -113.09 106.18 14.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 171.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -82.17 125.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 164.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -126.09 92.26 3.55 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -163.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -110.0 113.97 27.13 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.267 1.427 . . . . 0.0 108.658 -162.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.45 -55.27 3.35 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.192 0.905 . . . . 0.0 110.677 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -169.46 -90.96 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 117.901 0.319 . . . . 0.0 110.76 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.63 -23.53 77.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -175.35 4.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.613 0.765 . . . . 0.0 109.646 176.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.75 166.54 26.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.286 2.234 . . . . 0.0 106.624 -171.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 t -130.24 153.83 48.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 156.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 p -116.82 137.99 51.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.16 156.64 44.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.71 152.19 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.114 0.566 . . . . 0.0 110.236 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -123.6 138.13 54.61 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.915 1.286 . . . . 0.0 108.641 168.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -156.16 146.69 21.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.733 2.013 . . . . 0.0 106.471 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.09 122.22 22.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.624 0.77 . . . . 0.0 109.133 169.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.46 176.41 4.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 159.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.3 t70 51.76 -117.58 1.15 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -129.7 15.25 5.72 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.234 1.397 . . . . 0.0 110.588 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -123.81 134.22 53.66 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.759 0.78 . . . . 0.0 110.453 -167.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 tp -97.66 116.35 29.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.814 1.645 . . . . 0.0 108.311 -171.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.7 mm -86.29 120.94 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.76 113.34 26.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 167.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -111.46 127.78 55.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 170.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 108.53 6.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.347 1.459 . . . . 0.0 107.689 -166.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -131.48 138.65 49.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.885 0.85 . . . . 0.0 112.211 -170.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -139.72 92.05 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.62 -118.37 12.58 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -61.85 -43.46 98.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.697 1.199 . . . . 0.0 111.323 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.64 68.07 5.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.218 -167.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.9 136.42 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.62 160.7 41.29 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.361 -1.462 . . . . 0.0 109.929 177.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -142.07 154.61 45.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.362 0.414 . . . . 0.0 110.783 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -132.95 169.29 17.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 151.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 119.07 11.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 -176.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -112.24 163.69 14.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.983 1.713 . . . . 0.0 109.283 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -133.56 123.8 25.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 127.364 2.266 . . . . 0.0 107.934 -174.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.97 111.15 3.19 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.13 -34.04 10.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 110.636 -173.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 C-N-CA 123.878 0.871 . . . . 0.0 109.936 174.63 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.53 60.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 129.304 3.042 . . . . 0.0 112.096 -169.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.53 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.159 1.784 . . . . 0.0 107.754 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -58.52 -36.6 74.09 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.752 1.221 . . . . 0.0 111.404 -176.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.5 104.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.14 0.976 . . . . 0.0 111.773 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.58 -177.26 27.87 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.349 1.452 . . . . 0.0 113.347 169.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -85.45 108.45 17.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.147 1.779 . . . . 0.0 111.075 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -97.01 155.86 16.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 174.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -123.97 129.67 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.161 1.784 . . . . 0.0 106.555 174.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.86 131.2 35.82 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.51 -42.75 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.439 0.563 . . . . 0.0 110.781 172.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 66.86 151.55 0.07 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.898 2.079 . . . . 0.0 111.953 -173.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -166.88 30.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.675 163.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -166.91 87.34 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.249 -0.907 . . . . 0.0 110.851 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 63.05 50.98 2.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.44 1.096 . . . . 0.0 110.787 161.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -82.46 -60.65 2.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.212 0.605 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -43.17 -66.34 0.39 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.124 2.169 . . . . 0.0 109.647 171.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.7 OUTLIER -20.48 -60.55 0.02 OUTLIER 'General case' 0 C--N 1.34 0.175 0 C-N-CA 127.732 2.413 . . . . 0.0 113.039 164.122 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -63.84 -48.97 74.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.234 -171.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 mtt -62.16 -45.13 94.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.981 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -57.06 -31.34 65.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.125 2.57 . . . . 0.0 111.988 177.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -85.95 -57.27 3.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.598 1.159 . . . . 0.0 110.033 178.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.29 -25.25 68.23 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.191 0.596 . . . . 0.0 112.568 -173.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.16 21.61 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.99 -27.74 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.12 -109.3 0.01 OUTLIER Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.176 1.846 . . . . 0.0 113.631 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 27.94 54.25 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.081 2.553 . . . . 0.0 114.36 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 138.87 -61.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.602 2.761 . . . . 0.0 107.743 -172.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 p -66.23 -48.59 70.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -173.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -49.49 -18.92 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.401 1.88 . . . . 0.0 115.74 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -107.16 -13.6 15.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.787 0.835 . . . . 0.0 113.034 -177.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -143.23 -68.61 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.894 0.77 . . . . 0.0 109.169 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.39 60.45 1.53 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.777 1.656 . . . . 0.0 111.223 -176.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.9 -48.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.978 2.111 . . . . 0.0 107.643 -174.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.5 ttm -99.91 -16.9 17.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.321 1.048 . . . . 0.0 111.482 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 t -69.43 72.06 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.825 0.85 . . . . 0.0 111.327 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 45.51 66.62 5.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 111.947 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.16 105.16 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.005 2.47 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -108.82 139.37 43.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.793 1.237 . . . . 0.0 108.48 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.5 m -126.3 106.84 9.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -71.43 130.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 164.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -121.89 133.27 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 165.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.2 139.57 37.54 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 119.145 0.884 . . . . 0.0 109.421 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.72 138.62 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.32 164.26 19.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.0 108.173 175.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.81 -71.8 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.934 2.207 . . . . 0.0 115.521 -175.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -123.98 23.48 8.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.998 1.719 . . . . 0.0 110.319 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.85 -178.75 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.273 1.029 . . . . 0.0 108.681 -152.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.04 134.25 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 172.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.2 tt -99.1 141.31 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.078 0.951 . . . . 0.0 108.554 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 133.52 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.689 1.596 . . . . 0.0 107.422 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -127.32 95.75 4.37 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.811 1.244 . . . . 0.0 109.071 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.28 82.7 7.68 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.677 0.791 . . . . 0.0 109.685 -174.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -74.92 72.9 2.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.627 0.771 . . . . 0.0 109.018 173.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.9 t -142.99 -68.55 0.35 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.067 1.747 . . . . 0.0 106.977 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 m -60.3 144.38 50.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.113 0.965 . . . . 0.0 110.279 175.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -48.55 135.69 14.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.944 0.498 . . . . 0.0 110.115 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 73.39 -4.73 2.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 0.0 113.458 -178.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.6 72.49 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 111.821 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 150.01 38.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.623 -174.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -139.02 135.67 34.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.879 1.672 . . . . 0.0 107.863 -174.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 tp -159.45 159.42 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.535 0.607 . . . . 0.0 109.961 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.7 p -110.59 129.59 55.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.867 . . . . 0.0 109.834 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -131.16 179.87 5.75 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 110.225 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -139.59 147.16 40.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.901 1.28 . . . . 0.0 107.864 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.54 68.7 1.64 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.007 0.523 . . . . 0.0 109.603 174.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.38 69.72 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.11 165.79 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.827 0.851 . . . . 0.0 108.908 175.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -156.85 166.95 31.92 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.771 0.829 . . . . 0.0 109.005 174.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -74.47 124.11 25.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.91 58.93 0.73 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 107.433 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -57.61 106.14 0.31 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 165.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 t -147.64 134.6 20.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.895 0.478 . . . . 0.0 110.393 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.36 -36.19 41.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.13 . . . . 0.0 113.367 -174.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.43 1.07 23.36 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.669 1.188 . . . . 0.0 113.21 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -132.4 -57.05 0.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 109.7 174.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 128.64 -147.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 1 C-N-CA 132.553 4.341 . . . . 0.0 107.255 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -86.69 117.11 25.23 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.85 148.0 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -169.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -95.61 141.1 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.8 p -121.06 87.76 2.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.513 1.125 . . . . 0.0 109.622 -166.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.1 105.34 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 175.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.59 139.92 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.835 0.854 . . . . 0.0 110.913 -172.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.35 171.0 19.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.23 1.812 . . . . 0.0 107.423 -152.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -142.16 131.53 23.65 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -136.7 150.81 48.66 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.182 0.993 . . . . 0.0 109.181 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.46 -80.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.61 1.1 . . . . 0.0 111.66 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.25 30.61 0.27 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.111 1.339 . . . . 0.0 110.651 171.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -132.1 141.55 49.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.111 1.364 . . . . 0.0 108.013 -176.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tt -96.78 112.32 24.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.632 1.173 . . . . 0.0 108.203 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.91 118.33 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 109.335 -174.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -111.35 99.43 8.23 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.601 2.36 . . . . 0.0 106.771 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 132.76 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 170.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -135.19 98.4 3.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -156.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -116.08 118.48 32.99 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.225 1.01 . . . . 0.0 111.232 -163.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -109.4 -26.16 10.15 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.235 0.614 . . . . 0.0 112.5 -176.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -144.61 -135.53 0.09 Allowed 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.54 66.85 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.287 0.949 . . . . 0.0 111.058 170.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -94.6 166.28 12.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.843 0.857 . . . . 0.0 111.643 -174.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 172.76 12.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.681 1.992 . . . . 0.0 110.597 173.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 t -113.67 154.2 27.66 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 153.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 p -112.9 106.52 14.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.652 1.181 . . . . 0.0 108.753 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mp -102.74 109.65 21.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.72 116.45 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.33 0.652 . . . . 0.0 109.403 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -95.93 131.58 42.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.836 1.654 . . . . 0.0 108.752 177.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -144.51 143.1 30.68 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -118.22 119.83 35.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -125.32 -169.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 159.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.26 -113.81 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.035 0.534 . . . . 0.0 109.649 176.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.32 20.68 3.15 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.095 1.807 . . . . 0.0 110.172 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -140.31 143.03 35.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.978 0.889 . . . . 0.0 109.895 -172.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.4 tt -97.01 99.61 11.14 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.23 125.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -115.95 103.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -92.6 125.55 37.29 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.45 85.05 2.26 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.682 1.193 . . . . 0.0 108.383 -174.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.58 124.19 30.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -145.26 145.47 31.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 160.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.64 -36.07 4.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.1 1.333 . . . . 0.0 113.898 -175.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -54.8 -41.21 70.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.388 0.594 . . . . 0.0 111.623 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -171.2 128.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.196 0.599 . . . . 0.0 110.33 -175.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.82 128.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 166.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.47 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 24.2 m -145.1 153.07 41.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.086 -1.009 . . . . 0.0 108.436 -177.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.3 p -140.94 123.67 16.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.154 0.888 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -95.9 102.89 14.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.358 1.863 . . . . 0.0 107.559 175.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 110.04 18.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -92.92 147.99 22.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.54 0.686 . . . . 0.0 111.334 176.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -134.38 123.27 23.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.311 2.244 . . . . 0.0 107.148 -172.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -75.49 130.54 39.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.771 0.714 . . . . 0.0 109.782 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.84 -21.42 11.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.137 0.426 . . . . 0.0 112.011 164.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 118.333 0.515 . . . . 0.0 111.171 -179.455 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.758 0.313 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.86 60.28 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 130.5 3.52 . . . . 0.0 111.174 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.07 -44.83 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.074 1.75 . . . . 0.0 107.884 -169.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -61.59 -39.86 92.71 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.534 0.734 . . . . 0.0 111.391 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -38.26 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.906 1.682 . . . . 0.0 111.753 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.19 -172.41 23.21 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.271 0.928 . . . . 0.0 113.172 170.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -84.24 116.98 23.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.64 1.576 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -99.99 161.21 13.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 166.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.17 135.42 22.82 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.85 135.42 52.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.981 -0.45 . . . . 0.0 109.846 -173.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.33 -39.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 175.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -141.6 162.72 34.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.8 t -174.38 148.89 1.29 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 171.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -121.68 164.43 17.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.33 -22.86 0.21 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 166.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.09 -43.2 20.13 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -166.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -67.35 -61.82 1.72 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.245 0.93 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -40.8 -50.17 3.15 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.868 1.267 . . . . 0.0 111.92 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -50.36 -49.15 55.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.855 1.662 . . . . 0.0 111.876 177.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -37.17 70.76 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.501 -0.75 . . . . 0.0 110.256 176.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.95 48.82 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.914 2.486 . . . . 0.0 109.073 -169.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 p -172.96 -49.26 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.865 1.666 . . . . 0.0 107.26 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -66.16 33.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.226 1.411 . . . . 0.0 114.339 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.87 2.87 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 120.09 -1.631 . . . . 0.0 111.754 -178.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.61 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.299 2.64 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.82 145.39 17.84 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.916 1.246 . . . . 0.0 110.054 172.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -175.19 171.98 2.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.926 1.69 . . . . 0.0 106.568 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.25 44.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.845 0.748 . . . . 0.0 112.999 -175.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 -52.17 11.01 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.32 -0.863 . . . . 0.0 112.896 -167.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -63.87 -40.09 95.73 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -157.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -36.63 -43.31 0.4 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.686 1.595 . . . . 0.0 113.764 163.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.86 -50.04 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.75 -31.79 5.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.042 2.258 . . . . 0.0 115.702 -176.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -85.5 -37.51 19.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.36 1.08 . . . . 0.0 110.463 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -32.7 66.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.975 0.91 . . . . 0.0 109.885 -174.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -76.17 52.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.399 1.08 . . . . 0.0 111.763 -177.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 30.56 58.45 0.94 Allowed Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 127.599 2.36 . . . . 0.0 114.116 172.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.67 142.0 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.444 1.429 . . . . 0.0 112.023 -166.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.26 175.11 4.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.924 1.289 . . . . 0.0 109.825 172.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -159.29 112.15 2.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.486 1.914 . . . . 0.0 106.146 151.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.41 136.58 22.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 174.007 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.4 114.82 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 173.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -118.79 128.81 54.82 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.08 96.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -77.81 65.13 3.2 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.27 -87.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.453 1.502 . . . . 0.0 112.572 -179.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.42 -15.94 18.56 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.956 1.703 . . . . 0.0 111.621 -175.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.1 p -108.11 157.18 18.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.75 118.11 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 tt -101.35 137.89 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.794 0.837 . . . . 0.0 108.99 -174.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mp -117.44 131.72 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.416 1.487 . . . . 0.0 107.165 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -124.54 115.92 21.64 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -64.89 -46.79 80.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.274 0.23 . . . . 0.0 110.475 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 56.5 78.52 0.21 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.59 0.756 . . . . 0.0 112.538 169.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -148.06 149.37 31.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 162.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.7 p -11.41 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 129.129 2.972 . . . . 0.0 114.363 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -118.24 46.48 1.78 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.98 1.312 . . . . 0.0 108.085 177.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -158.96 55.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -110.57 139.66 45.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.748 1.619 . . . . 0.0 108.892 177.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 p -146.41 160.83 41.55 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 173.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -138.99 128.14 23.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -144.12 132.67 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.596 0.758 . . . . 0.0 109.439 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.1 p -106.14 99.5 9.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.547 1.539 . . . . 0.0 109.98 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -84.91 110.22 18.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.424 0.556 . . . . 0.0 110.218 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -76.84 97.99 4.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 161.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.05 110.5 0.61 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 170.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.09 22.55 6.17 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.09 1.805 . . . . 0.0 113.11 175.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -149.11 159.95 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.905 1.352 . . . . 0.0 109.388 -177.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.14 121.81 42.94 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.593 1.557 . . . . 0.0 108.371 166.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -132.52 155.77 48.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.959 1.303 . . . . 0.0 109.401 -177.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.57 148.39 51.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.057 0.543 . . . . 0.0 109.867 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -141.39 158.01 44.43 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.044 1.337 . . . . 0.0 108.786 -167.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -130.18 119.42 22.93 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.969 0.508 . . . . 0.0 110.945 -175.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.82 150.44 20.41 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.68 14.68 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -166.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -106.41 11.58 30.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.569 1.948 . . . . 0.0 110.094 164.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 t0 58.96 26.26 14.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.26 1.824 . . . . 0.0 111.909 -170.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -68.75 100.88 1.22 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 156.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.92 125.59 19.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 151.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.45 -165.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -139.42 144.32 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.458 1.027 . . . . 0.0 110.935 171.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -110.16 118.5 36.53 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.701 2.0 . . . . 0.0 108.71 -175.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.7 tt -96.57 125.47 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 164.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.5 139.69 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 m -144.94 161.84 38.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 170.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -123.33 115.02 20.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.03 130.73 53.89 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.88 -82.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.091 0.853 . . . . 0.0 113.705 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.35 25.45 1.1 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.353 1.454 . . . . 0.0 111.683 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -117.99 126.14 51.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 107.222 177.071 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.38 106.02 17.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 170.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.8 109.08 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -107.81 123.42 48.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -115.94 140.38 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.26 110.08 12.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.858 1.663 . . . . 0.0 107.907 -169.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.99 132.55 56.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.724 2.01 . . . . 0.0 108.233 -164.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -119.72 -65.01 1.2 Allowed 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.825 0.284 . . . . 0.0 111.443 177.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.49 -84.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.183 0.447 . . . . 0.0 111.11 -173.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.45 -30.22 74.91 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -175.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -171.75 3.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.557 0.694 . . . . 0.0 109.251 173.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.23 168.36 20.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.817 2.847 . . . . 0.0 104.767 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.5 t -144.26 147.79 34.02 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.9 m -109.74 143.99 38.77 Favored 'General case' 0 C--O 1.228 -0.075 0 C-N-CA 123.289 0.635 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.24 63.85 1.57 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.044 2.138 . . . . 0.0 107.322 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 p -74.02 128.94 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -110.82 114.64 28.15 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.904 1.282 . . . . 0.0 108.068 174.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 44.9 tt0 -121.74 144.49 48.76 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 165.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.71 127.8 54.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.929 1.292 . . . . 0.0 108.393 169.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.59 -178.59 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.4 -110.78 0.58 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.3 21.0 2.25 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.866 1.698 . . . . 0.0 110.695 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -140.2 156.74 46.39 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -173.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.06 137.9 54.82 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.375 0.534 . . . . 0.0 109.776 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.63 106.97 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -176.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.12 103.72 16.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 170.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 m -85.91 93.66 8.99 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.84 95.63 9.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -121.07 131.61 54.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.66 0.784 . . . . 0.0 111.538 -174.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -113.97 -39.28 3.99 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.539 1.536 . . . . 0.0 110.224 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.84 -80.29 0.26 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 174.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.2 t -58.24 -39.86 80.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.45 141.38 40.4 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 108.766 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -146.22 112.02 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.634 1.574 . . . . 0.0 107.798 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.12 101.46 8.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.245 1.418 . . . . 0.0 110.33 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -56.59 129.83 42.58 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 150.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.94 108.55 10.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.1 113.55 26.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.893 1.277 . . . . 0.0 108.721 -156.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.56 147.57 35.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.946 1.298 . . . . 0.0 112.245 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -124.51 124.22 41.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.219 2.207 . . . . 0.0 106.501 -171.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -75.86 124.7 27.76 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -107.02 -28.51 9.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.387 0.275 . . . . 0.0 111.218 173.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 123.2 0.6 . . . . 0.0 110.705 -177.345 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.764 -0.16 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.97 63.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.084 2.154 . . . . 0.0 110.53 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.18 -43.02 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.88 1.672 . . . . 0.0 108.084 -163.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.15 -43.66 21.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.257 0.623 . . . . 0.0 111.309 -177.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -43.97 102.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.75 1.62 . . . . 0.0 112.949 -169.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.86 -167.52 25.34 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.345 0.974 . . . . 0.0 113.224 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -76.34 110.58 10.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.301 1.441 . . . . 0.0 110.229 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -83.57 113.82 21.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 13.4 tttm -96.74 125.15 41.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.211 1.004 . . . . 0.0 109.073 174.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.52 141.64 58.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.491 0.587 . . . . 0.0 111.339 -175.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.81 25.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -161.41 158.11 26.26 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.856 1.662 . . . . 0.0 107.506 163.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 t -177.96 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.357 1.463 . . . . 0.0 109.7 -168.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -96.25 138.92 33.15 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 167.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 62.86 -3.69 0.3 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 167.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -59.16 -31.0 68.59 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.542 -1.348 . . . . 0.0 112.106 -173.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.72 -71.18 0.22 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -27.41 -61.24 0.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.458 2.303 . . . . 0.0 111.761 170.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.27 -61.12 1.43 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.912 1.285 . . . . 0.0 111.365 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.8 ptp -74.44 -31.56 62.32 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.859 -0.526 . . . . 0.0 111.718 -176.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.28 47.06 0.35 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.869 2.467 . . . . 0.0 109.29 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m 177.47 -45.65 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 128.061 2.545 . . . . 0.0 107.691 -172.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.6 -45.09 66.39 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.204 -0.31 . . . . 0.0 110.93 172.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.95 -84.22 0.13 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -9.01 -68.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.522 2.329 . . . . 0.0 115.549 167.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 38.04 39.61 0.7 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.418 1.009 . . . . 0.0 115.067 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 150.66 44.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 72.86 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.463 1.105 . . . . 0.0 108.929 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -162.65 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.993 1.317 . . . . 0.0 109.454 -176.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -44.2 63.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.194 0.598 . . . . 0.0 110.651 -172.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -34.79 -41.26 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.637 2.375 . . . . 0.0 114.789 168.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.84 -30.24 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.307 1.443 . . . . 0.0 110.448 177.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.37 59.21 0.63 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.1 2.286 . . . . 0.0 111.668 174.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.93 -69.01 0.07 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.516 3.526 . . . . 0.0 104.886 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -61.53 -36.23 79.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.101 1.36 . . . . 0.0 110.457 -179.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -75.52 14.44 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.64 56.24 12.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.928 1.24 . . . . 0.0 111.773 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.61 153.24 73.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.581 2.188 . . . . 0.0 111.802 -165.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -109.48 165.45 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.216 1.006 . . . . 0.0 109.058 -176.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 m -151.55 106.69 3.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.14 121.07 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mm -111.1 123.08 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 164.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.79 145.53 48.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.9 m -105.15 110.33 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.7 56.97 3.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.06 -85.55 0.02 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.925 0.774 . . . . 0.0 112.33 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.12 -29.65 21.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.893 1.277 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 173.52 6.29 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.015 1.726 . . . . 0.0 107.95 -177.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.83 148.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -177.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.8 tt -129.84 129.29 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.639 0.776 . . . . 0.0 110.167 -173.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.62 135.9 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 125.354 1.461 . . . . 0.0 107.164 172.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -127.13 119.89 27.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.086 0.954 . . . . 0.0 109.361 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -94.25 84.11 4.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 111.46 -166.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -88.07 95.7 10.24 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.442 1.019 . . . . 0.0 112.778 -168.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.9 p -108.12 154.34 21.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 164.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -76.17 61.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -177.93 -49.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.731 0.812 . . . . 0.0 110.148 -170.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -146.13 135.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -173.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -134.31 123.32 23.98 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.2 p -134.42 167.06 21.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.52 149.52 33.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.096 0.407 . . . . 0.0 110.544 168.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 pt -146.38 140.75 20.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.321 1.049 . . . . 0.0 109.106 177.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 p -105.03 153.97 20.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 110.335 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -158.9 160.62 36.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.345 0.658 . . . . 0.0 110.167 -178.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -84.48 131.87 34.61 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.94 54.89 1.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.079 0.854 . . . . 0.0 109.954 167.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.78 57.74 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.001 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -173.12 162.57 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.351 1.076 . . . . 0.0 111.037 169.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -100.44 126.22 46.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.063 2.545 . . . . 0.0 109.385 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.32 157.42 35.67 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.603 -0.685 . . . . 0.0 110.603 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -70.57 150.7 45.8 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.512 0.725 . . . . 0.0 109.626 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -163.65 177.01 9.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.167 1.387 . . . . 0.0 107.276 -164.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.4 m -160.46 99.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 120.168 -1.583 . . . . 0.0 108.255 -163.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 t -82.62 174.76 10.74 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.354 -178.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.17 21.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.204 1.802 . . . . 0.0 115.585 -163.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -139.8 15.6 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.119 2.168 . . . . 0.0 111.37 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.34 40.12 21.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 111.576 -169.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -68.2 111.08 4.32 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 149.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -74.58 71.54 1.88 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.03 154.42 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.802 -175.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.35 120.43 32.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 159.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.18 125.14 30.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 167.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.89 107.35 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.301 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.27 135.51 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 -169.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.7 p -145.85 -168.93 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 107.413 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.59 135.52 38.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 167.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.0 24.67 0.23 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.603 1.092 . . . . 0.0 112.602 -167.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -32.21 3.17 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.337 -163.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.36 -46.83 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.108 1.337 . . . . 0.0 113.143 -172.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -127.21 155.92 42.67 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.382 1.873 . . . . 0.0 109.039 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tt -81.49 121.56 26.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.85 104.57 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.893 1.277 . . . . 0.0 107.675 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -99.6 104.26 16.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.42 143.06 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 169.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.03 108.74 10.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -117.86 139.66 50.8 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.712 1.605 . . . . 0.0 107.66 -170.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.63 -78.76 0.58 Allowed 'General case' 0 C--N 1.337 0.064 0 CA-C-N 119.565 1.075 . . . . 0.0 110.717 172.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.23 -60.04 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.57 0.07 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.402 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 153.36 38.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -125.79 170.15 11.89 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 108.233 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -143.57 149.75 37.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 110.269 165.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 p -109.57 138.03 46.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.512 1.125 . . . . 0.0 108.255 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.54 69.03 1.44 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.124 1.369 . . . . 0.0 107.997 -177.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.21 146.35 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.566 -174.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.99 136.94 35.9 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.723 1.209 . . . . 0.0 110.254 176.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -161.25 147.71 14.59 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 157.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -93.0 102.6 14.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.478 1.511 . . . . 0.0 109.09 167.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.49 -173.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 158.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 50.99 -110.82 0.5 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.79 25.03 2.11 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.072 1.32 . . . . 0.0 110.803 174.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -150.74 153.45 35.54 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.3 1.05 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.7 120.62 31.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -89.0 133.52 30.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.58 121.6 36.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.6 m -110.99 109.61 19.81 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.49 124.79 35.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 168.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.3 m -141.57 135.14 29.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.684 0.675 . . . . 0.0 110.723 173.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -137.71 154.7 49.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.376 2.27 . . . . 0.0 108.001 -177.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -30.6 -48.22 0.16 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.569 2.033 . . . . 0.0 115.627 -178.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 t -135.27 41.28 2.81 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.805 0.803 . . . . 0.0 110.6 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.6 126.07 4.44 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.325 -0.86 . . . . 0.0 109.202 169.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 p -118.09 132.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.732 1.213 . . . . 0.0 107.774 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -139.24 112.56 8.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 p -67.12 143.48 56.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 158.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -139.14 162.28 35.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 160.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.73 145.64 26.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 170.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -125.48 162.82 24.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.416 1.486 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 30.6 tt0 -124.87 103.22 7.94 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.045 2.138 . . . . 0.0 105.485 -175.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.53 108.71 12.11 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 -55.98 26.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.865 -173.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 O-C-N 121.93 -0.481 . . . . 0.0 110.939 -171.712 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.92 54.05 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.526 2.731 . . . . 0.0 111.833 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.38 -56.52 0.08 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.81 1.644 . . . . 0.0 106.65 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -47.18 -44.52 22.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.266 1.826 . . . . 0.0 111.93 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -35.52 102.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.037 2.135 . . . . 0.0 112.093 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.43 -156.63 26.28 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.162 0.892 . . . . 0.0 112.906 165.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 m -116.32 127.09 54.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.632 1.173 . . . . 0.0 109.019 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -112.04 156.93 21.39 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.531 1.132 . . . . 0.0 110.463 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 25.7 ttpp -119.31 130.65 55.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.503 2.321 . . . . 0.0 107.355 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.93 137.35 58.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.15 -71.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.156 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -111.42 139.78 46.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.958 0.799 . . . . 0.0 109.448 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -163.45 160.28 23.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.771 0.828 . . . . 0.0 108.779 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 171.66 19.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.808 2.043 . . . . 0.0 107.678 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 m120 64.5 12.98 7.84 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.508 1.523 . . . . 0.0 113.78 166.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.91 -39.94 93.76 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 120.426 -1.421 . . . . 0.0 109.895 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.25 -71.75 0.06 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 109.619 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -37.88 -57.74 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.698 1.999 . . . . 0.0 111.971 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.54 -40.65 75.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.971 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -33.04 44.38 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.523 -0.735 . . . . 0.0 111.004 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -72.01 46.76 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 0.0 110.436 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p 179.04 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.303 1.841 . . . . 0.0 107.229 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -64.5 -27.88 69.28 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.97 44.31 37.29 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 25' ' ' VAL . 8.2 t -113.29 43.79 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.82 -72.84 0.28 Allowed Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.75 20.49 3.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.104 0.961 . . . . 0.0 111.984 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 171.32 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 126.613 1.965 . . . . 0.0 107.456 -168.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -53.79 -43.84 69.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.232 1.013 . . . . 0.0 111.416 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -65.86 -12.25 52.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.271 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -60.2 -23.24 63.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.331 1.423 . . . . 0.0 112.056 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.95 -39.53 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 110.269 167.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.03 47.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.199 -0.938 . . . . 0.0 113.735 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -57.77 -47.15 83.34 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.413 1.485 . . . . 0.0 109.731 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.6 ttt -92.3 -42.31 9.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.884 1.274 . . . . 0.0 110.394 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -74.45 66.26 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 0.0 112.604 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -149.26 58.57 3.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.871 1.268 . . . . 0.0 110.084 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.3 -44.67 8.67 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.685 2.923 . . . . 0.0 111.869 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.7 m -107.16 157.07 18.15 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.663 0.744 . . . . 0.0 109.217 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 m -148.02 116.83 6.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 162.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 83.1 mt -80.59 137.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.7 mm -130.96 91.19 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.556 1.543 . . . . 0.0 106.992 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.84 105.63 17.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.79 140.79 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -125.05 165.57 17.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.499 1.519 . . . . 0.0 107.912 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -25.12 -66.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.613 2.054 . . . . 0.0 115.121 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -118.36 15.05 13.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.792 2.037 . . . . 0.0 110.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.09 179.69 7.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.065 1.746 . . . . 0.0 109.727 -151.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.9 150.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.86 127.61 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.4 tt -94.64 138.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -127.74 99.02 5.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.539 1.536 . . . . 0.0 108.587 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.5 m -72.94 83.89 1.24 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -83.74 113.11 20.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.966 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -139.01 -172.64 3.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.93 1.292 . . . . 0.0 108.372 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -82.86 -80.69 0.17 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -84.06 116.53 22.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 109.662 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 81.29 133.04 0.06 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.586 1.954 . . . . 0.0 108.904 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.12 155.75 49.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 p -150.48 153.45 35.91 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.29 143.23 17.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.989 171.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mm -153.61 142.67 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.688 1.195 . . . . 0.0 108.791 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -89.69 136.87 32.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.779 2.032 . . . . 0.0 109.391 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.1 144.59 38.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.991 0.917 . . . . 0.0 110.345 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 106.23 16.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.55 1.54 . . . . 0.0 107.309 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.82 105.01 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.959 0.504 . . . . 0.0 111.076 168.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.97 30.42 2.98 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.688 2.09 . . . . 0.0 112.698 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.3 t -146.95 159.88 9.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 107.986 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.76 137.35 49.81 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 111.605 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -135.43 135.74 40.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.84 1.256 . . . . 0.0 109.512 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.15 114.98 27.62 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.565 1.546 . . . . 0.0 108.281 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.54 159.15 38.28 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.209 0.459 . . . . 0.0 110.32 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 t -122.38 98.76 6.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.641 1.577 . . . . 0.0 112.063 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -83.78 142.95 30.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.39 -40.91 27.33 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.053 0.941 . . . . 0.0 110.869 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -102.45 42.19 1.17 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.874 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.58 -37.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.213 1.005 . . . . 0.0 110.079 154.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 86.55 -172.24 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.949 2.5 . . . . 0.0 107.093 -163.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -72.71 123.95 24.32 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.738 0.699 . . . . 0.0 110.193 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.93 147.86 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.216 1.406 . . . . 0.0 108.172 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -93.94 101.6 13.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 122.095 0.95 . . . . 0.0 109.932 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.5 m -83.81 116.15 22.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.015 1.326 . . . . 0.0 109.787 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.26 125.23 54.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 166.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.34 138.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -155.24 -176.66 6.05 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 164.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -132.44 105.58 7.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.865 1.266 . . . . 0.0 108.439 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.27 120.57 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.71 -80.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.722 0.677 . . . . 0.0 111.964 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.14 17.7 1.54 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.195 1.379 . . . . 0.0 111.587 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.5 117.06 30.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 108.342 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 tp -80.1 98.56 7.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.0 m -87.95 107.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -98.25 100.99 12.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.83 141.82 13.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -133.53 99.67 4.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -108.63 114.95 29.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.58 1.952 . . . . 0.0 108.502 -163.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -107.74 -67.25 0.97 Allowed 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.572 0.624 . . . . 0.0 110.99 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -172.11 -81.32 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.322 0.51 . . . . 0.0 111.734 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.96 80.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.68 -172.82 3.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -131.39 -178.99 5.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.118 1.767 . . . . 0.0 107.274 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.5 t -143.56 177.64 8.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.7 p -138.05 136.75 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.669 1.188 . . . . 0.0 108.264 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 115' ' ' LEU . 2.3 mt -129.87 71.33 1.44 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.139 2.176 . . . . 0.0 106.259 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.92 124.92 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.822 -0.549 . . . . 0.0 109.819 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.13 139.42 49.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.784 1.634 . . . . 0.0 110.348 -171.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -156.44 144.29 19.46 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -110.61 120.4 42.28 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 162.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.45 167.4 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 156.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.85 -124.44 2.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.13 13.63 7.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.945 1.26 . . . . 0.0 111.93 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -122.93 127.02 48.35 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.389 1.095 . . . . 0.0 109.333 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.65 103.02 4.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 165.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 pt -85.95 127.73 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 104' ' ' LEU . 7.5 tp -115.1 111.3 20.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.67 1.588 . . . . 0.0 106.785 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -88.85 115.35 26.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -102.93 109.78 21.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 m -132.17 131.15 41.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.279 1.031 . . . . 0.0 110.548 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.49 169.14 12.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.814 1.646 . . . . 0.0 108.921 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.44 83.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 166.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 85.52 140.22 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.186 2.594 . . . . 0.0 109.585 -166.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 77.55 145.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 112.346 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -137.05 153.61 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.434 1.893 . . . . 0.0 107.29 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.6 137.64 32.04 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.821 -1.175 . . . . 0.0 108.559 161.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -85.37 128.09 34.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 161.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -125.94 113.96 17.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 p -113.31 136.77 52.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.333 0.97 . . . . 0.0 110.386 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.41 146.17 47.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.925 1.69 . . . . 0.0 108.646 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 40.8 tt0 -130.09 125.04 34.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.056 2.143 . . . . 0.0 106.77 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -66.05 116.6 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.417 1.008 . . . . 0.0 110.146 -171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -91.23 -30.12 16.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.645 0.378 . . . . 0.0 111.048 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.503 0.592 . . . . 0.0 111.138 173.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 63.9 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.078 2.951 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.94 -44.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.873 1.669 . . . . 0.0 107.956 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 42' ' ' ILE . 30.6 m-85 -61.7 -44.82 96.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -174.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -37.04 105.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.992 2.117 . . . . 0.0 111.676 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.91 -163.76 25.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.499 0.571 . . . . 0.0 112.41 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 m -108.94 122.66 47.7 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 110.481 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 61.7 m95 -103.09 162.37 13.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.462 1.905 . . . . 0.0 110.624 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -129.34 132.86 47.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.455 2.302 . . . . 0.0 108.139 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.63 131.38 45.87 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.281 0.633 . . . . 0.0 110.121 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.33 31.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.247 0.619 . . . . 0.0 110.918 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.76 159.49 8.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.401 1.48 . . . . 0.0 108.175 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 177.07 102.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.442 1.897 . . . . 0.0 107.868 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -135.94 148.71 48.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.179 0.445 . . . . 0.0 110.385 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.34 35.49 20.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.544 1.538 . . . . 0.0 110.807 174.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.35 -19.14 27.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.78 1.276 . . . . 0.0 109.948 -177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -52.99 4.84 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 129.494 3.118 . . . . 0.0 106.146 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -49.68 -40.76 41.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.895 1.278 . . . . 0.0 111.148 166.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.89 -50.6 34.23 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.576 0.75 . . . . 0.0 111.165 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 -37.51 84.69 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.425 -0.797 . . . . 0.0 111.652 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -70.42 61.65 0.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 110.063 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m 168.6 -58.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 129.165 2.986 . . . . 0.0 106.795 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.73 -34.78 24.8 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 52.61 42.65 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -170.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.31 -52.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.195 0.998 . . . . 0.0 110.611 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.89 -65.6 3.21 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.873 -0.404 . . . . 0.0 113.579 -163.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.45 101.46 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.779 1.632 . . . . 0.0 112.454 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 135.16 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.707 3.203 . . . . 0.0 109.461 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -113.19 -26.5 8.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.929 1.692 . . . . 0.0 111.343 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -66.46 -41.95 88.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.83 1.195 . . . . 0.0 110.888 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -53.21 -36.67 61.26 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.287 1.035 . . . . 0.0 111.197 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.0 t -39.42 -50.86 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.401 1.88 . . . . 0.0 110.329 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.06 54.56 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.643 0.64 . . . . 0.0 113.075 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.45 24.97 10.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.85 1.26 . . . . 0.0 111.198 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.5 ttt -152.62 -2.57 0.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.0 m -158.3 169.96 23.32 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.793 -1.192 . . . . 0.0 109.602 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -117.08 73.02 6.53 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.204 1.402 . . . . 0.0 108.977 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.22 158.2 58.58 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.431 2.087 . . . . 0.0 109.809 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -100.83 164.54 11.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.74 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.95 113.1 11.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 163.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.37 127.66 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 4' ' ' PHE . 17.2 mm -120.79 110.84 29.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.57 115.95 29.44 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.3 85.87 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -50.41 154.64 1.22 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.521 0.728 . . . . 0.0 110.171 170.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -23.79 -59.28 0.04 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.317 1.913 . . . . 0.0 115.352 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.11 13.35 9.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.944 1.298 . . . . 0.0 111.805 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.89 -170.37 3.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.937 1.695 . . . . 0.0 108.767 -158.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.29 149.1 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 120.72 -1.238 . . . . 0.0 110.53 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.67 140.75 47.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.88 1.272 . . . . 0.0 109.17 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 tt -129.43 145.5 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.454 1.901 . . . . 0.0 109.371 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.0 152.75 51.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.952 2.101 . . . . 0.0 107.842 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 m -111.61 62.95 0.62 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.032 1.287 . . . . 0.0 107.717 159.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.07 108.15 0.84 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.488 -0.758 . . . . 0.0 110.794 -173.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -116.24 102.1 9.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.334 1.454 . . . . 0.0 108.55 -168.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m 63.92 -75.7 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.155 1.382 . . . . 0.0 111.451 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.33 27.85 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.119 0.968 . . . . 0.0 110.865 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 96.99 2.71 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.862 -0.524 . . . . 0.0 110.989 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -161.61 163.77 29.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.516 -0.74 . . . . 0.0 111.157 161.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -94.72 175.03 6.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.97 3.308 . . . . 0.0 109.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 152.25 47.98 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.065 1.346 . . . . 0.0 107.976 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.73 137.79 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 p -126.24 147.33 49.7 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.556 0.743 . . . . 0.0 109.399 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -160.82 163.25 32.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.056 0.931 . . . . 0.0 113.124 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -98.83 133.71 42.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -76.56 64.64 2.25 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.83 -0.544 . . . . 0.0 110.161 -178.087 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.82 57.92 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.21 159.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.4 1.1 . . . . 0.0 111.119 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -88.89 151.61 22.23 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.072 1.349 . . . . 0.0 109.56 160.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.48 150.1 21.16 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.377 0.671 . . . . 0.0 109.265 164.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.44 141.24 32.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.4 156.86 47.2 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.193 0.997 . . . . 0.0 108.946 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -149.71 118.77 6.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.686 0.394 . . . . 0.0 110.178 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -147.35 143.45 28.02 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.88 78.94 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.531 0.732 . . . . 0.0 111.912 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -94.83 19.71 9.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.17 1.788 . . . . 0.0 112.511 -171.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.25 -42.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.782 0.833 . . . . 0.0 110.721 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 114.69 -160.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 131.383 3.873 . . . . 0.0 108.89 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -85.71 118.4 25.19 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.26 142.04 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.263 1.025 . . . . 0.0 108.527 -167.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -80.82 126.8 31.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -97.36 143.77 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.894 0.878 . . . . 0.0 108.714 168.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 94' ' ' VAL . 5.4 tt -136.4 127.62 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 168.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.6 139.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.0 m -158.98 173.82 15.91 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.379 2.672 . . . . 0.0 104.657 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.45 153.76 43.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.425 1.466 . . . . 0.0 111.977 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.77 143.27 49.47 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.414 1.486 . . . . 0.0 108.421 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 -77.13 0.04 OUTLIER Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.24 0.924 . . . . 0.0 111.118 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.17 21.27 0.19 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.115 1.341 . . . . 0.0 111.918 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.42 134.21 54.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.119 1.368 . . . . 0.0 108.204 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.06 122.27 29.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.78 109.11 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -94.92 90.96 6.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 166.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 83' ' ' ILE . 14.5 p -89.84 146.58 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -147.06 121.43 9.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -159.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -127.51 127.72 44.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.342 1.457 . . . . 0.0 108.748 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -100.12 -55.01 2.74 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -163.66 -85.1 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.973 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.31 71.8 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.225 0.466 . . . . 0.0 112.458 -170.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 177.31 10.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.922 0.889 . . . . 0.0 109.073 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.51 163.92 30.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 109.741 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -126.84 152.6 46.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.553 1.541 . . . . 0.0 108.453 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -111.0 124.94 53.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.409 1.483 . . . . 0.0 109.377 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.44 106.71 17.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.182 1.793 . . . . 0.0 106.771 171.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.35 131.58 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -138.64 142.37 39.06 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -159.11 155.81 27.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.284 2.233 . . . . 0.0 106.024 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -106.17 122.63 46.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 160.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.15 162.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 155.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.75 -129.66 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -166.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.01 0.33 24.16 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.526 1.536 . . . . 0.0 111.672 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.44 136.4 50.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.971 0.908 . . . . 0.0 108.982 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 8.2 tt -92.67 112.25 24.14 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.31 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.4 tp -87.51 131.28 34.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.4 m -126.47 135.46 51.38 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.37 114.87 29.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 128.986 2.914 . . . . 0.0 106.71 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.1 m -120.95 130.34 53.8 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -124.22 159.21 30.66 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.88 -35.35 12.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.658 0.647 . . . . 0.0 112.291 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -124.31 123.87 41.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 92.14 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.042 2.137 . . . . 0.0 112.147 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.14 139.58 27.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.344 1.457 . . . . 0.0 107.293 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.3 t -150.75 128.24 11.44 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.986 0.914 . . . . 0.0 110.457 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 p -81.69 155.22 25.66 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -144.87 68.19 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.08 141.37 58.79 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.604 -0.685 . . . . 0.0 111.225 176.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.75 165.43 19.28 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 126.021 1.728 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.23 151.22 51.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.168 1.387 . . . . 0.0 109.681 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -86.65 128.5 35.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.908 1.283 . . . . 0.0 109.938 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.86 -15.43 14.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.961 0.8 . . . . 0.0 113.119 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.115 0 C-N-CA 123.193 0.597 . . . . 0.0 110.401 -177.23 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.26 -22.31 11.43 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.979 2.512 . . . . 0.0 112.857 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.95 -34.2 33.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.917 0.887 . . . . 0.0 111.272 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -48.19 56.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.23 108.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.477 1.511 . . . . 0.0 112.211 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.29 -157.46 21.28 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.25 0.477 . . . . 0.0 112.522 171.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.1 m -97.67 113.54 25.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.12 1.368 . . . . 0.0 110.791 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 16.6 m0 -84.77 113.07 21.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.579 1.552 . . . . 0.0 107.753 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.69 129.8 51.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.49 143.93 55.94 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.286 -0.884 . . . . 0.0 110.996 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.34 -42.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 120.706 -1.246 . . . . 0.0 111.854 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -138.33 162.58 34.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 t -171.49 126.47 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.67 133.17 45.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.18 29.97 5.92 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.347 1.859 . . . . 0.0 111.06 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -75.41 -53.33 8.87 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.45 -0.782 . . . . 0.0 109.671 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.56 -30.62 67.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.391 -0.193 . . . . 0.0 110.962 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.5 -48.72 62.82 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.22 -0.3 . . . . 0.0 110.56 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -56.82 -61.71 2.25 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 0.0 111.507 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -35.1 66.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 63.97 0.23 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.941 0.897 . . . . 0.0 109.874 167.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t 162.77 -56.96 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.963 2.505 . . . . 0.0 106.978 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -26.96 68.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.683 0.793 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 -19.81 15.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.885 0.755 . . . . 0.0 113.769 168.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.6 m -40.59 -32.43 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 128.21 2.604 . . . . 0.0 113.951 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.11 73.23 0.17 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -45.21 -58.66 3.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.576 1.15 . . . . 0.0 111.236 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.77 -29.54 11.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.641 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.2 p -81.87 -65.87 0.96 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.973 0.909 . . . . 0.0 111.092 -167.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -54.0 -33.1 56.16 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.829 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.9 -27.65 65.43 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.79 1.177 . . . . 0.0 113.9 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.1 t -85.53 -49.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.78 45.65 1.64 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.097 0.856 . . . . 0.0 113.684 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -160.41 -42.38 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 110.555 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtm -60.07 -26.53 66.24 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.793 0.724 . . . . 0.0 110.763 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 m -67.06 66.53 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.107 1.763 . . . . 0.0 112.367 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 44.24 72.57 1.16 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.412 1.885 . . . . 0.0 112.228 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.32 147.79 37.65 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.69 1.593 . . . . 0.0 111.904 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -152.7 160.5 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 108.175 -169.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -154.31 144.86 22.29 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pt -110.32 148.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.225 0.92 . . . . 0.0 108.772 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 30.5 mm -129.68 130.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.734 1.214 . . . . 0.0 108.761 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.17 114.88 20.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.507 1.523 . . . . 0.0 109.25 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.87 70.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.9 0.857 . . . . 0.0 110.259 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.89 149.87 43.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.571 -0.706 . . . . 0.0 109.976 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -19.89 -67.84 0.01 OUTLIER Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.494 1.997 . . . . 0.0 116.309 -171.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -113.52 14.35 18.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.599 1.559 . . . . 0.0 111.791 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.31 179.75 7.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.606 1.563 . . . . 0.0 109.0 -158.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -139.79 101.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.05 143.99 12.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.56 144.14 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -128.62 101.95 6.38 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -76.33 145.95 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.32 66.75 1.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.08 1.352 . . . . 0.0 108.591 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 m -72.17 -44.81 62.49 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -150.7 -109.51 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -113.93 -49.52 2.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.677 1.126 . . . . 0.0 111.566 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -77.77 66.72 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -101.41 -171.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.079 1.751 . . . . 0.0 109.402 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 74' ' ' THR . 11.9 p -152.77 171.95 17.44 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.664 1.186 . . . . 0.0 110.047 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -145.34 135.87 24.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.916 1.686 . . . . 0.0 108.21 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -145.26 147.81 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.227 1.011 . . . . 0.0 108.577 -172.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.5 p -99.7 97.41 8.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.608 1.563 . . . . 0.0 110.322 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -72.27 148.89 45.01 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.58 20.38 14.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.41 1.084 . . . . 0.0 113.845 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 37.04 32.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.602 1.961 . . . . 0.0 115.934 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.87 47.74 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.307 -0.718 . . . . 0.0 112.006 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -174.7 168.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.394 1.097 . . . . 0.0 109.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -104.86 143.47 33.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.621 0.768 . . . . 0.0 111.682 170.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -139.23 156.26 47.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 107.316 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.64 138.62 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.61 62.57 1.59 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -52.46 100.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.873 0.869 . . . . 0.0 110.379 163.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 60' ' ' THR . 10.1 t -117.66 136.05 53.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.261 0.553 . . . . 0.0 110.032 165.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.48 49.64 1.03 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.794 1.237 . . . . 0.0 111.374 -171.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -172.04 -58.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.565 2.346 . . . . 0.0 107.96 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.77 5.1 26.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.84 0.856 . . . . 0.0 113.22 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 83.4 -169.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 163.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -97.88 80.39 2.75 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 109.968 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.74 167.73 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.14 0.976 . . . . 0.0 109.377 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -127.33 97.12 4.79 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.5 t -113.48 114.86 27.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -157.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.3 119.11 29.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.878 1.671 . . . . 0.0 109.007 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.02 140.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 123.675 0.79 . . . . 0.0 110.031 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 p -136.81 166.71 22.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.777 1.631 . . . . 0.0 107.346 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.05 108.76 10.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.65 121.81 45.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.538 0.608 . . . . 0.0 109.835 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.52 -77.73 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.498 1.047 . . . . 0.0 111.344 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.85 21.47 0.69 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.995 1.283 . . . . 0.0 111.173 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -116.43 123.56 47.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.1 tt -84.23 110.26 18.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.2 t -95.28 116.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -113.05 117.79 32.98 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.1 t -102.79 119.15 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.438 ' CB ' HD21 ' A' ' 104' ' ' LEU . 42.6 tt0 -104.27 85.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 108.713 -169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.42 143.14 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.349 1.86 . . . . 0.0 108.396 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -125.74 -59.19 1.37 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.51 166.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -167.2 -87.32 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.353 0.524 . . . . 0.0 111.311 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.72 -23.31 77.92 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.47 175.61 9.42 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.807 0.843 . . . . 0.0 108.728 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -134.45 176.04 8.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.918 2.087 . . . . 0.0 106.455 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -138.14 165.59 26.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 162.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.488 ' C ' HD23 ' A' ' 104' ' ' LEU . 77.4 p -117.9 138.7 51.96 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.155 0.582 . . . . 0.0 110.282 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 103' ' ' SER . 0.1 OUTLIER -134.18 98.0 4.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.032 1.733 . . . . 0.0 107.387 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.3 OUTLIER -93.37 142.26 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -130.99 105.0 7.45 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.774 1.629 . . . . 0.0 108.668 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -131.98 142.93 49.76 Favored 'General case' 0 C--O 1.228 -0.042 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -116.67 124.5 49.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 164.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.57 -177.39 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.7 t70 52.36 -111.74 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.55 33.43 1.31 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -139.89 140.59 36.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -98.44 105.65 17.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.287 1.035 . . . . 0.0 108.412 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.22 105.16 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.32 95.25 9.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' HG12 ' A' ' 105' ' ' VAL . 7.3 m -81.92 115.22 21.0 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.67 105.39 13.25 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.129 1.372 . . . . 0.0 107.466 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 t -135.56 137.4 41.97 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.369 0.532 . . . . 0.0 111.35 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -109.73 -35.17 6.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.148 1.379 . . . . 0.0 111.293 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 -100.65 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 -172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 34.9 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.681 1.192 . . . . 0.0 112.749 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.34 126.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.124 2.169 . . . . 0.0 106.443 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.36 134.44 63.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 126.562 1.945 . . . . 0.0 107.016 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.47 154.27 49.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.897 0.879 . . . . 0.0 109.813 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.6 t -119.14 139.23 52.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 157.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -117.15 95.62 5.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.94 101.1 11.46 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -91.43 165.85 13.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.704 1.602 . . . . 0.0 111.028 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -139.31 109.23 6.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -66.06 98.3 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -70.36 -45.72 65.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 110.459 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 C-N-CA 126.057 1.743 . . . . 0.0 107.597 -176.386 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.46 65.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.11 2.964 . . . . 0.0 111.491 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.72 -49.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.03 2.132 . . . . 0.0 106.203 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -76.22 44.87 0.35 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.496 2.318 . . . . 0.0 111.421 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.1 96.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.53 -157.94 25.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -132.17 140.44 48.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.597 0.759 . . . . 0.0 110.185 -168.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -126.22 161.65 27.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.398 1.479 . . . . 0.0 109.548 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -127.65 139.01 52.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.513 1.125 . . . . 0.0 108.359 174.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 13' ' ' SER . 5.9 tt -67.73 145.4 54.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.277 0.49 . . . . 0.0 111.007 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.5 -32.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 0.0 113.474 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 14' ' ' LYS . 18.9 t0 -133.06 154.06 50.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.97 1.259 . . . . 0.0 108.683 170.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' HD21 ' A' ' 10' ' ' LEU . 36.2 t -163.51 27.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.507 2.323 . . . . 0.0 110.879 -164.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 4.3 ptpp? -57.44 146.99 27.66 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.892 -1.13 . . . . 0.0 110.435 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 66.95 5.36 4.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 114.19 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.73 -39.08 76.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.467 1.485 . . . . 0.0 111.466 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.83 -69.69 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.0 110.24 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -30.9 -57.52 0.22 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.94 2.496 . . . . 0.0 111.146 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.51 -54.45 7.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 112.66 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -40.41 75.2 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.883 -0.51 . . . . 0.0 110.227 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -73.88 45.81 0.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.52 1.528 . . . . 0.0 110.75 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -171.35 -48.21 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.517 1.927 . . . . 0.0 109.053 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.54 -34.31 70.86 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.885 -0.509 . . . . 0.0 110.914 168.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.85 44.81 3.27 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.92 -30.02 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.376 1.47 . . . . 0.0 108.058 162.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -21.29 114.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.996 0 C-N-CA 127.688 2.566 . . . . 0.0 114.86 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -162.73 -177.13 5.36 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.114 1.366 . . . . 0.0 108.985 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.99 65.24 9.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.22 0.608 . . . . 0.0 109.89 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 m -154.57 -51.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.415 0.686 . . . . 0.0 109.624 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -43.81 -34.85 1.7 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 0.0 113.529 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.01 -30.54 68.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.042 0.937 . . . . 0.0 112.724 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.74 -37.77 9.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.8 65.3 0.07 OUTLIER Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.239 2.352 . . . . 0.0 112.788 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -179.07 -37.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.462 2.705 . . . . 0.0 108.336 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.44 -30.22 17.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.227 1.011 . . . . 0.0 110.65 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -64.15 -179.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.374 0.607 . . . . 0.0 111.108 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.44 80.8 2.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.738 1.215 . . . . 0.0 110.054 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' HD13 ' A' ' 10' ' ' LEU . 36.1 Cg_endo -64.31 140.98 73.05 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.471 1.447 . . . . 0.0 110.642 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -121.79 146.53 46.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.155 1.782 . . . . 0.0 107.521 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.2 m -145.49 118.91 9.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.646 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.1 mt -92.76 128.84 44.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.88 110.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.11 104.5 10.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.445 1.098 . . . . 0.0 108.504 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.18 110.0 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.693 0.759 . . . . 0.0 109.122 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.72 60.21 5.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.11 -81.45 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.022 1.296 . . . . 0.0 112.3 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -36.81 20.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.056 1.342 . . . . 0.0 110.242 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -177.84 3.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.579 1.952 . . . . 0.0 108.225 -173.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.53 143.81 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -124.4 132.8 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 122.94 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -101.47 102.45 13.22 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.16 70.32 1.1 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.973 1.309 . . . . 0.0 107.67 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -78.22 128.62 34.01 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.499 -0.75 . . . . 0.0 110.103 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 t 74.87 -55.52 0.65 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.898 1.679 . . . . 0.0 110.291 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -39.93 81.68 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.603 3.161 . . . . 0.0 114.101 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 66.0 52.98 1.14 Allowed 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.999 1.719 . . . . 0.0 109.852 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 78.22 157.96 0.18 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.094 1.758 . . . . 0.0 107.709 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -71.01 104.76 3.09 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -124.86 177.28 6.1 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.267 1.027 . . . . 0.0 109.089 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -158.61 145.05 17.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -172.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 mt -135.4 120.05 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.484 1.114 . . . . 0.0 108.144 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.0 p -89.29 132.86 34.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.499 1.52 . . . . 0.0 108.805 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -146.39 157.55 43.79 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.71 0.686 . . . . 0.0 110.701 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -124.6 112.29 16.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.03 110.16 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.272 0.229 . . . . 0.0 110.676 170.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.31 37.76 2.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 0.0 111.682 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.5 t -147.14 151.7 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.787 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.12 136.95 46.93 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.742 1.617 . . . . 0.0 107.764 163.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.96 -173.5 3.48 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.964 0.905 . . . . 0.0 109.43 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 79' ' ' LYS . 8.1 t0 -110.64 124.19 51.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.408 1.483 . . . . 0.0 108.858 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -112.83 158.8 19.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.536 1.534 . . . . 0.0 109.209 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -147.02 101.55 3.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.71 154.46 36.86 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.1 0.96 . . . . 0.0 110.4 -171.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.19 72.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.83 -4.7 59.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.198 -171.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.76 2.79 0.21 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.62 -148.13 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.921 -1.737 . . . . 0.0 109.736 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 71' ' ' ASP . 63.8 tttp -79.32 128.04 32.83 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.642 1.177 . . . . 0.0 109.388 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.62 139.33 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -83.27 125.05 31.18 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.8 t -125.16 147.17 49.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.69 0.677 . . . . 0.0 110.647 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.57 136.56 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.44 141.73 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 t -161.36 -171.4 2.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.714 1.206 . . . . 0.0 108.243 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 pp -127.66 135.43 50.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.045 0.938 . . . . 0.0 111.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -108.37 91.06 3.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.909 1.683 . . . . 0.0 108.186 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.64 -70.76 0.9 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.74 0.686 . . . . 0.0 111.771 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 14.87 1.19 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -115.48 165.94 12.45 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.5 tt -117.43 115.45 25.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 m -91.16 119.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -113.27 110.97 21.25 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 167.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.52 133.34 60.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -132.12 106.43 7.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.668 0.787 . . . . 0.0 108.948 -158.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -106.23 151.31 24.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.59 2.356 . . . . 0.0 109.529 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -130.32 -62.93 0.91 Allowed 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.624 -0.673 . . . . 0.0 109.601 163.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -159.31 -87.54 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 119.41 -0.329 . . . . 0.0 111.375 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.76 -25.28 76.01 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.929 0.786 . . . . 0.0 112.016 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 -177.39 5.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.138 0.975 . . . . 0.0 109.025 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -159.38 -176.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.288 1.435 . . . . 0.0 109.56 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.4 t -144.63 153.43 41.75 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 111.129 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -83.89 155.29 22.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 162.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -142.01 65.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.125 1.77 . . . . 0.0 107.26 161.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.58 141.41 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -124.74 128.41 48.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.322 1.049 . . . . 0.0 109.589 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -141.51 141.3 33.6 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.88 103.23 13.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 166.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.71 172.88 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 154.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 48.83 -122.58 1.68 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -166.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.44 29.91 4.64 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.438 1.494 . . . . 0.0 109.813 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -128.35 126.48 40.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.278 0.631 . . . . 0.0 110.889 -167.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.72 109.42 17.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.01 120.39 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -104.37 89.5 3.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.247 1.419 . . . . 0.0 108.026 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 m -76.91 82.81 3.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.222 0.534 . . . . 0.0 109.752 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.57 101.36 6.49 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 108.54 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.39 112.64 20.26 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -110.93 148.52 32.3 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.751 1.22 . . . . 0.0 108.714 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.28 84.68 0.01 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 169.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t 126.82 -2.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 131.631 3.972 . . . . 0.0 113.217 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.63 140.67 18.37 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.856 1.207 . . . . 0.0 109.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.54 130.41 69.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 124.466 1.106 . . . . 0.0 108.141 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.55 110.87 7.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.542 0.737 . . . . 0.0 109.808 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 76.5 p -70.27 79.63 0.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -64.46 136.65 57.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 158.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 t -156.81 147.28 21.41 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.051 -1.031 . . . . 0.0 108.909 169.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.78 159.95 33.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.836 1.255 . . . . 0.0 110.751 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 9' ' ' LYS . 36.1 tt0 -121.49 130.76 53.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.565 2.346 . . . . 0.0 106.231 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -69.89 120.01 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.719 0.69 . . . . 0.0 109.623 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -94.76 -31.41 13.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.478 0.711 . . . . 0.0 111.24 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.154 0 CA-C-N 118.428 0.558 . . . . 0.0 110.712 177.682 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.07 53.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.638 2.775 . . . . 0.0 111.393 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.36 -37.04 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.346 1.459 . . . . 0.0 109.133 -159.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.3 -47.46 6.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.965 0.906 . . . . 0.0 109.448 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -48.28 114.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.664 0.785 . . . . 0.0 112.404 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.75 -172.84 21.78 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.521 0.582 . . . . 0.0 112.311 162.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -102.75 123.62 46.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.283 0.633 . . . . 0.0 109.585 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -118.87 154.78 32.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.461 1.104 . . . . 0.0 108.975 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -128.6 136.8 51.2 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.41 1.084 . . . . 0.0 108.082 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.08 140.31 58.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.87 -2.6 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.6 145.07 38.09 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.472 1.033 . . . . 0.0 108.511 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -162.53 148.33 12.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.223 1.409 . . . . 0.0 108.765 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -159.46 154.14 24.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.709 1.203 . . . . 0.0 107.816 163.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 44.06 29.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.883 1.273 . . . . 0.0 110.649 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -56.26 4.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.778 0.799 . . . . 0.0 109.844 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -54.67 43.91 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.183 2.193 . . . . 0.0 108.902 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.68 -46.2 74.03 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.254 1.022 . . . . 0.0 112.286 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -55.67 -50.17 70.98 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.4 mtt -61.89 -36.61 81.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.219 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.62 46.9 0.05 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.808 1.643 . . . . 0.0 111.653 172.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.0 p -165.02 -41.02 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.857 1.263 . . . . 0.0 109.129 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.95 -32.46 74.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 19.98 35.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.194 0.426 . . . . 0.0 112.495 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -38.85 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 162.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.92 -138.32 6.42 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -165.98 -71.35 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -46.57 4.21 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.499 1.52 . . . . 0.0 113.1 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -36.77 -35.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.579 2.352 . . . . 0.0 114.01 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -25.37 40.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.148 -0.97 . . . . 0.0 112.436 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -45.12 -35.85 3.37 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.144 0.884 . . . . 0.0 112.711 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.73 -45.41 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.38 -3.55 62.17 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.23 -1.317 . . . . 0.0 115.824 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -110.53 1.37 18.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.645 1.578 . . . . 0.0 111.06 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 ttm -120.42 -59.26 1.78 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.908 0.883 . . . . 0.0 109.503 -162.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.5 m -78.31 76.16 4.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.989 -0.444 . . . . 0.0 109.98 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 5.68 77.96 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 128.846 2.858 . . . . 0.0 113.379 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.79 122.4 11.67 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.691 1.594 . . . . 0.0 109.655 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.0 m -88.21 155.21 19.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 m -147.48 87.95 1.68 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -171.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.9 mt -72.5 119.87 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.81 103.26 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.05 146.82 23.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.52 1.528 . . . . 0.0 108.69 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.19 141.81 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.5 165.27 21.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.79 -69.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.627 2.06 . . . . 0.0 115.04 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -131.63 35.05 3.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.393 1.477 . . . . 0.0 110.015 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -147.62 162.97 38.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.81 153.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 165.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.22 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 135.14 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -110.54 105.19 14.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.118 0.967 . . . . 0.0 110.387 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -70.24 107.84 3.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 168.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -122.69 112.75 18.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.554 0.742 . . . . 0.0 110.932 -166.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -149.82 170.24 19.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 110.251 168.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -79.41 38.01 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.792 1.237 . . . . 0.0 113.621 -160.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -161.96 -43.4 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.444 -0.785 . . . . 0.0 110.064 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -135.19 130.91 36.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.23 121.57 36.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -136.5 128.91 30.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.567 0.621 . . . . 0.0 110.232 -171.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 134.13 41.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.138 1.375 . . . . 0.0 109.147 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.13 123.1 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 p -80.7 160.04 25.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.263 1.025 . . . . 0.0 109.417 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -140.83 86.22 2.03 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.333 1.453 . . . . 0.0 108.591 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -79.99 93.97 5.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 110.79 0.59 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.395 0.678 . . . . 0.0 112.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.32 28.15 8.25 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.683 1.135 . . . . 0.0 112.016 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.0 t -150.46 159.35 4.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.667 1.187 . . . . 0.0 108.165 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -108.89 140.83 41.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.107 0.963 . . . . 0.0 110.189 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -154.78 157.53 38.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 148.07 47.3 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.096 0.407 . . . . 0.0 110.73 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.66 86.97 2.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.934 2.094 . . . . 0.0 105.795 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.8 m -90.55 96.76 10.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 t -121.16 137.99 54.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.581 0.753 . . . . 0.0 110.634 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.44 49.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.059 0.944 . . . . 0.0 113.436 -168.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.66 -75.13 0.51 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -87.35 17.28 4.53 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -162.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 mtm-85 80.54 -163.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.295 1.838 . . . . 0.0 110.969 165.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.4 109.37 19.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.192 0.997 . . . . 0.0 108.553 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.07 168.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -108.3 135.36 49.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 t -105.03 87.88 2.74 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.196 1.798 . . . . 0.0 109.624 -168.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -80.52 104.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.85 135.78 41.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.4 t -152.48 -162.7 1.56 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 161.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.4 pp -147.47 154.83 41.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.308 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.13 146.61 28.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.08 0.952 . . . . 0.0 109.33 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.52 -82.42 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.105 0.859 . . . . 0.0 111.25 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.73 15.5 0.62 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.105 1.336 . . . . 0.0 111.721 171.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.34 127.49 55.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.543 1.537 . . . . 0.0 108.008 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.18 113.02 25.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.44 132.67 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.99 0.916 . . . . 0.0 109.442 -167.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -115.47 99.3 7.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.18 1.792 . . . . 0.0 106.655 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.08 103.99 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 169.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -96.36 96.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -105.37 121.96 44.98 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.612 1.565 . . . . 0.0 109.434 -171.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -104.23 -75.87 0.61 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.243 0.474 . . . . 0.0 109.852 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.31 139.04 6.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.25 -34.88 1.31 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.031 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.08 -175.37 5.3 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.072 0.949 . . . . 0.0 110.459 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -133.93 177.15 7.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.133 1.773 . . . . 0.0 108.271 165.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.4 143.0 50.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 159.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.72 125.19 50.2 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.173 0.589 . . . . 0.0 109.502 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.46 120.02 32.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.951 1.3 . . . . 0.0 107.646 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -114.4 118.33 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.558 0.617 . . . . 0.0 110.78 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HG2' HD11 ' A' ' 115' ' ' LEU . 28.9 mtm180 -102.0 136.77 41.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.187 1.395 . . . . 0.0 110.824 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -160.38 156.67 26.53 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.514 1.126 . . . . 0.0 108.081 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -134.78 130.8 36.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 166.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.15 159.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.52 -72.18 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.699 1.6 . . . . 0.0 112.61 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.28 68.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 mttt 174.02 164.77 0.2 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 129.307 3.043 . . . . 0.0 106.057 160.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.32 117.4 33.03 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.23 140.16 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.6 0.76 . . . . 0.0 110.304 -172.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 106' ' ' ARG . 1.1 mm? -126.15 118.8 25.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.182 1.393 . . . . 0.0 107.757 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.1 m -100.46 121.35 41.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 161.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -106.52 117.46 34.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -118.39 146.51 44.36 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.979 0.809 . . . . 0.0 109.384 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -127.09 170.82 11.95 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.225 1.81 . . . . 0.0 106.545 175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.83 55.99 3.04 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.472 -0.626 . . . . 0.0 111.765 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t 160.57 -63.51 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.09 2.956 . . . . 0.0 108.414 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.05 143.22 34.21 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.825 0.45 . . . . 0.0 110.362 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.45 136.93 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.4 t -151.46 133.94 15.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.011 0.524 . . . . 0.0 110.679 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 p -85.77 158.46 20.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.229 0.611 . . . . 0.0 110.14 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -134.84 142.8 46.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 153.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 137.43 38.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.152 0.887 . . . . 0.0 108.924 164.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.06 162.54 21.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.093 1.757 . . . . 0.0 109.579 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.17 153.19 51.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 165.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -67.73 121.19 15.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.42 1.488 . . . . 0.0 108.468 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -80.27 -25.28 39.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.408 0.549 . . . . 0.0 112.041 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.846 0.858 . . . . 0.0 109.183 176.258 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -74.65 60.11 0.89 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.251 1.82 . . . . 0.0 110.154 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 -53.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -164.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.16 -45.62 10.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.529 0.732 . . . . 0.0 111.437 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -47.41 120.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.325 0.65 . . . . 0.0 112.276 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.86 -163.07 12.18 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.778 1.18 . . . . 0.0 112.294 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -84.98 139.95 31.42 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.456 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CE2' HD13 ' A' ' 42' ' ' ILE . 2.1 m0 -119.93 155.18 33.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.778 1.631 . . . . 0.0 108.343 169.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 137.57 54.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.51 0.724 . . . . 0.0 109.766 163.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.17 147.07 53.88 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.22 0.608 . . . . 0.0 110.289 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.69 42.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.179 0.514 . . . . 0.0 110.935 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.89 153.96 3.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.721 2.009 . . . . 0.0 106.792 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.5 t -159.18 25.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.589 0.756 . . . . 0.0 111.72 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 122.53 16.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.586 1.085 . . . . 0.0 110.048 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 68.11 62.67 0.38 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.097 1.759 . . . . 0.0 110.996 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -83.0 -63.92 1.27 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.35 -0.844 . . . . 0.0 111.486 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.82 -34.52 62.36 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.435 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -36.61 -54.3 0.88 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.754 1.221 . . . . 0.0 110.087 165.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 2.5 t80 -53.93 -51.0 65.19 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.407 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -38.41 76.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.634 0.774 . . . . 0.0 111.421 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -73.13 63.25 0.69 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.457 1.903 . . . . 0.0 111.509 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 158.34 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 130.061 3.344 . . . . 0.0 107.368 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.19 -27.13 68.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.665 0.386 . . . . 0.0 111.588 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.43 -53.88 0.61 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.843 1.211 . . . . 0.0 110.309 169.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t 1.23 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 129.001 2.92 . . . . 0.0 115.284 -170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.1 110.47 0.27 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.992 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -65.74 173.27 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.137 0.468 . . . . 0.0 110.261 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.4 -68.99 0.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.134 1.774 . . . . 0.0 111.902 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.4 m -55.77 -54.74 40.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -65.38 -42.49 92.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.047 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.7 -7.92 48.26 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.12 -43.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 118.675 0.67 . . . . 0.0 109.804 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.36 -25.79 67.19 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.07 0.843 . . . . 0.0 112.847 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -66.95 -24.85 66.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.09 0.956 . . . . 0.0 112.239 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.0 tpt -83.97 -39.3 19.89 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.746 -0.596 . . . . 0.0 110.668 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -63.25 -57.43 10.49 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -177.25 88.61 0.25 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.162 0.985 . . . . 0.0 110.463 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -75.25 92.47 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.562 2.175 . . . . 0.0 108.833 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 m -87.94 163.18 16.47 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -142.78 152.33 42.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -130.28 128.47 64.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.454 HD13 ' CE2' ' A' ' 8' ' ' TRP . 1.7 mp -111.8 125.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 165.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 128.21 54.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 169.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.31 75.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -58.81 153.19 17.51 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.5 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -39.56 -52.0 3.05 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.365 0.983 . . . . 0.0 114.257 -167.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -112.0 0.62 16.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.523 1.529 . . . . 0.0 112.008 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -147.6 -171.48 3.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.809 1.186 . . . . 0.0 109.819 -161.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.63 130.69 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 166.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.02 150.25 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 165.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -137.06 118.62 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -108.15 131.08 55.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.79 0.836 . . . . 0.0 109.753 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.74 27.3 4.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.213 1.405 . . . . 0.0 111.265 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -49.83 97.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.843 1.657 . . . . 0.0 114.166 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 59' ' ' ASN . 3.7 t -138.53 126.9 23.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 128.212 2.605 . . . . 0.0 104.453 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t 55.45 -171.68 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.541 1.937 . . . . 0.0 114.729 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -83.66 18.98 1.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.395 1.478 . . . . 0.0 112.776 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -159.3 115.42 2.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 55' ' ' SER . 2.0 t-20 -165.31 -176.73 4.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.271 0.487 . . . . 0.0 110.8 -169.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 p -142.84 171.1 14.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.36 1.464 . . . . 0.0 108.681 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.7 150.22 38.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.4 mt -134.47 164.44 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.806 1.642 . . . . 0.0 106.596 -170.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.8 p -139.19 161.95 36.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.76 167.53 22.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.335 0.654 . . . . 0.0 110.091 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -109.31 131.14 55.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 166.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 84.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 165.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.56 42.33 0.14 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.628 1.585 . . . . 0.0 111.725 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -153.46 152.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.195 0.998 . . . . 0.0 109.066 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -111.95 140.92 46.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.213 1.005 . . . . 0.0 109.891 163.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -161.07 158.32 27.56 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.16 134.43 50.51 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -118.57 129.91 55.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -124.23 98.54 5.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 t -122.94 145.61 48.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.949 0.795 . . . . 0.0 111.012 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.44 48.85 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.399 1.079 . . . . 0.0 111.003 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.0 -83.47 0.05 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.918 1.687 . . . . 0.0 106.929 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -75.77 16.24 0.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 76.25 -147.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.03 1.332 . . . . 0.0 109.505 166.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -101.04 136.81 40.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 m -151.54 175.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.254 1.822 . . . . 0.0 107.257 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -103.24 132.08 49.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 155.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -92.82 109.54 20.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 mt -104.38 103.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.8 139.23 47.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 122.25 0.22 . . . . 0.0 110.759 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -151.87 156.29 39.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.546 1.139 . . . . 0.0 108.362 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -142.45 145.08 33.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.575 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 86' ' ' LEU . 4.5 p-10 -164.45 -146.76 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.874 1.67 . . . . 0.0 106.708 175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.78 48.61 2.99 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.331 0.969 . . . . 0.0 110.864 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.93 27.6 0.2 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.234 0.921 . . . . 0.0 111.663 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 74.76 163.85 0.27 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.647 1.579 . . . . 0.0 111.475 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -79.18 101.53 8.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.86 106.34 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -93.88 95.51 9.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 162.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.77 122.28 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 102' ' ' THR . 6.0 tp60 -117.16 99.44 7.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -168.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -119.58 115.11 23.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.513 1.125 . . . . 0.0 111.448 -161.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -96.51 -66.04 0.93 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.333 0.515 . . . . 0.0 109.847 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -169.03 -78.31 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 117.751 0.251 . . . . 0.0 111.649 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.58 -30.19 74.66 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 173.45 11.59 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.25 142.27 30.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.199 1.8 . . . . 0.0 106.277 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 95' ' ' GLN . 9.8 t -108.86 148.39 30.68 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.85 0.86 . . . . 0.0 109.565 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 p -104.0 112.75 25.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mt -95.47 92.07 6.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 164.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 126.05 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.16 137.38 48.97 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.754 1.222 . . . . 0.0 110.627 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -161.81 151.52 16.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.957 1.303 . . . . 0.0 107.716 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -107.14 120.53 42.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.766 0.826 . . . . 0.0 109.261 170.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.21 -171.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 163.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.15 -111.15 0.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.02 21.02 3.55 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 126.046 1.784 . . . . 0.0 109.792 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -145.02 147.31 32.48 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.345 1.072 . . . . 0.0 111.112 -166.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tt -102.51 106.73 17.5 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.74 1.216 . . . . 0.0 108.116 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.82 96.17 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.16 106.73 17.48 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -96.42 134.62 39.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 36.0 tp -131.43 94.1 3.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -117.79 125.04 49.86 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.429 0.692 . . . . 0.0 110.816 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -103.38 -49.38 3.73 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.235 1.014 . . . . 0.0 110.491 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.22 120.57 2.2 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 106.939 -2.465 . . . . 0.0 106.939 -166.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m 65.65 -68.54 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.962 1.305 . . . . 0.0 109.317 -165.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.96 134.27 45.86 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -146.83 138.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 106.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.73 136.98 31.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.624 0.77 . . . . 0.0 110.125 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 149.42 22.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 164.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -140.42 73.39 1.42 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 161.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.22 123.2 14.49 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.625 -0.672 . . . . 0.0 109.522 171.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -109.63 157.11 19.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.044 1.738 . . . . 0.0 109.38 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.38 118.82 24.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -85.4 104.38 15.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 110.536 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -77.35 -20.2 55.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.479 1.036 . . . . 0.0 111.516 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 124.305 1.042 . . . . 0.0 110.124 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.237 0.412 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 64.01 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.872 2.469 . . . . 0.0 110.398 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.13 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.282 1.433 . . . . 0.0 107.147 -155.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.99 -46.51 8.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.891 1.276 . . . . 0.0 110.733 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.4 t -48.99 97.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.893 1.677 . . . . 0.0 112.526 -172.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.31 -161.74 27.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.131 0.872 . . . . 0.0 111.318 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -96.89 128.06 43.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.66 0.784 . . . . 0.0 109.99 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.538 ' CG ' HD13 ' A' ' 42' ' ' ILE . 19.5 m0 -98.83 132.74 43.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -110.2 125.69 53.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.897 0.771 . . . . 0.0 109.324 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.51 148.54 48.14 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.754 0.422 . . . . 0.0 110.131 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.251 4.6 p -137.8 -68.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.011 171.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -103.93 123.45 47.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.052 0.842 . . . . 0.0 110.313 -169.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -167.82 148.76 5.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.088 0.555 . . . . 0.0 109.937 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -163.91 174.25 11.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.814 1.245 . . . . 0.0 109.165 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.32 38.1 4.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.744 1.618 . . . . 0.0 111.642 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.75 -40.46 5.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.011 0.925 . . . . 0.0 108.601 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -23.97 -77.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.212 1.805 . . . . 0.0 111.88 147.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 9.0 t70 -50.55 -44.49 56.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.297 1.439 . . . . 0.0 112.167 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -55.5 -55.53 30.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.318 0.647 . . . . 0.0 111.107 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 tpt -52.92 -47.02 68.29 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.809 0.844 . . . . 0.0 109.44 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 ttpm? -67.86 62.0 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.627 1.571 . . . . 0.0 110.444 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m 160.65 -57.32 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 129.564 3.145 . . . . 0.0 106.833 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.463 HD13 ' NE2' ' A' ' 119' ' ' HIS . 14.2 tp -82.17 -26.14 33.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -167.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.83 91.29 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.055 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -121.76 -58.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.799 1.239 . . . . 0.0 108.844 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.41 -162.54 7.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.3 t80 118.21 130.65 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.531 3.132 . . . . 0.0 107.328 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 62.0 8.2 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 -164.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 p -95.6 -62.49 1.29 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.411 1.484 . . . . 0.0 109.65 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -53.62 -52.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.642 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -60.39 -23.74 64.57 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.383 1.473 . . . . 0.0 113.179 -169.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.02 -52.46 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.69 26.96 1.93 Allowed Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.983 -0.898 . . . . 0.0 114.471 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -141.23 21.51 2.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.468 1.507 . . . . 0.0 109.562 164.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.3 ttm -143.24 -54.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -166.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -92.83 176.4 6.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 156.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.55 82.87 16.24 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.07 156.29 67.0 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.089 1.859 . . . . 0.0 110.36 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -110.8 158.34 18.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.736 0.814 . . . . 0.0 108.935 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 m -138.1 126.87 23.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 42' ' ' ILE . 1.9 mm -85.52 126.74 40.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.538 HD13 ' CG ' ' A' ' 8' ' ' TRP . 3.9 mp -124.03 112.85 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.18 134.74 54.59 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.89 0.876 . . . . 0.0 109.945 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.13 79.69 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.856 0.836 . . . . 0.0 109.407 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -54.3 154.76 4.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.605 167.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.54 -75.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.465 2.459 . . . . 0.0 115.956 -168.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.79 10.34 19.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.826 1.65 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -168.27 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.966 2.106 . . . . 0.0 107.644 -151.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.67 147.23 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 161.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -122.14 136.15 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 123.387 0.675 . . . . 0.0 109.253 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mt -112.57 138.57 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.267 1.427 . . . . 0.0 108.051 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -135.48 117.95 15.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.473 2.309 . . . . 0.0 108.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -91.07 100.96 13.72 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.842 1.201 . . . . 0.0 112.596 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 72.12 10.2 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.581 -1.325 . . . . 0.0 108.671 169.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -88.65 -178.56 5.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 153.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -103.41 37.67 1.95 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.046 0.938 . . . . 0.0 111.553 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.07 82.63 0.86 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -102.53 102.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 156.26 46.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.674 1.99 . . . . 0.0 106.316 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -152.77 144.6 23.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 129.88 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 p -99.31 127.42 45.32 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.023 2.129 . . . . 0.0 109.214 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.09 156.62 46.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.128 0.876 . . . . 0.0 111.901 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.45 115.74 31.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.92 71.19 0.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.473 0.709 . . . . 0.0 111.363 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.26 38.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.635 1.112 . . . . 0.0 111.847 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 t -152.05 154.8 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.566 1.183 . . . . 0.0 109.199 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -106.83 123.57 48.35 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.739 2.016 . . . . 0.0 108.616 166.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -165.36 164.74 19.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.097 0.959 . . . . 0.0 109.924 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.77 144.13 55.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.916 0.78 . . . . 0.0 111.56 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -132.64 72.11 1.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.405 2.282 . . . . 0.0 107.166 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.8 m -71.25 108.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.437 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.1 t -140.57 144.67 35.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.138 0.575 . . . . 0.0 110.679 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.5 57.59 2.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.045 1.338 . . . . 0.0 111.948 -167.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.48 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.755 1.622 . . . . 0.0 108.512 -170.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -73.79 -15.94 61.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.71 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 90.9 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.587 2.755 . . . . 0.0 109.334 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -78.86 59.11 2.51 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.626 -0.672 . . . . 0.0 109.274 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 81' ' ' LYS . 7.7 p -77.83 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.399 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 80' ' ' VAL . 32.1 ttmt -111.17 126.24 54.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.715 0.689 . . . . 0.0 109.655 170.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 p -78.26 108.49 11.63 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -102.14 110.22 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 155.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.06 145.37 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.9 t -155.38 -165.76 2.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.2 1.8 . . . . 0.0 107.112 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -138.82 145.12 39.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.2 0.27 46.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -166.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.604 ' H ' HD12 ' A' ' 86' ' ' LEU . . . 122.92 -39.18 2.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -160.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.92 -63.11 0.09 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.7 1.143 . . . . 0.0 111.126 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 142.54 38.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -169.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.1 tt -79.85 114.7 18.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.88 105.08 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.62 1.168 . . . . 0.0 108.241 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.34 107.81 19.75 Favored 'General case' 0 CA--C 1.524 -0.054 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.43 101.93 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 167.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.403 ' CG ' HG21 ' A' ' 80' ' ' VAL . 25.2 tt0 -89.92 102.42 15.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.752 1.221 . . . . 0.0 107.782 -166.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -116.85 127.34 54.2 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.126 0.57 . . . . 0.0 110.987 -165.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -97.72 -107.15 0.18 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.48 136.14 29.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.679 1.592 . . . . 0.0 108.642 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.8 -45.68 3.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.65 177.41 8.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.585 0.692 . . . . 0.0 111.552 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.01 176.79 11.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.532 1.933 . . . . 0.0 108.69 -172.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -132.7 138.42 47.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.954 1.301 . . . . 0.0 109.868 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.6 p -76.22 136.64 39.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 168.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 115' ' ' LEU . 29.4 mt -133.69 76.87 1.69 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 164.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.31 120.97 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.502 ' HG3' HD13 ' A' ' 115' ' ' LEU . 1.5 mpt_? -116.0 133.15 56.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.1 1.76 . . . . 0.0 109.868 -174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.33 146.66 29.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.704 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -124.55 107.28 10.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.288 1.435 . . . . 0.0 108.926 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.99 179.95 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 168.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.36 -98.32 0.08 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 0.0 109.664 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.16 32.79 0.5 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.458 1.028 . . . . 0.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -150.73 159.13 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.25 122.31 47.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.85 118.86 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.556 HD11 HD23 ' A' ' 104' ' ' LEU . 4.0 tp -113.31 116.4 29.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 m -96.19 124.35 40.16 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.24 93.28 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.68 1.192 . . . . 0.0 108.276 -171.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -143.47 153.42 42.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 0.0 111.354 -165.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -160.69 138.6 9.64 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 122.738 0.415 . . . . 0.0 110.96 166.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 47.95 -119.01 4.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.857 0.741 . . . . 0.0 111.428 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -73.72 -30.96 63.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.019 0.528 . . . . 0.0 112.193 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 126.3 42.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.365 0.53 . . . . 0.0 109.861 -166.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.69 144.17 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.025 0 C-N-CA 125.602 1.561 . . . . 0.0 109.168 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.25 151.42 32.96 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.6 -1.313 . . . . 0.0 110.826 172.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.5 p -114.89 142.44 46.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.937 1.695 . . . . 0.0 107.384 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -139.73 82.21 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.83 142.16 31.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.774 0.797 . . . . 0.0 109.707 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -119.88 169.0 10.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.711 1.604 . . . . 0.0 108.509 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -116.45 117.45 29.94 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 163.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -75.69 108.67 8.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -78.95 -31.51 45.12 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 118.352 0.524 . . . . 0.0 111.672 -170.767 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.485 0.179 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.68 59.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.758 3.223 . . . . 0.0 111.959 -168.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.98 -50.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.284 1.834 . . . . 0.0 107.26 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.86 -40.49 87.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.813 1.245 . . . . 0.0 110.639 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.25 116.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.123 1.369 . . . . 0.0 111.259 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -129.56 4.28 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.834 1.207 . . . . 0.0 111.199 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 m -148.67 121.9 8.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.77 -0.841 . . . . 0.0 109.837 -171.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -115.15 130.09 56.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.761 1.624 . . . . 0.0 110.484 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -114.0 141.8 46.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.883 0.873 . . . . 0.0 109.483 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.8 144.01 29.13 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 123.399 0.437 . . . . 0.0 110.199 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.6 p -125.83 -73.99 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.513 0.725 . . . . 0.0 109.726 168.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' H ' HG13 ' A' ' 11' ' ' VAL . 5.8 m-20 -108.92 149.58 28.97 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.368 0.985 . . . . 0.0 110.102 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 t -170.89 -175.58 1.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.054 1.742 . . . . 0.0 107.805 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 pttt 177.14 154.16 0.25 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.366 2.666 . . . . 0.0 107.336 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.04 34.08 21.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.675 0.79 . . . . 0.0 109.743 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -95.76 -50.68 4.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -21.45 -74.98 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.719 2.408 . . . . 0.0 113.433 148.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.14 -57.55 8.44 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.988 0.813 . . . . 0.0 111.03 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.59 -48.16 19.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.331 0.586 . . . . 0.0 112.178 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -28.06 69.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -74.97 47.07 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.52 1.928 . . . . 0.0 110.514 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.1 t -174.89 -51.86 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.939 1.695 . . . . 0.0 106.887 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.58 -35.71 80.38 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.974 0.51 . . . . 0.0 111.073 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.32 -45.71 1.28 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 76' ' ' ASP . 7.3 p -37.61 -26.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.508 2.323 . . . . 0.0 114.327 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -27.75 -68.64 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.807 1.67 . . . . 0.0 112.96 159.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.58 155.83 38.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.959 0.38 . . . . 0.0 110.111 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 71.89 -52.07 0.69 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.969 1.708 . . . . 0.0 113.786 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.6 m -105.25 -67.37 0.92 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.424 1.089 . . . . 0.0 110.647 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -68.38 -17.42 64.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.282 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -41.22 -49.7 3.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.651 0.78 . . . . 0.0 111.972 163.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -94.33 -38.93 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.09 -40.79 59.56 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.075 0.845 . . . . 0.0 113.165 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -79.31 -12.42 59.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.273 1.037 . . . . 0.0 112.381 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -61.5 1.44 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.253 3.8 t -83.74 79.29 9.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.627 0.727 . . . . 0.0 109.656 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt 12.85 76.44 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 128.766 2.826 . . . . 0.0 113.91 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.25 150.17 76.38 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.998 2.465 . . . . 0.0 113.229 -161.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 m -102.53 159.1 15.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.055 1.742 . . . . 0.0 108.75 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 119.35 12.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 42' ' ' ILE . 87.0 mt -87.49 126.71 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 41' ' ' ILE . 1.5 mp -119.92 114.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.06 140.33 53.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.337 0.517 . . . . 0.0 110.302 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 79.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -62.42 74.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.597 1.559 . . . . 0.0 112.11 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.34 -92.73 0.06 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.486 1.041 . . . . 0.0 111.749 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.37 -30.09 19.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.409 1.083 . . . . 0.0 110.745 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.05 -175.54 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.493 2.317 . . . . 0.0 109.161 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.13 138.04 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -114.94 131.48 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.509 1.123 . . . . 0.0 108.732 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -120.68 120.45 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.718 2.407 . . . . 0.0 106.346 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -128.88 99.92 5.49 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 t -82.41 43.21 0.8 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.778 -172.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 124.03 18.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.959 1.704 . . . . 0.0 112.669 -175.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -123.8 -166.54 1.5 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 162.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -46.9 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.941 0.896 . . . . 0.0 111.459 -166.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.1 p90 38.66 34.29 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.081 2.152 . . . . 0.0 114.464 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -156.26 162.87 40.09 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.663 0.665 . . . . 0.0 110.634 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 96.71 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 129.547 3.139 . . . . 0.0 110.491 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 p -110.43 174.54 5.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.481 1.512 . . . . 0.0 112.385 -156.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.98 122.17 37.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.593 2.357 . . . . 0.0 106.583 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -129.38 136.73 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 p -141.48 122.23 14.36 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 119.183 0.901 . . . . 0.0 110.316 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -147.54 165.86 29.05 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.095 0.861 . . . . 0.0 111.915 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -101.1 138.34 38.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 166.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -75.0 59.06 0.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.113 0.565 . . . . 0.0 110.506 175.409 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 157.31 60.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -166.85 172.55 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.855 0.828 . . . . 0.0 109.041 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -131.35 152.07 50.94 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.859 0.864 . . . . 0.0 110.793 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.92 160.17 14.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 109.478 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.74 129.03 36.42 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -123.93 123.71 41.02 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -116.1 95.53 5.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 t -113.01 140.63 47.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.065 0.946 . . . . 0.0 109.899 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.71 48.54 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.481 1.112 . . . . 0.0 112.217 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 25' ' ' VAL . 34.6 p-10 -163.42 -62.45 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.729 1.612 . . . . 0.0 109.392 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -87.12 -3.64 59.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.75 0.82 . . . . 0.0 111.631 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 83.33 -157.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.837 1.655 . . . . 0.0 109.696 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -74.62 116.34 15.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 168.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.63 154.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -81.29 138.18 35.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 150.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -100.6 119.74 39.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 161.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tt -121.02 123.36 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.02 144.68 32.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.562 0.345 . . . . 0.0 110.944 -167.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -157.54 144.15 17.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.55 1.14 . . . . 0.0 109.317 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -85.15 109.11 18.05 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 90' ' ' LYS . 26.7 p-10 -78.58 29.2 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.325 0.65 . . . . 0.0 112.625 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.4 -36.47 1.56 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.597 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 -24.94 5.91 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.097 1.449 . . . . 0.0 113.087 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -163.3 159.97 23.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.733 1.267 . . . . 0.0 109.855 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 100.3 8.03 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.16 118.33 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.581 ' HB3' HD12 ' A' ' 104' ' ' LEU . 3.4 t-160 -114.97 108.38 16.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.41 132.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -129.68 99.67 5.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -161.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HZ3' ' CD ' ' A' ' 101' ' ' GLU . 39.1 tttp -113.89 110.63 20.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.941 0.896 . . . . 0.0 111.648 -159.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -96.56 -27.31 14.9 Favored 'General case' 0 C--O 1.228 -0.048 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -155.68 -143.79 0.13 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.683 0.674 . . . . 0.0 109.897 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -42.74 -41.18 4.27 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.205 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -97.03 175.35 6.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 112.283 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.481 ' CD ' ' HZ3' ' A' ' 96' ' ' LYS . 2.3 pm0 -143.71 167.11 23.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.988 2.115 . . . . 0.0 108.301 173.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -98.59 148.14 24.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 148.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -119.31 137.11 53.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -150.94 138.13 19.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.207 0.458 . . . . 0.0 111.138 -175.002 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.7 m -130.69 117.3 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.663 1.185 . . . . 0.0 110.203 -164.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.424 ' NH1' HD13 ' A' ' 104' ' ' LEU . 8.5 mpt_? -102.77 139.64 38.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.873 0.76 . . . . 0.0 109.573 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.71 155.63 36.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 153.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 19.8 ttt -91.83 119.36 31.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.857 0.863 . . . . 0.0 108.994 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.46 170.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 166.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.73 -85.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.627 1.171 . . . . 0.0 109.616 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.3 26.19 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.04 1.305 . . . . 0.0 110.467 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.48 154.54 47.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.89 117.42 16.71 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.95 120.77 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 168.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.93 104.81 9.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.8 m -94.25 131.93 39.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.93 130.37 53.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 t -141.19 131.99 25.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.546 0.689 . . . . 0.0 110.211 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -119.51 165.37 14.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.169 2.587 . . . . 0.0 105.838 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.78 65.09 1.47 Allowed Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.092 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t 156.45 -59.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 130.105 3.362 . . . . 0.0 108.432 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.15 137.24 35.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.197 0.599 . . . . 0.0 109.931 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.12 134.02 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 127.53 7.32 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.197 0.908 . . . . 0.0 112.98 -176.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.6 p -78.48 153.57 31.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.958 0.903 . . . . 0.0 109.072 168.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.69 140.13 19.64 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.2 p -133.36 160.34 37.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.945 0.793 . . . . 0.0 109.363 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -145.37 144.99 31.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.576 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -128.39 134.2 48.78 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -79.68 111.81 16.34 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.26 -39.08 82.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.956 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.71 -45.06 6.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.386 2.274 . . . . 0.0 111.731 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.87 -21.6 8.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.581 1.952 . . . . 0.0 112.511 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -120.22 17.65 12.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.915 1.286 . . . . 0.0 111.314 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -99.56 94.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.539 0.736 . . . . 0.0 110.954 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.66 -165.92 23.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.824 0.726 . . . . 0.0 113.486 159.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -83.64 143.05 30.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.503 0.721 . . . . 0.0 110.125 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -133.26 141.41 48.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.963 1.305 . . . . 0.0 108.513 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 133.01 36.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 165.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.11 144.56 56.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 166.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 -57.69 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.492 0.717 . . . . 0.0 111.483 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -78.98 160.08 27.37 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.815 1.189 . . . . 0.0 109.605 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -170.42 56.72 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.779 1.632 . . . . 0.0 108.302 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.38 127.18 35.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 66.97 27.92 8.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.995 1.718 . . . . 0.0 109.876 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.6 -51.34 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 120.033 -1.667 . . . . 0.0 108.089 -171.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -17.9 -77.39 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.835 2.054 . . . . 0.0 112.485 144.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -37.12 -57.45 0.85 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 111.12 175.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' SG ' ' A' ' 124' ' ' CYS . 0.8 OUTLIER -50.9 -50.18 57.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -166.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.72 81.43 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.528 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -77.08 49.52 0.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.535 1.934 . . . . 0.0 109.185 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -178.98 -55.99 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.368 1.867 . . . . 0.0 106.955 -168.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.69 -41.9 95.7 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.92 -44.16 0.87 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.5 42.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.979 1.312 . . . . 0.0 111.327 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.3 146.06 17.97 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.871 1.224 . . . . 0.0 112.406 -166.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.1 162.2 1.98 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.014 1.726 . . . . 0.0 107.175 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -18.73 65.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -47.9 -40.01 20.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 112.432 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -31.53 63.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.759 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -62.42 -23.94 67.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.117 0.871 . . . . 0.0 111.729 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.3 t -91.1 -47.94 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.79 -58.75 3.49 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.137 1.351 . . . . 0.0 112.884 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -55.66 -41.94 74.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.774 0.787 . . . . 0.0 110.913 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.359 1.064 . . . . 0.0 112.205 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -86.13 -132.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -145.61 76.53 12.91 Favored Pre-proline 0 C--O 1.234 0.274 0 O-C-N 121.086 -1.009 . . . . 0.0 109.085 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 82.7 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.344 2.696 . . . . 0.0 108.761 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -83.03 148.21 27.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.299 1.84 . . . . 0.0 107.902 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m -140.58 122.31 15.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.183 -0.323 . . . . 0.0 110.282 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -77.77 127.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mt -124.29 117.76 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.29 129.6 49.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.79 96.94 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -78.18 69.82 4.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.37 -89.25 0.05 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.759 1.171 . . . . 0.0 111.531 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -24.67 16.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.52 . . . . 0.0 110.747 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.48 9.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.165 1.786 . . . . 0.0 106.866 -172.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.98 141.7 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.96 133.31 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.762 0.825 . . . . 0.0 108.899 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.9 tt -110.35 132.32 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.754 1.222 . . . . 0.0 107.713 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -133.95 95.96 3.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 107.328 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.71 138.48 31.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -132.77 116.38 16.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.841 1.656 . . . . 0.0 110.903 -162.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -161.56 151.27 16.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.784 2.034 . . . . 0.0 106.314 161.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -56.73 -49.38 75.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.416 0.687 . . . . 0.0 109.502 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -48.87 -38.16 21.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.704 1.201 . . . . 0.0 112.755 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.59 136.27 0.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.922 0.889 . . . . 0.0 109.848 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -141.87 151.07 42.35 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.654 1.582 . . . . 0.0 108.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p -156.34 148.18 22.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.46 0.704 . . . . 0.0 109.351 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -128.04 117.79 22.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.071 2.149 . . . . 0.0 108.284 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.96 143.3 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.692 0.797 . . . . 0.0 109.287 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 p -108.19 150.06 27.74 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.472 1.509 . . . . 0.0 110.814 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 84' ' ' VAL . 26.5 p90 -159.61 175.58 13.05 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.909 1.283 . . . . 0.0 108.91 -174.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -134.79 143.64 47.2 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.999 0.92 . . . . 0.0 108.943 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 53.05 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.302 1.041 . . . . 0.0 112.027 -175.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.12 40.13 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.24 151.18 12.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.1 138.88 35.57 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.926 1.291 . . . . 0.0 109.469 166.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -142.19 158.35 43.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.381 1.472 . . . . 0.0 108.177 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.27 134.55 36.64 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -134.37 151.67 51.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -139.82 166.87 23.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.955 -0.466 . . . . 0.0 109.833 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 t -136.85 -177.27 4.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.162 0.985 . . . . 0.0 109.371 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.78 -25.02 62.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -156.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -95.22 15.02 20.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.233 1.413 . . . . 0.0 111.633 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t0 49.76 41.02 21.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.359 2.264 . . . . 0.0 112.969 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -66.76 87.44 0.13 Allowed 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -77.87 92.86 4.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.607 1.563 . . . . 0.0 109.464 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 97' ' ' TRP . 6.1 m -104.41 171.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.778 1.231 . . . . 0.0 110.079 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.64 135.85 41.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 m -124.57 123.73 40.72 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 107.857 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -117.93 126.21 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.471 HG21 ' CD2' ' A' ' 64' ' ' PHE . 39.1 t -110.24 145.32 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.6 m -148.7 164.32 34.69 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -113.39 113.44 25.21 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.83 107.98 20.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.833 1.253 . . . . 0.0 108.012 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.35 -80.94 0.06 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.318 0.961 . . . . 0.0 112.106 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.67 4.18 3.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.495 1.521 . . . . 0.0 112.344 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -105.17 120.99 42.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 107.203 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.7 tt -78.87 106.17 10.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 169.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 m -95.32 111.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -99.4 106.76 18.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 83' ' ' ILE . 9.9 p -100.65 133.73 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.9 112.31 12.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -162.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -127.98 125.82 40.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.375 1.87 . . . . 0.0 108.688 -157.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.47 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.7 p90 -108.86 -81.55 0.57 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -162.19 150.76 15.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.96 -44.47 1.55 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.419 0.533 . . . . 0.0 112.044 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.58 -164.91 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.554 1.542 . . . . 0.0 109.196 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.77 -170.36 3.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.613 1.565 . . . . 0.0 109.334 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 t -136.14 150.72 49.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.623 1.569 . . . . 0.0 107.991 162.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.4 p -98.56 138.47 35.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 163.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.1 mt -131.64 96.83 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.401 1.88 . . . . 0.0 105.939 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.71 131.83 42.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.07 124.84 53.09 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.199 1.4 . . . . 0.0 108.27 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -141.91 122.42 14.13 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -106.74 115.89 30.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.09 -173.3 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 156.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 52.08 -108.91 0.42 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.48 28.76 2.05 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.859 1.695 . . . . 0.0 109.615 171.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -137.45 122.09 18.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.674 0.737 . . . . 0.0 110.128 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.24 92.73 5.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.8 mt -73.1 138.53 21.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.57 105.09 4.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.098 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.0 m -95.33 136.0 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.81 119.9 38.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -126.28 125.2 41.95 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.942 0.337 . . . . 0.0 110.309 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -129.5 165.01 22.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.54 1.536 . . . . 0.0 107.095 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.33 126.07 18.37 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 168.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.99 -58.84 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 112.146 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.78 133.15 34.34 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.694 -0.629 . . . . 0.0 111.862 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.21 130.3 69.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.773 1.629 . . . . 0.0 107.26 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' TYR . 4.4 m -146.99 158.76 44.02 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 121.379 -0.826 . . . . 0.0 109.174 -170.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.7 p -134.35 151.81 51.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.101 0.409 . . . . 0.0 110.738 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -145.2 167.26 23.21 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 156.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 p -136.47 146.43 46.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.22 129.68 52.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.551 1.54 . . . . 0.0 108.779 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -106.18 136.79 45.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.907 1.283 . . . . 0.0 108.422 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -65.25 139.0 58.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.358 0.263 . . . . 0.0 110.728 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.81 -6.0 7.99 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 111.722 159.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.144 0 C-N-CA 124.616 1.167 . . . . 0.0 110.922 172.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.236 0.378 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.41 67.9 0.02 OUTLIER 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.53 2.332 . . . . 0.0 111.091 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.37 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 107.09 -163.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -86.71 -45.67 10.75 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.914 1.286 . . . . 0.0 110.69 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -46.11 108.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.385 1.474 . . . . 0.0 111.645 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.83 -166.46 13.02 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.416 1.008 . . . . 0.0 112.37 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -84.2 138.84 32.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.131 0.973 . . . . 0.0 111.324 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.6 141.17 43.27 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.474 0.709 . . . . 0.0 110.314 167.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -107.87 153.84 22.43 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.463 1.105 . . . . 0.0 109.867 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.96 148.64 16.87 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 167.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.41 -54.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.867 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.49 147.24 39.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.631 1.105 . . . . 0.0 109.01 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -160.47 153.86 22.06 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.234 -0.916 . . . . 0.0 110.73 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -158.13 155.88 29.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.499 1.12 . . . . 0.0 108.541 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 m120 63.71 -10.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.36 -41.52 9.08 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.264 1.025 . . . . 0.0 110.869 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -71.76 -24.78 61.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.19 -46.44 56.26 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 165.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.88 -51.36 61.4 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.972 0.909 . . . . 0.0 112.327 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -57.68 -42.65 84.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.294 0.638 . . . . 0.0 109.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.94 57.71 1.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.448 1.499 . . . . 0.0 109.22 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t 179.63 -52.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.712 2.405 . . . . 0.0 107.028 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.27 -27.6 68.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.679 0.392 . . . . 0.0 111.575 172.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 -47.14 3.69 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 26' ' ' GLY . 8.6 p 0.28 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 130.324 3.45 . . . . 0.0 116.074 167.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' H ' HG13 ' A' ' 25' ' ' VAL . . . -156.05 58.24 0.38 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -31.56 -61.42 0.22 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 128.003 2.521 . . . . 0.0 111.484 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.21 57.94 1.29 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.318 1.047 . . . . 0.0 108.202 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -149.67 -52.54 0.15 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.859 -0.526 . . . . 0.0 109.802 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -59.23 -22.99 61.93 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.453 -1.261 . . . . 0.0 110.863 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -41.57 -35.52 0.75 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.218 1.007 . . . . 0.0 112.696 169.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.82 -67.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.05 45.21 2.23 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.443 1.02 . . . . 0.0 113.817 -173.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -154.03 -34.61 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.958 1.703 . . . . 0.0 110.886 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.2 ttm -92.22 -21.12 20.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.89 1.676 . . . . 0.0 110.307 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -65.71 -165.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.409 0.623 . . . . 0.0 109.995 159.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -107.37 78.97 0.7 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.597 1.159 . . . . 0.0 109.411 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.65 145.11 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.113 1.875 . . . . 0.0 110.344 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 m -104.26 126.18 51.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.505 1.122 . . . . 0.0 108.039 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -109.19 99.42 8.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.34 121.22 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.16 128.6 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -107.1 141.56 38.15 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.04 71.39 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.151 0.98 . . . . 0.0 108.695 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -55.05 139.69 40.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.882 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.46 -75.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.9 2.191 . . . . 0.0 116.457 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -111.18 18.45 19.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.519 1.928 . . . . 0.0 111.03 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.26 -162.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.954 1.301 . . . . 0.0 108.253 -155.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.89 142.74 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.8 tt -124.98 117.68 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.67 135.79 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -115.3 107.55 15.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.944 2.098 . . . . 0.0 105.746 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -88.25 102.64 15.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.59 138.48 43.74 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.034 0.834 . . . . 0.0 111.008 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -169.81 54.86 0.04 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.196 1.398 . . . . 0.0 108.748 -173.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 m 65.71 -75.13 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.653 1.581 . . . . 0.0 111.637 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.33 -51.79 4.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.062 0.945 . . . . 0.0 109.2 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -77.07 76.9 3.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.58 59.84 0.61 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.575 1.15 . . . . 0.0 110.537 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.14 163.62 18.64 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.936 1.294 . . . . 0.0 111.123 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -123.58 156.62 35.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.908 0.883 . . . . 0.0 110.067 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mp -133.53 101.16 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.6 122.6 36.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.811 2.044 . . . . 0.0 108.926 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.58 168.81 22.49 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.097 0.862 . . . . 0.0 112.61 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.58 108.79 13.53 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.539 1.535 . . . . 0.0 107.812 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 96.78 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 122.051 -0.406 . . . . 0.0 110.017 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.14 33.3 0.2 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.365 1.936 . . . . 0.0 111.832 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.72 149.39 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.835 1.317 . . . . 0.0 109.32 -171.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.85 121.95 44.74 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.268 1.427 . . . . 0.0 107.612 161.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.37 155.02 23.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.821 0.737 . . . . 0.0 111.366 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.88 120.11 13.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.203 0.601 . . . . 0.0 110.237 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.76 95.43 5.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 m -103.77 102.6 12.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 t -131.28 146.79 52.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.013 0.925 . . . . 0.0 109.405 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.2 43.92 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.588 1.155 . . . . 0.0 112.066 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -149.98 -68.39 0.2 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.771 1.628 . . . . 0.0 108.264 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.99 -12.79 61.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.242 0.928 . . . . 0.0 111.525 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.12 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.256 2.222 . . . . 0.0 108.566 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -80.91 112.37 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 166.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.52 138.21 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -80.41 109.54 15.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.9 p -74.57 149.64 40.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 tt -137.36 107.75 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 163.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.18 139.92 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.184 -170.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -156.99 176.96 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.731 2.013 . . . . 0.0 107.206 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -132.17 122.08 24.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 159.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 176.11 167.51 0.43 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.109 2.564 . . . . 0.0 105.32 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.44 -64.56 1.06 Allowed Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.49 104.93 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 91.83 162.3 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.706 2.402 . . . . 0.0 110.05 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 121.09 26.28 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.24 86.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.992 1.717 . . . . 0.0 108.484 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -81.57 81.13 7.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.5 149.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -153.34 106.17 2.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -158.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -116.13 100.98 8.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.062 2.145 . . . . 0.0 108.121 -160.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -90.61 -62.36 1.47 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.592 1.087 . . . . 0.0 110.48 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -170.13 -85.27 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.157 0.435 . . . . 0.0 111.465 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.82 -20.81 79.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.44 170.02 16.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -133.22 175.48 9.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.945 1.698 . . . . 0.0 107.429 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.3 t -143.02 160.88 39.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.174 0.99 . . . . 0.0 109.218 168.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -127.53 116.8 20.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 108.126 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.32 105.7 15.2 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.194 0.998 . . . . 0.0 108.536 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.46 114.82 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.268 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.56 ' CG ' HD23 ' A' ' 115' ' ' LEU . 67.9 mtt85 -109.75 139.62 44.58 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.97 0.908 . . . . 0.0 109.075 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -161.28 151.09 17.0 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.087 0.403 . . . . 0.0 110.907 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -113.57 107.59 16.0 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.008 0.923 . . . . 0.0 109.756 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.28 -176.97 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 159.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.0 t70 52.21 -113.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -148.29 34.41 1.19 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.559 1.076 . . . . 0.0 110.777 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -144.47 148.45 34.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.39 98.04 10.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.5 128.21 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.8 tm? -131.51 122.85 26.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -119.48 132.28 55.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.3 123.33 45.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.7 m -124.73 132.98 53.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.053 1.341 . . . . 0.0 109.411 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -144.31 170.02 16.79 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.451 0.569 . . . . 0.0 110.565 169.017 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -45.31 106.82 0.13 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 60.04 45.48 11.96 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.959 1.304 . . . . 0.0 112.556 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 119' ' ' HIS . . . -173.01 140.87 0.93 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 144.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.6 144.16 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.542 1.937 . . . . 0.0 106.67 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -149.85 126.44 10.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.186 0.448 . . . . 0.0 111.172 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -76.49 138.06 40.04 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.868 1.267 . . . . 0.0 108.311 163.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -150.75 100.84 2.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 161.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.3 m -97.0 138.44 34.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.889 0.852 . . . . 0.0 109.421 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -114.87 171.2 7.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.063 1.745 . . . . 0.0 108.976 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.02 142.07 47.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.109 1.763 . . . . 0.0 106.257 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -101.23 121.38 41.75 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.129 0.572 . . . . 0.0 110.577 -167.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -126.43 61.77 1.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.275 1.43 . . . . 0.0 109.366 -172.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 C-N-CA 123.696 0.799 . . . . 0.0 109.123 168.453 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.52 -37.6 50.08 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.571 1.948 . . . . 0.0 111.492 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.96 -16.5 63.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.392 1.877 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -119.04 -54.01 2.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.739 1.216 . . . . 0.0 110.426 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -52.56 109.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.6 1.16 . . . . 0.0 111.36 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.85 -177.21 31.46 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 123.849 0.737 . . . . 0.0 112.617 167.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -91.02 129.84 36.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.651 1.58 . . . . 0.0 108.991 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 36.6 m95 -126.59 142.18 51.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 109.536 -177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -110.23 140.77 44.02 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.215 1.006 . . . . 0.0 109.551 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.4 tt -70.78 117.74 12.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 p -141.73 53.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 122.245 1.021 . . . . 0.0 108.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t0 163.59 156.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 130.347 3.459 . . . . 0.0 106.039 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 t 164.46 135.71 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.541 2.736 . . . . 0.0 108.138 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -106.38 159.07 16.42 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.05 48.19 8.84 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.584 0.707 . . . . 0.0 111.949 161.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -56.53 18.34 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.787 0.803 . . . . 0.0 109.718 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.63 -23.38 31.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.847 -166.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -44.25 -60.64 1.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.854 0.835 . . . . 0.0 109.688 161.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.51 -50.68 67.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.663 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.2 ttp -49.38 -47.16 47.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.353 1.061 . . . . 0.0 111.04 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -73.74 56.0 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.467 1.107 . . . . 0.0 111.201 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 m 175.17 -54.71 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.296 2.238 . . . . 0.0 107.374 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -65.48 -38.92 91.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.621 178.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.18 86.96 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 23' ' ' LEU . 32.8 m -61.91 -34.35 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 117.163 0.481 . . . . 0.0 110.979 174.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.16 102.36 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -48.95 -59.45 3.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.306 1.042 . . . . 0.0 110.512 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -55.75 19.98 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.236 0.541 . . . . 0.0 109.834 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -47.67 14.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.16 1.784 . . . . 0.0 112.874 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -61.08 -32.08 71.74 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.046 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.18 -55.79 19.29 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.149 0.886 . . . . 0.0 109.204 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.07 -46.83 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.08 45.27 1.4 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.259 1.409 . . . . 0.0 113.557 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -158.07 -41.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.419 1.887 . . . . 0.0 108.838 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -34.96 75.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.642 167.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.6 t -69.88 22.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 35.13 64.66 1.88 Allowed Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.2 1.8 . . . . 0.0 112.692 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.84 156.97 50.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.082 2.522 . . . . 0.0 112.706 -166.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.1 p -119.33 161.27 20.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 109.42 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -149.35 155.45 40.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.8 147.47 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 160.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.59 121.25 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -137.05 110.85 8.14 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.593 0.633 . . . . 0.0 109.765 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 95.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.345 1.058 . . . . 0.0 108.353 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -77.35 61.09 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.649 1.179 . . . . 0.0 108.691 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.16 -86.0 0.1 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.742 -0.599 . . . . 0.0 111.766 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -83.31 -43.46 15.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.136 0.969 . . . . 0.0 109.239 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.93 162.07 17.1 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.955 1.702 . . . . 0.0 109.554 -172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.39 118.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 103.568 -2.752 . . . . 0.0 103.568 169.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.1 tt -93.42 136.46 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.18 149.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 141.02 38.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.076 0.853 . . . . 0.0 110.721 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -103.46 44.52 1.01 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.851 1.26 . . . . 0.0 110.82 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.13 116.97 3.09 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.529 1.131 . . . . 0.0 113.409 -157.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 t -102.89 -172.43 2.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.653 1.181 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -28.8 61.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.311 1.444 . . . . 0.0 112.322 -167.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.28 51.84 2.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 109.555 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.8 tttt 68.76 173.41 0.29 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.972 0.909 . . . . 0.0 109.087 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -152.41 -173.92 4.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 164.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.4 p -64.99 164.75 12.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.735 0.778 . . . . 0.0 111.536 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.69 136.15 54.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 165.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.3 mt -132.2 146.62 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.01 2.524 . . . . 0.0 106.232 -161.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -146.48 91.27 2.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.716 1.144 . . . . 0.0 111.617 -161.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 84' ' ' VAL . 9.4 p90 -118.12 161.89 19.11 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 110.149 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 130.18 52.32 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.51 60.49 3.9 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.743 0.817 . . . . 0.0 112.286 -162.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.07 49.28 0.05 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -171.68 160.9 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.974 . . . . 0.0 110.082 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.92 147.87 36.18 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.356 1.062 . . . . 0.0 109.798 162.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.74 161.36 15.51 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.93 133.31 44.3 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -124.32 128.97 49.91 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.1 m -124.74 108.17 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -132.5 137.44 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.413 1.085 . . . . 0.0 109.897 -172.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.78 39.96 0.23 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.275 -0.891 . . . . 0.0 113.043 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -145.88 -54.37 0.27 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.855 1.662 . . . . 0.0 108.191 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.87 1.99 44.6 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -150.08 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.556 1.542 . . . . 0.0 111.089 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -99.07 118.85 36.75 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.097 1.759 . . . . 0.0 108.156 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.98 144.98 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -173.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -70.79 127.7 33.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 153.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -108.28 99.81 9.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.244 1.418 . . . . 0.0 107.275 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.17 103.82 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.998 1.319 . . . . 0.0 107.93 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 64' ' ' PHE . 3.3 t -117.88 139.25 45.77 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 117.882 0.31 . . . . 0.0 110.461 -173.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 p -151.93 -168.43 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.32 2.248 . . . . 0.0 106.971 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.6 pp -140.82 156.33 46.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 163.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -123.41 134.98 53.9 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.043 1.337 . . . . 0.0 107.514 171.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.86 -82.96 0.02 OUTLIER Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.678 0.656 . . . . 0.0 112.289 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.66 33.76 0.63 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 110.059 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -126.98 123.28 36.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.771 2.028 . . . . 0.0 106.301 -171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.531 HD22 HH21 ' A' ' 106' ' ' ARG . 9.4 tt -82.99 123.5 29.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.06 134.15 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 125.416 1.487 . . . . 0.0 108.63 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -132.81 103.63 6.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.17 140.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 166.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -144.8 114.67 7.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.014 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -127.65 119.36 25.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.751 0.821 . . . . 0.0 110.228 -160.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -102.09 -62.64 1.24 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.801 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -163.44 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.56 0.618 . . . . 0.0 112.375 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.58 70.03 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 118.948 0.795 . . . . 0.0 111.713 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -179.75 7.49 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.705 1.202 . . . . 0.0 107.804 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -144.68 -178.82 6.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.76 2.024 . . . . 0.0 107.775 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 t -140.93 160.79 39.32 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.176 0.991 . . . . 0.0 108.351 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -137.13 137.54 39.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.58 154.59 47.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.11 141.92 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.531 HH21 HD22 ' A' ' 91' ' ' LEU . 61.4 mtm180 -126.64 133.33 51.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.838 1.255 . . . . 0.0 109.865 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -149.85 141.69 23.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -110.53 116.02 30.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 161.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.28 -176.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 161.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.3 t70 51.55 -109.11 0.42 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.27 30.99 1.85 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.322 1.439 . . . . 0.0 110.47 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -147.61 150.15 33.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.169 0.985 . . . . 0.0 110.404 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -89.67 97.93 11.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.35 112.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tp -121.84 109.73 15.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.412 1.085 . . . . 0.0 108.346 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.7 p -102.55 127.26 49.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.18 118.71 37.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.375 1.47 . . . . 0.0 107.762 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.6 p -121.15 125.64 47.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.528 1.131 . . . . 0.0 110.579 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -129.75 71.28 1.44 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.323 1.449 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 -90.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.085 1.326 . . . . 0.0 111.941 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 t -84.15 -38.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.07 0.948 . . . . 0.0 110.346 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.05 141.76 32.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.96 115.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 O-C-N 122.211 -0.306 . . . . 0.0 110.57 -162.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.4 t -131.78 105.06 7.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.099 0.96 . . . . 0.0 110.669 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.4 p -62.85 145.57 54.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 157.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -152.37 119.58 5.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.791 0.836 . . . . 0.0 110.149 161.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 81.8 p -92.89 97.32 10.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.764 -1.21 . . . . 0.0 109.382 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -67.65 164.41 19.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.863 . . . . 0.0 109.611 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.04 140.01 34.2 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.612 0.765 . . . . 0.0 109.598 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -73.17 109.0 6.37 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -90.39 -27.88 19.04 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.76 0.255 . . . . 0.0 110.778 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 123.231 0.613 . . . . 0.0 110.999 -175.682 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.73 60.84 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.64 1.976 . . . . 0.0 111.662 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.26 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.189 1.396 . . . . 0.0 107.494 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -59.04 -54.71 44.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 110.935 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -11.96 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 129.668 3.187 . . . . 0.0 113.613 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.19 -125.47 4.88 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 118.72 0.691 . . . . 0.0 112.172 168.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -129.88 121.49 26.78 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.7 0.8 . . . . 0.0 110.591 -159.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -106.17 132.07 52.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.496 1.118 . . . . 0.0 108.773 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -105.42 125.39 50.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.576 1.55 . . . . 0.0 108.371 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.77 144.91 45.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.542 0.61 . . . . 0.0 110.928 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.15 69.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 118.352 0.523 . . . . 0.0 111.92 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -164.38 178.75 7.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.212 1.405 . . . . 0.0 107.957 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -162.0 59.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.554 1.07 . . . . 0.0 112.453 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.64 114.62 21.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.229 0.612 . . . . 0.0 110.877 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 52.23 28.26 5.43 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.394 2.277 . . . . 0.0 113.065 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -81.52 -43.43 18.78 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.74 -1.225 . . . . 0.0 111.386 -167.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -71.32 -55.31 8.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -36.17 -63.17 0.4 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.086 1.354 . . . . 0.0 112.499 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -48.55 -49.93 34.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.372 1.069 . . . . 0.0 110.702 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.1 mtp -68.04 -35.57 78.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.91 0.484 . . . . 0.0 110.903 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -83.31 40.83 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.662 1.985 . . . . 0.0 109.98 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 p -169.66 -42.44 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.999 2.12 . . . . 0.0 107.146 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.24 -45.75 68.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.276 -0.265 . . . . 0.0 111.292 162.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.98 0.4 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.121 1.343 . . . . 0.0 111.354 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.71 -5.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.45 51.6 4.23 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 119.379 -2.076 . . . . 0.0 112.961 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -50.49 -60.43 3.02 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.192 1.397 . . . . 0.0 112.999 -159.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.83 -31.81 27.91 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.504 -170.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m 64.52 122.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.239 1.816 . . . . 0.0 112.513 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 52.86 35.99 20.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 112.243 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.06 -51.7 0.1 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.445 1.098 . . . . 0.0 108.482 170.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -35.25 -41.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 128.424 2.69 . . . . 0.0 114.576 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.85 46.34 1.04 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-O 119.194 -0.781 . . . . 0.0 111.268 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -164.11 -37.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.591 0.757 . . . . 0.0 112.139 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.22 -56.35 4.64 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -64.1 -29.18 70.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.198 0.999 . . . . 0.0 112.539 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 73.33 83.41 0.13 Allowed Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.663 1.585 . . . . 0.0 110.007 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.49 134.96 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.441 1.427 . . . . 0.0 109.244 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 m -118.27 144.48 45.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.1 m -126.44 107.21 10.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -83.34 117.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.98 111.08 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 148.45 42.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 123.701 0.626 . . . . 0.0 109.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.23 111.46 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.961 0.904 . . . . 0.0 109.52 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.82 56.77 3.54 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.07 -83.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.946 0.784 . . . . 0.0 112.231 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.38 -36.44 16.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.763 1.225 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 177.02 5.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.962 2.105 . . . . 0.0 107.913 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 p -152.45 138.45 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 tt -119.98 127.05 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.627 0.771 . . . . 0.0 109.573 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 138.81 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 125.007 1.323 . . . . 0.0 108.751 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -130.09 119.69 23.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.451 1.5 . . . . 0.0 109.085 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -80.96 96.95 7.24 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.374 1.469 . . . . 0.0 108.656 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.21 106.76 11.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.857 0.837 . . . . 0.0 109.301 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -131.76 -176.97 4.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.945 2.498 . . . . 0.0 107.812 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 m -145.18 64.26 1.27 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -169.86 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.493 1.517 . . . . 0.0 108.569 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -158.73 131.59 7.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -126.09 156.8 39.45 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -150.29 154.29 37.62 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -150.53 139.15 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.216 0.606 . . . . 0.0 110.113 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -150.78 145.37 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.343 1.057 . . . . 0.0 108.712 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -97.21 145.85 25.65 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 109.67 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 84' ' ' VAL . 48.3 p90 -151.04 179.45 8.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.15 0.98 . . . . 0.0 109.406 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.81 146.5 28.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.838 0.855 . . . . 0.0 109.264 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.41 69.17 0.38 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.066 1.346 . . . . 0.0 111.151 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 51.87 0.04 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -146.97 140.58 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.849 0.824 . . . . 0.0 109.152 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 129.55 53.38 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 166.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.43 168.42 20.31 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.53 136.14 36.81 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.291 0.636 . . . . 0.0 110.264 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.34 90.63 3.26 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.607 2.363 . . . . 0.0 106.132 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -86.46 110.69 19.92 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -143.58 160.93 39.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.408 0.683 . . . . 0.0 110.783 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.41 -10.68 53.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.695 0.798 . . . . 0.0 113.139 -168.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -92.64 -57.72 2.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.679 1.592 . . . . 0.0 108.652 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 78' ' ' ARG 0.416 0.7 OUTLIER -97.76 10.6 39.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.31 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 67.03 -154.24 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.836 1.255 . . . . 0.0 109.163 172.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.45 114.18 21.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.56 154.92 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -86.62 127.27 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.084 0.856 . . . . 0.0 110.262 167.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -83.83 114.57 21.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.29 1.836 . . . . 0.0 107.636 167.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.31 94.64 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 64' ' ' PHE . 4.0 t -116.94 138.85 46.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 O-C-N 122.124 -0.36 . . . . 0.0 111.177 -165.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -156.8 173.62 16.71 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.963 2.105 . . . . 0.0 106.55 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.55 135.23 48.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.594 1.088 . . . . 0.0 110.612 161.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -88.87 61.86 6.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -168.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.25 -35.32 0.66 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.485 -0.619 . . . . 0.0 113.827 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.24 59.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt 171.61 125.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.375 2.27 . . . . 0.0 107.91 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -83.95 127.01 33.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.842 0.746 . . . . 0.0 110.038 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.14 110.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.649 1.579 . . . . 0.0 106.961 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -98.82 89.27 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 170.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.0 t -74.5 139.56 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -130.96 94.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -159.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.31 114.86 24.2 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.489 0.715 . . . . 0.0 111.243 -167.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.64 -56.73 2.8 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.147 0.43 . . . . 0.0 110.153 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -167.9 -87.07 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.964 0.347 . . . . 0.0 111.425 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.83 -24.69 76.79 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -173.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 172.42 12.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.8 167.56 20.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.49 2.316 . . . . 0.0 107.14 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.0 p -133.82 157.54 45.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.448 0.699 . . . . 0.0 109.499 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 p -88.52 138.18 31.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.1 mt -125.09 84.32 2.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 159.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -106.23 144.59 15.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.437 0.695 . . . . 0.0 110.105 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 158.0 43.61 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.926 0.491 . . . . 0.0 111.56 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -165.09 153.84 12.23 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.738 1.215 . . . . 0.0 109.132 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.9 ttp -114.98 124.83 52.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.163 1.385 . . . . 0.0 109.902 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.88 179.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 157.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.01 -112.65 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -172.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.62 30.08 1.56 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.512 1.053 . . . . 0.0 110.988 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -141.61 156.71 45.66 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.2 108.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.477 1.111 . . . . 0.0 108.373 -170.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.11 141.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 0.0 109.548 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 128' ' ' TYR . 26.9 tp -128.0 85.85 2.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.464 1.106 . . . . 0.0 110.037 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -95.85 111.69 23.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt -113.17 120.35 40.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.8 m -119.24 125.44 49.16 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.776 0.716 . . . . 0.0 109.435 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -123.23 146.15 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 106.844 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -36.24 -52.55 1.29 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.191 0.901 . . . . 0.0 113.469 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -34.05 57.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.05 133.1 29.49 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.188 0.595 . . . . 0.0 110.362 -159.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.08 121.38 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.68 1.192 . . . . 0.0 108.336 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.86 109.4 14.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.673 1.189 . . . . 0.0 109.298 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.86 104.21 12.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.917 1.287 . . . . 0.0 108.217 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -122.43 -177.91 3.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.711 0.804 . . . . 0.0 109.985 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -145.6 155.33 42.97 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.151 0.58 . . . . 0.0 109.835 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.431 ' CE2' HD22 ' A' ' 115' ' ' LEU . 53.6 m-85 -115.87 164.95 13.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.588 1.955 . . . . 0.0 108.99 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.17 136.99 49.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -75.53 109.69 9.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.835 -0.541 . . . . 0.0 110.086 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.31 -23.65 23.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.544 0.338 . . . . 0.0 111.542 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 111.508 -178.44 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.48 63.22 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.75 2.82 . . . . 0.0 111.725 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.09 -48.14 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.802 2.041 . . . . 0.0 107.099 -171.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -54.82 -43.02 72.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.742 1.617 . . . . 0.0 111.566 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.4 t -41.4 109.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.754 1.622 . . . . 0.0 112.487 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.17 -168.45 23.73 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.436 1.017 . . . . 0.0 113.758 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -91.04 122.43 33.69 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.4 1.48 . . . . 0.0 110.451 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -108.32 156.52 19.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.673 1.589 . . . . 0.0 110.415 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 135.74 31.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.35 148.05 49.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.994 0.918 . . . . 0.0 111.873 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.65 -15.12 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.233 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HB3' HG22 ' A' ' 127' ' ' THR . 48.0 t0 -145.86 155.83 43.16 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.145 1.339 . . . . 0.0 110.52 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -173.98 134.52 0.46 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 127.678 2.391 . . . . 0.0 109.095 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.82 166.73 31.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 163.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 63.4 12.3 6.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.267 1.827 . . . . 0.0 112.394 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.02 -52.25 30.71 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.028 -1.045 . . . . 0.0 109.885 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.06 -50.7 63.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.051 2.14 . . . . 0.0 110.101 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -61.69 -39.58 91.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.834 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -47.35 -49.55 24.14 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.316 0.646 . . . . 0.0 110.864 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.67 -28.62 70.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.678 -0.677 . . . . 0.0 112.029 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -73.78 58.96 0.65 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.711 1.204 . . . . 0.0 110.511 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 p 168.24 -48.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.945 3.298 . . . . 0.0 106.691 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.04 -35.27 79.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 112.088 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.39 -15.46 63.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.297 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -76.21 42.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -161.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.42 96.7 0.05 OUTLIER Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.063 -1.023 . . . . 0.0 113.538 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -62.66 -17.97 61.45 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.851 -1.381 . . . . 0.0 112.786 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.63 -53.73 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.308 1.043 . . . . 0.0 111.679 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 m -66.2 -31.01 71.59 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.994 -0.441 . . . . 0.0 110.896 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -38.96 86.18 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -58.61 -58.12 9.96 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.101 0.864 . . . . 0.0 108.976 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -45.82 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.31 -14.07 71.22 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.453 -1.748 . . . . 0.0 114.937 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -103.12 -38.0 7.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.63 . . . . 0.0 110.744 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.54 -47.42 7.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.866 0.866 . . . . 0.0 111.875 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 m -99.15 90.9 4.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 118.861 -0.59 . . . . 0.0 109.722 -161.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 6.35 75.01 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 127.384 2.274 . . . . 0.0 113.415 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.17 93.64 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.363 2.042 . . . . 0.0 109.366 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.0 m -89.19 150.97 22.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.848 1.259 . . . . 0.0 107.889 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.2 m -140.91 140.89 34.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.73 -1.231 . . . . 0.0 108.674 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.0 132.75 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.0 mt -128.14 107.57 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.88 107.03 15.91 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.116 1.767 . . . . 0.0 109.274 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.97 109.31 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -93.79 65.49 3.6 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.17 -87.69 0.09 OUTLIER Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.299 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.15 -6.11 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.501 1.12 . . . . 0.0 112.302 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -102.2 169.43 8.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.26 117.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 mt -88.32 132.96 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tt -116.44 133.57 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -122.2 137.07 54.96 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.406 1.083 . . . . 0.0 109.043 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 p -105.73 16.83 24.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.04 1.336 . . . . 0.0 113.007 -166.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.13 109.05 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.259 1.423 . . . . 0.0 114.418 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -66.81 -41.47 87.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 171.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -149.62 -75.85 0.16 Allowed 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -71.68 -54.56 9.95 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.115 -0.366 . . . . 0.0 110.453 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -174.58 156.36 2.39 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.52 -79.02 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -142.52 157.94 44.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.297 1.039 . . . . 0.0 109.29 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.06 133.69 54.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 166.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.72 117.52 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 p -106.54 81.45 1.59 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.181 1.792 . . . . 0.0 110.537 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -72.23 143.18 48.9 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.396 -0.815 . . . . 0.0 111.637 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -121.54 112.56 18.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.65 102.98 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.785 0.834 . . . . 0.0 111.665 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.54 54.79 1.3 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.44 170.64 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.51 149.02 43.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.934 0.494 . . . . 0.0 110.387 163.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -141.83 153.44 44.5 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.366 1.066 . . . . 0.0 109.254 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.69 144.53 56.95 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.84 158.21 43.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.815 1.246 . . . . 0.0 108.672 -168.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 t -137.53 146.58 44.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.574 0.75 . . . . 0.0 109.639 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -128.19 170.36 13.09 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.42 -15.46 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -156.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -95.37 13.52 25.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.374 1.47 . . . . 0.0 111.551 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.25 38.2 t0 31.15 57.17 0.25 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.016 2.126 . . . . 0.0 113.658 -156.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -61.63 123.93 19.28 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 116.282 -2.167 . . . . 0.0 106.546 149.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -78.72 112.71 16.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 97' ' ' TRP . 2.0 m -126.27 172.47 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -174.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -108.99 130.38 55.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -88.89 102.17 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.929 1.291 . . . . 0.0 107.636 164.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.75 134.5 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 166.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.01 139.54 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.651 0.659 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -151.76 -172.15 4.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.101 1.361 . . . . 0.0 107.668 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 tt -137.51 113.21 9.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.806 1.642 . . . . 0.0 108.376 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -115.06 105.88 13.47 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.58 1.181 . . . . 0.0 110.843 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.87 -62.14 3.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.141 0.877 . . . . 0.0 111.774 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.04 69.88 0.08 OUTLIER Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 pttm 173.5 142.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 106.527 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 91' ' ' LEU 0.302 0.0 OUTLIER -88.81 136.81 32.81 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.121 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 105' ' ' VAL . 23.2 m -115.69 97.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.95 104.03 13.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.25 126.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -116.19 105.51 12.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.64 126.69 55.29 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.233 1.013 . . . . 0.0 110.417 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.499 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.2 p90 -99.62 -62.53 1.23 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.931 0.492 . . . . 0.0 109.732 172.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.92 -92.85 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.31 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.77 -12.61 83.74 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.938 0.79 . . . . 0.0 112.265 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -137.84 164.3 29.28 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -142.11 152.07 42.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 167.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -116.55 148.03 41.25 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -107.66 134.45 50.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.013 0.525 . . . . 0.0 109.931 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.08 90.05 3.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.346 1.859 . . . . 0.0 106.733 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 92' ' ' VAL . 17.5 m -90.15 139.41 17.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.472 HH11 HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -139.17 148.42 43.15 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.059 0.544 . . . . 0.0 111.324 174.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -164.09 155.0 15.59 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.656 1.582 . . . . 0.0 108.06 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.7 ttp -105.08 118.37 36.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.616 0.767 . . . . 0.0 109.086 161.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.24 170.41 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 154.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 52.05 -124.28 2.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -165.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.75 21.75 4.68 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.906 1.241 . . . . 0.0 111.58 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 65.2 mttm -137.28 140.77 41.79 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.117 0.958 . . . . 0.0 108.779 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.61 121.56 31.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.38 150.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 HH11 ' A' ' 106' ' ' ARG . 0.5 OUTLIER -137.7 118.0 13.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.8 m -111.89 100.03 8.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.8 115.84 18.75 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.2 m -118.38 114.2 22.55 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.002 0.921 . . . . 0.0 109.98 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 -27.84 14.42 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.471 1.508 . . . . 0.0 109.827 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.39 -92.87 0.2 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 t -58.72 -44.33 90.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.81 141.5 29.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.091 0.557 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.28 129.21 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 126.109 1.763 . . . . 0.0 107.086 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.9 t -116.52 104.74 11.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 108.973 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.4 p -70.37 143.84 51.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 163.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.88 153.9 28.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 12' ' ' ASP . 3.7 t -146.68 155.7 42.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.734 0.697 . . . . 0.0 110.984 -175.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.03 154.25 51.26 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.032 2.133 . . . . 0.0 109.395 -165.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 112' ' ' LYS . 42.5 tt0 -129.22 134.23 47.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.945 1.298 . . . . 0.0 107.843 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -78.22 119.52 21.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -104.11 -29.69 10.71 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.656 0.782 . . . . 0.0 110.978 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.379 0.672 . . . . 0.0 110.968 -178.374 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.237 0.418 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.41 55.87 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.979 2.512 . . . . 0.0 111.625 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.65 -38.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.766 1.626 . . . . 0.0 108.849 -161.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -96.55 -34.84 11.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.732 1.213 . . . . 0.0 110.758 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.43 105.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.88 176.93 27.67 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.912 0.778 . . . . 0.0 113.081 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 m -102.49 118.24 36.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -114.66 134.67 54.89 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.417 1.487 . . . . 0.0 107.659 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -112.09 121.12 44.08 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.99 131.89 52.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.266 0.939 . . . . 0.0 108.793 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.51 -64.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 125.068 1.48 . . . . 0.0 110.288 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.21 158.18 17.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.078 0.854 . . . . 0.0 110.171 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -175.08 165.02 3.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 107.709 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -149.31 153.94 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 166.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.39 42.49 32.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.217 1.007 . . . . 0.0 110.633 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.8 -55.48 26.04 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.179 -0.951 . . . . 0.0 109.278 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.522 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -25.93 -60.27 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.542 1.537 . . . . 0.0 112.822 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -51.08 -59.9 3.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.131 0.972 . . . . 0.0 112.695 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.2 ptp -63.43 -29.7 70.95 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.674 -0.641 . . . . 0.0 112.403 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp -78.73 45.74 0.62 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.764 2.026 . . . . 0.0 111.379 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m 177.29 -46.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 128.061 2.544 . . . . 0.0 107.396 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -54.34 -31.47 54.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.472 0.709 . . . . 0.0 110.39 173.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 45.6 0.59 Allowed Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 160.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -139.01 -36.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 109.179 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.66 68.46 2.17 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.279 -0.888 . . . . 0.0 112.28 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.73 70.7 0.72 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 109.92 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.8 -60.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.947 2.099 . . . . 0.0 112.55 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -33.08 -46.07 0.15 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.092 2.957 . . . . 0.0 112.801 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -112.47 23.71 13.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.798 . . . . 0.0 112.575 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.86 -23.33 15.4 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.962 1.705 . . . . 0.0 110.053 157.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.67 -46.05 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.32 61.02 2.32 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.296 0.951 . . . . 0.0 113.708 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -178.02 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.033 1.733 . . . . 0.0 108.922 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.1 ttm -54.36 -35.48 62.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.291 0.636 . . . . 0.0 109.946 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 m -65.19 76.54 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.274 0.63 . . . . 0.0 109.852 161.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -20.08 95.04 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.943 2.897 . . . . 0.0 112.562 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.64 165.18 26.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.998 -167.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.5 m -131.46 149.5 52.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.463 -0.79 . . . . 0.0 108.888 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -138.34 95.05 2.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.057 -161.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 41' ' ' ILE . 1.8 mp -79.46 127.91 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.9 mt -126.49 109.39 20.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.92 135.99 49.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.102 0.961 . . . . 0.0 109.743 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.08 84.84 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.732 0.813 . . . . 0.0 108.817 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.63 71.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.109 1.764 . . . . 0.0 111.177 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.78 -105.01 0.58 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -34.67 55.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.351 0.66 . . . . 0.0 110.414 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -179.01 4.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.755 2.022 . . . . 0.0 107.236 -167.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.68 146.55 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.98 132.73 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 133.29 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.391 1.076 . . . . 0.0 108.441 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -114.4 114.5 25.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.859 1.263 . . . . 0.0 108.579 170.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 p -82.21 120.84 25.87 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -117.3 139.49 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.591 1.156 . . . . 0.0 110.818 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 t -167.0 -165.88 0.76 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.829 1.652 . . . . 0.0 109.207 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -62.82 93.61 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.276 1.431 . . . . 0.0 111.837 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 58.49 18.0 5.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.515 1.526 . . . . 0.0 112.463 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -134.04 77.11 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -115.99 127.28 54.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -173.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.68 159.78 43.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -152.29 158.12 42.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -140.99 121.65 13.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -84.41 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 165.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -156.75 144.39 19.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.393 -0.817 . . . . 0.0 111.402 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.56 105.58 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -49.85 109.13 0.25 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.413 0.285 . . . . 0.0 111.051 174.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.65 39.9 1.68 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -154.8 157.26 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.79 145.1 37.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.692 0.797 . . . . 0.0 110.474 161.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.65 148.72 24.52 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.77 143.17 40.05 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.0 156.08 44.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.552 1.541 . . . . 0.0 107.845 -173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.1 m -141.12 82.23 1.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.232 1.013 . . . . 0.0 109.09 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -98.32 130.9 44.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.3 -35.49 27.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.962 0.905 . . . . 0.0 112.404 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -96.77 16.6 18.68 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.172 1.789 . . . . 0.0 112.766 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -150.15 2.25 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 163.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 79.76 -164.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.383 1.473 . . . . 0.0 109.003 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -73.81 126.48 30.47 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.12 143.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.679 1.592 . . . . 0.0 108.043 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -83.27 127.1 33.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 166.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.2 m -94.63 114.83 26.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.98 123.78 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 166.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 p -132.78 136.9 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -158.2 158.93 35.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 pp -105.98 137.82 43.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.337 0.972 . . . . 0.0 108.813 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -84.03 -11.51 56.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.282 0.633 . . . . 0.0 111.65 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.29 -32.92 5.67 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.22 -39.66 3.45 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.173 1.368 . . . . 0.0 110.905 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -142.05 167.62 21.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.65 1.18 . . . . 0.0 111.424 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.7 tt -96.94 114.99 26.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.198 0.999 . . . . 0.0 108.519 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.55 112.2 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.099 1.76 . . . . 0.0 108.76 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -103.99 108.94 20.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.56 126.07 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -110.63 117.22 32.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -131.71 120.38 22.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.79 1.236 . . . . 0.0 109.909 -164.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -56.75 2.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -161.8 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.07 -16.26 78.5 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 118.629 0.65 . . . . 0.0 112.592 -171.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.29 173.24 15.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.474 1.11 . . . . 0.0 108.403 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.49 154.83 33.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.962 1.705 . . . . 0.0 108.186 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.9 p -109.4 145.75 35.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 110.018 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.09 121.22 36.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.85 98.51 6.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.437 1.495 . . . . 0.0 107.554 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.94 118.74 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.05 145.91 38.86 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.963 0.905 . . . . 0.0 109.376 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -160.72 156.7 25.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 164.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -121.46 121.88 38.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.117 0.967 . . . . 0.0 109.29 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.39 -177.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 160.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t70 53.23 -108.53 0.42 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.97 29.65 1.38 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.678 1.132 . . . . 0.0 111.336 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -140.18 145.22 37.18 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.968 0.884 . . . . 0.0 109.158 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -90.48 110.82 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.07 139.86 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tp -142.44 106.1 4.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 m -98.43 121.59 40.55 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 133.5 45.15 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -155.12 156.22 35.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.809 0.731 . . . . 0.0 111.483 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -160.08 168.23 26.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 107.234 165.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.59 -35.39 7.35 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 118.847 0.749 . . . . 0.0 112.44 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 m -46.23 -49.73 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.577 1.551 . . . . 0.0 113.026 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 175.89 169.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.135 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.41 144.94 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 125.404 1.481 . . . . 0.0 108.533 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 16.7 t -158.5 116.32 2.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.581 0.628 . . . . 0.0 111.633 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -73.12 151.09 41.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.239 0.616 . . . . 0.0 109.551 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -140.5 154.46 46.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.597 1.959 . . . . 0.0 106.266 156.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 t -151.84 148.6 28.02 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.67 0.668 . . . . 0.0 110.697 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -129.77 139.04 51.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.606 1.562 . . . . 0.0 108.553 -167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -110.92 138.8 46.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.373 1.069 . . . . 0.0 108.899 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -73.02 84.04 1.27 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.607 0.363 . . . . 0.0 111.081 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -59.28 -35.95 74.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.749 0.309 . . . . 0.0 110.726 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 O-C-N 121.842 -0.536 . . . . 0.0 109.735 173.274 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.27 66.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 129.992 3.317 . . . . 0.0 111.311 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.19 -61.35 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.04 48.62 0.87 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.855 2.062 . . . . 0.0 111.282 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 44' ' ' VAL . 45.1 t -142.77 78.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.771 2.028 . . . . 0.0 106.558 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.8 -160.35 23.21 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.668 0.652 . . . . 0.0 113.108 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -87.73 138.65 31.28 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 111.752 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 56.3 m95 -118.9 158.38 25.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.166 1.386 . . . . 0.0 109.084 168.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 155.96 46.89 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.403 0.44 . . . . 0.0 110.668 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 11' ' ' VAL . 2.9 tt -66.95 145.26 55.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.588 1.555 . . . . 0.0 111.051 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 10' ' ' LEU . 6.6 p -127.83 -56.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 164.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.39 141.98 47.66 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -167.79 152.78 6.85 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -173.19 159.23 3.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.505 1.522 . . . . 0.0 107.497 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 72.02 -4.74 1.89 Allowed 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.148 1.779 . . . . 0.0 111.49 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -41.71 83.52 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -34.92 -69.01 0.1 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.696 1.998 . . . . 0.0 111.916 160.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.36 -47.89 80.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.536 1.062 . . . . 0.0 111.611 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.71 -52.5 10.83 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 111.235 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -31.42 72.48 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -64.46 -62.79 1.38 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -54.72 -46.64 74.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.079 1.351 . . . . 0.0 111.69 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.57 -9.6 57.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.702 1.201 . . . . 0.0 112.247 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.44 51.49 42.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.92 -40.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 109.797 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -45.18 -64.24 2.32 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 125.928 1.727 . . . . 0.0 113.562 -171.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 36.11 -122.7 0.15 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.374 1.87 . . . . 0.0 110.754 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.19 48.57 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 m -151.32 -73.32 0.15 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.692 -0.63 . . . . 0.0 110.84 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -70.45 -14.38 62.51 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -55.08 -39.55 69.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.426 0.557 . . . . 0.0 111.341 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.22 -56.18 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.2 -49.77 4.47 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.128 1.347 . . . . 0.0 113.826 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -80.53 -14.78 57.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.21 2.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 163.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.255 1.2 t -72.24 83.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.682 1.229 . . . . 0.0 111.261 -164.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 84.05 0.98 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 125.826 1.65 . . . . 0.0 107.749 159.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.95 -48.68 1.77 Allowed 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.629 1.553 . . . . 0.0 108.44 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -87.7 141.06 28.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.914 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -147.72 117.43 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.057 -1.027 . . . . 0.0 108.534 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.43 140.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.78 111.52 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -130.15 125.74 35.78 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.345 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -64.16 99.84 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 122.029 0.919 . . . . 0.0 110.686 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -74.52 65.15 1.24 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.63 -82.63 0.02 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.396 0.998 . . . . 0.0 112.973 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -99.78 -6.59 26.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 0.0 112.259 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.36 166.33 17.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.223 1.809 . . . . 0.0 107.217 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.98 109.24 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 tt -90.02 129.36 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.48 134.3 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -124.98 105.9 9.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 109.962 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 m -70.09 113.12 6.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.857 2.063 . . . . 0.0 108.083 170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -120.01 135.25 54.99 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.336 0.516 . . . . 0.0 111.243 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -139.69 17.92 2.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.068 0.947 . . . . 0.0 111.256 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t 39.97 38.06 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 111.426 -164.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -174.3 95.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -166.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? 54.85 54.95 8.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.709 0.804 . . . . 0.0 110.146 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -63.08 162.65 11.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.906 1.283 . . . . 0.0 109.893 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.88 164.12 31.11 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.998 0.919 . . . . 0.0 108.756 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -156.04 151.94 27.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.922 0.489 . . . . 0.0 109.994 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.4 144.57 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 p -106.86 88.17 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.908 0.883 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.87 148.37 47.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -132.26 117.41 18.16 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 166.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 96.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.612 1.165 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.34 51.9 1.19 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.35 0.976 . . . . 0.0 111.148 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.38 162.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.0 0.9 . . . . 0.0 110.939 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -101.97 136.48 41.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.436 1.894 . . . . 0.0 107.863 167.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.44 149.84 38.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.734 0.814 . . . . 0.0 109.191 170.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.32 136.83 37.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.29 153.6 47.8 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.82 1.248 . . . . 0.0 109.144 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -130.66 68.58 1.47 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.875 1.67 . . . . 0.0 110.016 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -83.76 143.73 29.79 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.09 40.23 0.33 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.618 1.167 . . . . 0.0 112.851 -167.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -161.02 -75.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.569 1.548 . . . . 0.0 107.859 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -27.64 65.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.69 0.796 . . . . 0.0 111.729 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 98.8 -155.63 0.0 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 128.628 2.771 . . . . 0.0 107.971 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -81.4 116.33 21.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.13 177.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.474 1.51 . . . . 0.0 107.709 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -107.42 128.25 54.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.768 0.713 . . . . 0.0 110.176 164.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.93 126.08 35.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.44 125.26 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.63 145.37 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 160.51 41.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.5 2.72 . . . . 0.0 105.811 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tt -140.93 73.62 1.43 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 p30 176.4 164.18 0.42 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -156.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 -69.17 0.9 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.21 56.91 0.65 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 56.94 -130.66 1.65 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.007 0.923 . . . . 0.0 109.208 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp -81.88 79.29 8.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 109.834 -170.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.39 111.5 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.846 0.858 . . . . 0.0 109.984 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -117.95 115.8 25.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.798 1.239 . . . . 0.0 109.639 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.19 150.74 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 170.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -131.81 95.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 106.354 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -112.64 117.14 31.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -89.56 -111.0 0.08 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -122.87 -74.01 0.63 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.761 1.224 . . . . 0.0 111.488 -173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.74 61.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.569 0.622 . . . . 0.0 111.722 -170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -179.91 6.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -149.29 156.85 42.74 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.371 1.869 . . . . 0.0 106.291 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.6 t -127.8 155.9 43.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.536 0.684 . . . . 0.0 109.254 160.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.1 p -96.17 150.7 20.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 164.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 pp -151.94 101.63 2.75 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 164.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.91 128.85 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.043 0.537 . . . . 0.0 109.601 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -94.26 99.23 11.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 108.318 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.94 143.67 28.29 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -137.11 120.01 16.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.09 -168.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 51.91 -116.93 1.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.35 23.58 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 126.137 1.827 . . . . 0.0 109.485 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -134.26 129.55 35.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.401 0.681 . . . . 0.0 109.461 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 6.8 tt -87.68 105.09 17.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.6 mt -82.05 103.22 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.88 101.23 13.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.4 t -99.27 130.92 45.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.65 126.36 43.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.296 1.439 . . . . 0.0 109.775 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.7 m -131.88 114.0 14.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -97.62 146.63 25.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.764 2.026 . . . . 0.0 107.456 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.01 92.06 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 167.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 m 135.2 -28.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 131.402 3.881 . . . . 0.0 111.851 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.27 153.62 37.82 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.28 1.4 . . . . 0.0 112.46 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.9 t -124.79 143.73 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.093 1.757 . . . . 0.0 107.964 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 t -158.6 158.54 34.08 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 t -126.24 158.06 36.67 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.672 -0.642 . . . . 0.0 109.942 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -119.59 130.89 55.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 150.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -108.79 124.94 51.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -112.89 154.54 26.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.005 1.722 . . . . 0.0 109.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -122.01 137.07 54.94 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.756 1.622 . . . . 0.0 107.395 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -75.37 125.38 28.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.23 -4.06 17.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.033 0.533 . . . . 0.0 111.336 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 C-N-CA 124.778 1.231 . . . . 0.0 110.864 174.111 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 58.38 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 129.345 3.058 . . . . 0.0 111.894 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.27 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.153 1.781 . . . . 0.0 107.516 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -59.27 -42.88 92.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.495 1.118 . . . . 0.0 111.221 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.1 t -40.62 101.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.197 1.799 . . . . 0.0 111.814 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.29 -154.69 25.92 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.188 0.899 . . . . 0.0 112.196 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -118.25 119.71 35.49 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.502 1.521 . . . . 0.0 109.656 -170.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 87.7 m95 -109.29 141.93 40.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.521 1.128 . . . . 0.0 110.177 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -115.11 137.71 51.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -77.75 128.34 33.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.94 -45.64 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -128.92 151.14 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 110.008 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -170.14 150.55 3.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.596 2.358 . . . . 0.0 108.719 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -138.87 148.74 44.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m120 62.68 43.86 7.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.222 1.409 . . . . 0.0 111.452 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -70.53 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.804 -0.56 . . . . 0.0 109.75 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.57 -49.66 72.13 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -30.03 -53.88 0.16 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.702 2.001 . . . . 0.0 112.547 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -51.93 -51.93 53.57 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.752 -0.593 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.0 ptp -74.23 -33.12 63.25 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.434 -0.791 . . . . 0.0 111.793 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -40.96 75.97 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.473 -0.767 . . . . 0.0 111.166 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -82.09 -41.18 20.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.494 1.117 . . . . 0.0 110.219 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.1 -39.13 74.44 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.199 0.454 . . . . 0.0 111.844 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 55.14 0.81 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.78 -9.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.64 1.176 . . . . 0.0 111.678 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.48 78.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.105 -0.997 . . . . 0.0 114.248 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -48.81 139.26 10.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.911 1.285 . . . . 0.0 109.039 156.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.95 62.76 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.22 1.008 . . . . 0.0 111.01 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 m -147.9 -37.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.814 -1.179 . . . . 0.0 111.272 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.8 tpt85 -56.69 -37.83 71.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.229 0.922 . . . . 0.0 109.678 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -43.01 -32.96 0.72 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.386 2.675 . . . . 0.0 115.074 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -110.29 -35.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.007 0.821 . . . . 0.0 111.347 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 26.85 0.65 Allowed Glycine 0 CA--C 1.539 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 113.973 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -122.96 -39.21 2.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.062 3.345 . . . . 0.0 109.54 -173.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -42.6 70.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.733 1.213 . . . . 0.0 108.731 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -60.12 116.26 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 156.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.66 114.44 14.53 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.983 -168.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.85 156.57 56.53 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 120.246 1.124 . . . . 0.0 109.667 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.6 m -130.99 153.98 48.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.298 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -147.51 117.42 7.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.82 144.13 11.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 166.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.53 111.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.39 143.75 51.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 0.701 . . . . 0.0 110.993 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 80.5 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 122.46 1.124 . . . . 0.0 110.133 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -65.42 78.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.008 0.923 . . . . 0.0 111.398 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.04 -114.0 6.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -86.6 -12.55 48.27 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.431 0.615 . . . . 0.0 111.296 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -102.05 179.32 4.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.449 1.1 . . . . 0.0 108.36 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.82 138.94 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 166.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.6 tt -112.55 134.25 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.59 143.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 O-C-N 123.98 0.8 . . . . 0.0 109.137 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -131.94 111.7 11.77 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 m -104.12 128.33 51.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.728 1.611 . . . . 0.0 110.104 -167.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -105.38 125.1 50.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.697 1.999 . . . . 0.0 109.121 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -148.92 68.61 1.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 p 48.3 96.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.157 2.183 . . . . 0.0 114.194 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.6 t80 71.02 -64.98 0.36 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.302 1.841 . . . . 0.0 109.615 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.31 134.76 45.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.05 156.34 39.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.14 158.18 43.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.82 132.23 13.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -147.52 127.68 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 p -88.94 133.68 34.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.859 1.264 . . . . 0.0 108.469 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.75 160.65 42.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 127.56 43.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 86.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 169.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.07 41.98 0.19 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.095 1.807 . . . . 0.0 111.474 168.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.5 t -147.71 153.05 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.368 1.084 . . . . 0.0 109.575 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -113.04 133.98 54.73 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 126.724 2.01 . . . . 0.0 107.463 167.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -163.21 -179.34 6.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.268 0.94 . . . . 0.0 111.136 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.5 121.53 29.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 109.225 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 107.52 15.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.453 1.901 . . . . 0.0 106.255 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.3 53.85 0.76 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.095 0.558 . . . . 0.0 111.233 -164.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 146.8 50.42 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.456 -0.777 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.02 63.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.009 0.923 . . . . 0.0 112.267 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -94.81 -50.41 5.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.836 1.654 . . . . 0.0 110.299 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -56.44 -25.62 51.17 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.182 0.446 . . . . 0.0 111.802 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 77.64 -166.05 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.889 2.075 . . . . 0.0 109.021 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.33 89.32 2.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.93 149.93 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.917 0.887 . . . . 0.0 109.747 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -85.08 116.9 23.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -80.63 146.87 30.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -139.57 125.74 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 157.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.93 143.92 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -166.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -155.57 -172.82 4.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.51 1.924 . . . . 0.0 108.232 -176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.63 113.02 10.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.12 125.97 43.36 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.84 -78.95 0.01 OUTLIER Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.342 0.973 . . . . 0.0 113.465 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.34 26.49 1.1 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.524 1.535 . . . . 0.0 111.742 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 130.53 48.9 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.084 1.354 . . . . 0.0 109.182 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.6 112.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.318 1.447 . . . . 0.0 107.36 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.01 126.62 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.376 1.07 . . . . 0.0 108.258 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -135.07 102.44 5.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.516 0.727 . . . . 0.0 109.891 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.87 147.2 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -141.8 99.39 3.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -119.74 108.81 14.87 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.441 1.897 . . . . 0.0 109.655 -160.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -60.2 1.68 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.322 0.51 . . . . 0.0 110.557 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -165.01 -81.51 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.235 0.47 . . . . 0.0 112.217 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.93 -26.16 74.46 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.786 0.721 . . . . 0.0 111.58 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 173.37 16.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.14 1.376 . . . . 0.0 107.725 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -131.21 140.29 49.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.968 2.107 . . . . 0.0 107.956 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 t -98.05 174.8 6.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.7 p -155.82 155.04 32.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 153.93 39.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.739 172.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.65 139.56 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -128.18 140.37 51.95 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.381 1.072 . . . . 0.0 109.51 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.08 133.74 16.7 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.416 0.686 . . . . 0.0 109.228 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -103.98 119.49 39.04 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.2 176.51 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 153.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.31 -118.1 1.26 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -170.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.92 21.22 3.75 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.188 1.375 . . . . 0.0 110.873 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -124.6 127.42 47.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.794 0.838 . . . . 0.0 108.764 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 2.4 tt -91.75 91.1 7.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.06 143.28 13.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.72 141.51 22.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.701 0.763 . . . . 0.0 112.712 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.9 m -106.81 124.73 50.04 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 125.109 1.364 . . . . 0.0 107.992 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.47 75.7 1.04 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.087 1.755 . . . . 0.0 107.192 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -128.13 138.81 52.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.281 0.562 . . . . 0.0 110.365 -165.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -160.18 155.64 25.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.62 -34.55 6.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.026 0.822 . . . . 0.0 113.121 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 t -51.75 -41.83 61.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.377 1.071 . . . . 0.0 111.852 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.87 127.15 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.678 1.591 . . . . 0.0 110.063 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.04 136.81 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -150.66 156.0 40.47 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.349 -1.469 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -143.5 163.37 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.648 0.779 . . . . 0.0 109.321 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -167.27 168.74 13.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.302 1.041 . . . . 0.0 111.069 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -136.8 136.49 38.89 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.957 0.884 . . . . 0.0 109.591 163.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -89.02 155.81 19.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.736 164.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.6 146.58 44.16 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.771 1.228 . . . . 0.0 107.867 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -81.79 114.53 20.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -90.82 -26.64 19.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.031 0.378 . . . . 0.0 111.697 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.161 0 CA-C-N 118.39 0.541 . . . . 0.0 110.781 174.471 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.238 0.47 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.6 61.42 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.932 2.093 . . . . 0.0 110.576 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.08 -40.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.028 1.731 . . . . 0.0 108.298 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -95.11 -47.73 6.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.859 1.264 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.5 t -45.37 117.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.435 1.094 . . . . 0.0 112.81 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.65 -120.77 3.42 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.851 0.739 . . . . 0.0 111.277 158.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -152.05 140.57 20.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.869 -0.783 . . . . 0.0 109.176 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -138.41 162.85 33.39 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.699 1.6 . . . . 0.0 107.166 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -135.69 142.37 45.08 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.792 1.237 . . . . 0.0 108.953 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 141.57 55.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.774 0.715 . . . . 0.0 110.974 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.76 -35.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 118.451 -0.785 . . . . 0.0 112.338 169.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.08 151.24 51.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.554 1.07 . . . . 0.0 110.749 169.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -168.24 165.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.065 2.546 . . . . 0.0 106.532 167.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -146.58 178.13 8.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.586 1.554 . . . . 0.0 107.138 169.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 m120 58.55 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.36 1.064 . . . . 0.0 110.834 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -57.11 14.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.58 0.752 . . . . 0.0 110.286 -172.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.56 -52.87 18.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.141 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -35.06 -57.96 0.55 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.0 112.222 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 117' ' ' LEU . 4.7 t80 -57.79 -45.97 85.26 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.61 -0.681 . . . . 0.0 112.141 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -68.83 -30.17 68.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.838 . . . . 0.0 111.994 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -72.83 58.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.873 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m 175.59 -55.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.764 2.426 . . . . 0.0 107.143 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.15 -37.76 75.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.781 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.41 32.91 68.02 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.28 -31.35 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.694 0.747 . . . . 0.0 110.442 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.4 71.15 0.03 OUTLIER Glycine 0 C--N 1.336 0.572 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -54.33 146.59 15.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.33 -12.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.627 1.571 . . . . 0.0 114.636 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.1 m -102.16 -61.86 1.34 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 108.586 -168.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -70.71 7.33 1.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.104 -0.998 . . . . 0.0 113.382 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.59 -46.48 85.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.206 -0.934 . . . . 0.0 108.993 159.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -44.7 96.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.66 43.15 1.84 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.327 0.965 . . . . 0.0 112.98 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -163.72 -32.52 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.222 1.809 . . . . 0.0 109.588 167.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 90.2 mmm -53.26 -45.0 68.64 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 159.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -64.05 108.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -35.15 104.97 0.27 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.463 1.905 . . . . 0.0 112.302 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.77 123.93 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.734 1.622 . . . . 0.0 109.42 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.8 m -79.96 179.94 7.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -152.09 88.71 1.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -79.03 128.36 38.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mt -127.98 101.73 7.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -109.24 115.59 30.29 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.825 1.25 . . . . 0.0 108.653 -171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.1 t -78.74 103.58 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -77.81 65.08 3.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.867 1.267 . . . . 0.0 108.764 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.53 -88.14 0.05 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.665 0.65 . . . . 0.0 111.752 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.38 17.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.132 0.973 . . . . 0.0 110.081 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.42 173.12 7.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.77 2.028 . . . . 0.0 108.093 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.41 130.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.81 131.52 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 62' ' ' ILE . 13.9 tt -114.37 128.15 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -135.04 131.38 36.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.805 0.442 . . . . 0.0 111.002 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -29.52 39.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.609 1.563 . . . . 0.0 112.951 -159.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 33.72 56.96 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.215 1.806 . . . . 0.0 113.691 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -66.07 -60.5 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -114.23 62.03 0.66 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 69.22 -21.16 0.16 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.92 88.4 1.67 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 0.0 108.078 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.49 55.88 1.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.58 0.752 . . . . 0.0 109.776 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 58.59 175.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.892 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -151.11 155.63 39.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.834 0.454 . . . . 0.0 110.811 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 51' ' ' ILE . 47.0 mt -128.87 143.0 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.2 p -149.46 97.78 2.69 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -149.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.26 176.93 8.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.939 0.496 . . . . 0.0 110.905 -160.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -151.88 122.43 7.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -175.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -61.93 103.76 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 109.871 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.5 40.48 1.35 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.556 2.027 . . . . 0.0 111.802 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -148.02 149.86 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.024 1.33 . . . . 0.0 107.641 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 146.89 40.78 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.614 1.166 . . . . 0.0 109.194 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.27 161.98 12.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.474 0.309 . . . . 0.0 110.666 -168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -76.37 112.79 13.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -100.8 110.22 22.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -113.71 121.83 45.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 t -145.45 145.62 31.18 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.79 44.07 0.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.204 1.001 . . . . 0.0 111.942 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -152.93 -63.91 0.16 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.43 1.892 . . . . 0.0 106.963 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -79.64 1.37 26.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.331 0.652 . . . . 0.0 111.599 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 78.28 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.059 1.344 . . . . 0.0 108.671 169.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -92.25 124.42 36.31 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.81 139.09 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -78.99 131.38 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 162.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 p -130.42 161.92 30.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.0 0.364 . . . . 0.0 110.673 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.6 tt -129.53 142.42 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.327 1.851 . . . . 0.0 106.485 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.7 144.93 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -150.89 -170.62 3.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 164.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tt -135.4 124.85 24.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 107.355 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.22 145.13 51.4 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.811 0.844 . . . . 0.0 109.461 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.85 -78.93 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.632 1.11 . . . . 0.0 111.548 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.82 26.97 0.26 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.037 1.303 . . . . 0.0 110.932 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.69 136.32 52.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.377 1.471 . . . . 0.0 107.341 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 91' ' ' LEU . 8.1 tt -92.21 118.61 31.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.84 121.36 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.705 0.802 . . . . 0.0 109.377 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -105.53 123.11 47.36 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.92 1.688 . . . . 0.0 106.453 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.33 129.7 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -148.08 112.65 5.34 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.629 -151.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -130.61 163.84 26.26 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.749 1.22 . . . . 0.0 112.245 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -136.83 -65.85 0.54 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.33 143.71 10.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.19 -7.5 5.91 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.128 -0.818 . . . . 0.0 114.206 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 165.08 14.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.935 1.367 . . . . 0.0 110.423 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -142.07 125.56 16.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.33 1.852 . . . . 0.0 106.948 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.33 153.54 24.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 110.482 164.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -123.12 136.9 54.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.913 1.285 . . . . 0.0 107.581 172.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 110.12 7.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.19 129.8 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -122.21 124.71 44.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 127.063 2.145 . . . . 0.0 107.801 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -143.6 144.21 31.82 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -115.57 123.46 48.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 161.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.03 -179.73 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 159.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 52.16 -113.83 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.1 28.39 2.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.897 1.237 . . . . 0.0 110.075 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -127.59 127.31 43.64 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 tt -83.8 93.99 8.09 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.9 mt -73.44 111.96 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.8 135.5 44.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 163.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.6 m -128.36 124.19 35.79 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' CE2' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -117.77 125.82 51.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.599 0.76 . . . . 0.0 109.235 -178.024 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.8 m -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.195 1.798 . . . . 0.0 108.994 -172.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -97.34 161.88 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.01 63.84 1.61 Allowed Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.646 -0.659 . . . . 0.0 111.802 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.8 t 161.13 -60.44 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.544 3.138 . . . . 0.0 108.265 172.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.71 137.74 33.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.429 0.692 . . . . 0.0 110.391 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.84 123.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.496 1.118 . . . . 0.0 108.712 -173.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.1 t -133.37 111.67 10.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.416 0.687 . . . . 0.0 109.903 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -63.82 153.53 36.37 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 160.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -159.54 83.57 0.76 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.344 0.657 . . . . 0.0 109.3 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -88.46 126.88 35.45 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.459 -0.776 . . . . 0.0 109.973 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -102.61 144.37 31.1 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.695 1.198 . . . . 0.0 109.169 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.86 133.72 55.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.209 2.204 . . . . 0.0 106.864 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -58.8 141.27 53.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.058 0.845 . . . . 0.0 110.839 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -71.37 -31.25 67.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.953 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.657 1.183 . . . . 0.0 108.488 179.461 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.572 0.225 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.54 54.36 0.45 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.695 2.798 . . . . 0.0 111.578 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.71 -51.44 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.573 1.149 . . . . 0.0 108.279 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -57.64 -46.83 83.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.436 1.095 . . . . 0.0 110.96 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 p -38.23 110.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.412 1.885 . . . . 0.0 111.908 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.83 -146.48 18.42 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -130.78 134.74 47.12 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.639 0.775 . . . . 0.0 110.708 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -118.58 162.28 18.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.799 1.64 . . . . 0.0 109.744 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -136.8 132.96 35.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.604 1.162 . . . . 0.0 108.643 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.14 147.86 42.59 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.1 p -130.98 -70.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 122.856 0.463 . . . . 0.0 111.284 164.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 127' ' ' THR . 26.7 m-20 -93.47 144.14 25.64 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -171.93 43.34 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.66 155.36 33.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.053 0.842 . . . . 0.0 112.381 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.99 25.52 13.92 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.519 1.528 . . . . 0.0 111.991 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -75.18 -49.82 18.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.124 -0.985 . . . . 0.0 109.898 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.91 -61.38 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.466 0.65 . . . . 0.0 110.093 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 17.9 t70 -45.56 -48.56 14.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.559 1.944 . . . . 0.0 112.065 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -55.24 -44.62 75.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.262 1.025 . . . . 0.0 111.257 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.25 -33.2 59.17 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.679 -0.638 . . . . 0.0 111.088 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.7 ttpm? -73.41 51.89 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.473 1.509 . . . . 0.0 109.358 170.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 m -178.59 -60.17 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 128.372 2.669 . . . . 0.0 107.058 -173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.55 -20.26 62.05 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.91 -22.16 32.85 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.78 -1.011 . . . . 0.0 112.62 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -66.15 66.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.664 1.986 . . . . 0.0 114.776 -162.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.87 44.23 3.15 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.92 2.2 . . . . 0.0 110.438 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -36.17 -43.77 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.183 2.193 . . . . 0.0 114.027 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.29 44.48 2.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.489 1.116 . . . . 0.0 110.799 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.9 t -152.04 -44.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.65 . . . . 0.0 111.177 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -27.48 45.0 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.928 -1.107 . . . . 0.0 110.022 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.24 -20.14 64.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.361 1.464 . . . . 0.0 112.522 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.35 -30.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.15 0.58 . . . . 0.0 110.293 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.22 63.61 0.77 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.155 0.883 . . . . 0.0 111.925 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -162.3 -51.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.721 1.608 . . . . 0.0 110.455 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.4 mtt -57.21 -47.54 81.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.035 1.334 . . . . 0.0 109.983 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -68.16 66.85 0.11 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.148 2.179 . . . . 0.0 110.412 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -18.66 91.73 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 128.032 2.533 . . . . 0.0 113.549 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.27 136.89 67.16 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.125 1.216 . . . . 0.0 110.806 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.71 141.74 28.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 m -130.91 102.28 5.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.22 131.2 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.1 mt -126.2 103.41 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.12 134.57 40.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.77 119.34 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -95.13 168.78 10.55 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.253 1.021 . . . . 0.0 108.585 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -29.54 -60.38 0.18 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.886 1.707 . . . . 0.0 114.645 -170.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -126.47 22.19 7.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.867 1.667 . . . . 0.0 109.919 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.96 -178.67 6.61 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.834 0.854 . . . . 0.0 109.455 -153.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.45 150.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 121.122 -0.986 . . . . 0.0 108.96 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.4 tt -133.65 126.66 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -93.19 127.06 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -133.51 91.55 2.87 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -80.79 131.5 35.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.024 1.33 . . . . 0.0 109.17 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 114.13 23.51 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.559 0.744 . . . . 0.0 109.479 169.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.8 t -140.97 54.1 1.57 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t 39.67 -118.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.735 1.214 . . . . 0.0 110.045 -168.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -57.59 -9.37 1.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.889 1.676 . . . . 0.0 115.125 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -118.03 32.24 6.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.608 1.095 . . . . 0.0 111.129 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -63.21 159.76 17.02 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.65 -0.656 . . . . 0.0 110.653 162.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 160.16 23.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.807 1.243 . . . . 0.0 108.203 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.54 120.08 6.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.286 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mt -143.65 124.26 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.001 0.92 . . . . 0.0 109.928 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 p -91.2 142.19 27.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.955 2.102 . . . . 0.0 110.071 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -156.68 -175.68 5.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.436 1.094 . . . . 0.0 109.213 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -124.7 145.51 49.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 54.55 0.59 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.881 1.273 . . . . 0.0 110.154 174.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.42 58.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 p -164.99 162.33 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.49 148.16 23.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.778 0.674 . . . . 0.0 109.751 165.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.88 145.84 22.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.742 0.817 . . . . 0.0 110.263 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.68 133.59 48.65 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.697 1.599 . . . . 0.0 108.347 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -143.51 131.25 21.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 t -103.07 121.66 43.05 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.74 0.816 . . . . 0.0 108.857 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 171.72 8.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.43 -7.96 11.74 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -155.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -105.41 11.03 33.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.275 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t0 43.84 46.98 6.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.202 2.201 . . . . 0.0 113.222 -162.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 117.219 -1.792 . . . . 0.0 106.359 148.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.25 84.07 7.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -82.67 178.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.839 1.256 . . . . 0.0 109.536 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -124.44 119.36 28.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -100.74 157.68 16.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.852 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 120.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.6 t -107.57 131.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p -126.06 119.96 29.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.348 1.059 . . . . 0.0 108.352 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.87 103.99 15.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -86.25 -167.53 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.941 0.401 . . . . 0.0 110.16 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.2 55.02 2.75 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.585 -0.697 . . . . 0.0 111.798 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 -57.49 0.27 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.93 152.28 47.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.334 0.654 . . . . 0.0 111.116 -162.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.66 102.71 15.13 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -80.32 96.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.05 99.95 12.83 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.96 142.09 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 167.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -131.43 100.19 5.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.242 1.417 . . . . 0.0 107.76 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -114.55 157.01 23.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.609 1.164 . . . . 0.0 108.567 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.423 ' HE1' ' CD ' ' A' ' 100' ' ' GLN . 12.9 p90 -140.71 -62.5 0.49 Allowed 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.714 -0.617 . . . . 0.0 110.916 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -166.75 -82.58 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.075 0.398 . . . . 0.0 110.9 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.45 -17.02 80.28 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.84 -0.538 . . . . 0.0 112.099 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' CD ' ' HE1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -135.79 163.49 30.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.318 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.88 151.45 50.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.646 1.978 . . . . 0.0 106.213 173.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.8 p -137.06 166.9 22.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.011 0.924 . . . . 0.0 109.206 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 p -133.59 154.73 50.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.2 68.97 1.1 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.01 132.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.937 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.507 HH11 HD13 ' A' ' 115' ' ' LEU . 14.5 mtt-85 -123.08 153.32 40.06 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.483 0.583 . . . . 0.0 110.756 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 90' ' ' LYS . 45.4 tt0 -157.54 159.6 37.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.75 120.9 35.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 160.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.72 172.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 155.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.23 -120.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -165.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.63 21.71 3.56 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.828 1.204 . . . . 0.0 111.357 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -122.26 134.55 54.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.81 0.805 . . . . 0.0 109.454 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.94 79.82 1.66 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mt -64.27 132.55 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.187 0.995 . . . . 0.0 108.347 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.507 HD13 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -143.69 158.25 43.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 165.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 t -126.18 127.07 45.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 166.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tt -109.34 106.75 16.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.691 1.996 . . . . 0.0 105.782 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 p -124.76 138.53 54.28 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.695 1.198 . . . . 0.0 110.941 -162.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -134.19 141.28 47.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 107.859 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.4 91.22 0.02 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 165.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m 136.19 -27.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 131.28 3.832 . . . . 0.0 111.337 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.83 152.23 36.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.007 1.276 . . . . 0.0 111.206 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.16 135.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.727 0.811 . . . . 0.0 109.35 -170.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.0 t -141.32 106.85 5.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.442 0.697 . . . . 0.0 110.887 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.1 p -58.28 143.81 43.36 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 159.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -156.01 154.84 31.7 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.322 0.964 . . . . 0.0 108.978 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 12' ' ' ASP . 1.6 t -157.57 156.59 32.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.26 150.6 52.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.832 1.653 . . . . 0.0 107.956 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.61 136.22 52.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.053 1.341 . . . . 0.0 108.151 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -67.01 121.9 16.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -86.86 -38.43 16.78 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.133 0 C-N-CA 122.985 0.514 . . . . 0.0 109.879 -178.112 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.48 50.76 0.43 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.11 2.564 . . . . 0.0 111.84 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.01 -55.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.57 -46.71 66.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 111.421 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.01 104.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.416 1.487 . . . . 0.0 112.066 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.62 -169.68 29.15 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -109.93 132.74 53.89 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.73 0.812 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 53.0 m95 -115.71 140.88 48.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.384 1.074 . . . . 0.0 109.568 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -95.93 132.35 41.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 13' ' ' SER . 7.7 tt -61.72 141.48 57.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.51 -52.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.719 -0.657 . . . . 0.0 110.584 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.58 137.69 49.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.941 0.791 . . . . 0.0 108.995 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' HD21 ' A' ' 10' ' ' LEU . 35.6 t -155.36 144.57 20.94 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.931 1.692 . . . . 0.0 108.074 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -170.62 159.46 6.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.786 0.835 . . . . 0.0 111.787 163.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 t30 62.16 34.42 16.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.361 1.864 . . . . 0.0 112.756 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -74.78 -43.66 53.63 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.78 -48.22 75.7 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 117.493 0.133 . . . . 0.0 111.01 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -50.36 -46.87 56.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.942 0.897 . . . . 0.0 111.568 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 1.8 t80 -57.15 -55.52 33.6 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -36.64 31.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.757 1.223 . . . . 0.0 112.333 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -74.72 55.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.484 1.914 . . . . 0.0 109.611 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.4 p -178.88 -48.59 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.859 2.464 . . . . 0.0 107.065 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.15 -28.07 59.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.373 0.669 . . . . 0.0 112.322 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.78 29.35 72.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.688 0.661 . . . . 0.0 113.259 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.14 -51.62 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.588 1.155 . . . . 0.0 110.986 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.39 -65.52 2.31 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -155.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 25.5 -96.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.564 1.946 . . . . 0.0 114.788 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.78 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.488 0.715 . . . . 0.0 110.954 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 m -57.87 -36.97 73.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.753 1.621 . . . . 0.0 110.456 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -51.22 63.42 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.414 0.686 . . . . 0.0 111.003 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' NE2' HG23 ' A' ' 32' ' ' VAL 0.275 4.9 pp0? -63.78 -46.33 85.69 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.717 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.579 HG23 ' NE2' ' A' ' 31' ' ' GLN . 2.6 t -47.02 -49.38 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.216 0.462 . . . . 0.0 109.837 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.06 -23.68 1.2 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 128.239 2.828 . . . . 0.0 115.087 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -137.96 39.38 2.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.422 0.689 . . . . 0.0 110.34 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.0 ttt -156.86 -56.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.622 0.369 . . . . 0.0 111.684 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -115.13 56.93 0.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.084 0.553 . . . . 0.0 111.446 -157.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 33.38 61.61 1.66 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.989 1.716 . . . . 0.0 113.823 172.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.13 116.31 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.241 2.628 . . . . 0.0 109.187 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.33 157.75 19.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.371 1.068 . . . . 0.0 108.273 -170.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 m -148.09 101.55 3.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.508 -0.745 . . . . 0.0 110.865 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.79 126.47 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 107.995 161.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.3 mm -123.85 110.07 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.418 1.487 . . . . 0.0 107.558 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -112.02 115.94 29.73 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.203 1.001 . . . . 0.0 109.128 -168.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.09 123.3 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.05 164.9 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.855 1.262 . . . . 0.0 108.288 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -36.41 -53.7 1.33 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.028 1.299 . . . . 0.0 113.381 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -106.79 -42.19 5.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.651 1.581 . . . . 0.0 111.292 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -101.36 -170.65 1.86 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.754 2.021 . . . . 0.0 110.645 -162.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.76 133.55 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 162.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 133.11 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -101.32 124.91 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.63 103.23 10.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.493 1.917 . . . . 0.0 106.804 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -80.58 124.42 28.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.147 0.579 . . . . 0.0 109.895 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -93.78 119.69 33.08 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -136.65 36.99 2.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.898 0.479 . . . . 0.0 110.212 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.7 m 61.22 101.26 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.318 1.447 . . . . 0.0 112.129 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 t80 72.4 -62.13 0.47 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.611 1.164 . . . . 0.0 109.359 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 145.97 46.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.156 0.979 . . . . 0.0 109.081 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.93 178.26 7.09 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 163.6 38.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 161.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.66 149.71 40.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -140.37 133.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.4 p -96.74 124.71 40.8 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.825 1.65 . . . . 0.0 108.425 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.62 159.5 41.95 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 119.704 1.138 . . . . 0.0 111.056 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.14 135.58 50.04 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 66.74 0.37 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.299 0.5 . . . . 0.0 110.545 169.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.35 63.4 0.03 OUTLIER Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.181 0.896 . . . . 0.0 111.127 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -170.77 169.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.227 1.011 . . . . 0.0 108.347 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.99 157.35 40.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.292 0.637 . . . . 0.0 109.948 165.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -167.57 152.3 6.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.178 0.591 . . . . 0.0 111.205 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -72.34 133.06 44.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.755 1.622 . . . . 0.0 107.075 170.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -140.63 155.82 46.43 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.402 1.081 . . . . 0.0 108.729 -165.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -154.22 145.22 22.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.705 -0.622 . . . . 0.0 110.509 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.3 t -157.97 151.6 23.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.348 0.594 . . . . 0.0 111.865 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.75 65.56 3.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.822 1.649 . . . . 0.0 110.515 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 p30 171.49 -64.76 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 129.132 2.973 . . . . 0.0 108.015 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.274 9.3 t70 -78.1 -1.65 33.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 73.73 -156.74 0.07 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.964 1.306 . . . . 0.0 109.191 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -79.98 140.24 36.7 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 164.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.69 166.84 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.01 126.13 55.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 167.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -90.21 135.06 33.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.466 HG23 ' HB ' ' A' ' 94' ' ' VAL . 10.6 tt -129.2 115.77 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.08 134.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.92 0.888 . . . . 0.0 108.952 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -160.12 150.88 18.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.71 151.9 21.61 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.654 0.661 . . . . 0.0 111.2 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.21 178.97 4.74 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 161.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -19.07 -47.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 128.0 2.714 . . . . 0.0 115.363 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.42 62.09 0.28 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.305 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -172.73 149.9 2.08 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 108.893 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -86.95 131.51 34.07 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.35 108.44 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -94.83 107.5 19.52 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 83' ' ' ILE . 42.1 t -93.08 131.39 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -122.15 101.93 7.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 107.108 -163.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -115.62 114.49 24.98 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.611 1.564 . . . . 0.0 110.905 -163.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -104.79 -62.5 1.33 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.599 0.636 . . . . 0.0 111.599 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.81 106.27 1.84 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.758 0.708 . . . . 0.0 112.597 -171.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.95 25.25 65.77 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.939 0.781 . . . . 0.0 112.177 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -175.15 167.66 3.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.368 1.467 . . . . 0.0 107.045 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -157.3 160.91 39.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.9 p -124.15 149.43 46.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.138 0.575 . . . . 0.0 109.824 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.9 p -88.45 135.11 33.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.945 0.898 . . . . 0.0 109.123 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.94 87.72 2.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 161.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.21 129.92 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.0 138.11 51.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.445 1.098 . . . . 0.0 110.944 -171.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.02 155.34 32.51 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.743 0.652 . . . . 0.0 109.287 154.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -96.59 112.39 24.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.14 0.976 . . . . 0.0 109.188 165.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.6 -171.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.8 t70 51.07 -110.27 0.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.14 29.64 2.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.646 1.593 . . . . 0.0 109.678 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -150.01 146.12 26.81 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.99 0.895 . . . . 0.0 109.732 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 5.2 tt -85.09 113.19 21.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.4 mt -89.33 105.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.41 117.44 29.12 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 166.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.0 m -103.43 133.95 47.62 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 35.5 tp -130.67 86.78 2.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.475 1.11 . . . . 0.0 108.199 -161.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -115.59 133.03 56.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.414 0.552 . . . . 0.0 110.65 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -134.45 138.38 44.72 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.166 2.187 . . . . 0.0 107.783 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.58 108.01 0.72 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 165.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 m 121.8 -37.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 130.001 3.32 . . . . 0.0 112.174 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.63 162.64 38.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.098 1.317 . . . . 0.0 112.122 -168.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.87 151.74 20.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.699 0.799 . . . . 0.0 109.86 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.5 m -143.72 159.52 42.35 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.162 -0.961 . . . . 0.0 108.776 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.35 145.43 37.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 159.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -142.34 101.91 3.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -103.05 123.68 47.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -108.86 149.23 29.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.23 1.812 . . . . 0.0 110.101 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -124.35 127.36 47.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.512 1.525 . . . . 0.0 107.798 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -68.64 119.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.28 -29.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.244 0.618 . . . . 0.0 111.451 -173.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.138 0 CA-C-N 118.403 0.547 . . . . 0.0 109.907 170.384 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.25 -36.72 32.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.02 1.728 . . . . 0.0 111.438 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.64 -15.32 62.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.715 1.606 . . . . 0.0 112.016 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.75 -52.41 2.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.563 1.145 . . . . 0.0 110.098 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.11 114.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.422 1.489 . . . . 0.0 111.603 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.99 -178.66 22.64 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 121.722 0.624 . . . . 0.0 112.84 164.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -96.39 127.41 42.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 169.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -117.61 157.34 26.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.323 1.049 . . . . 0.0 108.355 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -120.33 149.92 41.55 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 162.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.16 148.36 31.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.47 -56.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 118.25 0.477 . . . . 0.0 111.42 168.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 148.82 27.65 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -166.07 154.24 10.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.768 0.827 . . . . 0.0 109.129 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -148.57 145.93 28.04 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.425 1.09 . . . . 0.0 108.701 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 66.77 17.8 10.61 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.32 1.848 . . . . 0.0 113.147 168.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -59.58 -38.88 82.34 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.753 -1.217 . . . . 0.0 109.341 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.94 -41.78 96.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 111.194 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -58.53 -48.0 82.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.326 0.65 . . . . 0.0 109.558 173.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -51.97 -56.27 15.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -48.85 -50.52 34.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.436 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -77.38 53.58 1.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.086 1.754 . . . . 0.0 110.056 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.3 p -177.92 -50.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.266 2.227 . . . . 0.0 106.592 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.94 -32.45 74.17 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.54 23.87 74.22 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.675 0.655 . . . . 0.0 112.064 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 30' ' ' ARG . 34.1 m -85.82 53.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.518 -0.99 . . . . 0.0 110.417 -173.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.25 109.14 0.05 OUTLIER Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.717 0.675 . . . . 0.0 112.256 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.78 -64.91 0.76 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 120.776 -1.426 . . . . 0.0 111.049 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.28 65.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.101 0.56 . . . . 0.0 110.736 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -51.3 -51.75 51.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.211 1.404 . . . . 0.0 110.98 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 25' ' ' VAL . 7.5 mmt85 -72.77 -42.19 64.25 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.468 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.32 -56.91 7.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.842 1.201 . . . . 0.0 110.248 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.01 -52.13 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 42.54 2.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.84 0.733 . . . . 0.0 113.514 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -157.71 -37.16 0.07 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.712 2.005 . . . . 0.0 109.91 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.9 ttt -76.77 -33.98 58.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.881 0.472 . . . . 0.0 109.942 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -66.24 166.68 11.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.539 166.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.29 80.59 3.46 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.719 0.808 . . . . 0.0 109.223 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.61 158.81 46.93 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.784 2.323 . . . . 0.0 112.338 -168.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 164.54 25.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.348 166.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -145.43 121.93 11.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 155.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mt -90.91 135.58 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -133.44 104.4 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -109.88 109.15 19.69 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.81 88.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -50.53 157.67 0.71 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.481 1.112 . . . . 0.0 110.854 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -26.0 -59.72 0.07 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.202 1.858 . . . . 0.0 115.182 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.75 13.63 9.29 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.718 1.207 . . . . 0.0 111.524 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.18 -172.16 4.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.557 1.543 . . . . 0.0 108.264 -157.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.06 149.56 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 120.766 -1.209 . . . . 0.0 109.974 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.49 128.9 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.11 125.01 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -115.09 106.04 13.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.568 1.547 . . . . 0.0 108.976 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -83.59 63.02 7.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.749 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -71.31 144.63 49.88 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 122.14 0.971 . . . . 0.0 112.957 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -158.53 168.11 27.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 168.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -80.81 56.72 2.78 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -172.7 -51.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -172.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -138.3 146.01 41.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -148.34 49.62 1.03 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.489 0.715 . . . . 0.0 110.138 -163.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 75' ' ' ALA . 27.9 p -85.61 151.4 23.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.592 0.357 . . . . 0.0 110.443 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -121.55 142.93 49.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 0.0 110.292 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.34 93.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -172.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 p -104.36 125.32 50.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.97 1.708 . . . . 0.0 110.113 -174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -161.27 170.55 20.01 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -93.77 127.46 39.51 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 165.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.06 64.73 1.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 110.867 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.46 55.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -169.61 173.5 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.26 1.024 . . . . 0.0 108.274 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -107.16 148.56 28.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.458 160.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.67 169.34 22.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.363 1.465 . . . . 0.0 108.469 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -92.2 121.85 34.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -116.65 138.17 51.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.413 1.485 . . . . 0.0 107.226 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -138.65 108.37 6.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -128.64 129.57 46.04 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.449 ' H ' HG21 ' A' ' 60' ' ' THR . . . -75.31 44.56 0.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.944 -1.097 . . . . 0.0 113.934 -172.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.27 48.9 p30 -147.36 -52.32 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.975 0.91 . . . . 0.0 109.382 156.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -6.07 47.6 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 82.72 -159.53 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.433 2.293 . . . . 0.0 111.9 165.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -83.76 127.98 34.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.263 1.425 . . . . 0.0 107.835 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 143.98 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.925 1.29 . . . . 0.0 107.641 -174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -81.35 114.39 20.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 166.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -96.58 119.49 35.16 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.312 1.045 . . . . 0.0 108.846 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.59 126.5 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.67 134.93 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.1 m -142.59 170.33 15.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.4 133.53 55.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 165.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -82.08 -23.01 36.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.747 0.419 . . . . 0.0 111.378 -174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.01 -32.55 3.96 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.021 1.296 . . . . 0.0 110.298 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.19 -23.96 8.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.643 1.592 . . . . 0.0 111.985 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -150.25 161.26 42.78 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.233 1.413 . . . . 0.0 111.522 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.29 124.55 31.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 163.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.21 128.74 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.302 1.041 . . . . 0.0 109.424 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -114.64 95.85 5.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.438 2.295 . . . . 0.0 106.78 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.65 96.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -97.9 107.9 20.49 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.326 1.45 . . . . 0.0 108.486 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -121.42 155.71 34.27 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.525 0.602 . . . . 0.0 111.954 -171.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -130.71 -60.94 0.97 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.406 -0.331 . . . . 0.0 110.788 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -160.63 -76.62 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 118.346 0.521 . . . . 0.0 111.962 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.8 -11.8 85.1 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.592 0.633 . . . . 0.0 113.094 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -173.13 175.87 3.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.6 1.56 . . . . 0.0 107.649 -172.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -154.06 158.96 41.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.294 1.437 . . . . 0.0 109.417 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.13 121.31 44.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.715 2.006 . . . . 0.0 108.814 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.17 99.16 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.536 1.134 . . . . 0.0 108.32 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.66 146.48 25.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.91 146.57 31.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -136.23 140.78 43.75 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.539 1.536 . . . . 0.0 108.248 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -163.96 153.18 14.02 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.437 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -111.66 118.74 36.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.477 0.58 . . . . 0.0 109.799 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 -174.43 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 t70 52.73 -107.09 0.32 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.67 29.62 1.43 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.036 1.303 . . . . 0.0 110.544 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -143.35 144.03 31.91 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.134 0.967 . . . . 0.0 109.875 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.84 93.59 6.29 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 171.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.5 mt -70.34 129.57 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -144.95 142.73 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.89 113.68 14.94 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -171.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 p -117.88 129.0 55.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 108.842 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -125.15 169.92 11.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.261 1.424 . . . . 0.0 107.191 173.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.09 118.57 2.39 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 161.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.285 0.5 OUTLIER 67.91 -58.25 0.45 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.6 2.36 . . . . 0.0 113.281 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.55 112.21 12.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.527 -0.733 . . . . 0.0 111.26 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.73 125.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 126.201 1.8 . . . . 0.0 106.573 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 3.9 m -144.8 167.42 22.62 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.926 -1.109 . . . . 0.0 110.281 -174.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.8 p -136.4 144.41 44.5 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.927 0.491 . . . . 0.0 111.249 -170.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -138.04 151.09 47.52 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 166.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.24 139.67 47.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -115.66 156.53 25.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.615 1.166 . . . . 0.0 109.568 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.1 127.45 26.49 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.509 1.124 . . . . 0.0 108.41 -168.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -64.24 119.54 10.46 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.198 0.999 . . . . 0.0 108.96 -173.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -82.01 -50.93 8.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 C-N-CA 123.795 0.838 . . . . 0.0 109.088 176.755 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.6 48.02 0.19 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.25 2.62 . . . . 0.0 112.483 -175.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.32 -60.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -172.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -61.67 -33.65 74.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.271 1.028 . . . . 0.0 110.716 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 5' ' ' VAL . 9.2 p -73.63 78.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.724 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.94 -166.86 26.51 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 160.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 m -76.97 124.05 27.21 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.196 1.398 . . . . 0.0 110.984 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.429 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 11.3 m0 -104.16 149.42 25.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.841 1.256 . . . . 0.0 109.002 169.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.2 134.94 54.69 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.992 0.917 . . . . 0.0 108.888 162.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.31 144.77 56.38 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.4 -25.71 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.667 177.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.08 157.08 47.05 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.61 1.096 . . . . 0.0 110.124 173.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 t 176.72 86.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.414 1.886 . . . . 0.0 109.903 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -116.1 160.89 19.71 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.088 0.555 . . . . 0.0 110.925 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 58.33 8.05 0.77 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.329 1.852 . . . . 0.0 112.89 -177.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -31.15 64.46 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.878 -1.139 . . . . 0.0 109.397 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.57 -65.4 0.62 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -44.13 -52.06 7.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.1 1.76 . . . . 0.0 112.229 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -46.43 -50.38 16.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.032 1.333 . . . . 0.0 112.035 176.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.8 mtp -76.9 -34.5 57.73 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.728 -0.607 . . . . 0.0 110.291 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 43.64 0.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.515 2.326 . . . . 0.0 110.313 171.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -171.23 -54.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 119' ' ' HIS . 84.1 mt -61.2 -27.68 68.6 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 172.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.29 -18.72 55.69 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 119.28 0.945 . . . . 0.0 113.103 171.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 m -41.12 -47.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 127.133 2.173 . . . . 0.0 113.453 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.25 72.27 0.2 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -172.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.85 158.36 2.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 110.605 172.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.13 -78.06 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.438 1.495 . . . . 0.0 110.478 -170.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.7 p -35.24 -44.68 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.756 2.823 . . . . 0.0 113.992 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -34.9 -40.11 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 170.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -50.54 -34.88 27.09 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.007 1.723 . . . . 0.0 113.361 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.72 -44.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.31 18.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.071 0.843 . . . . 0.0 113.109 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -55.57 -53.81 51.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.895 . . . . 0.0 111.978 174.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.4 mtt -81.08 -21.7 39.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.477 1.511 . . . . 0.0 111.511 -172.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -70.44 60.66 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.802 0.728 . . . . 0.0 110.903 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -147.8 48.51 0.65 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.234 2.614 . . . . 0.0 109.043 172.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 -41.58 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.138 2.559 . . . . 0.0 112.311 -167.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -119.62 142.61 48.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 m -146.09 105.19 3.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.769 -0.582 . . . . 0.0 109.592 177.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.4 mt -77.11 113.47 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 170.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.429 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 40.1 mm -101.41 138.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 163.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -142.99 109.8 5.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -166.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.64 81.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -54.62 156.77 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.286 171.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.0 -72.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.419 2.438 . . . . 0.0 115.604 -171.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -116.42 10.0 14.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.898 1.679 . . . . 0.0 111.132 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.83 -166.48 2.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.296 1.838 . . . . 0.0 108.197 -157.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.28 136.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -112.16 133.58 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 tt -93.62 137.65 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 169.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -138.79 88.11 2.27 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.92 1.688 . . . . 0.0 107.398 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -77.91 129.94 35.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.804 1.642 . . . . 0.0 108.636 178.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.31 143.61 51.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.707 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -158.99 -173.0 4.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.213 1.005 . . . . 0.0 109.461 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -82.18 116.48 21.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.3 t80 59.98 27.25 16.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.093 0.957 . . . . 0.0 112.665 173.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -163.66 75.07 0.35 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.264 -0.898 . . . . 0.0 109.661 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -105.91 139.86 39.82 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 p -150.77 148.81 28.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.85 142.9 24.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.252 0.478 . . . . 0.0 110.989 179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.9 mt -149.96 136.14 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.784 1.234 . . . . 0.0 109.095 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 p -90.22 133.78 34.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.923 1.689 . . . . 0.0 110.075 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.67 177.81 8.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.034 0.934 . . . . 0.0 111.009 176.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 68' ' ' VAL . 53.3 tptt -125.58 139.33 53.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 107.042 -176.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 57.14 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.465 0.706 . . . . 0.0 109.65 169.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.07 57.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -167.44 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.015 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.4 142.69 50.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.558 0.536 . . . . 0.0 111.174 161.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -133.78 150.53 51.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.498 1.519 . . . . 0.0 107.556 -174.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -72.22 131.09 42.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -125.65 131.14 52.69 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 t -126.97 145.35 50.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -146.0 172.32 13.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.56 0.695 . . . . 0.0 110.275 174.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.88 30.73 0.25 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.972 1.309 . . . . 0.0 113.433 -158.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -126.18 11.85 7.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.12 2.568 . . . . 0.0 109.85 165.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t0 63.05 29.33 16.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.492 2.317 . . . . 0.0 112.751 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.81 74.67 1.6 Allowed 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.247 -1.533 . . . . 0.0 109.674 164.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.81 68.86 1.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.196 1.398 . . . . 0.0 109.092 170.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.81 -168.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 110.415 -174.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -135.38 134.67 39.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.224 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -122.36 122.6 39.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.285 1.034 . . . . 0.0 109.703 -163.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.39 132.02 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.07 132.19 68.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.275 0.63 . . . . 0.0 109.663 -176.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.05 103.06 2.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.552 1.541 . . . . 0.0 107.661 -178.061 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.83 130.81 40.09 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.907 -1.12 . . . . 0.0 110.563 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.64 27.59 0.21 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -164.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.81 -38.74 3.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.607 -1.107 . . . . 0.0 111.081 -158.079 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.54 -64.77 0.17 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.309 1.554 . . . . 0.0 112.544 -175.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 135.82 34.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -174.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.28 89.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.414 ' HA ' HG23 ' A' ' 105' ' ' VAL . 6.5 t -69.78 113.6 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -115.05 117.97 32.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -117.08 140.46 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -128.6 97.98 4.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -157.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -90.93 162.56 14.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 109.133 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -138.52 -56.15 0.63 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.642 -0.661 . . . . 0.0 110.789 166.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -163.88 -76.11 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.805 0.275 . . . . 0.0 111.11 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.63 -21.76 59.37 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.569 -0.573 . . . . 0.0 111.773 -177.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.73 174.71 11.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.792 . . . . 0.0 109.348 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -133.02 176.17 8.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.845 2.458 . . . . 0.0 109.069 177.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.7 t -133.59 153.77 51.4 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.49 1.116 . . . . 0.0 109.454 165.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.7 m -109.78 134.03 52.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.953 0.901 . . . . 0.0 108.879 -176.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.67 80.4 1.28 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.801 0.81 . . . . 0.0 109.658 -176.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 92' ' ' VAL . 0.3 OUTLIER -67.95 148.72 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.771 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -126.12 110.05 13.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -132.54 147.73 52.36 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.243 -177.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.0 ttt -118.09 134.3 55.11 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.21 1.404 . . . . 0.0 108.541 171.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -148.91 177.68 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 54.67 -103.78 0.19 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.35 26.24 1.54 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.123 1.344 . . . . 0.0 109.869 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -140.37 169.08 18.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.756 0.822 . . . . 0.0 109.194 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.62 128.37 45.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -171.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.5 mt -111.82 130.77 64.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -112.7 114.67 27.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.989 0.916 . . . . 0.0 108.693 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 105' ' ' VAL . 65.6 p -94.63 76.16 3.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.18 101.45 3.97 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.6 t -128.71 128.33 43.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.471 0.578 . . . . 0.0 110.846 -176.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.41 ' CD2' HD21 ' A' ' 23' ' ' LEU . 16.0 t60 -173.38 143.69 1.1 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.769 1.227 . . . . 0.0 109.336 175.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.31 54.74 32.29 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 167.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 m 73.98 -44.96 0.58 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.8 1.24 . . . . 0.0 112.11 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.05 115.98 4.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.67 0.788 . . . . 0.0 111.279 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.09 99.19 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.297 1.439 . . . . 0.0 107.497 172.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.9 t -100.36 105.66 17.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.229 1.012 . . . . 0.0 110.479 175.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -65.29 138.48 58.23 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 155.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -115.51 155.88 26.72 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 144.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.84 137.84 46.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 165.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.81 166.03 11.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.284 2.234 . . . . 0.0 108.77 174.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.37 114.11 15.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -75.35 73.82 2.43 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.382 0.611 . . . . 0.0 109.538 -171.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -45.06 62.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.611 1.564 . . . . 0.0 111.526 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.007 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.93 51.07 0.21 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 131.02 3.728 . . . . 0.0 111.329 -166.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.3 -53.87 0.05 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -158.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.93 47.67 0.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.454 1.102 . . . . 0.0 109.494 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 49.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.847 1.259 . . . . 0.0 108.593 -174.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.3 -165.04 35.28 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.627 -0.671 . . . . 0.0 112.793 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m -87.83 136.39 32.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.499 1.12 . . . . 0.0 111.17 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -115.8 154.5 29.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.912 1.685 . . . . 0.0 108.824 172.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -121.19 152.92 38.23 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 167.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.05 134.65 34.2 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.005 1.322 . . . . 0.0 109.635 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.65 -41.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.451 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -144.48 158.25 43.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.135 0.879 . . . . 0.0 109.192 170.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -174.35 111.93 0.16 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.929 2.092 . . . . 0.0 109.422 -163.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.3 145.26 24.47 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m120 77.11 -5.9 2.1 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.484 2.313 . . . . 0.0 111.476 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -76.21 -41.95 47.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.604 1.562 . . . . 0.0 107.678 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -32.21 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.032 1.733 . . . . 0.0 111.995 151.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -56.49 -40.15 74.46 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.346 0.521 . . . . 0.0 112.381 -173.058 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE2' HD21 ' A' ' 117' ' ' LEU . 29.6 t80 -36.04 -58.91 0.63 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.832 1.253 . . . . 0.0 112.826 178.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.73 -26.29 65.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.103 -174.025 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -76.79 51.99 0.81 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.226 1.01 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -168.28 -44.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.372 2.269 . . . . 0.0 107.428 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.44 -12.19 13.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.69 63.07 1.72 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.1 OUTLIER -166.16 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.826 1.65 . . . . 0.0 110.205 -176.85 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.04 149.45 20.36 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.88 62.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.97 1.308 . . . . 0.0 108.362 -178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 65.59 -19.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.157 1.783 . . . . 0.0 115.255 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 m -99.77 -54.48 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.291 1.436 . . . . 0.0 109.072 -170.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -63.65 -10.94 21.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -56.11 -43.53 78.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.265 0.939 . . . . 0.0 110.884 165.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -50.96 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.682 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.19 39.94 1.22 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.116 1.341 . . . . 0.0 113.376 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.1 -25.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.245 1.018 . . . . 0.0 112.227 171.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.86 -36.93 85.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 162.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 36' ' ' THR . 2.4 t -63.13 82.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.151 0.977 . . . . 0.0 109.873 167.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -144.47 60.6 7.82 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.792 1.637 . . . . 0.0 108.732 164.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.72 -21.18 25.52 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.381 2.721 . . . . 0.0 110.87 -174.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.3 m -142.87 152.06 41.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.494 -0.754 . . . . 0.0 109.244 -177.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.3 m -154.86 125.99 7.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.0 mt -78.26 134.0 29.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 166.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.9 105.36 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 166.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.1 108.31 12.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.866 0.866 . . . . 0.0 110.224 -170.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.96 114.97 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 169.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -99.74 169.38 9.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.303 1.441 . . . . 0.0 108.495 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -22.49 -65.24 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.433 1.968 . . . . 0.0 114.913 -172.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -116.88 5.06 12.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.097 1.359 . . . . 0.0 111.865 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.8 -172.73 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.717 1.607 . . . . 0.0 109.96 -154.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.11 136.08 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 166.231 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 tt -104.0 140.21 22.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 tt -124.96 125.68 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.614 1.565 . . . . 0.0 108.456 177.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -134.73 105.9 6.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.84 0.856 . . . . 0.0 109.397 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.82 38.73 0.72 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.609 1.163 . . . . 0.0 113.274 -159.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -44.05 121.52 2.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 113.943 -164.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -141.63 62.87 1.44 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.277 0.631 . . . . 0.0 110.004 -176.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 m 73.03 125.66 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.137 1.375 . . . . 0.0 109.96 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 72.9 -53.68 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.99 1.316 . . . . 0.0 111.911 -178.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.77 -163.73 0.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -169.28 -168.49 0.83 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 p -54.58 147.59 14.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.256 1.423 . . . . 0.0 110.959 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -134.78 122.71 22.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.704 1.601 . . . . 0.0 106.832 176.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.49 158.41 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -129.64 159.72 35.53 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 165.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.13 179.55 8.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.919 0.888 . . . . 0.0 108.717 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -145.75 128.11 15.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 76.03 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.133 0.973 . . . . 0.0 110.052 171.047 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.54 59.3 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.274 1.416 . . . . 0.0 111.084 174.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -168.32 168.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.103 0.952 . . . . 0.0 109.148 174.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.18 152.56 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 110.774 168.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -172.62 163.81 5.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.539 1.136 . . . . 0.0 109.622 -172.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.5 132.78 44.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.738 0.415 . . . . 0.0 110.115 177.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -123.08 87.02 2.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.58 1.952 . . . . 0.0 107.11 -176.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.7 m -89.4 109.07 20.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.436 0.694 . . . . 0.0 109.514 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -131.88 157.7 43.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.523 0.677 . . . . 0.0 112.256 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.76 49.27 1.03 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.506 1.522 . . . . 0.0 111.727 -173.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -172.01 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.342 1.457 . . . . 0.0 107.346 -173.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.268 5.6 m-20 -74.43 9.47 1.71 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.348 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 70.12 -154.9 0.13 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 109.108 162.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.96 81.61 3.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG21 ' HG2' ' A' ' 95' ' ' GLN . 6.4 p -96.68 165.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -108.19 128.03 54.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.165 -0.959 . . . . 0.0 109.127 171.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 134.55 36.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 tt -129.1 115.52 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 153.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.698 0.799 . . . . 0.0 110.254 -166.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -156.29 173.7 16.48 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.546 1.539 . . . . 0.0 106.934 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.27 148.14 49.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.448 1.022 . . . . 0.0 109.886 161.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -116.89 108.83 16.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.519 1.127 . . . . 0.0 108.151 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.67 -68.01 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.637 1.113 . . . . 0.0 111.715 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.8 60.82 0.16 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.679 -2.169 . . . . 0.0 107.679 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.07 113.58 1.22 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 -177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.09 120.63 31.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.04 129.93 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.693 1.597 . . . . 0.0 108.116 -174.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -113.09 106.18 14.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 171.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -82.17 125.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 164.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' HG21 ' A' ' 80' ' ' VAL . 49.6 tt0 -126.09 92.26 3.55 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -163.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -110.0 113.97 27.13 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.267 1.427 . . . . 0.0 108.658 -162.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.45 -55.27 3.35 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.192 0.905 . . . . 0.0 110.677 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -169.46 -90.96 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 117.901 0.319 . . . . 0.0 110.76 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.63 -23.53 77.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -175.35 4.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.613 0.765 . . . . 0.0 109.646 176.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.75 166.54 26.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.286 2.234 . . . . 0.0 106.624 -171.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 t -130.24 153.83 48.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 156.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 p -116.82 137.99 51.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.16 156.64 44.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.71 152.19 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.114 0.566 . . . . 0.0 110.236 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -123.6 138.13 54.61 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.915 1.286 . . . . 0.0 108.641 168.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -156.16 146.69 21.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.733 2.013 . . . . 0.0 106.471 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.09 122.22 22.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.624 0.77 . . . . 0.0 109.133 169.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.46 176.41 4.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 159.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.3 t70 51.76 -117.58 1.15 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -129.7 15.25 5.72 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.234 1.397 . . . . 0.0 110.588 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -123.81 134.22 53.66 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.759 0.78 . . . . 0.0 110.453 -167.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 tp -97.66 116.35 29.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.814 1.645 . . . . 0.0 108.311 -171.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.7 mm -86.29 120.94 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.76 113.34 26.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 167.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -111.46 127.78 55.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 170.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -138.46 108.53 6.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.347 1.459 . . . . 0.0 107.689 -166.496 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -131.48 138.65 49.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.885 0.85 . . . . 0.0 112.211 -170.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -139.72 92.05 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.62 -118.37 12.58 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -61.85 -43.46 98.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.697 1.199 . . . . 0.0 111.323 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.64 68.07 5.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.218 -167.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.9 136.42 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.195 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' HD23 ' A' ' 117' ' ' LEU . 4.0 m -145.62 160.7 41.29 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.361 -1.462 . . . . 0.0 109.929 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -142.07 154.61 45.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.362 0.414 . . . . 0.0 110.783 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -132.95 169.29 17.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 151.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 119.07 11.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 -176.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -112.24 163.69 14.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.983 1.713 . . . . 0.0 109.283 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -133.56 123.8 25.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 127.364 2.266 . . . . 0.0 107.934 -174.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.97 111.15 3.19 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.13 -34.04 10.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 110.636 -173.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 C-N-CA 123.878 0.871 . . . . 0.0 109.936 174.63 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.53 60.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 129.304 3.042 . . . . 0.0 112.096 -169.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.53 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.159 1.784 . . . . 0.0 107.754 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -58.52 -36.6 74.09 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.752 1.221 . . . . 0.0 111.404 -176.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.5 104.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.14 0.976 . . . . 0.0 111.773 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.58 -177.26 27.87 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.349 1.452 . . . . 0.0 113.347 169.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -85.45 108.45 17.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.147 1.779 . . . . 0.0 111.075 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -97.01 155.86 16.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 174.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -123.97 129.67 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.161 1.784 . . . . 0.0 106.555 174.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.86 131.2 35.82 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.51 -42.75 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.439 0.563 . . . . 0.0 110.781 172.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 66.86 151.55 0.07 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.898 2.079 . . . . 0.0 111.953 -173.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -166.88 30.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.675 163.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -166.91 87.34 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.249 -0.907 . . . . 0.0 110.851 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 63.05 50.98 2.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.44 1.096 . . . . 0.0 110.787 161.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -82.46 -60.65 2.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.212 0.605 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -43.17 -66.34 0.39 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.124 2.169 . . . . 0.0 109.647 171.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.7 OUTLIER -20.48 -60.55 0.02 OUTLIER 'General case' 0 C--N 1.34 0.175 0 C-N-CA 127.732 2.413 . . . . 0.0 113.039 164.122 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CD2' HD12 ' A' ' 117' ' ' LEU . 3.9 t80 -63.84 -48.97 74.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.234 -171.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 mtt -62.16 -45.13 94.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.981 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -57.06 -31.34 65.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.125 2.57 . . . . 0.0 111.988 177.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -85.95 -57.27 3.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.598 1.159 . . . . 0.0 110.033 178.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.29 -25.25 68.23 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.191 0.596 . . . . 0.0 112.568 -173.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.16 21.61 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.99 -27.74 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.099 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.12 -109.3 0.01 OUTLIER Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.176 1.846 . . . . 0.0 113.631 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 27.94 54.25 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.081 2.553 . . . . 0.0 114.36 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 138.87 -61.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.602 2.761 . . . . 0.0 107.743 -172.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 p -66.23 -48.59 70.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -173.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -49.49 -18.92 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.401 1.88 . . . . 0.0 115.74 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -107.16 -13.6 15.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.787 0.835 . . . . 0.0 113.034 -177.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -143.23 -68.61 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.894 0.77 . . . . 0.0 109.169 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.39 60.45 1.53 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.777 1.656 . . . . 0.0 111.223 -176.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.9 -48.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.978 2.111 . . . . 0.0 107.643 -174.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.5 ttm -99.91 -16.9 17.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.321 1.048 . . . . 0.0 111.482 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 36' ' ' THR . 6.7 t -69.43 72.06 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.825 0.85 . . . . 0.0 111.327 178.662 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 45.51 66.62 5.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 111.947 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.16 105.16 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.005 2.47 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -108.82 139.37 43.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.793 1.237 . . . . 0.0 108.48 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.5 m -126.3 106.84 9.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -71.43 130.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 164.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -121.89 133.27 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 165.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.2 139.57 37.54 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 119.145 0.884 . . . . 0.0 109.421 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.72 138.62 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.32 164.26 19.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.0 108.173 175.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.81 -71.8 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.934 2.207 . . . . 0.0 115.521 -175.033 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -123.98 23.48 8.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.998 1.719 . . . . 0.0 110.319 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.85 -178.75 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.273 1.029 . . . . 0.0 108.681 -152.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.04 134.25 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 172.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.2 tt -99.1 141.31 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.078 0.951 . . . . 0.0 108.554 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 133.52 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.689 1.596 . . . . 0.0 107.422 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -127.32 95.75 4.37 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.811 1.244 . . . . 0.0 109.071 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.28 82.7 7.68 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.677 0.791 . . . . 0.0 109.685 -174.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -74.92 72.9 2.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.627 0.771 . . . . 0.0 109.018 173.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.9 t -142.99 -68.55 0.35 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.067 1.747 . . . . 0.0 106.977 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 m -60.3 144.38 50.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.113 0.965 . . . . 0.0 110.279 175.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -48.55 135.69 14.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.944 0.498 . . . . 0.0 110.115 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 73.39 -4.73 2.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 0.0 113.458 -178.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.6 72.49 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 111.821 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 150.01 38.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.623 -174.381 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -139.02 135.67 34.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.879 1.672 . . . . 0.0 107.863 -174.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 tp -159.45 159.42 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.535 0.607 . . . . 0.0 109.961 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.7 p -110.59 129.59 55.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.867 . . . . 0.0 109.834 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -131.16 179.87 5.75 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 110.225 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -139.59 147.16 40.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.901 1.28 . . . . 0.0 107.864 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.54 68.7 1.64 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.007 0.523 . . . . 0.0 109.603 174.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.38 69.72 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.11 165.79 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.827 0.851 . . . . 0.0 108.908 175.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -156.85 166.95 31.92 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.771 0.829 . . . . 0.0 109.005 174.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -74.47 124.11 25.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.91 58.93 0.73 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 107.433 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -57.61 106.14 0.31 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 165.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 t -147.64 134.6 20.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.895 0.478 . . . . 0.0 110.393 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.36 -36.19 41.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.13 . . . . 0.0 113.367 -174.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.43 1.07 23.36 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.669 1.188 . . . . 0.0 113.21 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -132.4 -57.05 0.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 109.7 174.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 128.64 -147.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 1 C-N-CA 132.553 4.341 . . . . 0.0 107.255 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -86.69 117.11 25.23 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 95' ' ' GLN . 7.2 p -151.85 148.0 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -169.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -95.61 141.1 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.8 p -121.06 87.76 2.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.513 1.125 . . . . 0.0 109.622 -166.058 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.1 105.34 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 175.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.59 139.92 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.835 0.854 . . . . 0.0 110.913 -172.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.35 171.0 19.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.23 1.812 . . . . 0.0 107.423 -152.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -142.16 131.53 23.65 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -136.7 150.81 48.66 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.182 0.993 . . . . 0.0 109.181 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.46 -80.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.61 1.1 . . . . 0.0 111.66 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.25 30.61 0.27 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.111 1.339 . . . . 0.0 110.651 171.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -132.1 141.55 49.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.111 1.364 . . . . 0.0 108.013 -176.54 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tt -96.78 112.32 24.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.632 1.173 . . . . 0.0 108.203 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.91 118.33 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 109.335 -174.042 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -111.35 99.43 8.23 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.601 2.36 . . . . 0.0 106.771 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 132.76 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 170.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HG3' HG21 ' A' ' 80' ' ' VAL . 8.2 tp60 -135.19 98.4 3.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -156.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -116.08 118.48 32.99 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.225 1.01 . . . . 0.0 111.232 -163.089 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -109.4 -26.16 10.15 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.235 0.614 . . . . 0.0 112.5 -176.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -144.61 -135.53 0.09 Allowed 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.54 66.85 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.287 0.949 . . . . 0.0 111.058 170.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -94.6 166.28 12.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.843 0.857 . . . . 0.0 111.643 -174.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 172.76 12.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.681 1.992 . . . . 0.0 110.597 173.33 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 t -113.67 154.2 27.66 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 153.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 p -112.9 106.52 14.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.652 1.181 . . . . 0.0 108.753 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 115' ' ' LEU . 2.1 mp -102.74 109.65 21.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.154 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.72 116.45 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.33 0.652 . . . . 0.0 109.403 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.472 ' CG ' HD23 ' A' ' 115' ' ' LEU . 12.0 mtt85 -95.93 131.58 42.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.836 1.654 . . . . 0.0 108.752 177.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -144.51 143.1 30.68 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -118.22 119.83 35.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -125.32 -169.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 159.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.26 -113.81 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.035 0.534 . . . . 0.0 109.649 176.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.32 20.68 3.15 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.095 1.807 . . . . 0.0 110.172 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -140.31 143.03 35.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.978 0.889 . . . . 0.0 109.895 -172.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.4 tt -97.01 99.61 11.14 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.23 125.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.5 tm? -115.95 103.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -92.6 125.55 37.29 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.44 HD12 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -117.45 85.05 2.26 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.682 1.193 . . . . 0.0 108.383 -174.455 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.58 124.19 30.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -145.26 145.47 31.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 160.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.64 -36.07 4.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.1 1.333 . . . . 0.0 113.898 -175.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -54.8 -41.21 70.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.388 0.594 . . . . 0.0 111.623 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -171.2 128.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.196 0.599 . . . . 0.0 110.33 -175.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.82 128.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 166.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.467 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 24.2 m -145.1 153.07 41.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.086 -1.009 . . . . 0.0 108.436 -177.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.3 p -140.94 123.67 16.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.154 0.888 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -95.9 102.89 14.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.358 1.863 . . . . 0.0 107.559 175.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 110.04 18.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -92.92 147.99 22.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.54 0.686 . . . . 0.0 111.334 176.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -134.38 123.27 23.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.311 2.244 . . . . 0.0 107.148 -172.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -75.49 130.54 39.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.771 0.714 . . . . 0.0 109.782 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -21.42 11.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.137 0.426 . . . . 0.0 112.011 164.111 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 118.333 0.515 . . . . 0.0 111.171 -179.455 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.758 0.313 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.86 60.28 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 130.5 3.52 . . . . 0.0 111.174 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.07 -44.83 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.074 1.75 . . . . 0.0 107.884 -169.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -61.59 -39.86 92.71 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.534 0.734 . . . . 0.0 111.391 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -38.26 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.906 1.682 . . . . 0.0 111.753 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.19 -172.41 23.21 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.271 0.928 . . . . 0.0 113.172 170.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -84.24 116.98 23.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.64 1.576 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -99.99 161.21 13.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 166.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.17 135.42 22.82 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.85 135.42 52.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.981 -0.45 . . . . 0.0 109.846 -173.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.33 -39.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 175.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -141.6 162.72 34.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.8 t -174.38 148.89 1.29 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 171.438 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -121.68 164.43 17.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.33 -22.86 0.21 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 166.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.09 -43.2 20.13 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -166.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -67.35 -61.82 1.72 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.245 0.93 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -40.8 -50.17 3.15 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.868 1.267 . . . . 0.0 111.92 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -50.36 -49.15 55.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.855 1.662 . . . . 0.0 111.876 177.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -37.17 70.76 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.501 -0.75 . . . . 0.0 110.256 176.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.95 48.82 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.914 2.486 . . . . 0.0 109.073 -169.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 p -172.96 -49.26 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.865 1.666 . . . . 0.0 107.26 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -66.16 33.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.226 1.411 . . . . 0.0 114.339 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.87 2.87 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 120.09 -1.631 . . . . 0.0 111.754 -178.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.61 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.299 2.64 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.82 145.39 17.84 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.916 1.246 . . . . 0.0 110.054 172.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -175.19 171.98 2.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.926 1.69 . . . . 0.0 106.568 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.25 44.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.845 0.748 . . . . 0.0 112.999 -175.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 -52.17 11.01 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.32 -0.863 . . . . 0.0 112.896 -167.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -63.87 -40.09 95.73 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -157.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -36.63 -43.31 0.4 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.686 1.595 . . . . 0.0 113.764 163.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.86 -50.04 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.75 -31.79 5.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.042 2.258 . . . . 0.0 115.702 -176.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -85.5 -37.51 19.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.36 1.08 . . . . 0.0 110.463 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -32.7 66.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.975 0.91 . . . . 0.0 109.885 -174.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -76.17 52.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.399 1.08 . . . . 0.0 111.763 -177.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 30.56 58.45 0.94 Allowed Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 127.599 2.36 . . . . 0.0 114.116 172.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.67 142.0 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.444 1.429 . . . . 0.0 112.023 -166.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.26 175.11 4.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.924 1.289 . . . . 0.0 109.825 172.424 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -159.29 112.15 2.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.486 1.914 . . . . 0.0 106.146 151.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.41 136.58 22.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 174.007 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.4 114.82 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 173.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -118.79 128.81 54.82 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.08 96.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -77.81 65.13 3.2 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.27 -87.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.453 1.502 . . . . 0.0 112.572 -179.104 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.42 -15.94 18.56 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.956 1.703 . . . . 0.0 111.621 -175.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.1 p -108.11 157.18 18.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.75 118.11 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 tt -101.35 137.89 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.794 0.837 . . . . 0.0 108.99 -174.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mp -117.44 131.72 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.416 1.487 . . . . 0.0 107.165 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -124.54 115.92 21.64 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -64.89 -46.79 80.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.274 0.23 . . . . 0.0 110.475 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 56.5 78.52 0.21 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.59 0.756 . . . . 0.0 112.538 169.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -148.06 149.37 31.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 162.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.7 p -11.41 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 129.129 2.972 . . . . 0.0 114.363 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -118.24 46.48 1.78 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.98 1.312 . . . . 0.0 108.085 177.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -158.96 55.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -110.57 139.66 45.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.748 1.619 . . . . 0.0 108.892 177.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 p -146.41 160.83 41.55 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 173.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -138.99 128.14 23.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -144.12 132.67 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.596 0.758 . . . . 0.0 109.439 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.1 p -106.14 99.5 9.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.547 1.539 . . . . 0.0 109.98 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -84.91 110.22 18.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.424 0.556 . . . . 0.0 110.218 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -76.84 97.99 4.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 161.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.05 110.5 0.61 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 170.06 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.09 22.55 6.17 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.09 1.805 . . . . 0.0 113.11 175.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -149.11 159.95 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.905 1.352 . . . . 0.0 109.388 -177.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.14 121.81 42.94 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.593 1.557 . . . . 0.0 108.371 166.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -132.52 155.77 48.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.959 1.303 . . . . 0.0 109.401 -177.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.57 148.39 51.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.057 0.543 . . . . 0.0 109.867 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -141.39 158.01 44.43 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.044 1.337 . . . . 0.0 108.786 -167.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -130.18 119.42 22.93 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.969 0.508 . . . . 0.0 110.945 -175.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.82 150.44 20.41 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.123 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.68 14.68 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -166.073 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -106.41 11.58 30.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.569 1.948 . . . . 0.0 110.094 164.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 t0 58.96 26.26 14.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.26 1.824 . . . . 0.0 111.909 -170.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -68.75 100.88 1.22 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 156.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.92 125.59 19.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 151.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' HB3' ' A' ' 97' ' ' TRP . 11.6 m -135.45 -165.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -139.42 144.32 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.458 1.027 . . . . 0.0 110.935 171.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -110.16 118.5 36.53 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.701 2.0 . . . . 0.0 108.71 -175.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.7 tt -96.57 125.47 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 164.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.5 139.69 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 m -144.94 161.84 38.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 170.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -123.33 115.02 20.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.03 130.73 53.89 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.88 -82.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.091 0.853 . . . . 0.0 113.705 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.35 25.45 1.1 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.353 1.454 . . . . 0.0 111.683 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.99 126.14 51.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 107.222 177.071 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 91' ' ' LEU . 5.6 tt -86.38 106.02 17.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 170.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.8 109.08 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -107.81 123.42 48.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -115.94 140.38 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.26 110.08 12.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.858 1.663 . . . . 0.0 107.907 -169.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.99 132.55 56.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.724 2.01 . . . . 0.0 108.233 -164.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.482 ' HB3' HG12 ' A' ' 80' ' ' VAL . 6.3 p90 -119.72 -65.01 1.2 Allowed 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.825 0.284 . . . . 0.0 111.443 177.36 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.49 -84.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.183 0.447 . . . . 0.0 111.11 -173.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.45 -30.22 74.91 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -175.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -171.75 3.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.557 0.694 . . . . 0.0 109.251 173.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.23 168.36 20.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.817 2.847 . . . . 0.0 104.767 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.5 t -144.26 147.79 34.02 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.9 m -109.74 143.99 38.77 Favored 'General case' 0 C--O 1.228 -0.075 0 C-N-CA 123.289 0.635 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.24 63.85 1.57 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.044 2.138 . . . . 0.0 107.322 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 p -74.02 128.94 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -110.82 114.64 28.15 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.904 1.282 . . . . 0.0 108.068 174.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -121.74 144.49 48.76 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 165.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.71 127.8 54.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.929 1.292 . . . . 0.0 108.393 169.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.59 -178.59 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.4 -110.78 0.58 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.3 21.0 2.25 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.866 1.698 . . . . 0.0 110.695 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -140.2 156.74 46.39 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -173.097 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -123.06 137.9 54.82 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.375 0.534 . . . . 0.0 109.776 173.898 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.63 106.97 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -176.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 115' ' ' LEU . 4.7 tt -88.12 103.72 16.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 170.054 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 m -85.91 93.66 8.99 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.84 95.63 9.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -121.07 131.61 54.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.66 0.784 . . . . 0.0 111.538 -174.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -113.97 -39.28 3.99 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.539 1.536 . . . . 0.0 110.224 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.84 -80.29 0.26 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 174.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.2 t -58.24 -39.86 80.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.45 141.38 40.4 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 108.766 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -146.22 112.02 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.634 1.574 . . . . 0.0 107.798 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.12 101.46 8.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.245 1.418 . . . . 0.0 110.33 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -56.59 129.83 42.58 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 150.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.94 108.55 10.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.1 113.55 26.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.893 1.277 . . . . 0.0 108.721 -156.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.56 147.57 35.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.946 1.298 . . . . 0.0 112.245 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -124.51 124.22 41.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.219 2.207 . . . . 0.0 106.501 -171.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -75.86 124.7 27.76 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -107.02 -28.51 9.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.387 0.275 . . . . 0.0 111.218 173.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 123.2 0.6 . . . . 0.0 110.705 -177.345 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.764 -0.16 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.97 63.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.084 2.154 . . . . 0.0 110.53 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.18 -43.02 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.88 1.672 . . . . 0.0 108.084 -163.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.15 -43.66 21.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.257 0.623 . . . . 0.0 111.309 -177.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -43.97 102.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.75 1.62 . . . . 0.0 112.949 -169.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.86 -167.52 25.34 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.345 0.974 . . . . 0.0 113.224 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -76.34 110.58 10.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.301 1.441 . . . . 0.0 110.229 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.439 ' CE2' HG13 ' A' ' 42' ' ' ILE . 32.7 m0 -83.57 113.82 21.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 168.579 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -96.74 125.15 41.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.211 1.004 . . . . 0.0 109.073 174.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.52 141.64 58.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.491 0.587 . . . . 0.0 111.339 -175.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.81 25.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -161.41 158.11 26.26 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.856 1.662 . . . . 0.0 107.506 163.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 t -177.96 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.357 1.463 . . . . 0.0 109.7 -168.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -96.25 138.92 33.15 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 167.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 62.86 -3.69 0.3 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 167.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -59.16 -31.0 68.59 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.542 -1.348 . . . . 0.0 112.106 -173.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.72 -71.18 0.22 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -27.41 -61.24 0.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.458 2.303 . . . . 0.0 111.761 170.207 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.27 -61.12 1.43 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.912 1.285 . . . . 0.0 111.365 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.412 ' HB2' HG13 ' A' ' 25' ' ' VAL . 22.8 ptp -74.44 -31.56 62.32 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.859 -0.526 . . . . 0.0 111.718 -176.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.28 47.06 0.35 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.869 2.467 . . . . 0.0 109.29 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m 177.47 -45.65 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 128.061 2.545 . . . . 0.0 107.691 -172.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.6 -45.09 66.39 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.204 -0.31 . . . . 0.0 110.93 172.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.95 -84.22 0.13 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.6 OUTLIER -9.01 -68.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.522 2.329 . . . . 0.0 115.549 167.014 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 38.04 39.61 0.7 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.418 1.009 . . . . 0.0 115.067 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 150.66 44.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 72.86 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.463 1.105 . . . . 0.0 108.929 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 57' ' ' PHE . 24.4 m -162.65 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.993 1.317 . . . . 0.0 109.454 -176.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -44.2 63.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.194 0.598 . . . . 0.0 110.651 -172.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -34.79 -41.26 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.637 2.375 . . . . 0.0 114.789 168.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.84 -30.24 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.307 1.443 . . . . 0.0 110.448 177.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.37 59.21 0.63 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.1 2.286 . . . . 0.0 111.668 174.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.93 -69.01 0.07 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.516 3.526 . . . . 0.0 104.886 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -61.53 -36.23 79.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.101 1.36 . . . . 0.0 110.457 -179.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -75.52 14.44 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.64 56.24 12.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.928 1.24 . . . . 0.0 111.773 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.61 153.24 73.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.581 2.188 . . . . 0.0 111.802 -165.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -109.48 165.45 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.216 1.006 . . . . 0.0 109.058 -176.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 m -151.55 106.69 3.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.14 121.07 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 8' ' ' TRP . 41.2 mm -111.1 123.08 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 164.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.79 145.53 48.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.9 m -105.15 110.33 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.7 56.97 3.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.06 -85.55 0.02 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.925 0.774 . . . . 0.0 112.33 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.12 -29.65 21.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.893 1.277 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 173.52 6.29 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.015 1.726 . . . . 0.0 107.95 -177.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.83 148.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -177.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.8 tt -129.84 129.29 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.639 0.776 . . . . 0.0 110.167 -173.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.62 135.9 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 125.354 1.461 . . . . 0.0 107.164 172.664 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -127.13 119.89 27.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.086 0.954 . . . . 0.0 109.361 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -94.25 84.11 4.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 111.46 -166.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -88.07 95.7 10.24 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.442 1.019 . . . . 0.0 112.778 -168.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.9 p -108.12 154.34 21.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 164.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -76.17 61.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' HG23 ' A' ' 29' ' ' THR . 0.5 OUTLIER -177.93 -49.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.731 0.812 . . . . 0.0 110.148 -170.278 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -146.13 135.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -173.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -134.31 123.32 23.98 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.2 p -134.42 167.06 21.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.52 149.52 33.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.096 0.407 . . . . 0.0 110.544 168.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 pt -146.38 140.75 20.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.321 1.049 . . . . 0.0 109.106 177.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 p -105.03 153.97 20.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 110.335 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -158.9 160.62 36.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.345 0.658 . . . . 0.0 110.167 -178.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -84.48 131.87 34.61 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.518 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.94 54.89 1.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.079 0.854 . . . . 0.0 109.954 167.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.78 57.74 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.001 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -173.12 162.57 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.351 1.076 . . . . 0.0 111.037 169.304 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -100.44 126.22 46.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.063 2.545 . . . . 0.0 109.385 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.32 157.42 35.67 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.603 -0.685 . . . . 0.0 110.603 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -70.57 150.7 45.8 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.512 0.725 . . . . 0.0 109.626 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -163.65 177.01 9.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.167 1.387 . . . . 0.0 107.276 -164.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.4 m -160.46 99.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 120.168 -1.583 . . . . 0.0 108.255 -163.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.544 HG22 ' HB2' ' A' ' 78' ' ' ARG . 5.5 t -82.62 174.76 10.74 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.354 -178.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.17 21.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.204 1.802 . . . . 0.0 115.585 -163.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -139.8 15.6 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.119 2.168 . . . . 0.0 111.37 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.34 40.12 21.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 111.576 -169.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.544 ' HB2' HG22 ' A' ' 74' ' ' THR . 10.4 mmt180 -68.2 111.08 4.32 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 149.029 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -74.58 71.54 1.88 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.03 154.42 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.802 -175.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.35 120.43 32.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 159.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.18 125.14 30.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 167.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.89 107.35 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.301 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.27 135.51 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 -169.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.7 p -145.85 -168.93 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 107.413 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.59 135.52 38.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 167.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.0 24.67 0.23 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.603 1.092 . . . . 0.0 112.602 -167.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -32.21 3.17 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.337 -163.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.36 -46.83 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.108 1.337 . . . . 0.0 113.143 -172.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -127.21 155.92 42.67 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.382 1.873 . . . . 0.0 109.039 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tt -81.49 121.56 26.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.85 104.57 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.893 1.277 . . . . 0.0 107.675 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -99.6 104.26 16.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.42 143.06 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 169.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.03 108.74 10.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -117.86 139.66 50.8 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.712 1.605 . . . . 0.0 107.66 -170.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.63 -78.76 0.58 Allowed 'General case' 0 C--N 1.337 0.064 0 CA-C-N 119.565 1.075 . . . . 0.0 110.717 172.208 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.23 -60.04 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.57 0.07 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.402 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 153.36 38.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.258 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -125.79 170.15 11.89 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 108.233 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -143.57 149.75 37.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 110.269 165.326 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 p -109.57 138.03 46.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.512 1.125 . . . . 0.0 108.255 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.54 69.03 1.44 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.124 1.369 . . . . 0.0 107.997 -177.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -77.21 146.35 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.566 -174.519 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.99 136.94 35.9 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.723 1.209 . . . . 0.0 110.254 176.728 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -161.25 147.71 14.59 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 157.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -93.0 102.6 14.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.478 1.511 . . . . 0.0 109.09 167.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.49 -173.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 158.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 50.99 -110.82 0.5 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.79 25.03 2.11 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.072 1.32 . . . . 0.0 110.803 174.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -150.74 153.45 35.54 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.3 1.05 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.7 120.62 31.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -89.0 133.52 30.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.58 121.6 36.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.535 ' HB ' HG12 ' A' ' 105' ' ' VAL . 5.6 m -110.99 109.61 19.81 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.24 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.49 124.79 35.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 168.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.3 m -141.57 135.14 29.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.684 0.675 . . . . 0.0 110.723 173.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -137.71 154.7 49.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.376 2.27 . . . . 0.0 108.001 -177.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -30.6 -48.22 0.16 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.569 2.033 . . . . 0.0 115.627 -178.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 t -135.27 41.28 2.81 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.805 0.803 . . . . 0.0 110.6 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.6 126.07 4.44 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.325 -0.86 . . . . 0.0 109.202 169.215 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 p -118.09 132.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.732 1.213 . . . . 0.0 107.774 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -139.24 112.56 8.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 p -67.12 143.48 56.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 158.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -139.14 162.28 35.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 160.03 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.73 145.64 26.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 170.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -125.48 162.82 24.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.416 1.486 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -124.87 103.22 7.94 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.045 2.138 . . . . 0.0 105.485 -175.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.53 108.71 12.11 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 -55.98 26.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.865 -173.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 O-C-N 121.93 -0.481 . . . . 0.0 110.939 -171.712 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.92 54.05 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.526 2.731 . . . . 0.0 111.833 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.38 -56.52 0.08 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.81 1.644 . . . . 0.0 106.65 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -47.18 -44.52 22.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.266 1.826 . . . . 0.0 111.93 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -35.52 102.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.037 2.135 . . . . 0.0 112.093 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.43 -156.63 26.28 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.162 0.892 . . . . 0.0 112.906 165.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 m -116.32 127.09 54.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.632 1.173 . . . . 0.0 109.019 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -112.04 156.93 21.39 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.531 1.132 . . . . 0.0 110.463 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 25.7 ttpp -119.31 130.65 55.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.503 2.321 . . . . 0.0 107.355 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.93 137.35 58.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.15 -71.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.156 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -111.42 139.78 46.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.958 0.799 . . . . 0.0 109.448 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -163.45 160.28 23.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.771 0.828 . . . . 0.0 108.779 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 171.66 19.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.808 2.043 . . . . 0.0 107.678 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 m120 64.5 12.98 7.84 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.508 1.523 . . . . 0.0 113.78 166.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.91 -39.94 93.76 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 120.426 -1.421 . . . . 0.0 109.895 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.25 -71.75 0.06 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 109.619 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -37.88 -57.74 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.698 1.999 . . . . 0.0 111.971 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.54 -40.65 75.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.971 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -33.04 44.38 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.523 -0.735 . . . . 0.0 111.004 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -72.01 46.76 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 0.0 110.436 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p 179.04 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.303 1.841 . . . . 0.0 107.229 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -64.5 -27.88 69.28 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.97 44.31 37.29 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 25' ' ' VAL . 8.2 t -113.29 43.79 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.82 -72.84 0.28 Allowed Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.75 20.49 3.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.104 0.961 . . . . 0.0 111.984 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 171.32 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 126.613 1.965 . . . . 0.0 107.456 -168.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -53.79 -43.84 69.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.232 1.013 . . . . 0.0 111.416 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -65.86 -12.25 52.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.271 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -60.2 -23.24 63.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.331 1.423 . . . . 0.0 112.056 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.95 -39.53 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 110.269 167.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.03 47.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.199 -0.938 . . . . 0.0 113.735 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -57.77 -47.15 83.34 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.413 1.485 . . . . 0.0 109.731 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.6 ttt -92.3 -42.31 9.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.884 1.274 . . . . 0.0 110.394 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -74.45 66.26 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 0.0 112.604 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -149.26 58.57 3.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.871 1.268 . . . . 0.0 110.084 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.3 -44.67 8.67 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.685 2.923 . . . . 0.0 111.869 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.7 m -107.16 157.07 18.15 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.663 0.744 . . . . 0.0 109.217 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 m -148.02 116.83 6.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 162.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 83.1 mt -80.59 137.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.7 mm -130.96 91.19 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.556 1.543 . . . . 0.0 106.992 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.84 105.63 17.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.79 140.79 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -125.05 165.57 17.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.499 1.519 . . . . 0.0 107.912 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -25.12 -66.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.613 2.054 . . . . 0.0 115.121 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -118.36 15.05 13.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.792 2.037 . . . . 0.0 110.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.09 179.69 7.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.065 1.746 . . . . 0.0 109.727 -151.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.9 150.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.86 127.61 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.4 tt -94.64 138.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -127.74 99.02 5.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.539 1.536 . . . . 0.0 108.587 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.5 m -72.94 83.89 1.24 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -83.74 113.11 20.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.966 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -139.01 -172.64 3.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.93 1.292 . . . . 0.0 108.372 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -82.86 -80.69 0.17 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -84.06 116.53 22.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 109.662 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 81.29 133.04 0.06 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.586 1.954 . . . . 0.0 108.904 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.12 155.75 49.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 p -150.48 153.45 35.91 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.29 143.23 17.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.989 171.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mm -153.61 142.67 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.688 1.195 . . . . 0.0 108.791 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -89.69 136.87 32.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.779 2.032 . . . . 0.0 109.391 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.1 144.59 38.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.991 0.917 . . . . 0.0 110.345 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 106.23 16.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.55 1.54 . . . . 0.0 107.309 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.82 105.01 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.959 0.504 . . . . 0.0 111.076 168.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.97 30.42 2.98 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.688 2.09 . . . . 0.0 112.698 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.3 t -146.95 159.88 9.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 107.986 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.76 137.35 49.81 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 111.605 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -135.43 135.74 40.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.84 1.256 . . . . 0.0 109.512 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.15 114.98 27.62 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.565 1.546 . . . . 0.0 108.281 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.54 159.15 38.28 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.209 0.459 . . . . 0.0 110.32 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 t -122.38 98.76 6.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.641 1.577 . . . . 0.0 112.063 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -83.78 142.95 30.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.39 -40.91 27.33 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.053 0.941 . . . . 0.0 110.869 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -102.45 42.19 1.17 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.874 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.58 -37.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.213 1.005 . . . . 0.0 110.079 154.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 86.55 -172.24 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.949 2.5 . . . . 0.0 107.093 -163.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -72.71 123.95 24.32 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.738 0.699 . . . . 0.0 110.193 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.93 147.86 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.216 1.406 . . . . 0.0 108.172 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -93.94 101.6 13.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 122.095 0.95 . . . . 0.0 109.932 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.5 m -83.81 116.15 22.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.015 1.326 . . . . 0.0 109.787 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.26 125.23 54.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 166.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.34 138.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -155.24 -176.66 6.05 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 164.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -132.44 105.58 7.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.865 1.266 . . . . 0.0 108.439 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.27 120.57 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.71 -80.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.722 0.677 . . . . 0.0 111.964 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.14 17.7 1.54 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.195 1.379 . . . . 0.0 111.587 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.5 117.06 30.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 108.342 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 tp -80.1 98.56 7.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.0 m -87.95 107.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -98.25 100.99 12.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.83 141.82 13.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -133.53 99.67 4.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -108.63 114.95 29.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.58 1.952 . . . . 0.0 108.502 -163.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -107.74 -67.25 0.97 Allowed 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.572 0.624 . . . . 0.0 110.99 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -172.11 -81.32 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.322 0.51 . . . . 0.0 111.734 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.96 80.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.68 -172.82 3.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -131.39 -178.99 5.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.118 1.767 . . . . 0.0 107.274 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.5 t -143.56 177.64 8.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.7 p -138.05 136.75 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.669 1.188 . . . . 0.0 108.264 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 115' ' ' LEU . 2.3 mt -129.87 71.33 1.44 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.139 2.176 . . . . 0.0 106.259 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.92 124.92 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.822 -0.549 . . . . 0.0 109.819 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.13 139.42 49.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.784 1.634 . . . . 0.0 110.348 -171.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -156.44 144.29 19.46 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -110.61 120.4 42.28 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 162.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.45 167.4 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 156.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.85 -124.44 2.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.13 13.63 7.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.945 1.26 . . . . 0.0 111.93 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -122.93 127.02 48.35 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.389 1.095 . . . . 0.0 109.333 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.65 103.02 4.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 165.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 pt -85.95 127.73 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 104' ' ' LEU . 7.5 tp -115.1 111.3 20.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.67 1.588 . . . . 0.0 106.785 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -88.85 115.35 26.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -102.93 109.78 21.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 m -132.17 131.15 41.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.279 1.031 . . . . 0.0 110.548 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.49 169.14 12.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.814 1.646 . . . . 0.0 108.921 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.44 83.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 166.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 85.52 140.22 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.186 2.594 . . . . 0.0 109.585 -166.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 77.55 145.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 112.346 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -137.05 153.61 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.434 1.893 . . . . 0.0 107.29 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.6 137.64 32.04 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.821 -1.175 . . . . 0.0 108.559 161.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -85.37 128.09 34.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 161.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -125.94 113.96 17.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 p -113.31 136.77 52.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.333 0.97 . . . . 0.0 110.386 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.41 146.17 47.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.925 1.69 . . . . 0.0 108.646 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 40.8 tt0 -130.09 125.04 34.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.056 2.143 . . . . 0.0 106.77 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -66.05 116.6 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.417 1.008 . . . . 0.0 110.146 -171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -91.23 -30.12 16.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.645 0.378 . . . . 0.0 111.048 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.503 0.592 . . . . 0.0 111.138 173.973 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 63.9 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.078 2.951 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.94 -44.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.873 1.669 . . . . 0.0 107.956 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 42' ' ' ILE . 30.6 m-85 -61.7 -44.82 96.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -174.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -37.04 105.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.992 2.117 . . . . 0.0 111.676 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.91 -163.76 25.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.499 0.571 . . . . 0.0 112.41 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 m -108.94 122.66 47.7 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 110.481 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 61.7 m95 -103.09 162.37 13.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.462 1.905 . . . . 0.0 110.624 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -129.34 132.86 47.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.455 2.302 . . . . 0.0 108.139 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.63 131.38 45.87 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.281 0.633 . . . . 0.0 110.121 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.33 31.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.247 0.619 . . . . 0.0 110.918 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.76 159.49 8.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.401 1.48 . . . . 0.0 108.175 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 177.07 102.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.442 1.897 . . . . 0.0 107.868 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -135.94 148.71 48.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.179 0.445 . . . . 0.0 110.385 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.34 35.49 20.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.544 1.538 . . . . 0.0 110.807 174.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.35 -19.14 27.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.78 1.276 . . . . 0.0 109.948 -177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -52.99 4.84 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 129.494 3.118 . . . . 0.0 106.146 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -49.68 -40.76 41.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.895 1.278 . . . . 0.0 111.148 166.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.89 -50.6 34.23 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.576 0.75 . . . . 0.0 111.165 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 -37.51 84.69 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.425 -0.797 . . . . 0.0 111.652 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -70.42 61.65 0.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 110.063 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m 168.6 -58.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 129.165 2.986 . . . . 0.0 106.795 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.73 -34.78 24.8 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 52.61 42.65 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -170.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.31 -52.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.195 0.998 . . . . 0.0 110.611 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.89 -65.6 3.21 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.873 -0.404 . . . . 0.0 113.579 -163.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.45 101.46 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.779 1.632 . . . . 0.0 112.454 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 135.16 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.707 3.203 . . . . 0.0 109.461 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -113.19 -26.5 8.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.929 1.692 . . . . 0.0 111.343 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -66.46 -41.95 88.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.83 1.195 . . . . 0.0 110.888 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -53.21 -36.67 61.26 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.287 1.035 . . . . 0.0 111.197 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.0 t -39.42 -50.86 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.401 1.88 . . . . 0.0 110.329 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.06 54.56 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.643 0.64 . . . . 0.0 113.075 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.45 24.97 10.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.85 1.26 . . . . 0.0 111.198 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.5 ttt -152.62 -2.57 0.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.0 m -158.3 169.96 23.32 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.793 -1.192 . . . . 0.0 109.602 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -117.08 73.02 6.53 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.204 1.402 . . . . 0.0 108.977 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.22 158.2 58.58 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.431 2.087 . . . . 0.0 109.809 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -100.83 164.54 11.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.74 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.95 113.1 11.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 163.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.37 127.66 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 4' ' ' PHE . 17.2 mm -120.79 110.84 29.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.57 115.95 29.44 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.3 85.87 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -50.41 154.64 1.22 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.521 0.728 . . . . 0.0 110.171 170.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -23.79 -59.28 0.04 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.317 1.913 . . . . 0.0 115.352 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.11 13.35 9.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.944 1.298 . . . . 0.0 111.805 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.89 -170.37 3.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.937 1.695 . . . . 0.0 108.767 -158.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.29 149.1 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 120.72 -1.238 . . . . 0.0 110.53 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.67 140.75 47.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.88 1.272 . . . . 0.0 109.17 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 tt -129.43 145.5 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.454 1.901 . . . . 0.0 109.371 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.0 152.75 51.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.952 2.101 . . . . 0.0 107.842 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 m -111.61 62.95 0.62 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.032 1.287 . . . . 0.0 107.717 159.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.07 108.15 0.84 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.488 -0.758 . . . . 0.0 110.794 -173.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -116.24 102.1 9.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.334 1.454 . . . . 0.0 108.55 -168.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m 63.92 -75.7 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.155 1.382 . . . . 0.0 111.451 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.33 27.85 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.119 0.968 . . . . 0.0 110.865 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 96.99 2.71 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.862 -0.524 . . . . 0.0 110.989 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -161.61 163.77 29.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.516 -0.74 . . . . 0.0 111.157 161.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -94.72 175.03 6.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.97 3.308 . . . . 0.0 109.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 152.25 47.98 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.065 1.346 . . . . 0.0 107.976 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.73 137.79 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 p -126.24 147.33 49.7 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.556 0.743 . . . . 0.0 109.399 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -160.82 163.25 32.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.056 0.931 . . . . 0.0 113.124 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -98.83 133.71 42.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -76.56 64.64 2.25 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.83 -0.544 . . . . 0.0 110.161 -178.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.82 57.92 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.21 159.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.4 1.1 . . . . 0.0 111.119 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -88.89 151.61 22.23 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.072 1.349 . . . . 0.0 109.56 160.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.48 150.1 21.16 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.377 0.671 . . . . 0.0 109.265 164.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.44 141.24 32.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.4 156.86 47.2 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.193 0.997 . . . . 0.0 108.946 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -149.71 118.77 6.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.686 0.394 . . . . 0.0 110.178 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -147.35 143.45 28.02 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.88 78.94 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.531 0.732 . . . . 0.0 111.912 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -94.83 19.71 9.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.17 1.788 . . . . 0.0 112.511 -171.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.25 -42.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.782 0.833 . . . . 0.0 110.721 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 114.69 -160.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 131.383 3.873 . . . . 0.0 108.89 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -85.71 118.4 25.19 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.26 142.04 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.263 1.025 . . . . 0.0 108.527 -167.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -80.82 126.8 31.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -97.36 143.77 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.894 0.878 . . . . 0.0 108.714 168.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 94' ' ' VAL . 5.4 tt -136.4 127.62 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 168.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.6 139.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.0 m -158.98 173.82 15.91 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.379 2.672 . . . . 0.0 104.657 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.45 153.76 43.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.425 1.466 . . . . 0.0 111.977 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.77 143.27 49.47 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.414 1.486 . . . . 0.0 108.421 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 -77.13 0.04 OUTLIER Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.24 0.924 . . . . 0.0 111.118 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.17 21.27 0.19 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.115 1.341 . . . . 0.0 111.918 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.42 134.21 54.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.119 1.368 . . . . 0.0 108.204 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.06 122.27 29.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.78 109.11 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -94.92 90.96 6.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 166.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 83' ' ' ILE . 14.5 p -89.84 146.58 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -147.06 121.43 9.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -159.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -127.51 127.72 44.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.342 1.457 . . . . 0.0 108.748 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -100.12 -55.01 2.74 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -163.66 -85.1 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.973 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.31 71.8 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.225 0.466 . . . . 0.0 112.458 -170.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 177.31 10.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.922 0.889 . . . . 0.0 109.073 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.51 163.92 30.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 109.741 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -126.84 152.6 46.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.553 1.541 . . . . 0.0 108.453 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -111.0 124.94 53.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.409 1.483 . . . . 0.0 109.377 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.44 106.71 17.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.182 1.793 . . . . 0.0 106.771 171.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.35 131.58 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -138.64 142.37 39.06 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -159.11 155.81 27.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.284 2.233 . . . . 0.0 106.024 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -106.17 122.63 46.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 160.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.15 162.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 155.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.75 -129.66 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -166.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.01 0.33 24.16 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.526 1.536 . . . . 0.0 111.672 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.44 136.4 50.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.971 0.908 . . . . 0.0 108.982 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 8.2 tt -92.67 112.25 24.14 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.31 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.4 tp -87.51 131.28 34.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.4 m -126.47 135.46 51.38 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.37 114.87 29.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 128.986 2.914 . . . . 0.0 106.71 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.1 m -120.95 130.34 53.8 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -124.22 159.21 30.66 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.88 -35.35 12.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.658 0.647 . . . . 0.0 112.291 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -124.31 123.87 41.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 92.14 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.042 2.137 . . . . 0.0 112.147 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.14 139.58 27.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.344 1.457 . . . . 0.0 107.293 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.3 t -150.75 128.24 11.44 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.986 0.914 . . . . 0.0 110.457 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 p -81.69 155.22 25.66 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -144.87 68.19 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.08 141.37 58.79 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.604 -0.685 . . . . 0.0 111.225 176.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.75 165.43 19.28 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 126.021 1.728 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.23 151.22 51.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.168 1.387 . . . . 0.0 109.681 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -86.65 128.5 35.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.908 1.283 . . . . 0.0 109.938 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.86 -15.43 14.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.961 0.8 . . . . 0.0 113.119 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.115 0 C-N-CA 123.193 0.597 . . . . 0.0 110.401 -177.23 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.26 -22.31 11.43 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.979 2.512 . . . . 0.0 112.857 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.95 -34.2 33.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.917 0.887 . . . . 0.0 111.272 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -48.19 56.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.23 108.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.477 1.511 . . . . 0.0 112.211 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.29 -157.46 21.28 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.25 0.477 . . . . 0.0 112.522 171.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.1 m -97.67 113.54 25.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.12 1.368 . . . . 0.0 110.791 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 16.6 m0 -84.77 113.07 21.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.579 1.552 . . . . 0.0 107.753 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.69 129.8 51.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.49 143.93 55.94 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.286 -0.884 . . . . 0.0 110.996 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.34 -42.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 120.706 -1.246 . . . . 0.0 111.854 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -138.33 162.58 34.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 t -171.49 126.47 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.67 133.17 45.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.18 29.97 5.92 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.347 1.859 . . . . 0.0 111.06 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -75.41 -53.33 8.87 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.45 -0.782 . . . . 0.0 109.671 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.56 -30.62 67.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.391 -0.193 . . . . 0.0 110.962 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.5 -48.72 62.82 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.22 -0.3 . . . . 0.0 110.56 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -56.82 -61.71 2.25 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 0.0 111.507 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -35.1 66.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 63.97 0.23 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.941 0.897 . . . . 0.0 109.874 167.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t 162.77 -56.96 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.963 2.505 . . . . 0.0 106.978 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -26.96 68.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.683 0.793 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 -19.81 15.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.885 0.755 . . . . 0.0 113.769 168.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.6 m -40.59 -32.43 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 128.21 2.604 . . . . 0.0 113.951 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.11 73.23 0.17 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -45.21 -58.66 3.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.576 1.15 . . . . 0.0 111.236 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.77 -29.54 11.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.641 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.2 p -81.87 -65.87 0.96 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.973 0.909 . . . . 0.0 111.092 -167.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -54.0 -33.1 56.16 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.829 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.9 -27.65 65.43 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.79 1.177 . . . . 0.0 113.9 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.1 t -85.53 -49.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.78 45.65 1.64 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.097 0.856 . . . . 0.0 113.684 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -160.41 -42.38 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 110.555 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtm -60.07 -26.53 66.24 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.793 0.724 . . . . 0.0 110.763 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 m -67.06 66.53 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.107 1.763 . . . . 0.0 112.367 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 44.24 72.57 1.16 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.412 1.885 . . . . 0.0 112.228 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.32 147.79 37.65 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.69 1.593 . . . . 0.0 111.904 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -152.7 160.5 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 108.175 -169.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -154.31 144.86 22.29 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pt -110.32 148.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.225 0.92 . . . . 0.0 108.772 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 30.5 mm -129.68 130.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.734 1.214 . . . . 0.0 108.761 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.17 114.88 20.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.507 1.523 . . . . 0.0 109.25 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.87 70.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.9 0.857 . . . . 0.0 110.259 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.89 149.87 43.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.571 -0.706 . . . . 0.0 109.976 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -19.89 -67.84 0.01 OUTLIER Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.494 1.997 . . . . 0.0 116.309 -171.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -113.52 14.35 18.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.599 1.559 . . . . 0.0 111.791 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.31 179.75 7.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.606 1.563 . . . . 0.0 109.0 -158.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -139.79 101.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.05 143.99 12.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.56 144.14 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -128.62 101.95 6.38 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -76.33 145.95 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.32 66.75 1.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.08 1.352 . . . . 0.0 108.591 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 m -72.17 -44.81 62.49 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -150.7 -109.51 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -113.93 -49.52 2.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.677 1.126 . . . . 0.0 111.566 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -77.77 66.72 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -101.41 -171.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.079 1.751 . . . . 0.0 109.402 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 74' ' ' THR . 11.9 p -152.77 171.95 17.44 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.664 1.186 . . . . 0.0 110.047 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -145.34 135.87 24.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.916 1.686 . . . . 0.0 108.21 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -145.26 147.81 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.227 1.011 . . . . 0.0 108.577 -172.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.5 p -99.7 97.41 8.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.608 1.563 . . . . 0.0 110.322 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -72.27 148.89 45.01 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.58 20.38 14.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.41 1.084 . . . . 0.0 113.845 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 37.04 32.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.602 1.961 . . . . 0.0 115.934 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.87 47.74 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.307 -0.718 . . . . 0.0 112.006 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -174.7 168.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.394 1.097 . . . . 0.0 109.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -104.86 143.47 33.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.621 0.768 . . . . 0.0 111.682 170.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -139.23 156.26 47.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 107.316 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.64 138.62 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.61 62.57 1.59 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -52.46 100.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.873 0.869 . . . . 0.0 110.379 163.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 60' ' ' THR . 10.1 t -117.66 136.05 53.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.261 0.553 . . . . 0.0 110.032 165.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.48 49.64 1.03 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.794 1.237 . . . . 0.0 111.374 -171.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -172.04 -58.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.565 2.346 . . . . 0.0 107.96 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.77 5.1 26.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.84 0.856 . . . . 0.0 113.22 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 83.4 -169.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 163.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -97.88 80.39 2.75 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 109.968 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.74 167.73 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.14 0.976 . . . . 0.0 109.377 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -127.33 97.12 4.79 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.5 t -113.48 114.86 27.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -157.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.3 119.11 29.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.878 1.671 . . . . 0.0 109.007 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.02 140.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 123.675 0.79 . . . . 0.0 110.031 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 p -136.81 166.71 22.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.777 1.631 . . . . 0.0 107.346 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.05 108.76 10.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.65 121.81 45.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.538 0.608 . . . . 0.0 109.835 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.52 -77.73 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.498 1.047 . . . . 0.0 111.344 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.85 21.47 0.69 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.995 1.283 . . . . 0.0 111.173 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -116.43 123.56 47.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.1 tt -84.23 110.26 18.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.2 t -95.28 116.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -113.05 117.79 32.98 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.1 t -102.79 119.15 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.438 ' CB ' HD21 ' A' ' 104' ' ' LEU . 42.6 tt0 -104.27 85.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 108.713 -169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.42 143.14 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.349 1.86 . . . . 0.0 108.396 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -125.74 -59.19 1.37 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.51 166.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -167.2 -87.32 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.353 0.524 . . . . 0.0 111.311 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.72 -23.31 77.92 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.47 175.61 9.42 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.807 0.843 . . . . 0.0 108.728 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -134.45 176.04 8.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.918 2.087 . . . . 0.0 106.455 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -138.14 165.59 26.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 162.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.488 ' C ' HD23 ' A' ' 104' ' ' LEU . 77.4 p -117.9 138.7 51.96 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.155 0.582 . . . . 0.0 110.282 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 103' ' ' SER . 0.1 OUTLIER -134.18 98.0 4.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.032 1.733 . . . . 0.0 107.387 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.3 OUTLIER -93.37 142.26 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -130.99 105.0 7.45 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.774 1.629 . . . . 0.0 108.668 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -131.98 142.93 49.76 Favored 'General case' 0 C--O 1.228 -0.042 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -116.67 124.5 49.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 164.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.57 -177.39 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.7 t70 52.36 -111.74 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.55 33.43 1.31 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -139.89 140.59 36.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -98.44 105.65 17.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.287 1.035 . . . . 0.0 108.412 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.22 105.16 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.32 95.25 9.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' HG12 ' A' ' 105' ' ' VAL . 7.3 m -81.92 115.22 21.0 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.67 105.39 13.25 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.129 1.372 . . . . 0.0 107.466 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 t -135.56 137.4 41.97 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.369 0.532 . . . . 0.0 111.35 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -109.73 -35.17 6.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.148 1.379 . . . . 0.0 111.293 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 -100.65 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 -172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 34.9 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.681 1.192 . . . . 0.0 112.749 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.34 126.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.124 2.169 . . . . 0.0 106.443 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.36 134.44 63.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 126.562 1.945 . . . . 0.0 107.016 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.47 154.27 49.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.897 0.879 . . . . 0.0 109.813 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.6 t -119.14 139.23 52.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 157.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -117.15 95.62 5.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.94 101.1 11.46 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -91.43 165.85 13.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.704 1.602 . . . . 0.0 111.028 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -139.31 109.23 6.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -66.06 98.3 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -70.36 -45.72 65.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 110.459 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 C-N-CA 126.057 1.743 . . . . 0.0 107.597 -176.386 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.46 65.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.11 2.964 . . . . 0.0 111.491 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.72 -49.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.03 2.132 . . . . 0.0 106.203 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -76.22 44.87 0.35 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.496 2.318 . . . . 0.0 111.421 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.1 96.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.53 -157.94 25.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -132.17 140.44 48.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.597 0.759 . . . . 0.0 110.185 -168.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -126.22 161.65 27.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.398 1.479 . . . . 0.0 109.548 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -127.65 139.01 52.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.513 1.125 . . . . 0.0 108.359 174.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 13' ' ' SER . 5.9 tt -67.73 145.4 54.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.277 0.49 . . . . 0.0 111.007 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.5 -32.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 0.0 113.474 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 14' ' ' LYS . 18.9 t0 -133.06 154.06 50.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.97 1.259 . . . . 0.0 108.683 170.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' HD21 ' A' ' 10' ' ' LEU . 36.2 t -163.51 27.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.507 2.323 . . . . 0.0 110.879 -164.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 4.3 ptpp? -57.44 146.99 27.66 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.892 -1.13 . . . . 0.0 110.435 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 66.95 5.36 4.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 114.19 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.73 -39.08 76.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.467 1.485 . . . . 0.0 111.466 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.83 -69.69 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.0 110.24 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -30.9 -57.52 0.22 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.94 2.496 . . . . 0.0 111.146 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.51 -54.45 7.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 112.66 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -40.41 75.2 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.883 -0.51 . . . . 0.0 110.227 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -73.88 45.81 0.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.52 1.528 . . . . 0.0 110.75 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -171.35 -48.21 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.517 1.927 . . . . 0.0 109.053 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.54 -34.31 70.86 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.885 -0.509 . . . . 0.0 110.914 168.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.85 44.81 3.27 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.92 -30.02 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.376 1.47 . . . . 0.0 108.058 162.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -21.29 114.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.996 0 C-N-CA 127.688 2.566 . . . . 0.0 114.86 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -162.73 -177.13 5.36 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.114 1.366 . . . . 0.0 108.985 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.99 65.24 9.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.22 0.608 . . . . 0.0 109.89 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 m -154.57 -51.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.415 0.686 . . . . 0.0 109.624 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -43.81 -34.85 1.7 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 0.0 113.529 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.01 -30.54 68.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.042 0.937 . . . . 0.0 112.724 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.74 -37.77 9.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.8 65.3 0.07 OUTLIER Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.239 2.352 . . . . 0.0 112.788 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -179.07 -37.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.462 2.705 . . . . 0.0 108.336 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.44 -30.22 17.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.227 1.011 . . . . 0.0 110.65 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -64.15 -179.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.374 0.607 . . . . 0.0 111.108 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.44 80.8 2.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.738 1.215 . . . . 0.0 110.054 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' HD13 ' A' ' 10' ' ' LEU . 36.1 Cg_endo -64.31 140.98 73.05 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.471 1.447 . . . . 0.0 110.642 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -121.79 146.53 46.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.155 1.782 . . . . 0.0 107.521 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.2 m -145.49 118.91 9.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.646 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.1 mt -92.76 128.84 44.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.88 110.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.11 104.5 10.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.445 1.098 . . . . 0.0 108.504 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.18 110.0 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.693 0.759 . . . . 0.0 109.122 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.72 60.21 5.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.11 -81.45 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.022 1.296 . . . . 0.0 112.3 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -36.81 20.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.056 1.342 . . . . 0.0 110.242 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -177.84 3.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.579 1.952 . . . . 0.0 108.225 -173.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.53 143.81 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -124.4 132.8 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 122.94 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -101.47 102.45 13.22 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.16 70.32 1.1 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.973 1.309 . . . . 0.0 107.67 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -78.22 128.62 34.01 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.499 -0.75 . . . . 0.0 110.103 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 t 74.87 -55.52 0.65 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.898 1.679 . . . . 0.0 110.291 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -39.93 81.68 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.603 3.161 . . . . 0.0 114.101 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 66.0 52.98 1.14 Allowed 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.999 1.719 . . . . 0.0 109.852 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 78.22 157.96 0.18 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.094 1.758 . . . . 0.0 107.709 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -71.01 104.76 3.09 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -124.86 177.28 6.1 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.267 1.027 . . . . 0.0 109.089 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -158.61 145.05 17.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -172.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 mt -135.4 120.05 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.484 1.114 . . . . 0.0 108.144 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.0 p -89.29 132.86 34.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.499 1.52 . . . . 0.0 108.805 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -146.39 157.55 43.79 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.71 0.686 . . . . 0.0 110.701 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -124.6 112.29 16.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.03 110.16 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.272 0.229 . . . . 0.0 110.676 170.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.31 37.76 2.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 0.0 111.682 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.5 t -147.14 151.7 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.787 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.12 136.95 46.93 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.742 1.617 . . . . 0.0 107.764 163.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.96 -173.5 3.48 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.964 0.905 . . . . 0.0 109.43 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 79' ' ' LYS . 8.1 t0 -110.64 124.19 51.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.408 1.483 . . . . 0.0 108.858 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -112.83 158.8 19.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.536 1.534 . . . . 0.0 109.209 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -147.02 101.55 3.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.71 154.46 36.86 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.1 0.96 . . . . 0.0 110.4 -171.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.19 72.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.83 -4.7 59.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.198 -171.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.76 2.79 0.21 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.62 -148.13 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.921 -1.737 . . . . 0.0 109.736 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 71' ' ' ASP . 63.8 tttp -79.32 128.04 32.83 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.642 1.177 . . . . 0.0 109.388 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.62 139.33 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -83.27 125.05 31.18 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.8 t -125.16 147.17 49.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.69 0.677 . . . . 0.0 110.647 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.57 136.56 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.44 141.73 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 t -161.36 -171.4 2.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.714 1.206 . . . . 0.0 108.243 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 pp -127.66 135.43 50.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.045 0.938 . . . . 0.0 111.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -108.37 91.06 3.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.909 1.683 . . . . 0.0 108.186 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.64 -70.76 0.9 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.74 0.686 . . . . 0.0 111.771 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 14.87 1.19 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -115.48 165.94 12.45 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.5 tt -117.43 115.45 25.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 m -91.16 119.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -113.27 110.97 21.25 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 167.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.52 133.34 60.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -132.12 106.43 7.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.668 0.787 . . . . 0.0 108.948 -158.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -106.23 151.31 24.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.59 2.356 . . . . 0.0 109.529 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -130.32 -62.93 0.91 Allowed 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.624 -0.673 . . . . 0.0 109.601 163.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -159.31 -87.54 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 119.41 -0.329 . . . . 0.0 111.375 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.76 -25.28 76.01 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.929 0.786 . . . . 0.0 112.016 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 -177.39 5.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.138 0.975 . . . . 0.0 109.025 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -159.38 -176.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.288 1.435 . . . . 0.0 109.56 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.4 t -144.63 153.43 41.75 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 111.129 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -83.89 155.29 22.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 162.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -142.01 65.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.125 1.77 . . . . 0.0 107.26 161.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.58 141.41 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -124.74 128.41 48.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.322 1.049 . . . . 0.0 109.589 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -141.51 141.3 33.6 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.88 103.23 13.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 166.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.71 172.88 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 154.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 48.83 -122.58 1.68 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -166.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.44 29.91 4.64 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.438 1.494 . . . . 0.0 109.813 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -128.35 126.48 40.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.278 0.631 . . . . 0.0 110.889 -167.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.72 109.42 17.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.01 120.39 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -104.37 89.5 3.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.247 1.419 . . . . 0.0 108.026 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 m -76.91 82.81 3.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.222 0.534 . . . . 0.0 109.752 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.57 101.36 6.49 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 108.54 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.39 112.64 20.26 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -110.93 148.52 32.3 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.751 1.22 . . . . 0.0 108.714 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.28 84.68 0.01 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 169.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t 126.82 -2.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 131.631 3.972 . . . . 0.0 113.217 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.63 140.67 18.37 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.856 1.207 . . . . 0.0 109.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.54 130.41 69.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 124.466 1.106 . . . . 0.0 108.141 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.55 110.87 7.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.542 0.737 . . . . 0.0 109.808 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 76.5 p -70.27 79.63 0.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -64.46 136.65 57.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 158.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 t -156.81 147.28 21.41 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.051 -1.031 . . . . 0.0 108.909 169.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.78 159.95 33.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.836 1.255 . . . . 0.0 110.751 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 9' ' ' LYS . 36.1 tt0 -121.49 130.76 53.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.565 2.346 . . . . 0.0 106.231 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -69.89 120.01 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.719 0.69 . . . . 0.0 109.623 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -94.76 -31.41 13.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.478 0.711 . . . . 0.0 111.24 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.154 0 CA-C-N 118.428 0.558 . . . . 0.0 110.712 177.682 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.07 53.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.638 2.775 . . . . 0.0 111.393 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.36 -37.04 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.346 1.459 . . . . 0.0 109.133 -159.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.3 -47.46 6.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.965 0.906 . . . . 0.0 109.448 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -48.28 114.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.664 0.785 . . . . 0.0 112.404 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.75 -172.84 21.78 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.521 0.582 . . . . 0.0 112.311 162.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -102.75 123.62 46.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.283 0.633 . . . . 0.0 109.585 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -118.87 154.78 32.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.461 1.104 . . . . 0.0 108.975 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -128.6 136.8 51.2 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.41 1.084 . . . . 0.0 108.082 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.08 140.31 58.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.87 -2.6 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.6 145.07 38.09 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.472 1.033 . . . . 0.0 108.511 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -162.53 148.33 12.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.223 1.409 . . . . 0.0 108.765 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -159.46 154.14 24.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.709 1.203 . . . . 0.0 107.816 163.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 44.06 29.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.883 1.273 . . . . 0.0 110.649 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -56.26 4.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.778 0.799 . . . . 0.0 109.844 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -54.67 43.91 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.183 2.193 . . . . 0.0 108.902 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.68 -46.2 74.03 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.254 1.022 . . . . 0.0 112.286 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -55.67 -50.17 70.98 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.4 mtt -61.89 -36.61 81.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.219 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.62 46.9 0.05 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.808 1.643 . . . . 0.0 111.653 172.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.0 p -165.02 -41.02 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.857 1.263 . . . . 0.0 109.129 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.95 -32.46 74.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 19.98 35.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.194 0.426 . . . . 0.0 112.495 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -38.85 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 162.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.92 -138.32 6.42 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -165.98 -71.35 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -46.57 4.21 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.499 1.52 . . . . 0.0 113.1 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -36.77 -35.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.579 2.352 . . . . 0.0 114.01 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -25.37 40.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.148 -0.97 . . . . 0.0 112.436 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -45.12 -35.85 3.37 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.144 0.884 . . . . 0.0 112.711 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.73 -45.41 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.38 -3.55 62.17 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.23 -1.317 . . . . 0.0 115.824 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -110.53 1.37 18.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.645 1.578 . . . . 0.0 111.06 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 ttm -120.42 -59.26 1.78 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.908 0.883 . . . . 0.0 109.503 -162.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.5 m -78.31 76.16 4.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.989 -0.444 . . . . 0.0 109.98 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 5.68 77.96 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 128.846 2.858 . . . . 0.0 113.379 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.79 122.4 11.67 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.691 1.594 . . . . 0.0 109.655 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.0 m -88.21 155.21 19.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 m -147.48 87.95 1.68 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -171.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.9 mt -72.5 119.87 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.81 103.26 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.05 146.82 23.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.52 1.528 . . . . 0.0 108.69 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.19 141.81 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.5 165.27 21.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.79 -69.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.627 2.06 . . . . 0.0 115.04 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -131.63 35.05 3.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.393 1.477 . . . . 0.0 110.015 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -147.62 162.97 38.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.81 153.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 165.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.22 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 135.14 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -110.54 105.19 14.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.118 0.967 . . . . 0.0 110.387 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -70.24 107.84 3.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 168.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -122.69 112.75 18.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.554 0.742 . . . . 0.0 110.932 -166.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -149.82 170.24 19.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 110.251 168.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -79.41 38.01 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.792 1.237 . . . . 0.0 113.621 -160.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -161.96 -43.4 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.444 -0.785 . . . . 0.0 110.064 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -135.19 130.91 36.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.23 121.57 36.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -136.5 128.91 30.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.567 0.621 . . . . 0.0 110.232 -171.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 134.13 41.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.138 1.375 . . . . 0.0 109.147 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.13 123.1 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 p -80.7 160.04 25.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.263 1.025 . . . . 0.0 109.417 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -140.83 86.22 2.03 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.333 1.453 . . . . 0.0 108.591 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -79.99 93.97 5.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 110.79 0.59 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.395 0.678 . . . . 0.0 112.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.32 28.15 8.25 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.683 1.135 . . . . 0.0 112.016 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.0 t -150.46 159.35 4.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.667 1.187 . . . . 0.0 108.165 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -108.89 140.83 41.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.107 0.963 . . . . 0.0 110.189 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -154.78 157.53 38.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 148.07 47.3 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.096 0.407 . . . . 0.0 110.73 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.66 86.97 2.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.934 2.094 . . . . 0.0 105.795 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.8 m -90.55 96.76 10.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 t -121.16 137.99 54.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.581 0.753 . . . . 0.0 110.634 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.44 49.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.059 0.944 . . . . 0.0 113.436 -168.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.66 -75.13 0.51 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -87.35 17.28 4.53 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -162.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 mtm-85 80.54 -163.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.295 1.838 . . . . 0.0 110.969 165.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.4 109.37 19.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.192 0.997 . . . . 0.0 108.553 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.07 168.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -108.3 135.36 49.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 t -105.03 87.88 2.74 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.196 1.798 . . . . 0.0 109.624 -168.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -80.52 104.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.85 135.78 41.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.4 t -152.48 -162.7 1.56 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 161.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.4 pp -147.47 154.83 41.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.308 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.13 146.61 28.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.08 0.952 . . . . 0.0 109.33 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.52 -82.42 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.105 0.859 . . . . 0.0 111.25 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.73 15.5 0.62 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.105 1.336 . . . . 0.0 111.721 171.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.34 127.49 55.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.543 1.537 . . . . 0.0 108.008 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.18 113.02 25.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.44 132.67 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.99 0.916 . . . . 0.0 109.442 -167.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -115.47 99.3 7.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.18 1.792 . . . . 0.0 106.655 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.08 103.99 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 169.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -96.36 96.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -105.37 121.96 44.98 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.612 1.565 . . . . 0.0 109.434 -171.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -104.23 -75.87 0.61 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.243 0.474 . . . . 0.0 109.852 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.31 139.04 6.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.25 -34.88 1.31 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.031 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.08 -175.37 5.3 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.072 0.949 . . . . 0.0 110.459 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -133.93 177.15 7.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.133 1.773 . . . . 0.0 108.271 165.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.4 143.0 50.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 159.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.72 125.19 50.2 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.173 0.589 . . . . 0.0 109.502 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.46 120.02 32.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.951 1.3 . . . . 0.0 107.646 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -114.4 118.33 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.558 0.617 . . . . 0.0 110.78 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HG2' HD11 ' A' ' 115' ' ' LEU . 28.9 mtm180 -102.0 136.77 41.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.187 1.395 . . . . 0.0 110.824 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -160.38 156.67 26.53 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.514 1.126 . . . . 0.0 108.081 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -134.78 130.8 36.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 166.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.15 159.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.52 -72.18 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.699 1.6 . . . . 0.0 112.61 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.28 68.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 mttt 174.02 164.77 0.2 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 129.307 3.043 . . . . 0.0 106.057 160.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.32 117.4 33.03 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.23 140.16 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.6 0.76 . . . . 0.0 110.304 -172.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 106' ' ' ARG . 1.1 mm? -126.15 118.8 25.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.182 1.393 . . . . 0.0 107.757 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.1 m -100.46 121.35 41.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 161.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -106.52 117.46 34.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -118.39 146.51 44.36 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.979 0.809 . . . . 0.0 109.384 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -127.09 170.82 11.95 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.225 1.81 . . . . 0.0 106.545 175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.83 55.99 3.04 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.472 -0.626 . . . . 0.0 111.765 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t 160.57 -63.51 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.09 2.956 . . . . 0.0 108.414 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.05 143.22 34.21 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.825 0.45 . . . . 0.0 110.362 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.45 136.93 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.4 t -151.46 133.94 15.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.011 0.524 . . . . 0.0 110.679 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 p -85.77 158.46 20.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.229 0.611 . . . . 0.0 110.14 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -134.84 142.8 46.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 153.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 137.43 38.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.152 0.887 . . . . 0.0 108.924 164.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.06 162.54 21.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.093 1.757 . . . . 0.0 109.579 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.17 153.19 51.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 165.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -67.73 121.19 15.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.42 1.488 . . . . 0.0 108.468 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -80.27 -25.28 39.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.408 0.549 . . . . 0.0 112.041 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.846 0.858 . . . . 0.0 109.183 176.258 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -74.65 60.11 0.89 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.251 1.82 . . . . 0.0 110.154 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 -53.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -164.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.16 -45.62 10.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.529 0.732 . . . . 0.0 111.437 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -47.41 120.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.325 0.65 . . . . 0.0 112.276 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.86 -163.07 12.18 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.778 1.18 . . . . 0.0 112.294 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -84.98 139.95 31.42 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.456 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CE2' HD13 ' A' ' 42' ' ' ILE . 2.1 m0 -119.93 155.18 33.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.778 1.631 . . . . 0.0 108.343 169.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 137.57 54.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.51 0.724 . . . . 0.0 109.766 163.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.17 147.07 53.88 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.22 0.608 . . . . 0.0 110.289 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.69 42.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.179 0.514 . . . . 0.0 110.935 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.89 153.96 3.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.721 2.009 . . . . 0.0 106.792 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.5 t -159.18 25.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.589 0.756 . . . . 0.0 111.72 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 122.53 16.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.586 1.085 . . . . 0.0 110.048 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 68.11 62.67 0.38 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.097 1.759 . . . . 0.0 110.996 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -83.0 -63.92 1.27 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.35 -0.844 . . . . 0.0 111.486 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.82 -34.52 62.36 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.435 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -36.61 -54.3 0.88 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.754 1.221 . . . . 0.0 110.087 165.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 2.5 t80 -53.93 -51.0 65.19 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.407 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -38.41 76.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.634 0.774 . . . . 0.0 111.421 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -73.13 63.25 0.69 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.457 1.903 . . . . 0.0 111.509 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 158.34 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 130.061 3.344 . . . . 0.0 107.368 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.19 -27.13 68.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.665 0.386 . . . . 0.0 111.588 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.43 -53.88 0.61 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.843 1.211 . . . . 0.0 110.309 169.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t 1.23 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 129.001 2.92 . . . . 0.0 115.284 -170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.1 110.47 0.27 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.992 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -65.74 173.27 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.137 0.468 . . . . 0.0 110.261 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.4 -68.99 0.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.134 1.774 . . . . 0.0 111.902 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.4 m -55.77 -54.74 40.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -65.38 -42.49 92.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.047 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.7 -7.92 48.26 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.12 -43.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 118.675 0.67 . . . . 0.0 109.804 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.36 -25.79 67.19 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.07 0.843 . . . . 0.0 112.847 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -66.95 -24.85 66.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.09 0.956 . . . . 0.0 112.239 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.0 tpt -83.97 -39.3 19.89 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.746 -0.596 . . . . 0.0 110.668 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -63.25 -57.43 10.49 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -177.25 88.61 0.25 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.162 0.985 . . . . 0.0 110.463 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -75.25 92.47 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.562 2.175 . . . . 0.0 108.833 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 m -87.94 163.18 16.47 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -142.78 152.33 42.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -130.28 128.47 64.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.454 HD13 ' CE2' ' A' ' 8' ' ' TRP . 1.7 mp -111.8 125.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 165.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 128.21 54.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 169.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.31 75.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -58.81 153.19 17.51 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.5 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -39.56 -52.0 3.05 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.365 0.983 . . . . 0.0 114.257 -167.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -112.0 0.62 16.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.523 1.529 . . . . 0.0 112.008 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -147.6 -171.48 3.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.809 1.186 . . . . 0.0 109.819 -161.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.63 130.69 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 166.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.02 150.25 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 165.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -137.06 118.62 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -108.15 131.08 55.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.79 0.836 . . . . 0.0 109.753 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.74 27.3 4.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.213 1.405 . . . . 0.0 111.265 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -49.83 97.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.843 1.657 . . . . 0.0 114.166 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 59' ' ' ASN . 3.7 t -138.53 126.9 23.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 128.212 2.605 . . . . 0.0 104.453 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t 55.45 -171.68 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.541 1.937 . . . . 0.0 114.729 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -83.66 18.98 1.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.395 1.478 . . . . 0.0 112.776 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -159.3 115.42 2.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 55' ' ' SER . 2.0 t-20 -165.31 -176.73 4.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.271 0.487 . . . . 0.0 110.8 -169.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 p -142.84 171.1 14.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.36 1.464 . . . . 0.0 108.681 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.7 150.22 38.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.4 mt -134.47 164.44 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.806 1.642 . . . . 0.0 106.596 -170.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.8 p -139.19 161.95 36.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.76 167.53 22.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.335 0.654 . . . . 0.0 110.091 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -109.31 131.14 55.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 166.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 84.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 165.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.56 42.33 0.14 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.628 1.585 . . . . 0.0 111.725 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -153.46 152.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.195 0.998 . . . . 0.0 109.066 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -111.95 140.92 46.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.213 1.005 . . . . 0.0 109.891 163.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -161.07 158.32 27.56 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.16 134.43 50.51 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -118.57 129.91 55.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -124.23 98.54 5.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 t -122.94 145.61 48.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.949 0.795 . . . . 0.0 111.012 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.44 48.85 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.399 1.079 . . . . 0.0 111.003 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.0 -83.47 0.05 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.918 1.687 . . . . 0.0 106.929 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -75.77 16.24 0.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 76.25 -147.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.03 1.332 . . . . 0.0 109.505 166.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -101.04 136.81 40.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 m -151.54 175.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.254 1.822 . . . . 0.0 107.257 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -103.24 132.08 49.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 155.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -92.82 109.54 20.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 mt -104.38 103.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.8 139.23 47.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 122.25 0.22 . . . . 0.0 110.759 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -151.87 156.29 39.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.546 1.139 . . . . 0.0 108.362 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -142.45 145.08 33.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 86' ' ' LEU . 4.5 p-10 -164.45 -146.76 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.874 1.67 . . . . 0.0 106.708 175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.78 48.61 2.99 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.331 0.969 . . . . 0.0 110.864 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.93 27.6 0.2 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.234 0.921 . . . . 0.0 111.663 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 74.76 163.85 0.27 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.647 1.579 . . . . 0.0 111.475 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -79.18 101.53 8.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.86 106.34 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -93.88 95.51 9.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 162.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.77 122.28 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 102' ' ' THR . 6.0 tp60 -117.16 99.44 7.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -168.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -119.58 115.11 23.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.513 1.125 . . . . 0.0 111.448 -161.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -96.51 -66.04 0.93 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.333 0.515 . . . . 0.0 109.847 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -169.03 -78.31 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 117.751 0.251 . . . . 0.0 111.649 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.58 -30.19 74.66 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 173.45 11.59 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.25 142.27 30.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.199 1.8 . . . . 0.0 106.277 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 95' ' ' GLN . 9.8 t -108.86 148.39 30.68 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.85 0.86 . . . . 0.0 109.565 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 p -104.0 112.75 25.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mt -95.47 92.07 6.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 164.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 126.05 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.16 137.38 48.97 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.754 1.222 . . . . 0.0 110.627 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -161.81 151.52 16.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.957 1.303 . . . . 0.0 107.716 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -107.14 120.53 42.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.766 0.826 . . . . 0.0 109.261 170.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.21 -171.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 163.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.15 -111.15 0.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.02 21.02 3.55 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 126.046 1.784 . . . . 0.0 109.792 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -145.02 147.31 32.48 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.345 1.072 . . . . 0.0 111.112 -166.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tt -102.51 106.73 17.5 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.74 1.216 . . . . 0.0 108.116 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.82 96.17 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.16 106.73 17.48 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -96.42 134.62 39.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 36.0 tp -131.43 94.1 3.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -117.79 125.04 49.86 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.429 0.692 . . . . 0.0 110.816 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -103.38 -49.38 3.73 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.235 1.014 . . . . 0.0 110.491 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.22 120.57 2.2 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 106.939 -2.465 . . . . 0.0 106.939 -166.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m 65.65 -68.54 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.962 1.305 . . . . 0.0 109.317 -165.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.96 134.27 45.86 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -146.83 138.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 106.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.73 136.98 31.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.624 0.77 . . . . 0.0 110.125 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 149.42 22.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 164.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -140.42 73.39 1.42 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 161.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.22 123.2 14.49 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.625 -0.672 . . . . 0.0 109.522 171.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -109.63 157.11 19.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.044 1.738 . . . . 0.0 109.38 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.38 118.82 24.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -85.4 104.38 15.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 110.536 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -77.35 -20.2 55.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.479 1.036 . . . . 0.0 111.516 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 124.305 1.042 . . . . 0.0 110.124 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.237 0.412 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 64.01 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.872 2.469 . . . . 0.0 110.398 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.13 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.282 1.433 . . . . 0.0 107.147 -155.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.99 -46.51 8.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.891 1.276 . . . . 0.0 110.733 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.4 t -48.99 97.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.893 1.677 . . . . 0.0 112.526 -172.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.31 -161.74 27.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.131 0.872 . . . . 0.0 111.318 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -96.89 128.06 43.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.66 0.784 . . . . 0.0 109.99 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.538 ' CG ' HD13 ' A' ' 42' ' ' ILE . 19.5 m0 -98.83 132.74 43.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -110.2 125.69 53.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.897 0.771 . . . . 0.0 109.324 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.51 148.54 48.14 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.754 0.422 . . . . 0.0 110.131 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.251 4.6 p -137.8 -68.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.011 171.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -103.93 123.45 47.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.052 0.842 . . . . 0.0 110.313 -169.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -167.82 148.76 5.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.088 0.555 . . . . 0.0 109.937 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -163.91 174.25 11.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.814 1.245 . . . . 0.0 109.165 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.32 38.1 4.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.744 1.618 . . . . 0.0 111.642 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.75 -40.46 5.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.011 0.925 . . . . 0.0 108.601 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -23.97 -77.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.212 1.805 . . . . 0.0 111.88 147.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 9.0 t70 -50.55 -44.49 56.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.297 1.439 . . . . 0.0 112.167 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -55.5 -55.53 30.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.318 0.647 . . . . 0.0 111.107 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 tpt -52.92 -47.02 68.29 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.809 0.844 . . . . 0.0 109.44 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 ttpm? -67.86 62.0 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.627 1.571 . . . . 0.0 110.444 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m 160.65 -57.32 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 129.564 3.145 . . . . 0.0 106.833 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD13 ' NE2' ' A' ' 119' ' ' HIS . 14.2 tp -82.17 -26.14 33.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -167.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.83 91.29 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.055 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -121.76 -58.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.799 1.239 . . . . 0.0 108.844 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.41 -162.54 7.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.3 t80 118.21 130.65 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.531 3.132 . . . . 0.0 107.328 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 62.0 8.2 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 -164.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 p -95.6 -62.49 1.29 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.411 1.484 . . . . 0.0 109.65 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -53.62 -52.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.642 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -60.39 -23.74 64.57 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.383 1.473 . . . . 0.0 113.179 -169.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.02 -52.46 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.69 26.96 1.93 Allowed Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.983 -0.898 . . . . 0.0 114.471 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -141.23 21.51 2.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.468 1.507 . . . . 0.0 109.562 164.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.3 ttm -143.24 -54.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -166.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -92.83 176.4 6.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 156.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.55 82.87 16.24 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.07 156.29 67.0 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.089 1.859 . . . . 0.0 110.36 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -110.8 158.34 18.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.736 0.814 . . . . 0.0 108.935 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 m -138.1 126.87 23.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 42' ' ' ILE . 1.9 mm -85.52 126.74 40.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.538 HD13 ' CG ' ' A' ' 8' ' ' TRP . 3.9 mp -124.03 112.85 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.18 134.74 54.59 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.89 0.876 . . . . 0.0 109.945 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.13 79.69 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.856 0.836 . . . . 0.0 109.407 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -54.3 154.76 4.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.605 167.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.54 -75.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.465 2.459 . . . . 0.0 115.956 -168.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.79 10.34 19.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.826 1.65 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -168.27 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.966 2.106 . . . . 0.0 107.644 -151.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.67 147.23 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 161.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -122.14 136.15 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 123.387 0.675 . . . . 0.0 109.253 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mt -112.57 138.57 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.267 1.427 . . . . 0.0 108.051 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -135.48 117.95 15.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.473 2.309 . . . . 0.0 108.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -91.07 100.96 13.72 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.842 1.201 . . . . 0.0 112.596 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 72.12 10.2 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.581 -1.325 . . . . 0.0 108.671 169.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -88.65 -178.56 5.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 153.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -103.41 37.67 1.95 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.046 0.938 . . . . 0.0 111.553 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.07 82.63 0.86 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -102.53 102.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 156.26 46.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.674 1.99 . . . . 0.0 106.316 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -152.77 144.6 23.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 129.88 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 p -99.31 127.42 45.32 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.023 2.129 . . . . 0.0 109.214 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.09 156.62 46.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.128 0.876 . . . . 0.0 111.901 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.45 115.74 31.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.92 71.19 0.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.473 0.709 . . . . 0.0 111.363 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.26 38.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.635 1.112 . . . . 0.0 111.847 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 t -152.05 154.8 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.566 1.183 . . . . 0.0 109.199 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -106.83 123.57 48.35 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.739 2.016 . . . . 0.0 108.616 166.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -165.36 164.74 19.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.097 0.959 . . . . 0.0 109.924 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.77 144.13 55.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.916 0.78 . . . . 0.0 111.56 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -132.64 72.11 1.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.405 2.282 . . . . 0.0 107.166 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.8 m -71.25 108.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.437 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.1 t -140.57 144.67 35.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.138 0.575 . . . . 0.0 110.679 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.5 57.59 2.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.045 1.338 . . . . 0.0 111.948 -167.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.48 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.755 1.622 . . . . 0.0 108.512 -170.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -73.79 -15.94 61.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.71 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 90.9 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.587 2.755 . . . . 0.0 109.334 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -78.86 59.11 2.51 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.626 -0.672 . . . . 0.0 109.274 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 81' ' ' LYS . 7.7 p -77.83 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.399 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 80' ' ' VAL . 32.1 ttmt -111.17 126.24 54.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.715 0.689 . . . . 0.0 109.655 170.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 p -78.26 108.49 11.63 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -102.14 110.22 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 155.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.06 145.37 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.9 t -155.38 -165.76 2.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.2 1.8 . . . . 0.0 107.112 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -138.82 145.12 39.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.2 0.27 46.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -166.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.604 ' H ' HD12 ' A' ' 86' ' ' LEU . . . 122.92 -39.18 2.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -160.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.92 -63.11 0.09 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.7 1.143 . . . . 0.0 111.126 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 142.54 38.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -169.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.1 tt -79.85 114.7 18.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.88 105.08 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.62 1.168 . . . . 0.0 108.241 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.34 107.81 19.75 Favored 'General case' 0 CA--C 1.524 -0.054 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.43 101.93 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 167.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.403 ' CG ' HG21 ' A' ' 80' ' ' VAL . 25.2 tt0 -89.92 102.42 15.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.752 1.221 . . . . 0.0 107.782 -166.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -116.85 127.34 54.2 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.126 0.57 . . . . 0.0 110.987 -165.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -97.72 -107.15 0.18 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.48 136.14 29.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.679 1.592 . . . . 0.0 108.642 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.8 -45.68 3.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.65 177.41 8.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.585 0.692 . . . . 0.0 111.552 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.01 176.79 11.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.532 1.933 . . . . 0.0 108.69 -172.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -132.7 138.42 47.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.954 1.301 . . . . 0.0 109.868 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.6 p -76.22 136.64 39.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 168.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 115' ' ' LEU . 29.4 mt -133.69 76.87 1.69 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 164.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.31 120.97 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.502 ' HG3' HD13 ' A' ' 115' ' ' LEU . 1.5 mpt_? -116.0 133.15 56.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.1 1.76 . . . . 0.0 109.868 -174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.33 146.66 29.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.704 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -124.55 107.28 10.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.288 1.435 . . . . 0.0 108.926 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.99 179.95 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 168.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.36 -98.32 0.08 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 0.0 109.664 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.16 32.79 0.5 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.458 1.028 . . . . 0.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -150.73 159.13 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.25 122.31 47.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.85 118.86 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.556 HD11 HD23 ' A' ' 104' ' ' LEU . 4.0 tp -113.31 116.4 29.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 m -96.19 124.35 40.16 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.24 93.28 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.68 1.192 . . . . 0.0 108.276 -171.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -143.47 153.42 42.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 0.0 111.354 -165.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -160.69 138.6 9.64 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 122.738 0.415 . . . . 0.0 110.96 166.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 47.95 -119.01 4.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.857 0.741 . . . . 0.0 111.428 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -73.72 -30.96 63.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.019 0.528 . . . . 0.0 112.193 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 126.3 42.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.365 0.53 . . . . 0.0 109.861 -166.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.69 144.17 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.025 0 C-N-CA 125.602 1.561 . . . . 0.0 109.168 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.25 151.42 32.96 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.6 -1.313 . . . . 0.0 110.826 172.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.5 p -114.89 142.44 46.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.937 1.695 . . . . 0.0 107.384 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -139.73 82.21 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.83 142.16 31.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.774 0.797 . . . . 0.0 109.707 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -119.88 169.0 10.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.711 1.604 . . . . 0.0 108.509 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -116.45 117.45 29.94 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 163.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -75.69 108.67 8.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -78.95 -31.51 45.12 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 118.352 0.524 . . . . 0.0 111.672 -170.767 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.485 0.179 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.68 59.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.758 3.223 . . . . 0.0 111.959 -168.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.98 -50.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.284 1.834 . . . . 0.0 107.26 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.86 -40.49 87.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.813 1.245 . . . . 0.0 110.639 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.25 116.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.123 1.369 . . . . 0.0 111.259 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -129.56 4.28 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.834 1.207 . . . . 0.0 111.199 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 m -148.67 121.9 8.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.77 -0.841 . . . . 0.0 109.837 -171.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -115.15 130.09 56.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.761 1.624 . . . . 0.0 110.484 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -114.0 141.8 46.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.883 0.873 . . . . 0.0 109.483 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.8 144.01 29.13 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 123.399 0.437 . . . . 0.0 110.199 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.6 p -125.83 -73.99 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.513 0.725 . . . . 0.0 109.726 168.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' H ' HG13 ' A' ' 11' ' ' VAL . 5.8 m-20 -108.92 149.58 28.97 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.368 0.985 . . . . 0.0 110.102 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 t -170.89 -175.58 1.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.054 1.742 . . . . 0.0 107.805 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 pttt 177.14 154.16 0.25 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.366 2.666 . . . . 0.0 107.336 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.04 34.08 21.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.675 0.79 . . . . 0.0 109.743 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -95.76 -50.68 4.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -21.45 -74.98 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.719 2.408 . . . . 0.0 113.433 148.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.14 -57.55 8.44 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.988 0.813 . . . . 0.0 111.03 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.59 -48.16 19.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.331 0.586 . . . . 0.0 112.178 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -28.06 69.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -74.97 47.07 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.52 1.928 . . . . 0.0 110.514 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.1 t -174.89 -51.86 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.939 1.695 . . . . 0.0 106.887 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.58 -35.71 80.38 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.974 0.51 . . . . 0.0 111.073 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.32 -45.71 1.28 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 76' ' ' ASP . 7.3 p -37.61 -26.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.508 2.323 . . . . 0.0 114.327 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -27.75 -68.64 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.807 1.67 . . . . 0.0 112.96 159.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.58 155.83 38.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.959 0.38 . . . . 0.0 110.111 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 71.89 -52.07 0.69 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.969 1.708 . . . . 0.0 113.786 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.6 m -105.25 -67.37 0.92 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.424 1.089 . . . . 0.0 110.647 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -68.38 -17.42 64.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.282 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -41.22 -49.7 3.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.651 0.78 . . . . 0.0 111.972 163.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -94.33 -38.93 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.09 -40.79 59.56 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.075 0.845 . . . . 0.0 113.165 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -79.31 -12.42 59.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.273 1.037 . . . . 0.0 112.381 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -61.5 1.44 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.253 3.8 t -83.74 79.29 9.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.627 0.727 . . . . 0.0 109.656 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt 12.85 76.44 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 128.766 2.826 . . . . 0.0 113.91 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.25 150.17 76.38 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.998 2.465 . . . . 0.0 113.229 -161.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 m -102.53 159.1 15.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.055 1.742 . . . . 0.0 108.75 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 119.35 12.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 42' ' ' ILE . 87.0 mt -87.49 126.71 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 41' ' ' ILE . 1.5 mp -119.92 114.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.06 140.33 53.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.337 0.517 . . . . 0.0 110.302 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 79.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -62.42 74.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.597 1.559 . . . . 0.0 112.11 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.34 -92.73 0.06 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.486 1.041 . . . . 0.0 111.749 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.37 -30.09 19.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.409 1.083 . . . . 0.0 110.745 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.05 -175.54 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.493 2.317 . . . . 0.0 109.161 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.13 138.04 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -114.94 131.48 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.509 1.123 . . . . 0.0 108.732 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -120.68 120.45 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.718 2.407 . . . . 0.0 106.346 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -128.88 99.92 5.49 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 t -82.41 43.21 0.8 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.778 -172.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 124.03 18.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.959 1.704 . . . . 0.0 112.669 -175.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -123.8 -166.54 1.5 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 162.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -46.9 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.941 0.896 . . . . 0.0 111.459 -166.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.1 p90 38.66 34.29 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.081 2.152 . . . . 0.0 114.464 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -156.26 162.87 40.09 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.663 0.665 . . . . 0.0 110.634 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 96.71 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 129.547 3.139 . . . . 0.0 110.491 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 p -110.43 174.54 5.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.481 1.512 . . . . 0.0 112.385 -156.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.98 122.17 37.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.593 2.357 . . . . 0.0 106.583 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -129.38 136.73 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 p -141.48 122.23 14.36 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 119.183 0.901 . . . . 0.0 110.316 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -147.54 165.86 29.05 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.095 0.861 . . . . 0.0 111.915 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -101.1 138.34 38.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 166.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -75.0 59.06 0.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.113 0.565 . . . . 0.0 110.506 175.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 157.31 60.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -166.85 172.55 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.855 0.828 . . . . 0.0 109.041 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -131.35 152.07 50.94 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.859 0.864 . . . . 0.0 110.793 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.92 160.17 14.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 109.478 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.74 129.03 36.42 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -123.93 123.71 41.02 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -116.1 95.53 5.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 t -113.01 140.63 47.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.065 0.946 . . . . 0.0 109.899 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.71 48.54 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.481 1.112 . . . . 0.0 112.217 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 25' ' ' VAL . 34.6 p-10 -163.42 -62.45 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.729 1.612 . . . . 0.0 109.392 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -87.12 -3.64 59.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.75 0.82 . . . . 0.0 111.631 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 83.33 -157.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.837 1.655 . . . . 0.0 109.696 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -74.62 116.34 15.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 168.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.63 154.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -81.29 138.18 35.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 150.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -100.6 119.74 39.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 161.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tt -121.02 123.36 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.02 144.68 32.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.562 0.345 . . . . 0.0 110.944 -167.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -157.54 144.15 17.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.55 1.14 . . . . 0.0 109.317 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -85.15 109.11 18.05 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 90' ' ' LYS . 26.7 p-10 -78.58 29.2 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.325 0.65 . . . . 0.0 112.625 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.4 -36.47 1.56 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.597 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 -24.94 5.91 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.097 1.449 . . . . 0.0 113.087 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -163.3 159.97 23.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.733 1.267 . . . . 0.0 109.855 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 100.3 8.03 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.16 118.33 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.581 ' HB3' HD12 ' A' ' 104' ' ' LEU . 3.4 t-160 -114.97 108.38 16.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.41 132.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -129.68 99.67 5.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -161.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HZ3' ' CD ' ' A' ' 101' ' ' GLU . 39.1 tttp -113.89 110.63 20.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.941 0.896 . . . . 0.0 111.648 -159.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -96.56 -27.31 14.9 Favored 'General case' 0 C--O 1.228 -0.048 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -155.68 -143.79 0.13 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.683 0.674 . . . . 0.0 109.897 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -42.74 -41.18 4.27 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.205 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -97.03 175.35 6.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 112.283 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' CD ' ' HZ3' ' A' ' 96' ' ' LYS . 2.3 pm0 -143.71 167.11 23.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.988 2.115 . . . . 0.0 108.301 173.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -98.59 148.14 24.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 148.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -119.31 137.11 53.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -150.94 138.13 19.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.207 0.458 . . . . 0.0 111.138 -175.002 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.7 m -130.69 117.3 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.663 1.185 . . . . 0.0 110.203 -164.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.424 ' NH1' HD13 ' A' ' 104' ' ' LEU . 8.5 mpt_? -102.77 139.64 38.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.873 0.76 . . . . 0.0 109.573 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.71 155.63 36.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 153.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 19.8 ttt -91.83 119.36 31.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.857 0.863 . . . . 0.0 108.994 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.46 170.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 166.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.73 -85.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.627 1.171 . . . . 0.0 109.616 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.3 26.19 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.04 1.305 . . . . 0.0 110.467 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.48 154.54 47.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.89 117.42 16.71 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.95 120.77 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 168.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.93 104.81 9.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.8 m -94.25 131.93 39.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.93 130.37 53.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 t -141.19 131.99 25.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.546 0.689 . . . . 0.0 110.211 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -119.51 165.37 14.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.169 2.587 . . . . 0.0 105.838 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.78 65.09 1.47 Allowed Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.092 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t 156.45 -59.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 130.105 3.362 . . . . 0.0 108.432 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.15 137.24 35.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.197 0.599 . . . . 0.0 109.931 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.12 134.02 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 127.53 7.32 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.197 0.908 . . . . 0.0 112.98 -176.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.6 p -78.48 153.57 31.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.958 0.903 . . . . 0.0 109.072 168.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.69 140.13 19.64 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.2 p -133.36 160.34 37.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.945 0.793 . . . . 0.0 109.363 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -145.37 144.99 31.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.576 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -128.39 134.2 48.78 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -79.68 111.81 16.34 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.26 -39.08 82.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.956 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.71 -45.06 6.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.386 2.274 . . . . 0.0 111.731 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.87 -21.6 8.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.581 1.952 . . . . 0.0 112.511 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -120.22 17.65 12.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.915 1.286 . . . . 0.0 111.314 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -99.56 94.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.539 0.736 . . . . 0.0 110.954 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.66 -165.92 23.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.824 0.726 . . . . 0.0 113.486 159.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -83.64 143.05 30.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.503 0.721 . . . . 0.0 110.125 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -133.26 141.41 48.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.963 1.305 . . . . 0.0 108.513 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 133.01 36.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 165.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.11 144.56 56.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 166.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 -57.69 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.492 0.717 . . . . 0.0 111.483 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -78.98 160.08 27.37 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.815 1.189 . . . . 0.0 109.605 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -170.42 56.72 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.779 1.632 . . . . 0.0 108.302 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.38 127.18 35.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 66.97 27.92 8.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.995 1.718 . . . . 0.0 109.876 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.6 -51.34 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 120.033 -1.667 . . . . 0.0 108.089 -171.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -17.9 -77.39 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.835 2.054 . . . . 0.0 112.485 144.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -37.12 -57.45 0.85 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 111.12 175.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' SG ' ' A' ' 124' ' ' CYS . 0.8 OUTLIER -50.9 -50.18 57.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -166.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.72 81.43 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.528 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -77.08 49.52 0.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.535 1.934 . . . . 0.0 109.185 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -178.98 -55.99 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.368 1.867 . . . . 0.0 106.955 -168.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.69 -41.9 95.7 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.92 -44.16 0.87 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.5 42.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.979 1.312 . . . . 0.0 111.327 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.3 146.06 17.97 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.871 1.224 . . . . 0.0 112.406 -166.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.1 162.2 1.98 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.014 1.726 . . . . 0.0 107.175 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -18.73 65.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -47.9 -40.01 20.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 112.432 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -31.53 63.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.759 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -62.42 -23.94 67.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.117 0.871 . . . . 0.0 111.729 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.3 t -91.1 -47.94 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.79 -58.75 3.49 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.137 1.351 . . . . 0.0 112.884 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -55.66 -41.94 74.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.774 0.787 . . . . 0.0 110.913 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.359 1.064 . . . . 0.0 112.205 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -86.13 -132.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -145.61 76.53 12.91 Favored Pre-proline 0 C--O 1.234 0.274 0 O-C-N 121.086 -1.009 . . . . 0.0 109.085 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 82.7 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.344 2.696 . . . . 0.0 108.761 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -83.03 148.21 27.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.299 1.84 . . . . 0.0 107.902 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m -140.58 122.31 15.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.183 -0.323 . . . . 0.0 110.282 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -77.77 127.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mt -124.29 117.76 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.29 129.6 49.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.79 96.94 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -78.18 69.82 4.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.37 -89.25 0.05 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.759 1.171 . . . . 0.0 111.531 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -24.67 16.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.52 . . . . 0.0 110.747 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.48 9.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.165 1.786 . . . . 0.0 106.866 -172.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.98 141.7 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.96 133.31 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.762 0.825 . . . . 0.0 108.899 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.9 tt -110.35 132.32 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.754 1.222 . . . . 0.0 107.713 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -133.95 95.96 3.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 107.328 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.71 138.48 31.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -132.77 116.38 16.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.841 1.656 . . . . 0.0 110.903 -162.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -161.56 151.27 16.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.784 2.034 . . . . 0.0 106.314 161.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -56.73 -49.38 75.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.416 0.687 . . . . 0.0 109.502 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -48.87 -38.16 21.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.704 1.201 . . . . 0.0 112.755 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.59 136.27 0.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.922 0.889 . . . . 0.0 109.848 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -141.87 151.07 42.35 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.654 1.582 . . . . 0.0 108.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p -156.34 148.18 22.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.46 0.704 . . . . 0.0 109.351 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -128.04 117.79 22.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.071 2.149 . . . . 0.0 108.284 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.96 143.3 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.692 0.797 . . . . 0.0 109.287 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 p -108.19 150.06 27.74 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.472 1.509 . . . . 0.0 110.814 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 84' ' ' VAL . 26.5 p90 -159.61 175.58 13.05 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.909 1.283 . . . . 0.0 108.91 -174.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -134.79 143.64 47.2 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.999 0.92 . . . . 0.0 108.943 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 53.05 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.302 1.041 . . . . 0.0 112.027 -175.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.12 40.13 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.24 151.18 12.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.1 138.88 35.57 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.926 1.291 . . . . 0.0 109.469 166.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -142.19 158.35 43.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.381 1.472 . . . . 0.0 108.177 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.27 134.55 36.64 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -134.37 151.67 51.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -139.82 166.87 23.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.955 -0.466 . . . . 0.0 109.833 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 t -136.85 -177.27 4.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.162 0.985 . . . . 0.0 109.371 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.78 -25.02 62.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -156.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -95.22 15.02 20.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.233 1.413 . . . . 0.0 111.633 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t0 49.76 41.02 21.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.359 2.264 . . . . 0.0 112.969 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -66.76 87.44 0.13 Allowed 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -77.87 92.86 4.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.607 1.563 . . . . 0.0 109.464 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 97' ' ' TRP . 6.1 m -104.41 171.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.778 1.231 . . . . 0.0 110.079 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.64 135.85 41.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 m -124.57 123.73 40.72 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 107.857 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -117.93 126.21 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.471 HG21 ' CD2' ' A' ' 64' ' ' PHE . 39.1 t -110.24 145.32 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.6 m -148.7 164.32 34.69 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -113.39 113.44 25.21 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.83 107.98 20.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.833 1.253 . . . . 0.0 108.012 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.35 -80.94 0.06 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.318 0.961 . . . . 0.0 112.106 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.67 4.18 3.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.495 1.521 . . . . 0.0 112.344 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -105.17 120.99 42.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 107.203 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.7 tt -78.87 106.17 10.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 169.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 m -95.32 111.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -99.4 106.76 18.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 83' ' ' ILE . 9.9 p -100.65 133.73 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.9 112.31 12.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -162.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -127.98 125.82 40.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.375 1.87 . . . . 0.0 108.688 -157.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.47 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.7 p90 -108.86 -81.55 0.57 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -162.19 150.76 15.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.96 -44.47 1.55 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.419 0.533 . . . . 0.0 112.044 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.58 -164.91 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.554 1.542 . . . . 0.0 109.196 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.77 -170.36 3.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.613 1.565 . . . . 0.0 109.334 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 t -136.14 150.72 49.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.623 1.569 . . . . 0.0 107.991 162.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.4 p -98.56 138.47 35.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 163.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.1 mt -131.64 96.83 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.401 1.88 . . . . 0.0 105.939 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.71 131.83 42.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.07 124.84 53.09 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.199 1.4 . . . . 0.0 108.27 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -141.91 122.42 14.13 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -106.74 115.89 30.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.09 -173.3 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 156.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 52.08 -108.91 0.42 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.48 28.76 2.05 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.859 1.695 . . . . 0.0 109.615 171.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -137.45 122.09 18.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.674 0.737 . . . . 0.0 110.128 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.24 92.73 5.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.8 mt -73.1 138.53 21.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.57 105.09 4.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.098 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.0 m -95.33 136.0 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.81 119.9 38.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -126.28 125.2 41.95 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.942 0.337 . . . . 0.0 110.309 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -129.5 165.01 22.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.54 1.536 . . . . 0.0 107.095 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.33 126.07 18.37 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 168.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.99 -58.84 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 112.146 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.78 133.15 34.34 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.694 -0.629 . . . . 0.0 111.862 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.21 130.3 69.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.773 1.629 . . . . 0.0 107.26 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' TYR . 4.4 m -146.99 158.76 44.02 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 121.379 -0.826 . . . . 0.0 109.174 -170.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.7 p -134.35 151.81 51.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.101 0.409 . . . . 0.0 110.738 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -145.2 167.26 23.21 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 156.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 p -136.47 146.43 46.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.22 129.68 52.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.551 1.54 . . . . 0.0 108.779 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -106.18 136.79 45.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.907 1.283 . . . . 0.0 108.422 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -65.25 139.0 58.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.358 0.263 . . . . 0.0 110.728 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.81 -6.0 7.99 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 111.722 159.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.144 0 C-N-CA 124.616 1.167 . . . . 0.0 110.922 172.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.236 0.378 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.41 67.9 0.02 OUTLIER 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.53 2.332 . . . . 0.0 111.091 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.37 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 107.09 -163.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -86.71 -45.67 10.75 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.914 1.286 . . . . 0.0 110.69 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -46.11 108.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.385 1.474 . . . . 0.0 111.645 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.83 -166.46 13.02 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.416 1.008 . . . . 0.0 112.37 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -84.2 138.84 32.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.131 0.973 . . . . 0.0 111.324 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.6 141.17 43.27 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.474 0.709 . . . . 0.0 110.314 167.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -107.87 153.84 22.43 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.463 1.105 . . . . 0.0 109.867 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.96 148.64 16.87 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 167.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.41 -54.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.867 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.49 147.24 39.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.631 1.105 . . . . 0.0 109.01 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -160.47 153.86 22.06 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.234 -0.916 . . . . 0.0 110.73 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -158.13 155.88 29.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.499 1.12 . . . . 0.0 108.541 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 m120 63.71 -10.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.36 -41.52 9.08 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.264 1.025 . . . . 0.0 110.869 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -71.76 -24.78 61.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.19 -46.44 56.26 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 165.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.88 -51.36 61.4 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.972 0.909 . . . . 0.0 112.327 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -57.68 -42.65 84.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.294 0.638 . . . . 0.0 109.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.94 57.71 1.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.448 1.499 . . . . 0.0 109.22 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t 179.63 -52.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.712 2.405 . . . . 0.0 107.028 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.27 -27.6 68.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.679 0.392 . . . . 0.0 111.575 172.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 -47.14 3.69 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 26' ' ' GLY . 8.6 p 0.28 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 130.324 3.45 . . . . 0.0 116.074 167.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' H ' HG13 ' A' ' 25' ' ' VAL . . . -156.05 58.24 0.38 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -31.56 -61.42 0.22 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 128.003 2.521 . . . . 0.0 111.484 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.21 57.94 1.29 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.318 1.047 . . . . 0.0 108.202 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -149.67 -52.54 0.15 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.859 -0.526 . . . . 0.0 109.802 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -59.23 -22.99 61.93 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.453 -1.261 . . . . 0.0 110.863 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -41.57 -35.52 0.75 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.218 1.007 . . . . 0.0 112.696 169.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.82 -67.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.05 45.21 2.23 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.443 1.02 . . . . 0.0 113.817 -173.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -154.03 -34.61 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.958 1.703 . . . . 0.0 110.886 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.2 ttm -92.22 -21.12 20.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.89 1.676 . . . . 0.0 110.307 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -65.71 -165.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.409 0.623 . . . . 0.0 109.995 159.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -107.37 78.97 0.7 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.597 1.159 . . . . 0.0 109.411 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.65 145.11 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.113 1.875 . . . . 0.0 110.344 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 m -104.26 126.18 51.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.505 1.122 . . . . 0.0 108.039 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -109.19 99.42 8.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.34 121.22 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.16 128.6 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -107.1 141.56 38.15 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.04 71.39 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.151 0.98 . . . . 0.0 108.695 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -55.05 139.69 40.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.882 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.46 -75.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.9 2.191 . . . . 0.0 116.457 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -111.18 18.45 19.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.519 1.928 . . . . 0.0 111.03 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.26 -162.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.954 1.301 . . . . 0.0 108.253 -155.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.89 142.74 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.8 tt -124.98 117.68 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.67 135.79 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -115.3 107.55 15.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.944 2.098 . . . . 0.0 105.746 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -88.25 102.64 15.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.59 138.48 43.74 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.034 0.834 . . . . 0.0 111.008 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -169.81 54.86 0.04 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.196 1.398 . . . . 0.0 108.748 -173.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 m 65.71 -75.13 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.653 1.581 . . . . 0.0 111.637 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.33 -51.79 4.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.062 0.945 . . . . 0.0 109.2 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -77.07 76.9 3.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.58 59.84 0.61 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.575 1.15 . . . . 0.0 110.537 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.14 163.62 18.64 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.936 1.294 . . . . 0.0 111.123 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -123.58 156.62 35.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.908 0.883 . . . . 0.0 110.067 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mp -133.53 101.16 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.6 122.6 36.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.811 2.044 . . . . 0.0 108.926 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.58 168.81 22.49 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.097 0.862 . . . . 0.0 112.61 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.58 108.79 13.53 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.539 1.535 . . . . 0.0 107.812 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 96.78 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 122.051 -0.406 . . . . 0.0 110.017 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.14 33.3 0.2 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.365 1.936 . . . . 0.0 111.832 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.72 149.39 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.835 1.317 . . . . 0.0 109.32 -171.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.85 121.95 44.74 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.268 1.427 . . . . 0.0 107.612 161.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.37 155.02 23.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.821 0.737 . . . . 0.0 111.366 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.88 120.11 13.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.203 0.601 . . . . 0.0 110.237 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.76 95.43 5.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 m -103.77 102.6 12.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 t -131.28 146.79 52.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.013 0.925 . . . . 0.0 109.405 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.2 43.92 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.588 1.155 . . . . 0.0 112.066 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -149.98 -68.39 0.2 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.771 1.628 . . . . 0.0 108.264 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.99 -12.79 61.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.242 0.928 . . . . 0.0 111.525 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.12 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.256 2.222 . . . . 0.0 108.566 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -80.91 112.37 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 166.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.52 138.21 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -80.41 109.54 15.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.9 p -74.57 149.64 40.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 tt -137.36 107.75 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 163.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.18 139.92 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.184 -170.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -156.99 176.96 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.731 2.013 . . . . 0.0 107.206 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -132.17 122.08 24.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 159.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 176.11 167.51 0.43 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.109 2.564 . . . . 0.0 105.32 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.44 -64.56 1.06 Allowed Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.49 104.93 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 91.83 162.3 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.706 2.402 . . . . 0.0 110.05 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 121.09 26.28 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.24 86.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.992 1.717 . . . . 0.0 108.484 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -81.57 81.13 7.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.5 149.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -153.34 106.17 2.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -158.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -116.13 100.98 8.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.062 2.145 . . . . 0.0 108.121 -160.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -90.61 -62.36 1.47 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.592 1.087 . . . . 0.0 110.48 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -170.13 -85.27 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.157 0.435 . . . . 0.0 111.465 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.82 -20.81 79.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.44 170.02 16.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -133.22 175.48 9.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.945 1.698 . . . . 0.0 107.429 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.3 t -143.02 160.88 39.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.174 0.99 . . . . 0.0 109.218 168.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -127.53 116.8 20.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 108.126 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.32 105.7 15.2 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.194 0.998 . . . . 0.0 108.536 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.46 114.82 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.268 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.56 ' CG ' HD23 ' A' ' 115' ' ' LEU . 67.9 mtt85 -109.75 139.62 44.58 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.97 0.908 . . . . 0.0 109.075 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -161.28 151.09 17.0 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.087 0.403 . . . . 0.0 110.907 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -113.57 107.59 16.0 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.008 0.923 . . . . 0.0 109.756 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.28 -176.97 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 159.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.0 t70 52.21 -113.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -148.29 34.41 1.19 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.559 1.076 . . . . 0.0 110.777 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -144.47 148.45 34.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.39 98.04 10.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.5 128.21 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.8 tm? -131.51 122.85 26.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -119.48 132.28 55.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.3 123.33 45.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.7 m -124.73 132.98 53.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.053 1.341 . . . . 0.0 109.411 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -144.31 170.02 16.79 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.451 0.569 . . . . 0.0 110.565 169.017 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -45.31 106.82 0.13 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 60.04 45.48 11.96 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.959 1.304 . . . . 0.0 112.556 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 119' ' ' HIS . . . -173.01 140.87 0.93 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 144.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.6 144.16 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.542 1.937 . . . . 0.0 106.67 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -149.85 126.44 10.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.186 0.448 . . . . 0.0 111.172 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -76.49 138.06 40.04 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.868 1.267 . . . . 0.0 108.311 163.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -150.75 100.84 2.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 161.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.3 m -97.0 138.44 34.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.889 0.852 . . . . 0.0 109.421 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -114.87 171.2 7.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.063 1.745 . . . . 0.0 108.976 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.02 142.07 47.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.109 1.763 . . . . 0.0 106.257 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -101.23 121.38 41.75 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.129 0.572 . . . . 0.0 110.577 -167.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -126.43 61.77 1.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.275 1.43 . . . . 0.0 109.366 -172.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 C-N-CA 123.696 0.799 . . . . 0.0 109.123 168.453 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.52 -37.6 50.08 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.571 1.948 . . . . 0.0 111.492 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.96 -16.5 63.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.392 1.877 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -119.04 -54.01 2.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.739 1.216 . . . . 0.0 110.426 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -52.56 109.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.6 1.16 . . . . 0.0 111.36 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.85 -177.21 31.46 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 123.849 0.737 . . . . 0.0 112.617 167.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -91.02 129.84 36.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.651 1.58 . . . . 0.0 108.991 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 36.6 m95 -126.59 142.18 51.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 109.536 -177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -110.23 140.77 44.02 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.215 1.006 . . . . 0.0 109.551 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.4 tt -70.78 117.74 12.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 p -141.73 53.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 122.245 1.021 . . . . 0.0 108.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t0 163.59 156.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 130.347 3.459 . . . . 0.0 106.039 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 t 164.46 135.71 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.541 2.736 . . . . 0.0 108.138 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -106.38 159.07 16.42 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.05 48.19 8.84 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.584 0.707 . . . . 0.0 111.949 161.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -56.53 18.34 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.787 0.803 . . . . 0.0 109.718 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.63 -23.38 31.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.847 -166.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -44.25 -60.64 1.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.854 0.835 . . . . 0.0 109.688 161.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.51 -50.68 67.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.663 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.2 ttp -49.38 -47.16 47.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.353 1.061 . . . . 0.0 111.04 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -73.74 56.0 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.467 1.107 . . . . 0.0 111.201 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 m 175.17 -54.71 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.296 2.238 . . . . 0.0 107.374 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -65.48 -38.92 91.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.621 178.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.18 86.96 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 23' ' ' LEU . 32.8 m -61.91 -34.35 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 117.163 0.481 . . . . 0.0 110.979 174.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.16 102.36 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -48.95 -59.45 3.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.306 1.042 . . . . 0.0 110.512 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -55.75 19.98 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.236 0.541 . . . . 0.0 109.834 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -47.67 14.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.16 1.784 . . . . 0.0 112.874 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -61.08 -32.08 71.74 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.046 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.18 -55.79 19.29 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.149 0.886 . . . . 0.0 109.204 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.07 -46.83 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.08 45.27 1.4 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.259 1.409 . . . . 0.0 113.557 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -158.07 -41.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.419 1.887 . . . . 0.0 108.838 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -34.96 75.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.642 167.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.6 t -69.88 22.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 35.13 64.66 1.88 Allowed Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.2 1.8 . . . . 0.0 112.692 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.84 156.97 50.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.082 2.522 . . . . 0.0 112.706 -166.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.1 p -119.33 161.27 20.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 109.42 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -149.35 155.45 40.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.8 147.47 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 160.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.59 121.25 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -137.05 110.85 8.14 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.593 0.633 . . . . 0.0 109.765 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 95.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.345 1.058 . . . . 0.0 108.353 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -77.35 61.09 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.649 1.179 . . . . 0.0 108.691 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.16 -86.0 0.1 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.742 -0.599 . . . . 0.0 111.766 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -83.31 -43.46 15.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.136 0.969 . . . . 0.0 109.239 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.93 162.07 17.1 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.955 1.702 . . . . 0.0 109.554 -172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.39 118.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 103.568 -2.752 . . . . 0.0 103.568 169.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.1 tt -93.42 136.46 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.18 149.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 141.02 38.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.076 0.853 . . . . 0.0 110.721 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -103.46 44.52 1.01 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.851 1.26 . . . . 0.0 110.82 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.13 116.97 3.09 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.529 1.131 . . . . 0.0 113.409 -157.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 t -102.89 -172.43 2.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.653 1.181 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -28.8 61.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.311 1.444 . . . . 0.0 112.322 -167.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.28 51.84 2.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 109.555 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.8 tttt 68.76 173.41 0.29 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.972 0.909 . . . . 0.0 109.087 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -152.41 -173.92 4.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 164.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.4 p -64.99 164.75 12.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.735 0.778 . . . . 0.0 111.536 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.69 136.15 54.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 165.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.3 mt -132.2 146.62 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.01 2.524 . . . . 0.0 106.232 -161.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -146.48 91.27 2.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.716 1.144 . . . . 0.0 111.617 -161.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 84' ' ' VAL . 9.4 p90 -118.12 161.89 19.11 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 110.149 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 130.18 52.32 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.51 60.49 3.9 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.743 0.817 . . . . 0.0 112.286 -162.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.07 49.28 0.05 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -171.68 160.9 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.974 . . . . 0.0 110.082 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.92 147.87 36.18 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.356 1.062 . . . . 0.0 109.798 162.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.74 161.36 15.51 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.93 133.31 44.3 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -124.32 128.97 49.91 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.1 m -124.74 108.17 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -132.5 137.44 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.413 1.085 . . . . 0.0 109.897 -172.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.78 39.96 0.23 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.275 -0.891 . . . . 0.0 113.043 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -145.88 -54.37 0.27 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.855 1.662 . . . . 0.0 108.191 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.87 1.99 44.6 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -150.08 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.556 1.542 . . . . 0.0 111.089 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -99.07 118.85 36.75 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.097 1.759 . . . . 0.0 108.156 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.98 144.98 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -173.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -70.79 127.7 33.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 153.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -108.28 99.81 9.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.244 1.418 . . . . 0.0 107.275 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.17 103.82 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.998 1.319 . . . . 0.0 107.93 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 64' ' ' PHE . 3.3 t -117.88 139.25 45.77 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 117.882 0.31 . . . . 0.0 110.461 -173.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 p -151.93 -168.43 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.32 2.248 . . . . 0.0 106.971 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.6 pp -140.82 156.33 46.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 163.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -123.41 134.98 53.9 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.043 1.337 . . . . 0.0 107.514 171.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.86 -82.96 0.02 OUTLIER Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.678 0.656 . . . . 0.0 112.289 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.66 33.76 0.63 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 110.059 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -126.98 123.28 36.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.771 2.028 . . . . 0.0 106.301 -171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.531 HD22 HH21 ' A' ' 106' ' ' ARG . 9.4 tt -82.99 123.5 29.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.06 134.15 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 125.416 1.487 . . . . 0.0 108.63 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -132.81 103.63 6.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.17 140.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 166.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -144.8 114.67 7.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.014 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -127.65 119.36 25.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.751 0.821 . . . . 0.0 110.228 -160.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -102.09 -62.64 1.24 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.801 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -163.44 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.56 0.618 . . . . 0.0 112.375 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.58 70.03 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 118.948 0.795 . . . . 0.0 111.713 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -179.75 7.49 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.705 1.202 . . . . 0.0 107.804 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -144.68 -178.82 6.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.76 2.024 . . . . 0.0 107.775 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 t -140.93 160.79 39.32 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.176 0.991 . . . . 0.0 108.351 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -137.13 137.54 39.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.58 154.59 47.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.11 141.92 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.531 HH21 HD22 ' A' ' 91' ' ' LEU . 61.4 mtm180 -126.64 133.33 51.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.838 1.255 . . . . 0.0 109.865 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -149.85 141.69 23.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -110.53 116.02 30.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 161.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.28 -176.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 161.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.3 t70 51.55 -109.11 0.42 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.27 30.99 1.85 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.322 1.439 . . . . 0.0 110.47 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -147.61 150.15 33.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.169 0.985 . . . . 0.0 110.404 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -89.67 97.93 11.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.35 112.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tp -121.84 109.73 15.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.412 1.085 . . . . 0.0 108.346 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.7 p -102.55 127.26 49.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.18 118.71 37.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.375 1.47 . . . . 0.0 107.762 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.6 p -121.15 125.64 47.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.528 1.131 . . . . 0.0 110.579 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -129.75 71.28 1.44 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.323 1.449 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 -90.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.085 1.326 . . . . 0.0 111.941 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 t -84.15 -38.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.07 0.948 . . . . 0.0 110.346 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.05 141.76 32.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.96 115.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 O-C-N 122.211 -0.306 . . . . 0.0 110.57 -162.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.4 t -131.78 105.06 7.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.099 0.96 . . . . 0.0 110.669 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.4 p -62.85 145.57 54.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 157.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -152.37 119.58 5.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.791 0.836 . . . . 0.0 110.149 161.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 81.8 p -92.89 97.32 10.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.764 -1.21 . . . . 0.0 109.382 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -67.65 164.41 19.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.863 . . . . 0.0 109.611 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.04 140.01 34.2 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.612 0.765 . . . . 0.0 109.598 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -73.17 109.0 6.37 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -90.39 -27.88 19.04 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.76 0.255 . . . . 0.0 110.778 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 123.231 0.613 . . . . 0.0 110.999 -175.682 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.73 60.84 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.64 1.976 . . . . 0.0 111.662 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.26 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.189 1.396 . . . . 0.0 107.494 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -59.04 -54.71 44.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 110.935 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -11.96 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 129.668 3.187 . . . . 0.0 113.613 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.19 -125.47 4.88 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 118.72 0.691 . . . . 0.0 112.172 168.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -129.88 121.49 26.78 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.7 0.8 . . . . 0.0 110.591 -159.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -106.17 132.07 52.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.496 1.118 . . . . 0.0 108.773 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -105.42 125.39 50.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.576 1.55 . . . . 0.0 108.371 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.77 144.91 45.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.542 0.61 . . . . 0.0 110.928 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.15 69.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 118.352 0.523 . . . . 0.0 111.92 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -164.38 178.75 7.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.212 1.405 . . . . 0.0 107.957 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -162.0 59.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.554 1.07 . . . . 0.0 112.453 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.64 114.62 21.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.229 0.612 . . . . 0.0 110.877 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 52.23 28.26 5.43 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.394 2.277 . . . . 0.0 113.065 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -81.52 -43.43 18.78 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.74 -1.225 . . . . 0.0 111.386 -167.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -71.32 -55.31 8.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -36.17 -63.17 0.4 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.086 1.354 . . . . 0.0 112.499 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -48.55 -49.93 34.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.372 1.069 . . . . 0.0 110.702 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.1 mtp -68.04 -35.57 78.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.91 0.484 . . . . 0.0 110.903 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -83.31 40.83 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.662 1.985 . . . . 0.0 109.98 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 p -169.66 -42.44 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.999 2.12 . . . . 0.0 107.146 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.24 -45.75 68.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.276 -0.265 . . . . 0.0 111.292 162.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.98 0.4 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.121 1.343 . . . . 0.0 111.354 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.71 -5.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.45 51.6 4.23 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 119.379 -2.076 . . . . 0.0 112.961 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -50.49 -60.43 3.02 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.192 1.397 . . . . 0.0 112.999 -159.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.83 -31.81 27.91 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.504 -170.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m 64.52 122.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.239 1.816 . . . . 0.0 112.513 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 52.86 35.99 20.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 112.243 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.06 -51.7 0.1 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.445 1.098 . . . . 0.0 108.482 170.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -35.25 -41.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 128.424 2.69 . . . . 0.0 114.576 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.85 46.34 1.04 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-O 119.194 -0.781 . . . . 0.0 111.268 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -164.11 -37.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.591 0.757 . . . . 0.0 112.139 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.22 -56.35 4.64 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -64.1 -29.18 70.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.198 0.999 . . . . 0.0 112.539 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 73.33 83.41 0.13 Allowed Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.663 1.585 . . . . 0.0 110.007 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.49 134.96 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.441 1.427 . . . . 0.0 109.244 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 m -118.27 144.48 45.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.1 m -126.44 107.21 10.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -83.34 117.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.98 111.08 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 148.45 42.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 123.701 0.626 . . . . 0.0 109.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.23 111.46 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.961 0.904 . . . . 0.0 109.52 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.82 56.77 3.54 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.07 -83.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.946 0.784 . . . . 0.0 112.231 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.38 -36.44 16.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.763 1.225 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 177.02 5.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.962 2.105 . . . . 0.0 107.913 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 p -152.45 138.45 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 tt -119.98 127.05 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.627 0.771 . . . . 0.0 109.573 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 138.81 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 125.007 1.323 . . . . 0.0 108.751 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -130.09 119.69 23.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.451 1.5 . . . . 0.0 109.085 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -80.96 96.95 7.24 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.374 1.469 . . . . 0.0 108.656 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.21 106.76 11.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.857 0.837 . . . . 0.0 109.301 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -131.76 -176.97 4.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.945 2.498 . . . . 0.0 107.812 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 m -145.18 64.26 1.27 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -169.86 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.493 1.517 . . . . 0.0 108.569 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -158.73 131.59 7.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -126.09 156.8 39.45 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -150.29 154.29 37.62 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -150.53 139.15 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.216 0.606 . . . . 0.0 110.113 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -150.78 145.37 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.343 1.057 . . . . 0.0 108.712 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -97.21 145.85 25.65 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 109.67 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 84' ' ' VAL . 48.3 p90 -151.04 179.45 8.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.15 0.98 . . . . 0.0 109.406 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.81 146.5 28.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.838 0.855 . . . . 0.0 109.264 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.41 69.17 0.38 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.066 1.346 . . . . 0.0 111.151 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 51.87 0.04 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -146.97 140.58 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.849 0.824 . . . . 0.0 109.152 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 129.55 53.38 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 166.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.43 168.42 20.31 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.53 136.14 36.81 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.291 0.636 . . . . 0.0 110.264 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.34 90.63 3.26 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.607 2.363 . . . . 0.0 106.132 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -86.46 110.69 19.92 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -143.58 160.93 39.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.408 0.683 . . . . 0.0 110.783 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.41 -10.68 53.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.695 0.798 . . . . 0.0 113.139 -168.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -92.64 -57.72 2.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.679 1.592 . . . . 0.0 108.652 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 78' ' ' ARG 0.416 0.7 OUTLIER -97.76 10.6 39.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.31 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 67.03 -154.24 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.836 1.255 . . . . 0.0 109.163 172.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.45 114.18 21.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.56 154.92 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -86.62 127.27 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.084 0.856 . . . . 0.0 110.262 167.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -83.83 114.57 21.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.29 1.836 . . . . 0.0 107.636 167.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.31 94.64 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 64' ' ' PHE . 4.0 t -116.94 138.85 46.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 O-C-N 122.124 -0.36 . . . . 0.0 111.177 -165.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -156.8 173.62 16.71 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.963 2.105 . . . . 0.0 106.55 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.55 135.23 48.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.594 1.088 . . . . 0.0 110.612 161.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -88.87 61.86 6.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -168.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.25 -35.32 0.66 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.485 -0.619 . . . . 0.0 113.827 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.24 59.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt 171.61 125.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.375 2.27 . . . . 0.0 107.91 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -83.95 127.01 33.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.842 0.746 . . . . 0.0 110.038 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.14 110.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.649 1.579 . . . . 0.0 106.961 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -98.82 89.27 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 170.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.0 t -74.5 139.56 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -130.96 94.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -159.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.31 114.86 24.2 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.489 0.715 . . . . 0.0 111.243 -167.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.64 -56.73 2.8 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.147 0.43 . . . . 0.0 110.153 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -167.9 -87.07 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.964 0.347 . . . . 0.0 111.425 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.83 -24.69 76.79 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -173.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 172.42 12.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.8 167.56 20.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.49 2.316 . . . . 0.0 107.14 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.0 p -133.82 157.54 45.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.448 0.699 . . . . 0.0 109.499 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 p -88.52 138.18 31.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.1 mt -125.09 84.32 2.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 159.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -106.23 144.59 15.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.437 0.695 . . . . 0.0 110.105 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 158.0 43.61 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.926 0.491 . . . . 0.0 111.56 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -165.09 153.84 12.23 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.738 1.215 . . . . 0.0 109.132 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.9 ttp -114.98 124.83 52.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.163 1.385 . . . . 0.0 109.902 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.88 179.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 157.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.01 -112.65 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -172.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.62 30.08 1.56 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.512 1.053 . . . . 0.0 110.988 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -141.61 156.71 45.66 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.2 108.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.477 1.111 . . . . 0.0 108.373 -170.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.11 141.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 0.0 109.548 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 128' ' ' TYR . 26.9 tp -128.0 85.85 2.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.464 1.106 . . . . 0.0 110.037 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -95.85 111.69 23.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt -113.17 120.35 40.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.8 m -119.24 125.44 49.16 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.776 0.716 . . . . 0.0 109.435 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -123.23 146.15 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 106.844 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -36.24 -52.55 1.29 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.191 0.901 . . . . 0.0 113.469 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -34.05 57.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.05 133.1 29.49 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.188 0.595 . . . . 0.0 110.362 -159.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.08 121.38 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.68 1.192 . . . . 0.0 108.336 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.86 109.4 14.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.673 1.189 . . . . 0.0 109.298 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.86 104.21 12.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.917 1.287 . . . . 0.0 108.217 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -122.43 -177.91 3.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.711 0.804 . . . . 0.0 109.985 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -145.6 155.33 42.97 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.151 0.58 . . . . 0.0 109.835 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.431 ' CE2' HD22 ' A' ' 115' ' ' LEU . 53.6 m-85 -115.87 164.95 13.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.588 1.955 . . . . 0.0 108.99 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.17 136.99 49.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -75.53 109.69 9.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.835 -0.541 . . . . 0.0 110.086 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.31 -23.65 23.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.544 0.338 . . . . 0.0 111.542 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 111.508 -178.44 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.48 63.22 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.75 2.82 . . . . 0.0 111.725 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.09 -48.14 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.802 2.041 . . . . 0.0 107.099 -171.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -54.82 -43.02 72.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.742 1.617 . . . . 0.0 111.566 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.4 t -41.4 109.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.754 1.622 . . . . 0.0 112.487 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.17 -168.45 23.73 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.436 1.017 . . . . 0.0 113.758 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -91.04 122.43 33.69 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.4 1.48 . . . . 0.0 110.451 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -108.32 156.52 19.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.673 1.589 . . . . 0.0 110.415 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 135.74 31.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.35 148.05 49.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.994 0.918 . . . . 0.0 111.873 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.65 -15.12 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.233 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HB3' HG22 ' A' ' 127' ' ' THR . 48.0 t0 -145.86 155.83 43.16 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.145 1.339 . . . . 0.0 110.52 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -173.98 134.52 0.46 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 127.678 2.391 . . . . 0.0 109.095 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.82 166.73 31.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 163.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 63.4 12.3 6.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.267 1.827 . . . . 0.0 112.394 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.02 -52.25 30.71 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.028 -1.045 . . . . 0.0 109.885 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.06 -50.7 63.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.051 2.14 . . . . 0.0 110.101 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -61.69 -39.58 91.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.834 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -47.35 -49.55 24.14 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.316 0.646 . . . . 0.0 110.864 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.67 -28.62 70.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.678 -0.677 . . . . 0.0 112.029 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -73.78 58.96 0.65 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.711 1.204 . . . . 0.0 110.511 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 p 168.24 -48.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.945 3.298 . . . . 0.0 106.691 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.04 -35.27 79.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 112.088 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.39 -15.46 63.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.297 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -76.21 42.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -161.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.42 96.7 0.05 OUTLIER Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.063 -1.023 . . . . 0.0 113.538 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -62.66 -17.97 61.45 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.851 -1.381 . . . . 0.0 112.786 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.63 -53.73 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.308 1.043 . . . . 0.0 111.679 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 m -66.2 -31.01 71.59 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.994 -0.441 . . . . 0.0 110.896 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -38.96 86.18 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -58.61 -58.12 9.96 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.101 0.864 . . . . 0.0 108.976 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -45.82 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.31 -14.07 71.22 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.453 -1.748 . . . . 0.0 114.937 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -103.12 -38.0 7.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.63 . . . . 0.0 110.744 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.54 -47.42 7.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.866 0.866 . . . . 0.0 111.875 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 m -99.15 90.9 4.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 118.861 -0.59 . . . . 0.0 109.722 -161.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 6.35 75.01 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 127.384 2.274 . . . . 0.0 113.415 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.17 93.64 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.363 2.042 . . . . 0.0 109.366 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.0 m -89.19 150.97 22.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.848 1.259 . . . . 0.0 107.889 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.2 m -140.91 140.89 34.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.73 -1.231 . . . . 0.0 108.674 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.0 132.75 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.0 mt -128.14 107.57 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.88 107.03 15.91 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.116 1.767 . . . . 0.0 109.274 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.97 109.31 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -93.79 65.49 3.6 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.17 -87.69 0.09 OUTLIER Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.299 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.15 -6.11 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.501 1.12 . . . . 0.0 112.302 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -102.2 169.43 8.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.26 117.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 mt -88.32 132.96 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tt -116.44 133.57 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -122.2 137.07 54.96 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.406 1.083 . . . . 0.0 109.043 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 p -105.73 16.83 24.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.04 1.336 . . . . 0.0 113.007 -166.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.13 109.05 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.259 1.423 . . . . 0.0 114.418 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -66.81 -41.47 87.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 171.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -149.62 -75.85 0.16 Allowed 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -71.68 -54.56 9.95 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.115 -0.366 . . . . 0.0 110.453 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -174.58 156.36 2.39 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.52 -79.02 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -142.52 157.94 44.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.297 1.039 . . . . 0.0 109.29 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.06 133.69 54.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 166.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.72 117.52 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 p -106.54 81.45 1.59 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.181 1.792 . . . . 0.0 110.537 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -72.23 143.18 48.9 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.396 -0.815 . . . . 0.0 111.637 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -121.54 112.56 18.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.65 102.98 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.785 0.834 . . . . 0.0 111.665 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.54 54.79 1.3 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.44 170.64 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.51 149.02 43.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.934 0.494 . . . . 0.0 110.387 163.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -141.83 153.44 44.5 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.366 1.066 . . . . 0.0 109.254 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.69 144.53 56.95 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.84 158.21 43.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.815 1.246 . . . . 0.0 108.672 -168.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 t -137.53 146.58 44.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.574 0.75 . . . . 0.0 109.639 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -128.19 170.36 13.09 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.42 -15.46 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -156.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -95.37 13.52 25.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.374 1.47 . . . . 0.0 111.551 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.25 38.2 t0 31.15 57.17 0.25 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.016 2.126 . . . . 0.0 113.658 -156.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -61.63 123.93 19.28 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 116.282 -2.167 . . . . 0.0 106.546 149.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -78.72 112.71 16.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 97' ' ' TRP . 2.0 m -126.27 172.47 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -174.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -108.99 130.38 55.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -88.89 102.17 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.929 1.291 . . . . 0.0 107.636 164.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.75 134.5 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 166.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.01 139.54 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.651 0.659 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -151.76 -172.15 4.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.101 1.361 . . . . 0.0 107.668 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 tt -137.51 113.21 9.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.806 1.642 . . . . 0.0 108.376 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -115.06 105.88 13.47 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.58 1.181 . . . . 0.0 110.843 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.87 -62.14 3.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.141 0.877 . . . . 0.0 111.774 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.04 69.88 0.08 OUTLIER Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 pttm 173.5 142.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 106.527 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 91' ' ' LEU 0.302 0.0 OUTLIER -88.81 136.81 32.81 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.121 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 105' ' ' VAL . 23.2 m -115.69 97.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.95 104.03 13.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.25 126.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -116.19 105.51 12.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.64 126.69 55.29 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.233 1.013 . . . . 0.0 110.417 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.499 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.2 p90 -99.62 -62.53 1.23 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.931 0.492 . . . . 0.0 109.732 172.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.92 -92.85 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.31 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.77 -12.61 83.74 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.938 0.79 . . . . 0.0 112.265 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -137.84 164.3 29.28 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -142.11 152.07 42.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 167.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -116.55 148.03 41.25 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -107.66 134.45 50.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.013 0.525 . . . . 0.0 109.931 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.08 90.05 3.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.346 1.859 . . . . 0.0 106.733 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 92' ' ' VAL . 17.5 m -90.15 139.41 17.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.472 HH11 HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -139.17 148.42 43.15 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.059 0.544 . . . . 0.0 111.324 174.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -164.09 155.0 15.59 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.656 1.582 . . . . 0.0 108.06 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.7 ttp -105.08 118.37 36.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.616 0.767 . . . . 0.0 109.086 161.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.24 170.41 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 154.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 52.05 -124.28 2.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -165.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.75 21.75 4.68 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.906 1.241 . . . . 0.0 111.58 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 65.2 mttm -137.28 140.77 41.79 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.117 0.958 . . . . 0.0 108.779 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.61 121.56 31.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.38 150.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 HH11 ' A' ' 106' ' ' ARG . 0.5 OUTLIER -137.7 118.0 13.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.8 m -111.89 100.03 8.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.8 115.84 18.75 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.2 m -118.38 114.2 22.55 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.002 0.921 . . . . 0.0 109.98 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 -27.84 14.42 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.471 1.508 . . . . 0.0 109.827 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.39 -92.87 0.2 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 t -58.72 -44.33 90.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.81 141.5 29.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.091 0.557 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.28 129.21 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 126.109 1.763 . . . . 0.0 107.086 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.9 t -116.52 104.74 11.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 108.973 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.4 p -70.37 143.84 51.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 163.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.88 153.9 28.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 12' ' ' ASP . 3.7 t -146.68 155.7 42.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.734 0.697 . . . . 0.0 110.984 -175.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.03 154.25 51.26 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.032 2.133 . . . . 0.0 109.395 -165.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 112' ' ' LYS . 42.5 tt0 -129.22 134.23 47.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.945 1.298 . . . . 0.0 107.843 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -78.22 119.52 21.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -104.11 -29.69 10.71 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.656 0.782 . . . . 0.0 110.978 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.379 0.672 . . . . 0.0 110.968 -178.374 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.237 0.418 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.41 55.87 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.979 2.512 . . . . 0.0 111.625 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.65 -38.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.766 1.626 . . . . 0.0 108.849 -161.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -96.55 -34.84 11.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.732 1.213 . . . . 0.0 110.758 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.43 105.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.88 176.93 27.67 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.912 0.778 . . . . 0.0 113.081 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 m -102.49 118.24 36.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -114.66 134.67 54.89 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.417 1.487 . . . . 0.0 107.659 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -112.09 121.12 44.08 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.99 131.89 52.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.266 0.939 . . . . 0.0 108.793 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.51 -64.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 125.068 1.48 . . . . 0.0 110.288 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.21 158.18 17.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.078 0.854 . . . . 0.0 110.171 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -175.08 165.02 3.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 107.709 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -149.31 153.94 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 166.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.39 42.49 32.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.217 1.007 . . . . 0.0 110.633 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.8 -55.48 26.04 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.179 -0.951 . . . . 0.0 109.278 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.522 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -25.93 -60.27 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.542 1.537 . . . . 0.0 112.822 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -51.08 -59.9 3.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.131 0.972 . . . . 0.0 112.695 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.2 ptp -63.43 -29.7 70.95 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.674 -0.641 . . . . 0.0 112.403 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp -78.73 45.74 0.62 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.764 2.026 . . . . 0.0 111.379 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m 177.29 -46.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 128.061 2.544 . . . . 0.0 107.396 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -54.34 -31.47 54.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.472 0.709 . . . . 0.0 110.39 173.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 45.6 0.59 Allowed Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 160.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -139.01 -36.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 109.179 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.66 68.46 2.17 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.279 -0.888 . . . . 0.0 112.28 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.73 70.7 0.72 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 109.92 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.8 -60.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.947 2.099 . . . . 0.0 112.55 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -33.08 -46.07 0.15 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.092 2.957 . . . . 0.0 112.801 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -112.47 23.71 13.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.798 . . . . 0.0 112.575 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.86 -23.33 15.4 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.962 1.705 . . . . 0.0 110.053 157.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.67 -46.05 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.32 61.02 2.32 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.296 0.951 . . . . 0.0 113.708 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -178.02 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.033 1.733 . . . . 0.0 108.922 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.1 ttm -54.36 -35.48 62.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.291 0.636 . . . . 0.0 109.946 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 m -65.19 76.54 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.274 0.63 . . . . 0.0 109.852 161.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -20.08 95.04 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.943 2.897 . . . . 0.0 112.562 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.64 165.18 26.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.998 -167.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.5 m -131.46 149.5 52.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.463 -0.79 . . . . 0.0 108.888 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -138.34 95.05 2.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.057 -161.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 41' ' ' ILE . 1.8 mp -79.46 127.91 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.9 mt -126.49 109.39 20.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.92 135.99 49.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.102 0.961 . . . . 0.0 109.743 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.08 84.84 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.732 0.813 . . . . 0.0 108.817 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.63 71.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.109 1.764 . . . . 0.0 111.177 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.78 -105.01 0.58 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -34.67 55.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.351 0.66 . . . . 0.0 110.414 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -179.01 4.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.755 2.022 . . . . 0.0 107.236 -167.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.68 146.55 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.98 132.73 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 133.29 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.391 1.076 . . . . 0.0 108.441 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -114.4 114.5 25.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.859 1.263 . . . . 0.0 108.579 170.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 p -82.21 120.84 25.87 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -117.3 139.49 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.591 1.156 . . . . 0.0 110.818 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 t -167.0 -165.88 0.76 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.829 1.652 . . . . 0.0 109.207 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -62.82 93.61 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.276 1.431 . . . . 0.0 111.837 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 58.49 18.0 5.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.515 1.526 . . . . 0.0 112.463 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -134.04 77.11 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -115.99 127.28 54.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -173.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.68 159.78 43.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -152.29 158.12 42.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -140.99 121.65 13.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -84.41 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 165.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -156.75 144.39 19.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.393 -0.817 . . . . 0.0 111.402 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.56 105.58 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -49.85 109.13 0.25 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.413 0.285 . . . . 0.0 111.051 174.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.65 39.9 1.68 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -154.8 157.26 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.79 145.1 37.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.692 0.797 . . . . 0.0 110.474 161.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.65 148.72 24.52 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.77 143.17 40.05 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.0 156.08 44.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.552 1.541 . . . . 0.0 107.845 -173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.1 m -141.12 82.23 1.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.232 1.013 . . . . 0.0 109.09 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -98.32 130.9 44.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.3 -35.49 27.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.962 0.905 . . . . 0.0 112.404 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -96.77 16.6 18.68 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.172 1.789 . . . . 0.0 112.766 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -150.15 2.25 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 163.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 79.76 -164.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.383 1.473 . . . . 0.0 109.003 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -73.81 126.48 30.47 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.12 143.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.679 1.592 . . . . 0.0 108.043 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -83.27 127.1 33.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 166.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.2 m -94.63 114.83 26.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.98 123.78 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 166.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 p -132.78 136.9 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -158.2 158.93 35.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 pp -105.98 137.82 43.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.337 0.972 . . . . 0.0 108.813 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -84.03 -11.51 56.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.282 0.633 . . . . 0.0 111.65 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.29 -32.92 5.67 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.22 -39.66 3.45 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.173 1.368 . . . . 0.0 110.905 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -142.05 167.62 21.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.65 1.18 . . . . 0.0 111.424 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.7 tt -96.94 114.99 26.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.198 0.999 . . . . 0.0 108.519 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.55 112.2 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.099 1.76 . . . . 0.0 108.76 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -103.99 108.94 20.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.56 126.07 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -110.63 117.22 32.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -131.71 120.38 22.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.79 1.236 . . . . 0.0 109.909 -164.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -56.75 2.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -161.8 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.07 -16.26 78.5 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 118.629 0.65 . . . . 0.0 112.592 -171.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.29 173.24 15.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.474 1.11 . . . . 0.0 108.403 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.49 154.83 33.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.962 1.705 . . . . 0.0 108.186 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.9 p -109.4 145.75 35.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 110.018 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.09 121.22 36.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.85 98.51 6.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.437 1.495 . . . . 0.0 107.554 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.94 118.74 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.05 145.91 38.86 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.963 0.905 . . . . 0.0 109.376 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -160.72 156.7 25.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 164.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -121.46 121.88 38.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.117 0.967 . . . . 0.0 109.29 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.39 -177.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 160.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t70 53.23 -108.53 0.42 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.97 29.65 1.38 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.678 1.132 . . . . 0.0 111.336 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -140.18 145.22 37.18 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.968 0.884 . . . . 0.0 109.158 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -90.48 110.82 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.07 139.86 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tp -142.44 106.1 4.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 m -98.43 121.59 40.55 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 133.5 45.15 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -155.12 156.22 35.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.809 0.731 . . . . 0.0 111.483 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -160.08 168.23 26.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 107.234 165.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.59 -35.39 7.35 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 118.847 0.749 . . . . 0.0 112.44 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 m -46.23 -49.73 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.577 1.551 . . . . 0.0 113.026 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 175.89 169.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.135 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.41 144.94 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 125.404 1.481 . . . . 0.0 108.533 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 16.7 t -158.5 116.32 2.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.581 0.628 . . . . 0.0 111.633 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -73.12 151.09 41.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.239 0.616 . . . . 0.0 109.551 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -140.5 154.46 46.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.597 1.959 . . . . 0.0 106.266 156.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 t -151.84 148.6 28.02 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.67 0.668 . . . . 0.0 110.697 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -129.77 139.04 51.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.606 1.562 . . . . 0.0 108.553 -167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -110.92 138.8 46.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.373 1.069 . . . . 0.0 108.899 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -73.02 84.04 1.27 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.607 0.363 . . . . 0.0 111.081 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -59.28 -35.95 74.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.749 0.309 . . . . 0.0 110.726 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 O-C-N 121.842 -0.536 . . . . 0.0 109.735 173.274 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.27 66.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 129.992 3.317 . . . . 0.0 111.311 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.19 -61.35 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.04 48.62 0.87 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.855 2.062 . . . . 0.0 111.282 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 44' ' ' VAL . 45.1 t -142.77 78.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.771 2.028 . . . . 0.0 106.558 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.8 -160.35 23.21 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.668 0.652 . . . . 0.0 113.108 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -87.73 138.65 31.28 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 111.752 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 56.3 m95 -118.9 158.38 25.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.166 1.386 . . . . 0.0 109.084 168.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 155.96 46.89 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.403 0.44 . . . . 0.0 110.668 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 11' ' ' VAL . 2.9 tt -66.95 145.26 55.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.588 1.555 . . . . 0.0 111.051 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 10' ' ' LEU . 6.6 p -127.83 -56.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 164.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.39 141.98 47.66 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -167.79 152.78 6.85 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -173.19 159.23 3.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.505 1.522 . . . . 0.0 107.497 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 72.02 -4.74 1.89 Allowed 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.148 1.779 . . . . 0.0 111.49 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -41.71 83.52 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -34.92 -69.01 0.1 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.696 1.998 . . . . 0.0 111.916 160.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.36 -47.89 80.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.536 1.062 . . . . 0.0 111.611 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.71 -52.5 10.83 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 111.235 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -31.42 72.48 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -64.46 -62.79 1.38 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -54.72 -46.64 74.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.079 1.351 . . . . 0.0 111.69 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.57 -9.6 57.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.702 1.201 . . . . 0.0 112.247 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.44 51.49 42.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.92 -40.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 109.797 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -45.18 -64.24 2.32 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 125.928 1.727 . . . . 0.0 113.562 -171.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 36.11 -122.7 0.15 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.374 1.87 . . . . 0.0 110.754 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.19 48.57 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 m -151.32 -73.32 0.15 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.692 -0.63 . . . . 0.0 110.84 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -70.45 -14.38 62.51 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -55.08 -39.55 69.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.426 0.557 . . . . 0.0 111.341 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.22 -56.18 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.2 -49.77 4.47 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.128 1.347 . . . . 0.0 113.826 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -80.53 -14.78 57.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.21 2.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 163.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.255 1.2 t -72.24 83.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.682 1.229 . . . . 0.0 111.261 -164.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 84.05 0.98 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 125.826 1.65 . . . . 0.0 107.749 159.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.95 -48.68 1.77 Allowed 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.629 1.553 . . . . 0.0 108.44 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -87.7 141.06 28.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.914 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -147.72 117.43 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.057 -1.027 . . . . 0.0 108.534 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.43 140.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.78 111.52 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -130.15 125.74 35.78 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.345 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -64.16 99.84 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 122.029 0.919 . . . . 0.0 110.686 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -74.52 65.15 1.24 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.63 -82.63 0.02 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.396 0.998 . . . . 0.0 112.973 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -99.78 -6.59 26.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 0.0 112.259 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.36 166.33 17.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.223 1.809 . . . . 0.0 107.217 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.98 109.24 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 tt -90.02 129.36 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.48 134.3 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -124.98 105.9 9.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 109.962 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 m -70.09 113.12 6.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.857 2.063 . . . . 0.0 108.083 170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -120.01 135.25 54.99 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.336 0.516 . . . . 0.0 111.243 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -139.69 17.92 2.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.068 0.947 . . . . 0.0 111.256 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t 39.97 38.06 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 111.426 -164.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -174.3 95.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -166.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? 54.85 54.95 8.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.709 0.804 . . . . 0.0 110.146 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -63.08 162.65 11.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.906 1.283 . . . . 0.0 109.893 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.88 164.12 31.11 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.998 0.919 . . . . 0.0 108.756 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -156.04 151.94 27.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.922 0.489 . . . . 0.0 109.994 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.4 144.57 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 p -106.86 88.17 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.908 0.883 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.87 148.37 47.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -132.26 117.41 18.16 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 166.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 96.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.612 1.165 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.34 51.9 1.19 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.35 0.976 . . . . 0.0 111.148 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.38 162.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.0 0.9 . . . . 0.0 110.939 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -101.97 136.48 41.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.436 1.894 . . . . 0.0 107.863 167.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.44 149.84 38.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.734 0.814 . . . . 0.0 109.191 170.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.32 136.83 37.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.29 153.6 47.8 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.82 1.248 . . . . 0.0 109.144 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -130.66 68.58 1.47 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.875 1.67 . . . . 0.0 110.016 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -83.76 143.73 29.79 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.09 40.23 0.33 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.618 1.167 . . . . 0.0 112.851 -167.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -161.02 -75.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.569 1.548 . . . . 0.0 107.859 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -27.64 65.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.69 0.796 . . . . 0.0 111.729 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 98.8 -155.63 0.0 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 128.628 2.771 . . . . 0.0 107.971 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -81.4 116.33 21.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.13 177.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.474 1.51 . . . . 0.0 107.709 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -107.42 128.25 54.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.768 0.713 . . . . 0.0 110.176 164.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.93 126.08 35.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.44 125.26 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.63 145.37 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 160.51 41.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.5 2.72 . . . . 0.0 105.811 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tt -140.93 73.62 1.43 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 p30 176.4 164.18 0.42 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -156.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 -69.17 0.9 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.21 56.91 0.65 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 56.94 -130.66 1.65 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.007 0.923 . . . . 0.0 109.208 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp -81.88 79.29 8.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 109.834 -170.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.39 111.5 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.846 0.858 . . . . 0.0 109.984 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -117.95 115.8 25.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.798 1.239 . . . . 0.0 109.639 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.19 150.74 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 170.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -131.81 95.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 106.354 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -112.64 117.14 31.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -89.56 -111.0 0.08 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -122.87 -74.01 0.63 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.761 1.224 . . . . 0.0 111.488 -173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.74 61.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.569 0.622 . . . . 0.0 111.722 -170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -179.91 6.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -149.29 156.85 42.74 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.371 1.869 . . . . 0.0 106.291 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.6 t -127.8 155.9 43.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.536 0.684 . . . . 0.0 109.254 160.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.1 p -96.17 150.7 20.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 164.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 pp -151.94 101.63 2.75 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 164.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.91 128.85 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.043 0.537 . . . . 0.0 109.601 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -94.26 99.23 11.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 108.318 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.94 143.67 28.29 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -137.11 120.01 16.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.09 -168.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 51.91 -116.93 1.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.35 23.58 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 126.137 1.827 . . . . 0.0 109.485 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -134.26 129.55 35.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.401 0.681 . . . . 0.0 109.461 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 6.8 tt -87.68 105.09 17.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.6 mt -82.05 103.22 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.88 101.23 13.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.4 t -99.27 130.92 45.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.65 126.36 43.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.296 1.439 . . . . 0.0 109.775 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.7 m -131.88 114.0 14.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -97.62 146.63 25.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.764 2.026 . . . . 0.0 107.456 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.01 92.06 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 167.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 m 135.2 -28.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 131.402 3.881 . . . . 0.0 111.851 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.27 153.62 37.82 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.28 1.4 . . . . 0.0 112.46 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.9 t -124.79 143.73 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.093 1.757 . . . . 0.0 107.964 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 t -158.6 158.54 34.08 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 t -126.24 158.06 36.67 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.672 -0.642 . . . . 0.0 109.942 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -119.59 130.89 55.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 150.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -108.79 124.94 51.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -112.89 154.54 26.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.005 1.722 . . . . 0.0 109.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -122.01 137.07 54.94 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.756 1.622 . . . . 0.0 107.395 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -75.37 125.38 28.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.23 -4.06 17.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.033 0.533 . . . . 0.0 111.336 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 C-N-CA 124.778 1.231 . . . . 0.0 110.864 174.111 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 58.38 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 129.345 3.058 . . . . 0.0 111.894 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.27 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.153 1.781 . . . . 0.0 107.516 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -59.27 -42.88 92.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.495 1.118 . . . . 0.0 111.221 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.1 t -40.62 101.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.197 1.799 . . . . 0.0 111.814 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.29 -154.69 25.92 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.188 0.899 . . . . 0.0 112.196 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -118.25 119.71 35.49 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.502 1.521 . . . . 0.0 109.656 -170.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 87.7 m95 -109.29 141.93 40.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.521 1.128 . . . . 0.0 110.177 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -115.11 137.71 51.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -77.75 128.34 33.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.94 -45.64 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -128.92 151.14 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 110.008 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -170.14 150.55 3.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.596 2.358 . . . . 0.0 108.719 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -138.87 148.74 44.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m120 62.68 43.86 7.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.222 1.409 . . . . 0.0 111.452 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -70.53 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.804 -0.56 . . . . 0.0 109.75 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.57 -49.66 72.13 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -30.03 -53.88 0.16 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.702 2.001 . . . . 0.0 112.547 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -51.93 -51.93 53.57 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.752 -0.593 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.0 ptp -74.23 -33.12 63.25 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.434 -0.791 . . . . 0.0 111.793 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -40.96 75.97 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.473 -0.767 . . . . 0.0 111.166 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -82.09 -41.18 20.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.494 1.117 . . . . 0.0 110.219 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.1 -39.13 74.44 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.199 0.454 . . . . 0.0 111.844 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 55.14 0.81 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.78 -9.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.64 1.176 . . . . 0.0 111.678 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.48 78.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.105 -0.997 . . . . 0.0 114.248 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -48.81 139.26 10.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.911 1.285 . . . . 0.0 109.039 156.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.95 62.76 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.22 1.008 . . . . 0.0 111.01 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 m -147.9 -37.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.814 -1.179 . . . . 0.0 111.272 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.8 tpt85 -56.69 -37.83 71.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.229 0.922 . . . . 0.0 109.678 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -43.01 -32.96 0.72 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.386 2.675 . . . . 0.0 115.074 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -110.29 -35.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.007 0.821 . . . . 0.0 111.347 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 26.85 0.65 Allowed Glycine 0 CA--C 1.539 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 113.973 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -122.96 -39.21 2.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.062 3.345 . . . . 0.0 109.54 -173.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -42.6 70.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.733 1.213 . . . . 0.0 108.731 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -60.12 116.26 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 156.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.66 114.44 14.53 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.983 -168.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.85 156.57 56.53 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 120.246 1.124 . . . . 0.0 109.667 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.6 m -130.99 153.98 48.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.298 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -147.51 117.42 7.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.82 144.13 11.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 166.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.53 111.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.39 143.75 51.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 0.701 . . . . 0.0 110.993 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 80.5 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 122.46 1.124 . . . . 0.0 110.133 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -65.42 78.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.008 0.923 . . . . 0.0 111.398 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.04 -114.0 6.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -86.6 -12.55 48.27 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.431 0.615 . . . . 0.0 111.296 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -102.05 179.32 4.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.449 1.1 . . . . 0.0 108.36 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.82 138.94 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 166.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.6 tt -112.55 134.25 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.59 143.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 O-C-N 123.98 0.8 . . . . 0.0 109.137 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -131.94 111.7 11.77 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 m -104.12 128.33 51.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.728 1.611 . . . . 0.0 110.104 -167.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -105.38 125.1 50.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.697 1.999 . . . . 0.0 109.121 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -148.92 68.61 1.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 p 48.3 96.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.157 2.183 . . . . 0.0 114.194 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.6 t80 71.02 -64.98 0.36 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.302 1.841 . . . . 0.0 109.615 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.31 134.76 45.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.05 156.34 39.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.14 158.18 43.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.82 132.23 13.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -147.52 127.68 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 p -88.94 133.68 34.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.859 1.264 . . . . 0.0 108.469 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.75 160.65 42.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 127.56 43.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 86.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 169.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.07 41.98 0.19 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.095 1.807 . . . . 0.0 111.474 168.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.5 t -147.71 153.05 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.368 1.084 . . . . 0.0 109.575 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -113.04 133.98 54.73 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 126.724 2.01 . . . . 0.0 107.463 167.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -163.21 -179.34 6.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.268 0.94 . . . . 0.0 111.136 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.5 121.53 29.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 109.225 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 107.52 15.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.453 1.901 . . . . 0.0 106.255 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.3 53.85 0.76 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.095 0.558 . . . . 0.0 111.233 -164.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 146.8 50.42 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.456 -0.777 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.02 63.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.009 0.923 . . . . 0.0 112.267 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -94.81 -50.41 5.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.836 1.654 . . . . 0.0 110.299 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -56.44 -25.62 51.17 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.182 0.446 . . . . 0.0 111.802 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 77.64 -166.05 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.889 2.075 . . . . 0.0 109.021 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.33 89.32 2.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.93 149.93 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.917 0.887 . . . . 0.0 109.747 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -85.08 116.9 23.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -80.63 146.87 30.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -139.57 125.74 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 157.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.93 143.92 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -166.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -155.57 -172.82 4.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.51 1.924 . . . . 0.0 108.232 -176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.63 113.02 10.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.12 125.97 43.36 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.84 -78.95 0.01 OUTLIER Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.342 0.973 . . . . 0.0 113.465 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.34 26.49 1.1 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.524 1.535 . . . . 0.0 111.742 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 130.53 48.9 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.084 1.354 . . . . 0.0 109.182 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.6 112.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.318 1.447 . . . . 0.0 107.36 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.01 126.62 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.376 1.07 . . . . 0.0 108.258 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -135.07 102.44 5.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.516 0.727 . . . . 0.0 109.891 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.87 147.2 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -141.8 99.39 3.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -119.74 108.81 14.87 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.441 1.897 . . . . 0.0 109.655 -160.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -60.2 1.68 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.322 0.51 . . . . 0.0 110.557 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -165.01 -81.51 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.235 0.47 . . . . 0.0 112.217 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.93 -26.16 74.46 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.786 0.721 . . . . 0.0 111.58 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 173.37 16.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.14 1.376 . . . . 0.0 107.725 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -131.21 140.29 49.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.968 2.107 . . . . 0.0 107.956 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 t -98.05 174.8 6.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.7 p -155.82 155.04 32.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 153.93 39.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.739 172.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.65 139.56 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -128.18 140.37 51.95 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.381 1.072 . . . . 0.0 109.51 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.08 133.74 16.7 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.416 0.686 . . . . 0.0 109.228 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -103.98 119.49 39.04 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.2 176.51 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 153.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.31 -118.1 1.26 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -170.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.92 21.22 3.75 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.188 1.375 . . . . 0.0 110.873 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -124.6 127.42 47.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.794 0.838 . . . . 0.0 108.764 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 2.4 tt -91.75 91.1 7.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.06 143.28 13.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.72 141.51 22.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.701 0.763 . . . . 0.0 112.712 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.9 m -106.81 124.73 50.04 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 125.109 1.364 . . . . 0.0 107.992 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.47 75.7 1.04 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.087 1.755 . . . . 0.0 107.192 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -128.13 138.81 52.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.281 0.562 . . . . 0.0 110.365 -165.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -160.18 155.64 25.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.62 -34.55 6.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.026 0.822 . . . . 0.0 113.121 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 t -51.75 -41.83 61.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.377 1.071 . . . . 0.0 111.852 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.87 127.15 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.678 1.591 . . . . 0.0 110.063 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.04 136.81 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -150.66 156.0 40.47 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.349 -1.469 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -143.5 163.37 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.648 0.779 . . . . 0.0 109.321 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -167.27 168.74 13.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.302 1.041 . . . . 0.0 111.069 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -136.8 136.49 38.89 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.957 0.884 . . . . 0.0 109.591 163.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -89.02 155.81 19.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.736 164.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.6 146.58 44.16 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.771 1.228 . . . . 0.0 107.867 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -81.79 114.53 20.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -90.82 -26.64 19.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.031 0.378 . . . . 0.0 111.697 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.161 0 CA-C-N 118.39 0.541 . . . . 0.0 110.781 174.471 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.238 0.47 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.6 61.42 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.932 2.093 . . . . 0.0 110.576 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.08 -40.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.028 1.731 . . . . 0.0 108.298 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -95.11 -47.73 6.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.859 1.264 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.5 t -45.37 117.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.435 1.094 . . . . 0.0 112.81 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.65 -120.77 3.42 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.851 0.739 . . . . 0.0 111.277 158.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -152.05 140.57 20.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.869 -0.783 . . . . 0.0 109.176 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -138.41 162.85 33.39 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.699 1.6 . . . . 0.0 107.166 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -135.69 142.37 45.08 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.792 1.237 . . . . 0.0 108.953 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 141.57 55.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.774 0.715 . . . . 0.0 110.974 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.76 -35.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 118.451 -0.785 . . . . 0.0 112.338 169.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.08 151.24 51.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.554 1.07 . . . . 0.0 110.749 169.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -168.24 165.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.065 2.546 . . . . 0.0 106.532 167.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -146.58 178.13 8.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.586 1.554 . . . . 0.0 107.138 169.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 m120 58.55 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.36 1.064 . . . . 0.0 110.834 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -57.11 14.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.58 0.752 . . . . 0.0 110.286 -172.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.56 -52.87 18.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.141 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -35.06 -57.96 0.55 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.0 112.222 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 117' ' ' LEU . 4.7 t80 -57.79 -45.97 85.26 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.61 -0.681 . . . . 0.0 112.141 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -68.83 -30.17 68.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.838 . . . . 0.0 111.994 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -72.83 58.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.873 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m 175.59 -55.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.764 2.426 . . . . 0.0 107.143 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.15 -37.76 75.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.781 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.41 32.91 68.02 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.28 -31.35 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.694 0.747 . . . . 0.0 110.442 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.4 71.15 0.03 OUTLIER Glycine 0 C--N 1.336 0.572 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -54.33 146.59 15.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.33 -12.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.627 1.571 . . . . 0.0 114.636 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.1 m -102.16 -61.86 1.34 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 108.586 -168.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -70.71 7.33 1.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.104 -0.998 . . . . 0.0 113.382 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.59 -46.48 85.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.206 -0.934 . . . . 0.0 108.993 159.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -44.7 96.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.66 43.15 1.84 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.327 0.965 . . . . 0.0 112.98 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -163.72 -32.52 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.222 1.809 . . . . 0.0 109.588 167.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 90.2 mmm -53.26 -45.0 68.64 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 159.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -64.05 108.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -35.15 104.97 0.27 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.463 1.905 . . . . 0.0 112.302 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.77 123.93 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.734 1.622 . . . . 0.0 109.42 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.8 m -79.96 179.94 7.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -152.09 88.71 1.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -79.03 128.36 38.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mt -127.98 101.73 7.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -109.24 115.59 30.29 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.825 1.25 . . . . 0.0 108.653 -171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.1 t -78.74 103.58 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -77.81 65.08 3.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.867 1.267 . . . . 0.0 108.764 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.53 -88.14 0.05 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.665 0.65 . . . . 0.0 111.752 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.38 17.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.132 0.973 . . . . 0.0 110.081 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.42 173.12 7.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.77 2.028 . . . . 0.0 108.093 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.41 130.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.81 131.52 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 62' ' ' ILE . 13.9 tt -114.37 128.15 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -135.04 131.38 36.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.805 0.442 . . . . 0.0 111.002 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -29.52 39.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.609 1.563 . . . . 0.0 112.951 -159.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 33.72 56.96 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.215 1.806 . . . . 0.0 113.691 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -66.07 -60.5 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -114.23 62.03 0.66 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 69.22 -21.16 0.16 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.92 88.4 1.67 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 0.0 108.078 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.49 55.88 1.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.58 0.752 . . . . 0.0 109.776 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 58.59 175.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.892 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -151.11 155.63 39.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.834 0.454 . . . . 0.0 110.811 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 51' ' ' ILE . 47.0 mt -128.87 143.0 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.2 p -149.46 97.78 2.69 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -149.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.26 176.93 8.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.939 0.496 . . . . 0.0 110.905 -160.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -151.88 122.43 7.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -175.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -61.93 103.76 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 109.871 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.5 40.48 1.35 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.556 2.027 . . . . 0.0 111.802 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -148.02 149.86 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.024 1.33 . . . . 0.0 107.641 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 146.89 40.78 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.614 1.166 . . . . 0.0 109.194 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.27 161.98 12.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.474 0.309 . . . . 0.0 110.666 -168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -76.37 112.79 13.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -100.8 110.22 22.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -113.71 121.83 45.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 t -145.45 145.62 31.18 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.79 44.07 0.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.204 1.001 . . . . 0.0 111.942 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -152.93 -63.91 0.16 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.43 1.892 . . . . 0.0 106.963 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -79.64 1.37 26.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.331 0.652 . . . . 0.0 111.599 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 78.28 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.059 1.344 . . . . 0.0 108.671 169.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -92.25 124.42 36.31 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.81 139.09 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -78.99 131.38 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 162.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 p -130.42 161.92 30.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.0 0.364 . . . . 0.0 110.673 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.6 tt -129.53 142.42 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.327 1.851 . . . . 0.0 106.485 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.7 144.93 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -150.89 -170.62 3.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 164.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tt -135.4 124.85 24.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 107.355 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.22 145.13 51.4 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.811 0.844 . . . . 0.0 109.461 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.85 -78.93 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.632 1.11 . . . . 0.0 111.548 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.82 26.97 0.26 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.037 1.303 . . . . 0.0 110.932 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.69 136.32 52.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.377 1.471 . . . . 0.0 107.341 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 91' ' ' LEU . 8.1 tt -92.21 118.61 31.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.84 121.36 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.705 0.802 . . . . 0.0 109.377 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -105.53 123.11 47.36 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.92 1.688 . . . . 0.0 106.453 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.33 129.7 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -148.08 112.65 5.34 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.629 -151.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -130.61 163.84 26.26 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.749 1.22 . . . . 0.0 112.245 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -136.83 -65.85 0.54 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.33 143.71 10.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.19 -7.5 5.91 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.128 -0.818 . . . . 0.0 114.206 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 165.08 14.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.935 1.367 . . . . 0.0 110.423 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -142.07 125.56 16.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.33 1.852 . . . . 0.0 106.948 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.33 153.54 24.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 110.482 164.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -123.12 136.9 54.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.913 1.285 . . . . 0.0 107.581 172.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 110.12 7.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.19 129.8 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -122.21 124.71 44.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 127.063 2.145 . . . . 0.0 107.801 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -143.6 144.21 31.82 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -115.57 123.46 48.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 161.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.03 -179.73 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 159.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 52.16 -113.83 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.1 28.39 2.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.897 1.237 . . . . 0.0 110.075 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -127.59 127.31 43.64 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 tt -83.8 93.99 8.09 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.9 mt -73.44 111.96 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.8 135.5 44.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 163.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.6 m -128.36 124.19 35.79 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' CE2' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -117.77 125.82 51.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.599 0.76 . . . . 0.0 109.235 -178.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.8 m -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.195 1.798 . . . . 0.0 108.994 -172.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -97.34 161.88 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.01 63.84 1.61 Allowed Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.646 -0.659 . . . . 0.0 111.802 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.8 t 161.13 -60.44 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.544 3.138 . . . . 0.0 108.265 172.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.71 137.74 33.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.429 0.692 . . . . 0.0 110.391 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.84 123.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.496 1.118 . . . . 0.0 108.712 -173.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.1 t -133.37 111.67 10.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.416 0.687 . . . . 0.0 109.903 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -63.82 153.53 36.37 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 160.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -159.54 83.57 0.76 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.344 0.657 . . . . 0.0 109.3 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -88.46 126.88 35.45 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.459 -0.776 . . . . 0.0 109.973 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -102.61 144.37 31.1 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.695 1.198 . . . . 0.0 109.169 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.86 133.72 55.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.209 2.204 . . . . 0.0 106.864 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -58.8 141.27 53.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.058 0.845 . . . . 0.0 110.839 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -71.37 -31.25 67.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.953 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.657 1.183 . . . . 0.0 108.488 179.461 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.572 0.225 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.54 54.36 0.45 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.695 2.798 . . . . 0.0 111.578 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.71 -51.44 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.573 1.149 . . . . 0.0 108.279 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -57.64 -46.83 83.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.436 1.095 . . . . 0.0 110.96 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 p -38.23 110.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.412 1.885 . . . . 0.0 111.908 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.83 -146.48 18.42 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -130.78 134.74 47.12 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.639 0.775 . . . . 0.0 110.708 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -118.58 162.28 18.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.799 1.64 . . . . 0.0 109.744 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -136.8 132.96 35.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.604 1.162 . . . . 0.0 108.643 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.14 147.86 42.59 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.1 p -130.98 -70.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 122.856 0.463 . . . . 0.0 111.284 164.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 127' ' ' THR . 26.7 m-20 -93.47 144.14 25.64 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -171.93 43.34 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.66 155.36 33.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.053 0.842 . . . . 0.0 112.381 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.99 25.52 13.92 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.519 1.528 . . . . 0.0 111.991 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -75.18 -49.82 18.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.124 -0.985 . . . . 0.0 109.898 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.91 -61.38 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.466 0.65 . . . . 0.0 110.093 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 17.9 t70 -45.56 -48.56 14.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.559 1.944 . . . . 0.0 112.065 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -55.24 -44.62 75.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.262 1.025 . . . . 0.0 111.257 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.25 -33.2 59.17 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.679 -0.638 . . . . 0.0 111.088 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.7 ttpm? -73.41 51.89 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.473 1.509 . . . . 0.0 109.358 170.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 m -178.59 -60.17 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 128.372 2.669 . . . . 0.0 107.058 -173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.55 -20.26 62.05 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.91 -22.16 32.85 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.78 -1.011 . . . . 0.0 112.62 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -66.15 66.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.664 1.986 . . . . 0.0 114.776 -162.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.87 44.23 3.15 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.92 2.2 . . . . 0.0 110.438 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -36.17 -43.77 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.183 2.193 . . . . 0.0 114.027 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.29 44.48 2.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.489 1.116 . . . . 0.0 110.799 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.9 t -152.04 -44.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.65 . . . . 0.0 111.177 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -27.48 45.0 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.928 -1.107 . . . . 0.0 110.022 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.24 -20.14 64.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.361 1.464 . . . . 0.0 112.522 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.35 -30.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.15 0.58 . . . . 0.0 110.293 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.22 63.61 0.77 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.155 0.883 . . . . 0.0 111.925 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -162.3 -51.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.721 1.608 . . . . 0.0 110.455 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.4 mtt -57.21 -47.54 81.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.035 1.334 . . . . 0.0 109.983 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -68.16 66.85 0.11 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.148 2.179 . . . . 0.0 110.412 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -18.66 91.73 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 128.032 2.533 . . . . 0.0 113.549 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.27 136.89 67.16 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.125 1.216 . . . . 0.0 110.806 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.71 141.74 28.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 m -130.91 102.28 5.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.22 131.2 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.1 mt -126.2 103.41 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.12 134.57 40.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.77 119.34 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -95.13 168.78 10.55 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.253 1.021 . . . . 0.0 108.585 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -29.54 -60.38 0.18 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.886 1.707 . . . . 0.0 114.645 -170.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -126.47 22.19 7.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.867 1.667 . . . . 0.0 109.919 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.96 -178.67 6.61 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.834 0.854 . . . . 0.0 109.455 -153.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.45 150.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 121.122 -0.986 . . . . 0.0 108.96 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.4 tt -133.65 126.66 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -93.19 127.06 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -133.51 91.55 2.87 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -80.79 131.5 35.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.024 1.33 . . . . 0.0 109.17 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 114.13 23.51 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.559 0.744 . . . . 0.0 109.479 169.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.8 t -140.97 54.1 1.57 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t 39.67 -118.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.735 1.214 . . . . 0.0 110.045 -168.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -57.59 -9.37 1.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.889 1.676 . . . . 0.0 115.125 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -118.03 32.24 6.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.608 1.095 . . . . 0.0 111.129 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -63.21 159.76 17.02 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.65 -0.656 . . . . 0.0 110.653 162.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 160.16 23.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.807 1.243 . . . . 0.0 108.203 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.54 120.08 6.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.286 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mt -143.65 124.26 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.001 0.92 . . . . 0.0 109.928 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 p -91.2 142.19 27.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.955 2.102 . . . . 0.0 110.071 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -156.68 -175.68 5.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.436 1.094 . . . . 0.0 109.213 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -124.7 145.51 49.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 54.55 0.59 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.881 1.273 . . . . 0.0 110.154 174.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.42 58.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 p -164.99 162.33 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.49 148.16 23.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.778 0.674 . . . . 0.0 109.751 165.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.88 145.84 22.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.742 0.817 . . . . 0.0 110.263 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.68 133.59 48.65 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.697 1.599 . . . . 0.0 108.347 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -143.51 131.25 21.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 t -103.07 121.66 43.05 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.74 0.816 . . . . 0.0 108.857 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 171.72 8.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.43 -7.96 11.74 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -155.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -105.41 11.03 33.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.275 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t0 43.84 46.98 6.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.202 2.201 . . . . 0.0 113.222 -162.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 117.219 -1.792 . . . . 0.0 106.359 148.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.25 84.07 7.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -82.67 178.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.839 1.256 . . . . 0.0 109.536 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -124.44 119.36 28.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -100.74 157.68 16.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.852 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 120.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.6 t -107.57 131.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p -126.06 119.96 29.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.348 1.059 . . . . 0.0 108.352 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.87 103.99 15.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -86.25 -167.53 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.941 0.401 . . . . 0.0 110.16 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.2 55.02 2.75 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.585 -0.697 . . . . 0.0 111.798 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 -57.49 0.27 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.93 152.28 47.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.334 0.654 . . . . 0.0 111.116 -162.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.66 102.71 15.13 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -80.32 96.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.05 99.95 12.83 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.96 142.09 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 167.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -131.43 100.19 5.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.242 1.417 . . . . 0.0 107.76 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -114.55 157.01 23.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.609 1.164 . . . . 0.0 108.567 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.423 ' HE1' ' CD ' ' A' ' 100' ' ' GLN . 12.9 p90 -140.71 -62.5 0.49 Allowed 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.714 -0.617 . . . . 0.0 110.916 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -166.75 -82.58 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.075 0.398 . . . . 0.0 110.9 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.45 -17.02 80.28 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.84 -0.538 . . . . 0.0 112.099 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' CD ' ' HE1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -135.79 163.49 30.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.318 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.88 151.45 50.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.646 1.978 . . . . 0.0 106.213 173.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.8 p -137.06 166.9 22.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.011 0.924 . . . . 0.0 109.206 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 p -133.59 154.73 50.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.2 68.97 1.1 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.01 132.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.937 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.507 HH11 HD13 ' A' ' 115' ' ' LEU . 14.5 mtt-85 -123.08 153.32 40.06 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.483 0.583 . . . . 0.0 110.756 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 90' ' ' LYS . 45.4 tt0 -157.54 159.6 37.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.75 120.9 35.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 160.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.72 172.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 155.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.23 -120.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -165.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.63 21.71 3.56 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.828 1.204 . . . . 0.0 111.357 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -122.26 134.55 54.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.81 0.805 . . . . 0.0 109.454 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.94 79.82 1.66 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mt -64.27 132.55 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.187 0.995 . . . . 0.0 108.347 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.507 HD13 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -143.69 158.25 43.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 165.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 t -126.18 127.07 45.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 166.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tt -109.34 106.75 16.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.691 1.996 . . . . 0.0 105.782 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 p -124.76 138.53 54.28 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.695 1.198 . . . . 0.0 110.941 -162.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -134.19 141.28 47.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 107.859 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.4 91.22 0.02 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 165.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m 136.19 -27.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 131.28 3.832 . . . . 0.0 111.337 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.83 152.23 36.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.007 1.276 . . . . 0.0 111.206 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.16 135.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.727 0.811 . . . . 0.0 109.35 -170.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.0 t -141.32 106.85 5.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.442 0.697 . . . . 0.0 110.887 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.1 p -58.28 143.81 43.36 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 159.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -156.01 154.84 31.7 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.322 0.964 . . . . 0.0 108.978 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 12' ' ' ASP . 1.6 t -157.57 156.59 32.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.26 150.6 52.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.832 1.653 . . . . 0.0 107.956 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.61 136.22 52.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.053 1.341 . . . . 0.0 108.151 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -67.01 121.9 16.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -86.86 -38.43 16.78 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.133 0 C-N-CA 122.985 0.514 . . . . 0.0 109.879 -178.112 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.48 50.76 0.43 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.11 2.564 . . . . 0.0 111.84 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.01 -55.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.57 -46.71 66.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 111.421 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.01 104.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.416 1.487 . . . . 0.0 112.066 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.62 -169.68 29.15 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -109.93 132.74 53.89 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.73 0.812 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 53.0 m95 -115.71 140.88 48.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.384 1.074 . . . . 0.0 109.568 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -95.93 132.35 41.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 13' ' ' SER . 7.7 tt -61.72 141.48 57.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.51 -52.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.719 -0.657 . . . . 0.0 110.584 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.58 137.69 49.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.941 0.791 . . . . 0.0 108.995 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' HD21 ' A' ' 10' ' ' LEU . 35.6 t -155.36 144.57 20.94 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.931 1.692 . . . . 0.0 108.074 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -170.62 159.46 6.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.786 0.835 . . . . 0.0 111.787 163.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 t30 62.16 34.42 16.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.361 1.864 . . . . 0.0 112.756 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -74.78 -43.66 53.63 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.78 -48.22 75.7 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 117.493 0.133 . . . . 0.0 111.01 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -50.36 -46.87 56.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.942 0.897 . . . . 0.0 111.568 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 1.8 t80 -57.15 -55.52 33.6 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -36.64 31.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.757 1.223 . . . . 0.0 112.333 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -74.72 55.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.484 1.914 . . . . 0.0 109.611 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.4 p -178.88 -48.59 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.859 2.464 . . . . 0.0 107.065 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.15 -28.07 59.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.373 0.669 . . . . 0.0 112.322 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.78 29.35 72.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.688 0.661 . . . . 0.0 113.259 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.14 -51.62 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.588 1.155 . . . . 0.0 110.986 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.39 -65.52 2.31 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -155.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 25.5 -96.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.564 1.946 . . . . 0.0 114.788 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.78 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.488 0.715 . . . . 0.0 110.954 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 m -57.87 -36.97 73.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.753 1.621 . . . . 0.0 110.456 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -51.22 63.42 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.414 0.686 . . . . 0.0 111.003 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' NE2' HG23 ' A' ' 32' ' ' VAL 0.275 4.9 pp0? -63.78 -46.33 85.69 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.717 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.579 HG23 ' NE2' ' A' ' 31' ' ' GLN . 2.6 t -47.02 -49.38 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.216 0.462 . . . . 0.0 109.837 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.06 -23.68 1.2 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 128.239 2.828 . . . . 0.0 115.087 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -137.96 39.38 2.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.422 0.689 . . . . 0.0 110.34 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.0 ttt -156.86 -56.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.622 0.369 . . . . 0.0 111.684 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -115.13 56.93 0.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.084 0.553 . . . . 0.0 111.446 -157.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 33.38 61.61 1.66 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.989 1.716 . . . . 0.0 113.823 172.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.13 116.31 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.241 2.628 . . . . 0.0 109.187 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.33 157.75 19.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.371 1.068 . . . . 0.0 108.273 -170.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 m -148.09 101.55 3.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.508 -0.745 . . . . 0.0 110.865 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.79 126.47 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 107.995 161.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.3 mm -123.85 110.07 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.418 1.487 . . . . 0.0 107.558 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -112.02 115.94 29.73 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.203 1.001 . . . . 0.0 109.128 -168.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.09 123.3 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.05 164.9 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.855 1.262 . . . . 0.0 108.288 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -36.41 -53.7 1.33 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.028 1.299 . . . . 0.0 113.381 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -106.79 -42.19 5.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.651 1.581 . . . . 0.0 111.292 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -101.36 -170.65 1.86 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.754 2.021 . . . . 0.0 110.645 -162.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.76 133.55 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 162.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 133.11 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -101.32 124.91 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.63 103.23 10.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.493 1.917 . . . . 0.0 106.804 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -80.58 124.42 28.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.147 0.579 . . . . 0.0 109.895 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -93.78 119.69 33.08 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -136.65 36.99 2.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.898 0.479 . . . . 0.0 110.212 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.7 m 61.22 101.26 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.318 1.447 . . . . 0.0 112.129 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 t80 72.4 -62.13 0.47 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.611 1.164 . . . . 0.0 109.359 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 145.97 46.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.156 0.979 . . . . 0.0 109.081 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.93 178.26 7.09 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 163.6 38.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 161.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.66 149.71 40.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -140.37 133.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.4 p -96.74 124.71 40.8 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.825 1.65 . . . . 0.0 108.425 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.62 159.5 41.95 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 119.704 1.138 . . . . 0.0 111.056 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.14 135.58 50.04 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 66.74 0.37 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.299 0.5 . . . . 0.0 110.545 169.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.35 63.4 0.03 OUTLIER Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.181 0.896 . . . . 0.0 111.127 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -170.77 169.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.227 1.011 . . . . 0.0 108.347 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.99 157.35 40.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.292 0.637 . . . . 0.0 109.948 165.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -167.57 152.3 6.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.178 0.591 . . . . 0.0 111.205 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -72.34 133.06 44.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.755 1.622 . . . . 0.0 107.075 170.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -140.63 155.82 46.43 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.402 1.081 . . . . 0.0 108.729 -165.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -154.22 145.22 22.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.705 -0.622 . . . . 0.0 110.509 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.3 t -157.97 151.6 23.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.348 0.594 . . . . 0.0 111.865 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.75 65.56 3.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.822 1.649 . . . . 0.0 110.515 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 p30 171.49 -64.76 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 129.132 2.973 . . . . 0.0 108.015 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.274 9.3 t70 -78.1 -1.65 33.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 73.73 -156.74 0.07 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.964 1.306 . . . . 0.0 109.191 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -79.98 140.24 36.7 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 164.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.69 166.84 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.01 126.13 55.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 167.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -90.21 135.06 33.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.466 HG23 ' HB ' ' A' ' 94' ' ' VAL . 10.6 tt -129.2 115.77 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.08 134.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.92 0.888 . . . . 0.0 108.952 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -160.12 150.88 18.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.71 151.9 21.61 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.654 0.661 . . . . 0.0 111.2 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.21 178.97 4.74 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 161.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -19.07 -47.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 128.0 2.714 . . . . 0.0 115.363 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.42 62.09 0.28 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.305 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -172.73 149.9 2.08 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 108.893 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -86.95 131.51 34.07 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.35 108.44 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -94.83 107.5 19.52 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 83' ' ' ILE . 42.1 t -93.08 131.39 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -122.15 101.93 7.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 107.108 -163.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -115.62 114.49 24.98 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.611 1.564 . . . . 0.0 110.905 -163.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -104.79 -62.5 1.33 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.599 0.636 . . . . 0.0 111.599 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.81 106.27 1.84 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.758 0.708 . . . . 0.0 112.597 -171.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.95 25.25 65.77 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.939 0.781 . . . . 0.0 112.177 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -175.15 167.66 3.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.368 1.467 . . . . 0.0 107.045 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -157.3 160.91 39.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.9 p -124.15 149.43 46.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.138 0.575 . . . . 0.0 109.824 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.9 p -88.45 135.11 33.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.945 0.898 . . . . 0.0 109.123 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.94 87.72 2.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 161.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.21 129.92 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.0 138.11 51.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.445 1.098 . . . . 0.0 110.944 -171.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.02 155.34 32.51 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.743 0.652 . . . . 0.0 109.287 154.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -96.59 112.39 24.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.14 0.976 . . . . 0.0 109.188 165.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.6 -171.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.8 t70 51.07 -110.27 0.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.14 29.64 2.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.646 1.593 . . . . 0.0 109.678 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -150.01 146.12 26.81 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.99 0.895 . . . . 0.0 109.732 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 5.2 tt -85.09 113.19 21.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.4 mt -89.33 105.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.41 117.44 29.12 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 166.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.0 m -103.43 133.95 47.62 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 35.5 tp -130.67 86.78 2.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.475 1.11 . . . . 0.0 108.199 -161.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -115.59 133.03 56.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.414 0.552 . . . . 0.0 110.65 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -134.45 138.38 44.72 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.166 2.187 . . . . 0.0 107.783 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.58 108.01 0.72 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 165.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 m 121.8 -37.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 130.001 3.32 . . . . 0.0 112.174 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.63 162.64 38.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.098 1.317 . . . . 0.0 112.122 -168.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.87 151.74 20.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.699 0.799 . . . . 0.0 109.86 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.5 m -143.72 159.52 42.35 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.162 -0.961 . . . . 0.0 108.776 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.35 145.43 37.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 159.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -142.34 101.91 3.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -103.05 123.68 47.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -108.86 149.23 29.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.23 1.812 . . . . 0.0 110.101 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -124.35 127.36 47.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.512 1.525 . . . . 0.0 107.798 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -68.64 119.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.28 -29.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.244 0.618 . . . . 0.0 111.451 -173.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.138 0 CA-C-N 118.403 0.547 . . . . 0.0 109.907 170.384 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.25 -36.72 32.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.02 1.728 . . . . 0.0 111.438 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.64 -15.32 62.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.715 1.606 . . . . 0.0 112.016 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.75 -52.41 2.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.563 1.145 . . . . 0.0 110.098 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.11 114.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.422 1.489 . . . . 0.0 111.603 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.99 -178.66 22.64 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 121.722 0.624 . . . . 0.0 112.84 164.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -96.39 127.41 42.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 169.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -117.61 157.34 26.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.323 1.049 . . . . 0.0 108.355 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -120.33 149.92 41.55 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 162.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.16 148.36 31.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.47 -56.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 118.25 0.477 . . . . 0.0 111.42 168.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 148.82 27.65 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -166.07 154.24 10.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.768 0.827 . . . . 0.0 109.129 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -148.57 145.93 28.04 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.425 1.09 . . . . 0.0 108.701 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 66.77 17.8 10.61 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.32 1.848 . . . . 0.0 113.147 168.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -59.58 -38.88 82.34 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.753 -1.217 . . . . 0.0 109.341 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.94 -41.78 96.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 111.194 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -58.53 -48.0 82.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.326 0.65 . . . . 0.0 109.558 173.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -51.97 -56.27 15.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -48.85 -50.52 34.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.436 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -77.38 53.58 1.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.086 1.754 . . . . 0.0 110.056 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.3 p -177.92 -50.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.266 2.227 . . . . 0.0 106.592 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.94 -32.45 74.17 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.54 23.87 74.22 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.675 0.655 . . . . 0.0 112.064 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 30' ' ' ARG . 34.1 m -85.82 53.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.518 -0.99 . . . . 0.0 110.417 -173.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.25 109.14 0.05 OUTLIER Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.717 0.675 . . . . 0.0 112.256 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.78 -64.91 0.76 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 120.776 -1.426 . . . . 0.0 111.049 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.28 65.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.101 0.56 . . . . 0.0 110.736 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -51.3 -51.75 51.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.211 1.404 . . . . 0.0 110.98 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 25' ' ' VAL . 7.5 mmt85 -72.77 -42.19 64.25 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.468 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.32 -56.91 7.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.842 1.201 . . . . 0.0 110.248 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.01 -52.13 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 42.54 2.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.84 0.733 . . . . 0.0 113.514 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -157.71 -37.16 0.07 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.712 2.005 . . . . 0.0 109.91 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.9 ttt -76.77 -33.98 58.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.881 0.472 . . . . 0.0 109.942 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -66.24 166.68 11.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.539 166.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.29 80.59 3.46 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.719 0.808 . . . . 0.0 109.223 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.61 158.81 46.93 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.784 2.323 . . . . 0.0 112.338 -168.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 164.54 25.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.348 166.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -145.43 121.93 11.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 155.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mt -90.91 135.58 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -133.44 104.4 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -109.88 109.15 19.69 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.81 88.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -50.53 157.67 0.71 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.481 1.112 . . . . 0.0 110.854 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -26.0 -59.72 0.07 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.202 1.858 . . . . 0.0 115.182 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.75 13.63 9.29 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.718 1.207 . . . . 0.0 111.524 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.18 -172.16 4.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.557 1.543 . . . . 0.0 108.264 -157.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.06 149.56 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 120.766 -1.209 . . . . 0.0 109.974 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.49 128.9 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.11 125.01 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -115.09 106.04 13.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.568 1.547 . . . . 0.0 108.976 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -83.59 63.02 7.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.749 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -71.31 144.63 49.88 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 122.14 0.971 . . . . 0.0 112.957 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -158.53 168.11 27.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 168.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -80.81 56.72 2.78 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -172.7 -51.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -172.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -138.3 146.01 41.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -148.34 49.62 1.03 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.489 0.715 . . . . 0.0 110.138 -163.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 75' ' ' ALA . 27.9 p -85.61 151.4 23.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.592 0.357 . . . . 0.0 110.443 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -121.55 142.93 49.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 0.0 110.292 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.34 93.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -172.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 p -104.36 125.32 50.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.97 1.708 . . . . 0.0 110.113 -174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -161.27 170.55 20.01 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -93.77 127.46 39.51 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 165.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.06 64.73 1.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 110.867 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.46 55.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -169.61 173.5 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.26 1.024 . . . . 0.0 108.274 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -107.16 148.56 28.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.458 160.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.67 169.34 22.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.363 1.465 . . . . 0.0 108.469 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -92.2 121.85 34.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -116.65 138.17 51.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.413 1.485 . . . . 0.0 107.226 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -138.65 108.37 6.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -128.64 129.57 46.04 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' H ' HG21 ' A' ' 60' ' ' THR . . . -75.31 44.56 0.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.944 -1.097 . . . . 0.0 113.934 -172.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.27 48.9 p30 -147.36 -52.32 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.975 0.91 . . . . 0.0 109.382 156.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -6.07 47.6 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 82.72 -159.53 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.433 2.293 . . . . 0.0 111.9 165.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -83.76 127.98 34.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.263 1.425 . . . . 0.0 107.835 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 143.98 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.925 1.29 . . . . 0.0 107.641 -174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -81.35 114.39 20.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 166.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -96.58 119.49 35.16 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.312 1.045 . . . . 0.0 108.846 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.59 126.5 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.67 134.93 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.1 m -142.59 170.33 15.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.4 133.53 55.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 165.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -82.08 -23.01 36.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.747 0.419 . . . . 0.0 111.378 -174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.01 -32.55 3.96 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.021 1.296 . . . . 0.0 110.298 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.19 -23.96 8.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.643 1.592 . . . . 0.0 111.985 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -150.25 161.26 42.78 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.233 1.413 . . . . 0.0 111.522 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.29 124.55 31.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 163.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.21 128.74 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.302 1.041 . . . . 0.0 109.424 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -114.64 95.85 5.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.438 2.295 . . . . 0.0 106.78 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.65 96.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -97.9 107.9 20.49 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.326 1.45 . . . . 0.0 108.486 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -121.42 155.71 34.27 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.525 0.602 . . . . 0.0 111.954 -171.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -130.71 -60.94 0.97 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.406 -0.331 . . . . 0.0 110.788 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -160.63 -76.62 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 118.346 0.521 . . . . 0.0 111.962 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.8 -11.8 85.1 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.592 0.633 . . . . 0.0 113.094 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -173.13 175.87 3.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.6 1.56 . . . . 0.0 107.649 -172.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -154.06 158.96 41.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.294 1.437 . . . . 0.0 109.417 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.13 121.31 44.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.715 2.006 . . . . 0.0 108.814 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.17 99.16 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.536 1.134 . . . . 0.0 108.32 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.66 146.48 25.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.91 146.57 31.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -136.23 140.78 43.75 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.539 1.536 . . . . 0.0 108.248 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -163.96 153.18 14.02 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.437 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -111.66 118.74 36.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.477 0.58 . . . . 0.0 109.799 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 -174.43 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 t70 52.73 -107.09 0.32 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.67 29.62 1.43 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.036 1.303 . . . . 0.0 110.544 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -143.35 144.03 31.91 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.134 0.967 . . . . 0.0 109.875 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.84 93.59 6.29 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 171.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.5 mt -70.34 129.57 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -144.95 142.73 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.89 113.68 14.94 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -171.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 p -117.88 129.0 55.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 108.842 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -125.15 169.92 11.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.261 1.424 . . . . 0.0 107.191 173.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.09 118.57 2.39 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 161.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.285 0.5 OUTLIER 67.91 -58.25 0.45 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.6 2.36 . . . . 0.0 113.281 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.55 112.21 12.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.527 -0.733 . . . . 0.0 111.26 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.73 125.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 126.201 1.8 . . . . 0.0 106.573 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 3.9 m -144.8 167.42 22.62 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.926 -1.109 . . . . 0.0 110.281 -174.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.8 p -136.4 144.41 44.5 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.927 0.491 . . . . 0.0 111.249 -170.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -138.04 151.09 47.52 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 166.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.24 139.67 47.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -115.66 156.53 25.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.615 1.166 . . . . 0.0 109.568 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.1 127.45 26.49 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.509 1.124 . . . . 0.0 108.41 -168.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -64.24 119.54 10.46 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.198 0.999 . . . . 0.0 108.96 -173.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -82.01 -50.93 8.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 C-N-CA 123.795 0.838 . . . . 0.0 109.088 176.755 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.6 48.02 0.19 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.25 2.62 . . . . 0.0 112.483 -175.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.32 -60.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -172.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -61.67 -33.65 74.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.271 1.028 . . . . 0.0 110.716 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 5' ' ' VAL . 9.2 p -73.63 78.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.724 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.94 -166.86 26.51 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 160.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 m -76.97 124.05 27.21 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.196 1.398 . . . . 0.0 110.984 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.429 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 11.3 m0 -104.16 149.42 25.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.841 1.256 . . . . 0.0 109.002 169.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.2 134.94 54.69 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.992 0.917 . . . . 0.0 108.888 162.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.31 144.77 56.38 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.4 -25.71 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.667 177.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.08 157.08 47.05 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.61 1.096 . . . . 0.0 110.124 173.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 t 176.72 86.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.414 1.886 . . . . 0.0 109.903 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -116.1 160.89 19.71 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.088 0.555 . . . . 0.0 110.925 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 58.33 8.05 0.77 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.329 1.852 . . . . 0.0 112.89 -177.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -31.15 64.46 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.878 -1.139 . . . . 0.0 109.397 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.57 -65.4 0.62 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -44.13 -52.06 7.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.1 1.76 . . . . 0.0 112.229 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -46.43 -50.38 16.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.032 1.333 . . . . 0.0 112.035 176.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.8 mtp -76.9 -34.5 57.73 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.728 -0.607 . . . . 0.0 110.291 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 43.64 0.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.515 2.326 . . . . 0.0 110.313 171.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -171.23 -54.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 119' ' ' HIS . 84.1 mt -61.2 -27.68 68.6 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 172.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.29 -18.72 55.69 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 119.28 0.945 . . . . 0.0 113.103 171.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 m -41.12 -47.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 127.133 2.173 . . . . 0.0 113.453 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.25 72.27 0.2 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -172.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.85 158.36 2.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 110.605 172.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.13 -78.06 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.438 1.495 . . . . 0.0 110.478 -170.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.7 p -35.24 -44.68 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.756 2.823 . . . . 0.0 113.992 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -34.9 -40.11 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 170.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -50.54 -34.88 27.09 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.007 1.723 . . . . 0.0 113.361 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.72 -44.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.31 18.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.071 0.843 . . . . 0.0 113.109 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -55.57 -53.81 51.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.895 . . . . 0.0 111.978 174.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.4 mtt -81.08 -21.7 39.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.477 1.511 . . . . 0.0 111.511 -172.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -70.44 60.66 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.802 0.728 . . . . 0.0 110.903 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -147.8 48.51 0.65 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.234 2.614 . . . . 0.0 109.043 172.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 -41.58 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.138 2.559 . . . . 0.0 112.311 -167.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -119.62 142.61 48.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 m -146.09 105.19 3.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.769 -0.582 . . . . 0.0 109.592 177.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.4 mt -77.11 113.47 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 170.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.429 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 40.1 mm -101.41 138.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 163.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -142.99 109.8 5.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -166.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.64 81.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -54.62 156.77 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.286 171.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.0 -72.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.419 2.438 . . . . 0.0 115.604 -171.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -116.42 10.0 14.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.898 1.679 . . . . 0.0 111.132 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.83 -166.48 2.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.296 1.838 . . . . 0.0 108.197 -157.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.28 136.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -112.16 133.58 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 tt -93.62 137.65 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 169.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -138.79 88.11 2.27 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.92 1.688 . . . . 0.0 107.398 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -77.91 129.94 35.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.804 1.642 . . . . 0.0 108.636 178.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.31 143.61 51.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.707 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -158.99 -173.0 4.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.213 1.005 . . . . 0.0 109.461 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -82.18 116.48 21.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.3 t80 59.98 27.25 16.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.093 0.957 . . . . 0.0 112.665 173.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -163.66 75.07 0.35 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.264 -0.898 . . . . 0.0 109.661 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -105.91 139.86 39.82 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 p -150.77 148.81 28.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.85 142.9 24.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.252 0.478 . . . . 0.0 110.989 179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.9 mt -149.96 136.14 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.784 1.234 . . . . 0.0 109.095 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 p -90.22 133.78 34.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.923 1.689 . . . . 0.0 110.075 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.67 177.81 8.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.034 0.934 . . . . 0.0 111.009 176.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 68' ' ' VAL . 53.3 tptt -125.58 139.33 53.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 107.042 -176.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 57.14 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.465 0.706 . . . . 0.0 109.65 169.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.07 57.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -167.44 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.015 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.4 142.69 50.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.558 0.536 . . . . 0.0 111.174 161.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -133.78 150.53 51.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.498 1.519 . . . . 0.0 107.556 -174.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -72.22 131.09 42.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -125.65 131.14 52.69 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 t -126.97 145.35 50.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -146.0 172.32 13.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.56 0.695 . . . . 0.0 110.275 174.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.88 30.73 0.25 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.972 1.309 . . . . 0.0 113.433 -158.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -126.18 11.85 7.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.12 2.568 . . . . 0.0 109.85 165.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t0 63.05 29.33 16.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.492 2.317 . . . . 0.0 112.751 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.81 74.67 1.6 Allowed 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.247 -1.533 . . . . 0.0 109.674 164.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.81 68.86 1.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.196 1.398 . . . . 0.0 109.092 170.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.81 -168.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 110.415 -174.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -135.38 134.67 39.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -122.36 122.6 39.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.285 1.034 . . . . 0.0 109.703 -163.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.39 132.02 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.07 132.19 68.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.275 0.63 . . . . 0.0 109.663 -176.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.05 103.06 2.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.552 1.541 . . . . 0.0 107.661 -178.061 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.83 130.81 40.09 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.907 -1.12 . . . . 0.0 110.563 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.64 27.59 0.21 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -164.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.81 -38.74 3.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.607 -1.107 . . . . 0.0 111.081 -158.079 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.54 -64.77 0.17 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.309 1.554 . . . . 0.0 112.544 -175.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 135.82 34.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -174.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.28 89.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.414 ' HA ' HG23 ' A' ' 105' ' ' VAL . 6.5 t -69.78 113.6 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -115.05 117.97 32.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -117.08 140.46 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -128.6 97.98 4.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -157.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -90.93 162.56 14.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 109.133 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -138.52 -56.15 0.63 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.642 -0.661 . . . . 0.0 110.789 166.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -163.88 -76.11 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.805 0.275 . . . . 0.0 111.11 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.63 -21.76 59.37 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.569 -0.573 . . . . 0.0 111.773 -177.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.73 174.71 11.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.792 . . . . 0.0 109.348 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -133.02 176.17 8.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.845 2.458 . . . . 0.0 109.069 177.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.7 t -133.59 153.77 51.4 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.49 1.116 . . . . 0.0 109.454 165.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.7 m -109.78 134.03 52.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.953 0.901 . . . . 0.0 108.879 -176.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.67 80.4 1.28 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.801 0.81 . . . . 0.0 109.658 -176.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 92' ' ' VAL . 0.3 OUTLIER -67.95 148.72 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.771 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -126.12 110.05 13.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -132.54 147.73 52.36 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.243 -177.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.0 ttt -118.09 134.3 55.11 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.21 1.404 . . . . 0.0 108.541 171.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -148.91 177.68 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 54.67 -103.78 0.19 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.35 26.24 1.54 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.123 1.344 . . . . 0.0 109.869 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -140.37 169.08 18.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.756 0.822 . . . . 0.0 109.194 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.62 128.37 45.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -171.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.5 mt -111.82 130.77 64.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -112.7 114.67 27.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.989 0.916 . . . . 0.0 108.693 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 105' ' ' VAL . 65.6 p -94.63 76.16 3.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.18 101.45 3.97 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.6 t -128.71 128.33 43.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.471 0.578 . . . . 0.0 110.846 -176.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.41 ' CD2' HD21 ' A' ' 23' ' ' LEU . 16.0 t60 -173.38 143.69 1.1 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.769 1.227 . . . . 0.0 109.336 175.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.31 54.74 32.29 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 167.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 m 73.98 -44.96 0.58 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.8 1.24 . . . . 0.0 112.11 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.05 115.98 4.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.67 0.788 . . . . 0.0 111.279 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.09 99.19 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.297 1.439 . . . . 0.0 107.497 172.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.9 t -100.36 105.66 17.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.229 1.012 . . . . 0.0 110.479 175.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -65.29 138.48 58.23 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 155.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -115.51 155.88 26.72 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 144.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.84 137.84 46.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 165.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.81 166.03 11.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.284 2.234 . . . . 0.0 108.77 174.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.37 114.11 15.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -75.35 73.82 2.43 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.382 0.611 . . . . 0.0 109.538 -171.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -45.06 62.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.611 1.564 . . . . 0.0 111.526 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.007 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.93 51.07 0.21 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 131.02 3.728 . . . . 0.0 111.329 -166.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.3 -53.87 0.05 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -158.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.93 47.67 0.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.454 1.102 . . . . 0.0 109.494 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 49.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.847 1.259 . . . . 0.0 108.593 -174.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.3 -165.04 35.28 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.627 -0.671 . . . . 0.0 112.793 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m -87.83 136.39 32.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.499 1.12 . . . . 0.0 111.17 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -115.8 154.5 29.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.912 1.685 . . . . 0.0 108.824 172.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -121.19 152.92 38.23 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 167.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.05 134.65 34.2 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.005 1.322 . . . . 0.0 109.635 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.65 -41.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.451 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -144.48 158.25 43.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.135 0.879 . . . . 0.0 109.192 170.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -174.35 111.93 0.16 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.929 2.092 . . . . 0.0 109.422 -163.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.3 145.26 24.47 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m120 77.11 -5.9 2.1 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.484 2.313 . . . . 0.0 111.476 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -76.21 -41.95 47.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.604 1.562 . . . . 0.0 107.678 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -32.21 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.032 1.733 . . . . 0.0 111.995 151.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -56.49 -40.15 74.46 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.346 0.521 . . . . 0.0 112.381 -173.058 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE2' HD21 ' A' ' 117' ' ' LEU . 29.6 t80 -36.04 -58.91 0.63 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.832 1.253 . . . . 0.0 112.826 178.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.73 -26.29 65.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.103 -174.025 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -76.79 51.99 0.81 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.226 1.01 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -168.28 -44.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.372 2.269 . . . . 0.0 107.428 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.44 -12.19 13.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.69 63.07 1.72 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.1 OUTLIER -166.16 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.826 1.65 . . . . 0.0 110.205 -176.85 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.04 149.45 20.36 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.88 62.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.97 1.308 . . . . 0.0 108.362 -178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 65.59 -19.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.157 1.783 . . . . 0.0 115.255 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 m -99.77 -54.48 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.291 1.436 . . . . 0.0 109.072 -170.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -63.65 -10.94 21.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -56.11 -43.53 78.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.265 0.939 . . . . 0.0 110.884 165.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -50.96 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.682 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.19 39.94 1.22 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.116 1.341 . . . . 0.0 113.376 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.1 -25.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.245 1.018 . . . . 0.0 112.227 171.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.86 -36.93 85.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 162.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 36' ' ' THR . 2.4 t -63.13 82.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.151 0.977 . . . . 0.0 109.873 167.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -144.47 60.6 7.82 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.792 1.637 . . . . 0.0 108.732 164.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.72 -21.18 25.52 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.381 2.721 . . . . 0.0 110.87 -174.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.3 m -142.87 152.06 41.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.494 -0.754 . . . . 0.0 109.244 -177.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.3 m -154.86 125.99 7.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.0 mt -78.26 134.0 29.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 166.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.9 105.36 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 166.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.1 108.31 12.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.866 0.866 . . . . 0.0 110.224 -170.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.96 114.97 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 169.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -99.74 169.38 9.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.303 1.441 . . . . 0.0 108.495 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -22.49 -65.24 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.433 1.968 . . . . 0.0 114.913 -172.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -116.88 5.06 12.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.097 1.359 . . . . 0.0 111.865 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.8 -172.73 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.717 1.607 . . . . 0.0 109.96 -154.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.11 136.08 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 166.231 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 tt -104.0 140.21 22.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 tt -124.96 125.68 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.614 1.565 . . . . 0.0 108.456 177.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -134.73 105.9 6.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.84 0.856 . . . . 0.0 109.397 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.82 38.73 0.72 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.609 1.163 . . . . 0.0 113.274 -159.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -44.05 121.52 2.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 113.943 -164.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -141.63 62.87 1.44 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.277 0.631 . . . . 0.0 110.004 -176.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 m 73.03 125.66 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.137 1.375 . . . . 0.0 109.96 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 72.9 -53.68 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.99 1.316 . . . . 0.0 111.911 -178.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.77 -163.73 0.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -169.28 -168.49 0.83 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 p -54.58 147.59 14.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.256 1.423 . . . . 0.0 110.959 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -134.78 122.71 22.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.704 1.601 . . . . 0.0 106.832 176.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.49 158.41 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -129.64 159.72 35.53 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 165.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.13 179.55 8.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.919 0.888 . . . . 0.0 108.717 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -145.75 128.11 15.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 76.03 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.133 0.973 . . . . 0.0 110.052 171.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.54 59.3 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.274 1.416 . . . . 0.0 111.084 174.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -168.32 168.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.103 0.952 . . . . 0.0 109.148 174.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.18 152.56 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 110.774 168.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -172.62 163.81 5.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.539 1.136 . . . . 0.0 109.622 -172.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.5 132.78 44.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.738 0.415 . . . . 0.0 110.115 177.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -123.08 87.02 2.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.58 1.952 . . . . 0.0 107.11 -176.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.7 m -89.4 109.07 20.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.436 0.694 . . . . 0.0 109.514 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -131.88 157.7 43.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.523 0.677 . . . . 0.0 112.256 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.76 49.27 1.03 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.506 1.522 . . . . 0.0 111.727 -173.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -172.01 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.342 1.457 . . . . 0.0 107.346 -173.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.268 5.6 m-20 -74.43 9.47 1.71 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.348 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 70.12 -154.9 0.13 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 109.108 162.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.96 81.61 3.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG21 ' HG2' ' A' ' 95' ' ' GLN . 6.4 p -96.68 165.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -108.19 128.03 54.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.165 -0.959 . . . . 0.0 109.127 171.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 134.55 36.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 tt -129.1 115.52 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 153.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.698 0.799 . . . . 0.0 110.254 -166.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -156.29 173.7 16.48 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.546 1.539 . . . . 0.0 106.934 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.27 148.14 49.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.448 1.022 . . . . 0.0 109.886 161.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -116.89 108.83 16.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.519 1.127 . . . . 0.0 108.151 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.67 -68.01 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.637 1.113 . . . . 0.0 111.715 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.8 60.82 0.16 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.679 -2.169 . . . . 0.0 107.679 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.07 113.58 1.22 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 -177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.09 120.63 31.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.04 129.93 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.693 1.597 . . . . 0.0 108.116 -174.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -113.09 106.18 14.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 171.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -82.17 125.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 164.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' HG21 ' A' ' 80' ' ' VAL . 49.6 tt0 -126.09 92.26 3.55 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -163.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -110.0 113.97 27.13 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.267 1.427 . . . . 0.0 108.658 -162.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.45 -55.27 3.35 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.192 0.905 . . . . 0.0 110.677 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -169.46 -90.96 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 117.901 0.319 . . . . 0.0 110.76 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.63 -23.53 77.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -175.35 4.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.613 0.765 . . . . 0.0 109.646 176.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.75 166.54 26.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.286 2.234 . . . . 0.0 106.624 -171.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 t -130.24 153.83 48.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 156.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 p -116.82 137.99 51.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.16 156.64 44.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.71 152.19 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.114 0.566 . . . . 0.0 110.236 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -123.6 138.13 54.61 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.915 1.286 . . . . 0.0 108.641 168.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -156.16 146.69 21.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.733 2.013 . . . . 0.0 106.471 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.09 122.22 22.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.624 0.77 . . . . 0.0 109.133 169.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.46 176.41 4.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 159.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.3 t70 51.76 -117.58 1.15 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -129.7 15.25 5.72 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.234 1.397 . . . . 0.0 110.588 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -123.81 134.22 53.66 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.759 0.78 . . . . 0.0 110.453 -167.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 tp -97.66 116.35 29.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.814 1.645 . . . . 0.0 108.311 -171.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.7 mm -86.29 120.94 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.76 113.34 26.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 167.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -111.46 127.78 55.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 170.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -138.46 108.53 6.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.347 1.459 . . . . 0.0 107.689 -166.496 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -131.48 138.65 49.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.885 0.85 . . . . 0.0 112.211 -170.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -139.72 92.05 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.62 -118.37 12.58 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -61.85 -43.46 98.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.697 1.199 . . . . 0.0 111.323 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.64 68.07 5.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.218 -167.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.9 136.42 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' HD23 ' A' ' 117' ' ' LEU . 4.0 m -145.62 160.7 41.29 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.361 -1.462 . . . . 0.0 109.929 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -142.07 154.61 45.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.362 0.414 . . . . 0.0 110.783 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -132.95 169.29 17.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 151.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 119.07 11.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 -176.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -112.24 163.69 14.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.983 1.713 . . . . 0.0 109.283 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -133.56 123.8 25.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 127.364 2.266 . . . . 0.0 107.934 -174.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.97 111.15 3.19 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.13 -34.04 10.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 110.636 -173.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 C-N-CA 123.878 0.871 . . . . 0.0 109.936 174.63 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.53 60.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 129.304 3.042 . . . . 0.0 112.096 -169.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.53 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.159 1.784 . . . . 0.0 107.754 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -58.52 -36.6 74.09 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.752 1.221 . . . . 0.0 111.404 -176.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.5 104.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.14 0.976 . . . . 0.0 111.773 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.58 -177.26 27.87 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.349 1.452 . . . . 0.0 113.347 169.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -85.45 108.45 17.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.147 1.779 . . . . 0.0 111.075 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -97.01 155.86 16.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 174.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -123.97 129.67 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.161 1.784 . . . . 0.0 106.555 174.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.86 131.2 35.82 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.51 -42.75 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.439 0.563 . . . . 0.0 110.781 172.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 66.86 151.55 0.07 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.898 2.079 . . . . 0.0 111.953 -173.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -166.88 30.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.675 163.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -166.91 87.34 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.249 -0.907 . . . . 0.0 110.851 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 63.05 50.98 2.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.44 1.096 . . . . 0.0 110.787 161.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -82.46 -60.65 2.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.212 0.605 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -43.17 -66.34 0.39 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.124 2.169 . . . . 0.0 109.647 171.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.7 OUTLIER -20.48 -60.55 0.02 OUTLIER 'General case' 0 C--N 1.34 0.175 0 C-N-CA 127.732 2.413 . . . . 0.0 113.039 164.122 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CD2' HD12 ' A' ' 117' ' ' LEU . 3.9 t80 -63.84 -48.97 74.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.234 -171.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 mtt -62.16 -45.13 94.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.981 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -57.06 -31.34 65.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.125 2.57 . . . . 0.0 111.988 177.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -85.95 -57.27 3.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.598 1.159 . . . . 0.0 110.033 178.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.29 -25.25 68.23 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.191 0.596 . . . . 0.0 112.568 -173.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.16 21.61 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.99 -27.74 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.099 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.12 -109.3 0.01 OUTLIER Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.176 1.846 . . . . 0.0 113.631 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 27.94 54.25 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.081 2.553 . . . . 0.0 114.36 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 138.87 -61.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.602 2.761 . . . . 0.0 107.743 -172.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 p -66.23 -48.59 70.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -173.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -49.49 -18.92 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.401 1.88 . . . . 0.0 115.74 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -107.16 -13.6 15.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.787 0.835 . . . . 0.0 113.034 -177.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -143.23 -68.61 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.894 0.77 . . . . 0.0 109.169 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.39 60.45 1.53 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.777 1.656 . . . . 0.0 111.223 -176.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.9 -48.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.978 2.111 . . . . 0.0 107.643 -174.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.5 ttm -99.91 -16.9 17.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.321 1.048 . . . . 0.0 111.482 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 36' ' ' THR . 6.7 t -69.43 72.06 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.825 0.85 . . . . 0.0 111.327 178.662 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 45.51 66.62 5.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 111.947 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.16 105.16 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.005 2.47 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -108.82 139.37 43.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.793 1.237 . . . . 0.0 108.48 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.5 m -126.3 106.84 9.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -71.43 130.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 164.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -121.89 133.27 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 165.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.2 139.57 37.54 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 119.145 0.884 . . . . 0.0 109.421 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.72 138.62 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.32 164.26 19.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.0 108.173 175.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.81 -71.8 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.934 2.207 . . . . 0.0 115.521 -175.033 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -123.98 23.48 8.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.998 1.719 . . . . 0.0 110.319 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.85 -178.75 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.273 1.029 . . . . 0.0 108.681 -152.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.04 134.25 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 172.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.2 tt -99.1 141.31 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.078 0.951 . . . . 0.0 108.554 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 133.52 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.689 1.596 . . . . 0.0 107.422 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -127.32 95.75 4.37 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.811 1.244 . . . . 0.0 109.071 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.28 82.7 7.68 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.677 0.791 . . . . 0.0 109.685 -174.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -74.92 72.9 2.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.627 0.771 . . . . 0.0 109.018 173.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.9 t -142.99 -68.55 0.35 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.067 1.747 . . . . 0.0 106.977 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 m -60.3 144.38 50.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.113 0.965 . . . . 0.0 110.279 175.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -48.55 135.69 14.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.944 0.498 . . . . 0.0 110.115 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 73.39 -4.73 2.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 0.0 113.458 -178.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.6 72.49 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 111.821 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 150.01 38.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.623 -174.381 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -139.02 135.67 34.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.879 1.672 . . . . 0.0 107.863 -174.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 tp -159.45 159.42 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.535 0.607 . . . . 0.0 109.961 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.7 p -110.59 129.59 55.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.867 . . . . 0.0 109.834 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -131.16 179.87 5.75 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 110.225 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -139.59 147.16 40.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.901 1.28 . . . . 0.0 107.864 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.54 68.7 1.64 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.007 0.523 . . . . 0.0 109.603 174.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.38 69.72 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.11 165.79 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.827 0.851 . . . . 0.0 108.908 175.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -156.85 166.95 31.92 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.771 0.829 . . . . 0.0 109.005 174.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -74.47 124.11 25.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.91 58.93 0.73 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 107.433 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -57.61 106.14 0.31 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 165.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 t -147.64 134.6 20.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.895 0.478 . . . . 0.0 110.393 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.36 -36.19 41.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.13 . . . . 0.0 113.367 -174.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.43 1.07 23.36 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.669 1.188 . . . . 0.0 113.21 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -132.4 -57.05 0.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 109.7 174.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 128.64 -147.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 1 C-N-CA 132.553 4.341 . . . . 0.0 107.255 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -86.69 117.11 25.23 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 95' ' ' GLN . 7.2 p -151.85 148.0 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -169.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -95.61 141.1 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.8 p -121.06 87.76 2.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.513 1.125 . . . . 0.0 109.622 -166.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.1 105.34 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 175.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.59 139.92 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.835 0.854 . . . . 0.0 110.913 -172.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.35 171.0 19.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.23 1.812 . . . . 0.0 107.423 -152.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -142.16 131.53 23.65 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -136.7 150.81 48.66 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.182 0.993 . . . . 0.0 109.181 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.46 -80.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.61 1.1 . . . . 0.0 111.66 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.25 30.61 0.27 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.111 1.339 . . . . 0.0 110.651 171.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -132.1 141.55 49.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.111 1.364 . . . . 0.0 108.013 -176.54 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tt -96.78 112.32 24.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.632 1.173 . . . . 0.0 108.203 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.91 118.33 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 109.335 -174.042 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -111.35 99.43 8.23 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.601 2.36 . . . . 0.0 106.771 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 132.76 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 170.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HG3' HG21 ' A' ' 80' ' ' VAL . 8.2 tp60 -135.19 98.4 3.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -156.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -116.08 118.48 32.99 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.225 1.01 . . . . 0.0 111.232 -163.089 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -109.4 -26.16 10.15 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.235 0.614 . . . . 0.0 112.5 -176.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -144.61 -135.53 0.09 Allowed 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.54 66.85 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.287 0.949 . . . . 0.0 111.058 170.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -94.6 166.28 12.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.843 0.857 . . . . 0.0 111.643 -174.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 172.76 12.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.681 1.992 . . . . 0.0 110.597 173.33 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 t -113.67 154.2 27.66 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 153.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 p -112.9 106.52 14.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.652 1.181 . . . . 0.0 108.753 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 115' ' ' LEU . 2.1 mp -102.74 109.65 21.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.154 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.72 116.45 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.33 0.652 . . . . 0.0 109.403 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.472 ' CG ' HD23 ' A' ' 115' ' ' LEU . 12.0 mtt85 -95.93 131.58 42.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.836 1.654 . . . . 0.0 108.752 177.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -144.51 143.1 30.68 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -118.22 119.83 35.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -125.32 -169.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 159.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.26 -113.81 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.035 0.534 . . . . 0.0 109.649 176.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.32 20.68 3.15 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.095 1.807 . . . . 0.0 110.172 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -140.31 143.03 35.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.978 0.889 . . . . 0.0 109.895 -172.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.4 tt -97.01 99.61 11.14 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.23 125.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.5 tm? -115.95 103.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -92.6 125.55 37.29 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.44 HD12 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -117.45 85.05 2.26 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.682 1.193 . . . . 0.0 108.383 -174.455 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.58 124.19 30.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -145.26 145.47 31.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 160.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.64 -36.07 4.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.1 1.333 . . . . 0.0 113.898 -175.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -54.8 -41.21 70.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.388 0.594 . . . . 0.0 111.623 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -171.2 128.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.196 0.599 . . . . 0.0 110.33 -175.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.82 128.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 166.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.467 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 24.2 m -145.1 153.07 41.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.086 -1.009 . . . . 0.0 108.436 -177.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.3 p -140.94 123.67 16.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.154 0.888 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -95.9 102.89 14.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.358 1.863 . . . . 0.0 107.559 175.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 110.04 18.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -92.92 147.99 22.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.54 0.686 . . . . 0.0 111.334 176.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -134.38 123.27 23.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.311 2.244 . . . . 0.0 107.148 -172.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -75.49 130.54 39.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.771 0.714 . . . . 0.0 109.782 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -21.42 11.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.137 0.426 . . . . 0.0 112.011 164.111 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 118.333 0.515 . . . . 0.0 111.171 -179.455 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.758 0.313 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.86 60.28 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 130.5 3.52 . . . . 0.0 111.174 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.07 -44.83 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.074 1.75 . . . . 0.0 107.884 -169.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -61.59 -39.86 92.71 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.534 0.734 . . . . 0.0 111.391 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -38.26 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.906 1.682 . . . . 0.0 111.753 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.19 -172.41 23.21 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.271 0.928 . . . . 0.0 113.172 170.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -84.24 116.98 23.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.64 1.576 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -99.99 161.21 13.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 166.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.17 135.42 22.82 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.85 135.42 52.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.981 -0.45 . . . . 0.0 109.846 -173.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.33 -39.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 175.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -141.6 162.72 34.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.8 t -174.38 148.89 1.29 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 171.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -121.68 164.43 17.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.33 -22.86 0.21 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 166.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.09 -43.2 20.13 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -166.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -67.35 -61.82 1.72 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.245 0.93 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -40.8 -50.17 3.15 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.868 1.267 . . . . 0.0 111.92 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -50.36 -49.15 55.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.855 1.662 . . . . 0.0 111.876 177.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -37.17 70.76 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.501 -0.75 . . . . 0.0 110.256 176.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.95 48.82 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.914 2.486 . . . . 0.0 109.073 -169.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 p -172.96 -49.26 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.865 1.666 . . . . 0.0 107.26 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -66.16 33.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.226 1.411 . . . . 0.0 114.339 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.87 2.87 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 120.09 -1.631 . . . . 0.0 111.754 -178.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.61 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.299 2.64 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.82 145.39 17.84 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.916 1.246 . . . . 0.0 110.054 172.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -175.19 171.98 2.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.926 1.69 . . . . 0.0 106.568 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.25 44.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.845 0.748 . . . . 0.0 112.999 -175.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 -52.17 11.01 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.32 -0.863 . . . . 0.0 112.896 -167.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -63.87 -40.09 95.73 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -157.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -36.63 -43.31 0.4 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.686 1.595 . . . . 0.0 113.764 163.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.86 -50.04 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.75 -31.79 5.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.042 2.258 . . . . 0.0 115.702 -176.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -85.5 -37.51 19.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.36 1.08 . . . . 0.0 110.463 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -32.7 66.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.975 0.91 . . . . 0.0 109.885 -174.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -76.17 52.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.399 1.08 . . . . 0.0 111.763 -177.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 30.56 58.45 0.94 Allowed Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 127.599 2.36 . . . . 0.0 114.116 172.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.67 142.0 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.444 1.429 . . . . 0.0 112.023 -166.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.26 175.11 4.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.924 1.289 . . . . 0.0 109.825 172.424 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -159.29 112.15 2.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.486 1.914 . . . . 0.0 106.146 151.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.41 136.58 22.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 174.007 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.4 114.82 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 173.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -118.79 128.81 54.82 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.08 96.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -77.81 65.13 3.2 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.27 -87.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.453 1.502 . . . . 0.0 112.572 -179.104 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.42 -15.94 18.56 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.956 1.703 . . . . 0.0 111.621 -175.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.1 p -108.11 157.18 18.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.75 118.11 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 tt -101.35 137.89 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.794 0.837 . . . . 0.0 108.99 -174.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mp -117.44 131.72 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.416 1.487 . . . . 0.0 107.165 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -124.54 115.92 21.64 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -64.89 -46.79 80.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.274 0.23 . . . . 0.0 110.475 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 56.5 78.52 0.21 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.59 0.756 . . . . 0.0 112.538 169.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -148.06 149.37 31.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 162.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.7 p -11.41 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 129.129 2.972 . . . . 0.0 114.363 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -118.24 46.48 1.78 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.98 1.312 . . . . 0.0 108.085 177.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -158.96 55.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -110.57 139.66 45.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.748 1.619 . . . . 0.0 108.892 177.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 p -146.41 160.83 41.55 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 173.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -138.99 128.14 23.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -144.12 132.67 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.596 0.758 . . . . 0.0 109.439 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.1 p -106.14 99.5 9.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.547 1.539 . . . . 0.0 109.98 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -84.91 110.22 18.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.424 0.556 . . . . 0.0 110.218 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -76.84 97.99 4.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 161.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.05 110.5 0.61 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 170.06 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.09 22.55 6.17 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.09 1.805 . . . . 0.0 113.11 175.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -149.11 159.95 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.905 1.352 . . . . 0.0 109.388 -177.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.14 121.81 42.94 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.593 1.557 . . . . 0.0 108.371 166.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -132.52 155.77 48.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.959 1.303 . . . . 0.0 109.401 -177.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.57 148.39 51.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.057 0.543 . . . . 0.0 109.867 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -141.39 158.01 44.43 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.044 1.337 . . . . 0.0 108.786 -167.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -130.18 119.42 22.93 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.969 0.508 . . . . 0.0 110.945 -175.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.82 150.44 20.41 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.123 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.68 14.68 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -166.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -106.41 11.58 30.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.569 1.948 . . . . 0.0 110.094 164.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 t0 58.96 26.26 14.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.26 1.824 . . . . 0.0 111.909 -170.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -68.75 100.88 1.22 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 156.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.92 125.59 19.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 151.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' HB3' ' A' ' 97' ' ' TRP . 11.6 m -135.45 -165.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -139.42 144.32 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.458 1.027 . . . . 0.0 110.935 171.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -110.16 118.5 36.53 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.701 2.0 . . . . 0.0 108.71 -175.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.7 tt -96.57 125.47 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 164.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.5 139.69 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 m -144.94 161.84 38.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 170.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -123.33 115.02 20.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.03 130.73 53.89 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.88 -82.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.091 0.853 . . . . 0.0 113.705 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.35 25.45 1.1 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.353 1.454 . . . . 0.0 111.683 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.99 126.14 51.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 107.222 177.071 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 91' ' ' LEU . 5.6 tt -86.38 106.02 17.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 170.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.8 109.08 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -107.81 123.42 48.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -115.94 140.38 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.26 110.08 12.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.858 1.663 . . . . 0.0 107.907 -169.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.99 132.55 56.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.724 2.01 . . . . 0.0 108.233 -164.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.482 ' HB3' HG12 ' A' ' 80' ' ' VAL . 6.3 p90 -119.72 -65.01 1.2 Allowed 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.825 0.284 . . . . 0.0 111.443 177.36 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.49 -84.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.183 0.447 . . . . 0.0 111.11 -173.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.45 -30.22 74.91 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -175.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -171.75 3.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.557 0.694 . . . . 0.0 109.251 173.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.23 168.36 20.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.817 2.847 . . . . 0.0 104.767 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.5 t -144.26 147.79 34.02 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.9 m -109.74 143.99 38.77 Favored 'General case' 0 C--O 1.228 -0.075 0 C-N-CA 123.289 0.635 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.24 63.85 1.57 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.044 2.138 . . . . 0.0 107.322 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 p -74.02 128.94 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -110.82 114.64 28.15 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.904 1.282 . . . . 0.0 108.068 174.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -121.74 144.49 48.76 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 165.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.71 127.8 54.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.929 1.292 . . . . 0.0 108.393 169.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.59 -178.59 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.4 -110.78 0.58 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.3 21.0 2.25 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.866 1.698 . . . . 0.0 110.695 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -140.2 156.74 46.39 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -173.097 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -123.06 137.9 54.82 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.375 0.534 . . . . 0.0 109.776 173.898 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.63 106.97 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -176.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 115' ' ' LEU . 4.7 tt -88.12 103.72 16.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 170.054 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 m -85.91 93.66 8.99 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.84 95.63 9.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -121.07 131.61 54.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.66 0.784 . . . . 0.0 111.538 -174.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -113.97 -39.28 3.99 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.539 1.536 . . . . 0.0 110.224 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.84 -80.29 0.26 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 174.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.2 t -58.24 -39.86 80.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.45 141.38 40.4 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 108.766 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -146.22 112.02 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.634 1.574 . . . . 0.0 107.798 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.12 101.46 8.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.245 1.418 . . . . 0.0 110.33 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -56.59 129.83 42.58 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 150.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.94 108.55 10.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.1 113.55 26.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.893 1.277 . . . . 0.0 108.721 -156.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.56 147.57 35.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.946 1.298 . . . . 0.0 112.245 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -124.51 124.22 41.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.219 2.207 . . . . 0.0 106.501 -171.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -75.86 124.7 27.76 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -107.02 -28.51 9.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.387 0.275 . . . . 0.0 111.218 173.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 123.2 0.6 . . . . 0.0 110.705 -177.345 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.764 -0.16 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.97 63.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.084 2.154 . . . . 0.0 110.53 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.18 -43.02 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.88 1.672 . . . . 0.0 108.084 -163.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.15 -43.66 21.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.257 0.623 . . . . 0.0 111.309 -177.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -43.97 102.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.75 1.62 . . . . 0.0 112.949 -169.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.86 -167.52 25.34 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.345 0.974 . . . . 0.0 113.224 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -76.34 110.58 10.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.301 1.441 . . . . 0.0 110.229 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.439 ' CE2' HG13 ' A' ' 42' ' ' ILE . 32.7 m0 -83.57 113.82 21.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 168.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -96.74 125.15 41.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.211 1.004 . . . . 0.0 109.073 174.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.52 141.64 58.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.491 0.587 . . . . 0.0 111.339 -175.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.81 25.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -161.41 158.11 26.26 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.856 1.662 . . . . 0.0 107.506 163.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 t -177.96 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.357 1.463 . . . . 0.0 109.7 -168.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -96.25 138.92 33.15 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 167.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 62.86 -3.69 0.3 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 167.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -59.16 -31.0 68.59 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.542 -1.348 . . . . 0.0 112.106 -173.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.72 -71.18 0.22 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -27.41 -61.24 0.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.458 2.303 . . . . 0.0 111.761 170.207 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.27 -61.12 1.43 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.912 1.285 . . . . 0.0 111.365 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.412 ' HB2' HG13 ' A' ' 25' ' ' VAL . 22.8 ptp -74.44 -31.56 62.32 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.859 -0.526 . . . . 0.0 111.718 -176.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.28 47.06 0.35 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.869 2.467 . . . . 0.0 109.29 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m 177.47 -45.65 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 128.061 2.545 . . . . 0.0 107.691 -172.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.6 -45.09 66.39 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.204 -0.31 . . . . 0.0 110.93 172.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.95 -84.22 0.13 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.6 OUTLIER -9.01 -68.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.522 2.329 . . . . 0.0 115.549 167.014 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 38.04 39.61 0.7 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.418 1.009 . . . . 0.0 115.067 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 150.66 44.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 72.86 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.463 1.105 . . . . 0.0 108.929 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 57' ' ' PHE . 24.4 m -162.65 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.993 1.317 . . . . 0.0 109.454 -176.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -44.2 63.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.194 0.598 . . . . 0.0 110.651 -172.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -34.79 -41.26 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.637 2.375 . . . . 0.0 114.789 168.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.84 -30.24 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.307 1.443 . . . . 0.0 110.448 177.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.37 59.21 0.63 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.1 2.286 . . . . 0.0 111.668 174.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.93 -69.01 0.07 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.516 3.526 . . . . 0.0 104.886 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -61.53 -36.23 79.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.101 1.36 . . . . 0.0 110.457 -179.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -75.52 14.44 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.64 56.24 12.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.928 1.24 . . . . 0.0 111.773 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.61 153.24 73.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.581 2.188 . . . . 0.0 111.802 -165.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -109.48 165.45 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.216 1.006 . . . . 0.0 109.058 -176.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 m -151.55 106.69 3.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.14 121.07 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 8' ' ' TRP . 41.2 mm -111.1 123.08 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 164.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.79 145.53 48.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.9 m -105.15 110.33 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.7 56.97 3.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.06 -85.55 0.02 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.925 0.774 . . . . 0.0 112.33 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.12 -29.65 21.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.893 1.277 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 173.52 6.29 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.015 1.726 . . . . 0.0 107.95 -177.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.83 148.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -177.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.8 tt -129.84 129.29 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.639 0.776 . . . . 0.0 110.167 -173.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.62 135.9 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 125.354 1.461 . . . . 0.0 107.164 172.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -127.13 119.89 27.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.086 0.954 . . . . 0.0 109.361 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -94.25 84.11 4.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 111.46 -166.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -88.07 95.7 10.24 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.442 1.019 . . . . 0.0 112.778 -168.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.9 p -108.12 154.34 21.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 164.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -76.17 61.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' HG23 ' A' ' 29' ' ' THR . 0.5 OUTLIER -177.93 -49.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.731 0.812 . . . . 0.0 110.148 -170.278 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -146.13 135.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -173.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -134.31 123.32 23.98 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.2 p -134.42 167.06 21.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.52 149.52 33.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.096 0.407 . . . . 0.0 110.544 168.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 pt -146.38 140.75 20.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.321 1.049 . . . . 0.0 109.106 177.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 p -105.03 153.97 20.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 110.335 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -158.9 160.62 36.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.345 0.658 . . . . 0.0 110.167 -178.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -84.48 131.87 34.61 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.518 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.94 54.89 1.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.079 0.854 . . . . 0.0 109.954 167.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.78 57.74 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.001 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -173.12 162.57 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.351 1.076 . . . . 0.0 111.037 169.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -100.44 126.22 46.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.063 2.545 . . . . 0.0 109.385 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.32 157.42 35.67 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.603 -0.685 . . . . 0.0 110.603 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -70.57 150.7 45.8 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.512 0.725 . . . . 0.0 109.626 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -163.65 177.01 9.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.167 1.387 . . . . 0.0 107.276 -164.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.4 m -160.46 99.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 120.168 -1.583 . . . . 0.0 108.255 -163.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.544 HG22 ' HB2' ' A' ' 78' ' ' ARG . 5.5 t -82.62 174.76 10.74 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.354 -178.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.17 21.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.204 1.802 . . . . 0.0 115.585 -163.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -139.8 15.6 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.119 2.168 . . . . 0.0 111.37 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.34 40.12 21.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 111.576 -169.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.544 ' HB2' HG22 ' A' ' 74' ' ' THR . 10.4 mmt180 -68.2 111.08 4.32 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 149.029 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -74.58 71.54 1.88 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.03 154.42 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.802 -175.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.35 120.43 32.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 159.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.18 125.14 30.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 167.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.89 107.35 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.301 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.27 135.51 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 -169.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.7 p -145.85 -168.93 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 107.413 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.59 135.52 38.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 167.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.0 24.67 0.23 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.603 1.092 . . . . 0.0 112.602 -167.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -32.21 3.17 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.337 -163.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.36 -46.83 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.108 1.337 . . . . 0.0 113.143 -172.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -127.21 155.92 42.67 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.382 1.873 . . . . 0.0 109.039 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tt -81.49 121.56 26.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.85 104.57 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.893 1.277 . . . . 0.0 107.675 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -99.6 104.26 16.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.42 143.06 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 169.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.03 108.74 10.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -117.86 139.66 50.8 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.712 1.605 . . . . 0.0 107.66 -170.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.63 -78.76 0.58 Allowed 'General case' 0 C--N 1.337 0.064 0 CA-C-N 119.565 1.075 . . . . 0.0 110.717 172.208 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.23 -60.04 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.57 0.07 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.402 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 153.36 38.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.258 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -125.79 170.15 11.89 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 108.233 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -143.57 149.75 37.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 110.269 165.326 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 p -109.57 138.03 46.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.512 1.125 . . . . 0.0 108.255 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.54 69.03 1.44 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.124 1.369 . . . . 0.0 107.997 -177.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -77.21 146.35 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.566 -174.519 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.99 136.94 35.9 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.723 1.209 . . . . 0.0 110.254 176.728 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -161.25 147.71 14.59 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 157.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -93.0 102.6 14.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.478 1.511 . . . . 0.0 109.09 167.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.49 -173.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 158.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 50.99 -110.82 0.5 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.79 25.03 2.11 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.072 1.32 . . . . 0.0 110.803 174.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -150.74 153.45 35.54 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.3 1.05 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.7 120.62 31.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -89.0 133.52 30.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.58 121.6 36.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.535 ' HB ' HG12 ' A' ' 105' ' ' VAL . 5.6 m -110.99 109.61 19.81 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.24 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.49 124.79 35.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 168.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.3 m -141.57 135.14 29.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.684 0.675 . . . . 0.0 110.723 173.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -137.71 154.7 49.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.376 2.27 . . . . 0.0 108.001 -177.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -30.6 -48.22 0.16 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.569 2.033 . . . . 0.0 115.627 -178.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 t -135.27 41.28 2.81 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.805 0.803 . . . . 0.0 110.6 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.6 126.07 4.44 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.325 -0.86 . . . . 0.0 109.202 169.215 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 p -118.09 132.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.732 1.213 . . . . 0.0 107.774 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -139.24 112.56 8.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 p -67.12 143.48 56.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 158.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -139.14 162.28 35.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 160.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.73 145.64 26.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 170.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -125.48 162.82 24.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.416 1.486 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -124.87 103.22 7.94 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.045 2.138 . . . . 0.0 105.485 -175.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.53 108.71 12.11 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 -55.98 26.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.865 -173.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 O-C-N 121.93 -0.481 . . . . 0.0 110.939 -171.712 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.92 54.05 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.526 2.731 . . . . 0.0 111.833 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.38 -56.52 0.08 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.81 1.644 . . . . 0.0 106.65 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -47.18 -44.52 22.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.266 1.826 . . . . 0.0 111.93 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -35.52 102.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.037 2.135 . . . . 0.0 112.093 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.43 -156.63 26.28 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.162 0.892 . . . . 0.0 112.906 165.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 m -116.32 127.09 54.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.632 1.173 . . . . 0.0 109.019 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -112.04 156.93 21.39 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.531 1.132 . . . . 0.0 110.463 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 25.7 ttpp -119.31 130.65 55.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.503 2.321 . . . . 0.0 107.355 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.93 137.35 58.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.15 -71.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.156 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -111.42 139.78 46.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.958 0.799 . . . . 0.0 109.448 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -163.45 160.28 23.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.771 0.828 . . . . 0.0 108.779 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 171.66 19.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.808 2.043 . . . . 0.0 107.678 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 m120 64.5 12.98 7.84 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.508 1.523 . . . . 0.0 113.78 166.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.91 -39.94 93.76 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 120.426 -1.421 . . . . 0.0 109.895 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.25 -71.75 0.06 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 109.619 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -37.88 -57.74 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.698 1.999 . . . . 0.0 111.971 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.54 -40.65 75.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.971 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -33.04 44.38 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.523 -0.735 . . . . 0.0 111.004 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -72.01 46.76 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 0.0 110.436 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p 179.04 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.303 1.841 . . . . 0.0 107.229 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -64.5 -27.88 69.28 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.97 44.31 37.29 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 25' ' ' VAL . 8.2 t -113.29 43.79 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.82 -72.84 0.28 Allowed Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.75 20.49 3.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.104 0.961 . . . . 0.0 111.984 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 171.32 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 126.613 1.965 . . . . 0.0 107.456 -168.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -53.79 -43.84 69.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.232 1.013 . . . . 0.0 111.416 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -65.86 -12.25 52.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.271 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -60.2 -23.24 63.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.331 1.423 . . . . 0.0 112.056 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.95 -39.53 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 110.269 167.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.03 47.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.199 -0.938 . . . . 0.0 113.735 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -57.77 -47.15 83.34 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.413 1.485 . . . . 0.0 109.731 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.6 ttt -92.3 -42.31 9.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.884 1.274 . . . . 0.0 110.394 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -74.45 66.26 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 0.0 112.604 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -149.26 58.57 3.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.871 1.268 . . . . 0.0 110.084 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.3 -44.67 8.67 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.685 2.923 . . . . 0.0 111.869 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.7 m -107.16 157.07 18.15 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.663 0.744 . . . . 0.0 109.217 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 m -148.02 116.83 6.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 162.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 83.1 mt -80.59 137.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.7 mm -130.96 91.19 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.556 1.543 . . . . 0.0 106.992 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.84 105.63 17.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.79 140.79 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -125.05 165.57 17.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.499 1.519 . . . . 0.0 107.912 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -25.12 -66.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.613 2.054 . . . . 0.0 115.121 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -118.36 15.05 13.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.792 2.037 . . . . 0.0 110.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.09 179.69 7.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.065 1.746 . . . . 0.0 109.727 -151.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.9 150.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.86 127.61 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.4 tt -94.64 138.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -127.74 99.02 5.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.539 1.536 . . . . 0.0 108.587 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.5 m -72.94 83.89 1.24 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -83.74 113.11 20.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.966 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -139.01 -172.64 3.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.93 1.292 . . . . 0.0 108.372 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -82.86 -80.69 0.17 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -84.06 116.53 22.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 109.662 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 81.29 133.04 0.06 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.586 1.954 . . . . 0.0 108.904 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.12 155.75 49.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 p -150.48 153.45 35.91 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.29 143.23 17.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.989 171.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mm -153.61 142.67 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.688 1.195 . . . . 0.0 108.791 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -89.69 136.87 32.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.779 2.032 . . . . 0.0 109.391 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.1 144.59 38.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.991 0.917 . . . . 0.0 110.345 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 106.23 16.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.55 1.54 . . . . 0.0 107.309 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.82 105.01 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.959 0.504 . . . . 0.0 111.076 168.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.97 30.42 2.98 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.688 2.09 . . . . 0.0 112.698 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.3 t -146.95 159.88 9.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 107.986 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.76 137.35 49.81 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 111.605 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -135.43 135.74 40.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.84 1.256 . . . . 0.0 109.512 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.15 114.98 27.62 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.565 1.546 . . . . 0.0 108.281 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.54 159.15 38.28 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.209 0.459 . . . . 0.0 110.32 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 t -122.38 98.76 6.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.641 1.577 . . . . 0.0 112.063 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -83.78 142.95 30.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.39 -40.91 27.33 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.053 0.941 . . . . 0.0 110.869 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -102.45 42.19 1.17 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.874 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.58 -37.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.213 1.005 . . . . 0.0 110.079 154.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 86.55 -172.24 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.949 2.5 . . . . 0.0 107.093 -163.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -72.71 123.95 24.32 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.738 0.699 . . . . 0.0 110.193 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.93 147.86 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.216 1.406 . . . . 0.0 108.172 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -93.94 101.6 13.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 122.095 0.95 . . . . 0.0 109.932 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.5 m -83.81 116.15 22.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.015 1.326 . . . . 0.0 109.787 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.26 125.23 54.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 166.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.34 138.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -155.24 -176.66 6.05 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 164.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -132.44 105.58 7.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.865 1.266 . . . . 0.0 108.439 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.27 120.57 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.71 -80.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.722 0.677 . . . . 0.0 111.964 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.14 17.7 1.54 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.195 1.379 . . . . 0.0 111.587 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.5 117.06 30.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 108.342 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 tp -80.1 98.56 7.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.0 m -87.95 107.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -98.25 100.99 12.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.83 141.82 13.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -133.53 99.67 4.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -108.63 114.95 29.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.58 1.952 . . . . 0.0 108.502 -163.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.417 ' HE1' ' NE2' ' A' ' 100' ' ' GLN . 14.1 p90 -107.74 -67.25 0.97 Allowed 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.572 0.624 . . . . 0.0 110.99 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -172.11 -81.32 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.322 0.51 . . . . 0.0 111.734 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.96 80.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.417 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -142.68 -172.82 3.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -131.39 -178.99 5.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.118 1.767 . . . . 0.0 107.274 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.5 t -143.56 177.64 8.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.7 p -138.05 136.75 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.669 1.188 . . . . 0.0 108.264 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 115' ' ' LEU . 2.3 mt -129.87 71.33 1.44 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.139 2.176 . . . . 0.0 106.259 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.92 124.92 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.822 -0.549 . . . . 0.0 109.819 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.13 139.42 49.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.784 1.634 . . . . 0.0 110.348 -171.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -156.44 144.29 19.46 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -110.61 120.4 42.28 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 162.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.45 167.4 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 156.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.85 -124.44 2.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.13 13.63 7.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.945 1.26 . . . . 0.0 111.93 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -122.93 127.02 48.35 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.389 1.095 . . . . 0.0 109.333 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.65 103.02 4.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 165.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 pt -85.95 127.73 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 104' ' ' LEU . 7.5 tp -115.1 111.3 20.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.67 1.588 . . . . 0.0 106.785 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -88.85 115.35 26.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -102.93 109.78 21.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 m -132.17 131.15 41.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.279 1.031 . . . . 0.0 110.548 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.49 169.14 12.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.814 1.646 . . . . 0.0 108.921 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.44 83.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 166.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 85.52 140.22 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.186 2.594 . . . . 0.0 109.585 -166.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 77.55 145.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 112.346 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -137.05 153.61 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.434 1.893 . . . . 0.0 107.29 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.6 137.64 32.04 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.821 -1.175 . . . . 0.0 108.559 161.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -85.37 128.09 34.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 161.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -125.94 113.96 17.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 p -113.31 136.77 52.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.333 0.97 . . . . 0.0 110.386 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.41 146.17 47.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.925 1.69 . . . . 0.0 108.646 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 40.8 tt0 -130.09 125.04 34.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.056 2.143 . . . . 0.0 106.77 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -66.05 116.6 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.417 1.008 . . . . 0.0 110.146 -171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -91.23 -30.12 16.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.645 0.378 . . . . 0.0 111.048 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.503 0.592 . . . . 0.0 111.138 173.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 63.9 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.078 2.951 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.94 -44.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.873 1.669 . . . . 0.0 107.956 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 42' ' ' ILE . 30.6 m-85 -61.7 -44.82 96.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -174.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -37.04 105.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.992 2.117 . . . . 0.0 111.676 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.91 -163.76 25.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.499 0.571 . . . . 0.0 112.41 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 m -108.94 122.66 47.7 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 110.481 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 61.7 m95 -103.09 162.37 13.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.462 1.905 . . . . 0.0 110.624 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -129.34 132.86 47.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.455 2.302 . . . . 0.0 108.139 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.63 131.38 45.87 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.281 0.633 . . . . 0.0 110.121 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.33 31.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.247 0.619 . . . . 0.0 110.918 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.76 159.49 8.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.401 1.48 . . . . 0.0 108.175 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 177.07 102.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.442 1.897 . . . . 0.0 107.868 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -135.94 148.71 48.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.179 0.445 . . . . 0.0 110.385 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.34 35.49 20.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.544 1.538 . . . . 0.0 110.807 174.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.35 -19.14 27.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.78 1.276 . . . . 0.0 109.948 -177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -52.99 4.84 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 129.494 3.118 . . . . 0.0 106.146 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -49.68 -40.76 41.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.895 1.278 . . . . 0.0 111.148 166.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.89 -50.6 34.23 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.576 0.75 . . . . 0.0 111.165 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 -37.51 84.69 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.425 -0.797 . . . . 0.0 111.652 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -70.42 61.65 0.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 110.063 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m 168.6 -58.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 129.165 2.986 . . . . 0.0 106.795 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.73 -34.78 24.8 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 52.61 42.65 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -170.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.31 -52.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.195 0.998 . . . . 0.0 110.611 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.89 -65.6 3.21 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.873 -0.404 . . . . 0.0 113.579 -163.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.45 101.46 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.779 1.632 . . . . 0.0 112.454 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 135.16 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.707 3.203 . . . . 0.0 109.461 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -113.19 -26.5 8.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.929 1.692 . . . . 0.0 111.343 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -66.46 -41.95 88.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.83 1.195 . . . . 0.0 110.888 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -53.21 -36.67 61.26 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.287 1.035 . . . . 0.0 111.197 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.0 t -39.42 -50.86 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.401 1.88 . . . . 0.0 110.329 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.06 54.56 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.643 0.64 . . . . 0.0 113.075 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.45 24.97 10.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.85 1.26 . . . . 0.0 111.198 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.5 ttt -152.62 -2.57 0.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.0 m -158.3 169.96 23.32 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.793 -1.192 . . . . 0.0 109.602 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -117.08 73.02 6.53 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.204 1.402 . . . . 0.0 108.977 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.22 158.2 58.58 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.431 2.087 . . . . 0.0 109.809 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -100.83 164.54 11.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.74 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.95 113.1 11.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 163.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.37 127.66 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 4' ' ' PHE . 17.2 mm -120.79 110.84 29.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.57 115.95 29.44 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.3 85.87 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -50.41 154.64 1.22 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.521 0.728 . . . . 0.0 110.171 170.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -23.79 -59.28 0.04 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.317 1.913 . . . . 0.0 115.352 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.11 13.35 9.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.944 1.298 . . . . 0.0 111.805 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.89 -170.37 3.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.937 1.695 . . . . 0.0 108.767 -158.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.29 149.1 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 120.72 -1.238 . . . . 0.0 110.53 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.67 140.75 47.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.88 1.272 . . . . 0.0 109.17 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 tt -129.43 145.5 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.454 1.901 . . . . 0.0 109.371 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.0 152.75 51.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.952 2.101 . . . . 0.0 107.842 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 m -111.61 62.95 0.62 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.032 1.287 . . . . 0.0 107.717 159.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.07 108.15 0.84 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.488 -0.758 . . . . 0.0 110.794 -173.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -116.24 102.1 9.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.334 1.454 . . . . 0.0 108.55 -168.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m 63.92 -75.7 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.155 1.382 . . . . 0.0 111.451 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.33 27.85 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.119 0.968 . . . . 0.0 110.865 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 96.99 2.71 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.862 -0.524 . . . . 0.0 110.989 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -161.61 163.77 29.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.516 -0.74 . . . . 0.0 111.157 161.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -94.72 175.03 6.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.97 3.308 . . . . 0.0 109.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 152.25 47.98 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.065 1.346 . . . . 0.0 107.976 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.73 137.79 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 p -126.24 147.33 49.7 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.556 0.743 . . . . 0.0 109.399 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -160.82 163.25 32.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.056 0.931 . . . . 0.0 113.124 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -98.83 133.71 42.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -76.56 64.64 2.25 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.83 -0.544 . . . . 0.0 110.161 -178.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.82 57.92 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.21 159.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.4 1.1 . . . . 0.0 111.119 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -88.89 151.61 22.23 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.072 1.349 . . . . 0.0 109.56 160.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.48 150.1 21.16 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.377 0.671 . . . . 0.0 109.265 164.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.44 141.24 32.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.4 156.86 47.2 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.193 0.997 . . . . 0.0 108.946 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -149.71 118.77 6.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.686 0.394 . . . . 0.0 110.178 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -147.35 143.45 28.02 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.88 78.94 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.531 0.732 . . . . 0.0 111.912 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -94.83 19.71 9.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.17 1.788 . . . . 0.0 112.511 -171.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.25 -42.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.782 0.833 . . . . 0.0 110.721 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 114.69 -160.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 131.383 3.873 . . . . 0.0 108.89 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -85.71 118.4 25.19 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.26 142.04 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.263 1.025 . . . . 0.0 108.527 -167.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -80.82 126.8 31.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -97.36 143.77 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.894 0.878 . . . . 0.0 108.714 168.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 94' ' ' VAL . 5.4 tt -136.4 127.62 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 168.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.6 139.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.0 m -158.98 173.82 15.91 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.379 2.672 . . . . 0.0 104.657 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.45 153.76 43.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.425 1.466 . . . . 0.0 111.977 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.77 143.27 49.47 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.414 1.486 . . . . 0.0 108.421 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 -77.13 0.04 OUTLIER Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.24 0.924 . . . . 0.0 111.118 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.17 21.27 0.19 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.115 1.341 . . . . 0.0 111.918 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.42 134.21 54.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.119 1.368 . . . . 0.0 108.204 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.06 122.27 29.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.78 109.11 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -94.92 90.96 6.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 166.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 83' ' ' ILE . 14.5 p -89.84 146.58 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -147.06 121.43 9.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -159.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -127.51 127.72 44.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.342 1.457 . . . . 0.0 108.748 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -100.12 -55.01 2.74 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -163.66 -85.1 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.973 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.31 71.8 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.225 0.466 . . . . 0.0 112.458 -170.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 177.31 10.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.922 0.889 . . . . 0.0 109.073 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.51 163.92 30.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 109.741 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -126.84 152.6 46.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.553 1.541 . . . . 0.0 108.453 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -111.0 124.94 53.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.409 1.483 . . . . 0.0 109.377 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.44 106.71 17.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.182 1.793 . . . . 0.0 106.771 171.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.35 131.58 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -138.64 142.37 39.06 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -159.11 155.81 27.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.284 2.233 . . . . 0.0 106.024 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -106.17 122.63 46.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 160.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.15 162.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 155.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.75 -129.66 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -166.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.01 0.33 24.16 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.526 1.536 . . . . 0.0 111.672 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.44 136.4 50.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.971 0.908 . . . . 0.0 108.982 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 8.2 tt -92.67 112.25 24.14 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.31 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.4 tp -87.51 131.28 34.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.4 m -126.47 135.46 51.38 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.37 114.87 29.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 128.986 2.914 . . . . 0.0 106.71 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.1 m -120.95 130.34 53.8 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -124.22 159.21 30.66 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.88 -35.35 12.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.658 0.647 . . . . 0.0 112.291 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -124.31 123.87 41.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 92.14 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.042 2.137 . . . . 0.0 112.147 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.14 139.58 27.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.344 1.457 . . . . 0.0 107.293 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.3 t -150.75 128.24 11.44 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.986 0.914 . . . . 0.0 110.457 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 p -81.69 155.22 25.66 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -144.87 68.19 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.08 141.37 58.79 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.604 -0.685 . . . . 0.0 111.225 176.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.75 165.43 19.28 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 126.021 1.728 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.23 151.22 51.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.168 1.387 . . . . 0.0 109.681 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -86.65 128.5 35.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.908 1.283 . . . . 0.0 109.938 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.86 -15.43 14.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.961 0.8 . . . . 0.0 113.119 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.115 0 C-N-CA 123.193 0.597 . . . . 0.0 110.401 -177.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.26 -22.31 11.43 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.979 2.512 . . . . 0.0 112.857 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.95 -34.2 33.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.917 0.887 . . . . 0.0 111.272 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -48.19 56.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.23 108.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.477 1.511 . . . . 0.0 112.211 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.29 -157.46 21.28 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.25 0.477 . . . . 0.0 112.522 171.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.1 m -97.67 113.54 25.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.12 1.368 . . . . 0.0 110.791 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 16.6 m0 -84.77 113.07 21.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.579 1.552 . . . . 0.0 107.753 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.69 129.8 51.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.49 143.93 55.94 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.286 -0.884 . . . . 0.0 110.996 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.34 -42.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 120.706 -1.246 . . . . 0.0 111.854 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -138.33 162.58 34.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 t -171.49 126.47 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.67 133.17 45.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.18 29.97 5.92 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.347 1.859 . . . . 0.0 111.06 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -75.41 -53.33 8.87 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.45 -0.782 . . . . 0.0 109.671 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.56 -30.62 67.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.391 -0.193 . . . . 0.0 110.962 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.5 -48.72 62.82 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.22 -0.3 . . . . 0.0 110.56 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -56.82 -61.71 2.25 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 0.0 111.507 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -35.1 66.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 63.97 0.23 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.941 0.897 . . . . 0.0 109.874 167.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t 162.77 -56.96 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.963 2.505 . . . . 0.0 106.978 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -26.96 68.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.683 0.793 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 -19.81 15.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.885 0.755 . . . . 0.0 113.769 168.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.6 m -40.59 -32.43 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 128.21 2.604 . . . . 0.0 113.951 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.11 73.23 0.17 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -45.21 -58.66 3.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.576 1.15 . . . . 0.0 111.236 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.77 -29.54 11.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.641 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.2 p -81.87 -65.87 0.96 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.973 0.909 . . . . 0.0 111.092 -167.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -54.0 -33.1 56.16 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.829 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.9 -27.65 65.43 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.79 1.177 . . . . 0.0 113.9 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.1 t -85.53 -49.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.78 45.65 1.64 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.097 0.856 . . . . 0.0 113.684 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -160.41 -42.38 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 110.555 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtm -60.07 -26.53 66.24 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.793 0.724 . . . . 0.0 110.763 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 m -67.06 66.53 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.107 1.763 . . . . 0.0 112.367 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 44.24 72.57 1.16 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.412 1.885 . . . . 0.0 112.228 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.32 147.79 37.65 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.69 1.593 . . . . 0.0 111.904 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -152.7 160.5 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 108.175 -169.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -154.31 144.86 22.29 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pt -110.32 148.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.225 0.92 . . . . 0.0 108.772 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 30.5 mm -129.68 130.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.734 1.214 . . . . 0.0 108.761 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.17 114.88 20.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.507 1.523 . . . . 0.0 109.25 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.87 70.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.9 0.857 . . . . 0.0 110.259 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.89 149.87 43.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.571 -0.706 . . . . 0.0 109.976 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -19.89 -67.84 0.01 OUTLIER Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.494 1.997 . . . . 0.0 116.309 -171.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -113.52 14.35 18.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.599 1.559 . . . . 0.0 111.791 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.31 179.75 7.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.606 1.563 . . . . 0.0 109.0 -158.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -139.79 101.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.05 143.99 12.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.56 144.14 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -128.62 101.95 6.38 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -76.33 145.95 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.32 66.75 1.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.08 1.352 . . . . 0.0 108.591 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 m -72.17 -44.81 62.49 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -150.7 -109.51 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -113.93 -49.52 2.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.677 1.126 . . . . 0.0 111.566 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -77.77 66.72 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -101.41 -171.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.079 1.751 . . . . 0.0 109.402 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 74' ' ' THR . 11.9 p -152.77 171.95 17.44 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.664 1.186 . . . . 0.0 110.047 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -145.34 135.87 24.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.916 1.686 . . . . 0.0 108.21 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -145.26 147.81 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.227 1.011 . . . . 0.0 108.577 -172.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.5 p -99.7 97.41 8.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.608 1.563 . . . . 0.0 110.322 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -72.27 148.89 45.01 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.58 20.38 14.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.41 1.084 . . . . 0.0 113.845 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 37.04 32.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.602 1.961 . . . . 0.0 115.934 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.87 47.74 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.307 -0.718 . . . . 0.0 112.006 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -174.7 168.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.394 1.097 . . . . 0.0 109.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -104.86 143.47 33.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.621 0.768 . . . . 0.0 111.682 170.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -139.23 156.26 47.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 107.316 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.64 138.62 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.61 62.57 1.59 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -52.46 100.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.873 0.869 . . . . 0.0 110.379 163.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 60' ' ' THR . 10.1 t -117.66 136.05 53.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.261 0.553 . . . . 0.0 110.032 165.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.48 49.64 1.03 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.794 1.237 . . . . 0.0 111.374 -171.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -172.04 -58.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.565 2.346 . . . . 0.0 107.96 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.77 5.1 26.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.84 0.856 . . . . 0.0 113.22 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 83.4 -169.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 163.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -97.88 80.39 2.75 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 109.968 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.74 167.73 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.14 0.976 . . . . 0.0 109.377 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -127.33 97.12 4.79 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.5 t -113.48 114.86 27.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -157.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.3 119.11 29.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.878 1.671 . . . . 0.0 109.007 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.02 140.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 123.675 0.79 . . . . 0.0 110.031 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 p -136.81 166.71 22.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.777 1.631 . . . . 0.0 107.346 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.05 108.76 10.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.65 121.81 45.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.538 0.608 . . . . 0.0 109.835 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.52 -77.73 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.498 1.047 . . . . 0.0 111.344 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.85 21.47 0.69 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.995 1.283 . . . . 0.0 111.173 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -116.43 123.56 47.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.1 tt -84.23 110.26 18.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.2 t -95.28 116.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -113.05 117.79 32.98 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.1 t -102.79 119.15 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.438 ' CB ' HD21 ' A' ' 104' ' ' LEU . 42.6 tt0 -104.27 85.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 108.713 -169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.42 143.14 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.349 1.86 . . . . 0.0 108.396 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -125.74 -59.19 1.37 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.51 166.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -167.2 -87.32 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.353 0.524 . . . . 0.0 111.311 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.72 -23.31 77.92 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.47 175.61 9.42 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.807 0.843 . . . . 0.0 108.728 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -134.45 176.04 8.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.918 2.087 . . . . 0.0 106.455 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -138.14 165.59 26.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 162.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.488 ' C ' HD23 ' A' ' 104' ' ' LEU . 77.4 p -117.9 138.7 51.96 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.155 0.582 . . . . 0.0 110.282 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 103' ' ' SER . 0.1 OUTLIER -134.18 98.0 4.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.032 1.733 . . . . 0.0 107.387 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.3 OUTLIER -93.37 142.26 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -130.99 105.0 7.45 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.774 1.629 . . . . 0.0 108.668 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -131.98 142.93 49.76 Favored 'General case' 0 C--O 1.228 -0.042 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -116.67 124.5 49.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 164.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.57 -177.39 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.7 t70 52.36 -111.74 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.55 33.43 1.31 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -139.89 140.59 36.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -98.44 105.65 17.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.287 1.035 . . . . 0.0 108.412 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.22 105.16 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.32 95.25 9.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' HG12 ' A' ' 105' ' ' VAL . 7.3 m -81.92 115.22 21.0 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.67 105.39 13.25 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.129 1.372 . . . . 0.0 107.466 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 t -135.56 137.4 41.97 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.369 0.532 . . . . 0.0 111.35 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -109.73 -35.17 6.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.148 1.379 . . . . 0.0 111.293 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 -100.65 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 -172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 34.9 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.681 1.192 . . . . 0.0 112.749 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.34 126.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.124 2.169 . . . . 0.0 106.443 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.36 134.44 63.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 126.562 1.945 . . . . 0.0 107.016 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.47 154.27 49.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.897 0.879 . . . . 0.0 109.813 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.6 t -119.14 139.23 52.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 157.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -117.15 95.62 5.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.94 101.1 11.46 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -91.43 165.85 13.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.704 1.602 . . . . 0.0 111.028 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -139.31 109.23 6.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -66.06 98.3 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.36 -45.72 65.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 110.459 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 C-N-CA 126.057 1.743 . . . . 0.0 107.597 -176.386 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.46 65.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.11 2.964 . . . . 0.0 111.491 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.72 -49.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.03 2.132 . . . . 0.0 106.203 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -76.22 44.87 0.35 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.496 2.318 . . . . 0.0 111.421 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.1 96.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.53 -157.94 25.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -132.17 140.44 48.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.597 0.759 . . . . 0.0 110.185 -168.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -126.22 161.65 27.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.398 1.479 . . . . 0.0 109.548 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -127.65 139.01 52.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.513 1.125 . . . . 0.0 108.359 174.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 13' ' ' SER . 5.9 tt -67.73 145.4 54.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.277 0.49 . . . . 0.0 111.007 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.5 -32.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 0.0 113.474 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 14' ' ' LYS . 18.9 t0 -133.06 154.06 50.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.97 1.259 . . . . 0.0 108.683 170.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' HD21 ' A' ' 10' ' ' LEU . 36.2 t -163.51 27.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.507 2.323 . . . . 0.0 110.879 -164.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 4.3 ptpp? -57.44 146.99 27.66 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.892 -1.13 . . . . 0.0 110.435 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 66.95 5.36 4.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 114.19 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.73 -39.08 76.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.467 1.485 . . . . 0.0 111.466 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.83 -69.69 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.0 110.24 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -30.9 -57.52 0.22 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.94 2.496 . . . . 0.0 111.146 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.51 -54.45 7.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 112.66 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -40.41 75.2 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.883 -0.51 . . . . 0.0 110.227 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -73.88 45.81 0.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.52 1.528 . . . . 0.0 110.75 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -171.35 -48.21 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.517 1.927 . . . . 0.0 109.053 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.54 -34.31 70.86 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.885 -0.509 . . . . 0.0 110.914 168.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.85 44.81 3.27 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.92 -30.02 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.376 1.47 . . . . 0.0 108.058 162.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -21.29 114.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.996 0 C-N-CA 127.688 2.566 . . . . 0.0 114.86 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -162.73 -177.13 5.36 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.114 1.366 . . . . 0.0 108.985 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.99 65.24 9.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.22 0.608 . . . . 0.0 109.89 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 m -154.57 -51.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.415 0.686 . . . . 0.0 109.624 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -43.81 -34.85 1.7 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 0.0 113.529 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.01 -30.54 68.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.042 0.937 . . . . 0.0 112.724 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.74 -37.77 9.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.8 65.3 0.07 OUTLIER Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.239 2.352 . . . . 0.0 112.788 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -179.07 -37.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.462 2.705 . . . . 0.0 108.336 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.44 -30.22 17.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.227 1.011 . . . . 0.0 110.65 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -64.15 -179.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.374 0.607 . . . . 0.0 111.108 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.44 80.8 2.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.738 1.215 . . . . 0.0 110.054 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' HD13 ' A' ' 10' ' ' LEU . 36.1 Cg_endo -64.31 140.98 73.05 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.471 1.447 . . . . 0.0 110.642 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -121.79 146.53 46.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.155 1.782 . . . . 0.0 107.521 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.2 m -145.49 118.91 9.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.646 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.1 mt -92.76 128.84 44.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.88 110.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.11 104.5 10.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.445 1.098 . . . . 0.0 108.504 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.18 110.0 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.693 0.759 . . . . 0.0 109.122 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.72 60.21 5.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.11 -81.45 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.022 1.296 . . . . 0.0 112.3 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -36.81 20.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.056 1.342 . . . . 0.0 110.242 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -177.84 3.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.579 1.952 . . . . 0.0 108.225 -173.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.53 143.81 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -124.4 132.8 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 122.94 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -101.47 102.45 13.22 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.16 70.32 1.1 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.973 1.309 . . . . 0.0 107.67 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -78.22 128.62 34.01 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.499 -0.75 . . . . 0.0 110.103 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 t 74.87 -55.52 0.65 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.898 1.679 . . . . 0.0 110.291 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -39.93 81.68 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.603 3.161 . . . . 0.0 114.101 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 66.0 52.98 1.14 Allowed 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.999 1.719 . . . . 0.0 109.852 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 78.22 157.96 0.18 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.094 1.758 . . . . 0.0 107.709 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -71.01 104.76 3.09 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -124.86 177.28 6.1 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.267 1.027 . . . . 0.0 109.089 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -158.61 145.05 17.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -172.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 mt -135.4 120.05 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.484 1.114 . . . . 0.0 108.144 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.0 p -89.29 132.86 34.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.499 1.52 . . . . 0.0 108.805 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -146.39 157.55 43.79 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.71 0.686 . . . . 0.0 110.701 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -124.6 112.29 16.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.03 110.16 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.272 0.229 . . . . 0.0 110.676 170.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.31 37.76 2.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 0.0 111.682 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.5 t -147.14 151.7 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.787 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.12 136.95 46.93 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.742 1.617 . . . . 0.0 107.764 163.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.96 -173.5 3.48 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.964 0.905 . . . . 0.0 109.43 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 79' ' ' LYS . 8.1 t0 -110.64 124.19 51.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.408 1.483 . . . . 0.0 108.858 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -112.83 158.8 19.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.536 1.534 . . . . 0.0 109.209 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -147.02 101.55 3.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.71 154.46 36.86 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.1 0.96 . . . . 0.0 110.4 -171.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.19 72.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.83 -4.7 59.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.198 -171.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.76 2.79 0.21 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.62 -148.13 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.921 -1.737 . . . . 0.0 109.736 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 71' ' ' ASP . 63.8 tttp -79.32 128.04 32.83 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.642 1.177 . . . . 0.0 109.388 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.62 139.33 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -83.27 125.05 31.18 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.8 t -125.16 147.17 49.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.69 0.677 . . . . 0.0 110.647 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.57 136.56 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.44 141.73 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 t -161.36 -171.4 2.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.714 1.206 . . . . 0.0 108.243 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 pp -127.66 135.43 50.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.045 0.938 . . . . 0.0 111.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -108.37 91.06 3.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.909 1.683 . . . . 0.0 108.186 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.64 -70.76 0.9 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.74 0.686 . . . . 0.0 111.771 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 14.87 1.19 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -115.48 165.94 12.45 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.5 tt -117.43 115.45 25.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 m -91.16 119.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -113.27 110.97 21.25 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 167.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.52 133.34 60.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -132.12 106.43 7.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.668 0.787 . . . . 0.0 108.948 -158.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -106.23 151.31 24.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.59 2.356 . . . . 0.0 109.529 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -130.32 -62.93 0.91 Allowed 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.624 -0.673 . . . . 0.0 109.601 163.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -159.31 -87.54 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 119.41 -0.329 . . . . 0.0 111.375 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.76 -25.28 76.01 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.929 0.786 . . . . 0.0 112.016 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 -177.39 5.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.138 0.975 . . . . 0.0 109.025 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -159.38 -176.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.288 1.435 . . . . 0.0 109.56 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.4 t -144.63 153.43 41.75 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 111.129 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -83.89 155.29 22.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 162.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -142.01 65.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.125 1.77 . . . . 0.0 107.26 161.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.58 141.41 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -124.74 128.41 48.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.322 1.049 . . . . 0.0 109.589 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -141.51 141.3 33.6 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.88 103.23 13.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 166.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.71 172.88 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 154.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 48.83 -122.58 1.68 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -166.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.44 29.91 4.64 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.438 1.494 . . . . 0.0 109.813 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -128.35 126.48 40.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.278 0.631 . . . . 0.0 110.889 -167.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.72 109.42 17.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.01 120.39 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -104.37 89.5 3.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.247 1.419 . . . . 0.0 108.026 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 m -76.91 82.81 3.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.222 0.534 . . . . 0.0 109.752 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.57 101.36 6.49 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 108.54 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.39 112.64 20.26 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -110.93 148.52 32.3 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.751 1.22 . . . . 0.0 108.714 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.28 84.68 0.01 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 169.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t 126.82 -2.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 131.631 3.972 . . . . 0.0 113.217 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.63 140.67 18.37 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.856 1.207 . . . . 0.0 109.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.54 130.41 69.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 124.466 1.106 . . . . 0.0 108.141 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.55 110.87 7.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.542 0.737 . . . . 0.0 109.808 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 76.5 p -70.27 79.63 0.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -64.46 136.65 57.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 158.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 t -156.81 147.28 21.41 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.051 -1.031 . . . . 0.0 108.909 169.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.78 159.95 33.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.836 1.255 . . . . 0.0 110.751 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 9' ' ' LYS . 36.1 tt0 -121.49 130.76 53.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.565 2.346 . . . . 0.0 106.231 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -69.89 120.01 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.719 0.69 . . . . 0.0 109.623 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -94.76 -31.41 13.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.478 0.711 . . . . 0.0 111.24 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.154 0 CA-C-N 118.428 0.558 . . . . 0.0 110.712 177.682 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.07 53.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.638 2.775 . . . . 0.0 111.393 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.36 -37.04 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.346 1.459 . . . . 0.0 109.133 -159.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.3 -47.46 6.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.965 0.906 . . . . 0.0 109.448 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -48.28 114.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.664 0.785 . . . . 0.0 112.404 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.75 -172.84 21.78 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.521 0.582 . . . . 0.0 112.311 162.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -102.75 123.62 46.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.283 0.633 . . . . 0.0 109.585 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -118.87 154.78 32.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.461 1.104 . . . . 0.0 108.975 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -128.6 136.8 51.2 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.41 1.084 . . . . 0.0 108.082 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.08 140.31 58.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.87 -2.6 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.6 145.07 38.09 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.472 1.033 . . . . 0.0 108.511 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -162.53 148.33 12.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.223 1.409 . . . . 0.0 108.765 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -159.46 154.14 24.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.709 1.203 . . . . 0.0 107.816 163.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 44.06 29.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.883 1.273 . . . . 0.0 110.649 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -56.26 4.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.778 0.799 . . . . 0.0 109.844 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -54.67 43.91 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.183 2.193 . . . . 0.0 108.902 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.68 -46.2 74.03 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.254 1.022 . . . . 0.0 112.286 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -55.67 -50.17 70.98 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.4 mtt -61.89 -36.61 81.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.219 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.62 46.9 0.05 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.808 1.643 . . . . 0.0 111.653 172.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.0 p -165.02 -41.02 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.857 1.263 . . . . 0.0 109.129 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.95 -32.46 74.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 19.98 35.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.194 0.426 . . . . 0.0 112.495 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -38.85 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 162.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.92 -138.32 6.42 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -165.98 -71.35 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -46.57 4.21 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.499 1.52 . . . . 0.0 113.1 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -36.77 -35.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.579 2.352 . . . . 0.0 114.01 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -25.37 40.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.148 -0.97 . . . . 0.0 112.436 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -45.12 -35.85 3.37 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.144 0.884 . . . . 0.0 112.711 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.73 -45.41 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.38 -3.55 62.17 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.23 -1.317 . . . . 0.0 115.824 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -110.53 1.37 18.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.645 1.578 . . . . 0.0 111.06 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 ttm -120.42 -59.26 1.78 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.908 0.883 . . . . 0.0 109.503 -162.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.5 m -78.31 76.16 4.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.989 -0.444 . . . . 0.0 109.98 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 5.68 77.96 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 128.846 2.858 . . . . 0.0 113.379 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.79 122.4 11.67 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.691 1.594 . . . . 0.0 109.655 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.0 m -88.21 155.21 19.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 m -147.48 87.95 1.68 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -171.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.9 mt -72.5 119.87 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.81 103.26 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.05 146.82 23.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.52 1.528 . . . . 0.0 108.69 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.19 141.81 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.5 165.27 21.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.79 -69.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.627 2.06 . . . . 0.0 115.04 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -131.63 35.05 3.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.393 1.477 . . . . 0.0 110.015 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -147.62 162.97 38.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.81 153.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 165.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.22 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 135.14 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -110.54 105.19 14.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.118 0.967 . . . . 0.0 110.387 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -70.24 107.84 3.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 168.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -122.69 112.75 18.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.554 0.742 . . . . 0.0 110.932 -166.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -149.82 170.24 19.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 110.251 168.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -79.41 38.01 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.792 1.237 . . . . 0.0 113.621 -160.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -161.96 -43.4 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.444 -0.785 . . . . 0.0 110.064 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -135.19 130.91 36.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.23 121.57 36.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -136.5 128.91 30.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.567 0.621 . . . . 0.0 110.232 -171.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 134.13 41.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.138 1.375 . . . . 0.0 109.147 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.13 123.1 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 p -80.7 160.04 25.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.263 1.025 . . . . 0.0 109.417 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -140.83 86.22 2.03 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.333 1.453 . . . . 0.0 108.591 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -79.99 93.97 5.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 110.79 0.59 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.395 0.678 . . . . 0.0 112.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.32 28.15 8.25 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.683 1.135 . . . . 0.0 112.016 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.0 t -150.46 159.35 4.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.667 1.187 . . . . 0.0 108.165 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -108.89 140.83 41.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.107 0.963 . . . . 0.0 110.189 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -154.78 157.53 38.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 148.07 47.3 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.096 0.407 . . . . 0.0 110.73 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.66 86.97 2.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.934 2.094 . . . . 0.0 105.795 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.8 m -90.55 96.76 10.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 t -121.16 137.99 54.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.581 0.753 . . . . 0.0 110.634 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.44 49.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.059 0.944 . . . . 0.0 113.436 -168.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.66 -75.13 0.51 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -87.35 17.28 4.53 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -162.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 mtm-85 80.54 -163.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.295 1.838 . . . . 0.0 110.969 165.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.4 109.37 19.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.192 0.997 . . . . 0.0 108.553 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.07 168.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -108.3 135.36 49.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 t -105.03 87.88 2.74 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.196 1.798 . . . . 0.0 109.624 -168.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -80.52 104.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.85 135.78 41.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.4 t -152.48 -162.7 1.56 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 161.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.4 pp -147.47 154.83 41.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.308 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.13 146.61 28.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.08 0.952 . . . . 0.0 109.33 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.52 -82.42 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.105 0.859 . . . . 0.0 111.25 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.73 15.5 0.62 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.105 1.336 . . . . 0.0 111.721 171.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.34 127.49 55.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.543 1.537 . . . . 0.0 108.008 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.18 113.02 25.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.44 132.67 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.99 0.916 . . . . 0.0 109.442 -167.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -115.47 99.3 7.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.18 1.792 . . . . 0.0 106.655 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.08 103.99 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 169.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -96.36 96.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -105.37 121.96 44.98 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.612 1.565 . . . . 0.0 109.434 -171.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -104.23 -75.87 0.61 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.243 0.474 . . . . 0.0 109.852 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.31 139.04 6.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.25 -34.88 1.31 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.031 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.08 -175.37 5.3 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.072 0.949 . . . . 0.0 110.459 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -133.93 177.15 7.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.133 1.773 . . . . 0.0 108.271 165.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.4 143.0 50.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 159.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.72 125.19 50.2 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.173 0.589 . . . . 0.0 109.502 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.46 120.02 32.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.951 1.3 . . . . 0.0 107.646 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -114.4 118.33 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.558 0.617 . . . . 0.0 110.78 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HG2' HD11 ' A' ' 115' ' ' LEU . 28.9 mtm180 -102.0 136.77 41.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.187 1.395 . . . . 0.0 110.824 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -160.38 156.67 26.53 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.514 1.126 . . . . 0.0 108.081 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -134.78 130.8 36.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 166.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.15 159.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.52 -72.18 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.699 1.6 . . . . 0.0 112.61 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.28 68.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 mttt 174.02 164.77 0.2 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 129.307 3.043 . . . . 0.0 106.057 160.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.32 117.4 33.03 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.23 140.16 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.6 0.76 . . . . 0.0 110.304 -172.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 106' ' ' ARG . 1.1 mm? -126.15 118.8 25.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.182 1.393 . . . . 0.0 107.757 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.1 m -100.46 121.35 41.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 161.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -106.52 117.46 34.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -118.39 146.51 44.36 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.979 0.809 . . . . 0.0 109.384 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -127.09 170.82 11.95 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.225 1.81 . . . . 0.0 106.545 175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.83 55.99 3.04 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.472 -0.626 . . . . 0.0 111.765 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t 160.57 -63.51 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.09 2.956 . . . . 0.0 108.414 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.05 143.22 34.21 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.825 0.45 . . . . 0.0 110.362 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.45 136.93 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.4 t -151.46 133.94 15.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.011 0.524 . . . . 0.0 110.679 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 p -85.77 158.46 20.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.229 0.611 . . . . 0.0 110.14 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -134.84 142.8 46.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 153.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 137.43 38.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.152 0.887 . . . . 0.0 108.924 164.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.06 162.54 21.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.093 1.757 . . . . 0.0 109.579 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.17 153.19 51.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 165.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -67.73 121.19 15.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.42 1.488 . . . . 0.0 108.468 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.27 -25.28 39.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.408 0.549 . . . . 0.0 112.041 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.846 0.858 . . . . 0.0 109.183 176.258 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -74.65 60.11 0.89 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.251 1.82 . . . . 0.0 110.154 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 -53.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -164.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.16 -45.62 10.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.529 0.732 . . . . 0.0 111.437 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -47.41 120.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.325 0.65 . . . . 0.0 112.276 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.86 -163.07 12.18 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.778 1.18 . . . . 0.0 112.294 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -84.98 139.95 31.42 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.456 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CE2' HD13 ' A' ' 42' ' ' ILE . 2.1 m0 -119.93 155.18 33.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.778 1.631 . . . . 0.0 108.343 169.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 137.57 54.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.51 0.724 . . . . 0.0 109.766 163.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.17 147.07 53.88 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.22 0.608 . . . . 0.0 110.289 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.69 42.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.179 0.514 . . . . 0.0 110.935 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.89 153.96 3.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.721 2.009 . . . . 0.0 106.792 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.5 t -159.18 25.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.589 0.756 . . . . 0.0 111.72 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 122.53 16.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.586 1.085 . . . . 0.0 110.048 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 68.11 62.67 0.38 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.097 1.759 . . . . 0.0 110.996 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -83.0 -63.92 1.27 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.35 -0.844 . . . . 0.0 111.486 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.82 -34.52 62.36 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.435 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -36.61 -54.3 0.88 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.754 1.221 . . . . 0.0 110.087 165.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 2.5 t80 -53.93 -51.0 65.19 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.407 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -38.41 76.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.634 0.774 . . . . 0.0 111.421 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -73.13 63.25 0.69 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.457 1.903 . . . . 0.0 111.509 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 158.34 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 130.061 3.344 . . . . 0.0 107.368 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.19 -27.13 68.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.665 0.386 . . . . 0.0 111.588 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.43 -53.88 0.61 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.843 1.211 . . . . 0.0 110.309 169.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t 1.23 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 129.001 2.92 . . . . 0.0 115.284 -170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.1 110.47 0.27 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.992 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -65.74 173.27 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.137 0.468 . . . . 0.0 110.261 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.4 -68.99 0.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.134 1.774 . . . . 0.0 111.902 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.4 m -55.77 -54.74 40.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -65.38 -42.49 92.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.047 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.7 -7.92 48.26 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.12 -43.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 118.675 0.67 . . . . 0.0 109.804 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.36 -25.79 67.19 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.07 0.843 . . . . 0.0 112.847 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -66.95 -24.85 66.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.09 0.956 . . . . 0.0 112.239 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.0 tpt -83.97 -39.3 19.89 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.746 -0.596 . . . . 0.0 110.668 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -63.25 -57.43 10.49 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -177.25 88.61 0.25 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.162 0.985 . . . . 0.0 110.463 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -75.25 92.47 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.562 2.175 . . . . 0.0 108.833 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 m -87.94 163.18 16.47 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -142.78 152.33 42.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -130.28 128.47 64.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.454 HD13 ' CE2' ' A' ' 8' ' ' TRP . 1.7 mp -111.8 125.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 165.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 128.21 54.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 169.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.31 75.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -58.81 153.19 17.51 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.5 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -39.56 -52.0 3.05 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.365 0.983 . . . . 0.0 114.257 -167.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -112.0 0.62 16.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.523 1.529 . . . . 0.0 112.008 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -147.6 -171.48 3.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.809 1.186 . . . . 0.0 109.819 -161.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.63 130.69 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 166.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.02 150.25 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 165.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -137.06 118.62 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -108.15 131.08 55.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.79 0.836 . . . . 0.0 109.753 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.74 27.3 4.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.213 1.405 . . . . 0.0 111.265 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -49.83 97.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.843 1.657 . . . . 0.0 114.166 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 59' ' ' ASN . 3.7 t -138.53 126.9 23.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 128.212 2.605 . . . . 0.0 104.453 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t 55.45 -171.68 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.541 1.937 . . . . 0.0 114.729 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -83.66 18.98 1.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.395 1.478 . . . . 0.0 112.776 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -159.3 115.42 2.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 55' ' ' SER . 2.0 t-20 -165.31 -176.73 4.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.271 0.487 . . . . 0.0 110.8 -169.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 p -142.84 171.1 14.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.36 1.464 . . . . 0.0 108.681 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.7 150.22 38.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.4 mt -134.47 164.44 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.806 1.642 . . . . 0.0 106.596 -170.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.8 p -139.19 161.95 36.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.76 167.53 22.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.335 0.654 . . . . 0.0 110.091 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -109.31 131.14 55.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 166.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 84.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 165.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.56 42.33 0.14 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.628 1.585 . . . . 0.0 111.725 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -153.46 152.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.195 0.998 . . . . 0.0 109.066 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -111.95 140.92 46.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.213 1.005 . . . . 0.0 109.891 163.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -161.07 158.32 27.56 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.16 134.43 50.51 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -118.57 129.91 55.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -124.23 98.54 5.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 t -122.94 145.61 48.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.949 0.795 . . . . 0.0 111.012 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.44 48.85 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.399 1.079 . . . . 0.0 111.003 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.0 -83.47 0.05 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.918 1.687 . . . . 0.0 106.929 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -75.77 16.24 0.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 76.25 -147.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.03 1.332 . . . . 0.0 109.505 166.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -101.04 136.81 40.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 m -151.54 175.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.254 1.822 . . . . 0.0 107.257 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -103.24 132.08 49.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 155.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -92.82 109.54 20.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 mt -104.38 103.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.8 139.23 47.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 122.25 0.22 . . . . 0.0 110.759 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -151.87 156.29 39.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.546 1.139 . . . . 0.0 108.362 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -142.45 145.08 33.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 86' ' ' LEU . 4.5 p-10 -164.45 -146.76 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.874 1.67 . . . . 0.0 106.708 175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.78 48.61 2.99 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.331 0.969 . . . . 0.0 110.864 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.93 27.6 0.2 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.234 0.921 . . . . 0.0 111.663 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 74.76 163.85 0.27 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.647 1.579 . . . . 0.0 111.475 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -79.18 101.53 8.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.86 106.34 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -93.88 95.51 9.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 162.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.77 122.28 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 102' ' ' THR . 6.0 tp60 -117.16 99.44 7.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -168.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -119.58 115.11 23.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.513 1.125 . . . . 0.0 111.448 -161.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -96.51 -66.04 0.93 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.333 0.515 . . . . 0.0 109.847 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -169.03 -78.31 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 117.751 0.251 . . . . 0.0 111.649 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.58 -30.19 74.66 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 173.45 11.59 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.25 142.27 30.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.199 1.8 . . . . 0.0 106.277 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 95' ' ' GLN . 9.8 t -108.86 148.39 30.68 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.85 0.86 . . . . 0.0 109.565 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 p -104.0 112.75 25.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mt -95.47 92.07 6.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 164.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 126.05 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.16 137.38 48.97 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.754 1.222 . . . . 0.0 110.627 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -161.81 151.52 16.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.957 1.303 . . . . 0.0 107.716 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -107.14 120.53 42.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.766 0.826 . . . . 0.0 109.261 170.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.21 -171.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 163.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.15 -111.15 0.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.02 21.02 3.55 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 126.046 1.784 . . . . 0.0 109.792 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -145.02 147.31 32.48 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.345 1.072 . . . . 0.0 111.112 -166.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tt -102.51 106.73 17.5 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.74 1.216 . . . . 0.0 108.116 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.82 96.17 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.16 106.73 17.48 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -96.42 134.62 39.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 36.0 tp -131.43 94.1 3.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -117.79 125.04 49.86 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.429 0.692 . . . . 0.0 110.816 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -103.38 -49.38 3.73 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.235 1.014 . . . . 0.0 110.491 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.22 120.57 2.2 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 106.939 -2.465 . . . . 0.0 106.939 -166.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m 65.65 -68.54 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.962 1.305 . . . . 0.0 109.317 -165.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.96 134.27 45.86 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -146.83 138.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 106.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.73 136.98 31.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.624 0.77 . . . . 0.0 110.125 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 149.42 22.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 164.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -140.42 73.39 1.42 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 161.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.22 123.2 14.49 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.625 -0.672 . . . . 0.0 109.522 171.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -109.63 157.11 19.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.044 1.738 . . . . 0.0 109.38 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.38 118.82 24.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -85.4 104.38 15.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 110.536 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -77.35 -20.2 55.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.479 1.036 . . . . 0.0 111.516 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 124.305 1.042 . . . . 0.0 110.124 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.237 0.412 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 64.01 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.872 2.469 . . . . 0.0 110.398 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.13 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.282 1.433 . . . . 0.0 107.147 -155.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.99 -46.51 8.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.891 1.276 . . . . 0.0 110.733 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.4 t -48.99 97.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.893 1.677 . . . . 0.0 112.526 -172.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.31 -161.74 27.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.131 0.872 . . . . 0.0 111.318 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -96.89 128.06 43.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.66 0.784 . . . . 0.0 109.99 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.538 ' CG ' HD13 ' A' ' 42' ' ' ILE . 19.5 m0 -98.83 132.74 43.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -110.2 125.69 53.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.897 0.771 . . . . 0.0 109.324 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.51 148.54 48.14 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.754 0.422 . . . . 0.0 110.131 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.251 4.6 p -137.8 -68.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.011 171.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -103.93 123.45 47.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.052 0.842 . . . . 0.0 110.313 -169.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -167.82 148.76 5.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.088 0.555 . . . . 0.0 109.937 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -163.91 174.25 11.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.814 1.245 . . . . 0.0 109.165 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.32 38.1 4.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.744 1.618 . . . . 0.0 111.642 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.75 -40.46 5.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.011 0.925 . . . . 0.0 108.601 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -23.97 -77.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.212 1.805 . . . . 0.0 111.88 147.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 9.0 t70 -50.55 -44.49 56.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.297 1.439 . . . . 0.0 112.167 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -55.5 -55.53 30.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.318 0.647 . . . . 0.0 111.107 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 tpt -52.92 -47.02 68.29 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.809 0.844 . . . . 0.0 109.44 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 ttpm? -67.86 62.0 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.627 1.571 . . . . 0.0 110.444 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m 160.65 -57.32 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 129.564 3.145 . . . . 0.0 106.833 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.463 HD13 ' NE2' ' A' ' 119' ' ' HIS . 14.2 tp -82.17 -26.14 33.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -167.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.83 91.29 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.055 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -121.76 -58.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.799 1.239 . . . . 0.0 108.844 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.41 -162.54 7.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.3 t80 118.21 130.65 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.531 3.132 . . . . 0.0 107.328 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 62.0 8.2 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 -164.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 p -95.6 -62.49 1.29 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.411 1.484 . . . . 0.0 109.65 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -53.62 -52.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.642 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -60.39 -23.74 64.57 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.383 1.473 . . . . 0.0 113.179 -169.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.02 -52.46 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.69 26.96 1.93 Allowed Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.983 -0.898 . . . . 0.0 114.471 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -141.23 21.51 2.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.468 1.507 . . . . 0.0 109.562 164.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.3 ttm -143.24 -54.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -166.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -92.83 176.4 6.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 156.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.55 82.87 16.24 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.07 156.29 67.0 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.089 1.859 . . . . 0.0 110.36 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -110.8 158.34 18.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.736 0.814 . . . . 0.0 108.935 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 m -138.1 126.87 23.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 42' ' ' ILE . 1.9 mm -85.52 126.74 40.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.538 HD13 ' CG ' ' A' ' 8' ' ' TRP . 3.9 mp -124.03 112.85 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.18 134.74 54.59 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.89 0.876 . . . . 0.0 109.945 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.13 79.69 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.856 0.836 . . . . 0.0 109.407 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -54.3 154.76 4.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.605 167.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.54 -75.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.465 2.459 . . . . 0.0 115.956 -168.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.79 10.34 19.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.826 1.65 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -168.27 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.966 2.106 . . . . 0.0 107.644 -151.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.67 147.23 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 161.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -122.14 136.15 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 123.387 0.675 . . . . 0.0 109.253 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mt -112.57 138.57 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.267 1.427 . . . . 0.0 108.051 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -135.48 117.95 15.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.473 2.309 . . . . 0.0 108.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -91.07 100.96 13.72 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.842 1.201 . . . . 0.0 112.596 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 72.12 10.2 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.581 -1.325 . . . . 0.0 108.671 169.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -88.65 -178.56 5.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 153.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -103.41 37.67 1.95 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.046 0.938 . . . . 0.0 111.553 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.07 82.63 0.86 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -102.53 102.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 156.26 46.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.674 1.99 . . . . 0.0 106.316 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -152.77 144.6 23.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 129.88 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 p -99.31 127.42 45.32 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.023 2.129 . . . . 0.0 109.214 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.09 156.62 46.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.128 0.876 . . . . 0.0 111.901 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.45 115.74 31.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.92 71.19 0.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.473 0.709 . . . . 0.0 111.363 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.26 38.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.635 1.112 . . . . 0.0 111.847 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 t -152.05 154.8 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.566 1.183 . . . . 0.0 109.199 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -106.83 123.57 48.35 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.739 2.016 . . . . 0.0 108.616 166.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -165.36 164.74 19.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.097 0.959 . . . . 0.0 109.924 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.77 144.13 55.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.916 0.78 . . . . 0.0 111.56 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -132.64 72.11 1.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.405 2.282 . . . . 0.0 107.166 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.8 m -71.25 108.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.437 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.1 t -140.57 144.67 35.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.138 0.575 . . . . 0.0 110.679 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.5 57.59 2.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.045 1.338 . . . . 0.0 111.948 -167.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.48 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.755 1.622 . . . . 0.0 108.512 -170.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -73.79 -15.94 61.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.71 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 90.9 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.587 2.755 . . . . 0.0 109.334 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -78.86 59.11 2.51 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.626 -0.672 . . . . 0.0 109.274 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 81' ' ' LYS . 7.7 p -77.83 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.399 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 80' ' ' VAL . 32.1 ttmt -111.17 126.24 54.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.715 0.689 . . . . 0.0 109.655 170.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 p -78.26 108.49 11.63 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -102.14 110.22 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 155.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.06 145.37 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.9 t -155.38 -165.76 2.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.2 1.8 . . . . 0.0 107.112 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -138.82 145.12 39.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.2 0.27 46.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -166.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.604 ' H ' HD12 ' A' ' 86' ' ' LEU . . . 122.92 -39.18 2.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -160.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.92 -63.11 0.09 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.7 1.143 . . . . 0.0 111.126 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 142.54 38.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -169.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.1 tt -79.85 114.7 18.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.88 105.08 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.62 1.168 . . . . 0.0 108.241 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.34 107.81 19.75 Favored 'General case' 0 CA--C 1.524 -0.054 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.43 101.93 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 167.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.403 ' CG ' HG21 ' A' ' 80' ' ' VAL . 25.2 tt0 -89.92 102.42 15.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.752 1.221 . . . . 0.0 107.782 -166.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -116.85 127.34 54.2 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.126 0.57 . . . . 0.0 110.987 -165.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -97.72 -107.15 0.18 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.48 136.14 29.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.679 1.592 . . . . 0.0 108.642 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.8 -45.68 3.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.65 177.41 8.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.585 0.692 . . . . 0.0 111.552 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.01 176.79 11.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.532 1.933 . . . . 0.0 108.69 -172.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -132.7 138.42 47.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.954 1.301 . . . . 0.0 109.868 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.6 p -76.22 136.64 39.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 168.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 115' ' ' LEU . 29.4 mt -133.69 76.87 1.69 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 164.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.31 120.97 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.502 ' HG3' HD13 ' A' ' 115' ' ' LEU . 1.5 mpt_? -116.0 133.15 56.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.1 1.76 . . . . 0.0 109.868 -174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.33 146.66 29.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.704 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -124.55 107.28 10.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.288 1.435 . . . . 0.0 108.926 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.99 179.95 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 168.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.36 -98.32 0.08 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 0.0 109.664 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.16 32.79 0.5 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.458 1.028 . . . . 0.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -150.73 159.13 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.25 122.31 47.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.85 118.86 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.556 HD11 HD23 ' A' ' 104' ' ' LEU . 4.0 tp -113.31 116.4 29.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 m -96.19 124.35 40.16 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.24 93.28 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.68 1.192 . . . . 0.0 108.276 -171.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -143.47 153.42 42.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 0.0 111.354 -165.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -160.69 138.6 9.64 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 122.738 0.415 . . . . 0.0 110.96 166.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 47.95 -119.01 4.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.857 0.741 . . . . 0.0 111.428 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -73.72 -30.96 63.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.019 0.528 . . . . 0.0 112.193 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 126.3 42.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.365 0.53 . . . . 0.0 109.861 -166.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.69 144.17 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.025 0 C-N-CA 125.602 1.561 . . . . 0.0 109.168 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.25 151.42 32.96 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.6 -1.313 . . . . 0.0 110.826 172.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.5 p -114.89 142.44 46.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.937 1.695 . . . . 0.0 107.384 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -139.73 82.21 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.83 142.16 31.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.774 0.797 . . . . 0.0 109.707 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -119.88 169.0 10.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.711 1.604 . . . . 0.0 108.509 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -116.45 117.45 29.94 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 163.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -75.69 108.67 8.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -78.95 -31.51 45.12 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 118.352 0.524 . . . . 0.0 111.672 -170.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.485 0.179 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.68 59.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.758 3.223 . . . . 0.0 111.959 -168.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.98 -50.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.284 1.834 . . . . 0.0 107.26 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.86 -40.49 87.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.813 1.245 . . . . 0.0 110.639 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.25 116.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.123 1.369 . . . . 0.0 111.259 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -129.56 4.28 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.834 1.207 . . . . 0.0 111.199 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 m -148.67 121.9 8.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.77 -0.841 . . . . 0.0 109.837 -171.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -115.15 130.09 56.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.761 1.624 . . . . 0.0 110.484 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -114.0 141.8 46.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.883 0.873 . . . . 0.0 109.483 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.8 144.01 29.13 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 123.399 0.437 . . . . 0.0 110.199 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.6 p -125.83 -73.99 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.513 0.725 . . . . 0.0 109.726 168.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' H ' HG13 ' A' ' 11' ' ' VAL . 5.8 m-20 -108.92 149.58 28.97 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.368 0.985 . . . . 0.0 110.102 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 t -170.89 -175.58 1.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.054 1.742 . . . . 0.0 107.805 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 pttt 177.14 154.16 0.25 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.366 2.666 . . . . 0.0 107.336 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.04 34.08 21.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.675 0.79 . . . . 0.0 109.743 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -95.76 -50.68 4.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -21.45 -74.98 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.719 2.408 . . . . 0.0 113.433 148.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.14 -57.55 8.44 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.988 0.813 . . . . 0.0 111.03 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.59 -48.16 19.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.331 0.586 . . . . 0.0 112.178 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -28.06 69.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -74.97 47.07 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.52 1.928 . . . . 0.0 110.514 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.1 t -174.89 -51.86 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.939 1.695 . . . . 0.0 106.887 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.58 -35.71 80.38 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.974 0.51 . . . . 0.0 111.073 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.32 -45.71 1.28 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 76' ' ' ASP . 7.3 p -37.61 -26.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.508 2.323 . . . . 0.0 114.327 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -27.75 -68.64 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.807 1.67 . . . . 0.0 112.96 159.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.58 155.83 38.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.959 0.38 . . . . 0.0 110.111 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 71.89 -52.07 0.69 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.969 1.708 . . . . 0.0 113.786 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.6 m -105.25 -67.37 0.92 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.424 1.089 . . . . 0.0 110.647 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -68.38 -17.42 64.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.282 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -41.22 -49.7 3.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.651 0.78 . . . . 0.0 111.972 163.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -94.33 -38.93 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.09 -40.79 59.56 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.075 0.845 . . . . 0.0 113.165 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -79.31 -12.42 59.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.273 1.037 . . . . 0.0 112.381 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -61.5 1.44 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.253 3.8 t -83.74 79.29 9.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.627 0.727 . . . . 0.0 109.656 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt 12.85 76.44 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 128.766 2.826 . . . . 0.0 113.91 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.25 150.17 76.38 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.998 2.465 . . . . 0.0 113.229 -161.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 m -102.53 159.1 15.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.055 1.742 . . . . 0.0 108.75 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 119.35 12.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 42' ' ' ILE . 87.0 mt -87.49 126.71 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 41' ' ' ILE . 1.5 mp -119.92 114.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.06 140.33 53.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.337 0.517 . . . . 0.0 110.302 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 79.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -62.42 74.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.597 1.559 . . . . 0.0 112.11 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.34 -92.73 0.06 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.486 1.041 . . . . 0.0 111.749 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.37 -30.09 19.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.409 1.083 . . . . 0.0 110.745 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.05 -175.54 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.493 2.317 . . . . 0.0 109.161 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.13 138.04 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -114.94 131.48 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.509 1.123 . . . . 0.0 108.732 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -120.68 120.45 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.718 2.407 . . . . 0.0 106.346 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -128.88 99.92 5.49 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 t -82.41 43.21 0.8 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.778 -172.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 124.03 18.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.959 1.704 . . . . 0.0 112.669 -175.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -123.8 -166.54 1.5 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 162.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -46.9 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.941 0.896 . . . . 0.0 111.459 -166.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.1 p90 38.66 34.29 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.081 2.152 . . . . 0.0 114.464 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -156.26 162.87 40.09 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.663 0.665 . . . . 0.0 110.634 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 96.71 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 129.547 3.139 . . . . 0.0 110.491 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 p -110.43 174.54 5.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.481 1.512 . . . . 0.0 112.385 -156.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.98 122.17 37.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.593 2.357 . . . . 0.0 106.583 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -129.38 136.73 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 p -141.48 122.23 14.36 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 119.183 0.901 . . . . 0.0 110.316 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -147.54 165.86 29.05 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.095 0.861 . . . . 0.0 111.915 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -101.1 138.34 38.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 166.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -75.0 59.06 0.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.113 0.565 . . . . 0.0 110.506 175.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 157.31 60.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -166.85 172.55 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.855 0.828 . . . . 0.0 109.041 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -131.35 152.07 50.94 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.859 0.864 . . . . 0.0 110.793 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.92 160.17 14.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 109.478 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.74 129.03 36.42 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -123.93 123.71 41.02 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -116.1 95.53 5.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 t -113.01 140.63 47.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.065 0.946 . . . . 0.0 109.899 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.71 48.54 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.481 1.112 . . . . 0.0 112.217 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 25' ' ' VAL . 34.6 p-10 -163.42 -62.45 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.729 1.612 . . . . 0.0 109.392 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -87.12 -3.64 59.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.75 0.82 . . . . 0.0 111.631 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 83.33 -157.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.837 1.655 . . . . 0.0 109.696 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -74.62 116.34 15.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 168.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.63 154.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -81.29 138.18 35.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 150.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -100.6 119.74 39.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 161.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tt -121.02 123.36 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.02 144.68 32.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.562 0.345 . . . . 0.0 110.944 -167.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -157.54 144.15 17.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.55 1.14 . . . . 0.0 109.317 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -85.15 109.11 18.05 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 90' ' ' LYS . 26.7 p-10 -78.58 29.2 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.325 0.65 . . . . 0.0 112.625 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.4 -36.47 1.56 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.597 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 -24.94 5.91 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.097 1.449 . . . . 0.0 113.087 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -163.3 159.97 23.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.733 1.267 . . . . 0.0 109.855 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 100.3 8.03 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.16 118.33 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.581 ' HB3' HD12 ' A' ' 104' ' ' LEU . 3.4 t-160 -114.97 108.38 16.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.41 132.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -129.68 99.67 5.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -161.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HZ3' ' CD ' ' A' ' 101' ' ' GLU . 39.1 tttp -113.89 110.63 20.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.941 0.896 . . . . 0.0 111.648 -159.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -96.56 -27.31 14.9 Favored 'General case' 0 C--O 1.228 -0.048 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -155.68 -143.79 0.13 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.683 0.674 . . . . 0.0 109.897 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -42.74 -41.18 4.27 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.205 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -97.03 175.35 6.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 112.283 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.481 ' CD ' ' HZ3' ' A' ' 96' ' ' LYS . 2.3 pm0 -143.71 167.11 23.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.988 2.115 . . . . 0.0 108.301 173.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -98.59 148.14 24.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 148.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -119.31 137.11 53.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -150.94 138.13 19.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.207 0.458 . . . . 0.0 111.138 -175.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.7 m -130.69 117.3 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.663 1.185 . . . . 0.0 110.203 -164.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.424 ' NH1' HD13 ' A' ' 104' ' ' LEU . 8.5 mpt_? -102.77 139.64 38.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.873 0.76 . . . . 0.0 109.573 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.71 155.63 36.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 153.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 19.8 ttt -91.83 119.36 31.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.857 0.863 . . . . 0.0 108.994 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.46 170.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 166.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.73 -85.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.627 1.171 . . . . 0.0 109.616 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.3 26.19 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.04 1.305 . . . . 0.0 110.467 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.48 154.54 47.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.89 117.42 16.71 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.95 120.77 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 168.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.93 104.81 9.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.8 m -94.25 131.93 39.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.93 130.37 53.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 t -141.19 131.99 25.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.546 0.689 . . . . 0.0 110.211 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -119.51 165.37 14.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.169 2.587 . . . . 0.0 105.838 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.78 65.09 1.47 Allowed Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.092 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t 156.45 -59.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 130.105 3.362 . . . . 0.0 108.432 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.15 137.24 35.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.197 0.599 . . . . 0.0 109.931 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.12 134.02 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 127.53 7.32 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.197 0.908 . . . . 0.0 112.98 -176.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.6 p -78.48 153.57 31.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.958 0.903 . . . . 0.0 109.072 168.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.69 140.13 19.64 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.2 p -133.36 160.34 37.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.945 0.793 . . . . 0.0 109.363 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -145.37 144.99 31.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.576 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -128.39 134.2 48.78 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -79.68 111.81 16.34 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.26 -39.08 82.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.71 -45.06 6.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.386 2.274 . . . . 0.0 111.731 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.87 -21.6 8.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.581 1.952 . . . . 0.0 112.511 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -120.22 17.65 12.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.915 1.286 . . . . 0.0 111.314 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -99.56 94.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.539 0.736 . . . . 0.0 110.954 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.66 -165.92 23.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.824 0.726 . . . . 0.0 113.486 159.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -83.64 143.05 30.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.503 0.721 . . . . 0.0 110.125 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -133.26 141.41 48.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.963 1.305 . . . . 0.0 108.513 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 133.01 36.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 165.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.11 144.56 56.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 166.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 -57.69 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.492 0.717 . . . . 0.0 111.483 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -78.98 160.08 27.37 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.815 1.189 . . . . 0.0 109.605 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -170.42 56.72 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.779 1.632 . . . . 0.0 108.302 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.38 127.18 35.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 66.97 27.92 8.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.995 1.718 . . . . 0.0 109.876 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.6 -51.34 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 120.033 -1.667 . . . . 0.0 108.089 -171.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -17.9 -77.39 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.835 2.054 . . . . 0.0 112.485 144.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -37.12 -57.45 0.85 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 111.12 175.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' SG ' ' A' ' 124' ' ' CYS . 0.8 OUTLIER -50.9 -50.18 57.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -166.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.72 81.43 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.528 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -77.08 49.52 0.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.535 1.934 . . . . 0.0 109.185 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -178.98 -55.99 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.368 1.867 . . . . 0.0 106.955 -168.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.69 -41.9 95.7 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.92 -44.16 0.87 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.5 42.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.979 1.312 . . . . 0.0 111.327 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.3 146.06 17.97 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.871 1.224 . . . . 0.0 112.406 -166.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.1 162.2 1.98 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.014 1.726 . . . . 0.0 107.175 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -18.73 65.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -47.9 -40.01 20.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 112.432 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -31.53 63.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.759 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -62.42 -23.94 67.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.117 0.871 . . . . 0.0 111.729 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.3 t -91.1 -47.94 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.79 -58.75 3.49 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.137 1.351 . . . . 0.0 112.884 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -55.66 -41.94 74.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.774 0.787 . . . . 0.0 110.913 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.359 1.064 . . . . 0.0 112.205 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -86.13 -132.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -145.61 76.53 12.91 Favored Pre-proline 0 C--O 1.234 0.274 0 O-C-N 121.086 -1.009 . . . . 0.0 109.085 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 82.7 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.344 2.696 . . . . 0.0 108.761 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -83.03 148.21 27.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.299 1.84 . . . . 0.0 107.902 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m -140.58 122.31 15.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.183 -0.323 . . . . 0.0 110.282 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -77.77 127.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mt -124.29 117.76 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.29 129.6 49.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.79 96.94 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -78.18 69.82 4.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.37 -89.25 0.05 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.759 1.171 . . . . 0.0 111.531 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -24.67 16.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.52 . . . . 0.0 110.747 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.48 9.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.165 1.786 . . . . 0.0 106.866 -172.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.98 141.7 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.96 133.31 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.762 0.825 . . . . 0.0 108.899 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.9 tt -110.35 132.32 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.754 1.222 . . . . 0.0 107.713 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -133.95 95.96 3.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 107.328 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.71 138.48 31.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -132.77 116.38 16.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.841 1.656 . . . . 0.0 110.903 -162.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -161.56 151.27 16.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.784 2.034 . . . . 0.0 106.314 161.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -56.73 -49.38 75.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.416 0.687 . . . . 0.0 109.502 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -48.87 -38.16 21.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.704 1.201 . . . . 0.0 112.755 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.59 136.27 0.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.922 0.889 . . . . 0.0 109.848 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -141.87 151.07 42.35 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.654 1.582 . . . . 0.0 108.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p -156.34 148.18 22.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.46 0.704 . . . . 0.0 109.351 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -128.04 117.79 22.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.071 2.149 . . . . 0.0 108.284 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.96 143.3 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.692 0.797 . . . . 0.0 109.287 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 p -108.19 150.06 27.74 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.472 1.509 . . . . 0.0 110.814 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 84' ' ' VAL . 26.5 p90 -159.61 175.58 13.05 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.909 1.283 . . . . 0.0 108.91 -174.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -134.79 143.64 47.2 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.999 0.92 . . . . 0.0 108.943 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 53.05 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.302 1.041 . . . . 0.0 112.027 -175.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.12 40.13 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.24 151.18 12.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.1 138.88 35.57 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.926 1.291 . . . . 0.0 109.469 166.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -142.19 158.35 43.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.381 1.472 . . . . 0.0 108.177 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.27 134.55 36.64 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -134.37 151.67 51.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -139.82 166.87 23.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.955 -0.466 . . . . 0.0 109.833 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 t -136.85 -177.27 4.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.162 0.985 . . . . 0.0 109.371 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.78 -25.02 62.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -156.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -95.22 15.02 20.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.233 1.413 . . . . 0.0 111.633 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t0 49.76 41.02 21.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.359 2.264 . . . . 0.0 112.969 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -66.76 87.44 0.13 Allowed 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -77.87 92.86 4.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.607 1.563 . . . . 0.0 109.464 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 97' ' ' TRP . 6.1 m -104.41 171.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.778 1.231 . . . . 0.0 110.079 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.64 135.85 41.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 m -124.57 123.73 40.72 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 107.857 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -117.93 126.21 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.471 HG21 ' CD2' ' A' ' 64' ' ' PHE . 39.1 t -110.24 145.32 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.6 m -148.7 164.32 34.69 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -113.39 113.44 25.21 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.83 107.98 20.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.833 1.253 . . . . 0.0 108.012 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.35 -80.94 0.06 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.318 0.961 . . . . 0.0 112.106 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.67 4.18 3.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.495 1.521 . . . . 0.0 112.344 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -105.17 120.99 42.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 107.203 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.7 tt -78.87 106.17 10.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 169.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 m -95.32 111.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -99.4 106.76 18.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 83' ' ' ILE . 9.9 p -100.65 133.73 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.9 112.31 12.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -162.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -127.98 125.82 40.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.375 1.87 . . . . 0.0 108.688 -157.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.47 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.7 p90 -108.86 -81.55 0.57 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -162.19 150.76 15.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.96 -44.47 1.55 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.419 0.533 . . . . 0.0 112.044 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.58 -164.91 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.554 1.542 . . . . 0.0 109.196 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.77 -170.36 3.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.613 1.565 . . . . 0.0 109.334 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 t -136.14 150.72 49.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.623 1.569 . . . . 0.0 107.991 162.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.4 p -98.56 138.47 35.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 163.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.1 mt -131.64 96.83 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.401 1.88 . . . . 0.0 105.939 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.71 131.83 42.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.07 124.84 53.09 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.199 1.4 . . . . 0.0 108.27 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -141.91 122.42 14.13 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -106.74 115.89 30.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.09 -173.3 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 156.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 52.08 -108.91 0.42 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.48 28.76 2.05 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.859 1.695 . . . . 0.0 109.615 171.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -137.45 122.09 18.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.674 0.737 . . . . 0.0 110.128 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.24 92.73 5.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.8 mt -73.1 138.53 21.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.57 105.09 4.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.098 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.0 m -95.33 136.0 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.81 119.9 38.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -126.28 125.2 41.95 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.942 0.337 . . . . 0.0 110.309 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -129.5 165.01 22.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.54 1.536 . . . . 0.0 107.095 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.33 126.07 18.37 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 168.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.99 -58.84 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 112.146 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.78 133.15 34.34 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.694 -0.629 . . . . 0.0 111.862 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.21 130.3 69.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.773 1.629 . . . . 0.0 107.26 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' TYR . 4.4 m -146.99 158.76 44.02 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 121.379 -0.826 . . . . 0.0 109.174 -170.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.7 p -134.35 151.81 51.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.101 0.409 . . . . 0.0 110.738 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -145.2 167.26 23.21 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 156.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 p -136.47 146.43 46.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.22 129.68 52.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.551 1.54 . . . . 0.0 108.779 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -106.18 136.79 45.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.907 1.283 . . . . 0.0 108.422 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -65.25 139.0 58.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.358 0.263 . . . . 0.0 110.728 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -123.81 -6.0 7.99 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 111.722 159.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.144 0 C-N-CA 124.616 1.167 . . . . 0.0 110.922 172.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.236 0.378 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.41 67.9 0.02 OUTLIER 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.53 2.332 . . . . 0.0 111.091 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.37 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 107.09 -163.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -86.71 -45.67 10.75 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.914 1.286 . . . . 0.0 110.69 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -46.11 108.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.385 1.474 . . . . 0.0 111.645 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.83 -166.46 13.02 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.416 1.008 . . . . 0.0 112.37 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -84.2 138.84 32.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.131 0.973 . . . . 0.0 111.324 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.6 141.17 43.27 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.474 0.709 . . . . 0.0 110.314 167.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -107.87 153.84 22.43 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.463 1.105 . . . . 0.0 109.867 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.96 148.64 16.87 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 167.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.41 -54.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.867 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.49 147.24 39.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.631 1.105 . . . . 0.0 109.01 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -160.47 153.86 22.06 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.234 -0.916 . . . . 0.0 110.73 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -158.13 155.88 29.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.499 1.12 . . . . 0.0 108.541 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 m120 63.71 -10.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.36 -41.52 9.08 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.264 1.025 . . . . 0.0 110.869 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -71.76 -24.78 61.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.19 -46.44 56.26 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 165.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.88 -51.36 61.4 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.972 0.909 . . . . 0.0 112.327 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -57.68 -42.65 84.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.294 0.638 . . . . 0.0 109.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.94 57.71 1.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.448 1.499 . . . . 0.0 109.22 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t 179.63 -52.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.712 2.405 . . . . 0.0 107.028 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.27 -27.6 68.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.679 0.392 . . . . 0.0 111.575 172.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 -47.14 3.69 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 26' ' ' GLY . 8.6 p 0.28 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 130.324 3.45 . . . . 0.0 116.074 167.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' H ' HG13 ' A' ' 25' ' ' VAL . . . -156.05 58.24 0.38 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -31.56 -61.42 0.22 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 128.003 2.521 . . . . 0.0 111.484 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.21 57.94 1.29 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.318 1.047 . . . . 0.0 108.202 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -149.67 -52.54 0.15 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.859 -0.526 . . . . 0.0 109.802 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -59.23 -22.99 61.93 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.453 -1.261 . . . . 0.0 110.863 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -41.57 -35.52 0.75 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.218 1.007 . . . . 0.0 112.696 169.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.82 -67.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.05 45.21 2.23 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.443 1.02 . . . . 0.0 113.817 -173.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -154.03 -34.61 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.958 1.703 . . . . 0.0 110.886 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.2 ttm -92.22 -21.12 20.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.89 1.676 . . . . 0.0 110.307 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -65.71 -165.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.409 0.623 . . . . 0.0 109.995 159.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -107.37 78.97 0.7 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.597 1.159 . . . . 0.0 109.411 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.65 145.11 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.113 1.875 . . . . 0.0 110.344 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 m -104.26 126.18 51.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.505 1.122 . . . . 0.0 108.039 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -109.19 99.42 8.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.34 121.22 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.16 128.6 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -107.1 141.56 38.15 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.04 71.39 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.151 0.98 . . . . 0.0 108.695 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -55.05 139.69 40.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.882 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.46 -75.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.9 2.191 . . . . 0.0 116.457 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -111.18 18.45 19.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.519 1.928 . . . . 0.0 111.03 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.26 -162.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.954 1.301 . . . . 0.0 108.253 -155.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.89 142.74 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.8 tt -124.98 117.68 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.67 135.79 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -115.3 107.55 15.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.944 2.098 . . . . 0.0 105.746 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -88.25 102.64 15.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.59 138.48 43.74 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.034 0.834 . . . . 0.0 111.008 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -169.81 54.86 0.04 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.196 1.398 . . . . 0.0 108.748 -173.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 m 65.71 -75.13 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.653 1.581 . . . . 0.0 111.637 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.33 -51.79 4.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.062 0.945 . . . . 0.0 109.2 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -77.07 76.9 3.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.58 59.84 0.61 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.575 1.15 . . . . 0.0 110.537 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.14 163.62 18.64 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.936 1.294 . . . . 0.0 111.123 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -123.58 156.62 35.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.908 0.883 . . . . 0.0 110.067 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mp -133.53 101.16 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.6 122.6 36.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.811 2.044 . . . . 0.0 108.926 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.58 168.81 22.49 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.097 0.862 . . . . 0.0 112.61 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.58 108.79 13.53 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.539 1.535 . . . . 0.0 107.812 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 96.78 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 122.051 -0.406 . . . . 0.0 110.017 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.14 33.3 0.2 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.365 1.936 . . . . 0.0 111.832 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.72 149.39 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.835 1.317 . . . . 0.0 109.32 -171.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.85 121.95 44.74 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.268 1.427 . . . . 0.0 107.612 161.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.37 155.02 23.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.821 0.737 . . . . 0.0 111.366 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.88 120.11 13.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.203 0.601 . . . . 0.0 110.237 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.76 95.43 5.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 m -103.77 102.6 12.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 t -131.28 146.79 52.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.013 0.925 . . . . 0.0 109.405 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.2 43.92 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.588 1.155 . . . . 0.0 112.066 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -149.98 -68.39 0.2 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.771 1.628 . . . . 0.0 108.264 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.99 -12.79 61.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.242 0.928 . . . . 0.0 111.525 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.12 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.256 2.222 . . . . 0.0 108.566 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -80.91 112.37 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 166.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.52 138.21 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -80.41 109.54 15.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.9 p -74.57 149.64 40.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 tt -137.36 107.75 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 163.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.18 139.92 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.184 -170.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -156.99 176.96 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.731 2.013 . . . . 0.0 107.206 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -132.17 122.08 24.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 159.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 176.11 167.51 0.43 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.109 2.564 . . . . 0.0 105.32 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.44 -64.56 1.06 Allowed Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.49 104.93 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 91.83 162.3 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.706 2.402 . . . . 0.0 110.05 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 121.09 26.28 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.24 86.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.992 1.717 . . . . 0.0 108.484 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -81.57 81.13 7.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.5 149.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -153.34 106.17 2.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -158.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -116.13 100.98 8.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.062 2.145 . . . . 0.0 108.121 -160.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -90.61 -62.36 1.47 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.592 1.087 . . . . 0.0 110.48 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -170.13 -85.27 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.157 0.435 . . . . 0.0 111.465 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.82 -20.81 79.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.44 170.02 16.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -133.22 175.48 9.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.945 1.698 . . . . 0.0 107.429 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.3 t -143.02 160.88 39.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.174 0.99 . . . . 0.0 109.218 168.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -127.53 116.8 20.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 108.126 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.32 105.7 15.2 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.194 0.998 . . . . 0.0 108.536 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.46 114.82 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.268 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.56 ' CG ' HD23 ' A' ' 115' ' ' LEU . 67.9 mtt85 -109.75 139.62 44.58 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.97 0.908 . . . . 0.0 109.075 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -161.28 151.09 17.0 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.087 0.403 . . . . 0.0 110.907 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -113.57 107.59 16.0 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.008 0.923 . . . . 0.0 109.756 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.28 -176.97 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 159.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.0 t70 52.21 -113.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -148.29 34.41 1.19 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.559 1.076 . . . . 0.0 110.777 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -144.47 148.45 34.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.39 98.04 10.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.5 128.21 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.8 tm? -131.51 122.85 26.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -119.48 132.28 55.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.3 123.33 45.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.7 m -124.73 132.98 53.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.053 1.341 . . . . 0.0 109.411 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -144.31 170.02 16.79 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.451 0.569 . . . . 0.0 110.565 169.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -45.31 106.82 0.13 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 60.04 45.48 11.96 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.959 1.304 . . . . 0.0 112.556 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 119' ' ' HIS . . . -173.01 140.87 0.93 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 144.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.6 144.16 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.542 1.937 . . . . 0.0 106.67 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -149.85 126.44 10.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.186 0.448 . . . . 0.0 111.172 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -76.49 138.06 40.04 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.868 1.267 . . . . 0.0 108.311 163.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -150.75 100.84 2.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 161.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.3 m -97.0 138.44 34.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.889 0.852 . . . . 0.0 109.421 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -114.87 171.2 7.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.063 1.745 . . . . 0.0 108.976 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.02 142.07 47.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.109 1.763 . . . . 0.0 106.257 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -101.23 121.38 41.75 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.129 0.572 . . . . 0.0 110.577 -167.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -126.43 61.77 1.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.275 1.43 . . . . 0.0 109.366 -172.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 C-N-CA 123.696 0.799 . . . . 0.0 109.123 168.453 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.52 -37.6 50.08 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.571 1.948 . . . . 0.0 111.492 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.96 -16.5 63.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.392 1.877 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -119.04 -54.01 2.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.739 1.216 . . . . 0.0 110.426 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -52.56 109.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.6 1.16 . . . . 0.0 111.36 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.85 -177.21 31.46 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 123.849 0.737 . . . . 0.0 112.617 167.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -91.02 129.84 36.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.651 1.58 . . . . 0.0 108.991 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 36.6 m95 -126.59 142.18 51.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 109.536 -177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -110.23 140.77 44.02 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.215 1.006 . . . . 0.0 109.551 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.4 tt -70.78 117.74 12.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 p -141.73 53.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 122.245 1.021 . . . . 0.0 108.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t0 163.59 156.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 130.347 3.459 . . . . 0.0 106.039 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 t 164.46 135.71 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.541 2.736 . . . . 0.0 108.138 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -106.38 159.07 16.42 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.05 48.19 8.84 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.584 0.707 . . . . 0.0 111.949 161.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -56.53 18.34 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.787 0.803 . . . . 0.0 109.718 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.63 -23.38 31.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.847 -166.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -44.25 -60.64 1.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.854 0.835 . . . . 0.0 109.688 161.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.51 -50.68 67.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.663 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.2 ttp -49.38 -47.16 47.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.353 1.061 . . . . 0.0 111.04 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -73.74 56.0 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.467 1.107 . . . . 0.0 111.201 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 m 175.17 -54.71 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.296 2.238 . . . . 0.0 107.374 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -65.48 -38.92 91.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.621 178.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.18 86.96 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 23' ' ' LEU . 32.8 m -61.91 -34.35 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 117.163 0.481 . . . . 0.0 110.979 174.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.16 102.36 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -48.95 -59.45 3.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.306 1.042 . . . . 0.0 110.512 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -55.75 19.98 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.236 0.541 . . . . 0.0 109.834 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -47.67 14.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.16 1.784 . . . . 0.0 112.874 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -61.08 -32.08 71.74 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.046 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.18 -55.79 19.29 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.149 0.886 . . . . 0.0 109.204 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.07 -46.83 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.08 45.27 1.4 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.259 1.409 . . . . 0.0 113.557 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -158.07 -41.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.419 1.887 . . . . 0.0 108.838 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -34.96 75.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.642 167.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.6 t -69.88 22.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 35.13 64.66 1.88 Allowed Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.2 1.8 . . . . 0.0 112.692 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.84 156.97 50.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.082 2.522 . . . . 0.0 112.706 -166.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.1 p -119.33 161.27 20.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 109.42 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -149.35 155.45 40.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.8 147.47 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 160.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.59 121.25 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -137.05 110.85 8.14 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.593 0.633 . . . . 0.0 109.765 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 95.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.345 1.058 . . . . 0.0 108.353 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -77.35 61.09 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.649 1.179 . . . . 0.0 108.691 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.16 -86.0 0.1 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.742 -0.599 . . . . 0.0 111.766 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -83.31 -43.46 15.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.136 0.969 . . . . 0.0 109.239 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.93 162.07 17.1 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.955 1.702 . . . . 0.0 109.554 -172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.39 118.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 103.568 -2.752 . . . . 0.0 103.568 169.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.1 tt -93.42 136.46 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.18 149.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 141.02 38.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.076 0.853 . . . . 0.0 110.721 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -103.46 44.52 1.01 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.851 1.26 . . . . 0.0 110.82 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.13 116.97 3.09 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.529 1.131 . . . . 0.0 113.409 -157.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 t -102.89 -172.43 2.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.653 1.181 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -28.8 61.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.311 1.444 . . . . 0.0 112.322 -167.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.28 51.84 2.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 109.555 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.8 tttt 68.76 173.41 0.29 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.972 0.909 . . . . 0.0 109.087 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -152.41 -173.92 4.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 164.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.4 p -64.99 164.75 12.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.735 0.778 . . . . 0.0 111.536 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.69 136.15 54.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 165.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.3 mt -132.2 146.62 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.01 2.524 . . . . 0.0 106.232 -161.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -146.48 91.27 2.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.716 1.144 . . . . 0.0 111.617 -161.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 84' ' ' VAL . 9.4 p90 -118.12 161.89 19.11 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 110.149 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 130.18 52.32 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.51 60.49 3.9 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.743 0.817 . . . . 0.0 112.286 -162.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.07 49.28 0.05 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -171.68 160.9 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.974 . . . . 0.0 110.082 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.92 147.87 36.18 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.356 1.062 . . . . 0.0 109.798 162.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.74 161.36 15.51 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.93 133.31 44.3 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -124.32 128.97 49.91 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.1 m -124.74 108.17 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -132.5 137.44 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.413 1.085 . . . . 0.0 109.897 -172.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.78 39.96 0.23 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.275 -0.891 . . . . 0.0 113.043 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -145.88 -54.37 0.27 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.855 1.662 . . . . 0.0 108.191 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.87 1.99 44.6 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -150.08 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.556 1.542 . . . . 0.0 111.089 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -99.07 118.85 36.75 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.097 1.759 . . . . 0.0 108.156 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.98 144.98 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -173.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -70.79 127.7 33.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 153.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -108.28 99.81 9.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.244 1.418 . . . . 0.0 107.275 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.17 103.82 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.998 1.319 . . . . 0.0 107.93 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 64' ' ' PHE . 3.3 t -117.88 139.25 45.77 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 117.882 0.31 . . . . 0.0 110.461 -173.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 p -151.93 -168.43 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.32 2.248 . . . . 0.0 106.971 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.6 pp -140.82 156.33 46.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 163.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -123.41 134.98 53.9 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.043 1.337 . . . . 0.0 107.514 171.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.86 -82.96 0.02 OUTLIER Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.678 0.656 . . . . 0.0 112.289 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.66 33.76 0.63 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 110.059 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -126.98 123.28 36.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.771 2.028 . . . . 0.0 106.301 -171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.531 HD22 HH21 ' A' ' 106' ' ' ARG . 9.4 tt -82.99 123.5 29.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.06 134.15 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 125.416 1.487 . . . . 0.0 108.63 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -132.81 103.63 6.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.17 140.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 166.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -144.8 114.67 7.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.014 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -127.65 119.36 25.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.751 0.821 . . . . 0.0 110.228 -160.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -102.09 -62.64 1.24 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.801 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -163.44 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.56 0.618 . . . . 0.0 112.375 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.58 70.03 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 118.948 0.795 . . . . 0.0 111.713 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -179.75 7.49 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.705 1.202 . . . . 0.0 107.804 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -144.68 -178.82 6.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.76 2.024 . . . . 0.0 107.775 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 t -140.93 160.79 39.32 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.176 0.991 . . . . 0.0 108.351 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -137.13 137.54 39.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.58 154.59 47.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.11 141.92 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.531 HH21 HD22 ' A' ' 91' ' ' LEU . 61.4 mtm180 -126.64 133.33 51.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.838 1.255 . . . . 0.0 109.865 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -149.85 141.69 23.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -110.53 116.02 30.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 161.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.28 -176.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 161.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.3 t70 51.55 -109.11 0.42 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.27 30.99 1.85 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.322 1.439 . . . . 0.0 110.47 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -147.61 150.15 33.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.169 0.985 . . . . 0.0 110.404 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -89.67 97.93 11.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.35 112.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tp -121.84 109.73 15.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.412 1.085 . . . . 0.0 108.346 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.7 p -102.55 127.26 49.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.18 118.71 37.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.375 1.47 . . . . 0.0 107.762 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.6 p -121.15 125.64 47.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.528 1.131 . . . . 0.0 110.579 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -129.75 71.28 1.44 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.323 1.449 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 -90.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.085 1.326 . . . . 0.0 111.941 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 t -84.15 -38.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.07 0.948 . . . . 0.0 110.346 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.05 141.76 32.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.96 115.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 O-C-N 122.211 -0.306 . . . . 0.0 110.57 -162.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.4 t -131.78 105.06 7.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.099 0.96 . . . . 0.0 110.669 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.4 p -62.85 145.57 54.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 157.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -152.37 119.58 5.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.791 0.836 . . . . 0.0 110.149 161.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 81.8 p -92.89 97.32 10.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.764 -1.21 . . . . 0.0 109.382 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -67.65 164.41 19.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.863 . . . . 0.0 109.611 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.04 140.01 34.2 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.612 0.765 . . . . 0.0 109.598 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -73.17 109.0 6.37 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -90.39 -27.88 19.04 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.76 0.255 . . . . 0.0 110.778 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 123.231 0.613 . . . . 0.0 110.999 -175.682 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.73 60.84 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.64 1.976 . . . . 0.0 111.662 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.26 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.189 1.396 . . . . 0.0 107.494 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -59.04 -54.71 44.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 110.935 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -11.96 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 129.668 3.187 . . . . 0.0 113.613 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.19 -125.47 4.88 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 118.72 0.691 . . . . 0.0 112.172 168.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -129.88 121.49 26.78 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.7 0.8 . . . . 0.0 110.591 -159.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -106.17 132.07 52.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.496 1.118 . . . . 0.0 108.773 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -105.42 125.39 50.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.576 1.55 . . . . 0.0 108.371 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.77 144.91 45.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.542 0.61 . . . . 0.0 110.928 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.15 69.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 118.352 0.523 . . . . 0.0 111.92 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -164.38 178.75 7.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.212 1.405 . . . . 0.0 107.957 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -162.0 59.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.554 1.07 . . . . 0.0 112.453 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.64 114.62 21.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.229 0.612 . . . . 0.0 110.877 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 52.23 28.26 5.43 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.394 2.277 . . . . 0.0 113.065 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -81.52 -43.43 18.78 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.74 -1.225 . . . . 0.0 111.386 -167.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -71.32 -55.31 8.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -36.17 -63.17 0.4 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.086 1.354 . . . . 0.0 112.499 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -48.55 -49.93 34.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.372 1.069 . . . . 0.0 110.702 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.1 mtp -68.04 -35.57 78.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.91 0.484 . . . . 0.0 110.903 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -83.31 40.83 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.662 1.985 . . . . 0.0 109.98 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 p -169.66 -42.44 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.999 2.12 . . . . 0.0 107.146 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.24 -45.75 68.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.276 -0.265 . . . . 0.0 111.292 162.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.98 0.4 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.121 1.343 . . . . 0.0 111.354 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.71 -5.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.45 51.6 4.23 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 119.379 -2.076 . . . . 0.0 112.961 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -50.49 -60.43 3.02 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.192 1.397 . . . . 0.0 112.999 -159.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.83 -31.81 27.91 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.504 -170.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m 64.52 122.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.239 1.816 . . . . 0.0 112.513 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 52.86 35.99 20.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 112.243 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.06 -51.7 0.1 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.445 1.098 . . . . 0.0 108.482 170.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -35.25 -41.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 128.424 2.69 . . . . 0.0 114.576 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.85 46.34 1.04 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-O 119.194 -0.781 . . . . 0.0 111.268 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -164.11 -37.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.591 0.757 . . . . 0.0 112.139 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.22 -56.35 4.64 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -64.1 -29.18 70.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.198 0.999 . . . . 0.0 112.539 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 73.33 83.41 0.13 Allowed Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.663 1.585 . . . . 0.0 110.007 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.49 134.96 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.441 1.427 . . . . 0.0 109.244 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 m -118.27 144.48 45.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.1 m -126.44 107.21 10.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -83.34 117.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.98 111.08 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 148.45 42.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 123.701 0.626 . . . . 0.0 109.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.23 111.46 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.961 0.904 . . . . 0.0 109.52 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.82 56.77 3.54 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.07 -83.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.946 0.784 . . . . 0.0 112.231 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.38 -36.44 16.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.763 1.225 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 177.02 5.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.962 2.105 . . . . 0.0 107.913 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 p -152.45 138.45 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 tt -119.98 127.05 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.627 0.771 . . . . 0.0 109.573 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 138.81 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 125.007 1.323 . . . . 0.0 108.751 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -130.09 119.69 23.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.451 1.5 . . . . 0.0 109.085 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -80.96 96.95 7.24 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.374 1.469 . . . . 0.0 108.656 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -79.21 106.76 11.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.857 0.837 . . . . 0.0 109.301 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -131.76 -176.97 4.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.945 2.498 . . . . 0.0 107.812 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 m -145.18 64.26 1.27 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -169.86 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.493 1.517 . . . . 0.0 108.569 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -158.73 131.59 7.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -126.09 156.8 39.45 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -150.29 154.29 37.62 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -150.53 139.15 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.216 0.606 . . . . 0.0 110.113 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -150.78 145.37 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.343 1.057 . . . . 0.0 108.712 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -97.21 145.85 25.65 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 109.67 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 84' ' ' VAL . 48.3 p90 -151.04 179.45 8.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.15 0.98 . . . . 0.0 109.406 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.81 146.5 28.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.838 0.855 . . . . 0.0 109.264 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.41 69.17 0.38 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.066 1.346 . . . . 0.0 111.151 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 51.87 0.04 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -146.97 140.58 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.849 0.824 . . . . 0.0 109.152 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 129.55 53.38 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 166.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.43 168.42 20.31 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.53 136.14 36.81 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.291 0.636 . . . . 0.0 110.264 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.34 90.63 3.26 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.607 2.363 . . . . 0.0 106.132 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -86.46 110.69 19.92 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -143.58 160.93 39.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.408 0.683 . . . . 0.0 110.783 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.41 -10.68 53.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.695 0.798 . . . . 0.0 113.139 -168.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -92.64 -57.72 2.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.679 1.592 . . . . 0.0 108.652 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 78' ' ' ARG 0.416 0.7 OUTLIER -97.76 10.6 39.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.31 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 67.03 -154.24 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.836 1.255 . . . . 0.0 109.163 172.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.45 114.18 21.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.56 154.92 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -86.62 127.27 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.084 0.856 . . . . 0.0 110.262 167.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -83.83 114.57 21.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.29 1.836 . . . . 0.0 107.636 167.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.31 94.64 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 64' ' ' PHE . 4.0 t -116.94 138.85 46.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 O-C-N 122.124 -0.36 . . . . 0.0 111.177 -165.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -156.8 173.62 16.71 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.963 2.105 . . . . 0.0 106.55 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.55 135.23 48.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.594 1.088 . . . . 0.0 110.612 161.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -88.87 61.86 6.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -168.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.25 -35.32 0.66 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.485 -0.619 . . . . 0.0 113.827 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.24 59.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt 171.61 125.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.375 2.27 . . . . 0.0 107.91 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -83.95 127.01 33.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.842 0.746 . . . . 0.0 110.038 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.14 110.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.649 1.579 . . . . 0.0 106.961 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -98.82 89.27 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 170.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.0 t -74.5 139.56 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -130.96 94.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -159.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.31 114.86 24.2 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.489 0.715 . . . . 0.0 111.243 -167.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.64 -56.73 2.8 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.147 0.43 . . . . 0.0 110.153 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -167.9 -87.07 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.964 0.347 . . . . 0.0 111.425 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.83 -24.69 76.79 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -173.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 172.42 12.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.8 167.56 20.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.49 2.316 . . . . 0.0 107.14 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.0 p -133.82 157.54 45.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.448 0.699 . . . . 0.0 109.499 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 p -88.52 138.18 31.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.1 mt -125.09 84.32 2.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 159.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -106.23 144.59 15.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.437 0.695 . . . . 0.0 110.105 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 158.0 43.61 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.926 0.491 . . . . 0.0 111.56 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -165.09 153.84 12.23 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.738 1.215 . . . . 0.0 109.132 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.9 ttp -114.98 124.83 52.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.163 1.385 . . . . 0.0 109.902 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.88 179.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 157.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.01 -112.65 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -172.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.62 30.08 1.56 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.512 1.053 . . . . 0.0 110.988 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -141.61 156.71 45.66 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.2 108.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.477 1.111 . . . . 0.0 108.373 -170.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.11 141.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 0.0 109.548 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 128' ' ' TYR . 26.9 tp -128.0 85.85 2.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.464 1.106 . . . . 0.0 110.037 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -95.85 111.69 23.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt -113.17 120.35 40.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.8 m -119.24 125.44 49.16 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.776 0.716 . . . . 0.0 109.435 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -123.23 146.15 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 106.844 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -36.24 -52.55 1.29 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.191 0.901 . . . . 0.0 113.469 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -34.05 57.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.05 133.1 29.49 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.188 0.595 . . . . 0.0 110.362 -159.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.08 121.38 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.68 1.192 . . . . 0.0 108.336 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.86 109.4 14.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.673 1.189 . . . . 0.0 109.298 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.86 104.21 12.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.917 1.287 . . . . 0.0 108.217 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -122.43 -177.91 3.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.711 0.804 . . . . 0.0 109.985 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -145.6 155.33 42.97 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.151 0.58 . . . . 0.0 109.835 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.431 ' CE2' HD22 ' A' ' 115' ' ' LEU . 53.6 m-85 -115.87 164.95 13.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.588 1.955 . . . . 0.0 108.99 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.17 136.99 49.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -75.53 109.69 9.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.835 -0.541 . . . . 0.0 110.086 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.31 -23.65 23.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.544 0.338 . . . . 0.0 111.542 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 111.508 -178.44 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.48 63.22 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.75 2.82 . . . . 0.0 111.725 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.09 -48.14 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.802 2.041 . . . . 0.0 107.099 -171.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -54.82 -43.02 72.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.742 1.617 . . . . 0.0 111.566 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.4 t -41.4 109.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.754 1.622 . . . . 0.0 112.487 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.17 -168.45 23.73 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.436 1.017 . . . . 0.0 113.758 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -91.04 122.43 33.69 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.4 1.48 . . . . 0.0 110.451 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -108.32 156.52 19.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.673 1.589 . . . . 0.0 110.415 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 135.74 31.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.35 148.05 49.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.994 0.918 . . . . 0.0 111.873 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.65 -15.12 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.233 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HB3' HG22 ' A' ' 127' ' ' THR . 48.0 t0 -145.86 155.83 43.16 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.145 1.339 . . . . 0.0 110.52 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -173.98 134.52 0.46 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 127.678 2.391 . . . . 0.0 109.095 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.82 166.73 31.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 163.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 63.4 12.3 6.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.267 1.827 . . . . 0.0 112.394 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.02 -52.25 30.71 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.028 -1.045 . . . . 0.0 109.885 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.06 -50.7 63.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.051 2.14 . . . . 0.0 110.101 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -61.69 -39.58 91.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.834 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -47.35 -49.55 24.14 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.316 0.646 . . . . 0.0 110.864 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.67 -28.62 70.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.678 -0.677 . . . . 0.0 112.029 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -73.78 58.96 0.65 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.711 1.204 . . . . 0.0 110.511 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 p 168.24 -48.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.945 3.298 . . . . 0.0 106.691 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.04 -35.27 79.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 112.088 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.39 -15.46 63.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.297 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -76.21 42.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -161.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.42 96.7 0.05 OUTLIER Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.063 -1.023 . . . . 0.0 113.538 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -62.66 -17.97 61.45 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.851 -1.381 . . . . 0.0 112.786 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.63 -53.73 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.308 1.043 . . . . 0.0 111.679 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 m -66.2 -31.01 71.59 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.994 -0.441 . . . . 0.0 110.896 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -38.96 86.18 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -58.61 -58.12 9.96 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.101 0.864 . . . . 0.0 108.976 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -45.82 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.31 -14.07 71.22 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.453 -1.748 . . . . 0.0 114.937 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -103.12 -38.0 7.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.63 . . . . 0.0 110.744 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.54 -47.42 7.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.866 0.866 . . . . 0.0 111.875 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 m -99.15 90.9 4.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 118.861 -0.59 . . . . 0.0 109.722 -161.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 6.35 75.01 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 127.384 2.274 . . . . 0.0 113.415 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.17 93.64 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.363 2.042 . . . . 0.0 109.366 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.0 m -89.19 150.97 22.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.848 1.259 . . . . 0.0 107.889 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.2 m -140.91 140.89 34.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.73 -1.231 . . . . 0.0 108.674 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.0 132.75 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.0 mt -128.14 107.57 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.88 107.03 15.91 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.116 1.767 . . . . 0.0 109.274 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.97 109.31 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -93.79 65.49 3.6 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.17 -87.69 0.09 OUTLIER Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.299 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.15 -6.11 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.501 1.12 . . . . 0.0 112.302 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -102.2 169.43 8.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.26 117.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 mt -88.32 132.96 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tt -116.44 133.57 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -122.2 137.07 54.96 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.406 1.083 . . . . 0.0 109.043 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 p -105.73 16.83 24.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.04 1.336 . . . . 0.0 113.007 -166.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.13 109.05 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.259 1.423 . . . . 0.0 114.418 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -66.81 -41.47 87.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 171.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -149.62 -75.85 0.16 Allowed 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -71.68 -54.56 9.95 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.115 -0.366 . . . . 0.0 110.453 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -174.58 156.36 2.39 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.52 -79.02 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -142.52 157.94 44.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.297 1.039 . . . . 0.0 109.29 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.06 133.69 54.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 166.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.72 117.52 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 p -106.54 81.45 1.59 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.181 1.792 . . . . 0.0 110.537 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -72.23 143.18 48.9 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.396 -0.815 . . . . 0.0 111.637 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -121.54 112.56 18.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.65 102.98 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.785 0.834 . . . . 0.0 111.665 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.54 54.79 1.3 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.44 170.64 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.51 149.02 43.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.934 0.494 . . . . 0.0 110.387 163.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -141.83 153.44 44.5 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.366 1.066 . . . . 0.0 109.254 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.69 144.53 56.95 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.84 158.21 43.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.815 1.246 . . . . 0.0 108.672 -168.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 t -137.53 146.58 44.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.574 0.75 . . . . 0.0 109.639 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -128.19 170.36 13.09 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.42 -15.46 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -156.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -95.37 13.52 25.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.374 1.47 . . . . 0.0 111.551 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.25 38.2 t0 31.15 57.17 0.25 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.016 2.126 . . . . 0.0 113.658 -156.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -61.63 123.93 19.28 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 116.282 -2.167 . . . . 0.0 106.546 149.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -78.72 112.71 16.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 97' ' ' TRP . 2.0 m -126.27 172.47 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -174.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -108.99 130.38 55.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -88.89 102.17 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.929 1.291 . . . . 0.0 107.636 164.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.75 134.5 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 166.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.01 139.54 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.651 0.659 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -151.76 -172.15 4.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.101 1.361 . . . . 0.0 107.668 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 tt -137.51 113.21 9.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.806 1.642 . . . . 0.0 108.376 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -115.06 105.88 13.47 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.58 1.181 . . . . 0.0 110.843 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.87 -62.14 3.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.141 0.877 . . . . 0.0 111.774 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.04 69.88 0.08 OUTLIER Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 pttm 173.5 142.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 106.527 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 91' ' ' LEU 0.302 0.0 OUTLIER -88.81 136.81 32.81 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.121 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 105' ' ' VAL . 23.2 m -115.69 97.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.95 104.03 13.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.25 126.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -116.19 105.51 12.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.64 126.69 55.29 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.233 1.013 . . . . 0.0 110.417 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.499 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.2 p90 -99.62 -62.53 1.23 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.931 0.492 . . . . 0.0 109.732 172.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.92 -92.85 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.31 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.77 -12.61 83.74 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.938 0.79 . . . . 0.0 112.265 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -137.84 164.3 29.28 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -142.11 152.07 42.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 167.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -116.55 148.03 41.25 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -107.66 134.45 50.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.013 0.525 . . . . 0.0 109.931 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.08 90.05 3.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.346 1.859 . . . . 0.0 106.733 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 92' ' ' VAL . 17.5 m -90.15 139.41 17.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.472 HH11 HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -139.17 148.42 43.15 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.059 0.544 . . . . 0.0 111.324 174.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -164.09 155.0 15.59 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.656 1.582 . . . . 0.0 108.06 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.7 ttp -105.08 118.37 36.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.616 0.767 . . . . 0.0 109.086 161.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.24 170.41 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 154.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 52.05 -124.28 2.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -165.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.75 21.75 4.68 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.906 1.241 . . . . 0.0 111.58 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 65.2 mttm -137.28 140.77 41.79 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.117 0.958 . . . . 0.0 108.779 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.61 121.56 31.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.38 150.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 HH11 ' A' ' 106' ' ' ARG . 0.5 OUTLIER -137.7 118.0 13.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.8 m -111.89 100.03 8.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.8 115.84 18.75 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.2 m -118.38 114.2 22.55 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.002 0.921 . . . . 0.0 109.98 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 -27.84 14.42 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.471 1.508 . . . . 0.0 109.827 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.39 -92.87 0.2 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 t -58.72 -44.33 90.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.81 141.5 29.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.091 0.557 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.28 129.21 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 126.109 1.763 . . . . 0.0 107.086 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.9 t -116.52 104.74 11.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 108.973 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.4 p -70.37 143.84 51.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 163.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.88 153.9 28.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 12' ' ' ASP . 3.7 t -146.68 155.7 42.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.734 0.697 . . . . 0.0 110.984 -175.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.03 154.25 51.26 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.032 2.133 . . . . 0.0 109.395 -165.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 112' ' ' LYS . 42.5 tt0 -129.22 134.23 47.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.945 1.298 . . . . 0.0 107.843 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -78.22 119.52 21.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -104.11 -29.69 10.71 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.656 0.782 . . . . 0.0 110.978 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.379 0.672 . . . . 0.0 110.968 -178.374 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.237 0.418 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.41 55.87 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.979 2.512 . . . . 0.0 111.625 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.65 -38.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.766 1.626 . . . . 0.0 108.849 -161.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -96.55 -34.84 11.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.732 1.213 . . . . 0.0 110.758 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.43 105.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.88 176.93 27.67 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.912 0.778 . . . . 0.0 113.081 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 m -102.49 118.24 36.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -114.66 134.67 54.89 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.417 1.487 . . . . 0.0 107.659 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -112.09 121.12 44.08 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.99 131.89 52.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.266 0.939 . . . . 0.0 108.793 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.51 -64.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 125.068 1.48 . . . . 0.0 110.288 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.21 158.18 17.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.078 0.854 . . . . 0.0 110.171 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -175.08 165.02 3.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 107.709 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -149.31 153.94 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 166.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.39 42.49 32.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.217 1.007 . . . . 0.0 110.633 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.8 -55.48 26.04 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.179 -0.951 . . . . 0.0 109.278 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.522 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -25.93 -60.27 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.542 1.537 . . . . 0.0 112.822 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -51.08 -59.9 3.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.131 0.972 . . . . 0.0 112.695 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.2 ptp -63.43 -29.7 70.95 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.674 -0.641 . . . . 0.0 112.403 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp -78.73 45.74 0.62 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.764 2.026 . . . . 0.0 111.379 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m 177.29 -46.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 128.061 2.544 . . . . 0.0 107.396 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -54.34 -31.47 54.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.472 0.709 . . . . 0.0 110.39 173.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 45.6 0.59 Allowed Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 160.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -139.01 -36.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 109.179 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.66 68.46 2.17 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.279 -0.888 . . . . 0.0 112.28 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.73 70.7 0.72 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 109.92 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.8 -60.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.947 2.099 . . . . 0.0 112.55 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -33.08 -46.07 0.15 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.092 2.957 . . . . 0.0 112.801 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -112.47 23.71 13.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.798 . . . . 0.0 112.575 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.86 -23.33 15.4 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.962 1.705 . . . . 0.0 110.053 157.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.67 -46.05 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.32 61.02 2.32 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.296 0.951 . . . . 0.0 113.708 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -178.02 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.033 1.733 . . . . 0.0 108.922 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.1 ttm -54.36 -35.48 62.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.291 0.636 . . . . 0.0 109.946 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 m -65.19 76.54 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.274 0.63 . . . . 0.0 109.852 161.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -20.08 95.04 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.943 2.897 . . . . 0.0 112.562 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.64 165.18 26.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.998 -167.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.5 m -131.46 149.5 52.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.463 -0.79 . . . . 0.0 108.888 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -138.34 95.05 2.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.057 -161.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 41' ' ' ILE . 1.8 mp -79.46 127.91 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.9 mt -126.49 109.39 20.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.92 135.99 49.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.102 0.961 . . . . 0.0 109.743 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.08 84.84 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.732 0.813 . . . . 0.0 108.817 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.63 71.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.109 1.764 . . . . 0.0 111.177 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.78 -105.01 0.58 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -34.67 55.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.351 0.66 . . . . 0.0 110.414 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -179.01 4.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.755 2.022 . . . . 0.0 107.236 -167.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.68 146.55 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.98 132.73 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 133.29 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.391 1.076 . . . . 0.0 108.441 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -114.4 114.5 25.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.859 1.263 . . . . 0.0 108.579 170.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 p -82.21 120.84 25.87 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -117.3 139.49 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.591 1.156 . . . . 0.0 110.818 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 t -167.0 -165.88 0.76 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.829 1.652 . . . . 0.0 109.207 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -62.82 93.61 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.276 1.431 . . . . 0.0 111.837 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 58.49 18.0 5.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.515 1.526 . . . . 0.0 112.463 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -134.04 77.11 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -115.99 127.28 54.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -173.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.68 159.78 43.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -152.29 158.12 42.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -140.99 121.65 13.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -84.41 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 165.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -156.75 144.39 19.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.393 -0.817 . . . . 0.0 111.402 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.56 105.58 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -49.85 109.13 0.25 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.413 0.285 . . . . 0.0 111.051 174.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.65 39.9 1.68 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -154.8 157.26 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.79 145.1 37.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.692 0.797 . . . . 0.0 110.474 161.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.65 148.72 24.52 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.77 143.17 40.05 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.0 156.08 44.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.552 1.541 . . . . 0.0 107.845 -173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.1 m -141.12 82.23 1.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.232 1.013 . . . . 0.0 109.09 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -98.32 130.9 44.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.3 -35.49 27.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.962 0.905 . . . . 0.0 112.404 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -96.77 16.6 18.68 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.172 1.789 . . . . 0.0 112.766 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -150.15 2.25 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 163.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 79.76 -164.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.383 1.473 . . . . 0.0 109.003 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -73.81 126.48 30.47 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.12 143.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.679 1.592 . . . . 0.0 108.043 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -83.27 127.1 33.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 166.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.2 m -94.63 114.83 26.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.98 123.78 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 166.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 p -132.78 136.9 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -158.2 158.93 35.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 pp -105.98 137.82 43.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.337 0.972 . . . . 0.0 108.813 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -84.03 -11.51 56.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.282 0.633 . . . . 0.0 111.65 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.29 -32.92 5.67 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.22 -39.66 3.45 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.173 1.368 . . . . 0.0 110.905 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -142.05 167.62 21.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.65 1.18 . . . . 0.0 111.424 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.7 tt -96.94 114.99 26.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.198 0.999 . . . . 0.0 108.519 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.55 112.2 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.099 1.76 . . . . 0.0 108.76 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -103.99 108.94 20.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.56 126.07 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -110.63 117.22 32.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -131.71 120.38 22.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.79 1.236 . . . . 0.0 109.909 -164.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -56.75 2.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -161.8 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.07 -16.26 78.5 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 118.629 0.65 . . . . 0.0 112.592 -171.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.29 173.24 15.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.474 1.11 . . . . 0.0 108.403 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.49 154.83 33.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.962 1.705 . . . . 0.0 108.186 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.9 p -109.4 145.75 35.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 110.018 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.09 121.22 36.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.85 98.51 6.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.437 1.495 . . . . 0.0 107.554 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.94 118.74 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.05 145.91 38.86 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.963 0.905 . . . . 0.0 109.376 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -160.72 156.7 25.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 164.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -121.46 121.88 38.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.117 0.967 . . . . 0.0 109.29 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.39 -177.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 160.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t70 53.23 -108.53 0.42 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.97 29.65 1.38 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.678 1.132 . . . . 0.0 111.336 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -140.18 145.22 37.18 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.968 0.884 . . . . 0.0 109.158 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -90.48 110.82 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.07 139.86 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tp -142.44 106.1 4.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 m -98.43 121.59 40.55 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 133.5 45.15 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -155.12 156.22 35.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.809 0.731 . . . . 0.0 111.483 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -160.08 168.23 26.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 107.234 165.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.59 -35.39 7.35 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 118.847 0.749 . . . . 0.0 112.44 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 m -46.23 -49.73 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.577 1.551 . . . . 0.0 113.026 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 175.89 169.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.135 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.41 144.94 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 125.404 1.481 . . . . 0.0 108.533 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 16.7 t -158.5 116.32 2.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.581 0.628 . . . . 0.0 111.633 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -73.12 151.09 41.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.239 0.616 . . . . 0.0 109.551 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -140.5 154.46 46.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.597 1.959 . . . . 0.0 106.266 156.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 t -151.84 148.6 28.02 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.67 0.668 . . . . 0.0 110.697 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -129.77 139.04 51.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.606 1.562 . . . . 0.0 108.553 -167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -110.92 138.8 46.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.373 1.069 . . . . 0.0 108.899 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -73.02 84.04 1.27 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.607 0.363 . . . . 0.0 111.081 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -59.28 -35.95 74.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.749 0.309 . . . . 0.0 110.726 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 O-C-N 121.842 -0.536 . . . . 0.0 109.735 173.274 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.27 66.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 129.992 3.317 . . . . 0.0 111.311 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.19 -61.35 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.04 48.62 0.87 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.855 2.062 . . . . 0.0 111.282 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 44' ' ' VAL . 45.1 t -142.77 78.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.771 2.028 . . . . 0.0 106.558 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.8 -160.35 23.21 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.668 0.652 . . . . 0.0 113.108 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -87.73 138.65 31.28 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 111.752 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 56.3 m95 -118.9 158.38 25.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.166 1.386 . . . . 0.0 109.084 168.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 155.96 46.89 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.403 0.44 . . . . 0.0 110.668 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 11' ' ' VAL . 2.9 tt -66.95 145.26 55.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.588 1.555 . . . . 0.0 111.051 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 10' ' ' LEU . 6.6 p -127.83 -56.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 164.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.39 141.98 47.66 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -167.79 152.78 6.85 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -173.19 159.23 3.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.505 1.522 . . . . 0.0 107.497 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 72.02 -4.74 1.89 Allowed 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.148 1.779 . . . . 0.0 111.49 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -41.71 83.52 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -34.92 -69.01 0.1 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.696 1.998 . . . . 0.0 111.916 160.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.36 -47.89 80.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.536 1.062 . . . . 0.0 111.611 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.71 -52.5 10.83 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 111.235 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -31.42 72.48 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -64.46 -62.79 1.38 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -54.72 -46.64 74.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.079 1.351 . . . . 0.0 111.69 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.57 -9.6 57.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.702 1.201 . . . . 0.0 112.247 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.44 51.49 42.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.92 -40.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 109.797 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -45.18 -64.24 2.32 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 125.928 1.727 . . . . 0.0 113.562 -171.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 36.11 -122.7 0.15 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.374 1.87 . . . . 0.0 110.754 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.19 48.57 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 m -151.32 -73.32 0.15 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.692 -0.63 . . . . 0.0 110.84 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -70.45 -14.38 62.51 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -55.08 -39.55 69.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.426 0.557 . . . . 0.0 111.341 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.22 -56.18 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.2 -49.77 4.47 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.128 1.347 . . . . 0.0 113.826 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -80.53 -14.78 57.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.21 2.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 163.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.255 1.2 t -72.24 83.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.682 1.229 . . . . 0.0 111.261 -164.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 84.05 0.98 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 125.826 1.65 . . . . 0.0 107.749 159.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.95 -48.68 1.77 Allowed 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.629 1.553 . . . . 0.0 108.44 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -87.7 141.06 28.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.914 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -147.72 117.43 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.057 -1.027 . . . . 0.0 108.534 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.43 140.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.78 111.52 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -130.15 125.74 35.78 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.345 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -64.16 99.84 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 122.029 0.919 . . . . 0.0 110.686 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -74.52 65.15 1.24 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.63 -82.63 0.02 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.396 0.998 . . . . 0.0 112.973 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -99.78 -6.59 26.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 0.0 112.259 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.36 166.33 17.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.223 1.809 . . . . 0.0 107.217 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.98 109.24 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 tt -90.02 129.36 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.48 134.3 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -124.98 105.9 9.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 109.962 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 m -70.09 113.12 6.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.857 2.063 . . . . 0.0 108.083 170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -120.01 135.25 54.99 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.336 0.516 . . . . 0.0 111.243 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -139.69 17.92 2.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.068 0.947 . . . . 0.0 111.256 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t 39.97 38.06 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 111.426 -164.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -174.3 95.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -166.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? 54.85 54.95 8.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.709 0.804 . . . . 0.0 110.146 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -63.08 162.65 11.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.906 1.283 . . . . 0.0 109.893 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.88 164.12 31.11 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.998 0.919 . . . . 0.0 108.756 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -156.04 151.94 27.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.922 0.489 . . . . 0.0 109.994 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.4 144.57 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 p -106.86 88.17 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.908 0.883 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.87 148.37 47.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -132.26 117.41 18.16 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 166.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 96.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.612 1.165 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.34 51.9 1.19 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.35 0.976 . . . . 0.0 111.148 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.38 162.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.0 0.9 . . . . 0.0 110.939 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -101.97 136.48 41.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.436 1.894 . . . . 0.0 107.863 167.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.44 149.84 38.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.734 0.814 . . . . 0.0 109.191 170.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.32 136.83 37.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.29 153.6 47.8 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.82 1.248 . . . . 0.0 109.144 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -130.66 68.58 1.47 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.875 1.67 . . . . 0.0 110.016 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -83.76 143.73 29.79 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.09 40.23 0.33 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.618 1.167 . . . . 0.0 112.851 -167.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -161.02 -75.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.569 1.548 . . . . 0.0 107.859 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -27.64 65.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.69 0.796 . . . . 0.0 111.729 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 98.8 -155.63 0.0 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 128.628 2.771 . . . . 0.0 107.971 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -81.4 116.33 21.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.13 177.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.474 1.51 . . . . 0.0 107.709 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -107.42 128.25 54.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.768 0.713 . . . . 0.0 110.176 164.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.93 126.08 35.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.44 125.26 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.63 145.37 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 160.51 41.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.5 2.72 . . . . 0.0 105.811 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tt -140.93 73.62 1.43 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 p30 176.4 164.18 0.42 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -156.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 -69.17 0.9 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.21 56.91 0.65 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 56.94 -130.66 1.65 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.007 0.923 . . . . 0.0 109.208 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp -81.88 79.29 8.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 109.834 -170.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.39 111.5 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.846 0.858 . . . . 0.0 109.984 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -117.95 115.8 25.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.798 1.239 . . . . 0.0 109.639 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.19 150.74 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 170.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -131.81 95.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 106.354 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -112.64 117.14 31.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -89.56 -111.0 0.08 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -122.87 -74.01 0.63 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.761 1.224 . . . . 0.0 111.488 -173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.74 61.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.569 0.622 . . . . 0.0 111.722 -170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -179.91 6.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -149.29 156.85 42.74 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.371 1.869 . . . . 0.0 106.291 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.6 t -127.8 155.9 43.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.536 0.684 . . . . 0.0 109.254 160.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.1 p -96.17 150.7 20.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 164.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 pp -151.94 101.63 2.75 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 164.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.91 128.85 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.043 0.537 . . . . 0.0 109.601 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -94.26 99.23 11.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 108.318 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.94 143.67 28.29 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -137.11 120.01 16.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.09 -168.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 51.91 -116.93 1.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.35 23.58 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 126.137 1.827 . . . . 0.0 109.485 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -134.26 129.55 35.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.401 0.681 . . . . 0.0 109.461 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 6.8 tt -87.68 105.09 17.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.6 mt -82.05 103.22 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.88 101.23 13.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.4 t -99.27 130.92 45.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.65 126.36 43.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.296 1.439 . . . . 0.0 109.775 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.7 m -131.88 114.0 14.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -97.62 146.63 25.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.764 2.026 . . . . 0.0 107.456 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.01 92.06 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 167.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 m 135.2 -28.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 131.402 3.881 . . . . 0.0 111.851 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.27 153.62 37.82 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.28 1.4 . . . . 0.0 112.46 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.9 t -124.79 143.73 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.093 1.757 . . . . 0.0 107.964 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 t -158.6 158.54 34.08 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 t -126.24 158.06 36.67 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.672 -0.642 . . . . 0.0 109.942 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -119.59 130.89 55.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 150.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -108.79 124.94 51.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -112.89 154.54 26.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.005 1.722 . . . . 0.0 109.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -122.01 137.07 54.94 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.756 1.622 . . . . 0.0 107.395 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -75.37 125.38 28.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.23 -4.06 17.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.033 0.533 . . . . 0.0 111.336 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 C-N-CA 124.778 1.231 . . . . 0.0 110.864 174.111 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 58.38 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 129.345 3.058 . . . . 0.0 111.894 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.27 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.153 1.781 . . . . 0.0 107.516 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -59.27 -42.88 92.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.495 1.118 . . . . 0.0 111.221 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.1 t -40.62 101.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.197 1.799 . . . . 0.0 111.814 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.29 -154.69 25.92 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.188 0.899 . . . . 0.0 112.196 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -118.25 119.71 35.49 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.502 1.521 . . . . 0.0 109.656 -170.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 87.7 m95 -109.29 141.93 40.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.521 1.128 . . . . 0.0 110.177 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -115.11 137.71 51.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -77.75 128.34 33.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.94 -45.64 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -128.92 151.14 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 110.008 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -170.14 150.55 3.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.596 2.358 . . . . 0.0 108.719 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -138.87 148.74 44.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m120 62.68 43.86 7.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.222 1.409 . . . . 0.0 111.452 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -70.53 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.804 -0.56 . . . . 0.0 109.75 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.57 -49.66 72.13 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -30.03 -53.88 0.16 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.702 2.001 . . . . 0.0 112.547 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -51.93 -51.93 53.57 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.752 -0.593 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.0 ptp -74.23 -33.12 63.25 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.434 -0.791 . . . . 0.0 111.793 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -40.96 75.97 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.473 -0.767 . . . . 0.0 111.166 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -82.09 -41.18 20.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.494 1.117 . . . . 0.0 110.219 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.1 -39.13 74.44 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.199 0.454 . . . . 0.0 111.844 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 55.14 0.81 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.78 -9.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.64 1.176 . . . . 0.0 111.678 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.48 78.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.105 -0.997 . . . . 0.0 114.248 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -48.81 139.26 10.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.911 1.285 . . . . 0.0 109.039 156.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.95 62.76 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.22 1.008 . . . . 0.0 111.01 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 m -147.9 -37.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.814 -1.179 . . . . 0.0 111.272 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.8 tpt85 -56.69 -37.83 71.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.229 0.922 . . . . 0.0 109.678 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -43.01 -32.96 0.72 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.386 2.675 . . . . 0.0 115.074 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -110.29 -35.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.007 0.821 . . . . 0.0 111.347 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 26.85 0.65 Allowed Glycine 0 CA--C 1.539 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 113.973 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -122.96 -39.21 2.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.062 3.345 . . . . 0.0 109.54 -173.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -42.6 70.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.733 1.213 . . . . 0.0 108.731 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -60.12 116.26 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 156.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.66 114.44 14.53 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.983 -168.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.85 156.57 56.53 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 120.246 1.124 . . . . 0.0 109.667 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.6 m -130.99 153.98 48.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.298 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -147.51 117.42 7.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.82 144.13 11.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 166.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.53 111.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.39 143.75 51.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 0.701 . . . . 0.0 110.993 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 80.5 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 122.46 1.124 . . . . 0.0 110.133 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -65.42 78.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.008 0.923 . . . . 0.0 111.398 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.04 -114.0 6.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -86.6 -12.55 48.27 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.431 0.615 . . . . 0.0 111.296 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -102.05 179.32 4.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.449 1.1 . . . . 0.0 108.36 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.82 138.94 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 166.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.6 tt -112.55 134.25 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.59 143.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 O-C-N 123.98 0.8 . . . . 0.0 109.137 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -131.94 111.7 11.77 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 m -104.12 128.33 51.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.728 1.611 . . . . 0.0 110.104 -167.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -105.38 125.1 50.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.697 1.999 . . . . 0.0 109.121 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -148.92 68.61 1.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 p 48.3 96.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.157 2.183 . . . . 0.0 114.194 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.6 t80 71.02 -64.98 0.36 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.302 1.841 . . . . 0.0 109.615 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.31 134.76 45.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.05 156.34 39.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.14 158.18 43.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.82 132.23 13.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -147.52 127.68 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 p -88.94 133.68 34.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.859 1.264 . . . . 0.0 108.469 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.75 160.65 42.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 127.56 43.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 86.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 169.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.07 41.98 0.19 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.095 1.807 . . . . 0.0 111.474 168.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.5 t -147.71 153.05 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.368 1.084 . . . . 0.0 109.575 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -113.04 133.98 54.73 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 126.724 2.01 . . . . 0.0 107.463 167.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -163.21 -179.34 6.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.268 0.94 . . . . 0.0 111.136 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.5 121.53 29.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 109.225 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 107.52 15.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.453 1.901 . . . . 0.0 106.255 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.3 53.85 0.76 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.095 0.558 . . . . 0.0 111.233 -164.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 146.8 50.42 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.456 -0.777 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.02 63.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.009 0.923 . . . . 0.0 112.267 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -94.81 -50.41 5.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.836 1.654 . . . . 0.0 110.299 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -56.44 -25.62 51.17 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.182 0.446 . . . . 0.0 111.802 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 77.64 -166.05 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.889 2.075 . . . . 0.0 109.021 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.33 89.32 2.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.93 149.93 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.917 0.887 . . . . 0.0 109.747 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -85.08 116.9 23.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -80.63 146.87 30.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -139.57 125.74 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 157.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.93 143.92 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -166.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -155.57 -172.82 4.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.51 1.924 . . . . 0.0 108.232 -176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.63 113.02 10.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.12 125.97 43.36 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.84 -78.95 0.01 OUTLIER Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.342 0.973 . . . . 0.0 113.465 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.34 26.49 1.1 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.524 1.535 . . . . 0.0 111.742 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 130.53 48.9 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.084 1.354 . . . . 0.0 109.182 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.6 112.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.318 1.447 . . . . 0.0 107.36 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.01 126.62 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.376 1.07 . . . . 0.0 108.258 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -135.07 102.44 5.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.516 0.727 . . . . 0.0 109.891 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.87 147.2 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -141.8 99.39 3.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -119.74 108.81 14.87 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.441 1.897 . . . . 0.0 109.655 -160.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -60.2 1.68 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.322 0.51 . . . . 0.0 110.557 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -165.01 -81.51 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.235 0.47 . . . . 0.0 112.217 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.93 -26.16 74.46 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.786 0.721 . . . . 0.0 111.58 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 173.37 16.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.14 1.376 . . . . 0.0 107.725 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -131.21 140.29 49.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.968 2.107 . . . . 0.0 107.956 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 t -98.05 174.8 6.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.7 p -155.82 155.04 32.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 153.93 39.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.739 172.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.65 139.56 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -128.18 140.37 51.95 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.381 1.072 . . . . 0.0 109.51 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.08 133.74 16.7 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.416 0.686 . . . . 0.0 109.228 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -103.98 119.49 39.04 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.2 176.51 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 153.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.31 -118.1 1.26 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -170.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.92 21.22 3.75 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.188 1.375 . . . . 0.0 110.873 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -124.6 127.42 47.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.794 0.838 . . . . 0.0 108.764 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 2.4 tt -91.75 91.1 7.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.06 143.28 13.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.72 141.51 22.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.701 0.763 . . . . 0.0 112.712 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.9 m -106.81 124.73 50.04 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 125.109 1.364 . . . . 0.0 107.992 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.47 75.7 1.04 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.087 1.755 . . . . 0.0 107.192 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -128.13 138.81 52.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.281 0.562 . . . . 0.0 110.365 -165.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -160.18 155.64 25.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.62 -34.55 6.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.026 0.822 . . . . 0.0 113.121 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 t -51.75 -41.83 61.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.377 1.071 . . . . 0.0 111.852 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.87 127.15 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.678 1.591 . . . . 0.0 110.063 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.04 136.81 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -150.66 156.0 40.47 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.349 -1.469 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -143.5 163.37 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.648 0.779 . . . . 0.0 109.321 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -167.27 168.74 13.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.302 1.041 . . . . 0.0 111.069 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -136.8 136.49 38.89 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.957 0.884 . . . . 0.0 109.591 163.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -89.02 155.81 19.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.736 164.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.6 146.58 44.16 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.771 1.228 . . . . 0.0 107.867 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -81.79 114.53 20.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -90.82 -26.64 19.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.031 0.378 . . . . 0.0 111.697 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.161 0 CA-C-N 118.39 0.541 . . . . 0.0 110.781 174.471 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.238 0.47 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.6 61.42 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.932 2.093 . . . . 0.0 110.576 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.08 -40.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.028 1.731 . . . . 0.0 108.298 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -95.11 -47.73 6.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.859 1.264 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.5 t -45.37 117.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.435 1.094 . . . . 0.0 112.81 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.65 -120.77 3.42 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.851 0.739 . . . . 0.0 111.277 158.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -152.05 140.57 20.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.869 -0.783 . . . . 0.0 109.176 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -138.41 162.85 33.39 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.699 1.6 . . . . 0.0 107.166 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -135.69 142.37 45.08 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.792 1.237 . . . . 0.0 108.953 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 141.57 55.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.774 0.715 . . . . 0.0 110.974 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.76 -35.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 118.451 -0.785 . . . . 0.0 112.338 169.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.08 151.24 51.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.554 1.07 . . . . 0.0 110.749 169.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -168.24 165.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.065 2.546 . . . . 0.0 106.532 167.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -146.58 178.13 8.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.586 1.554 . . . . 0.0 107.138 169.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 m120 58.55 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.36 1.064 . . . . 0.0 110.834 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -57.11 14.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.58 0.752 . . . . 0.0 110.286 -172.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.56 -52.87 18.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.141 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -35.06 -57.96 0.55 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.0 112.222 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 117' ' ' LEU . 4.7 t80 -57.79 -45.97 85.26 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.61 -0.681 . . . . 0.0 112.141 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -68.83 -30.17 68.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.838 . . . . 0.0 111.994 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -72.83 58.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.873 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m 175.59 -55.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.764 2.426 . . . . 0.0 107.143 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.15 -37.76 75.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.781 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.41 32.91 68.02 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.28 -31.35 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.694 0.747 . . . . 0.0 110.442 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.4 71.15 0.03 OUTLIER Glycine 0 C--N 1.336 0.572 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -54.33 146.59 15.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.33 -12.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.627 1.571 . . . . 0.0 114.636 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.1 m -102.16 -61.86 1.34 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 108.586 -168.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -70.71 7.33 1.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.104 -0.998 . . . . 0.0 113.382 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.59 -46.48 85.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.206 -0.934 . . . . 0.0 108.993 159.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -44.7 96.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.66 43.15 1.84 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.327 0.965 . . . . 0.0 112.98 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -163.72 -32.52 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.222 1.809 . . . . 0.0 109.588 167.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 90.2 mmm -53.26 -45.0 68.64 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 159.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -64.05 108.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -35.15 104.97 0.27 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.463 1.905 . . . . 0.0 112.302 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.77 123.93 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.734 1.622 . . . . 0.0 109.42 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.8 m -79.96 179.94 7.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -152.09 88.71 1.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -79.03 128.36 38.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mt -127.98 101.73 7.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -109.24 115.59 30.29 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.825 1.25 . . . . 0.0 108.653 -171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.1 t -78.74 103.58 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -77.81 65.08 3.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.867 1.267 . . . . 0.0 108.764 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.53 -88.14 0.05 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.665 0.65 . . . . 0.0 111.752 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.38 17.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.132 0.973 . . . . 0.0 110.081 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.42 173.12 7.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.77 2.028 . . . . 0.0 108.093 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.41 130.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.81 131.52 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 62' ' ' ILE . 13.9 tt -114.37 128.15 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -135.04 131.38 36.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.805 0.442 . . . . 0.0 111.002 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -29.52 39.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.609 1.563 . . . . 0.0 112.951 -159.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 33.72 56.96 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.215 1.806 . . . . 0.0 113.691 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -66.07 -60.5 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -114.23 62.03 0.66 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 69.22 -21.16 0.16 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.92 88.4 1.67 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 0.0 108.078 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.49 55.88 1.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.58 0.752 . . . . 0.0 109.776 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 58.59 175.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.892 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -151.11 155.63 39.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.834 0.454 . . . . 0.0 110.811 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 51' ' ' ILE . 47.0 mt -128.87 143.0 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.2 p -149.46 97.78 2.69 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -149.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.26 176.93 8.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.939 0.496 . . . . 0.0 110.905 -160.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -151.88 122.43 7.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -175.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -61.93 103.76 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 109.871 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.5 40.48 1.35 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.556 2.027 . . . . 0.0 111.802 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -148.02 149.86 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.024 1.33 . . . . 0.0 107.641 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 146.89 40.78 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.614 1.166 . . . . 0.0 109.194 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.27 161.98 12.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.474 0.309 . . . . 0.0 110.666 -168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -76.37 112.79 13.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -100.8 110.22 22.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -113.71 121.83 45.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 t -145.45 145.62 31.18 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.79 44.07 0.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.204 1.001 . . . . 0.0 111.942 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -152.93 -63.91 0.16 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.43 1.892 . . . . 0.0 106.963 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -79.64 1.37 26.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.331 0.652 . . . . 0.0 111.599 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 78.28 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.059 1.344 . . . . 0.0 108.671 169.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -92.25 124.42 36.31 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.81 139.09 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -78.99 131.38 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 162.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 p -130.42 161.92 30.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.0 0.364 . . . . 0.0 110.673 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.6 tt -129.53 142.42 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.327 1.851 . . . . 0.0 106.485 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.7 144.93 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -150.89 -170.62 3.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 164.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tt -135.4 124.85 24.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 107.355 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.22 145.13 51.4 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.811 0.844 . . . . 0.0 109.461 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.85 -78.93 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.632 1.11 . . . . 0.0 111.548 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.82 26.97 0.26 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.037 1.303 . . . . 0.0 110.932 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.69 136.32 52.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.377 1.471 . . . . 0.0 107.341 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 91' ' ' LEU . 8.1 tt -92.21 118.61 31.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.84 121.36 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.705 0.802 . . . . 0.0 109.377 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -105.53 123.11 47.36 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.92 1.688 . . . . 0.0 106.453 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.33 129.7 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -148.08 112.65 5.34 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.629 -151.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -130.61 163.84 26.26 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.749 1.22 . . . . 0.0 112.245 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -136.83 -65.85 0.54 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.33 143.71 10.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.19 -7.5 5.91 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.128 -0.818 . . . . 0.0 114.206 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 165.08 14.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.935 1.367 . . . . 0.0 110.423 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -142.07 125.56 16.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.33 1.852 . . . . 0.0 106.948 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.33 153.54 24.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 110.482 164.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -123.12 136.9 54.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.913 1.285 . . . . 0.0 107.581 172.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 110.12 7.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.19 129.8 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -122.21 124.71 44.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 127.063 2.145 . . . . 0.0 107.801 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -143.6 144.21 31.82 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -115.57 123.46 48.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 161.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.03 -179.73 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 159.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 52.16 -113.83 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.1 28.39 2.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.897 1.237 . . . . 0.0 110.075 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -127.59 127.31 43.64 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 tt -83.8 93.99 8.09 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.9 mt -73.44 111.96 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.8 135.5 44.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 163.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.6 m -128.36 124.19 35.79 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' CE2' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -117.77 125.82 51.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.599 0.76 . . . . 0.0 109.235 -178.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.8 m -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.195 1.798 . . . . 0.0 108.994 -172.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -97.34 161.88 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.01 63.84 1.61 Allowed Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.646 -0.659 . . . . 0.0 111.802 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.8 t 161.13 -60.44 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.544 3.138 . . . . 0.0 108.265 172.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.71 137.74 33.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.429 0.692 . . . . 0.0 110.391 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.84 123.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.496 1.118 . . . . 0.0 108.712 -173.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.1 t -133.37 111.67 10.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.416 0.687 . . . . 0.0 109.903 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -63.82 153.53 36.37 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 160.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -159.54 83.57 0.76 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.344 0.657 . . . . 0.0 109.3 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -88.46 126.88 35.45 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.459 -0.776 . . . . 0.0 109.973 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -102.61 144.37 31.1 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.695 1.198 . . . . 0.0 109.169 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.86 133.72 55.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.209 2.204 . . . . 0.0 106.864 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -58.8 141.27 53.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.058 0.845 . . . . 0.0 110.839 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -31.25 67.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.953 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.657 1.183 . . . . 0.0 108.488 179.461 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.572 0.225 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.54 54.36 0.45 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.695 2.798 . . . . 0.0 111.578 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.71 -51.44 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.573 1.149 . . . . 0.0 108.279 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -57.64 -46.83 83.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.436 1.095 . . . . 0.0 110.96 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 p -38.23 110.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.412 1.885 . . . . 0.0 111.908 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.83 -146.48 18.42 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -130.78 134.74 47.12 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.639 0.775 . . . . 0.0 110.708 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -118.58 162.28 18.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.799 1.64 . . . . 0.0 109.744 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -136.8 132.96 35.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.604 1.162 . . . . 0.0 108.643 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.14 147.86 42.59 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.1 p -130.98 -70.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 122.856 0.463 . . . . 0.0 111.284 164.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 127' ' ' THR . 26.7 m-20 -93.47 144.14 25.64 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -171.93 43.34 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.66 155.36 33.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.053 0.842 . . . . 0.0 112.381 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.99 25.52 13.92 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.519 1.528 . . . . 0.0 111.991 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -75.18 -49.82 18.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.124 -0.985 . . . . 0.0 109.898 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.91 -61.38 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.466 0.65 . . . . 0.0 110.093 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 17.9 t70 -45.56 -48.56 14.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.559 1.944 . . . . 0.0 112.065 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -55.24 -44.62 75.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.262 1.025 . . . . 0.0 111.257 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.25 -33.2 59.17 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.679 -0.638 . . . . 0.0 111.088 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.7 ttpm? -73.41 51.89 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.473 1.509 . . . . 0.0 109.358 170.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 m -178.59 -60.17 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 128.372 2.669 . . . . 0.0 107.058 -173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.55 -20.26 62.05 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.91 -22.16 32.85 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.78 -1.011 . . . . 0.0 112.62 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -66.15 66.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.664 1.986 . . . . 0.0 114.776 -162.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.87 44.23 3.15 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.92 2.2 . . . . 0.0 110.438 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -36.17 -43.77 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.183 2.193 . . . . 0.0 114.027 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.29 44.48 2.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.489 1.116 . . . . 0.0 110.799 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.9 t -152.04 -44.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.65 . . . . 0.0 111.177 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -27.48 45.0 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.928 -1.107 . . . . 0.0 110.022 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.24 -20.14 64.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.361 1.464 . . . . 0.0 112.522 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.35 -30.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.15 0.58 . . . . 0.0 110.293 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.22 63.61 0.77 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.155 0.883 . . . . 0.0 111.925 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -162.3 -51.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.721 1.608 . . . . 0.0 110.455 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.4 mtt -57.21 -47.54 81.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.035 1.334 . . . . 0.0 109.983 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -68.16 66.85 0.11 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.148 2.179 . . . . 0.0 110.412 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -18.66 91.73 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 128.032 2.533 . . . . 0.0 113.549 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.27 136.89 67.16 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.125 1.216 . . . . 0.0 110.806 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.71 141.74 28.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 m -130.91 102.28 5.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.22 131.2 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.1 mt -126.2 103.41 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.12 134.57 40.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.77 119.34 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -95.13 168.78 10.55 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.253 1.021 . . . . 0.0 108.585 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -29.54 -60.38 0.18 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.886 1.707 . . . . 0.0 114.645 -170.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -126.47 22.19 7.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.867 1.667 . . . . 0.0 109.919 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.96 -178.67 6.61 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.834 0.854 . . . . 0.0 109.455 -153.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.45 150.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 121.122 -0.986 . . . . 0.0 108.96 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.4 tt -133.65 126.66 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -93.19 127.06 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -133.51 91.55 2.87 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -80.79 131.5 35.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.024 1.33 . . . . 0.0 109.17 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 114.13 23.51 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.559 0.744 . . . . 0.0 109.479 169.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.8 t -140.97 54.1 1.57 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t 39.67 -118.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.735 1.214 . . . . 0.0 110.045 -168.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -57.59 -9.37 1.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.889 1.676 . . . . 0.0 115.125 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -118.03 32.24 6.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.608 1.095 . . . . 0.0 111.129 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -63.21 159.76 17.02 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.65 -0.656 . . . . 0.0 110.653 162.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 160.16 23.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.807 1.243 . . . . 0.0 108.203 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.54 120.08 6.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.286 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mt -143.65 124.26 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.001 0.92 . . . . 0.0 109.928 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 p -91.2 142.19 27.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.955 2.102 . . . . 0.0 110.071 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -156.68 -175.68 5.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.436 1.094 . . . . 0.0 109.213 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -124.7 145.51 49.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 54.55 0.59 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.881 1.273 . . . . 0.0 110.154 174.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.42 58.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 p -164.99 162.33 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.49 148.16 23.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.778 0.674 . . . . 0.0 109.751 165.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.88 145.84 22.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.742 0.817 . . . . 0.0 110.263 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.68 133.59 48.65 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.697 1.599 . . . . 0.0 108.347 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -143.51 131.25 21.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 t -103.07 121.66 43.05 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.74 0.816 . . . . 0.0 108.857 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 171.72 8.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.43 -7.96 11.74 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -155.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -105.41 11.03 33.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.275 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t0 43.84 46.98 6.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.202 2.201 . . . . 0.0 113.222 -162.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 117.219 -1.792 . . . . 0.0 106.359 148.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.25 84.07 7.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -82.67 178.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.839 1.256 . . . . 0.0 109.536 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -124.44 119.36 28.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -100.74 157.68 16.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.852 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 120.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.6 t -107.57 131.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p -126.06 119.96 29.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.348 1.059 . . . . 0.0 108.352 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.87 103.99 15.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -86.25 -167.53 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.941 0.401 . . . . 0.0 110.16 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.2 55.02 2.75 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.585 -0.697 . . . . 0.0 111.798 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 -57.49 0.27 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.93 152.28 47.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.334 0.654 . . . . 0.0 111.116 -162.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.66 102.71 15.13 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -80.32 96.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.05 99.95 12.83 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.96 142.09 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 167.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -131.43 100.19 5.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.242 1.417 . . . . 0.0 107.76 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -114.55 157.01 23.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.609 1.164 . . . . 0.0 108.567 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.423 ' HE1' ' CD ' ' A' ' 100' ' ' GLN . 12.9 p90 -140.71 -62.5 0.49 Allowed 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.714 -0.617 . . . . 0.0 110.916 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -166.75 -82.58 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.075 0.398 . . . . 0.0 110.9 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.45 -17.02 80.28 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.84 -0.538 . . . . 0.0 112.099 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' CD ' ' HE1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -135.79 163.49 30.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.318 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.88 151.45 50.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.646 1.978 . . . . 0.0 106.213 173.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.8 p -137.06 166.9 22.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.011 0.924 . . . . 0.0 109.206 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 p -133.59 154.73 50.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.2 68.97 1.1 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.01 132.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.937 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.507 HH11 HD13 ' A' ' 115' ' ' LEU . 14.5 mtt-85 -123.08 153.32 40.06 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.483 0.583 . . . . 0.0 110.756 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 90' ' ' LYS . 45.4 tt0 -157.54 159.6 37.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.75 120.9 35.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 160.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.72 172.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 155.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.23 -120.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -165.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.63 21.71 3.56 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.828 1.204 . . . . 0.0 111.357 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -122.26 134.55 54.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.81 0.805 . . . . 0.0 109.454 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.94 79.82 1.66 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mt -64.27 132.55 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.187 0.995 . . . . 0.0 108.347 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.507 HD13 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -143.69 158.25 43.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 165.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 t -126.18 127.07 45.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 166.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tt -109.34 106.75 16.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.691 1.996 . . . . 0.0 105.782 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 p -124.76 138.53 54.28 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.695 1.198 . . . . 0.0 110.941 -162.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -134.19 141.28 47.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 107.859 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.4 91.22 0.02 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 165.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m 136.19 -27.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 131.28 3.832 . . . . 0.0 111.337 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.83 152.23 36.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.007 1.276 . . . . 0.0 111.206 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.16 135.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.727 0.811 . . . . 0.0 109.35 -170.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.0 t -141.32 106.85 5.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.442 0.697 . . . . 0.0 110.887 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.1 p -58.28 143.81 43.36 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 159.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -156.01 154.84 31.7 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.322 0.964 . . . . 0.0 108.978 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 12' ' ' ASP . 1.6 t -157.57 156.59 32.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.26 150.6 52.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.832 1.653 . . . . 0.0 107.956 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.61 136.22 52.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.053 1.341 . . . . 0.0 108.151 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -67.01 121.9 16.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -86.86 -38.43 16.78 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.133 0 C-N-CA 122.985 0.514 . . . . 0.0 109.879 -178.112 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.48 50.76 0.43 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.11 2.564 . . . . 0.0 111.84 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.01 -55.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.57 -46.71 66.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 111.421 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.01 104.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.416 1.487 . . . . 0.0 112.066 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.62 -169.68 29.15 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -109.93 132.74 53.89 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.73 0.812 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 53.0 m95 -115.71 140.88 48.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.384 1.074 . . . . 0.0 109.568 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -95.93 132.35 41.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 13' ' ' SER . 7.7 tt -61.72 141.48 57.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.51 -52.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.719 -0.657 . . . . 0.0 110.584 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.58 137.69 49.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.941 0.791 . . . . 0.0 108.995 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' HD21 ' A' ' 10' ' ' LEU . 35.6 t -155.36 144.57 20.94 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.931 1.692 . . . . 0.0 108.074 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -170.62 159.46 6.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.786 0.835 . . . . 0.0 111.787 163.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 t30 62.16 34.42 16.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.361 1.864 . . . . 0.0 112.756 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -74.78 -43.66 53.63 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.78 -48.22 75.7 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 117.493 0.133 . . . . 0.0 111.01 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -50.36 -46.87 56.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.942 0.897 . . . . 0.0 111.568 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 1.8 t80 -57.15 -55.52 33.6 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -36.64 31.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.757 1.223 . . . . 0.0 112.333 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -74.72 55.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.484 1.914 . . . . 0.0 109.611 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.4 p -178.88 -48.59 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.859 2.464 . . . . 0.0 107.065 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.15 -28.07 59.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.373 0.669 . . . . 0.0 112.322 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.78 29.35 72.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.688 0.661 . . . . 0.0 113.259 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.14 -51.62 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.588 1.155 . . . . 0.0 110.986 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.39 -65.52 2.31 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -155.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 25.5 -96.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.564 1.946 . . . . 0.0 114.788 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.78 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.488 0.715 . . . . 0.0 110.954 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 m -57.87 -36.97 73.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.753 1.621 . . . . 0.0 110.456 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -51.22 63.42 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.414 0.686 . . . . 0.0 111.003 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' NE2' HG23 ' A' ' 32' ' ' VAL 0.275 4.9 pp0? -63.78 -46.33 85.69 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.717 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.579 HG23 ' NE2' ' A' ' 31' ' ' GLN . 2.6 t -47.02 -49.38 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.216 0.462 . . . . 0.0 109.837 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.06 -23.68 1.2 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 128.239 2.828 . . . . 0.0 115.087 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -137.96 39.38 2.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.422 0.689 . . . . 0.0 110.34 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.0 ttt -156.86 -56.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.622 0.369 . . . . 0.0 111.684 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -115.13 56.93 0.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.084 0.553 . . . . 0.0 111.446 -157.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 33.38 61.61 1.66 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.989 1.716 . . . . 0.0 113.823 172.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.13 116.31 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.241 2.628 . . . . 0.0 109.187 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.33 157.75 19.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.371 1.068 . . . . 0.0 108.273 -170.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 m -148.09 101.55 3.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.508 -0.745 . . . . 0.0 110.865 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.79 126.47 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 107.995 161.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.3 mm -123.85 110.07 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.418 1.487 . . . . 0.0 107.558 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -112.02 115.94 29.73 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.203 1.001 . . . . 0.0 109.128 -168.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.09 123.3 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.05 164.9 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.855 1.262 . . . . 0.0 108.288 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -36.41 -53.7 1.33 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.028 1.299 . . . . 0.0 113.381 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -106.79 -42.19 5.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.651 1.581 . . . . 0.0 111.292 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -101.36 -170.65 1.86 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.754 2.021 . . . . 0.0 110.645 -162.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.76 133.55 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 162.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 133.11 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -101.32 124.91 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.63 103.23 10.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.493 1.917 . . . . 0.0 106.804 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -80.58 124.42 28.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.147 0.579 . . . . 0.0 109.895 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -93.78 119.69 33.08 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -136.65 36.99 2.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.898 0.479 . . . . 0.0 110.212 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.7 m 61.22 101.26 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.318 1.447 . . . . 0.0 112.129 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 t80 72.4 -62.13 0.47 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.611 1.164 . . . . 0.0 109.359 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 145.97 46.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.156 0.979 . . . . 0.0 109.081 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.93 178.26 7.09 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 163.6 38.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 161.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.66 149.71 40.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -140.37 133.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.4 p -96.74 124.71 40.8 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.825 1.65 . . . . 0.0 108.425 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.62 159.5 41.95 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 119.704 1.138 . . . . 0.0 111.056 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.14 135.58 50.04 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 66.74 0.37 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.299 0.5 . . . . 0.0 110.545 169.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.35 63.4 0.03 OUTLIER Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.181 0.896 . . . . 0.0 111.127 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -170.77 169.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.227 1.011 . . . . 0.0 108.347 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.99 157.35 40.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.292 0.637 . . . . 0.0 109.948 165.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -167.57 152.3 6.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.178 0.591 . . . . 0.0 111.205 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -72.34 133.06 44.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.755 1.622 . . . . 0.0 107.075 170.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -140.63 155.82 46.43 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.402 1.081 . . . . 0.0 108.729 -165.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -154.22 145.22 22.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.705 -0.622 . . . . 0.0 110.509 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.3 t -157.97 151.6 23.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.348 0.594 . . . . 0.0 111.865 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.75 65.56 3.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.822 1.649 . . . . 0.0 110.515 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 p30 171.49 -64.76 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 129.132 2.973 . . . . 0.0 108.015 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.274 9.3 t70 -78.1 -1.65 33.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 73.73 -156.74 0.07 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.964 1.306 . . . . 0.0 109.191 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -79.98 140.24 36.7 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 164.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.69 166.84 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.01 126.13 55.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 167.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -90.21 135.06 33.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.466 HG23 ' HB ' ' A' ' 94' ' ' VAL . 10.6 tt -129.2 115.77 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.08 134.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.92 0.888 . . . . 0.0 108.952 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -160.12 150.88 18.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.71 151.9 21.61 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.654 0.661 . . . . 0.0 111.2 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.21 178.97 4.74 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 161.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -19.07 -47.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 128.0 2.714 . . . . 0.0 115.363 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.42 62.09 0.28 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.305 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -172.73 149.9 2.08 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 108.893 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -86.95 131.51 34.07 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.35 108.44 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -94.83 107.5 19.52 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 83' ' ' ILE . 42.1 t -93.08 131.39 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -122.15 101.93 7.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 107.108 -163.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -115.62 114.49 24.98 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.611 1.564 . . . . 0.0 110.905 -163.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -104.79 -62.5 1.33 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.599 0.636 . . . . 0.0 111.599 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.81 106.27 1.84 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.758 0.708 . . . . 0.0 112.597 -171.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.95 25.25 65.77 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.939 0.781 . . . . 0.0 112.177 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -175.15 167.66 3.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.368 1.467 . . . . 0.0 107.045 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -157.3 160.91 39.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.9 p -124.15 149.43 46.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.138 0.575 . . . . 0.0 109.824 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.9 p -88.45 135.11 33.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.945 0.898 . . . . 0.0 109.123 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.94 87.72 2.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 161.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.21 129.92 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.0 138.11 51.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.445 1.098 . . . . 0.0 110.944 -171.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.02 155.34 32.51 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.743 0.652 . . . . 0.0 109.287 154.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -96.59 112.39 24.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.14 0.976 . . . . 0.0 109.188 165.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.6 -171.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.8 t70 51.07 -110.27 0.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.14 29.64 2.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.646 1.593 . . . . 0.0 109.678 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -150.01 146.12 26.81 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.99 0.895 . . . . 0.0 109.732 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 5.2 tt -85.09 113.19 21.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.4 mt -89.33 105.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.41 117.44 29.12 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 166.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.0 m -103.43 133.95 47.62 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 35.5 tp -130.67 86.78 2.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.475 1.11 . . . . 0.0 108.199 -161.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -115.59 133.03 56.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.414 0.552 . . . . 0.0 110.65 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -134.45 138.38 44.72 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.166 2.187 . . . . 0.0 107.783 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.58 108.01 0.72 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 165.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 m 121.8 -37.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 130.001 3.32 . . . . 0.0 112.174 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.63 162.64 38.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.098 1.317 . . . . 0.0 112.122 -168.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.87 151.74 20.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.699 0.799 . . . . 0.0 109.86 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.5 m -143.72 159.52 42.35 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.162 -0.961 . . . . 0.0 108.776 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.35 145.43 37.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 159.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -142.34 101.91 3.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -103.05 123.68 47.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -108.86 149.23 29.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.23 1.812 . . . . 0.0 110.101 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -124.35 127.36 47.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.512 1.525 . . . . 0.0 107.798 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -68.64 119.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.28 -29.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.244 0.618 . . . . 0.0 111.451 -173.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.138 0 CA-C-N 118.403 0.547 . . . . 0.0 109.907 170.384 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.25 -36.72 32.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.02 1.728 . . . . 0.0 111.438 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.64 -15.32 62.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.715 1.606 . . . . 0.0 112.016 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.75 -52.41 2.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.563 1.145 . . . . 0.0 110.098 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.11 114.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.422 1.489 . . . . 0.0 111.603 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.99 -178.66 22.64 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 121.722 0.624 . . . . 0.0 112.84 164.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -96.39 127.41 42.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 169.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -117.61 157.34 26.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.323 1.049 . . . . 0.0 108.355 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -120.33 149.92 41.55 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 162.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.16 148.36 31.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.47 -56.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 118.25 0.477 . . . . 0.0 111.42 168.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 148.82 27.65 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -166.07 154.24 10.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.768 0.827 . . . . 0.0 109.129 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -148.57 145.93 28.04 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.425 1.09 . . . . 0.0 108.701 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 66.77 17.8 10.61 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.32 1.848 . . . . 0.0 113.147 168.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -59.58 -38.88 82.34 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.753 -1.217 . . . . 0.0 109.341 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.94 -41.78 96.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 111.194 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -58.53 -48.0 82.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.326 0.65 . . . . 0.0 109.558 173.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -51.97 -56.27 15.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -48.85 -50.52 34.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.436 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -77.38 53.58 1.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.086 1.754 . . . . 0.0 110.056 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.3 p -177.92 -50.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.266 2.227 . . . . 0.0 106.592 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.94 -32.45 74.17 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.54 23.87 74.22 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.675 0.655 . . . . 0.0 112.064 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 30' ' ' ARG . 34.1 m -85.82 53.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.518 -0.99 . . . . 0.0 110.417 -173.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.25 109.14 0.05 OUTLIER Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.717 0.675 . . . . 0.0 112.256 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.78 -64.91 0.76 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 120.776 -1.426 . . . . 0.0 111.049 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.28 65.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.101 0.56 . . . . 0.0 110.736 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -51.3 -51.75 51.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.211 1.404 . . . . 0.0 110.98 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 25' ' ' VAL . 7.5 mmt85 -72.77 -42.19 64.25 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.468 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.32 -56.91 7.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.842 1.201 . . . . 0.0 110.248 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.01 -52.13 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 42.54 2.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.84 0.733 . . . . 0.0 113.514 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -157.71 -37.16 0.07 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.712 2.005 . . . . 0.0 109.91 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.9 ttt -76.77 -33.98 58.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.881 0.472 . . . . 0.0 109.942 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -66.24 166.68 11.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.539 166.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.29 80.59 3.46 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.719 0.808 . . . . 0.0 109.223 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.61 158.81 46.93 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.784 2.323 . . . . 0.0 112.338 -168.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 164.54 25.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.348 166.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -145.43 121.93 11.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 155.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mt -90.91 135.58 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -133.44 104.4 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -109.88 109.15 19.69 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.81 88.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -50.53 157.67 0.71 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.481 1.112 . . . . 0.0 110.854 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -26.0 -59.72 0.07 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.202 1.858 . . . . 0.0 115.182 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.75 13.63 9.29 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.718 1.207 . . . . 0.0 111.524 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.18 -172.16 4.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.557 1.543 . . . . 0.0 108.264 -157.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.06 149.56 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 120.766 -1.209 . . . . 0.0 109.974 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.49 128.9 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.11 125.01 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -115.09 106.04 13.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.568 1.547 . . . . 0.0 108.976 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -83.59 63.02 7.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.749 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -71.31 144.63 49.88 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 122.14 0.971 . . . . 0.0 112.957 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -158.53 168.11 27.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 168.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -80.81 56.72 2.78 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -172.7 -51.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -172.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -138.3 146.01 41.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -148.34 49.62 1.03 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.489 0.715 . . . . 0.0 110.138 -163.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 75' ' ' ALA . 27.9 p -85.61 151.4 23.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.592 0.357 . . . . 0.0 110.443 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -121.55 142.93 49.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 0.0 110.292 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.34 93.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -172.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 p -104.36 125.32 50.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.97 1.708 . . . . 0.0 110.113 -174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -161.27 170.55 20.01 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -93.77 127.46 39.51 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 165.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.06 64.73 1.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 110.867 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.46 55.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -169.61 173.5 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.26 1.024 . . . . 0.0 108.274 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -107.16 148.56 28.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.458 160.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.67 169.34 22.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.363 1.465 . . . . 0.0 108.469 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -92.2 121.85 34.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -116.65 138.17 51.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.413 1.485 . . . . 0.0 107.226 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -138.65 108.37 6.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -128.64 129.57 46.04 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.449 ' H ' HG21 ' A' ' 60' ' ' THR . . . -75.31 44.56 0.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.944 -1.097 . . . . 0.0 113.934 -172.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.27 48.9 p30 -147.36 -52.32 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.975 0.91 . . . . 0.0 109.382 156.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -6.07 47.6 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 82.72 -159.53 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.433 2.293 . . . . 0.0 111.9 165.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -83.76 127.98 34.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.263 1.425 . . . . 0.0 107.835 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 143.98 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.925 1.29 . . . . 0.0 107.641 -174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -81.35 114.39 20.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 166.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -96.58 119.49 35.16 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.312 1.045 . . . . 0.0 108.846 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.59 126.5 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.67 134.93 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.1 m -142.59 170.33 15.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.4 133.53 55.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 165.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -82.08 -23.01 36.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.747 0.419 . . . . 0.0 111.378 -174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.01 -32.55 3.96 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.021 1.296 . . . . 0.0 110.298 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.19 -23.96 8.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.643 1.592 . . . . 0.0 111.985 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -150.25 161.26 42.78 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.233 1.413 . . . . 0.0 111.522 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.29 124.55 31.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 163.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.21 128.74 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.302 1.041 . . . . 0.0 109.424 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -114.64 95.85 5.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.438 2.295 . . . . 0.0 106.78 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.65 96.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -97.9 107.9 20.49 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.326 1.45 . . . . 0.0 108.486 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -121.42 155.71 34.27 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.525 0.602 . . . . 0.0 111.954 -171.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -130.71 -60.94 0.97 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.406 -0.331 . . . . 0.0 110.788 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -160.63 -76.62 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 118.346 0.521 . . . . 0.0 111.962 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.8 -11.8 85.1 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.592 0.633 . . . . 0.0 113.094 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -173.13 175.87 3.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.6 1.56 . . . . 0.0 107.649 -172.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -154.06 158.96 41.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.294 1.437 . . . . 0.0 109.417 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.13 121.31 44.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.715 2.006 . . . . 0.0 108.814 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.17 99.16 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.536 1.134 . . . . 0.0 108.32 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.66 146.48 25.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.91 146.57 31.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -136.23 140.78 43.75 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.539 1.536 . . . . 0.0 108.248 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -163.96 153.18 14.02 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.437 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -111.66 118.74 36.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.477 0.58 . . . . 0.0 109.799 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 -174.43 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 t70 52.73 -107.09 0.32 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.67 29.62 1.43 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.036 1.303 . . . . 0.0 110.544 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -143.35 144.03 31.91 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.134 0.967 . . . . 0.0 109.875 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.84 93.59 6.29 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 171.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.5 mt -70.34 129.57 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -144.95 142.73 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.89 113.68 14.94 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -171.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 p -117.88 129.0 55.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 108.842 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -125.15 169.92 11.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.261 1.424 . . . . 0.0 107.191 173.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.09 118.57 2.39 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 161.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.285 0.5 OUTLIER 67.91 -58.25 0.45 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.6 2.36 . . . . 0.0 113.281 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.55 112.21 12.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.527 -0.733 . . . . 0.0 111.26 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.73 125.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 126.201 1.8 . . . . 0.0 106.573 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 3.9 m -144.8 167.42 22.62 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.926 -1.109 . . . . 0.0 110.281 -174.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.8 p -136.4 144.41 44.5 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.927 0.491 . . . . 0.0 111.249 -170.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -138.04 151.09 47.52 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 166.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.24 139.67 47.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -115.66 156.53 25.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.615 1.166 . . . . 0.0 109.568 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.1 127.45 26.49 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.509 1.124 . . . . 0.0 108.41 -168.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -64.24 119.54 10.46 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.198 0.999 . . . . 0.0 108.96 -173.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -82.01 -50.93 8.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 C-N-CA 123.795 0.838 . . . . 0.0 109.088 176.755 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.6 48.02 0.19 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.25 2.62 . . . . 0.0 112.483 -175.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.32 -60.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -172.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -61.67 -33.65 74.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.271 1.028 . . . . 0.0 110.716 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 5' ' ' VAL . 9.2 p -73.63 78.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.724 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.94 -166.86 26.51 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 160.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 m -76.97 124.05 27.21 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.196 1.398 . . . . 0.0 110.984 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.429 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 11.3 m0 -104.16 149.42 25.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.841 1.256 . . . . 0.0 109.002 169.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.2 134.94 54.69 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.992 0.917 . . . . 0.0 108.888 162.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.31 144.77 56.38 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.4 -25.71 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.667 177.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.08 157.08 47.05 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.61 1.096 . . . . 0.0 110.124 173.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 t 176.72 86.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.414 1.886 . . . . 0.0 109.903 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -116.1 160.89 19.71 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.088 0.555 . . . . 0.0 110.925 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 58.33 8.05 0.77 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.329 1.852 . . . . 0.0 112.89 -177.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -31.15 64.46 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.878 -1.139 . . . . 0.0 109.397 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.57 -65.4 0.62 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -44.13 -52.06 7.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.1 1.76 . . . . 0.0 112.229 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -46.43 -50.38 16.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.032 1.333 . . . . 0.0 112.035 176.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.8 mtp -76.9 -34.5 57.73 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.728 -0.607 . . . . 0.0 110.291 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 43.64 0.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.515 2.326 . . . . 0.0 110.313 171.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -171.23 -54.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 119' ' ' HIS . 84.1 mt -61.2 -27.68 68.6 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 172.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.29 -18.72 55.69 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 119.28 0.945 . . . . 0.0 113.103 171.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 m -41.12 -47.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 127.133 2.173 . . . . 0.0 113.453 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.25 72.27 0.2 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -172.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.85 158.36 2.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 110.605 172.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.13 -78.06 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.438 1.495 . . . . 0.0 110.478 -170.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.7 p -35.24 -44.68 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.756 2.823 . . . . 0.0 113.992 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -34.9 -40.11 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 170.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -50.54 -34.88 27.09 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.007 1.723 . . . . 0.0 113.361 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.72 -44.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.31 18.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.071 0.843 . . . . 0.0 113.109 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -55.57 -53.81 51.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.895 . . . . 0.0 111.978 174.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.4 mtt -81.08 -21.7 39.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.477 1.511 . . . . 0.0 111.511 -172.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -70.44 60.66 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.802 0.728 . . . . 0.0 110.903 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -147.8 48.51 0.65 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.234 2.614 . . . . 0.0 109.043 172.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 -41.58 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.138 2.559 . . . . 0.0 112.311 -167.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -119.62 142.61 48.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 m -146.09 105.19 3.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.769 -0.582 . . . . 0.0 109.592 177.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.4 mt -77.11 113.47 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 170.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.429 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 40.1 mm -101.41 138.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 163.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -142.99 109.8 5.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -166.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.64 81.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -54.62 156.77 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.286 171.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.0 -72.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.419 2.438 . . . . 0.0 115.604 -171.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -116.42 10.0 14.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.898 1.679 . . . . 0.0 111.132 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.83 -166.48 2.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.296 1.838 . . . . 0.0 108.197 -157.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.28 136.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -112.16 133.58 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 tt -93.62 137.65 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 169.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -138.79 88.11 2.27 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.92 1.688 . . . . 0.0 107.398 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -77.91 129.94 35.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.804 1.642 . . . . 0.0 108.636 178.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.31 143.61 51.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.707 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -158.99 -173.0 4.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.213 1.005 . . . . 0.0 109.461 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -82.18 116.48 21.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.3 t80 59.98 27.25 16.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.093 0.957 . . . . 0.0 112.665 173.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -163.66 75.07 0.35 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.264 -0.898 . . . . 0.0 109.661 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -105.91 139.86 39.82 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 p -150.77 148.81 28.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.85 142.9 24.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.252 0.478 . . . . 0.0 110.989 179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.9 mt -149.96 136.14 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.784 1.234 . . . . 0.0 109.095 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 p -90.22 133.78 34.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.923 1.689 . . . . 0.0 110.075 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.67 177.81 8.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.034 0.934 . . . . 0.0 111.009 176.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 68' ' ' VAL . 53.3 tptt -125.58 139.33 53.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 107.042 -176.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 57.14 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.465 0.706 . . . . 0.0 109.65 169.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.07 57.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -167.44 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.015 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.4 142.69 50.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.558 0.536 . . . . 0.0 111.174 161.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -133.78 150.53 51.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.498 1.519 . . . . 0.0 107.556 -174.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -72.22 131.09 42.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -125.65 131.14 52.69 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 t -126.97 145.35 50.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -146.0 172.32 13.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.56 0.695 . . . . 0.0 110.275 174.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.88 30.73 0.25 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.972 1.309 . . . . 0.0 113.433 -158.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -126.18 11.85 7.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.12 2.568 . . . . 0.0 109.85 165.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t0 63.05 29.33 16.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.492 2.317 . . . . 0.0 112.751 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.81 74.67 1.6 Allowed 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.247 -1.533 . . . . 0.0 109.674 164.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.81 68.86 1.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.196 1.398 . . . . 0.0 109.092 170.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.81 -168.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 110.415 -174.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -135.38 134.67 39.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -122.36 122.6 39.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.285 1.034 . . . . 0.0 109.703 -163.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.39 132.02 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.07 132.19 68.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.275 0.63 . . . . 0.0 109.663 -176.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.05 103.06 2.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.552 1.541 . . . . 0.0 107.661 -178.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.83 130.81 40.09 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.907 -1.12 . . . . 0.0 110.563 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.64 27.59 0.21 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -164.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.81 -38.74 3.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.607 -1.107 . . . . 0.0 111.081 -158.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.54 -64.77 0.17 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.309 1.554 . . . . 0.0 112.544 -175.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 135.82 34.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -174.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.28 89.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.414 ' HA ' HG23 ' A' ' 105' ' ' VAL . 6.5 t -69.78 113.6 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -115.05 117.97 32.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -117.08 140.46 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -128.6 97.98 4.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -157.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -90.93 162.56 14.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 109.133 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -138.52 -56.15 0.63 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.642 -0.661 . . . . 0.0 110.789 166.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -163.88 -76.11 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.805 0.275 . . . . 0.0 111.11 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.63 -21.76 59.37 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.569 -0.573 . . . . 0.0 111.773 -177.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.73 174.71 11.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.792 . . . . 0.0 109.348 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -133.02 176.17 8.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.845 2.458 . . . . 0.0 109.069 177.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.7 t -133.59 153.77 51.4 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.49 1.116 . . . . 0.0 109.454 165.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.7 m -109.78 134.03 52.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.953 0.901 . . . . 0.0 108.879 -176.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.67 80.4 1.28 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.801 0.81 . . . . 0.0 109.658 -176.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 92' ' ' VAL . 0.3 OUTLIER -67.95 148.72 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -126.12 110.05 13.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -132.54 147.73 52.36 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.243 -177.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.0 ttt -118.09 134.3 55.11 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.21 1.404 . . . . 0.0 108.541 171.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -148.91 177.68 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 54.67 -103.78 0.19 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.35 26.24 1.54 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.123 1.344 . . . . 0.0 109.869 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -140.37 169.08 18.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.756 0.822 . . . . 0.0 109.194 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.62 128.37 45.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -171.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.5 mt -111.82 130.77 64.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -112.7 114.67 27.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.989 0.916 . . . . 0.0 108.693 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 105' ' ' VAL . 65.6 p -94.63 76.16 3.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.18 101.45 3.97 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.6 t -128.71 128.33 43.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.471 0.578 . . . . 0.0 110.846 -176.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.41 ' CD2' HD21 ' A' ' 23' ' ' LEU . 16.0 t60 -173.38 143.69 1.1 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.769 1.227 . . . . 0.0 109.336 175.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.31 54.74 32.29 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 167.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 m 73.98 -44.96 0.58 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.8 1.24 . . . . 0.0 112.11 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.05 115.98 4.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.67 0.788 . . . . 0.0 111.279 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.09 99.19 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.297 1.439 . . . . 0.0 107.497 172.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.9 t -100.36 105.66 17.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.229 1.012 . . . . 0.0 110.479 175.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -65.29 138.48 58.23 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 155.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -115.51 155.88 26.72 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 144.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.84 137.84 46.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 165.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.81 166.03 11.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.284 2.234 . . . . 0.0 108.77 174.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.37 114.11 15.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -75.35 73.82 2.43 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.382 0.611 . . . . 0.0 109.538 -171.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -45.06 62.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.611 1.564 . . . . 0.0 111.526 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.007 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.93 51.07 0.21 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 131.02 3.728 . . . . 0.0 111.329 -166.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.3 -53.87 0.05 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -158.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.93 47.67 0.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.454 1.102 . . . . 0.0 109.494 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 49.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.847 1.259 . . . . 0.0 108.593 -174.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.3 -165.04 35.28 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.627 -0.671 . . . . 0.0 112.793 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m -87.83 136.39 32.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.499 1.12 . . . . 0.0 111.17 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -115.8 154.5 29.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.912 1.685 . . . . 0.0 108.824 172.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -121.19 152.92 38.23 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 167.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.05 134.65 34.2 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.005 1.322 . . . . 0.0 109.635 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.65 -41.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.451 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -144.48 158.25 43.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.135 0.879 . . . . 0.0 109.192 170.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -174.35 111.93 0.16 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.929 2.092 . . . . 0.0 109.422 -163.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.3 145.26 24.47 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m120 77.11 -5.9 2.1 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.484 2.313 . . . . 0.0 111.476 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -76.21 -41.95 47.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.604 1.562 . . . . 0.0 107.678 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -32.21 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.032 1.733 . . . . 0.0 111.995 151.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -56.49 -40.15 74.46 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.346 0.521 . . . . 0.0 112.381 -173.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE2' HD21 ' A' ' 117' ' ' LEU . 29.6 t80 -36.04 -58.91 0.63 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.832 1.253 . . . . 0.0 112.826 178.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.73 -26.29 65.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.103 -174.025 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -76.79 51.99 0.81 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.226 1.01 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -168.28 -44.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.372 2.269 . . . . 0.0 107.428 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.44 -12.19 13.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.69 63.07 1.72 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.1 OUTLIER -166.16 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.826 1.65 . . . . 0.0 110.205 -176.85 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.04 149.45 20.36 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.88 62.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.97 1.308 . . . . 0.0 108.362 -178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 65.59 -19.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.157 1.783 . . . . 0.0 115.255 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 m -99.77 -54.48 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.291 1.436 . . . . 0.0 109.072 -170.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -63.65 -10.94 21.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -56.11 -43.53 78.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.265 0.939 . . . . 0.0 110.884 165.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -50.96 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.19 39.94 1.22 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.116 1.341 . . . . 0.0 113.376 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.1 -25.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.245 1.018 . . . . 0.0 112.227 171.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.86 -36.93 85.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 162.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 36' ' ' THR . 2.4 t -63.13 82.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.151 0.977 . . . . 0.0 109.873 167.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -144.47 60.6 7.82 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.792 1.637 . . . . 0.0 108.732 164.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.72 -21.18 25.52 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.381 2.721 . . . . 0.0 110.87 -174.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.3 m -142.87 152.06 41.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.494 -0.754 . . . . 0.0 109.244 -177.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.3 m -154.86 125.99 7.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.0 mt -78.26 134.0 29.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 166.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.9 105.36 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 166.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.1 108.31 12.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.866 0.866 . . . . 0.0 110.224 -170.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.96 114.97 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 169.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -99.74 169.38 9.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.303 1.441 . . . . 0.0 108.495 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -22.49 -65.24 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.433 1.968 . . . . 0.0 114.913 -172.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -116.88 5.06 12.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.097 1.359 . . . . 0.0 111.865 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.8 -172.73 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.717 1.607 . . . . 0.0 109.96 -154.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.11 136.08 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 166.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 tt -104.0 140.21 22.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 tt -124.96 125.68 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.614 1.565 . . . . 0.0 108.456 177.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -134.73 105.9 6.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.84 0.856 . . . . 0.0 109.397 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.82 38.73 0.72 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.609 1.163 . . . . 0.0 113.274 -159.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -44.05 121.52 2.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 113.943 -164.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -141.63 62.87 1.44 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.277 0.631 . . . . 0.0 110.004 -176.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 m 73.03 125.66 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.137 1.375 . . . . 0.0 109.96 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 72.9 -53.68 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.99 1.316 . . . . 0.0 111.911 -178.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.77 -163.73 0.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -169.28 -168.49 0.83 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 p -54.58 147.59 14.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.256 1.423 . . . . 0.0 110.959 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -134.78 122.71 22.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.704 1.601 . . . . 0.0 106.832 176.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.49 158.41 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -129.64 159.72 35.53 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 165.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.13 179.55 8.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.919 0.888 . . . . 0.0 108.717 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -145.75 128.11 15.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 76.03 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.133 0.973 . . . . 0.0 110.052 171.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.54 59.3 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.274 1.416 . . . . 0.0 111.084 174.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -168.32 168.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.103 0.952 . . . . 0.0 109.148 174.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.18 152.56 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 110.774 168.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -172.62 163.81 5.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.539 1.136 . . . . 0.0 109.622 -172.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.5 132.78 44.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.738 0.415 . . . . 0.0 110.115 177.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -123.08 87.02 2.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.58 1.952 . . . . 0.0 107.11 -176.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.7 m -89.4 109.07 20.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.436 0.694 . . . . 0.0 109.514 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -131.88 157.7 43.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.523 0.677 . . . . 0.0 112.256 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.76 49.27 1.03 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.506 1.522 . . . . 0.0 111.727 -173.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -172.01 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.342 1.457 . . . . 0.0 107.346 -173.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.268 5.6 m-20 -74.43 9.47 1.71 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 70.12 -154.9 0.13 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 109.108 162.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.96 81.61 3.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG21 ' HG2' ' A' ' 95' ' ' GLN . 6.4 p -96.68 165.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -108.19 128.03 54.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.165 -0.959 . . . . 0.0 109.127 171.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 134.55 36.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 tt -129.1 115.52 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 153.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.698 0.799 . . . . 0.0 110.254 -166.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -156.29 173.7 16.48 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.546 1.539 . . . . 0.0 106.934 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.27 148.14 49.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.448 1.022 . . . . 0.0 109.886 161.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -116.89 108.83 16.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.519 1.127 . . . . 0.0 108.151 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.67 -68.01 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.637 1.113 . . . . 0.0 111.715 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.8 60.82 0.16 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.679 -2.169 . . . . 0.0 107.679 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.07 113.58 1.22 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 -177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.09 120.63 31.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.04 129.93 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.693 1.597 . . . . 0.0 108.116 -174.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -113.09 106.18 14.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 171.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -82.17 125.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 164.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' HG21 ' A' ' 80' ' ' VAL . 49.6 tt0 -126.09 92.26 3.55 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -163.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -110.0 113.97 27.13 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.267 1.427 . . . . 0.0 108.658 -162.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.45 -55.27 3.35 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.192 0.905 . . . . 0.0 110.677 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -169.46 -90.96 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 117.901 0.319 . . . . 0.0 110.76 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.63 -23.53 77.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -175.35 4.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.613 0.765 . . . . 0.0 109.646 176.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.75 166.54 26.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.286 2.234 . . . . 0.0 106.624 -171.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 t -130.24 153.83 48.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 156.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 p -116.82 137.99 51.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.16 156.64 44.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.71 152.19 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.114 0.566 . . . . 0.0 110.236 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -123.6 138.13 54.61 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.915 1.286 . . . . 0.0 108.641 168.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -156.16 146.69 21.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.733 2.013 . . . . 0.0 106.471 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.09 122.22 22.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.624 0.77 . . . . 0.0 109.133 169.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.46 176.41 4.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 159.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.3 t70 51.76 -117.58 1.15 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -129.7 15.25 5.72 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.234 1.397 . . . . 0.0 110.588 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -123.81 134.22 53.66 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.759 0.78 . . . . 0.0 110.453 -167.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 tp -97.66 116.35 29.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.814 1.645 . . . . 0.0 108.311 -171.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.7 mm -86.29 120.94 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.76 113.34 26.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 167.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -111.46 127.78 55.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 170.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -138.46 108.53 6.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.347 1.459 . . . . 0.0 107.689 -166.496 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -131.48 138.65 49.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.885 0.85 . . . . 0.0 112.211 -170.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -139.72 92.05 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.62 -118.37 12.58 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -61.85 -43.46 98.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.697 1.199 . . . . 0.0 111.323 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.64 68.07 5.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.218 -167.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.9 136.42 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' HD23 ' A' ' 117' ' ' LEU . 4.0 m -145.62 160.7 41.29 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.361 -1.462 . . . . 0.0 109.929 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -142.07 154.61 45.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.362 0.414 . . . . 0.0 110.783 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -132.95 169.29 17.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 151.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 119.07 11.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 -176.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -112.24 163.69 14.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.983 1.713 . . . . 0.0 109.283 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -133.56 123.8 25.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 127.364 2.266 . . . . 0.0 107.934 -174.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.97 111.15 3.19 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.13 -34.04 10.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 110.636 -173.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 C-N-CA 123.878 0.871 . . . . 0.0 109.936 174.63 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.53 60.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 129.304 3.042 . . . . 0.0 112.096 -169.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.53 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.159 1.784 . . . . 0.0 107.754 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -58.52 -36.6 74.09 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.752 1.221 . . . . 0.0 111.404 -176.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.5 104.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.14 0.976 . . . . 0.0 111.773 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.58 -177.26 27.87 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.349 1.452 . . . . 0.0 113.347 169.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -85.45 108.45 17.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.147 1.779 . . . . 0.0 111.075 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -97.01 155.86 16.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 174.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -123.97 129.67 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.161 1.784 . . . . 0.0 106.555 174.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.86 131.2 35.82 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.51 -42.75 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.439 0.563 . . . . 0.0 110.781 172.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 66.86 151.55 0.07 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.898 2.079 . . . . 0.0 111.953 -173.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -166.88 30.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.675 163.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -166.91 87.34 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.249 -0.907 . . . . 0.0 110.851 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 63.05 50.98 2.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.44 1.096 . . . . 0.0 110.787 161.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -82.46 -60.65 2.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.212 0.605 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -43.17 -66.34 0.39 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.124 2.169 . . . . 0.0 109.647 171.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.7 OUTLIER -20.48 -60.55 0.02 OUTLIER 'General case' 0 C--N 1.34 0.175 0 C-N-CA 127.732 2.413 . . . . 0.0 113.039 164.122 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CD2' HD12 ' A' ' 117' ' ' LEU . 3.9 t80 -63.84 -48.97 74.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.234 -171.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 mtt -62.16 -45.13 94.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.981 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -57.06 -31.34 65.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.125 2.57 . . . . 0.0 111.988 177.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -85.95 -57.27 3.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.598 1.159 . . . . 0.0 110.033 178.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.29 -25.25 68.23 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.191 0.596 . . . . 0.0 112.568 -173.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.16 21.61 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.99 -27.74 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.12 -109.3 0.01 OUTLIER Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.176 1.846 . . . . 0.0 113.631 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 27.94 54.25 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.081 2.553 . . . . 0.0 114.36 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 138.87 -61.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.602 2.761 . . . . 0.0 107.743 -172.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 p -66.23 -48.59 70.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -173.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -49.49 -18.92 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.401 1.88 . . . . 0.0 115.74 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -107.16 -13.6 15.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.787 0.835 . . . . 0.0 113.034 -177.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -143.23 -68.61 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.894 0.77 . . . . 0.0 109.169 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.39 60.45 1.53 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.777 1.656 . . . . 0.0 111.223 -176.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.9 -48.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.978 2.111 . . . . 0.0 107.643 -174.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.5 ttm -99.91 -16.9 17.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.321 1.048 . . . . 0.0 111.482 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 36' ' ' THR . 6.7 t -69.43 72.06 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.825 0.85 . . . . 0.0 111.327 178.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 45.51 66.62 5.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 111.947 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.16 105.16 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.005 2.47 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -108.82 139.37 43.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.793 1.237 . . . . 0.0 108.48 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.5 m -126.3 106.84 9.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -71.43 130.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 164.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -121.89 133.27 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 165.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.2 139.57 37.54 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 119.145 0.884 . . . . 0.0 109.421 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.72 138.62 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.32 164.26 19.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.0 108.173 175.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.81 -71.8 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.934 2.207 . . . . 0.0 115.521 -175.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -123.98 23.48 8.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.998 1.719 . . . . 0.0 110.319 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.85 -178.75 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.273 1.029 . . . . 0.0 108.681 -152.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.04 134.25 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 172.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.2 tt -99.1 141.31 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.078 0.951 . . . . 0.0 108.554 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 133.52 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.689 1.596 . . . . 0.0 107.422 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -127.32 95.75 4.37 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.811 1.244 . . . . 0.0 109.071 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.28 82.7 7.68 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.677 0.791 . . . . 0.0 109.685 -174.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -74.92 72.9 2.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.627 0.771 . . . . 0.0 109.018 173.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.9 t -142.99 -68.55 0.35 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.067 1.747 . . . . 0.0 106.977 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 m -60.3 144.38 50.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.113 0.965 . . . . 0.0 110.279 175.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -48.55 135.69 14.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.944 0.498 . . . . 0.0 110.115 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 73.39 -4.73 2.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 0.0 113.458 -178.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.6 72.49 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 111.821 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 150.01 38.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.623 -174.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -139.02 135.67 34.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.879 1.672 . . . . 0.0 107.863 -174.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 tp -159.45 159.42 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.535 0.607 . . . . 0.0 109.961 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.7 p -110.59 129.59 55.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.867 . . . . 0.0 109.834 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -131.16 179.87 5.75 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 110.225 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -139.59 147.16 40.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.901 1.28 . . . . 0.0 107.864 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.54 68.7 1.64 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.007 0.523 . . . . 0.0 109.603 174.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.38 69.72 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.11 165.79 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.827 0.851 . . . . 0.0 108.908 175.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -156.85 166.95 31.92 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.771 0.829 . . . . 0.0 109.005 174.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -74.47 124.11 25.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.91 58.93 0.73 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 107.433 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -57.61 106.14 0.31 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 165.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 t -147.64 134.6 20.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.895 0.478 . . . . 0.0 110.393 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.36 -36.19 41.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.13 . . . . 0.0 113.367 -174.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.43 1.07 23.36 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.669 1.188 . . . . 0.0 113.21 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -132.4 -57.05 0.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 109.7 174.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 128.64 -147.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 1 C-N-CA 132.553 4.341 . . . . 0.0 107.255 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -86.69 117.11 25.23 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 95' ' ' GLN . 7.2 p -151.85 148.0 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -169.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -95.61 141.1 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.8 p -121.06 87.76 2.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.513 1.125 . . . . 0.0 109.622 -166.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.1 105.34 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 175.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.59 139.92 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.835 0.854 . . . . 0.0 110.913 -172.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.35 171.0 19.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.23 1.812 . . . . 0.0 107.423 -152.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -142.16 131.53 23.65 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -136.7 150.81 48.66 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.182 0.993 . . . . 0.0 109.181 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.46 -80.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.61 1.1 . . . . 0.0 111.66 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.25 30.61 0.27 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.111 1.339 . . . . 0.0 110.651 171.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -132.1 141.55 49.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.111 1.364 . . . . 0.0 108.013 -176.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tt -96.78 112.32 24.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.632 1.173 . . . . 0.0 108.203 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.91 118.33 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 109.335 -174.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -111.35 99.43 8.23 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.601 2.36 . . . . 0.0 106.771 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 132.76 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 170.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HG3' HG21 ' A' ' 80' ' ' VAL . 8.2 tp60 -135.19 98.4 3.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -156.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -116.08 118.48 32.99 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.225 1.01 . . . . 0.0 111.232 -163.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -109.4 -26.16 10.15 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.235 0.614 . . . . 0.0 112.5 -176.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -144.61 -135.53 0.09 Allowed 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.54 66.85 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.287 0.949 . . . . 0.0 111.058 170.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -94.6 166.28 12.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.843 0.857 . . . . 0.0 111.643 -174.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 172.76 12.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.681 1.992 . . . . 0.0 110.597 173.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 t -113.67 154.2 27.66 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 153.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 p -112.9 106.52 14.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.652 1.181 . . . . 0.0 108.753 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 115' ' ' LEU . 2.1 mp -102.74 109.65 21.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.72 116.45 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.33 0.652 . . . . 0.0 109.403 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.472 ' CG ' HD23 ' A' ' 115' ' ' LEU . 12.0 mtt85 -95.93 131.58 42.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.836 1.654 . . . . 0.0 108.752 177.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -144.51 143.1 30.68 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -118.22 119.83 35.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -125.32 -169.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 159.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.26 -113.81 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.035 0.534 . . . . 0.0 109.649 176.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.32 20.68 3.15 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.095 1.807 . . . . 0.0 110.172 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -140.31 143.03 35.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.978 0.889 . . . . 0.0 109.895 -172.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.4 tt -97.01 99.61 11.14 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.23 125.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.5 tm? -115.95 103.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -92.6 125.55 37.29 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.44 HD12 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -117.45 85.05 2.26 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.682 1.193 . . . . 0.0 108.383 -174.455 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.58 124.19 30.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -145.26 145.47 31.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 160.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.64 -36.07 4.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.1 1.333 . . . . 0.0 113.898 -175.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -54.8 -41.21 70.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.388 0.594 . . . . 0.0 111.623 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -171.2 128.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.196 0.599 . . . . 0.0 110.33 -175.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.82 128.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 166.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.467 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 24.2 m -145.1 153.07 41.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.086 -1.009 . . . . 0.0 108.436 -177.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.3 p -140.94 123.67 16.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.154 0.888 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -95.9 102.89 14.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.358 1.863 . . . . 0.0 107.559 175.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 110.04 18.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -92.92 147.99 22.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.54 0.686 . . . . 0.0 111.334 176.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -134.38 123.27 23.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.311 2.244 . . . . 0.0 107.148 -172.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -75.49 130.54 39.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.771 0.714 . . . . 0.0 109.782 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.84 -21.42 11.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.137 0.426 . . . . 0.0 112.011 164.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 118.333 0.515 . . . . 0.0 111.171 -179.455 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.758 0.313 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.86 60.28 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 130.5 3.52 . . . . 0.0 111.174 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.07 -44.83 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.074 1.75 . . . . 0.0 107.884 -169.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -61.59 -39.86 92.71 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.534 0.734 . . . . 0.0 111.391 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -38.26 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.906 1.682 . . . . 0.0 111.753 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.19 -172.41 23.21 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.271 0.928 . . . . 0.0 113.172 170.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -84.24 116.98 23.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.64 1.576 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -99.99 161.21 13.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 166.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.17 135.42 22.82 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.85 135.42 52.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.981 -0.45 . . . . 0.0 109.846 -173.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.33 -39.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 175.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -141.6 162.72 34.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.8 t -174.38 148.89 1.29 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 171.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -121.68 164.43 17.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.33 -22.86 0.21 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 166.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.09 -43.2 20.13 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -166.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -67.35 -61.82 1.72 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.245 0.93 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -40.8 -50.17 3.15 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.868 1.267 . . . . 0.0 111.92 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -50.36 -49.15 55.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.855 1.662 . . . . 0.0 111.876 177.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -37.17 70.76 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.501 -0.75 . . . . 0.0 110.256 176.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.95 48.82 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.914 2.486 . . . . 0.0 109.073 -169.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 p -172.96 -49.26 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.865 1.666 . . . . 0.0 107.26 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -66.16 33.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.226 1.411 . . . . 0.0 114.339 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.87 2.87 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 120.09 -1.631 . . . . 0.0 111.754 -178.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.61 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.299 2.64 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.82 145.39 17.84 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.916 1.246 . . . . 0.0 110.054 172.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -175.19 171.98 2.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.926 1.69 . . . . 0.0 106.568 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.25 44.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.845 0.748 . . . . 0.0 112.999 -175.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 -52.17 11.01 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.32 -0.863 . . . . 0.0 112.896 -167.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -63.87 -40.09 95.73 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -157.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -36.63 -43.31 0.4 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.686 1.595 . . . . 0.0 113.764 163.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.86 -50.04 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.75 -31.79 5.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.042 2.258 . . . . 0.0 115.702 -176.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -85.5 -37.51 19.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.36 1.08 . . . . 0.0 110.463 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -32.7 66.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.975 0.91 . . . . 0.0 109.885 -174.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -76.17 52.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.399 1.08 . . . . 0.0 111.763 -177.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 30.56 58.45 0.94 Allowed Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 127.599 2.36 . . . . 0.0 114.116 172.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.67 142.0 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.444 1.429 . . . . 0.0 112.023 -166.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.26 175.11 4.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.924 1.289 . . . . 0.0 109.825 172.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -159.29 112.15 2.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.486 1.914 . . . . 0.0 106.146 151.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.41 136.58 22.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 174.007 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.4 114.82 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 173.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -118.79 128.81 54.82 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.08 96.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -77.81 65.13 3.2 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.27 -87.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.453 1.502 . . . . 0.0 112.572 -179.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.42 -15.94 18.56 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.956 1.703 . . . . 0.0 111.621 -175.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.1 p -108.11 157.18 18.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.75 118.11 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 tt -101.35 137.89 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.794 0.837 . . . . 0.0 108.99 -174.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mp -117.44 131.72 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.416 1.487 . . . . 0.0 107.165 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -124.54 115.92 21.64 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -64.89 -46.79 80.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.274 0.23 . . . . 0.0 110.475 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 56.5 78.52 0.21 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.59 0.756 . . . . 0.0 112.538 169.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -148.06 149.37 31.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 162.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.7 p -11.41 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 129.129 2.972 . . . . 0.0 114.363 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -118.24 46.48 1.78 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.98 1.312 . . . . 0.0 108.085 177.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -158.96 55.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -110.57 139.66 45.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.748 1.619 . . . . 0.0 108.892 177.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 p -146.41 160.83 41.55 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 173.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -138.99 128.14 23.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -144.12 132.67 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.596 0.758 . . . . 0.0 109.439 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.1 p -106.14 99.5 9.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.547 1.539 . . . . 0.0 109.98 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -84.91 110.22 18.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.424 0.556 . . . . 0.0 110.218 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -76.84 97.99 4.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 161.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.05 110.5 0.61 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 170.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.09 22.55 6.17 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.09 1.805 . . . . 0.0 113.11 175.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -149.11 159.95 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.905 1.352 . . . . 0.0 109.388 -177.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.14 121.81 42.94 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.593 1.557 . . . . 0.0 108.371 166.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -132.52 155.77 48.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.959 1.303 . . . . 0.0 109.401 -177.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.57 148.39 51.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.057 0.543 . . . . 0.0 109.867 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -141.39 158.01 44.43 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.044 1.337 . . . . 0.0 108.786 -167.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -130.18 119.42 22.93 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.969 0.508 . . . . 0.0 110.945 -175.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.82 150.44 20.41 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.123 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.68 14.68 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -166.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -106.41 11.58 30.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.569 1.948 . . . . 0.0 110.094 164.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 t0 58.96 26.26 14.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.26 1.824 . . . . 0.0 111.909 -170.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -68.75 100.88 1.22 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 156.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.92 125.59 19.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 151.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' HB3' ' A' ' 97' ' ' TRP . 11.6 m -135.45 -165.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -139.42 144.32 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.458 1.027 . . . . 0.0 110.935 171.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -110.16 118.5 36.53 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.701 2.0 . . . . 0.0 108.71 -175.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.7 tt -96.57 125.47 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 164.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.5 139.69 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 m -144.94 161.84 38.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 170.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -123.33 115.02 20.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.03 130.73 53.89 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.88 -82.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.091 0.853 . . . . 0.0 113.705 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.35 25.45 1.1 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.353 1.454 . . . . 0.0 111.683 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.99 126.14 51.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 107.222 177.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 91' ' ' LEU . 5.6 tt -86.38 106.02 17.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 170.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.8 109.08 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -107.81 123.42 48.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -115.94 140.38 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.26 110.08 12.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.858 1.663 . . . . 0.0 107.907 -169.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.99 132.55 56.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.724 2.01 . . . . 0.0 108.233 -164.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.482 ' HB3' HG12 ' A' ' 80' ' ' VAL . 6.3 p90 -119.72 -65.01 1.2 Allowed 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.825 0.284 . . . . 0.0 111.443 177.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.49 -84.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.183 0.447 . . . . 0.0 111.11 -173.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.45 -30.22 74.91 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -175.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -171.75 3.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.557 0.694 . . . . 0.0 109.251 173.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.23 168.36 20.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.817 2.847 . . . . 0.0 104.767 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.5 t -144.26 147.79 34.02 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.9 m -109.74 143.99 38.77 Favored 'General case' 0 C--O 1.228 -0.075 0 C-N-CA 123.289 0.635 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.24 63.85 1.57 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.044 2.138 . . . . 0.0 107.322 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 p -74.02 128.94 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -110.82 114.64 28.15 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.904 1.282 . . . . 0.0 108.068 174.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -121.74 144.49 48.76 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 165.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.71 127.8 54.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.929 1.292 . . . . 0.0 108.393 169.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.59 -178.59 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.4 -110.78 0.58 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.3 21.0 2.25 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.866 1.698 . . . . 0.0 110.695 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -140.2 156.74 46.39 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -173.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -123.06 137.9 54.82 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.375 0.534 . . . . 0.0 109.776 173.898 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.63 106.97 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -176.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 115' ' ' LEU . 4.7 tt -88.12 103.72 16.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 170.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 m -85.91 93.66 8.99 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.84 95.63 9.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -121.07 131.61 54.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.66 0.784 . . . . 0.0 111.538 -174.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -113.97 -39.28 3.99 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.539 1.536 . . . . 0.0 110.224 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.84 -80.29 0.26 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 174.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.2 t -58.24 -39.86 80.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.45 141.38 40.4 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 108.766 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -146.22 112.02 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.634 1.574 . . . . 0.0 107.798 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.12 101.46 8.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.245 1.418 . . . . 0.0 110.33 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -56.59 129.83 42.58 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 150.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.94 108.55 10.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.1 113.55 26.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.893 1.277 . . . . 0.0 108.721 -156.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.56 147.57 35.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.946 1.298 . . . . 0.0 112.245 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -124.51 124.22 41.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.219 2.207 . . . . 0.0 106.501 -171.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -75.86 124.7 27.76 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -107.02 -28.51 9.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.387 0.275 . . . . 0.0 111.218 173.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 123.2 0.6 . . . . 0.0 110.705 -177.345 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.764 -0.16 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.97 63.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.084 2.154 . . . . 0.0 110.53 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.18 -43.02 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.88 1.672 . . . . 0.0 108.084 -163.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.15 -43.66 21.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.257 0.623 . . . . 0.0 111.309 -177.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -43.97 102.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.75 1.62 . . . . 0.0 112.949 -169.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.86 -167.52 25.34 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.345 0.974 . . . . 0.0 113.224 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -76.34 110.58 10.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.301 1.441 . . . . 0.0 110.229 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.439 ' CE2' HG13 ' A' ' 42' ' ' ILE . 32.7 m0 -83.57 113.82 21.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 168.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -96.74 125.15 41.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.211 1.004 . . . . 0.0 109.073 174.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.52 141.64 58.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.491 0.587 . . . . 0.0 111.339 -175.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.81 25.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -161.41 158.11 26.26 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.856 1.662 . . . . 0.0 107.506 163.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 t -177.96 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.357 1.463 . . . . 0.0 109.7 -168.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -96.25 138.92 33.15 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 167.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 62.86 -3.69 0.3 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 167.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -59.16 -31.0 68.59 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.542 -1.348 . . . . 0.0 112.106 -173.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.72 -71.18 0.22 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -27.41 -61.24 0.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.458 2.303 . . . . 0.0 111.761 170.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.27 -61.12 1.43 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.912 1.285 . . . . 0.0 111.365 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.412 ' HB2' HG13 ' A' ' 25' ' ' VAL . 22.8 ptp -74.44 -31.56 62.32 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.859 -0.526 . . . . 0.0 111.718 -176.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.28 47.06 0.35 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.869 2.467 . . . . 0.0 109.29 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m 177.47 -45.65 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 128.061 2.545 . . . . 0.0 107.691 -172.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.6 -45.09 66.39 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.204 -0.31 . . . . 0.0 110.93 172.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.95 -84.22 0.13 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.6 OUTLIER -9.01 -68.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.522 2.329 . . . . 0.0 115.549 167.014 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 38.04 39.61 0.7 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.418 1.009 . . . . 0.0 115.067 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 150.66 44.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 72.86 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.463 1.105 . . . . 0.0 108.929 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 57' ' ' PHE . 24.4 m -162.65 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.993 1.317 . . . . 0.0 109.454 -176.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -44.2 63.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.194 0.598 . . . . 0.0 110.651 -172.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -34.79 -41.26 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.637 2.375 . . . . 0.0 114.789 168.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.84 -30.24 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.307 1.443 . . . . 0.0 110.448 177.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.37 59.21 0.63 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.1 2.286 . . . . 0.0 111.668 174.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.93 -69.01 0.07 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.516 3.526 . . . . 0.0 104.886 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -61.53 -36.23 79.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.101 1.36 . . . . 0.0 110.457 -179.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -75.52 14.44 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.64 56.24 12.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.928 1.24 . . . . 0.0 111.773 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.61 153.24 73.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.581 2.188 . . . . 0.0 111.802 -165.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -109.48 165.45 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.216 1.006 . . . . 0.0 109.058 -176.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 m -151.55 106.69 3.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.14 121.07 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 8' ' ' TRP . 41.2 mm -111.1 123.08 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 164.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.79 145.53 48.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.9 m -105.15 110.33 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.7 56.97 3.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.06 -85.55 0.02 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.925 0.774 . . . . 0.0 112.33 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.12 -29.65 21.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.893 1.277 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 173.52 6.29 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.015 1.726 . . . . 0.0 107.95 -177.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.83 148.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -177.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.8 tt -129.84 129.29 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.639 0.776 . . . . 0.0 110.167 -173.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.62 135.9 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 125.354 1.461 . . . . 0.0 107.164 172.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -127.13 119.89 27.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.086 0.954 . . . . 0.0 109.361 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -94.25 84.11 4.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 111.46 -166.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -88.07 95.7 10.24 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.442 1.019 . . . . 0.0 112.778 -168.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.9 p -108.12 154.34 21.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 164.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -76.17 61.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' HG23 ' A' ' 29' ' ' THR . 0.5 OUTLIER -177.93 -49.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.731 0.812 . . . . 0.0 110.148 -170.278 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -146.13 135.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -173.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -134.31 123.32 23.98 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.2 p -134.42 167.06 21.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.52 149.52 33.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.096 0.407 . . . . 0.0 110.544 168.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 pt -146.38 140.75 20.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.321 1.049 . . . . 0.0 109.106 177.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 p -105.03 153.97 20.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 110.335 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -158.9 160.62 36.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.345 0.658 . . . . 0.0 110.167 -178.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -84.48 131.87 34.61 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.94 54.89 1.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.079 0.854 . . . . 0.0 109.954 167.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.78 57.74 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.001 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -173.12 162.57 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.351 1.076 . . . . 0.0 111.037 169.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -100.44 126.22 46.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.063 2.545 . . . . 0.0 109.385 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.32 157.42 35.67 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.603 -0.685 . . . . 0.0 110.603 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -70.57 150.7 45.8 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.512 0.725 . . . . 0.0 109.626 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -163.65 177.01 9.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.167 1.387 . . . . 0.0 107.276 -164.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.4 m -160.46 99.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 120.168 -1.583 . . . . 0.0 108.255 -163.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.544 HG22 ' HB2' ' A' ' 78' ' ' ARG . 5.5 t -82.62 174.76 10.74 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.354 -178.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.17 21.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.204 1.802 . . . . 0.0 115.585 -163.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -139.8 15.6 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.119 2.168 . . . . 0.0 111.37 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.34 40.12 21.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 111.576 -169.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.544 ' HB2' HG22 ' A' ' 74' ' ' THR . 10.4 mmt180 -68.2 111.08 4.32 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 149.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -74.58 71.54 1.88 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.03 154.42 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.802 -175.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.35 120.43 32.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 159.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.18 125.14 30.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 167.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.89 107.35 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.27 135.51 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 -169.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.7 p -145.85 -168.93 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 107.413 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.59 135.52 38.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 167.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.0 24.67 0.23 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.603 1.092 . . . . 0.0 112.602 -167.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -32.21 3.17 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.337 -163.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.36 -46.83 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.108 1.337 . . . . 0.0 113.143 -172.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -127.21 155.92 42.67 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.382 1.873 . . . . 0.0 109.039 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tt -81.49 121.56 26.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.85 104.57 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.893 1.277 . . . . 0.0 107.675 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -99.6 104.26 16.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.42 143.06 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 169.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.03 108.74 10.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -117.86 139.66 50.8 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.712 1.605 . . . . 0.0 107.66 -170.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.63 -78.76 0.58 Allowed 'General case' 0 C--N 1.337 0.064 0 CA-C-N 119.565 1.075 . . . . 0.0 110.717 172.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.23 -60.04 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.57 0.07 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.402 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 153.36 38.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -125.79 170.15 11.89 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 108.233 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -143.57 149.75 37.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 110.269 165.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 p -109.57 138.03 46.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.512 1.125 . . . . 0.0 108.255 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.54 69.03 1.44 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.124 1.369 . . . . 0.0 107.997 -177.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -77.21 146.35 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.566 -174.519 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.99 136.94 35.9 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.723 1.209 . . . . 0.0 110.254 176.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -161.25 147.71 14.59 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 157.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -93.0 102.6 14.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.478 1.511 . . . . 0.0 109.09 167.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.49 -173.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 158.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 50.99 -110.82 0.5 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.79 25.03 2.11 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.072 1.32 . . . . 0.0 110.803 174.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -150.74 153.45 35.54 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.3 1.05 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.7 120.62 31.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -89.0 133.52 30.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.58 121.6 36.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.535 ' HB ' HG12 ' A' ' 105' ' ' VAL . 5.6 m -110.99 109.61 19.81 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.49 124.79 35.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 168.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.3 m -141.57 135.14 29.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.684 0.675 . . . . 0.0 110.723 173.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -137.71 154.7 49.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.376 2.27 . . . . 0.0 108.001 -177.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -30.6 -48.22 0.16 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.569 2.033 . . . . 0.0 115.627 -178.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 t -135.27 41.28 2.81 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.805 0.803 . . . . 0.0 110.6 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.6 126.07 4.44 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.325 -0.86 . . . . 0.0 109.202 169.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 p -118.09 132.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.732 1.213 . . . . 0.0 107.774 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -139.24 112.56 8.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 p -67.12 143.48 56.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 158.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -139.14 162.28 35.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 160.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.73 145.64 26.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 170.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -125.48 162.82 24.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.416 1.486 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -124.87 103.22 7.94 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.045 2.138 . . . . 0.0 105.485 -175.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.53 108.71 12.11 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 -55.98 26.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.865 -173.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 O-C-N 121.93 -0.481 . . . . 0.0 110.939 -171.712 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.92 54.05 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.526 2.731 . . . . 0.0 111.833 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.38 -56.52 0.08 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.81 1.644 . . . . 0.0 106.65 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -47.18 -44.52 22.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.266 1.826 . . . . 0.0 111.93 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -35.52 102.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.037 2.135 . . . . 0.0 112.093 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.43 -156.63 26.28 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.162 0.892 . . . . 0.0 112.906 165.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 m -116.32 127.09 54.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.632 1.173 . . . . 0.0 109.019 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -112.04 156.93 21.39 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.531 1.132 . . . . 0.0 110.463 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 129' ' ' GLU . 25.7 ttpp -119.31 130.65 55.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.503 2.321 . . . . 0.0 107.355 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.93 137.35 58.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.15 -71.23 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.156 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -111.42 139.78 46.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.958 0.799 . . . . 0.0 109.448 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -163.45 160.28 23.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.771 0.828 . . . . 0.0 108.779 167.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 171.66 19.61 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.808 2.043 . . . . 0.0 107.678 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 m120 64.5 12.98 7.84 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.508 1.523 . . . . 0.0 113.78 166.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.91 -39.94 93.76 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 120.426 -1.421 . . . . 0.0 109.895 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.25 -71.75 0.06 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 109.619 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -37.88 -57.74 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.698 1.999 . . . . 0.0 111.971 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.54 -40.65 75.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.971 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -33.04 44.38 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.523 -0.735 . . . . 0.0 111.004 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -72.01 46.76 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.259 2.224 . . . . 0.0 110.436 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p 179.04 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.303 1.841 . . . . 0.0 107.229 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -64.5 -27.88 69.28 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.97 44.31 37.29 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 25' ' ' VAL . 8.2 t -113.29 43.79 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.82 -72.84 0.28 Allowed Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.75 20.49 3.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.104 0.961 . . . . 0.0 111.984 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 171.32 -66.82 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 126.613 1.965 . . . . 0.0 107.456 -168.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -53.79 -43.84 69.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.232 1.013 . . . . 0.0 111.416 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -65.86 -12.25 52.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.271 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -60.2 -23.24 63.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.331 1.423 . . . . 0.0 112.056 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.95 -39.53 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 110.269 167.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.47 -14.03 47.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.199 -0.938 . . . . 0.0 113.735 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -57.77 -47.15 83.34 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.413 1.485 . . . . 0.0 109.731 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.6 ttt -92.3 -42.31 9.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.884 1.274 . . . . 0.0 110.394 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -74.45 66.26 1.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 0.0 112.604 -168.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -149.26 58.57 3.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.871 1.268 . . . . 0.0 110.084 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.3 -44.67 8.67 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.685 2.923 . . . . 0.0 111.869 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.7 m -107.16 157.07 18.15 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.663 0.744 . . . . 0.0 109.217 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 m -148.02 116.83 6.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 162.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 83.1 mt -80.59 137.52 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.7 mm -130.96 91.19 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.556 1.543 . . . . 0.0 106.992 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.84 105.63 17.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.79 140.79 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -125.05 165.57 17.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.499 1.519 . . . . 0.0 107.912 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -25.12 -66.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.613 2.054 . . . . 0.0 115.121 -169.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -118.36 15.05 13.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.792 2.037 . . . . 0.0 110.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.09 179.69 7.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.065 1.746 . . . . 0.0 109.727 -151.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -157.9 150.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.3 tt -124.86 127.61 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.4 tt -94.64 138.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -127.74 99.02 5.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.539 1.536 . . . . 0.0 108.587 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.5 m -72.94 83.89 1.24 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -83.74 113.11 20.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.966 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -139.01 -172.64 3.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.93 1.292 . . . . 0.0 108.372 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -82.86 -80.69 0.17 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -84.06 116.53 22.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 109.662 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 81.29 133.04 0.06 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.586 1.954 . . . . 0.0 108.904 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.12 155.75 49.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 p -150.48 153.45 35.91 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.29 143.23 17.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.738 -0.649 . . . . 0.0 109.989 171.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mm -153.61 142.67 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.688 1.195 . . . . 0.0 108.791 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -89.69 136.87 32.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.779 2.032 . . . . 0.0 109.391 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.1 144.59 38.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.991 0.917 . . . . 0.0 110.345 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.14 106.23 16.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.55 1.54 . . . . 0.0 107.309 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.82 105.01 0.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.959 0.504 . . . . 0.0 111.076 168.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.97 30.42 2.98 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.688 2.09 . . . . 0.0 112.698 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.3 t -146.95 159.88 9.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 107.986 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.76 137.35 49.81 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 111.605 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -135.43 135.74 40.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.84 1.256 . . . . 0.0 109.512 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -93.15 114.98 27.62 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.565 1.546 . . . . 0.0 108.281 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.54 159.15 38.28 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.209 0.459 . . . . 0.0 110.32 -169.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 t -122.38 98.76 6.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.641 1.577 . . . . 0.0 112.063 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -83.78 142.95 30.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.39 -40.91 27.33 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.053 0.941 . . . . 0.0 110.869 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -102.45 42.19 1.17 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.874 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.58 -37.39 0.34 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.213 1.005 . . . . 0.0 110.079 154.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 86.55 -172.24 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.949 2.5 . . . . 0.0 107.093 -163.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -72.71 123.95 24.32 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.738 0.699 . . . . 0.0 110.193 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.93 147.86 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.216 1.406 . . . . 0.0 108.172 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -93.94 101.6 13.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 122.095 0.95 . . . . 0.0 109.932 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.5 m -83.81 116.15 22.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.015 1.326 . . . . 0.0 109.787 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.26 125.23 54.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 166.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.34 138.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -155.24 -176.66 6.05 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 164.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -132.44 105.58 7.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.865 1.266 . . . . 0.0 108.439 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.27 120.57 40.44 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.71 -80.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.722 0.677 . . . . 0.0 111.964 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.14 17.7 1.54 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.195 1.379 . . . . 0.0 111.587 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.5 117.06 30.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 108.342 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 tp -80.1 98.56 7.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.0 m -87.95 107.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -98.25 100.99 12.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.83 141.82 13.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -133.53 99.67 4.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -108.63 114.95 29.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.58 1.952 . . . . 0.0 108.502 -163.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.417 ' HE1' ' NE2' ' A' ' 100' ' ' GLN . 14.1 p90 -107.74 -67.25 0.97 Allowed 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.572 0.624 . . . . 0.0 110.99 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -172.11 -81.32 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.322 0.51 . . . . 0.0 111.734 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.16 -31.96 80.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.417 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -142.68 -172.82 3.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -131.39 -178.99 5.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.118 1.767 . . . . 0.0 107.274 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.5 t -143.56 177.64 8.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.7 p -138.05 136.75 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.669 1.188 . . . . 0.0 108.264 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 115' ' ' LEU . 2.3 mt -129.87 71.33 1.44 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.139 2.176 . . . . 0.0 106.259 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.92 124.92 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.822 -0.549 . . . . 0.0 109.819 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.13 139.42 49.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.784 1.634 . . . . 0.0 110.348 -171.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -156.44 144.29 19.46 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -110.61 120.4 42.28 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 162.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -121.45 167.4 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 156.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.85 -124.44 2.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.13 13.63 7.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.945 1.26 . . . . 0.0 111.93 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -122.93 127.02 48.35 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.389 1.095 . . . . 0.0 109.333 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.65 103.02 4.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 165.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 pt -85.95 127.73 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 104' ' ' LEU . 7.5 tp -115.1 111.3 20.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.67 1.588 . . . . 0.0 106.785 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -88.85 115.35 26.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -102.93 109.78 21.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 m -132.17 131.15 41.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.279 1.031 . . . . 0.0 110.548 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.49 169.14 12.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.814 1.646 . . . . 0.0 108.921 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.44 83.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 166.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 85.52 140.22 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.186 2.594 . . . . 0.0 109.585 -166.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 77.55 145.62 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.088 2.155 . . . . 0.0 112.346 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -137.05 153.61 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.434 1.893 . . . . 0.0 107.29 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.6 137.64 32.04 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.821 -1.175 . . . . 0.0 108.559 161.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -85.37 128.09 34.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 161.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -125.94 113.96 17.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 p -113.31 136.77 52.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.333 0.97 . . . . 0.0 110.386 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.41 146.17 47.6 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.925 1.69 . . . . 0.0 108.646 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 9' ' ' LYS . 40.8 tt0 -130.09 125.04 34.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.056 2.143 . . . . 0.0 106.77 -171.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -66.05 116.6 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.417 1.008 . . . . 0.0 110.146 -171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -91.23 -30.12 16.82 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.645 0.378 . . . . 0.0 111.048 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.16 0 CA-C-N 118.503 0.592 . . . . 0.0 111.138 173.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 63.9 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.078 2.951 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.94 -44.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.873 1.669 . . . . 0.0 107.956 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 42' ' ' ILE . 30.6 m-85 -61.7 -44.82 96.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -174.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -37.04 105.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.992 2.117 . . . . 0.0 111.676 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.91 -163.76 25.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.499 0.571 . . . . 0.0 112.41 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 m -108.94 122.66 47.7 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 110.481 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 61.7 m95 -103.09 162.37 13.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.462 1.905 . . . . 0.0 110.624 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -129.34 132.86 47.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.455 2.302 . . . . 0.0 108.139 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.63 131.38 45.87 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.281 0.633 . . . . 0.0 110.121 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.33 31.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.247 0.619 . . . . 0.0 110.918 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.76 159.49 8.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.401 1.48 . . . . 0.0 108.175 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t 177.07 102.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.442 1.897 . . . . 0.0 107.868 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -135.94 148.71 48.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.179 0.445 . . . . 0.0 110.385 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.34 35.49 20.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.544 1.538 . . . . 0.0 110.807 174.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.35 -19.14 27.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.78 1.276 . . . . 0.0 109.948 -177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -52.99 4.84 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 129.494 3.118 . . . . 0.0 106.146 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -49.68 -40.76 41.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.895 1.278 . . . . 0.0 111.148 166.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.89 -50.6 34.23 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.576 0.75 . . . . 0.0 111.165 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 -37.51 84.69 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.425 -0.797 . . . . 0.0 111.652 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -70.42 61.65 0.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 110.063 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m 168.6 -58.99 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 129.165 2.986 . . . . 0.0 106.795 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.73 -34.78 24.8 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 52.61 42.65 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -170.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.31 -52.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.195 0.998 . . . . 0.0 110.611 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.89 -65.6 3.21 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.873 -0.404 . . . . 0.0 113.579 -163.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.45 101.46 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.779 1.632 . . . . 0.0 112.454 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 135.16 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 129.707 3.203 . . . . 0.0 109.461 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -113.19 -26.5 8.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.929 1.692 . . . . 0.0 111.343 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -66.46 -41.95 88.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.83 1.195 . . . . 0.0 110.888 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -53.21 -36.67 61.26 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.287 1.035 . . . . 0.0 111.197 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.0 t -39.42 -50.86 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.401 1.88 . . . . 0.0 110.329 170.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.06 54.56 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.643 0.64 . . . . 0.0 113.075 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.45 24.97 10.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.85 1.26 . . . . 0.0 111.198 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.5 ttt -152.62 -2.57 0.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.0 m -158.3 169.96 23.32 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.793 -1.192 . . . . 0.0 109.602 -167.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -117.08 73.02 6.53 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 125.204 1.402 . . . . 0.0 108.977 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.22 158.2 58.58 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.431 2.087 . . . . 0.0 109.809 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -100.83 164.54 11.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.74 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.95 113.1 11.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 163.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.37 127.66 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 4' ' ' PHE . 17.2 mm -120.79 110.84 29.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.57 115.95 29.44 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.3 85.87 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -50.41 154.64 1.22 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.521 0.728 . . . . 0.0 110.171 170.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -23.79 -59.28 0.04 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.317 1.913 . . . . 0.0 115.352 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -124.11 13.35 9.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.944 1.298 . . . . 0.0 111.805 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.89 -170.37 3.61 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.937 1.695 . . . . 0.0 108.767 -158.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.29 149.1 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 120.72 -1.238 . . . . 0.0 110.53 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -125.67 140.75 47.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.88 1.272 . . . . 0.0 109.17 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 tt -129.43 145.5 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.454 1.901 . . . . 0.0 109.371 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.0 152.75 51.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.952 2.101 . . . . 0.0 107.842 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.5 m -111.61 62.95 0.62 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.032 1.287 . . . . 0.0 107.717 159.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -61.07 108.15 0.84 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.488 -0.758 . . . . 0.0 110.794 -173.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -116.24 102.1 9.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.334 1.454 . . . . 0.0 108.55 -168.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.8 m 63.92 -75.7 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.155 1.382 . . . . 0.0 111.451 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.33 27.85 0.24 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.119 0.968 . . . . 0.0 110.865 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 96.99 2.71 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.862 -0.524 . . . . 0.0 110.989 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -161.61 163.77 29.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.516 -0.74 . . . . 0.0 111.157 161.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -94.72 175.03 6.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.97 3.308 . . . . 0.0 109.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 152.25 47.98 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.065 1.346 . . . . 0.0 107.976 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.73 137.79 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 p -126.24 147.33 49.7 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.556 0.743 . . . . 0.0 109.399 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -160.82 163.25 32.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.056 0.931 . . . . 0.0 113.124 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -98.83 133.71 42.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -76.56 64.64 2.25 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.83 -0.544 . . . . 0.0 110.161 -178.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.82 57.92 0.01 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.21 159.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 118.4 1.1 . . . . 0.0 111.119 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -88.89 151.61 22.23 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.072 1.349 . . . . 0.0 109.56 160.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.48 150.1 21.16 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.377 0.671 . . . . 0.0 109.265 164.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.44 141.24 32.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.4 156.86 47.2 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.193 0.997 . . . . 0.0 108.946 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -149.71 118.77 6.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.686 0.394 . . . . 0.0 110.178 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -147.35 143.45 28.02 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.88 78.94 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.531 0.732 . . . . 0.0 111.912 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -94.83 19.71 9.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.17 1.788 . . . . 0.0 112.511 -171.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -148.25 -42.38 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.782 0.833 . . . . 0.0 110.721 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 114.69 -160.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 131.383 3.873 . . . . 0.0 108.89 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -85.71 118.4 25.19 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 m -142.26 142.04 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.263 1.025 . . . . 0.0 108.527 -167.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -80.82 126.8 31.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -97.36 143.77 27.78 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.894 0.878 . . . . 0.0 108.714 168.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 94' ' ' VAL . 5.4 tt -136.4 127.62 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 168.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.6 139.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.0 m -158.98 173.82 15.91 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.379 2.672 . . . . 0.0 104.657 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.45 153.76 43.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 120.425 1.466 . . . . 0.0 111.977 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.77 143.27 49.47 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.414 1.486 . . . . 0.0 108.421 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 -77.13 0.04 OUTLIER Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.24 0.924 . . . . 0.0 111.118 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.17 21.27 0.19 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.115 1.341 . . . . 0.0 111.918 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.42 134.21 54.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.119 1.368 . . . . 0.0 108.204 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.06 122.27 29.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.78 109.11 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -94.92 90.96 6.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 166.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 83' ' ' ILE . 14.5 p -89.84 146.58 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -147.06 121.43 9.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -159.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -127.51 127.72 44.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.342 1.457 . . . . 0.0 108.748 -169.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -100.12 -55.01 2.74 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -163.66 -85.1 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.973 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.31 71.8 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 118.225 0.466 . . . . 0.0 112.458 -170.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 177.31 10.62 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.922 0.889 . . . . 0.0 109.073 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.51 163.92 30.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 109.741 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -126.84 152.6 46.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.553 1.541 . . . . 0.0 108.453 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -111.0 124.94 53.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.409 1.483 . . . . 0.0 109.377 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.44 106.71 17.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.182 1.793 . . . . 0.0 106.771 171.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.35 131.58 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -138.64 142.37 39.06 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -159.11 155.81 27.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.284 2.233 . . . . 0.0 106.024 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.4 ttp -106.17 122.63 46.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 160.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.15 162.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 155.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.75 -129.66 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -166.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.01 0.33 24.16 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.526 1.536 . . . . 0.0 111.672 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.44 136.4 50.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.971 0.908 . . . . 0.0 108.982 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 8.2 tt -92.67 112.25 24.14 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.31 97.1 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.4 tp -87.51 131.28 34.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.4 m -126.47 135.46 51.38 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.37 114.87 29.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 128.986 2.914 . . . . 0.0 106.71 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.1 m -120.95 130.34 53.8 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -124.22 159.21 30.66 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.88 -35.35 12.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.658 0.647 . . . . 0.0 112.291 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -124.31 123.87 41.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 92.14 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.042 2.137 . . . . 0.0 112.147 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.14 139.58 27.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.344 1.457 . . . . 0.0 107.293 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.3 t -150.75 128.24 11.44 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.986 0.914 . . . . 0.0 110.457 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 p -81.69 155.22 25.66 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -144.87 68.19 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.08 141.37 58.79 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.604 -0.685 . . . . 0.0 111.225 176.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.75 165.43 19.28 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 126.021 1.728 . . . . 0.0 110.957 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.23 151.22 51.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.168 1.387 . . . . 0.0 109.681 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -86.65 128.5 35.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.908 1.283 . . . . 0.0 109.938 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.86 -15.43 14.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.961 0.8 . . . . 0.0 113.119 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.115 0 C-N-CA 123.193 0.597 . . . . 0.0 110.401 -177.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.26 -22.31 11.43 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 127.979 2.512 . . . . 0.0 112.857 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.95 -34.2 33.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.917 0.887 . . . . 0.0 111.272 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -48.19 56.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.23 108.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.477 1.511 . . . . 0.0 112.211 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.29 -157.46 21.28 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.25 0.477 . . . . 0.0 112.522 171.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.1 m -97.67 113.54 25.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.12 1.368 . . . . 0.0 110.791 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 16.6 m0 -84.77 113.07 21.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.579 1.552 . . . . 0.0 107.753 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.69 129.8 51.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -67.49 143.93 55.94 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.286 -0.884 . . . . 0.0 110.996 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.34 -42.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 120.706 -1.246 . . . . 0.0 111.854 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -138.33 162.58 34.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 t -171.49 126.47 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.67 133.17 45.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.18 29.97 5.92 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.347 1.859 . . . . 0.0 111.06 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -75.41 -53.33 8.87 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.45 -0.782 . . . . 0.0 109.671 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.56 -30.62 67.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.391 -0.193 . . . . 0.0 110.962 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.5 -48.72 62.82 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.22 -0.3 . . . . 0.0 110.56 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -56.82 -61.71 2.25 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 0.0 111.507 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -56.22 -35.1 66.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 63.97 0.23 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.941 0.897 . . . . 0.0 109.874 167.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.4 t 162.77 -56.96 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.963 2.505 . . . . 0.0 106.978 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -26.96 68.54 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.683 0.793 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 -19.81 15.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.885 0.755 . . . . 0.0 113.769 168.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.6 m -40.59 -32.43 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 128.21 2.604 . . . . 0.0 113.951 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.11 73.23 0.17 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -45.21 -58.66 3.1 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.576 1.15 . . . . 0.0 111.236 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.77 -29.54 11.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.641 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.2 p -81.87 -65.87 0.96 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.973 0.909 . . . . 0.0 111.092 -167.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -54.0 -33.1 56.16 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.829 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.9 -27.65 65.43 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.79 1.177 . . . . 0.0 113.9 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.1 t -85.53 -49.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.78 45.65 1.64 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.097 0.856 . . . . 0.0 113.684 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -160.41 -42.38 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.972 1.309 . . . . 0.0 110.555 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtm -60.07 -26.53 66.24 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.793 0.724 . . . . 0.0 110.763 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 m -67.06 66.53 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.107 1.763 . . . . 0.0 112.367 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 44.24 72.57 1.16 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.412 1.885 . . . . 0.0 112.228 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.32 147.79 37.65 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.69 1.593 . . . . 0.0 111.904 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -152.7 160.5 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.408 1.483 . . . . 0.0 108.175 -169.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -154.31 144.86 22.29 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pt -110.32 148.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.225 0.92 . . . . 0.0 108.772 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 30.5 mm -129.68 130.64 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.734 1.214 . . . . 0.0 108.761 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.17 114.88 20.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.507 1.523 . . . . 0.0 109.25 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.87 70.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.9 0.857 . . . . 0.0 110.259 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.89 149.87 43.39 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.571 -0.706 . . . . 0.0 109.976 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -19.89 -67.84 0.01 OUTLIER Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.494 1.997 . . . . 0.0 116.309 -171.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -113.52 14.35 18.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.599 1.559 . . . . 0.0 111.791 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.31 179.75 7.3 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.606 1.563 . . . . 0.0 109.0 -158.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -139.79 101.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.05 143.99 12.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.56 144.14 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -128.62 101.95 6.38 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -76.33 145.95 39.17 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.32 66.75 1.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.08 1.352 . . . . 0.0 108.591 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 m -72.17 -44.81 62.49 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.5 m -150.7 -109.51 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -113.93 -49.52 2.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.677 1.126 . . . . 0.0 111.566 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -77.77 66.72 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -101.41 -171.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.079 1.751 . . . . 0.0 109.402 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 74' ' ' THR . 11.9 p -152.77 171.95 17.44 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.664 1.186 . . . . 0.0 110.047 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -145.34 135.87 24.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.916 1.686 . . . . 0.0 108.21 -172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -145.26 147.81 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.227 1.011 . . . . 0.0 108.577 -172.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.5 p -99.7 97.41 8.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.608 1.563 . . . . 0.0 110.322 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -72.27 148.89 45.01 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.58 20.38 14.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.41 1.084 . . . . 0.0 113.845 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 37.04 32.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.602 1.961 . . . . 0.0 115.934 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.87 47.74 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.307 -0.718 . . . . 0.0 112.006 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -174.7 168.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 118.394 1.097 . . . . 0.0 109.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -104.86 143.47 33.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.621 0.768 . . . . 0.0 111.682 170.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -139.23 156.26 47.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.577 1.551 . . . . 0.0 107.316 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.64 138.62 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.61 62.57 1.59 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -52.46 100.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.873 0.869 . . . . 0.0 110.379 163.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 60' ' ' THR . 10.1 t -117.66 136.05 53.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.261 0.553 . . . . 0.0 110.032 165.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.48 49.64 1.03 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.794 1.237 . . . . 0.0 111.374 -171.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -172.04 -58.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.565 2.346 . . . . 0.0 107.96 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.77 5.1 26.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.84 0.856 . . . . 0.0 113.22 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 83.4 -169.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 163.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -97.88 80.39 2.75 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.168 0.987 . . . . 0.0 109.968 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.74 167.73 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.14 0.976 . . . . 0.0 109.377 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -127.33 97.12 4.79 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.5 t -113.48 114.86 27.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -157.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.3 119.11 29.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.878 1.671 . . . . 0.0 109.007 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.02 140.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 123.675 0.79 . . . . 0.0 110.031 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 p -136.81 166.71 22.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.777 1.631 . . . . 0.0 107.346 166.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -129.05 108.76 10.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.65 121.81 45.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.538 0.608 . . . . 0.0 109.835 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.52 -77.73 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.498 1.047 . . . . 0.0 111.344 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.85 21.47 0.69 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.995 1.283 . . . . 0.0 111.173 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -116.43 123.56 47.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.1 tt -84.23 110.26 18.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.2 t -95.28 116.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -113.05 117.79 32.98 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.1 t -102.79 119.15 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.438 ' CB ' HD21 ' A' ' 104' ' ' LEU . 42.6 tt0 -104.27 85.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 108.713 -169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -82.42 143.14 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.349 1.86 . . . . 0.0 108.396 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -125.74 -59.19 1.37 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.51 166.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -167.2 -87.32 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.353 0.524 . . . . 0.0 111.311 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.72 -23.31 77.92 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.47 175.61 9.42 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.807 0.843 . . . . 0.0 108.728 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -134.45 176.04 8.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.918 2.087 . . . . 0.0 106.455 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -138.14 165.59 26.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 162.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.488 ' C ' HD23 ' A' ' 104' ' ' LEU . 77.4 p -117.9 138.7 51.96 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.155 0.582 . . . . 0.0 110.282 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 103' ' ' SER . 0.1 OUTLIER -134.18 98.0 4.0 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.032 1.733 . . . . 0.0 107.387 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.3 OUTLIER -93.37 142.26 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -130.99 105.0 7.45 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.774 1.629 . . . . 0.0 108.668 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -131.98 142.93 49.76 Favored 'General case' 0 C--O 1.228 -0.042 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -116.67 124.5 49.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 164.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.57 -177.39 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 160.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.7 t70 52.36 -111.74 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.55 33.43 1.31 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -139.89 140.59 36.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -98.44 105.65 17.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.287 1.035 . . . . 0.0 108.412 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.22 105.16 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.32 95.25 9.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' HG12 ' A' ' 105' ' ' VAL . 7.3 m -81.92 115.22 21.0 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.67 105.39 13.25 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.129 1.372 . . . . 0.0 107.466 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 t -135.56 137.4 41.97 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.369 0.532 . . . . 0.0 111.35 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -109.73 -35.17 6.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.148 1.379 . . . . 0.0 111.293 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 -100.65 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 -172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 34.9 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.681 1.192 . . . . 0.0 112.749 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.34 126.04 0.25 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.124 2.169 . . . . 0.0 106.443 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.36 134.44 63.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 126.562 1.945 . . . . 0.0 107.016 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.47 154.27 49.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.897 0.879 . . . . 0.0 109.813 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.6 t -119.14 139.23 52.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 157.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -117.15 95.62 5.07 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.94 101.1 11.46 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -91.43 165.85 13.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.704 1.602 . . . . 0.0 111.028 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -139.31 109.23 6.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -66.06 98.3 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.36 -45.72 65.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 110.459 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 C-N-CA 126.057 1.743 . . . . 0.0 107.597 -176.386 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.46 65.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.11 2.964 . . . . 0.0 111.491 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.72 -49.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.03 2.132 . . . . 0.0 106.203 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -76.22 44.87 0.35 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.496 2.318 . . . . 0.0 111.421 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.1 96.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.53 -157.94 25.32 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -132.17 140.44 48.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.597 0.759 . . . . 0.0 110.185 -168.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -126.22 161.65 27.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.398 1.479 . . . . 0.0 109.548 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -127.65 139.01 52.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.513 1.125 . . . . 0.0 108.359 174.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 13' ' ' SER . 5.9 tt -67.73 145.4 54.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.277 0.49 . . . . 0.0 111.007 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.5 -32.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 0.0 113.474 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 14' ' ' LYS . 18.9 t0 -133.06 154.06 50.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.97 1.259 . . . . 0.0 108.683 170.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' HD21 ' A' ' 10' ' ' LEU . 36.2 t -163.51 27.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.507 2.323 . . . . 0.0 110.879 -164.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 4.3 ptpp? -57.44 146.99 27.66 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.892 -1.13 . . . . 0.0 110.435 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 66.95 5.36 4.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 114.19 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.73 -39.08 76.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.467 1.485 . . . . 0.0 111.466 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.83 -69.69 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.0 110.24 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -30.9 -57.52 0.22 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.94 2.496 . . . . 0.0 111.146 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -45.51 -54.45 7.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 112.66 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -40.41 75.2 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.883 -0.51 . . . . 0.0 110.227 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -73.88 45.81 0.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.52 1.528 . . . . 0.0 110.75 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -171.35 -48.21 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.517 1.927 . . . . 0.0 109.053 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.54 -34.31 70.86 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.885 -0.509 . . . . 0.0 110.914 168.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.85 44.81 3.27 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.92 -30.02 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.376 1.47 . . . . 0.0 108.058 162.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -21.29 114.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.996 0 C-N-CA 127.688 2.566 . . . . 0.0 114.86 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -162.73 -177.13 5.36 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.114 1.366 . . . . 0.0 108.985 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.99 65.24 9.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.22 0.608 . . . . 0.0 109.89 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 m -154.57 -51.12 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.415 0.686 . . . . 0.0 109.624 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -43.81 -34.85 1.7 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 0.0 113.529 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -59.01 -30.54 68.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.042 0.937 . . . . 0.0 112.724 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.74 -37.77 9.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.8 65.3 0.07 OUTLIER Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.239 2.352 . . . . 0.0 112.788 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -179.07 -37.68 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 128.462 2.705 . . . . 0.0 108.336 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.44 -30.22 17.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.227 1.011 . . . . 0.0 110.65 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -64.15 -179.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.374 0.607 . . . . 0.0 111.108 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.44 80.8 2.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.738 1.215 . . . . 0.0 110.054 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' HD13 ' A' ' 10' ' ' LEU . 36.1 Cg_endo -64.31 140.98 73.05 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.471 1.447 . . . . 0.0 110.642 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -121.79 146.53 46.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.155 1.782 . . . . 0.0 107.521 -172.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.2 m -145.49 118.91 9.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.646 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.1 mt -92.76 128.84 44.05 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.88 110.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -120.11 104.5 10.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.445 1.098 . . . . 0.0 108.504 -169.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.18 110.0 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.693 0.759 . . . . 0.0 109.122 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -83.72 60.21 5.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.11 -81.45 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.022 1.296 . . . . 0.0 112.3 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -36.81 20.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.056 1.342 . . . . 0.0 110.242 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 -177.84 3.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.579 1.952 . . . . 0.0 108.225 -173.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.53 143.81 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -124.4 132.8 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 122.94 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -101.47 102.45 13.22 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.16 70.32 1.1 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.973 1.309 . . . . 0.0 107.67 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -78.22 128.62 34.01 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.499 -0.75 . . . . 0.0 110.103 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 t 74.87 -55.52 0.65 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.898 1.679 . . . . 0.0 110.291 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -39.93 81.68 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.603 3.161 . . . . 0.0 114.101 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 66.0 52.98 1.14 Allowed 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.999 1.719 . . . . 0.0 109.852 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 78.22 157.96 0.18 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.094 1.758 . . . . 0.0 107.709 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -71.01 104.76 3.09 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -124.86 177.28 6.1 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.267 1.027 . . . . 0.0 109.089 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -158.61 145.05 17.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -172.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 mt -135.4 120.05 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.484 1.114 . . . . 0.0 108.144 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.0 p -89.29 132.86 34.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.499 1.52 . . . . 0.0 108.805 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -146.39 157.55 43.79 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.71 0.686 . . . . 0.0 110.701 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -124.6 112.29 16.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.03 110.16 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.272 0.229 . . . . 0.0 110.676 170.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.31 37.76 2.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 0.0 111.682 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.5 t -147.14 151.7 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.125 0.97 . . . . 0.0 108.787 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.12 136.95 46.93 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.742 1.617 . . . . 0.0 107.764 163.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.96 -173.5 3.48 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.964 0.905 . . . . 0.0 109.43 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' OD2' ' NZ ' ' A' ' 79' ' ' LYS . 8.1 t0 -110.64 124.19 51.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.408 1.483 . . . . 0.0 108.858 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -112.83 158.8 19.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.536 1.534 . . . . 0.0 109.209 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -147.02 101.55 3.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.71 154.46 36.86 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 124.1 0.96 . . . . 0.0 110.4 -171.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.19 72.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.535 -0.728 . . . . 0.0 111.167 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.83 -4.7 59.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.198 -171.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -154.76 2.79 0.21 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.62 -148.13 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.921 -1.737 . . . . 0.0 109.736 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 71' ' ' ASP . 63.8 tttp -79.32 128.04 32.83 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.642 1.177 . . . . 0.0 109.388 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.62 139.33 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -83.27 125.05 31.18 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.8 t -125.16 147.17 49.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.69 0.677 . . . . 0.0 110.647 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.57 136.56 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.44 141.73 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 t -161.36 -171.4 2.98 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.714 1.206 . . . . 0.0 108.243 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 pp -127.66 135.43 50.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 124.045 0.938 . . . . 0.0 111.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -108.37 91.06 3.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.909 1.683 . . . . 0.0 108.186 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.64 -70.76 0.9 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 123.74 0.686 . . . . 0.0 111.771 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.77 14.87 1.19 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.983 -0.898 . . . . 0.0 112.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -115.48 165.94 12.45 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.5 tt -117.43 115.45 25.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 m -91.16 119.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -113.27 110.97 21.25 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 167.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.52 133.34 60.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -132.12 106.43 7.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.668 0.787 . . . . 0.0 108.948 -158.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -106.23 151.31 24.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.59 2.356 . . . . 0.0 109.529 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -130.32 -62.93 0.91 Allowed 'General case' 0 CA--C 1.522 -0.125 0 O-C-N 121.624 -0.673 . . . . 0.0 109.601 163.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -159.31 -87.54 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 119.41 -0.329 . . . . 0.0 111.375 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.76 -25.28 76.01 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.929 0.786 . . . . 0.0 112.016 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 -177.39 5.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.138 0.975 . . . . 0.0 109.025 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -159.38 -176.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.288 1.435 . . . . 0.0 109.56 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.4 t -144.63 153.43 41.75 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 111.129 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -83.89 155.29 22.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 162.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -142.01 65.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.125 1.77 . . . . 0.0 107.26 161.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.58 141.41 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -124.74 128.41 48.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.322 1.049 . . . . 0.0 109.589 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -141.51 141.3 33.6 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.88 103.23 13.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 166.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.71 172.88 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 154.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 48.83 -122.58 1.68 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -166.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.44 29.91 4.64 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.438 1.494 . . . . 0.0 109.813 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -128.35 126.48 40.8 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.278 0.631 . . . . 0.0 110.889 -167.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.72 109.42 17.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.01 120.39 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -104.37 89.5 3.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.247 1.419 . . . . 0.0 108.026 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 m -76.91 82.81 3.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.222 0.534 . . . . 0.0 109.752 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.57 101.36 6.49 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 108.54 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.39 112.64 20.26 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -110.93 148.52 32.3 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.751 1.22 . . . . 0.0 108.714 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.28 84.68 0.01 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 169.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t 126.82 -2.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 131.631 3.972 . . . . 0.0 113.217 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.63 140.67 18.37 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 119.856 1.207 . . . . 0.0 109.678 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.54 130.41 69.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 124.466 1.106 . . . . 0.0 108.141 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.55 110.87 7.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.542 0.737 . . . . 0.0 109.808 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 76.5 p -70.27 79.63 0.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -64.46 136.65 57.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 158.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 t -156.81 147.28 21.41 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.051 -1.031 . . . . 0.0 108.909 169.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -127.78 159.95 33.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.836 1.255 . . . . 0.0 110.751 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 9' ' ' LYS . 36.1 tt0 -121.49 130.76 53.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.565 2.346 . . . . 0.0 106.231 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -69.89 120.01 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.719 0.69 . . . . 0.0 109.623 -174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -94.76 -31.41 13.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.478 0.711 . . . . 0.0 111.24 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.154 0 CA-C-N 118.428 0.558 . . . . 0.0 110.712 177.682 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.582 -0.247 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.07 53.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.638 2.775 . . . . 0.0 111.393 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.36 -37.04 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.346 1.459 . . . . 0.0 109.133 -159.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.3 -47.46 6.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.965 0.906 . . . . 0.0 109.448 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -48.28 114.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.664 0.785 . . . . 0.0 112.404 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.75 -172.84 21.78 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.521 0.582 . . . . 0.0 112.311 162.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -102.75 123.62 46.77 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.283 0.633 . . . . 0.0 109.585 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -118.87 154.78 32.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.461 1.104 . . . . 0.0 108.975 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -128.6 136.8 51.2 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.41 1.084 . . . . 0.0 108.082 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.08 140.31 58.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.87 -2.6 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.6 145.07 38.09 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.472 1.033 . . . . 0.0 108.511 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -162.53 148.33 12.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.223 1.409 . . . . 0.0 108.765 -172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -159.46 154.14 24.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.709 1.203 . . . . 0.0 107.816 163.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 44.06 29.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.883 1.273 . . . . 0.0 110.649 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -56.26 4.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.778 0.799 . . . . 0.0 109.844 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -54.67 43.91 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.183 2.193 . . . . 0.0 108.902 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.68 -46.2 74.03 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.254 1.022 . . . . 0.0 112.286 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -55.67 -50.17 70.98 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.4 mtt -61.89 -36.61 81.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.219 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -68.62 46.9 0.05 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.808 1.643 . . . . 0.0 111.653 172.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.0 p -165.02 -41.02 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.857 1.263 . . . . 0.0 109.129 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.95 -32.46 74.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 19.98 35.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.194 0.426 . . . . 0.0 112.495 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -38.85 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 162.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.92 -138.32 6.42 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -165.98 -71.35 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -46.57 4.21 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.499 1.52 . . . . 0.0 113.1 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -36.77 -35.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.579 2.352 . . . . 0.0 114.01 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -25.37 40.46 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.148 -0.97 . . . . 0.0 112.436 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -45.12 -35.85 3.37 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.144 0.884 . . . . 0.0 112.711 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.73 -45.41 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.38 -3.55 62.17 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.23 -1.317 . . . . 0.0 115.824 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -110.53 1.37 18.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.645 1.578 . . . . 0.0 111.06 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 ttm -120.42 -59.26 1.78 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.908 0.883 . . . . 0.0 109.503 -162.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.5 m -78.31 76.16 4.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.989 -0.444 . . . . 0.0 109.98 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 5.68 77.96 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 128.846 2.858 . . . . 0.0 113.379 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.79 122.4 11.67 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.691 1.594 . . . . 0.0 109.655 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.0 m -88.21 155.21 19.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 m -147.48 87.95 1.68 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -171.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.9 mt -72.5 119.87 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -116.81 103.26 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.05 146.82 23.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.52 1.528 . . . . 0.0 108.69 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.19 141.81 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.5 165.27 21.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.79 -69.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.627 2.06 . . . . 0.0 115.04 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -131.63 35.05 3.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.393 1.477 . . . . 0.0 110.015 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -147.62 162.97 38.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.81 153.6 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 165.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.22 138.79 53.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 135.14 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -110.54 105.19 14.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.118 0.967 . . . . 0.0 110.387 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -70.24 107.84 3.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 168.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -122.69 112.75 18.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.554 0.742 . . . . 0.0 110.932 -166.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -149.82 170.24 19.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 110.251 168.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -79.41 38.01 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.792 1.237 . . . . 0.0 113.621 -160.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -161.96 -43.4 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.444 -0.785 . . . . 0.0 110.064 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -135.19 130.91 36.06 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.23 121.57 36.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -136.5 128.91 30.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.567 0.621 . . . . 0.0 110.232 -171.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 134.13 41.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.138 1.375 . . . . 0.0 109.147 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.13 123.1 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 p -80.7 160.04 25.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.263 1.025 . . . . 0.0 109.417 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -140.83 86.22 2.03 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.333 1.453 . . . . 0.0 108.591 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -79.99 93.97 5.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 167.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 110.79 0.59 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.395 0.678 . . . . 0.0 112.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.32 28.15 8.25 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.683 1.135 . . . . 0.0 112.016 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.0 t -150.46 159.35 4.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.667 1.187 . . . . 0.0 108.165 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -108.89 140.83 41.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.107 0.963 . . . . 0.0 110.189 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -154.78 157.53 38.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 148.07 47.3 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.096 0.407 . . . . 0.0 110.73 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.66 86.97 2.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.934 2.094 . . . . 0.0 105.795 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.8 m -90.55 96.76 10.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 t -121.16 137.99 54.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.581 0.753 . . . . 0.0 110.634 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.44 49.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.059 0.944 . . . . 0.0 113.436 -168.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -93.66 -75.13 0.51 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -87.35 17.28 4.53 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -162.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.0 mtm-85 80.54 -163.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.295 1.838 . . . . 0.0 110.969 165.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.4 109.37 19.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.192 0.997 . . . . 0.0 108.553 171.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.07 168.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -108.3 135.36 49.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 t -105.03 87.88 2.74 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.196 1.798 . . . . 0.0 109.624 -168.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -80.52 104.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.85 135.78 41.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.4 t -152.48 -162.7 1.56 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 161.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.4 pp -147.47 154.83 41.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.308 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.13 146.61 28.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.08 0.952 . . . . 0.0 109.33 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.52 -82.42 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.105 0.859 . . . . 0.0 111.25 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.73 15.5 0.62 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.105 1.336 . . . . 0.0 111.721 171.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.34 127.49 55.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.543 1.537 . . . . 0.0 108.008 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.18 113.02 25.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.44 132.67 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.99 0.916 . . . . 0.0 109.442 -167.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -115.47 99.3 7.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.18 1.792 . . . . 0.0 106.655 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -87.08 103.99 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 169.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -96.36 96.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -105.37 121.96 44.98 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 125.612 1.565 . . . . 0.0 109.434 -171.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -104.23 -75.87 0.61 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 118.243 0.474 . . . . 0.0 109.852 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.31 139.04 6.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.25 -34.88 1.31 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.031 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.08 -175.37 5.3 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.072 0.949 . . . . 0.0 110.459 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -133.93 177.15 7.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.133 1.773 . . . . 0.0 108.271 165.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.4 143.0 50.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 159.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.72 125.19 50.2 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.173 0.589 . . . . 0.0 109.502 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.46 120.02 32.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.951 1.3 . . . . 0.0 107.646 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -114.4 118.33 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.558 0.617 . . . . 0.0 110.78 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HG2' HD11 ' A' ' 115' ' ' LEU . 28.9 mtm180 -102.0 136.77 41.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 125.187 1.395 . . . . 0.0 110.824 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -160.38 156.67 26.53 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.514 1.126 . . . . 0.0 108.081 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -134.78 130.8 36.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 166.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.15 159.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.52 -72.18 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.699 1.6 . . . . 0.0 112.61 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.28 68.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 mttt 174.02 164.77 0.2 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 129.307 3.043 . . . . 0.0 106.057 160.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.32 117.4 33.03 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.23 140.16 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.6 0.76 . . . . 0.0 110.304 -172.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.518 HD11 ' HG2' ' A' ' 106' ' ' ARG . 1.1 mm? -126.15 118.8 25.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.182 1.393 . . . . 0.0 107.757 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.1 m -100.46 121.35 41.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 161.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -106.52 117.46 34.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -118.39 146.51 44.36 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.979 0.809 . . . . 0.0 109.384 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -127.09 170.82 11.95 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.225 1.81 . . . . 0.0 106.545 175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.83 55.99 3.04 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.472 -0.626 . . . . 0.0 111.765 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t 160.57 -63.51 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.09 2.956 . . . . 0.0 108.414 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.05 143.22 34.21 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.825 0.45 . . . . 0.0 110.362 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 t -134.45 136.93 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.4 t -151.46 133.94 15.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.011 0.524 . . . . 0.0 110.679 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 p -85.77 158.46 20.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.229 0.611 . . . . 0.0 110.14 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -134.84 142.8 46.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 153.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 137.43 38.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.152 0.887 . . . . 0.0 108.924 164.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.06 162.54 21.02 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.093 1.757 . . . . 0.0 109.579 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -133.17 153.19 51.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 165.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -67.73 121.19 15.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.42 1.488 . . . . 0.0 108.468 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.27 -25.28 39.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.408 0.549 . . . . 0.0 112.041 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.846 0.858 . . . . 0.0 109.183 176.258 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -74.65 60.11 0.89 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.251 1.82 . . . . 0.0 110.154 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 -53.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -164.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -87.16 -45.62 10.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.529 0.732 . . . . 0.0 111.437 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.4 t -47.41 120.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.325 0.65 . . . . 0.0 112.276 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.86 -163.07 12.18 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.778 1.18 . . . . 0.0 112.294 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -84.98 139.95 31.42 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.456 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.454 ' CE2' HD13 ' A' ' 42' ' ' ILE . 2.1 m0 -119.93 155.18 33.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.778 1.631 . . . . 0.0 108.343 169.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 137.57 54.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.51 0.724 . . . . 0.0 109.766 163.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.17 147.07 53.88 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.22 0.608 . . . . 0.0 110.289 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.69 42.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.179 0.514 . . . . 0.0 110.935 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.89 153.96 3.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.721 2.009 . . . . 0.0 106.792 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.5 t -159.18 25.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.589 0.756 . . . . 0.0 111.72 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 122.53 16.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.586 1.085 . . . . 0.0 110.048 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 68.11 62.67 0.38 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.097 1.759 . . . . 0.0 110.996 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -83.0 -63.92 1.27 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.35 -0.844 . . . . 0.0 111.486 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.82 -34.52 62.36 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.435 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -36.61 -54.3 0.88 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.754 1.221 . . . . 0.0 110.087 165.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 2.5 t80 -53.93 -51.0 65.19 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.407 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -38.41 76.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.634 0.774 . . . . 0.0 111.421 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -73.13 63.25 0.69 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.457 1.903 . . . . 0.0 111.509 -172.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 158.34 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 130.061 3.344 . . . . 0.0 107.368 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.19 -27.13 68.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.665 0.386 . . . . 0.0 111.588 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.43 -53.88 0.61 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.843 1.211 . . . . 0.0 110.309 169.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t 1.23 -77.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 129.001 2.92 . . . . 0.0 115.284 -170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.1 110.47 0.27 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.992 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -65.74 173.27 2.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.137 0.468 . . . . 0.0 110.261 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.4 -68.99 0.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.134 1.774 . . . . 0.0 111.902 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.4 m -55.77 -54.74 40.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -65.38 -42.49 92.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.047 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.7 -7.92 48.26 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.12 -43.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 118.675 0.67 . . . . 0.0 109.804 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.36 -25.79 67.19 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.07 0.843 . . . . 0.0 112.847 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -66.95 -24.85 66.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.09 0.956 . . . . 0.0 112.239 171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.0 tpt -83.97 -39.3 19.89 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.746 -0.596 . . . . 0.0 110.668 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -63.25 -57.43 10.49 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -177.25 88.61 0.25 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 124.162 0.985 . . . . 0.0 110.463 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -75.25 92.47 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.562 2.175 . . . . 0.0 108.833 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 m -87.94 163.18 16.47 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -142.78 152.33 42.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.5 mt -130.28 128.47 64.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.454 HD13 ' CE2' ' A' ' 8' ' ' TRP . 1.7 mp -111.8 125.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 165.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 128.21 54.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 169.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.31 75.29 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -58.81 153.19 17.51 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.5 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -39.56 -52.0 3.05 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.365 0.983 . . . . 0.0 114.257 -167.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -112.0 0.62 16.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.523 1.529 . . . . 0.0 112.008 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -147.6 -171.48 3.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.809 1.186 . . . . 0.0 109.819 -161.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 t -126.63 130.69 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 166.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.02 150.25 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 165.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -137.06 118.62 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -108.15 131.08 55.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.79 0.836 . . . . 0.0 109.753 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.74 27.3 4.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.213 1.405 . . . . 0.0 111.265 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -49.83 97.86 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.843 1.657 . . . . 0.0 114.166 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 59' ' ' ASN . 3.7 t -138.53 126.9 23.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 128.212 2.605 . . . . 0.0 104.453 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t 55.45 -171.68 0.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.541 1.937 . . . . 0.0 114.729 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -83.66 18.98 1.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.395 1.478 . . . . 0.0 112.776 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -159.3 115.42 2.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 55' ' ' SER . 2.0 t-20 -165.31 -176.73 4.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.271 0.487 . . . . 0.0 110.8 -169.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 p -142.84 171.1 14.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.36 1.464 . . . . 0.0 108.681 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.7 150.22 38.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.4 mt -134.47 164.44 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.806 1.642 . . . . 0.0 106.596 -170.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.8 p -139.19 161.95 36.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -162.76 167.53 22.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.335 0.654 . . . . 0.0 110.091 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -109.31 131.14 55.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 166.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 84.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 165.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.56 42.33 0.14 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.628 1.585 . . . . 0.0 111.725 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -153.46 152.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.195 0.998 . . . . 0.0 109.066 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -111.95 140.92 46.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.213 1.005 . . . . 0.0 109.891 163.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -161.07 158.32 27.56 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.16 134.43 50.51 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -118.57 129.91 55.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -124.23 98.54 5.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 t -122.94 145.61 48.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.949 0.795 . . . . 0.0 111.012 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.44 48.85 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.399 1.079 . . . . 0.0 111.003 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.0 -83.47 0.05 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.918 1.687 . . . . 0.0 106.929 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -75.77 16.24 0.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 76.25 -147.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.03 1.332 . . . . 0.0 109.505 166.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -101.04 136.81 40.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 m -151.54 175.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 126.254 1.822 . . . . 0.0 107.257 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -103.24 132.08 49.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 155.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -92.82 109.54 20.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 mt -104.38 103.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.8 139.23 47.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 122.25 0.22 . . . . 0.0 110.759 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -151.87 156.29 39.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.546 1.139 . . . . 0.0 108.362 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -142.45 145.08 33.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 86' ' ' LEU . 4.5 p-10 -164.45 -146.76 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.874 1.67 . . . . 0.0 106.708 175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.78 48.61 2.99 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.331 0.969 . . . . 0.0 110.864 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.93 27.6 0.2 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.234 0.921 . . . . 0.0 111.663 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 74.76 163.85 0.27 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.647 1.579 . . . . 0.0 111.475 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -79.18 101.53 8.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -89.86 106.34 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -93.88 95.51 9.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 162.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.77 122.28 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 102' ' ' THR . 6.0 tp60 -117.16 99.44 7.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -168.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -119.58 115.11 23.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.513 1.125 . . . . 0.0 111.448 -161.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -96.51 -66.04 0.93 Allowed 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.333 0.515 . . . . 0.0 109.847 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -169.03 -78.31 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 117.751 0.251 . . . . 0.0 111.649 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.58 -30.19 74.66 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 173.45 11.59 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.25 142.27 30.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.199 1.8 . . . . 0.0 106.277 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 95' ' ' GLN . 9.8 t -108.86 148.39 30.68 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.85 0.86 . . . . 0.0 109.565 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 p -104.0 112.75 25.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mt -95.47 92.07 6.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 164.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 126.05 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.16 137.38 48.97 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.754 1.222 . . . . 0.0 110.627 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -161.81 151.52 16.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.957 1.303 . . . . 0.0 107.716 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -107.14 120.53 42.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.766 0.826 . . . . 0.0 109.261 170.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.21 -171.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 163.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.15 -111.15 0.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.02 21.02 3.55 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 126.046 1.784 . . . . 0.0 109.792 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -145.02 147.31 32.48 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.345 1.072 . . . . 0.0 111.112 -166.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tt -102.51 106.73 17.5 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.74 1.216 . . . . 0.0 108.116 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.82 96.17 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.16 106.73 17.48 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -96.42 134.62 39.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 36.0 tp -131.43 94.1 3.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -117.79 125.04 49.86 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.429 0.692 . . . . 0.0 110.816 -172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -103.38 -49.38 3.73 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.235 1.014 . . . . 0.0 110.491 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.22 120.57 2.2 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 106.939 -2.465 . . . . 0.0 106.939 -166.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m 65.65 -68.54 0.12 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.962 1.305 . . . . 0.0 109.317 -165.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.96 134.27 45.86 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -146.83 138.35 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.38 1.872 . . . . 0.0 106.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.73 136.98 31.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.624 0.77 . . . . 0.0 110.125 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 149.42 22.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 164.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -140.42 73.39 1.42 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 161.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.22 123.2 14.49 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.625 -0.672 . . . . 0.0 109.522 171.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -109.63 157.11 19.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.044 1.738 . . . . 0.0 109.38 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.38 118.82 24.86 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -85.4 104.38 15.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 110.536 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -77.35 -20.2 55.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.479 1.036 . . . . 0.0 111.516 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 124.305 1.042 . . . . 0.0 110.124 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.237 0.412 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.98 64.01 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.872 2.469 . . . . 0.0 110.398 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.13 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.282 1.433 . . . . 0.0 107.147 -155.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -90.99 -46.51 8.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.891 1.276 . . . . 0.0 110.733 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.4 t -48.99 97.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.893 1.677 . . . . 0.0 112.526 -172.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 143.31 -161.74 27.63 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.131 0.872 . . . . 0.0 111.318 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -96.89 128.06 43.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.66 0.784 . . . . 0.0 109.99 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.538 ' CG ' HD13 ' A' ' 42' ' ' ILE . 19.5 m0 -98.83 132.74 43.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -110.2 125.69 53.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.897 0.771 . . . . 0.0 109.324 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.51 148.54 48.14 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.754 0.422 . . . . 0.0 110.131 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.251 4.6 p -137.8 -68.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.011 171.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -103.93 123.45 47.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.052 0.842 . . . . 0.0 110.313 -169.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -167.82 148.76 5.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.088 0.555 . . . . 0.0 109.937 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -163.91 174.25 11.7 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.814 1.245 . . . . 0.0 109.165 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.32 38.1 4.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.744 1.618 . . . . 0.0 111.642 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.75 -40.46 5.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.011 0.925 . . . . 0.0 108.601 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -23.97 -77.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.212 1.805 . . . . 0.0 111.88 147.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 9.0 t70 -50.55 -44.49 56.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.297 1.439 . . . . 0.0 112.167 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -55.5 -55.53 30.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.318 0.647 . . . . 0.0 111.107 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 tpt -52.92 -47.02 68.29 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.809 0.844 . . . . 0.0 109.44 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 ttpm? -67.86 62.0 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.627 1.571 . . . . 0.0 110.444 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m 160.65 -57.32 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 129.564 3.145 . . . . 0.0 106.833 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD13 ' NE2' ' A' ' 119' ' ' HIS . 14.2 tp -82.17 -26.14 33.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -167.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.83 91.29 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.055 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -121.76 -58.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.799 1.239 . . . . 0.0 108.844 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.41 -162.54 7.51 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.3 t80 118.21 130.65 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.531 3.132 . . . . 0.0 107.328 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 62.0 8.2 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.028 0.931 . . . . 0.0 112.666 -164.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 p -95.6 -62.49 1.29 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.411 1.484 . . . . 0.0 109.65 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -53.62 -52.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.642 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -60.39 -23.74 64.57 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.383 1.473 . . . . 0.0 113.179 -169.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.02 -52.46 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.69 26.96 1.93 Allowed Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.983 -0.898 . . . . 0.0 114.471 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -141.23 21.51 2.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.468 1.507 . . . . 0.0 109.562 164.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.3 ttm -143.24 -54.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -166.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -92.83 176.4 6.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 156.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.55 82.87 16.24 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.07 156.29 67.0 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.089 1.859 . . . . 0.0 110.36 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -110.8 158.34 18.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.736 0.814 . . . . 0.0 108.935 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 m -138.1 126.87 23.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 42' ' ' ILE . 1.9 mm -85.52 126.74 40.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.538 HD13 ' CG ' ' A' ' 8' ' ' TRP . 3.9 mp -124.03 112.85 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.18 134.74 54.59 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.89 0.876 . . . . 0.0 109.945 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.13 79.69 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.856 0.836 . . . . 0.0 109.407 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -54.3 154.76 4.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.605 167.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.54 -75.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.465 2.459 . . . . 0.0 115.956 -168.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.79 10.34 19.17 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.826 1.65 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -168.27 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.966 2.106 . . . . 0.0 107.644 -151.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.67 147.23 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 161.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -122.14 136.15 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 123.387 0.675 . . . . 0.0 109.253 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mt -112.57 138.57 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.267 1.427 . . . . 0.0 108.051 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -135.48 117.95 15.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.473 2.309 . . . . 0.0 108.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -91.07 100.96 13.72 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.842 1.201 . . . . 0.0 112.596 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.28 72.12 10.2 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.581 -1.325 . . . . 0.0 108.671 169.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 t -88.65 -178.56 5.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 153.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -103.41 37.67 1.95 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.046 0.938 . . . . 0.0 111.553 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.07 82.63 0.86 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -102.53 102.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 156.26 46.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.674 1.99 . . . . 0.0 106.316 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -152.77 144.6 23.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 129.88 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.8 p -99.31 127.42 45.32 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.023 2.129 . . . . 0.0 109.214 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.09 156.62 46.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.128 0.876 . . . . 0.0 111.901 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -102.45 115.74 31.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.92 71.19 0.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.473 0.709 . . . . 0.0 111.363 174.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.26 38.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.635 1.112 . . . . 0.0 111.847 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 t -152.05 154.8 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.566 1.183 . . . . 0.0 109.199 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -106.83 123.57 48.35 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.739 2.016 . . . . 0.0 108.616 166.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -165.36 164.74 19.7 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.097 0.959 . . . . 0.0 109.924 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.77 144.13 55.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.916 0.78 . . . . 0.0 111.56 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -132.64 72.11 1.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.405 2.282 . . . . 0.0 107.166 -173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.8 m -71.25 108.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.437 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.1 t -140.57 144.67 35.98 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.138 0.575 . . . . 0.0 110.679 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.5 57.59 2.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.045 1.338 . . . . 0.0 111.948 -167.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.48 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.755 1.622 . . . . 0.0 108.512 -170.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -73.79 -15.94 61.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.71 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 90.9 -154.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.587 2.755 . . . . 0.0 109.334 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -78.86 59.11 2.51 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.626 -0.672 . . . . 0.0 109.274 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 81' ' ' LYS . 7.7 p -77.83 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.399 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 80' ' ' VAL . 32.1 ttmt -111.17 126.24 54.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.715 0.689 . . . . 0.0 109.655 170.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 p -78.26 108.49 11.63 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -102.14 110.22 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 155.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.06 145.37 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.9 t -155.38 -165.76 2.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.2 1.8 . . . . 0.0 107.112 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 88' ' ' GLY . 0.4 OUTLIER -138.82 145.12 39.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.2 0.27 46.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -166.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.604 ' H ' HD12 ' A' ' 86' ' ' LEU . . . 122.92 -39.18 2.31 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -160.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.92 -63.11 0.09 OUTLIER Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.7 1.143 . . . . 0.0 111.126 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 142.54 38.32 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -169.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.1 tt -79.85 114.7 18.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.88 105.08 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.62 1.168 . . . . 0.0 108.241 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -94.34 107.81 19.75 Favored 'General case' 0 CA--C 1.524 -0.054 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.43 101.93 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 167.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.403 ' CG ' HG21 ' A' ' 80' ' ' VAL . 25.2 tt0 -89.92 102.42 15.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.752 1.221 . . . . 0.0 107.782 -166.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -116.85 127.34 54.2 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.126 0.57 . . . . 0.0 110.987 -165.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -97.72 -107.15 0.18 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.48 136.14 29.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.679 1.592 . . . . 0.0 108.642 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.8 -45.68 3.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.65 177.41 8.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.585 0.692 . . . . 0.0 111.552 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.01 176.79 11.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.532 1.933 . . . . 0.0 108.69 -172.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -132.7 138.42 47.26 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.954 1.301 . . . . 0.0 109.868 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.6 p -76.22 136.64 39.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 168.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 115' ' ' LEU . 29.4 mt -133.69 76.87 1.69 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 164.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.31 120.97 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.502 ' HG3' HD13 ' A' ' 115' ' ' LEU . 1.5 mpt_? -116.0 133.15 56.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.1 1.76 . . . . 0.0 109.868 -174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.33 146.66 29.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.704 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -124.55 107.28 10.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.288 1.435 . . . . 0.0 108.926 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.99 179.95 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 168.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.7 t70 55.36 -98.32 0.08 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.822 0.849 . . . . 0.0 109.664 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.16 32.79 0.5 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.458 1.028 . . . . 0.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -150.73 159.13 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.25 122.31 47.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.85 118.86 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.556 HD11 HD23 ' A' ' 104' ' ' LEU . 4.0 tp -113.31 116.4 29.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 m -96.19 124.35 40.16 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.24 93.28 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.68 1.192 . . . . 0.0 108.276 -171.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -143.47 153.42 42.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 0.0 111.354 -165.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -160.69 138.6 9.64 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 122.738 0.415 . . . . 0.0 110.96 166.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 47.95 -119.01 4.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.857 0.741 . . . . 0.0 111.428 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -73.72 -30.96 63.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.019 0.528 . . . . 0.0 112.193 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 126.3 42.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.365 0.53 . . . . 0.0 109.861 -166.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.69 144.17 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.025 0 C-N-CA 125.602 1.561 . . . . 0.0 109.168 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.25 151.42 32.96 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.6 -1.313 . . . . 0.0 110.826 172.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.5 p -114.89 142.44 46.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.937 1.695 . . . . 0.0 107.384 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -139.73 82.21 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.83 142.16 31.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.774 0.797 . . . . 0.0 109.707 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -119.88 169.0 10.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.711 1.604 . . . . 0.0 108.509 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -116.45 117.45 29.94 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 163.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -75.69 108.67 8.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -78.95 -31.51 45.12 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 118.352 0.524 . . . . 0.0 111.672 -170.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.485 0.179 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.68 59.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.758 3.223 . . . . 0.0 111.959 -168.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.98 -50.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.284 1.834 . . . . 0.0 107.26 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -66.86 -40.49 87.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.813 1.245 . . . . 0.0 110.639 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.25 116.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.123 1.369 . . . . 0.0 111.259 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -129.56 4.28 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.834 1.207 . . . . 0.0 111.199 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 m -148.67 121.9 8.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.77 -0.841 . . . . 0.0 109.837 -171.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -115.15 130.09 56.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.761 1.624 . . . . 0.0 110.484 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -114.0 141.8 46.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.883 0.873 . . . . 0.0 109.483 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.8 144.01 29.13 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 123.399 0.437 . . . . 0.0 110.199 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.6 p -125.83 -73.99 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.513 0.725 . . . . 0.0 109.726 168.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' H ' HG13 ' A' ' 11' ' ' VAL . 5.8 m-20 -108.92 149.58 28.97 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.368 0.985 . . . . 0.0 110.102 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 t -170.89 -175.58 1.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.054 1.742 . . . . 0.0 107.805 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 pttt 177.14 154.16 0.25 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.366 2.666 . . . . 0.0 107.336 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.04 34.08 21.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.675 0.79 . . . . 0.0 109.743 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -95.76 -50.68 4.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -21.45 -74.98 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.719 2.408 . . . . 0.0 113.433 148.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.14 -57.55 8.44 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.988 0.813 . . . . 0.0 111.03 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.59 -48.16 19.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.331 0.586 . . . . 0.0 112.178 -174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -28.06 69.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -74.97 47.07 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.52 1.928 . . . . 0.0 110.514 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.1 t -174.89 -51.86 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.939 1.695 . . . . 0.0 106.887 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.58 -35.71 80.38 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.974 0.51 . . . . 0.0 111.073 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.32 -45.71 1.28 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 76' ' ' ASP . 7.3 p -37.61 -26.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.508 2.323 . . . . 0.0 114.327 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -27.75 -68.64 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.807 1.67 . . . . 0.0 112.96 159.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.58 155.83 38.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.959 0.38 . . . . 0.0 110.111 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 71.89 -52.07 0.69 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.969 1.708 . . . . 0.0 113.786 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.6 m -105.25 -67.37 0.92 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.424 1.089 . . . . 0.0 110.647 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -68.38 -17.42 64.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.282 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -41.22 -49.7 3.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.651 0.78 . . . . 0.0 111.972 163.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -94.33 -38.93 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.09 -40.79 59.56 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.075 0.845 . . . . 0.0 113.165 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -79.31 -12.42 59.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.273 1.037 . . . . 0.0 112.381 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -61.5 1.44 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.253 3.8 t -83.74 79.29 9.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.627 0.727 . . . . 0.0 109.656 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt 12.85 76.44 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 128.766 2.826 . . . . 0.0 113.91 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.25 150.17 76.38 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.998 2.465 . . . . 0.0 113.229 -161.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 m -102.53 159.1 15.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.055 1.742 . . . . 0.0 108.75 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 119.35 12.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 42' ' ' ILE . 87.0 mt -87.49 126.71 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 41' ' ' ILE . 1.5 mp -119.92 114.17 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.06 140.33 53.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.337 0.517 . . . . 0.0 110.302 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 79.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -62.42 74.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.597 1.559 . . . . 0.0 112.11 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.34 -92.73 0.06 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.486 1.041 . . . . 0.0 111.749 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -88.37 -30.09 19.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.409 1.083 . . . . 0.0 110.745 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.05 -175.54 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.493 2.317 . . . . 0.0 109.161 -169.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.13 138.04 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 tt -114.94 131.48 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.509 1.123 . . . . 0.0 108.732 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -120.68 120.45 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.718 2.407 . . . . 0.0 106.346 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -128.88 99.92 5.49 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 t -82.41 43.21 0.8 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.479 1.112 . . . . 0.0 111.778 -172.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.45 124.03 18.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.959 1.704 . . . . 0.0 112.669 -175.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -123.8 -166.54 1.5 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 162.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 t -46.9 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.941 0.896 . . . . 0.0 111.459 -166.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.1 p90 38.66 34.29 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.081 2.152 . . . . 0.0 114.464 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -156.26 162.87 40.09 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.663 0.665 . . . . 0.0 110.634 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 96.71 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 129.547 3.139 . . . . 0.0 110.491 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 p -110.43 174.54 5.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.481 1.512 . . . . 0.0 112.385 -156.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.98 122.17 37.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.593 2.357 . . . . 0.0 106.583 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -129.38 136.73 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 p -141.48 122.23 14.36 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 119.183 0.901 . . . . 0.0 110.316 -168.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -147.54 165.86 29.05 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.095 0.861 . . . . 0.0 111.915 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -101.1 138.34 38.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 166.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -75.0 59.06 0.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.113 0.565 . . . . 0.0 110.506 175.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 157.31 60.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -166.85 172.55 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 117.855 0.828 . . . . 0.0 109.041 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -131.35 152.07 50.94 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.859 0.864 . . . . 0.0 110.793 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.92 160.17 14.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 109.478 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.74 129.03 36.42 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -123.93 123.71 41.02 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -116.1 95.53 5.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.2 t -113.01 140.63 47.66 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.065 0.946 . . . . 0.0 109.899 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.71 48.54 0.82 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.481 1.112 . . . . 0.0 112.217 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 25' ' ' VAL . 34.6 p-10 -163.42 -62.45 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.729 1.612 . . . . 0.0 109.392 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -87.12 -3.64 59.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.75 0.82 . . . . 0.0 111.631 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 83.33 -157.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.837 1.655 . . . . 0.0 109.696 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -74.62 116.34 15.2 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 168.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.63 154.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -81.29 138.18 35.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 150.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 m -100.6 119.74 39.0 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 161.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tt -121.02 123.36 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.02 144.68 32.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 122.562 0.345 . . . . 0.0 110.944 -167.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -157.54 144.15 17.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.55 1.14 . . . . 0.0 109.317 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -85.15 109.11 18.05 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD2' ' NZ ' ' A' ' 90' ' ' LYS . 26.7 p-10 -78.58 29.2 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.325 0.65 . . . . 0.0 112.625 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.4 -36.47 1.56 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.597 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.65 -24.94 5.91 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.097 1.449 . . . . 0.0 113.087 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' NZ ' ' OD2' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -163.3 159.97 23.24 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.733 1.267 . . . . 0.0 109.855 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.95 100.3 8.03 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.16 118.33 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.581 ' HB3' HD12 ' A' ' 104' ' ' LEU . 3.4 t-160 -114.97 108.38 16.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.41 132.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -129.68 99.67 5.23 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -161.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HZ3' ' CD ' ' A' ' 101' ' ' GLU . 39.1 tttp -113.89 110.63 20.41 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.941 0.896 . . . . 0.0 111.648 -159.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -96.56 -27.31 14.9 Favored 'General case' 0 C--O 1.228 -0.048 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -155.68 -143.79 0.13 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.683 0.674 . . . . 0.0 109.897 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -42.74 -41.18 4.27 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.205 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -97.03 175.35 6.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 112.283 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' CD ' ' HZ3' ' A' ' 96' ' ' LYS . 2.3 pm0 -143.71 167.11 23.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.988 2.115 . . . . 0.0 108.301 173.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -98.59 148.14 24.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 148.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -119.31 137.11 53.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -150.94 138.13 19.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.207 0.458 . . . . 0.0 111.138 -175.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.7 m -130.69 117.3 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.663 1.185 . . . . 0.0 110.203 -164.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.424 ' NH1' HD13 ' A' ' 104' ' ' LEU . 8.5 mpt_? -102.77 139.64 38.09 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.873 0.76 . . . . 0.0 109.573 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -153.71 155.63 36.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 153.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 19.8 ttt -91.83 119.36 31.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.857 0.863 . . . . 0.0 108.994 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.6 m -140.46 170.09 14.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 166.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.1 t70 58.73 -85.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.627 1.171 . . . . 0.0 109.616 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.3 26.19 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.04 1.305 . . . . 0.0 110.467 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.48 154.54 47.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.89 117.42 16.71 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.95 120.77 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 168.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.93 104.81 9.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.8 m -94.25 131.93 39.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.93 130.37 53.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 t -141.19 131.99 25.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.546 0.689 . . . . 0.0 110.211 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -119.51 165.37 14.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.169 2.587 . . . . 0.0 105.838 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.78 65.09 1.47 Allowed Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.092 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t 156.45 -59.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 130.105 3.362 . . . . 0.0 108.432 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.15 137.24 35.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.197 0.599 . . . . 0.0 109.931 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.12 134.02 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -155.88 127.53 7.32 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.197 0.908 . . . . 0.0 112.98 -176.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.6 p -78.48 153.57 31.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.958 0.903 . . . . 0.0 109.072 168.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.69 140.13 19.64 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.2 p -133.36 160.34 37.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.945 0.793 . . . . 0.0 109.363 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -145.37 144.99 31.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.576 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -128.39 134.2 48.78 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -79.68 111.81 16.34 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.26 -39.08 82.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 172.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.71 -45.06 6.89 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.386 2.274 . . . . 0.0 111.731 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.87 -21.6 8.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.581 1.952 . . . . 0.0 112.511 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -120.22 17.65 12.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.915 1.286 . . . . 0.0 111.314 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -99.56 94.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.539 0.736 . . . . 0.0 110.954 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.66 -165.92 23.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.824 0.726 . . . . 0.0 113.486 159.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -83.64 143.05 30.35 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.503 0.721 . . . . 0.0 110.125 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -133.26 141.41 48.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.963 1.305 . . . . 0.0 108.513 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 133.01 36.43 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 165.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.11 144.56 56.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 166.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 -57.69 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.492 0.717 . . . . 0.0 111.483 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -78.98 160.08 27.37 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.815 1.189 . . . . 0.0 109.605 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -170.42 56.72 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.779 1.632 . . . . 0.0 108.302 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.38 127.18 35.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 66.97 27.92 8.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.995 1.718 . . . . 0.0 109.876 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.6 -51.34 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 120.033 -1.667 . . . . 0.0 108.089 -171.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -17.9 -77.39 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.835 2.054 . . . . 0.0 112.485 144.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -37.12 -57.45 0.85 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 111.12 175.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' SG ' ' A' ' 124' ' ' CYS . 0.8 OUTLIER -50.9 -50.18 57.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -166.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.72 81.43 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.528 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -77.08 49.52 0.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.535 1.934 . . . . 0.0 109.185 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -178.98 -55.99 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.368 1.867 . . . . 0.0 106.955 -168.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.69 -41.9 95.7 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.92 -44.16 0.87 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.5 42.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.979 1.312 . . . . 0.0 111.327 -172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.3 146.06 17.97 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.871 1.224 . . . . 0.0 112.406 -166.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.1 162.2 1.98 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.014 1.726 . . . . 0.0 107.175 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.35 -18.73 65.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -47.9 -40.01 20.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 112.432 -166.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -31.53 63.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.759 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -62.42 -23.94 67.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.117 0.871 . . . . 0.0 111.729 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.3 t -91.1 -47.94 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.79 -58.75 3.49 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.137 1.351 . . . . 0.0 112.884 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -55.66 -41.94 74.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.774 0.787 . . . . 0.0 110.913 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.359 1.064 . . . . 0.0 112.205 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -86.13 -132.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -145.61 76.53 12.91 Favored Pre-proline 0 C--O 1.234 0.274 0 O-C-N 121.086 -1.009 . . . . 0.0 109.085 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 82.7 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.344 2.696 . . . . 0.0 108.761 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -83.03 148.21 27.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.299 1.84 . . . . 0.0 107.902 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m -140.58 122.31 15.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.183 -0.323 . . . . 0.0 110.282 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -77.77 127.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mt -124.29 117.76 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.29 129.6 49.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.79 96.94 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -78.18 69.82 4.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.37 -89.25 0.05 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.759 1.171 . . . . 0.0 111.531 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -24.67 16.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.52 . . . . 0.0 110.747 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.48 9.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.165 1.786 . . . . 0.0 106.866 -172.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.98 141.7 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.96 133.31 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.762 0.825 . . . . 0.0 108.899 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.9 tt -110.35 132.32 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.754 1.222 . . . . 0.0 107.713 174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -133.95 95.96 3.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.427 1.491 . . . . 0.0 107.328 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.71 138.48 31.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -132.77 116.38 16.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.841 1.656 . . . . 0.0 110.903 -162.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -161.56 151.27 16.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.784 2.034 . . . . 0.0 106.314 161.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 p -56.73 -49.38 75.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.416 0.687 . . . . 0.0 109.502 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -48.87 -38.16 21.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.704 1.201 . . . . 0.0 112.755 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.59 136.27 0.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.922 0.889 . . . . 0.0 109.848 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -141.87 151.07 42.35 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.654 1.582 . . . . 0.0 108.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p -156.34 148.18 22.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.46 0.704 . . . . 0.0 109.351 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -128.04 117.79 22.31 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.071 2.149 . . . . 0.0 108.284 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.96 143.3 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.692 0.797 . . . . 0.0 109.287 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 p -108.19 150.06 27.74 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.472 1.509 . . . . 0.0 110.814 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 84' ' ' VAL . 26.5 p90 -159.61 175.58 13.05 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.909 1.283 . . . . 0.0 108.91 -174.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -134.79 143.64 47.2 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.999 0.92 . . . . 0.0 108.943 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 53.05 1.01 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.302 1.041 . . . . 0.0 112.027 -175.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.12 40.13 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.24 151.18 12.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.1 138.88 35.57 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.926 1.291 . . . . 0.0 109.469 166.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -142.19 158.35 43.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.381 1.472 . . . . 0.0 108.177 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.27 134.55 36.64 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -134.37 151.67 51.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -139.82 166.87 23.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.955 -0.466 . . . . 0.0 109.833 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 t -136.85 -177.27 4.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.162 0.985 . . . . 0.0 109.371 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.78 -25.02 62.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -156.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -95.22 15.02 20.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.233 1.413 . . . . 0.0 111.633 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t0 49.76 41.02 21.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.359 2.264 . . . . 0.0 112.969 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -66.76 87.44 0.13 Allowed 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -77.87 92.86 4.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.607 1.563 . . . . 0.0 109.464 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 97' ' ' TRP . 6.1 m -104.41 171.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.778 1.231 . . . . 0.0 110.079 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.64 135.85 41.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 m -124.57 123.73 40.72 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 107.857 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -117.93 126.21 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.471 HG21 ' CD2' ' A' ' 64' ' ' PHE . 39.1 t -110.24 145.32 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.6 m -148.7 164.32 34.69 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -113.39 113.44 25.21 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.83 107.98 20.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.833 1.253 . . . . 0.0 108.012 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.35 -80.94 0.06 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.318 0.961 . . . . 0.0 112.106 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.67 4.18 3.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.495 1.521 . . . . 0.0 112.344 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -105.17 120.99 42.9 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 107.203 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 91' ' ' LEU . 7.7 tt -78.87 106.17 10.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 169.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 m -95.32 111.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -99.4 106.76 18.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 83' ' ' ILE . 9.9 p -100.65 133.73 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 171.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.9 112.31 12.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -162.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -127.98 125.82 40.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.375 1.87 . . . . 0.0 108.688 -157.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.47 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.7 p90 -108.86 -81.55 0.57 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -162.19 150.76 15.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.96 -44.47 1.55 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.419 0.533 . . . . 0.0 112.044 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.58 -164.91 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.554 1.542 . . . . 0.0 109.196 -173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.77 -170.36 3.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.613 1.565 . . . . 0.0 109.334 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 t -136.14 150.72 49.2 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.623 1.569 . . . . 0.0 107.991 162.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.4 p -98.56 138.47 35.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 163.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.1 mt -131.64 96.83 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.401 1.88 . . . . 0.0 105.939 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.71 131.83 42.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.07 124.84 53.09 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.199 1.4 . . . . 0.0 108.27 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -141.91 122.42 14.13 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -106.74 115.89 30.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 169.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.09 -173.3 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 156.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 52.08 -108.91 0.42 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.48 28.76 2.05 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.859 1.695 . . . . 0.0 109.615 171.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -137.45 122.09 18.57 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.674 0.737 . . . . 0.0 110.128 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.24 92.73 5.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.8 mt -73.1 138.53 21.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.57 105.09 4.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.098 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.0 m -95.33 136.0 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.81 119.9 38.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -126.28 125.2 41.95 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.942 0.337 . . . . 0.0 110.309 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -129.5 165.01 22.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.54 1.536 . . . . 0.0 107.095 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.33 126.07 18.37 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 168.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.99 -58.84 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 112.146 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.78 133.15 34.34 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.694 -0.629 . . . . 0.0 111.862 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.21 130.3 69.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.773 1.629 . . . . 0.0 107.26 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' TYR . 4.4 m -146.99 158.76 44.02 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 121.379 -0.826 . . . . 0.0 109.174 -170.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.7 p -134.35 151.81 51.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.101 0.409 . . . . 0.0 110.738 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -145.2 167.26 23.21 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 156.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 p -136.47 146.43 46.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.22 129.68 52.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.551 1.54 . . . . 0.0 108.779 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -106.18 136.79 45.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.907 1.283 . . . . 0.0 108.422 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -65.25 139.0 58.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.358 0.263 . . . . 0.0 110.728 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -123.81 -6.0 7.99 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.895 0.878 . . . . 0.0 111.722 159.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.144 0 C-N-CA 124.616 1.167 . . . . 0.0 110.922 172.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.236 0.378 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.41 67.9 0.02 OUTLIER 'General case' 0 C--N 1.342 0.278 0 C-N-CA 127.53 2.332 . . . . 0.0 111.091 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.37 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 107.09 -163.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -86.71 -45.67 10.75 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.914 1.286 . . . . 0.0 110.69 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -46.11 108.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.385 1.474 . . . . 0.0 111.645 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.83 -166.46 13.02 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.416 1.008 . . . . 0.0 112.37 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -84.2 138.84 32.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.131 0.973 . . . . 0.0 111.324 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.6 141.17 43.27 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.474 0.709 . . . . 0.0 110.314 167.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -107.87 153.84 22.43 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.463 1.105 . . . . 0.0 109.867 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.96 148.64 16.87 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 167.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.41 -54.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.867 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.49 147.24 39.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.631 1.105 . . . . 0.0 109.01 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -160.47 153.86 22.06 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.234 -0.916 . . . . 0.0 110.73 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -158.13 155.88 29.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.499 1.12 . . . . 0.0 108.541 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 m120 63.71 -10.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.36 -41.52 9.08 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 124.264 1.025 . . . . 0.0 110.869 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -71.76 -24.78 61.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.19 -46.44 56.26 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 165.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.88 -51.36 61.4 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.972 0.909 . . . . 0.0 112.327 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -57.68 -42.65 84.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.294 0.638 . . . . 0.0 109.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.94 57.71 1.09 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.448 1.499 . . . . 0.0 109.22 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t 179.63 -52.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.712 2.405 . . . . 0.0 107.028 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.27 -27.6 68.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.679 0.392 . . . . 0.0 111.575 172.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.45 -47.14 3.69 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 26' ' ' GLY . 8.6 p 0.28 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 130.324 3.45 . . . . 0.0 116.074 167.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' H ' HG13 ' A' ' 25' ' ' VAL . . . -156.05 58.24 0.38 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 168.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -31.56 -61.42 0.22 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 128.003 2.521 . . . . 0.0 111.484 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -125.21 57.94 1.29 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.318 1.047 . . . . 0.0 108.202 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -149.67 -52.54 0.15 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.859 -0.526 . . . . 0.0 109.802 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -59.23 -22.99 61.93 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.453 -1.261 . . . . 0.0 110.863 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -41.57 -35.52 0.75 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.218 1.007 . . . . 0.0 112.696 169.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.82 -67.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.05 45.21 2.23 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.443 1.02 . . . . 0.0 113.817 -173.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -154.03 -34.61 0.1 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.958 1.703 . . . . 0.0 110.886 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.2 ttm -92.22 -21.12 20.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.89 1.676 . . . . 0.0 110.307 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -65.71 -165.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.409 0.623 . . . . 0.0 109.995 159.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -107.37 78.97 0.7 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.597 1.159 . . . . 0.0 109.411 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.65 145.11 62.56 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.113 1.875 . . . . 0.0 110.344 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 m -104.26 126.18 51.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.505 1.122 . . . . 0.0 108.039 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -109.19 99.42 8.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.34 121.22 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.16 128.6 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -107.1 141.56 38.15 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.04 71.39 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.151 0.98 . . . . 0.0 108.695 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -55.05 139.69 40.44 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.882 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.46 -75.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.9 2.191 . . . . 0.0 116.457 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -111.18 18.45 19.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.519 1.928 . . . . 0.0 111.03 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.26 -162.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.954 1.301 . . . . 0.0 108.253 -155.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.89 142.74 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.8 tt -124.98 117.68 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.67 135.79 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -115.3 107.55 15.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.944 2.098 . . . . 0.0 105.746 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -88.25 102.64 15.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -107.59 138.48 43.74 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.034 0.834 . . . . 0.0 111.008 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -169.81 54.86 0.04 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.196 1.398 . . . . 0.0 108.748 -173.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 m 65.71 -75.13 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.653 1.581 . . . . 0.0 111.637 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.33 -51.79 4.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.062 0.945 . . . . 0.0 109.2 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -77.07 76.9 3.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.58 59.84 0.61 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.575 1.15 . . . . 0.0 110.537 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.14 163.62 18.64 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.936 1.294 . . . . 0.0 111.123 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -123.58 156.62 35.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.908 0.883 . . . . 0.0 110.067 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mp -133.53 101.16 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.6 122.6 36.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.811 2.044 . . . . 0.0 108.926 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.58 168.81 22.49 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.097 0.862 . . . . 0.0 112.61 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.58 108.79 13.53 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.539 1.535 . . . . 0.0 107.812 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 96.78 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 122.051 -0.406 . . . . 0.0 110.017 169.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.14 33.3 0.2 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 126.365 1.936 . . . . 0.0 111.832 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.72 149.39 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.835 1.317 . . . . 0.0 109.32 -171.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.85 121.95 44.74 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.268 1.427 . . . . 0.0 107.612 161.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -160.37 155.02 23.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.821 0.737 . . . . 0.0 111.366 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.88 120.11 13.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.203 0.601 . . . . 0.0 110.237 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.76 95.43 5.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 m -103.77 102.6 12.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 t -131.28 146.79 52.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.013 0.925 . . . . 0.0 109.405 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.2 43.92 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.588 1.155 . . . . 0.0 112.066 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -149.98 -68.39 0.2 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.771 1.628 . . . . 0.0 108.264 169.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.99 -12.79 61.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.242 0.928 . . . . 0.0 111.525 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.12 -153.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.256 2.222 . . . . 0.0 108.566 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -80.91 112.37 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 166.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.52 138.21 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -80.41 109.54 15.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.9 p -74.57 149.64 40.06 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 tt -137.36 107.75 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 163.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.18 139.92 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.184 -170.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -156.99 176.96 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.731 2.013 . . . . 0.0 107.206 173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -132.17 122.08 24.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 159.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 176.11 167.51 0.43 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.109 2.564 . . . . 0.0 105.32 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.44 -64.56 1.06 Allowed Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.49 104.93 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 91.83 162.3 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.706 2.402 . . . . 0.0 110.05 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 121.09 26.28 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.24 86.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.992 1.717 . . . . 0.0 108.484 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -81.57 81.13 7.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.5 149.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -153.34 106.17 2.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -158.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -116.13 100.98 8.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.062 2.145 . . . . 0.0 108.121 -160.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -90.61 -62.36 1.47 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.592 1.087 . . . . 0.0 110.48 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -170.13 -85.27 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.157 0.435 . . . . 0.0 111.465 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.82 -20.81 79.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.44 170.02 16.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -133.22 175.48 9.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.945 1.698 . . . . 0.0 107.429 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.3 t -143.02 160.88 39.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.174 0.99 . . . . 0.0 109.218 168.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -127.53 116.8 20.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 108.126 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.32 105.7 15.2 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.194 0.998 . . . . 0.0 108.536 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.46 114.82 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.268 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.56 ' CG ' HD23 ' A' ' 115' ' ' LEU . 67.9 mtt85 -109.75 139.62 44.58 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.97 0.908 . . . . 0.0 109.075 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -161.28 151.09 17.0 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.087 0.403 . . . . 0.0 110.907 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -113.57 107.59 16.0 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.008 0.923 . . . . 0.0 109.756 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.28 -176.97 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 159.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.0 t70 52.21 -113.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -148.29 34.41 1.19 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.559 1.076 . . . . 0.0 110.777 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -144.47 148.45 34.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.39 98.04 10.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.5 128.21 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.8 tm? -131.51 122.85 26.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -119.48 132.28 55.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.3 123.33 45.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.7 m -124.73 132.98 53.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.053 1.341 . . . . 0.0 109.411 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -144.31 170.02 16.79 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.451 0.569 . . . . 0.0 110.565 169.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -45.31 106.82 0.13 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.191 0.901 . . . . 0.0 111.425 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 m 60.04 45.48 11.96 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.959 1.304 . . . . 0.0 112.556 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 119' ' ' HIS . . . -173.01 140.87 0.93 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 144.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.6 144.16 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.542 1.937 . . . . 0.0 106.67 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -149.85 126.44 10.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.186 0.448 . . . . 0.0 111.172 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -76.49 138.06 40.04 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.868 1.267 . . . . 0.0 108.311 163.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -150.75 100.84 2.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 161.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.3 m -97.0 138.44 34.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.889 0.852 . . . . 0.0 109.421 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -114.87 171.2 7.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.063 1.745 . . . . 0.0 108.976 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.02 142.07 47.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.109 1.763 . . . . 0.0 106.257 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -101.23 121.38 41.75 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.129 0.572 . . . . 0.0 110.577 -167.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -126.43 61.77 1.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.275 1.43 . . . . 0.0 109.366 -172.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 C-N-CA 123.696 0.799 . . . . 0.0 109.123 168.453 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.52 -37.6 50.08 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.571 1.948 . . . . 0.0 111.492 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.96 -16.5 63.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.392 1.877 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -119.04 -54.01 2.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.739 1.216 . . . . 0.0 110.426 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -52.56 109.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.6 1.16 . . . . 0.0 111.36 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.85 -177.21 31.46 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 123.849 0.737 . . . . 0.0 112.617 167.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -91.02 129.84 36.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.651 1.58 . . . . 0.0 108.991 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 36.6 m95 -126.59 142.18 51.62 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 109.536 -177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -110.23 140.77 44.02 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.215 1.006 . . . . 0.0 109.551 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.4 tt -70.78 117.74 12.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 p -141.73 53.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 122.245 1.021 . . . . 0.0 108.437 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t0 163.59 156.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 130.347 3.459 . . . . 0.0 106.039 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 t 164.46 135.71 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.541 2.736 . . . . 0.0 108.138 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -106.38 159.07 16.42 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.05 48.19 8.84 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.584 0.707 . . . . 0.0 111.949 161.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -56.53 18.34 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.787 0.803 . . . . 0.0 109.718 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.63 -23.38 31.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.847 -166.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -44.25 -60.64 1.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.854 0.835 . . . . 0.0 109.688 161.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.51 -50.68 67.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.663 -177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.2 ttp -49.38 -47.16 47.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.353 1.061 . . . . 0.0 111.04 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -73.74 56.0 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.467 1.107 . . . . 0.0 111.201 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 m 175.17 -54.71 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.296 2.238 . . . . 0.0 107.374 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -65.48 -38.92 91.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.621 178.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.18 86.96 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 23' ' ' LEU . 32.8 m -61.91 -34.35 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 117.163 0.481 . . . . 0.0 110.979 174.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.16 102.36 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -48.95 -59.45 3.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.306 1.042 . . . . 0.0 110.512 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -55.75 19.98 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.236 0.541 . . . . 0.0 109.834 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -47.67 14.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.16 1.784 . . . . 0.0 112.874 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -61.08 -32.08 71.74 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.046 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.18 -55.79 19.29 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.149 0.886 . . . . 0.0 109.204 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.07 -46.83 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.08 45.27 1.4 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.259 1.409 . . . . 0.0 113.557 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -158.07 -41.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.419 1.887 . . . . 0.0 108.838 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -34.96 75.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.642 167.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.6 t -69.88 22.45 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 35.13 64.66 1.88 Allowed Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.2 1.8 . . . . 0.0 112.692 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.84 156.97 50.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.082 2.522 . . . . 0.0 112.706 -166.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.1 p -119.33 161.27 20.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 109.42 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -149.35 155.45 40.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.8 147.47 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 160.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.59 121.25 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -137.05 110.85 8.14 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.593 0.633 . . . . 0.0 109.765 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.21 95.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.345 1.058 . . . . 0.0 108.353 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -77.35 61.09 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.649 1.179 . . . . 0.0 108.691 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.16 -86.0 0.1 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.742 -0.599 . . . . 0.0 111.766 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -83.31 -43.46 15.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.136 0.969 . . . . 0.0 109.239 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.93 162.07 17.1 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 125.955 1.702 . . . . 0.0 109.554 -172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.39 118.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 103.568 -2.752 . . . . 0.0 103.568 169.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.1 tt -93.42 136.46 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 tt -135.18 149.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.93 141.02 38.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.076 0.853 . . . . 0.0 110.721 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -103.46 44.52 1.01 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.851 1.26 . . . . 0.0 110.82 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.13 116.97 3.09 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.529 1.131 . . . . 0.0 113.409 -157.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.6 t -102.89 -172.43 2.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.653 1.181 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -28.8 61.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.311 1.444 . . . . 0.0 112.322 -167.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.28 51.84 2.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 109.555 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.8 tttt 68.76 173.41 0.29 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.972 0.909 . . . . 0.0 109.087 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -152.41 -173.92 4.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 164.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.4 p -64.99 164.75 12.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.735 0.778 . . . . 0.0 111.536 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.69 136.15 54.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 165.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.3 mt -132.2 146.62 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.01 2.524 . . . . 0.0 106.232 -161.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -146.48 91.27 2.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.716 1.144 . . . . 0.0 111.617 -161.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 84' ' ' VAL . 9.4 p90 -118.12 161.89 19.11 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 110.149 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 130.18 52.32 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.51 60.49 3.9 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.743 0.817 . . . . 0.0 112.286 -162.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.07 49.28 0.05 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -171.68 160.9 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.974 . . . . 0.0 110.082 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.92 147.87 36.18 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.356 1.062 . . . . 0.0 109.798 162.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.74 161.36 15.51 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.93 133.31 44.3 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -124.32 128.97 49.91 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 170.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.1 m -124.74 108.17 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -132.5 137.44 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.413 1.085 . . . . 0.0 109.897 -172.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.78 39.96 0.23 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.275 -0.891 . . . . 0.0 113.043 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -145.88 -54.37 0.27 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.855 1.662 . . . . 0.0 108.191 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.87 1.99 44.6 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -150.08 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.556 1.542 . . . . 0.0 111.089 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -99.07 118.85 36.75 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.097 1.759 . . . . 0.0 108.156 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.98 144.98 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -173.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -70.79 127.7 33.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 153.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -108.28 99.81 9.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.244 1.418 . . . . 0.0 107.275 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.17 103.82 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.998 1.319 . . . . 0.0 107.93 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 64' ' ' PHE . 3.3 t -117.88 139.25 45.77 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 117.882 0.31 . . . . 0.0 110.461 -173.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 p -151.93 -168.43 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.32 2.248 . . . . 0.0 106.971 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 86' ' ' LEU . 3.6 pp -140.82 156.33 46.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 163.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -123.41 134.98 53.9 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.043 1.337 . . . . 0.0 107.514 171.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.86 -82.96 0.02 OUTLIER Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.678 0.656 . . . . 0.0 112.289 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.66 33.76 0.63 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.33 1.443 . . . . 0.0 110.059 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -126.98 123.28 36.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.771 2.028 . . . . 0.0 106.301 -171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.531 HD22 HH21 ' A' ' 106' ' ' ARG . 9.4 tt -82.99 123.5 29.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.06 134.15 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 125.416 1.487 . . . . 0.0 108.63 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -132.81 103.63 6.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.17 140.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 166.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -144.8 114.67 7.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.522 -0.736 . . . . 0.0 109.014 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -127.65 119.36 25.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.751 0.821 . . . . 0.0 110.228 -160.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -102.09 -62.64 1.24 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 119.395 -0.336 . . . . 0.0 110.801 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -163.44 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.56 0.618 . . . . 0.0 112.375 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.58 70.03 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 118.948 0.795 . . . . 0.0 111.713 -172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -179.75 7.49 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.705 1.202 . . . . 0.0 107.804 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -144.68 -178.82 6.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.76 2.024 . . . . 0.0 107.775 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 t -140.93 160.79 39.32 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.176 0.991 . . . . 0.0 108.351 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -137.13 137.54 39.34 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.58 154.59 47.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.11 141.92 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.531 HH21 HD22 ' A' ' 91' ' ' LEU . 61.4 mtm180 -126.64 133.33 51.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.838 1.255 . . . . 0.0 109.865 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -149.85 141.69 23.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -110.53 116.02 30.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 161.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.28 -176.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 161.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.3 t70 51.55 -109.11 0.42 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.27 30.99 1.85 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.322 1.439 . . . . 0.0 110.47 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -147.61 150.15 33.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.169 0.985 . . . . 0.0 110.404 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -89.67 97.93 11.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.35 112.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tp -121.84 109.73 15.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.412 1.085 . . . . 0.0 108.346 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.7 p -102.55 127.26 49.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.18 118.71 37.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.375 1.47 . . . . 0.0 107.762 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.6 p -121.15 125.64 47.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.528 1.131 . . . . 0.0 110.579 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -129.75 71.28 1.44 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.323 1.449 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 -90.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.085 1.326 . . . . 0.0 111.941 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 t -84.15 -38.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.07 0.948 . . . . 0.0 110.346 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.05 141.76 32.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.96 115.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 O-C-N 122.211 -0.306 . . . . 0.0 110.57 -162.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.4 t -131.78 105.06 7.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.099 0.96 . . . . 0.0 110.669 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.4 p -62.85 145.57 54.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 157.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -152.37 119.58 5.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.791 0.836 . . . . 0.0 110.149 161.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 81.8 p -92.89 97.32 10.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.764 -1.21 . . . . 0.0 109.382 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -67.65 164.41 19.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.863 . . . . 0.0 109.611 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.04 140.01 34.2 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.612 0.765 . . . . 0.0 109.598 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -73.17 109.0 6.37 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -90.39 -27.88 19.04 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.76 0.255 . . . . 0.0 110.778 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 123.231 0.613 . . . . 0.0 110.999 -175.682 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.73 60.84 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.64 1.976 . . . . 0.0 111.662 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.26 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.189 1.396 . . . . 0.0 107.494 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -59.04 -54.71 44.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.921 1.288 . . . . 0.0 110.935 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -11.96 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 129.668 3.187 . . . . 0.0 113.613 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.19 -125.47 4.88 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 118.72 0.691 . . . . 0.0 112.172 168.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -129.88 121.49 26.78 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.7 0.8 . . . . 0.0 110.591 -159.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -106.17 132.07 52.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.496 1.118 . . . . 0.0 108.773 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -105.42 125.39 50.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.576 1.55 . . . . 0.0 108.371 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.77 144.91 45.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.542 0.61 . . . . 0.0 110.928 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.15 69.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 118.352 0.523 . . . . 0.0 111.92 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -164.38 178.75 7.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.212 1.405 . . . . 0.0 107.957 172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -162.0 59.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.554 1.07 . . . . 0.0 112.453 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.64 114.62 21.96 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.229 0.612 . . . . 0.0 110.877 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 52.23 28.26 5.43 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.394 2.277 . . . . 0.0 113.065 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -81.52 -43.43 18.78 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 120.74 -1.225 . . . . 0.0 111.386 -167.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -71.32 -55.31 8.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -36.17 -63.17 0.4 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.086 1.354 . . . . 0.0 112.499 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -48.55 -49.93 34.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.372 1.069 . . . . 0.0 110.702 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 68.1 mtp -68.04 -35.57 78.47 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.91 0.484 . . . . 0.0 110.903 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -83.31 40.83 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.662 1.985 . . . . 0.0 109.98 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 p -169.66 -42.44 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.999 2.12 . . . . 0.0 107.146 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.24 -45.75 68.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.276 -0.265 . . . . 0.0 111.292 162.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.98 0.4 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.121 1.343 . . . . 0.0 111.354 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.71 -5.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.45 51.6 4.23 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 119.379 -2.076 . . . . 0.0 112.961 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -50.49 -60.43 3.02 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.192 1.397 . . . . 0.0 112.999 -159.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.83 -31.81 27.91 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.504 -170.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m 64.52 122.3 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.239 1.816 . . . . 0.0 112.513 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 52.86 35.99 20.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 112.243 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.06 -51.7 0.1 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.445 1.098 . . . . 0.0 108.482 170.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 p -35.25 -41.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 128.424 2.69 . . . . 0.0 114.576 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.85 46.34 1.04 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-O 119.194 -0.781 . . . . 0.0 111.268 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -164.11 -37.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.591 0.757 . . . . 0.0 112.139 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.22 -56.35 4.64 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -64.1 -29.18 70.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.198 0.999 . . . . 0.0 112.539 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 73.33 83.41 0.13 Allowed Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.663 1.585 . . . . 0.0 110.007 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.49 134.96 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.441 1.427 . . . . 0.0 109.244 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 m -118.27 144.48 45.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.1 m -126.44 107.21 10.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -83.34 117.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.98 111.08 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.02 148.45 42.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 123.701 0.626 . . . . 0.0 109.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.23 111.46 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.961 0.904 . . . . 0.0 109.52 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -82.82 56.77 3.54 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.07 -83.16 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.946 0.784 . . . . 0.0 112.231 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.38 -36.44 16.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.763 1.225 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.87 177.02 5.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.962 2.105 . . . . 0.0 107.913 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.8 p -152.45 138.45 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 tt -119.98 127.05 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.627 0.771 . . . . 0.0 109.573 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 138.81 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 125.007 1.323 . . . . 0.0 108.751 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -130.09 119.69 23.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.451 1.5 . . . . 0.0 109.085 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -80.96 96.95 7.24 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.374 1.469 . . . . 0.0 108.656 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -79.21 106.76 11.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.857 0.837 . . . . 0.0 109.301 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -131.76 -176.97 4.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.945 2.498 . . . . 0.0 107.812 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 m -145.18 64.26 1.27 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -169.86 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.493 1.517 . . . . 0.0 108.569 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -158.73 131.59 7.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -126.09 156.8 39.45 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -150.29 154.29 37.62 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -150.53 139.15 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.216 0.606 . . . . 0.0 110.113 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mm -150.78 145.37 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.343 1.057 . . . . 0.0 108.712 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 p -97.21 145.85 25.65 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 109.67 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 84' ' ' VAL . 48.3 p90 -151.04 179.45 8.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.15 0.98 . . . . 0.0 109.406 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.81 146.5 28.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.838 0.855 . . . . 0.0 109.264 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.41 69.17 0.38 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.066 1.346 . . . . 0.0 111.151 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 51.87 0.04 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -146.97 140.58 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.849 0.824 . . . . 0.0 109.152 -176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 129.55 53.38 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 166.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.43 168.42 20.31 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -79.53 136.14 36.81 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.291 0.636 . . . . 0.0 110.264 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.34 90.63 3.26 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.607 2.363 . . . . 0.0 106.132 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -86.46 110.69 19.92 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -143.58 160.93 39.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.408 0.683 . . . . 0.0 110.783 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.41 -10.68 53.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.695 0.798 . . . . 0.0 113.139 -168.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -92.64 -57.72 2.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.679 1.592 . . . . 0.0 108.652 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HA ' ' NH1' ' A' ' 78' ' ' ARG 0.416 0.7 OUTLIER -97.76 10.6 39.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.31 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 67.03 -154.24 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.836 1.255 . . . . 0.0 109.163 172.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.45 114.18 21.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 170.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.56 154.92 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -86.62 127.27 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.084 0.856 . . . . 0.0 110.262 167.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -83.83 114.57 21.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.29 1.836 . . . . 0.0 107.636 167.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 mt -113.31 94.64 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 64' ' ' PHE . 4.0 t -116.94 138.85 46.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 O-C-N 122.124 -0.36 . . . . 0.0 111.177 -165.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -156.8 173.62 16.71 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.963 2.105 . . . . 0.0 106.55 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.55 135.23 48.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.594 1.088 . . . . 0.0 110.612 161.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -88.87 61.86 6.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -168.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.25 -35.32 0.66 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.485 -0.619 . . . . 0.0 113.827 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.24 59.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt 171.61 125.0 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.375 2.27 . . . . 0.0 107.91 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -83.95 127.01 33.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.842 0.746 . . . . 0.0 110.038 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.14 110.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.649 1.579 . . . . 0.0 106.961 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -98.82 89.27 4.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 170.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.0 t -74.5 139.56 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -130.96 94.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -159.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.31 114.86 24.2 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.489 0.715 . . . . 0.0 111.243 -167.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.64 -56.73 2.8 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.147 0.43 . . . . 0.0 110.153 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -167.9 -87.07 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.964 0.347 . . . . 0.0 111.425 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.83 -24.69 76.79 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -173.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 172.42 12.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.8 167.56 20.93 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.49 2.316 . . . . 0.0 107.14 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.0 p -133.82 157.54 45.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.448 0.699 . . . . 0.0 109.499 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 p -88.52 138.18 31.65 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.1 mt -125.09 84.32 2.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 159.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -106.23 144.59 15.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.437 0.695 . . . . 0.0 110.105 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 158.0 43.61 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.926 0.491 . . . . 0.0 111.56 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -165.09 153.84 12.23 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.738 1.215 . . . . 0.0 109.132 167.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.9 ttp -114.98 124.83 52.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.163 1.385 . . . . 0.0 109.902 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.88 179.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 157.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.01 -112.65 0.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -172.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.62 30.08 1.56 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.512 1.053 . . . . 0.0 110.988 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -141.61 156.71 45.66 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.2 108.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.477 1.111 . . . . 0.0 108.373 -170.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.5 mm -71.11 141.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 0.0 109.548 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 128' ' ' TYR . 26.9 tp -128.0 85.85 2.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.464 1.106 . . . . 0.0 110.037 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -95.85 111.69 23.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt -113.17 120.35 40.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.8 m -119.24 125.44 49.16 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.776 0.716 . . . . 0.0 109.435 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -123.23 146.15 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 106.844 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -36.24 -52.55 1.29 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.191 0.901 . . . . 0.0 113.469 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -34.05 57.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.05 133.1 29.49 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.188 0.595 . . . . 0.0 110.362 -159.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.08 121.38 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.68 1.192 . . . . 0.0 108.336 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.86 109.4 14.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.673 1.189 . . . . 0.0 109.298 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.86 104.21 12.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.917 1.287 . . . . 0.0 108.217 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -122.43 -177.91 3.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.711 0.804 . . . . 0.0 109.985 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 t -145.6 155.33 42.97 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.151 0.58 . . . . 0.0 109.835 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.431 ' CE2' HD22 ' A' ' 115' ' ' LEU . 53.6 m-85 -115.87 164.95 13.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.588 1.955 . . . . 0.0 108.99 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.17 136.99 49.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -75.53 109.69 9.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.835 -0.541 . . . . 0.0 110.086 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.31 -23.65 23.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.544 0.338 . . . . 0.0 111.542 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 111.508 -178.44 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 119.888 -0.101 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.48 63.22 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.75 2.82 . . . . 0.0 111.725 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.09 -48.14 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.802 2.041 . . . . 0.0 107.099 -171.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -54.82 -43.02 72.57 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.742 1.617 . . . . 0.0 111.566 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.4 t -41.4 109.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.754 1.622 . . . . 0.0 112.487 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.17 -168.45 23.73 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.436 1.017 . . . . 0.0 113.758 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -91.04 122.43 33.69 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.4 1.48 . . . . 0.0 110.451 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -108.32 156.52 19.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.673 1.589 . . . . 0.0 110.415 175.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 135.74 31.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.35 148.05 49.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.994 0.918 . . . . 0.0 111.873 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.65 -15.12 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.233 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' HB3' HG22 ' A' ' 127' ' ' THR . 48.0 t0 -145.86 155.83 43.16 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.145 1.339 . . . . 0.0 110.52 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -173.98 134.52 0.46 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 127.678 2.391 . . . . 0.0 109.095 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.82 166.73 31.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 163.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 63.4 12.3 6.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.267 1.827 . . . . 0.0 112.394 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.02 -52.25 30.71 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.028 -1.045 . . . . 0.0 109.885 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.06 -50.7 63.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.051 2.14 . . . . 0.0 110.101 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -61.69 -39.58 91.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.834 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -47.35 -49.55 24.14 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.316 0.646 . . . . 0.0 110.864 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.67 -28.62 70.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.678 -0.677 . . . . 0.0 112.029 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -73.78 58.96 0.65 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.711 1.204 . . . . 0.0 110.511 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.7 p 168.24 -48.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.945 3.298 . . . . 0.0 106.691 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.04 -35.27 79.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 112.088 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.39 -15.46 63.2 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.297 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -76.21 42.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -161.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.42 96.7 0.05 OUTLIER Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.063 -1.023 . . . . 0.0 113.538 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -62.66 -17.97 61.45 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.851 -1.381 . . . . 0.0 112.786 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.63 -53.73 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.308 1.043 . . . . 0.0 111.679 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 m -66.2 -31.01 71.59 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.994 -0.441 . . . . 0.0 110.896 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -38.96 86.18 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -58.61 -58.12 9.96 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.101 0.864 . . . . 0.0 108.976 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -45.82 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.31 -14.07 71.22 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.453 -1.748 . . . . 0.0 114.937 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -103.12 -38.0 7.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.63 . . . . 0.0 110.744 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.54 -47.42 7.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.866 0.866 . . . . 0.0 111.875 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 m -99.15 90.9 4.75 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 118.861 -0.59 . . . . 0.0 109.722 -161.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 6.35 75.01 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 127.384 2.274 . . . . 0.0 113.415 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.17 93.64 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.363 2.042 . . . . 0.0 109.366 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.0 m -89.19 150.97 22.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.848 1.259 . . . . 0.0 107.889 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.2 m -140.91 140.89 34.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.73 -1.231 . . . . 0.0 108.674 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.0 132.75 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.0 mt -128.14 107.57 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.88 107.03 15.91 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.116 1.767 . . . . 0.0 109.274 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.97 109.31 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -93.79 65.49 3.6 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.17 -87.69 0.09 OUTLIER Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.299 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.15 -6.11 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.501 1.12 . . . . 0.0 112.302 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.2 p -102.2 169.43 8.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.26 117.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 mt -88.32 132.96 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tt -116.44 133.57 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -122.2 137.07 54.96 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.406 1.083 . . . . 0.0 109.043 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 p -105.73 16.83 24.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.04 1.336 . . . . 0.0 113.007 -166.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -44.13 109.05 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.259 1.423 . . . . 0.0 114.418 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -66.81 -41.47 87.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.423 171.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -149.62 -75.85 0.16 Allowed 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -71.68 -54.56 9.95 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.115 -0.366 . . . . 0.0 110.453 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -174.58 156.36 2.39 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.52 -79.02 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -142.52 157.94 44.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.297 1.039 . . . . 0.0 109.29 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.06 133.69 54.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 166.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.72 117.52 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.0 p -106.54 81.45 1.59 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.181 1.792 . . . . 0.0 110.537 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -72.23 143.18 48.9 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.396 -0.815 . . . . 0.0 111.637 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -121.54 112.56 18.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.65 102.98 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.785 0.834 . . . . 0.0 111.665 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.54 54.79 1.3 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.44 170.64 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.51 149.02 43.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.934 0.494 . . . . 0.0 110.387 163.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -141.83 153.44 44.5 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.366 1.066 . . . . 0.0 109.254 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.69 144.53 56.95 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.84 158.21 43.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.815 1.246 . . . . 0.0 108.672 -168.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 t -137.53 146.58 44.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.574 0.75 . . . . 0.0 109.639 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -128.19 170.36 13.09 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.42 -15.46 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -156.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -95.37 13.52 25.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.374 1.47 . . . . 0.0 111.551 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.25 38.2 t0 31.15 57.17 0.25 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.016 2.126 . . . . 0.0 113.658 -156.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -61.63 123.93 19.28 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 116.282 -2.167 . . . . 0.0 106.546 149.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -78.72 112.71 16.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 97' ' ' TRP . 2.0 m -126.27 172.47 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -174.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -108.99 130.38 55.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -88.89 102.17 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.929 1.291 . . . . 0.0 107.636 164.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.75 134.5 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 166.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.01 139.54 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.651 0.659 . . . . 0.0 111.35 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -151.76 -172.15 4.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.101 1.361 . . . . 0.0 107.668 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.7 tt -137.51 113.21 9.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.806 1.642 . . . . 0.0 108.376 -174.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -115.06 105.88 13.47 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.58 1.181 . . . . 0.0 110.843 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.87 -62.14 3.28 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.141 0.877 . . . . 0.0 111.774 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.04 69.88 0.08 OUTLIER Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 pttm 173.5 142.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 106.527 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 91' ' ' LEU 0.302 0.0 OUTLIER -88.81 136.81 32.81 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.121 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 105' ' ' VAL . 23.2 m -115.69 97.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -83.95 104.03 13.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.25 126.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -116.19 105.51 12.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.64 126.69 55.29 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.233 1.013 . . . . 0.0 110.417 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.499 ' HB3' HG12 ' A' ' 80' ' ' VAL . 1.2 p90 -99.62 -62.53 1.23 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.931 0.492 . . . . 0.0 109.732 172.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.92 -92.85 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.31 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.77 -12.61 83.74 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.938 0.79 . . . . 0.0 112.265 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -137.84 164.3 29.28 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -142.11 152.07 42.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 167.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -116.55 148.03 41.25 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -107.66 134.45 50.63 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.013 0.525 . . . . 0.0 109.931 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mp -123.08 90.05 3.22 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.346 1.859 . . . . 0.0 106.733 175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 92' ' ' VAL . 17.5 m -90.15 139.41 17.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.472 HH11 HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -139.17 148.42 43.15 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.059 0.544 . . . . 0.0 111.324 174.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -164.09 155.0 15.59 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.656 1.582 . . . . 0.0 108.06 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.7 ttp -105.08 118.37 36.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.616 0.767 . . . . 0.0 109.086 161.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.24 170.41 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 154.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 52.05 -124.28 2.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -165.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.75 21.75 4.68 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.906 1.241 . . . . 0.0 111.58 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 129' ' ' GLU . 65.2 mttm -137.28 140.77 41.79 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.117 0.958 . . . . 0.0 108.779 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.61 121.56 31.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.38 150.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 HH11 ' A' ' 106' ' ' ARG . 0.5 OUTLIER -137.7 118.0 13.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.8 m -111.89 100.03 8.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.8 115.84 18.75 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.2 m -118.38 114.2 22.55 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.002 0.921 . . . . 0.0 109.98 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 -27.84 14.42 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.471 1.508 . . . . 0.0 109.827 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.39 -92.87 0.2 Allowed Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 t -58.72 -44.33 90.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.81 141.5 29.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.091 0.557 . . . . 0.0 110.717 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.28 129.21 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 126.109 1.763 . . . . 0.0 107.086 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.9 t -116.52 104.74 11.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 108.973 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.4 p -70.37 143.84 51.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 163.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.88 153.9 28.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 166.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 12' ' ' ASP . 3.7 t -146.68 155.7 42.62 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.734 0.697 . . . . 0.0 110.984 -175.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.03 154.25 51.26 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.032 2.133 . . . . 0.0 109.395 -165.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 112' ' ' LYS . 42.5 tt0 -129.22 134.23 47.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.945 1.298 . . . . 0.0 107.843 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -78.22 119.52 21.71 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -104.11 -29.69 10.71 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.656 0.782 . . . . 0.0 110.978 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.379 0.672 . . . . 0.0 110.968 -178.374 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.237 0.418 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.41 55.87 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.979 2.512 . . . . 0.0 111.625 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.65 -38.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.766 1.626 . . . . 0.0 108.849 -161.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -96.55 -34.84 11.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.732 1.213 . . . . 0.0 110.758 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.43 105.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.88 176.93 27.67 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.912 0.778 . . . . 0.0 113.081 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 m -102.49 118.24 36.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -114.66 134.67 54.89 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.417 1.487 . . . . 0.0 107.659 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -112.09 121.12 44.08 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.99 131.89 52.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.266 0.939 . . . . 0.0 108.793 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.51 -64.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 125.068 1.48 . . . . 0.0 110.288 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.21 158.18 17.03 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.078 0.854 . . . . 0.0 110.171 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -175.08 165.02 3.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 107.709 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -149.31 153.94 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 166.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.39 42.49 32.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.217 1.007 . . . . 0.0 110.633 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.8 -55.48 26.04 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.179 -0.951 . . . . 0.0 109.278 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.522 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -25.93 -60.27 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.542 1.537 . . . . 0.0 112.822 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -51.08 -59.9 3.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.131 0.972 . . . . 0.0 112.695 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.2 ptp -63.43 -29.7 70.95 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.674 -0.641 . . . . 0.0 112.403 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp -78.73 45.74 0.62 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.764 2.026 . . . . 0.0 111.379 -172.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.9 m 177.29 -46.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 128.061 2.544 . . . . 0.0 107.396 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -54.34 -31.47 54.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.472 0.709 . . . . 0.0 110.39 173.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 45.6 0.59 Allowed Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 160.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -139.01 -36.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 109.179 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.66 68.46 2.17 Favored Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.279 -0.888 . . . . 0.0 112.28 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.73 70.7 0.72 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 109.92 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 68.8 -60.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.947 2.099 . . . . 0.0 112.55 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -33.08 -46.07 0.15 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.092 2.957 . . . . 0.0 112.801 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -112.47 23.71 13.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.798 . . . . 0.0 112.575 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.86 -23.33 15.4 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.962 1.705 . . . . 0.0 110.053 157.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.67 -46.05 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.32 61.02 2.32 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.296 0.951 . . . . 0.0 113.708 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -178.02 -41.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.033 1.733 . . . . 0.0 108.922 -171.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.1 ttm -54.36 -35.48 62.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.291 0.636 . . . . 0.0 109.946 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 m -65.19 76.54 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.274 0.63 . . . . 0.0 109.852 161.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -20.08 95.04 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.943 2.897 . . . . 0.0 112.562 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.64 165.18 26.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.998 -167.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.5 m -131.46 149.5 52.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.463 -0.79 . . . . 0.0 108.888 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -138.34 95.05 2.94 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.057 -161.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 41' ' ' ILE . 1.8 mp -79.46 127.91 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.9 mt -126.49 109.39 20.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.92 135.99 49.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.102 0.961 . . . . 0.0 109.743 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.08 84.84 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.732 0.813 . . . . 0.0 108.817 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.63 71.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.109 1.764 . . . . 0.0 111.177 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.78 -105.01 0.58 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -34.67 55.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.351 0.66 . . . . 0.0 110.414 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -179.01 4.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.755 2.022 . . . . 0.0 107.236 -167.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.68 146.55 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.5 tt -130.98 132.73 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 133.29 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.391 1.076 . . . . 0.0 108.441 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -114.4 114.5 25.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.859 1.263 . . . . 0.0 108.579 170.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 p -82.21 120.84 25.87 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -117.3 139.49 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.591 1.156 . . . . 0.0 110.818 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 t -167.0 -165.88 0.76 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.829 1.652 . . . . 0.0 109.207 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -62.82 93.61 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.276 1.431 . . . . 0.0 111.837 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 58.49 18.0 5.34 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.515 1.526 . . . . 0.0 112.463 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -134.04 77.11 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -115.99 127.28 54.81 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -173.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.68 159.78 43.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -152.29 158.12 42.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.5 mt -140.99 121.65 13.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -84.41 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 165.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -156.75 144.39 19.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.393 -0.817 . . . . 0.0 111.402 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.56 105.58 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -49.85 109.13 0.25 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.413 0.285 . . . . 0.0 111.051 174.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.65 39.9 1.68 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -154.8 157.26 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.79 145.1 37.26 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.692 0.797 . . . . 0.0 110.474 161.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.65 148.72 24.52 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.77 143.17 40.05 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.0 156.08 44.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.552 1.541 . . . . 0.0 107.845 -173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.1 m -141.12 82.23 1.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.232 1.013 . . . . 0.0 109.09 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -98.32 130.9 44.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.3 -35.49 27.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.962 0.905 . . . . 0.0 112.404 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -96.77 16.6 18.68 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.172 1.789 . . . . 0.0 112.766 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -150.15 2.25 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 163.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 79.76 -164.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.383 1.473 . . . . 0.0 109.003 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -73.81 126.48 30.47 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.12 143.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.679 1.592 . . . . 0.0 108.043 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -83.27 127.1 33.35 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 166.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.2 m -94.63 114.83 26.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.98 123.78 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 166.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 p -132.78 136.9 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -158.2 158.93 35.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 pp -105.98 137.82 43.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.337 0.972 . . . . 0.0 108.813 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -84.03 -11.51 56.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.282 0.633 . . . . 0.0 111.65 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.29 -32.92 5.67 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.22 -39.66 3.45 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.173 1.368 . . . . 0.0 110.905 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -142.05 167.62 21.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.65 1.18 . . . . 0.0 111.424 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 91' ' ' LEU . 6.7 tt -96.94 114.99 26.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.198 0.999 . . . . 0.0 108.519 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.55 112.2 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 126.099 1.76 . . . . 0.0 108.76 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -103.99 108.94 20.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 166.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.56 126.07 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -110.63 117.22 32.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -131.71 120.38 22.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.79 1.236 . . . . 0.0 109.909 -164.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -56.75 2.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -161.8 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.07 -16.26 78.5 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 118.629 0.65 . . . . 0.0 112.592 -171.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.29 173.24 15.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.474 1.11 . . . . 0.0 108.403 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.49 154.83 33.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.962 1.705 . . . . 0.0 108.186 -170.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.9 p -109.4 145.75 35.6 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 110.018 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.09 121.22 36.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -118.85 98.51 6.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.437 1.495 . . . . 0.0 107.554 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.94 118.74 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.05 145.91 38.86 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.963 0.905 . . . . 0.0 109.376 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -160.72 156.7 25.78 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 164.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -121.46 121.88 38.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.117 0.967 . . . . 0.0 109.29 169.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.39 -177.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 160.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t70 53.23 -108.53 0.42 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.97 29.65 1.38 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.678 1.132 . . . . 0.0 111.336 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -140.18 145.22 37.18 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.968 0.884 . . . . 0.0 109.158 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 tt -90.48 110.82 21.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 167.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.07 139.86 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tp -142.44 106.1 4.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 m -98.43 121.59 40.55 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 133.5 45.15 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 t -155.12 156.22 35.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.809 0.731 . . . . 0.0 111.483 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -160.08 168.23 26.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 107.234 165.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.59 -35.39 7.35 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 118.847 0.749 . . . . 0.0 112.44 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 m -46.23 -49.73 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.577 1.551 . . . . 0.0 113.026 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 175.89 169.56 0.39 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.135 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.41 144.94 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 125.404 1.481 . . . . 0.0 108.533 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 16.7 t -158.5 116.32 2.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.581 0.628 . . . . 0.0 111.633 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -73.12 151.09 41.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.239 0.616 . . . . 0.0 109.551 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -140.5 154.46 46.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.597 1.959 . . . . 0.0 106.266 156.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 t -151.84 148.6 28.02 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.67 0.668 . . . . 0.0 110.697 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -129.77 139.04 51.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.606 1.562 . . . . 0.0 108.553 -167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -110.92 138.8 46.87 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.373 1.069 . . . . 0.0 108.899 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -73.02 84.04 1.27 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.607 0.363 . . . . 0.0 111.081 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -59.28 -35.95 74.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.749 0.309 . . . . 0.0 110.726 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 O-C-N 121.842 -0.536 . . . . 0.0 109.735 173.274 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.27 66.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 129.992 3.317 . . . . 0.0 111.311 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.19 -61.35 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.04 48.62 0.87 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.855 2.062 . . . . 0.0 111.282 -168.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 44' ' ' VAL . 45.1 t -142.77 78.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.771 2.028 . . . . 0.0 106.558 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.8 -160.35 23.21 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.668 0.652 . . . . 0.0 113.108 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -87.73 138.65 31.28 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 111.752 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 56.3 m95 -118.9 158.38 25.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.166 1.386 . . . . 0.0 109.084 168.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 155.96 46.89 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.403 0.44 . . . . 0.0 110.668 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 11' ' ' VAL . 2.9 tt -66.95 145.26 55.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.588 1.555 . . . . 0.0 111.051 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 10' ' ' LEU . 6.6 p -127.83 -56.22 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 164.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.39 141.98 47.66 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 t -167.79 152.78 6.85 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -173.19 159.23 3.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.505 1.522 . . . . 0.0 107.497 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 72.02 -4.74 1.89 Allowed 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.148 1.779 . . . . 0.0 111.49 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -41.71 83.52 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -34.92 -69.01 0.1 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.696 1.998 . . . . 0.0 111.916 160.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.36 -47.89 80.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.536 1.062 . . . . 0.0 111.611 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.71 -52.5 10.83 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 111.235 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -31.42 72.48 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -64.46 -62.79 1.38 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -54.72 -46.64 74.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.079 1.351 . . . . 0.0 111.69 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.57 -9.6 57.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.702 1.201 . . . . 0.0 112.247 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.44 51.49 42.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.92 -40.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 109.797 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -45.18 -64.24 2.32 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 125.928 1.727 . . . . 0.0 113.562 -171.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 36.11 -122.7 0.15 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.374 1.87 . . . . 0.0 110.754 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -115.19 48.57 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 m -151.32 -73.32 0.15 Allowed 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.692 -0.63 . . . . 0.0 110.84 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -70.45 -14.38 62.51 Favored 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -55.08 -39.55 69.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.426 0.557 . . . . 0.0 111.341 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.22 -56.18 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.2 -49.77 4.47 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.128 1.347 . . . . 0.0 113.826 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -80.53 -14.78 57.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -59.21 2.87 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 163.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . 0.255 1.2 t -72.24 83.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.682 1.229 . . . . 0.0 111.261 -164.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 84.05 0.98 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 125.826 1.65 . . . . 0.0 107.749 159.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.95 -48.68 1.77 Allowed 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.629 1.553 . . . . 0.0 108.44 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -87.7 141.06 28.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.914 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -147.72 117.43 7.1 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.057 -1.027 . . . . 0.0 108.534 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.43 140.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.78 111.52 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -130.15 125.74 35.78 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.345 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.426 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -64.16 99.84 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 122.029 0.919 . . . . 0.0 110.686 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -74.52 65.15 1.24 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.63 -82.63 0.02 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.396 0.998 . . . . 0.0 112.973 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -99.78 -6.59 26.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 0.0 112.259 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.36 166.33 17.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.223 1.809 . . . . 0.0 107.217 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.98 109.24 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 tt -90.02 129.36 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.48 134.3 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -124.98 105.9 9.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 109.962 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 m -70.09 113.12 6.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.857 2.063 . . . . 0.0 108.083 170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -120.01 135.25 54.99 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.336 0.516 . . . . 0.0 111.243 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -139.69 17.92 2.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.068 0.947 . . . . 0.0 111.256 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t 39.97 38.06 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 111.426 -164.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -174.3 95.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -166.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? 54.85 54.95 8.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.709 0.804 . . . . 0.0 110.146 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -63.08 162.65 11.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.906 1.283 . . . . 0.0 109.893 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.88 164.12 31.11 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.998 0.919 . . . . 0.0 108.756 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -156.04 151.94 27.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.922 0.489 . . . . 0.0 109.994 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.4 144.57 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 p -106.86 88.17 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.908 0.883 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.87 148.37 47.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -132.26 117.41 18.16 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 166.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 96.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.612 1.165 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.34 51.9 1.19 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.35 0.976 . . . . 0.0 111.148 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.38 162.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.0 0.9 . . . . 0.0 110.939 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -101.97 136.48 41.74 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.436 1.894 . . . . 0.0 107.863 167.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.44 149.84 38.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.734 0.814 . . . . 0.0 109.191 170.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.32 136.83 37.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.29 153.6 47.8 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.82 1.248 . . . . 0.0 109.144 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -130.66 68.58 1.47 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.875 1.67 . . . . 0.0 110.016 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -83.76 143.73 29.79 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.09 40.23 0.33 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.618 1.167 . . . . 0.0 112.851 -167.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -161.02 -75.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.569 1.548 . . . . 0.0 107.859 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -27.64 65.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.69 0.796 . . . . 0.0 111.729 174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 98.8 -155.63 0.0 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 128.628 2.771 . . . . 0.0 107.971 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -81.4 116.33 21.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.13 177.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.474 1.51 . . . . 0.0 107.709 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -107.42 128.25 54.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.768 0.713 . . . . 0.0 110.176 164.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.93 126.08 35.96 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 168.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.44 125.26 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.63 145.37 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 160.51 41.03 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.5 2.72 . . . . 0.0 105.811 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tt -140.93 73.62 1.43 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 p30 176.4 164.18 0.42 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -156.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 -69.17 0.9 Allowed Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.21 56.91 0.65 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt 56.94 -130.66 1.65 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.007 0.923 . . . . 0.0 109.208 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp -81.88 79.29 8.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 109.834 -170.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.39 111.5 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.846 0.858 . . . . 0.0 109.984 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -117.95 115.8 25.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.798 1.239 . . . . 0.0 109.639 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.19 150.74 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 170.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -131.81 95.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 106.354 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -112.64 117.14 31.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -170.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -89.56 -111.0 0.08 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -122.87 -74.01 0.63 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.761 1.224 . . . . 0.0 111.488 -173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.74 61.81 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.569 0.622 . . . . 0.0 111.722 -170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.5 -179.91 6.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -149.29 156.85 42.74 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.371 1.869 . . . . 0.0 106.291 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.6 t -127.8 155.9 43.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.536 0.684 . . . . 0.0 109.254 160.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.1 p -96.17 150.7 20.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 164.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 pp -151.94 101.63 2.75 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 164.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 m -108.91 128.85 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.043 0.537 . . . . 0.0 109.601 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -94.26 99.23 11.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 108.318 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.94 143.67 28.29 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -137.11 120.01 16.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.09 -168.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 51.91 -116.93 1.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.35 23.58 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 126.137 1.827 . . . . 0.0 109.485 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -134.26 129.55 35.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.401 0.681 . . . . 0.0 109.461 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 6.8 tt -87.68 105.09 17.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 64.6 mt -82.05 103.22 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.88 101.23 13.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 166.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.4 t -99.27 130.92 45.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.65 126.36 43.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.296 1.439 . . . . 0.0 109.775 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.7 m -131.88 114.0 14.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -97.62 146.63 25.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.764 2.026 . . . . 0.0 107.456 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.01 92.06 0.02 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 167.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 m 135.2 -28.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 131.402 3.881 . . . . 0.0 111.851 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.27 153.62 37.82 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.28 1.4 . . . . 0.0 112.46 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.9 t -124.79 143.73 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.093 1.757 . . . . 0.0 107.964 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 t -158.6 158.54 34.08 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 t -126.24 158.06 36.67 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.672 -0.642 . . . . 0.0 109.942 164.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -119.59 130.89 55.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 150.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -108.79 124.94 51.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -112.89 154.54 26.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.005 1.722 . . . . 0.0 109.839 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -122.01 137.07 54.94 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.756 1.622 . . . . 0.0 107.395 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -75.37 125.38 28.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.23 -4.06 17.92 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.033 0.533 . . . . 0.0 111.336 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 C-N-CA 124.778 1.231 . . . . 0.0 110.864 174.111 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.08 58.38 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 129.345 3.058 . . . . 0.0 111.894 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.27 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.153 1.781 . . . . 0.0 107.516 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -59.27 -42.88 92.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.495 1.118 . . . . 0.0 111.221 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.1 t -40.62 101.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.197 1.799 . . . . 0.0 111.814 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.29 -154.69 25.92 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.188 0.899 . . . . 0.0 112.196 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -118.25 119.71 35.49 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.502 1.521 . . . . 0.0 109.656 -170.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 87.7 m95 -109.29 141.93 40.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.521 1.128 . . . . 0.0 110.177 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -115.11 137.71 51.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 171.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -77.75 128.34 33.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.94 -45.64 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.429 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -128.92 151.14 49.98 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 110.008 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 t -170.14 150.55 3.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.596 2.358 . . . . 0.0 108.719 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -138.87 148.74 44.05 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m120 62.68 43.86 7.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.222 1.409 . . . . 0.0 111.452 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -70.53 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.804 -0.56 . . . . 0.0 109.75 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.57 -49.66 72.13 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -30.03 -53.88 0.16 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.702 2.001 . . . . 0.0 112.547 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -51.93 -51.93 53.57 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.752 -0.593 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.0 ptp -74.23 -33.12 63.25 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.434 -0.791 . . . . 0.0 111.793 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -40.96 75.97 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.473 -0.767 . . . . 0.0 111.166 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -82.09 -41.18 20.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.494 1.117 . . . . 0.0 110.219 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.1 -39.13 74.44 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.199 0.454 . . . . 0.0 111.844 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 55.14 0.81 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.78 -9.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.64 1.176 . . . . 0.0 111.678 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.48 78.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.105 -0.997 . . . . 0.0 114.248 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -48.81 139.26 10.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.911 1.285 . . . . 0.0 109.039 156.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.95 62.76 0.62 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.22 1.008 . . . . 0.0 111.01 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 m -147.9 -37.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.814 -1.179 . . . . 0.0 111.272 -175.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.8 tpt85 -56.69 -37.83 71.42 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.229 0.922 . . . . 0.0 109.678 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -43.01 -32.96 0.72 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.386 2.675 . . . . 0.0 115.074 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -110.29 -35.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.007 0.821 . . . . 0.0 111.347 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 26.85 0.65 Allowed Glycine 0 CA--C 1.539 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 113.973 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -122.96 -39.21 2.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.062 3.345 . . . . 0.0 109.54 -173.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -42.6 70.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.733 1.213 . . . . 0.0 108.731 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -60.12 116.26 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 156.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -64.66 114.44 14.53 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.983 -168.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.85 156.57 56.53 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 120.246 1.124 . . . . 0.0 109.667 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.6 m -130.99 153.98 48.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.298 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -147.51 117.42 7.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.82 144.13 11.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 166.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.53 111.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.39 143.75 51.04 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 0.701 . . . . 0.0 110.993 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 80.5 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 122.46 1.124 . . . . 0.0 110.133 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -65.42 78.29 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.008 0.923 . . . . 0.0 111.398 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.04 -114.0 6.21 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -86.6 -12.55 48.27 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.431 0.615 . . . . 0.0 111.296 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -102.05 179.32 4.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.449 1.1 . . . . 0.0 108.36 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.82 138.94 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 166.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.6 tt -112.55 134.25 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.59 143.61 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 O-C-N 123.98 0.8 . . . . 0.0 109.137 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -131.94 111.7 11.77 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 m -104.12 128.33 51.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.728 1.611 . . . . 0.0 110.104 -167.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -105.38 125.1 50.6 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.697 1.999 . . . . 0.0 109.121 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -148.92 68.61 1.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 p 48.3 96.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.157 2.183 . . . . 0.0 114.194 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.6 t80 71.02 -64.98 0.36 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.302 1.841 . . . . 0.0 109.615 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.31 134.76 45.25 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.05 156.34 39.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -172.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.14 158.18 43.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.82 132.23 13.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 mt -147.52 127.68 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 p -88.94 133.68 34.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.859 1.264 . . . . 0.0 108.469 164.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.75 160.65 42.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 127.56 43.52 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 86.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 169.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.07 41.98 0.19 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.095 1.807 . . . . 0.0 111.474 168.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.5 t -147.71 153.05 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.368 1.084 . . . . 0.0 109.575 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -113.04 133.98 54.73 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 126.724 2.01 . . . . 0.0 107.463 167.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -163.21 -179.34 6.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.268 0.94 . . . . 0.0 111.136 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.5 121.53 29.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 109.225 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 107.52 15.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.453 1.901 . . . . 0.0 106.255 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.3 53.85 0.76 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.095 0.558 . . . . 0.0 111.233 -164.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 146.8 50.42 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.456 -0.777 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.02 63.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.009 0.923 . . . . 0.0 112.267 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -94.81 -50.41 5.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.836 1.654 . . . . 0.0 110.299 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -56.44 -25.62 51.17 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.182 0.446 . . . . 0.0 111.802 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 77.64 -166.05 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.889 2.075 . . . . 0.0 109.021 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.33 89.32 2.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.93 149.93 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.917 0.887 . . . . 0.0 109.747 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -85.08 116.9 23.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -80.63 146.87 30.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -139.57 125.74 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 157.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.93 143.92 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -166.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -155.57 -172.82 4.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.51 1.924 . . . . 0.0 108.232 -176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -135.63 113.02 10.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.12 125.97 43.36 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.84 -78.95 0.01 OUTLIER Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.342 0.973 . . . . 0.0 113.465 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.34 26.49 1.1 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.524 1.535 . . . . 0.0 111.742 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 130.53 48.9 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.084 1.354 . . . . 0.0 109.182 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.6 112.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.318 1.447 . . . . 0.0 107.36 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.01 126.62 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.376 1.07 . . . . 0.0 108.258 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -135.07 102.44 5.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.516 0.727 . . . . 0.0 109.891 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -88.87 147.2 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -141.8 99.39 3.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -119.74 108.81 14.87 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.441 1.897 . . . . 0.0 109.655 -160.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -60.2 1.68 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.322 0.51 . . . . 0.0 110.557 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -165.01 -81.51 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.235 0.47 . . . . 0.0 112.217 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.93 -26.16 74.46 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 118.786 0.721 . . . . 0.0 111.58 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 173.37 16.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.14 1.376 . . . . 0.0 107.725 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -131.21 140.29 49.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.968 2.107 . . . . 0.0 107.956 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 t -98.05 174.8 6.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 163.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.7 p -155.82 155.04 32.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 153.93 39.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.739 172.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.65 139.56 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -128.18 140.37 51.95 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.381 1.072 . . . . 0.0 109.51 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.08 133.74 16.7 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.416 0.686 . . . . 0.0 109.228 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -103.98 119.49 39.04 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.2 176.51 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 153.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.31 -118.1 1.26 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -170.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.92 21.22 3.75 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.188 1.375 . . . . 0.0 110.873 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -124.6 127.42 47.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.794 0.838 . . . . 0.0 108.764 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 2.4 tt -91.75 91.1 7.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.06 143.28 13.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -150.72 141.51 22.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.701 0.763 . . . . 0.0 112.712 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.9 m -106.81 124.73 50.04 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 125.109 1.364 . . . . 0.0 107.992 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.47 75.7 1.04 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.087 1.755 . . . . 0.0 107.192 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -128.13 138.81 52.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.281 0.562 . . . . 0.0 110.365 -165.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -160.18 155.64 25.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -46.62 -34.55 6.88 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.026 0.822 . . . . 0.0 113.121 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.8 t -51.75 -41.83 61.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.377 1.071 . . . . 0.0 111.852 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.87 127.15 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.678 1.591 . . . . 0.0 110.063 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.04 136.81 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -150.66 156.0 40.47 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.349 -1.469 . . . . 0.0 110.154 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -143.5 163.37 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.648 0.779 . . . . 0.0 109.321 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -167.27 168.74 13.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.302 1.041 . . . . 0.0 111.069 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 t -136.8 136.49 38.89 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.957 0.884 . . . . 0.0 109.591 163.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -89.02 155.81 19.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.736 164.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.6 146.58 44.16 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.771 1.228 . . . . 0.0 107.867 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -81.79 114.53 20.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -90.82 -26.64 19.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.031 0.378 . . . . 0.0 111.697 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.161 0 CA-C-N 118.39 0.541 . . . . 0.0 110.781 174.471 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.238 0.47 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.6 61.42 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.932 2.093 . . . . 0.0 110.576 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.08 -40.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.028 1.731 . . . . 0.0 108.298 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -95.11 -47.73 6.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.859 1.264 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.5 t -45.37 117.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.435 1.094 . . . . 0.0 112.81 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.65 -120.77 3.42 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 123.851 0.739 . . . . 0.0 111.277 158.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -152.05 140.57 20.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.869 -0.783 . . . . 0.0 109.176 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -138.41 162.85 33.39 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.699 1.6 . . . . 0.0 107.166 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -135.69 142.37 45.08 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.792 1.237 . . . . 0.0 108.953 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 141.57 55.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.774 0.715 . . . . 0.0 110.974 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.76 -35.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 118.451 -0.785 . . . . 0.0 112.338 169.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.08 151.24 51.88 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.554 1.07 . . . . 0.0 110.749 169.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -168.24 165.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.065 2.546 . . . . 0.0 106.532 167.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -146.58 178.13 8.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.586 1.554 . . . . 0.0 107.138 169.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 m120 58.55 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.36 1.064 . . . . 0.0 110.834 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -57.11 14.17 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.58 0.752 . . . . 0.0 110.286 -172.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.56 -52.87 18.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.141 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -35.06 -57.96 0.55 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.0 112.222 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 117' ' ' LEU . 4.7 t80 -57.79 -45.97 85.26 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.61 -0.681 . . . . 0.0 112.141 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -68.83 -30.17 68.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.838 . . . . 0.0 111.994 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -72.83 58.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.873 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m 175.59 -55.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.764 2.426 . . . . 0.0 107.143 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.15 -37.76 75.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.781 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.41 32.91 68.02 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.28 -31.35 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 117.694 0.747 . . . . 0.0 110.442 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.4 71.15 0.03 OUTLIER Glycine 0 C--N 1.336 0.572 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -54.33 146.59 15.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.33 -12.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.627 1.571 . . . . 0.0 114.636 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.1 m -102.16 -61.86 1.34 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 108.586 -168.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -70.71 7.33 1.15 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.104 -0.998 . . . . 0.0 113.382 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.59 -46.48 85.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.206 -0.934 . . . . 0.0 108.993 159.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -44.7 96.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.66 43.15 1.84 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.327 0.965 . . . . 0.0 112.98 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -163.72 -32.52 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.222 1.809 . . . . 0.0 109.588 167.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 90.2 mmm -53.26 -45.0 68.64 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 159.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -64.05 108.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -35.15 104.97 0.27 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.463 1.905 . . . . 0.0 112.302 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.77 123.93 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 121.734 1.622 . . . . 0.0 109.42 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.8 m -79.96 179.94 7.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -152.09 88.71 1.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -79.03 128.36 38.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.2 mt -127.98 101.73 7.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -109.24 115.59 30.29 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.825 1.25 . . . . 0.0 108.653 -171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 79.1 t -78.74 103.58 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -77.81 65.08 3.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.867 1.267 . . . . 0.0 108.764 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.53 -88.14 0.05 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.665 0.65 . . . . 0.0 111.752 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -37.38 17.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.132 0.973 . . . . 0.0 110.081 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.42 173.12 7.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.77 2.028 . . . . 0.0 108.093 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 p -152.41 130.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.81 131.52 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 62' ' ' ILE . 13.9 tt -114.37 128.15 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -135.04 131.38 36.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.805 0.442 . . . . 0.0 111.002 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -29.52 39.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.609 1.563 . . . . 0.0 112.951 -159.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 33.72 56.96 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.215 1.806 . . . . 0.0 113.691 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -66.07 -60.5 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -114.23 62.03 0.66 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 69.22 -21.16 0.16 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -147.92 88.4 1.67 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 0.0 108.078 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -136.49 55.88 1.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.58 0.752 . . . . 0.0 109.776 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 58.59 175.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.892 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -151.11 155.63 39.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.834 0.454 . . . . 0.0 110.811 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 51' ' ' ILE . 47.0 mt -128.87 143.0 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 103.86 -2.644 . . . . 0.0 103.86 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.2 p -149.46 97.78 2.69 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -149.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.26 176.93 8.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.939 0.496 . . . . 0.0 110.905 -160.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -151.88 122.43 7.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -175.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -61.93 103.76 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 0.0 109.871 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.5 40.48 1.35 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.556 2.027 . . . . 0.0 111.802 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -148.02 149.86 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.024 1.33 . . . . 0.0 107.641 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 146.89 40.78 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.614 1.166 . . . . 0.0 109.194 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.27 161.98 12.45 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.474 0.309 . . . . 0.0 110.666 -168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -76.37 112.79 13.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -100.8 110.22 22.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -113.71 121.83 45.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 t -145.45 145.62 31.18 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.79 44.07 0.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.204 1.001 . . . . 0.0 111.942 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -152.93 -63.91 0.16 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.43 1.892 . . . . 0.0 106.963 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -79.64 1.37 26.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.331 0.652 . . . . 0.0 111.599 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 78.28 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.059 1.344 . . . . 0.0 108.671 169.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -92.25 124.42 36.31 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.81 139.09 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -78.99 131.38 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 162.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 p -130.42 161.92 30.29 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 118.0 0.364 . . . . 0.0 110.673 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.6 tt -129.53 142.42 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.327 1.851 . . . . 0.0 106.485 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.7 144.93 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.9 t -150.89 -170.62 3.71 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 164.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tt -135.4 124.85 24.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 107.355 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.22 145.13 51.4 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.811 0.844 . . . . 0.0 109.461 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.85 -78.93 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.632 1.11 . . . . 0.0 111.548 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.82 26.97 0.26 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.037 1.303 . . . . 0.0 110.932 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.69 136.32 52.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.377 1.471 . . . . 0.0 107.341 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 91' ' ' LEU . 8.1 tt -92.21 118.61 31.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -110.84 121.36 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.705 0.802 . . . . 0.0 109.377 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -105.53 123.11 47.36 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.92 1.688 . . . . 0.0 106.453 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.33 129.7 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -148.08 112.65 5.34 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.629 -151.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -130.61 163.84 26.26 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.749 1.22 . . . . 0.0 112.245 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -136.83 -65.85 0.54 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.33 143.71 10.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.19 -7.5 5.91 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.128 -0.818 . . . . 0.0 114.206 174.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 165.08 14.44 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.935 1.367 . . . . 0.0 110.423 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -142.07 125.56 16.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.33 1.852 . . . . 0.0 106.948 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.33 153.54 24.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 110.482 164.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 p -123.12 136.9 54.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.913 1.285 . . . . 0.0 107.581 172.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.2 110.12 7.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.19 129.8 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -122.21 124.71 44.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 127.063 2.145 . . . . 0.0 107.801 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -143.6 144.21 31.82 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -115.57 123.46 48.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 161.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.03 -179.73 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 159.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 52.16 -113.83 0.78 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.1 28.39 2.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.897 1.237 . . . . 0.0 110.075 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -127.59 127.31 43.64 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 tt -83.8 93.99 8.09 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.9 mt -73.44 111.96 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.8 135.5 44.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 163.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.6 m -128.36 124.19 35.79 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' CE2' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -117.77 125.82 51.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.599 0.76 . . . . 0.0 109.235 -178.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.8 m -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.195 1.798 . . . . 0.0 108.994 -172.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -97.34 161.88 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.01 63.84 1.61 Allowed Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.646 -0.659 . . . . 0.0 111.802 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.8 t 161.13 -60.44 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 129.544 3.138 . . . . 0.0 108.265 172.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.71 137.74 33.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.429 0.692 . . . . 0.0 110.391 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.84 123.01 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.496 1.118 . . . . 0.0 108.712 -173.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.1 t -133.37 111.67 10.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.416 0.687 . . . . 0.0 109.903 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -63.82 153.53 36.37 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 160.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -159.54 83.57 0.76 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.344 0.657 . . . . 0.0 109.3 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -88.46 126.88 35.45 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.459 -0.776 . . . . 0.0 109.973 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -102.61 144.37 31.1 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.695 1.198 . . . . 0.0 109.169 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -119.86 133.72 55.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.209 2.204 . . . . 0.0 106.864 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -58.8 141.27 53.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.058 0.845 . . . . 0.0 110.839 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -31.25 67.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.953 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.657 1.183 . . . . 0.0 108.488 179.461 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 120.572 0.225 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.54 54.36 0.45 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.695 2.798 . . . . 0.0 111.578 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.71 -51.44 0.06 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.573 1.149 . . . . 0.0 108.279 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -57.64 -46.83 83.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.436 1.095 . . . . 0.0 110.96 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 p -38.23 110.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.412 1.885 . . . . 0.0 111.908 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.83 -146.48 18.42 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -130.78 134.74 47.12 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.639 0.775 . . . . 0.0 110.708 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -118.58 162.28 18.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.799 1.64 . . . . 0.0 109.744 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -136.8 132.96 35.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.604 1.162 . . . . 0.0 108.643 177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.14 147.86 42.59 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 12' ' ' ASP . 7.1 p -130.98 -70.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 122.856 0.463 . . . . 0.0 111.284 164.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 127' ' ' THR . 26.7 m-20 -93.47 144.14 25.64 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -171.93 43.34 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.66 155.36 33.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.053 0.842 . . . . 0.0 112.381 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.99 25.52 13.92 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.519 1.528 . . . . 0.0 111.991 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -75.18 -49.82 18.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.124 -0.985 . . . . 0.0 109.898 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.91 -61.38 1.99 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.466 0.65 . . . . 0.0 110.093 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 17.9 t70 -45.56 -48.56 14.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.559 1.944 . . . . 0.0 112.065 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -55.24 -44.62 75.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.262 1.025 . . . . 0.0 111.257 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.25 -33.2 59.17 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 121.679 -0.638 . . . . 0.0 111.088 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 18' ' ' ASP . 1.7 ttpm? -73.41 51.89 0.35 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.473 1.509 . . . . 0.0 109.358 170.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 m -178.59 -60.17 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 128.372 2.669 . . . . 0.0 107.058 -173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.55 -20.26 62.05 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.91 -22.16 32.85 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.78 -1.011 . . . . 0.0 112.62 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 m -66.15 66.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 126.664 1.986 . . . . 0.0 114.776 -162.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.87 44.23 3.15 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.92 2.2 . . . . 0.0 110.438 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -36.17 -43.77 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.183 2.193 . . . . 0.0 114.027 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.29 44.48 2.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.489 1.116 . . . . 0.0 110.799 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.9 t -152.04 -44.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.65 . . . . 0.0 111.177 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -27.48 45.0 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.928 -1.107 . . . . 0.0 110.022 169.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.24 -20.14 64.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.361 1.464 . . . . 0.0 112.522 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.35 -30.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.15 0.58 . . . . 0.0 110.293 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.22 63.61 0.77 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.155 0.883 . . . . 0.0 111.925 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -162.3 -51.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.721 1.608 . . . . 0.0 110.455 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.4 mtt -57.21 -47.54 81.04 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.035 1.334 . . . . 0.0 109.983 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -68.16 66.85 0.11 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.148 2.179 . . . . 0.0 110.412 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -18.66 91.73 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 128.032 2.533 . . . . 0.0 113.549 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.27 136.89 67.16 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.125 1.216 . . . . 0.0 110.806 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.71 141.74 28.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 m -130.91 102.28 5.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.22 131.2 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.1 mt -126.2 103.41 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -97.12 134.57 40.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.77 119.34 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -95.13 168.78 10.55 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.253 1.021 . . . . 0.0 108.585 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -29.54 -60.38 0.18 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.886 1.707 . . . . 0.0 114.645 -170.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -126.47 22.19 7.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.867 1.667 . . . . 0.0 109.919 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.96 -178.67 6.61 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.834 0.854 . . . . 0.0 109.455 -153.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.45 150.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 121.122 -0.986 . . . . 0.0 108.96 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.4 tt -133.65 126.66 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -93.19 127.06 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 171.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -133.51 91.55 2.87 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -80.79 131.5 35.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.024 1.33 . . . . 0.0 109.17 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.81 114.13 23.51 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.559 0.744 . . . . 0.0 109.479 169.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.8 t -140.97 54.1 1.57 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t 39.67 -118.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.735 1.214 . . . . 0.0 110.045 -168.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -57.59 -9.37 1.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.889 1.676 . . . . 0.0 115.125 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -118.03 32.24 6.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.608 1.095 . . . . 0.0 111.129 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -63.21 159.76 17.02 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.65 -0.656 . . . . 0.0 110.653 162.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.23 160.16 23.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.807 1.243 . . . . 0.0 108.203 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -152.54 120.08 6.02 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.286 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mt -143.65 124.26 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.001 0.92 . . . . 0.0 109.928 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 p -91.2 142.19 27.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.955 2.102 . . . . 0.0 110.071 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -156.68 -175.68 5.56 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.436 1.094 . . . . 0.0 109.213 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -124.7 145.51 49.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 54.55 0.59 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.881 1.273 . . . . 0.0 110.154 174.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.42 58.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 p -164.99 162.33 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.49 148.16 23.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.778 0.674 . . . . 0.0 109.751 165.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.88 145.84 22.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.742 0.817 . . . . 0.0 110.263 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.68 133.59 48.65 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.697 1.599 . . . . 0.0 108.347 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -143.51 131.25 21.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 t -103.07 121.66 43.05 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.74 0.816 . . . . 0.0 108.857 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 171.72 8.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.43 -7.96 11.74 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -155.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -105.41 11.03 33.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.275 175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t0 43.84 46.98 6.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.202 2.201 . . . . 0.0 113.222 -162.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 117.219 -1.792 . . . . 0.0 106.359 148.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.25 84.07 7.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -82.67 178.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.839 1.256 . . . . 0.0 109.536 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -124.44 119.36 28.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -100.74 157.68 16.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.852 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 120.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.6 t -107.57 131.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p -126.06 119.96 29.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.348 1.059 . . . . 0.0 108.352 169.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.87 103.99 15.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -86.25 -167.53 1.9 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.941 0.401 . . . . 0.0 110.16 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.2 55.02 2.75 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.585 -0.697 . . . . 0.0 111.798 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.02 -57.49 0.27 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' NZ ' ' OE1' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.93 152.28 47.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.334 0.654 . . . . 0.0 111.116 -162.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.66 102.71 15.13 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -80.32 96.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -89.05 99.95 12.83 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.96 142.09 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 167.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -131.43 100.19 5.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.242 1.417 . . . . 0.0 107.76 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -114.55 157.01 23.59 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.609 1.164 . . . . 0.0 108.567 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.423 ' HE1' ' CD ' ' A' ' 100' ' ' GLN . 12.9 p90 -140.71 -62.5 0.49 Allowed 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 121.714 -0.617 . . . . 0.0 110.916 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -166.75 -82.58 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.075 0.398 . . . . 0.0 110.9 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.45 -17.02 80.28 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.84 -0.538 . . . . 0.0 112.099 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' CD ' ' HE1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -135.79 163.49 30.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.318 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.88 151.45 50.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.646 1.978 . . . . 0.0 106.213 173.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.8 p -137.06 166.9 22.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.011 0.924 . . . . 0.0 109.206 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 p -133.59 154.73 50.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.2 68.97 1.1 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.01 132.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.937 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.507 HH11 HD13 ' A' ' 115' ' ' LEU . 14.5 mtt-85 -123.08 153.32 40.06 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.483 0.583 . . . . 0.0 110.756 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.405 ' OE1' ' NZ ' ' A' ' 90' ' ' LYS . 45.4 tt0 -157.54 159.6 37.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.75 120.9 35.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 160.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.72 172.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 104.727 -2.324 . . . . 0.0 104.727 155.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.23 -120.15 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -165.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.63 21.71 3.56 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.828 1.204 . . . . 0.0 111.357 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -122.26 134.55 54.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.81 0.805 . . . . 0.0 109.454 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.94 79.82 1.66 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.7 mt -64.27 132.55 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.187 0.995 . . . . 0.0 108.347 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.507 HD13 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -143.69 158.25 43.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 165.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 t -126.18 127.07 45.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 166.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tt -109.34 106.75 16.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.691 1.996 . . . . 0.0 105.782 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 p -124.76 138.53 54.28 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.695 1.198 . . . . 0.0 110.941 -162.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -134.19 141.28 47.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 107.859 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.4 91.22 0.02 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 165.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m 136.19 -27.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 131.28 3.832 . . . . 0.0 111.337 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.83 152.23 36.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.007 1.276 . . . . 0.0 111.206 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.16 135.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.727 0.811 . . . . 0.0 109.35 -170.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.0 t -141.32 106.85 5.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.442 0.697 . . . . 0.0 110.887 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.1 p -58.28 143.81 43.36 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 159.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -156.01 154.84 31.7 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.322 0.964 . . . . 0.0 108.978 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 12' ' ' ASP . 1.6 t -157.57 156.59 32.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.26 150.6 52.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.832 1.653 . . . . 0.0 107.956 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.61 136.22 52.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.053 1.341 . . . . 0.0 108.151 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -67.01 121.9 16.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -86.86 -38.43 16.78 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.133 0 C-N-CA 122.985 0.514 . . . . 0.0 109.879 -178.112 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.48 50.76 0.43 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.11 2.564 . . . . 0.0 111.84 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.01 -55.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.57 -46.71 66.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.488 1.515 . . . . 0.0 111.421 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.01 104.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.416 1.487 . . . . 0.0 112.066 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.62 -169.68 29.15 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -109.93 132.74 53.89 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.73 0.812 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 113' ' ' LEU . 53.0 m95 -115.71 140.88 48.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.384 1.074 . . . . 0.0 109.568 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -95.93 132.35 41.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 13' ' ' SER . 7.7 tt -61.72 141.48 57.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 162.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.51 -52.23 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.719 -0.657 . . . . 0.0 110.584 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.58 137.69 49.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.941 0.791 . . . . 0.0 108.995 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' HD21 ' A' ' 10' ' ' LEU . 35.6 t -155.36 144.57 20.94 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.931 1.692 . . . . 0.0 108.074 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -170.62 159.46 6.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.786 0.835 . . . . 0.0 111.787 163.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 t30 62.16 34.42 16.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.361 1.864 . . . . 0.0 112.756 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -74.78 -43.66 53.63 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.78 -48.22 75.7 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 117.493 0.133 . . . . 0.0 111.01 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -50.36 -46.87 56.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.942 0.897 . . . . 0.0 111.568 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 117' ' ' LEU . 1.8 t80 -57.15 -55.52 33.6 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -36.64 31.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.757 1.223 . . . . 0.0 112.333 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -74.72 55.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.484 1.914 . . . . 0.0 109.611 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.4 p -178.88 -48.59 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.859 2.464 . . . . 0.0 107.065 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.15 -28.07 59.98 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.373 0.669 . . . . 0.0 112.322 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.78 29.35 72.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.688 0.661 . . . . 0.0 113.259 173.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.14 -51.62 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.588 1.155 . . . . 0.0 110.986 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.39 -65.52 2.31 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -155.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 25.5 -96.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.564 1.946 . . . . 0.0 114.788 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.78 54.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.488 0.715 . . . . 0.0 110.954 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 m -57.87 -36.97 73.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.753 1.621 . . . . 0.0 110.456 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -51.22 63.42 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.414 0.686 . . . . 0.0 111.003 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' NE2' HG23 ' A' ' 32' ' ' VAL 0.275 4.9 pp0? -63.78 -46.33 85.69 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.717 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.579 HG23 ' NE2' ' A' ' 31' ' ' GLN . 2.6 t -47.02 -49.38 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.216 0.462 . . . . 0.0 109.837 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.06 -23.68 1.2 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 128.239 2.828 . . . . 0.0 115.087 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -137.96 39.38 2.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.422 0.689 . . . . 0.0 110.34 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.0 ttt -156.86 -56.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.622 0.369 . . . . 0.0 111.684 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -115.13 56.93 0.73 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.084 0.553 . . . . 0.0 111.446 -157.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 33.38 61.61 1.66 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.989 1.716 . . . . 0.0 113.823 172.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.13 116.31 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.241 2.628 . . . . 0.0 109.187 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.33 157.75 19.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.371 1.068 . . . . 0.0 108.273 -170.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 m -148.09 101.55 3.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.508 -0.745 . . . . 0.0 110.865 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.79 126.47 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.071 1.348 . . . . 0.0 107.995 161.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.3 mm -123.85 110.07 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.418 1.487 . . . . 0.0 107.558 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -112.02 115.94 29.73 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.203 1.001 . . . . 0.0 109.128 -168.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.09 123.3 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.05 164.9 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.855 1.262 . . . . 0.0 108.288 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -36.41 -53.7 1.33 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.028 1.299 . . . . 0.0 113.381 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -106.79 -42.19 5.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.651 1.581 . . . . 0.0 111.292 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -101.36 -170.65 1.86 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.754 2.021 . . . . 0.0 110.645 -162.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.76 133.55 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 162.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.12 133.11 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -101.32 124.91 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.63 103.23 10.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.493 1.917 . . . . 0.0 106.804 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.1 m -80.58 124.42 28.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.147 0.579 . . . . 0.0 109.895 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -93.78 119.69 33.08 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 t -136.65 36.99 2.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.898 0.479 . . . . 0.0 110.212 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.7 m 61.22 101.26 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.318 1.447 . . . . 0.0 112.129 170.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 t80 72.4 -62.13 0.47 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.611 1.164 . . . . 0.0 109.359 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 145.97 46.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.156 0.979 . . . . 0.0 109.081 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.93 178.26 7.09 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 167.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 163.6 38.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 161.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.66 149.71 40.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -140.37 133.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.4 p -96.74 124.71 40.8 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.825 1.65 . . . . 0.0 108.425 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.62 159.5 41.95 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 119.704 1.138 . . . . 0.0 111.056 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.14 135.58 50.04 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.81 66.74 0.37 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.299 0.5 . . . . 0.0 110.545 169.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 141.35 63.4 0.03 OUTLIER Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.181 0.896 . . . . 0.0 111.127 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -170.77 169.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.227 1.011 . . . . 0.0 108.347 173.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.99 157.35 40.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.292 0.637 . . . . 0.0 109.948 165.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -167.57 152.3 6.88 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.178 0.591 . . . . 0.0 111.205 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -72.34 133.06 44.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.755 1.622 . . . . 0.0 107.075 170.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -140.63 155.82 46.43 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.402 1.081 . . . . 0.0 108.729 -165.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -154.22 145.22 22.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.705 -0.622 . . . . 0.0 110.509 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.3 t -157.97 151.6 23.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.348 0.594 . . . . 0.0 111.865 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.75 65.56 3.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.822 1.649 . . . . 0.0 110.515 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 p30 171.49 -64.76 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 129.132 2.973 . . . . 0.0 108.015 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.274 9.3 t70 -78.1 -1.65 33.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 73.73 -156.74 0.07 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.964 1.306 . . . . 0.0 109.191 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -79.98 140.24 36.7 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 164.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.69 166.84 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.01 126.13 55.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 167.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -90.21 135.06 33.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.466 HG23 ' HB ' ' A' ' 94' ' ' VAL . 10.6 tt -129.2 115.77 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.08 134.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.92 0.888 . . . . 0.0 108.952 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -160.12 150.88 18.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.71 151.9 21.61 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.654 0.661 . . . . 0.0 111.2 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.21 178.97 4.74 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 161.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -19.07 -47.27 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 128.0 2.714 . . . . 0.0 115.363 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.42 62.09 0.28 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.305 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -172.73 149.9 2.08 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 108.893 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -86.95 131.51 34.07 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.35 108.44 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -94.83 107.5 19.52 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 83' ' ' ILE . 42.1 t -93.08 131.39 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 172.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -122.15 101.93 7.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 107.108 -163.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -115.62 114.49 24.98 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.611 1.564 . . . . 0.0 110.905 -163.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -104.79 -62.5 1.33 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.599 0.636 . . . . 0.0 111.599 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.81 106.27 1.84 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.758 0.708 . . . . 0.0 112.597 -171.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.95 25.25 65.77 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.939 0.781 . . . . 0.0 112.177 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -175.15 167.66 3.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.368 1.467 . . . . 0.0 107.045 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -157.3 160.91 39.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.9 p -124.15 149.43 46.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.138 0.575 . . . . 0.0 109.824 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.9 p -88.45 135.11 33.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.945 0.898 . . . . 0.0 109.123 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.94 87.72 2.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 161.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.21 129.92 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.0 138.11 51.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.445 1.098 . . . . 0.0 110.944 -171.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.02 155.34 32.51 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.743 0.652 . . . . 0.0 109.287 154.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -96.59 112.39 24.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.14 0.976 . . . . 0.0 109.188 165.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.6 -171.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.8 t70 51.07 -110.27 0.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.14 29.64 2.17 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.646 1.593 . . . . 0.0 109.678 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -150.01 146.12 26.81 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.99 0.895 . . . . 0.0 109.732 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 8' ' ' TRP . 5.2 tt -85.09 113.19 21.3 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.4 mt -89.33 105.1 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.41 117.44 29.12 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 166.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.0 m -103.43 133.95 47.62 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HG ' ' CZ ' ' A' ' 19' ' ' TYR . 35.5 tp -130.67 86.78 2.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.475 1.11 . . . . 0.0 108.199 -161.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 m -115.59 133.03 56.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.414 0.552 . . . . 0.0 110.65 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -134.45 138.38 44.72 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.166 2.187 . . . . 0.0 107.783 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.58 108.01 0.72 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 165.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.9 m 121.8 -37.72 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 130.001 3.32 . . . . 0.0 112.174 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.63 162.64 38.7 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.098 1.317 . . . . 0.0 112.122 -168.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.87 151.74 20.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.699 0.799 . . . . 0.0 109.86 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.5 m -143.72 159.52 42.35 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.162 -0.961 . . . . 0.0 108.776 164.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.35 145.43 37.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 159.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -142.34 101.91 3.99 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -103.05 123.68 47.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -108.86 149.23 29.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.23 1.812 . . . . 0.0 110.101 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -124.35 127.36 47.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.512 1.525 . . . . 0.0 107.798 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -68.64 119.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.28 -29.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.244 0.618 . . . . 0.0 111.451 -173.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.138 0 CA-C-N 118.403 0.547 . . . . 0.0 109.907 170.384 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.25 -36.72 32.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.02 1.728 . . . . 0.0 111.438 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.64 -15.32 62.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.715 1.606 . . . . 0.0 112.016 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -114.75 -52.41 2.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.563 1.145 . . . . 0.0 110.098 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.11 114.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.422 1.489 . . . . 0.0 111.603 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.99 -178.66 22.64 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 121.722 0.624 . . . . 0.0 112.84 164.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -96.39 127.41 42.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 169.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -117.61 157.34 26.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.323 1.049 . . . . 0.0 108.355 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -120.33 149.92 41.55 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 162.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.16 148.36 31.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.47 -56.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 118.25 0.477 . . . . 0.0 111.42 168.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.39 148.82 27.65 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -166.07 154.24 10.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.768 0.827 . . . . 0.0 109.129 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -148.57 145.93 28.04 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.425 1.09 . . . . 0.0 108.701 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 66.77 17.8 10.61 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.32 1.848 . . . . 0.0 113.147 168.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -59.58 -38.88 82.34 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.753 -1.217 . . . . 0.0 109.341 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.94 -41.78 96.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 111.194 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -58.53 -48.0 82.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.326 0.65 . . . . 0.0 109.558 173.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -51.97 -56.27 15.24 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -48.85 -50.52 34.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.436 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -77.38 53.58 1.05 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.086 1.754 . . . . 0.0 110.056 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.3 p -177.92 -50.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.266 2.227 . . . . 0.0 106.592 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.94 -32.45 74.17 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.54 23.87 74.22 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.675 0.655 . . . . 0.0 112.064 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 30' ' ' ARG . 34.1 m -85.82 53.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 121.518 -0.99 . . . . 0.0 110.417 -173.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.25 109.14 0.05 OUTLIER Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.717 0.675 . . . . 0.0 112.256 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.78 -64.91 0.76 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 120.776 -1.426 . . . . 0.0 111.049 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.92 -42.28 65.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.101 0.56 . . . . 0.0 110.736 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -51.3 -51.75 51.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.211 1.404 . . . . 0.0 110.98 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 25' ' ' VAL . 7.5 mmt85 -72.77 -42.19 64.25 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.468 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.32 -56.91 7.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.842 1.201 . . . . 0.0 110.248 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.01 -52.13 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 42.54 2.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.84 0.733 . . . . 0.0 113.514 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -157.71 -37.16 0.07 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.712 2.005 . . . . 0.0 109.91 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.9 ttt -76.77 -33.98 58.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.881 0.472 . . . . 0.0 109.942 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -66.24 166.68 11.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.539 166.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.29 80.59 3.46 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.719 0.808 . . . . 0.0 109.223 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.61 158.81 46.93 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.784 2.323 . . . . 0.0 112.338 -168.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 164.54 25.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.348 166.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.9 m -145.43 121.93 11.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 155.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mt -90.91 135.58 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -133.44 104.4 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -109.88 109.15 19.69 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.81 88.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -50.53 157.67 0.71 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.481 1.112 . . . . 0.0 110.854 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -26.0 -59.72 0.07 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.202 1.858 . . . . 0.0 115.182 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.75 13.63 9.29 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.718 1.207 . . . . 0.0 111.524 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.18 -172.16 4.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.557 1.543 . . . . 0.0 108.264 -157.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.06 149.56 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 120.766 -1.209 . . . . 0.0 109.974 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.49 128.9 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.11 125.01 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -115.09 106.04 13.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.568 1.547 . . . . 0.0 108.976 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p -83.59 63.02 7.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.995 0.918 . . . . 0.0 109.749 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -71.31 144.63 49.88 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 122.14 0.971 . . . . 0.0 112.957 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -158.53 168.11 27.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 168.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -80.81 56.72 2.78 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -172.7 -51.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -172.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -138.3 146.01 41.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -148.34 49.62 1.03 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.489 0.715 . . . . 0.0 110.138 -163.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 75' ' ' ALA . 27.9 p -85.61 151.4 23.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.592 0.357 . . . . 0.0 110.443 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -121.55 142.93 49.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 0.0 110.292 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.34 93.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -172.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.1 p -104.36 125.32 50.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.97 1.708 . . . . 0.0 110.113 -174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -161.27 170.55 20.01 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -93.77 127.46 39.51 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 165.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.06 64.73 1.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 110.867 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.46 55.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -169.61 173.5 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.26 1.024 . . . . 0.0 108.274 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -107.16 148.56 28.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.458 160.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -152.67 169.34 22.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.363 1.465 . . . . 0.0 108.469 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -92.2 121.85 34.12 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -116.65 138.17 51.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.413 1.485 . . . . 0.0 107.226 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -138.65 108.37 6.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -128.64 129.57 46.04 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' H ' HG21 ' A' ' 60' ' ' THR . . . -75.31 44.56 0.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.944 -1.097 . . . . 0.0 113.934 -172.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.27 48.9 p30 -147.36 -52.32 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.975 0.91 . . . . 0.0 109.382 156.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -6.07 47.6 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 82.72 -159.53 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.433 2.293 . . . . 0.0 111.9 165.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -83.76 127.98 34.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.263 1.425 . . . . 0.0 107.835 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 143.98 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.925 1.29 . . . . 0.0 107.641 -174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -81.35 114.39 20.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 166.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -96.58 119.49 35.16 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.312 1.045 . . . . 0.0 108.846 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.59 126.5 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.67 134.93 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.1 m -142.59 170.33 15.91 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.4 133.53 55.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 165.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -82.08 -23.01 36.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.747 0.419 . . . . 0.0 111.378 -174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.01 -32.55 3.96 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.021 1.296 . . . . 0.0 110.298 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.19 -23.96 8.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.643 1.592 . . . . 0.0 111.985 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -150.25 161.26 42.78 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.233 1.413 . . . . 0.0 111.522 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.29 124.55 31.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 163.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.21 128.74 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.302 1.041 . . . . 0.0 109.424 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -114.64 95.85 5.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.438 2.295 . . . . 0.0 106.78 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.65 96.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -97.9 107.9 20.49 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.326 1.45 . . . . 0.0 108.486 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -121.42 155.71 34.27 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 118.525 0.602 . . . . 0.0 111.954 -171.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -130.71 -60.94 0.97 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.406 -0.331 . . . . 0.0 110.788 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -160.63 -76.62 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 118.346 0.521 . . . . 0.0 111.962 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.8 -11.8 85.1 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.592 0.633 . . . . 0.0 113.094 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -173.13 175.87 3.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.6 1.56 . . . . 0.0 107.649 -172.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -154.06 158.96 41.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.294 1.437 . . . . 0.0 109.417 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.13 121.31 44.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.715 2.006 . . . . 0.0 108.814 176.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.17 99.16 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.536 1.134 . . . . 0.0 108.32 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.66 146.48 25.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.91 146.57 31.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.2 mtt85 -136.23 140.78 43.75 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.539 1.536 . . . . 0.0 108.248 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -163.96 153.18 14.02 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.437 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -111.66 118.74 36.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.477 0.58 . . . . 0.0 109.799 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 -174.43 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 t70 52.73 -107.09 0.32 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.67 29.62 1.43 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.036 1.303 . . . . 0.0 110.544 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -143.35 144.03 31.91 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 118.134 0.967 . . . . 0.0 109.875 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.84 93.59 6.29 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 171.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.5 mt -70.34 129.57 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -144.95 142.73 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.89 113.68 14.94 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -171.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.8 p -117.88 129.0 55.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 108.842 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -125.15 169.92 11.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.261 1.424 . . . . 0.0 107.191 173.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.09 118.57 2.39 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 161.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.285 0.5 OUTLIER 67.91 -58.25 0.45 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.6 2.36 . . . . 0.0 113.281 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.55 112.21 12.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.527 -0.733 . . . . 0.0 111.26 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.73 125.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 126.201 1.8 . . . . 0.0 106.573 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 3.9 m -144.8 167.42 22.62 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.926 -1.109 . . . . 0.0 110.281 -174.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.8 p -136.4 144.41 44.5 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.927 0.491 . . . . 0.0 111.249 -170.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -138.04 151.09 47.52 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 166.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.24 139.67 47.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -115.66 156.53 25.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.615 1.166 . . . . 0.0 109.568 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.1 127.45 26.49 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.509 1.124 . . . . 0.0 108.41 -168.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -64.24 119.54 10.46 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.198 0.999 . . . . 0.0 108.96 -173.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -82.01 -50.93 8.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 C-N-CA 123.795 0.838 . . . . 0.0 109.088 176.755 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.6 48.02 0.19 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.25 2.62 . . . . 0.0 112.483 -175.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.32 -60.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -172.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -61.67 -33.65 74.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.271 1.028 . . . . 0.0 110.716 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 5' ' ' VAL . 9.2 p -73.63 78.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.724 177.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.94 -166.86 26.51 Favored Glycine 0 CA--C 1.534 1.247 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 160.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 m -76.97 124.05 27.21 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.196 1.398 . . . . 0.0 110.984 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.429 ' CZ2' HG13 ' A' ' 42' ' ' ILE . 11.3 m0 -104.16 149.42 25.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.841 1.256 . . . . 0.0 109.002 169.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.2 134.94 54.69 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.992 0.917 . . . . 0.0 108.888 162.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.31 144.77 56.38 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.4 -25.71 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 118.411 -0.804 . . . . 0.0 112.667 177.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.08 157.08 47.05 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.61 1.096 . . . . 0.0 110.124 173.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 t 176.72 86.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.414 1.886 . . . . 0.0 109.903 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -116.1 160.89 19.71 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.088 0.555 . . . . 0.0 110.925 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 58.33 8.05 0.77 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.329 1.852 . . . . 0.0 112.89 -177.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -31.15 64.46 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.878 -1.139 . . . . 0.0 109.397 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.57 -65.4 0.62 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 167.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -44.13 -52.06 7.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.1 1.76 . . . . 0.0 112.229 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -46.43 -50.38 16.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.032 1.333 . . . . 0.0 112.035 176.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.8 mtp -76.9 -34.5 57.73 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.728 -0.607 . . . . 0.0 110.291 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 43.64 0.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.515 2.326 . . . . 0.0 110.313 171.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -171.23 -54.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 119' ' ' HIS . 84.1 mt -61.2 -27.68 68.6 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 172.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.29 -18.72 55.69 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 119.28 0.945 . . . . 0.0 113.103 171.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 m -41.12 -47.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 127.133 2.173 . . . . 0.0 113.453 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.25 72.27 0.2 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -172.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.85 158.36 2.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 110.605 172.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 59.13 -78.06 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.438 1.495 . . . . 0.0 110.478 -170.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.7 p -35.24 -44.68 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.756 2.823 . . . . 0.0 113.992 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -34.9 -40.11 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 170.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -50.54 -34.88 27.09 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.007 1.723 . . . . 0.0 113.361 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.72 -44.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.31 18.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.071 0.843 . . . . 0.0 113.109 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -55.57 -53.81 51.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.895 . . . . 0.0 111.978 174.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.4 mtt -81.08 -21.7 39.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.477 1.511 . . . . 0.0 111.511 -172.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -70.44 60.66 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.802 0.728 . . . . 0.0 110.903 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -147.8 48.51 0.65 Allowed Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.234 2.614 . . . . 0.0 109.043 172.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 -41.58 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.138 2.559 . . . . 0.0 112.311 -167.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -119.62 142.61 48.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.2 m -146.09 105.19 3.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.769 -0.582 . . . . 0.0 109.592 177.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.4 mt -77.11 113.47 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 170.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.429 HG13 ' CZ2' ' A' ' 8' ' ' TRP . 40.1 mm -101.41 138.98 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 163.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -142.99 109.8 5.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -166.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.64 81.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -54.62 156.77 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.286 171.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -17.0 -72.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.419 2.438 . . . . 0.0 115.604 -171.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -116.42 10.0 14.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.898 1.679 . . . . 0.0 111.132 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.83 -166.48 2.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.296 1.838 . . . . 0.0 108.197 -157.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.28 136.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 tt -112.16 133.58 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 tt -93.62 137.65 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 169.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -138.79 88.11 2.27 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.92 1.688 . . . . 0.0 107.398 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -77.91 129.94 35.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.804 1.642 . . . . 0.0 108.636 178.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.31 143.61 51.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.707 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -158.99 -173.0 4.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.213 1.005 . . . . 0.0 109.461 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 t -82.18 116.48 21.75 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 167.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.3 t80 59.98 27.25 16.61 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.093 0.957 . . . . 0.0 112.665 173.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -163.66 75.07 0.35 Allowed 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.264 -0.898 . . . . 0.0 109.661 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -105.91 139.86 39.82 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 p -150.77 148.81 28.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.85 142.9 24.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.252 0.478 . . . . 0.0 110.989 179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.9 mt -149.96 136.14 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.784 1.234 . . . . 0.0 109.095 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.9 p -90.22 133.78 34.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.923 1.689 . . . . 0.0 110.075 177.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.67 177.81 8.24 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.034 0.934 . . . . 0.0 111.009 176.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 68' ' ' VAL . 53.3 tptt -125.58 139.33 53.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 107.042 -176.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.24 57.14 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.465 0.706 . . . . 0.0 109.65 169.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.07 57.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -167.44 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.015 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.4 142.69 50.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.558 0.536 . . . . 0.0 111.174 161.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -133.78 150.53 51.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.498 1.519 . . . . 0.0 107.556 -174.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -72.22 131.09 42.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -125.65 131.14 52.69 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 t -126.97 145.35 50.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -146.0 172.32 13.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.56 0.695 . . . . 0.0 110.275 174.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.88 30.73 0.25 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.972 1.309 . . . . 0.0 113.433 -158.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -126.18 11.85 7.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.12 2.568 . . . . 0.0 109.85 165.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t0 63.05 29.33 16.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.492 2.317 . . . . 0.0 112.751 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.81 74.67 1.6 Allowed 'General case' 0 C--O 1.226 -0.176 0 O-C-N 120.247 -1.533 . . . . 0.0 109.674 164.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.81 68.86 1.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.196 1.398 . . . . 0.0 109.092 170.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -95.81 -168.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 110.415 -174.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -135.38 134.67 39.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -122.36 122.6 39.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.285 1.034 . . . . 0.0 109.703 -163.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.39 132.02 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.07 132.19 68.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.275 0.63 . . . . 0.0 109.663 -176.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.05 103.06 2.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.552 1.541 . . . . 0.0 107.661 -178.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.83 130.81 40.09 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.907 -1.12 . . . . 0.0 110.563 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.64 27.59 0.21 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -164.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.81 -38.74 3.17 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.607 -1.107 . . . . 0.0 111.081 -158.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.54 -64.77 0.17 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.309 1.554 . . . . 0.0 112.544 -175.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 135.82 34.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -174.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.28 89.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.414 ' HA ' HG23 ' A' ' 105' ' ' VAL . 6.5 t -69.78 113.6 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -115.05 117.97 32.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -117.08 140.46 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -128.6 97.98 4.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -157.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -90.93 162.56 14.71 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.874 1.67 . . . . 0.0 109.133 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -138.52 -56.15 0.63 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.642 -0.661 . . . . 0.0 110.789 166.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -163.88 -76.11 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.805 0.275 . . . . 0.0 111.11 178.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.63 -21.76 59.37 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.569 -0.573 . . . . 0.0 111.773 -177.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.73 174.71 11.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.679 0.792 . . . . 0.0 109.348 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -133.02 176.17 8.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.845 2.458 . . . . 0.0 109.069 177.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.7 t -133.59 153.77 51.4 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.49 1.116 . . . . 0.0 109.454 165.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.7 m -109.78 134.03 52.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.953 0.901 . . . . 0.0 108.879 -176.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.67 80.4 1.28 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.801 0.81 . . . . 0.0 109.658 -176.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 92' ' ' VAL . 0.3 OUTLIER -67.95 148.72 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 -126.12 110.05 13.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -132.54 147.73 52.36 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.243 -177.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 8.0 ttt -118.09 134.3 55.11 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.21 1.404 . . . . 0.0 108.541 171.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 m -148.91 177.68 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 54.67 -103.78 0.19 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.35 26.24 1.54 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.123 1.344 . . . . 0.0 109.869 171.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -140.37 169.08 18.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.756 0.822 . . . . 0.0 109.194 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.62 128.37 45.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -171.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.5 mt -111.82 130.77 64.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -112.7 114.67 27.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.989 0.916 . . . . 0.0 108.693 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 105' ' ' VAL . 65.6 p -94.63 76.16 3.75 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.18 101.45 3.97 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.6 t -128.71 128.33 43.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.471 0.578 . . . . 0.0 110.846 -176.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.41 ' CD2' HD21 ' A' ' 23' ' ' LEU . 16.0 t60 -173.38 143.69 1.1 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.769 1.227 . . . . 0.0 109.336 175.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.31 54.74 32.29 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 167.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 m 73.98 -44.96 0.58 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.8 1.24 . . . . 0.0 112.11 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.05 115.98 4.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.67 0.788 . . . . 0.0 111.279 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.09 99.19 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.297 1.439 . . . . 0.0 107.497 172.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.9 t -100.36 105.66 17.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.229 1.012 . . . . 0.0 110.479 175.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -65.29 138.48 58.23 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 155.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -115.51 155.88 26.72 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 144.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.84 137.84 46.86 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 165.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.81 166.03 11.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.284 2.234 . . . . 0.0 108.77 174.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.37 114.11 15.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -75.35 73.82 2.43 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.382 0.611 . . . . 0.0 109.538 -171.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -45.06 62.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.611 1.564 . . . . 0.0 111.526 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.007 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.93 51.07 0.21 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 131.02 3.728 . . . . 0.0 111.329 -166.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.3 -53.87 0.05 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -158.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.93 47.67 0.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.454 1.102 . . . . 0.0 109.494 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 49.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.847 1.259 . . . . 0.0 108.593 -174.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.3 -165.04 35.28 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.627 -0.671 . . . . 0.0 112.793 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m -87.83 136.39 32.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.499 1.12 . . . . 0.0 111.17 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -115.8 154.5 29.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.912 1.685 . . . . 0.0 108.824 172.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -121.19 152.92 38.23 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 167.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.05 134.65 34.2 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.005 1.322 . . . . 0.0 109.635 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.65 -41.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.451 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -144.48 158.25 43.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.135 0.879 . . . . 0.0 109.192 170.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -174.35 111.93 0.16 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.929 2.092 . . . . 0.0 109.422 -163.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.3 145.26 24.47 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 m120 77.11 -5.9 2.1 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.484 2.313 . . . . 0.0 111.476 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -76.21 -41.95 47.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.604 1.562 . . . . 0.0 107.678 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -32.21 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.032 1.733 . . . . 0.0 111.995 151.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -56.49 -40.15 74.46 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.346 0.521 . . . . 0.0 112.381 -173.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE2' HD21 ' A' ' 117' ' ' LEU . 29.6 t80 -36.04 -58.91 0.63 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.832 1.253 . . . . 0.0 112.826 178.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.437 ' HB2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.73 -26.29 65.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.103 -174.025 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -76.79 51.99 0.81 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.226 1.01 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -168.28 -44.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.372 2.269 . . . . 0.0 107.428 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.44 -12.19 13.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.69 63.07 1.72 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.1 OUTLIER -166.16 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.826 1.65 . . . . 0.0 110.205 -176.85 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.04 149.45 20.36 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 173.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.88 62.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.97 1.308 . . . . 0.0 108.362 -178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 65.59 -19.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.157 1.783 . . . . 0.0 115.255 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 m -99.77 -54.48 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.291 1.436 . . . . 0.0 109.072 -170.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -63.65 -10.94 21.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -56.11 -43.53 78.22 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.265 0.939 . . . . 0.0 110.884 165.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -50.96 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.19 39.94 1.22 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.116 1.341 . . . . 0.0 113.376 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.1 -25.72 0.02 OUTLIER 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.245 1.018 . . . . 0.0 112.227 171.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.86 -36.93 85.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 162.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 36' ' ' THR . 2.4 t -63.13 82.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.151 0.977 . . . . 0.0 109.873 167.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -144.47 60.6 7.82 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.792 1.637 . . . . 0.0 108.732 164.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.72 -21.18 25.52 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.381 2.721 . . . . 0.0 110.87 -174.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.3 m -142.87 152.06 41.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.494 -0.754 . . . . 0.0 109.244 -177.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.3 m -154.86 125.99 7.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.0 mt -78.26 134.0 29.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 166.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.9 105.36 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 166.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.1 108.31 12.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.866 0.866 . . . . 0.0 110.224 -170.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.96 114.97 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 169.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -99.74 169.38 9.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.303 1.441 . . . . 0.0 108.495 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -22.49 -65.24 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.433 1.968 . . . . 0.0 114.913 -172.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -116.88 5.06 12.92 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.097 1.359 . . . . 0.0 111.865 178.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.8 -172.73 3.52 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.717 1.607 . . . . 0.0 109.96 -154.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.11 136.08 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 166.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 tt -104.0 140.21 22.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 tt -124.96 125.68 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.614 1.565 . . . . 0.0 108.456 177.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -134.73 105.9 6.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.84 0.856 . . . . 0.0 109.397 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.82 38.73 0.72 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.609 1.163 . . . . 0.0 113.274 -159.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -44.05 121.52 2.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 113.943 -164.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -141.63 62.87 1.44 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.277 0.631 . . . . 0.0 110.004 -176.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 m 73.03 125.66 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.137 1.375 . . . . 0.0 109.96 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 72.9 -53.68 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.99 1.316 . . . . 0.0 111.911 -178.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.77 -163.73 0.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -169.28 -168.49 0.83 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 p -54.58 147.59 14.01 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.256 1.423 . . . . 0.0 110.959 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -134.78 122.71 22.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.704 1.601 . . . . 0.0 106.832 176.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.49 158.41 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.2 p -129.64 159.72 35.53 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 165.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.13 179.55 8.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.919 0.888 . . . . 0.0 108.717 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -145.75 128.11 15.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 76.03 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.133 0.973 . . . . 0.0 110.052 171.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.54 59.3 0.13 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.274 1.416 . . . . 0.0 111.084 174.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -168.32 168.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.103 0.952 . . . . 0.0 109.148 174.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.18 152.56 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 110.774 168.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -172.62 163.81 5.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.539 1.136 . . . . 0.0 109.622 -172.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.5 132.78 44.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.738 0.415 . . . . 0.0 110.115 177.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -123.08 87.02 2.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.58 1.952 . . . . 0.0 107.11 -176.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.7 m -89.4 109.07 20.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.436 0.694 . . . . 0.0 109.514 175.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -131.88 157.7 43.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.523 0.677 . . . . 0.0 112.256 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.76 49.27 1.03 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.506 1.522 . . . . 0.0 111.727 -173.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -172.01 -83.96 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.342 1.457 . . . . 0.0 107.346 -173.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.268 5.6 m-20 -74.43 9.47 1.71 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 70.12 -154.9 0.13 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 109.108 162.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.96 81.61 3.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG21 ' HG2' ' A' ' 95' ' ' GLN . 6.4 p -96.68 165.55 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -108.19 128.03 54.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.165 -0.959 . . . . 0.0 109.127 171.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 134.55 36.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 tt -129.1 115.52 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 153.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.698 0.799 . . . . 0.0 110.254 -166.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m -156.29 173.7 16.48 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.546 1.539 . . . . 0.0 106.934 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.27 148.14 49.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.448 1.022 . . . . 0.0 109.886 161.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -116.89 108.83 16.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.519 1.127 . . . . 0.0 108.151 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.67 -68.01 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.637 1.113 . . . . 0.0 111.715 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.8 60.82 0.16 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.679 -2.169 . . . . 0.0 107.679 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.07 113.58 1.22 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 -177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.09 120.63 31.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.04 129.93 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.693 1.597 . . . . 0.0 108.116 -174.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -113.09 106.18 14.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 171.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -82.17 125.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 164.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' HG21 ' A' ' 80' ' ' VAL . 49.6 tt0 -126.09 92.26 3.55 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -163.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -110.0 113.97 27.13 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.267 1.427 . . . . 0.0 108.658 -162.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.45 -55.27 3.35 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.192 0.905 . . . . 0.0 110.677 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -169.46 -90.96 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 117.901 0.319 . . . . 0.0 110.76 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.63 -23.53 77.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -175.35 4.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.613 0.765 . . . . 0.0 109.646 176.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.75 166.54 26.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.286 2.234 . . . . 0.0 106.624 -171.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 t -130.24 153.83 48.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 156.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 p -116.82 137.99 51.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.16 156.64 44.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.71 152.19 36.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.114 0.566 . . . . 0.0 110.236 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -123.6 138.13 54.61 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.915 1.286 . . . . 0.0 108.641 168.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -156.16 146.69 21.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.733 2.013 . . . . 0.0 106.471 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.09 122.22 22.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.624 0.77 . . . . 0.0 109.133 169.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.46 176.41 4.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 159.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.3 t70 51.76 -117.58 1.15 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -167.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -129.7 15.25 5.72 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.234 1.397 . . . . 0.0 110.588 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -123.81 134.22 53.66 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.759 0.78 . . . . 0.0 110.453 -167.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 tp -97.66 116.35 29.71 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.814 1.645 . . . . 0.0 108.311 -171.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.7 mm -86.29 120.94 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.76 113.34 26.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 167.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -111.46 127.78 55.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 170.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.491 HD21 ' CE2' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -138.46 108.53 6.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.347 1.459 . . . . 0.0 107.689 -166.496 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -131.48 138.65 49.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.885 0.85 . . . . 0.0 112.211 -170.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -139.72 92.05 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.62 -118.37 12.58 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -61.85 -43.46 98.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.697 1.199 . . . . 0.0 111.323 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.64 68.07 5.58 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.218 -167.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.9 136.42 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' HD23 ' A' ' 117' ' ' LEU . 4.0 m -145.62 160.7 41.29 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.361 -1.462 . . . . 0.0 109.929 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -142.07 154.61 45.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.362 0.414 . . . . 0.0 110.783 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -132.95 169.29 17.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 151.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 119.07 11.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 -176.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -112.24 163.69 14.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.983 1.713 . . . . 0.0 109.283 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -133.56 123.8 25.77 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 127.364 2.266 . . . . 0.0 107.934 -174.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.97 111.15 3.19 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -98.13 -34.04 10.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 110.636 -173.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 C-N-CA 123.878 0.871 . . . . 0.0 109.936 174.63 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.53 60.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 129.304 3.042 . . . . 0.0 112.096 -169.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.53 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.159 1.784 . . . . 0.0 107.754 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -58.52 -36.6 74.09 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.752 1.221 . . . . 0.0 111.404 -176.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.5 104.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.14 0.976 . . . . 0.0 111.773 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.58 -177.26 27.87 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.349 1.452 . . . . 0.0 113.347 169.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -85.45 108.45 17.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.147 1.779 . . . . 0.0 111.075 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -97.01 155.86 16.6 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.166 0.986 . . . . 0.0 111.087 174.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -123.97 129.67 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.161 1.784 . . . . 0.0 106.555 174.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -79.86 131.2 35.82 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.51 -42.75 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.439 0.563 . . . . 0.0 110.781 172.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 66.86 151.55 0.07 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.898 2.079 . . . . 0.0 111.953 -173.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -166.88 30.21 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.675 163.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -166.91 87.34 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.249 -0.907 . . . . 0.0 110.851 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 63.05 50.98 2.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.44 1.096 . . . . 0.0 110.787 161.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -82.46 -60.65 2.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.212 0.605 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -43.17 -66.34 0.39 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.124 2.169 . . . . 0.0 109.647 171.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' OD2' ' SG ' ' A' ' 124' ' ' CYS . 0.7 OUTLIER -20.48 -60.55 0.02 OUTLIER 'General case' 0 C--N 1.34 0.175 0 C-N-CA 127.732 2.413 . . . . 0.0 113.039 164.122 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CD2' HD12 ' A' ' 117' ' ' LEU . 3.9 t80 -63.84 -48.97 74.66 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.234 -171.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 mtt -62.16 -45.13 94.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.981 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -57.06 -31.34 65.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.125 2.57 . . . . 0.0 111.988 177.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -85.95 -57.27 3.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.598 1.159 . . . . 0.0 110.033 178.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.29 -25.25 68.23 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.191 0.596 . . . . 0.0 112.568 -173.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.16 21.61 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.99 -27.74 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.12 -109.3 0.01 OUTLIER Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.176 1.846 . . . . 0.0 113.631 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 27.94 54.25 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.081 2.553 . . . . 0.0 114.36 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 138.87 -61.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.602 2.761 . . . . 0.0 107.743 -172.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 p -66.23 -48.59 70.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -173.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -49.49 -18.92 0.47 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.401 1.88 . . . . 0.0 115.74 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -107.16 -13.6 15.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.787 0.835 . . . . 0.0 113.034 -177.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -143.23 -68.61 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 118.894 0.77 . . . . 0.0 109.169 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.39 60.45 1.53 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.777 1.656 . . . . 0.0 111.223 -176.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.9 -48.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.978 2.111 . . . . 0.0 107.643 -174.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.5 ttm -99.91 -16.9 17.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.321 1.048 . . . . 0.0 111.482 -177.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 36' ' ' THR . 6.7 t -69.43 72.06 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.825 0.85 . . . . 0.0 111.327 178.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 45.51 66.62 5.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 111.947 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.16 105.16 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.005 2.47 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -108.82 139.37 43.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.793 1.237 . . . . 0.0 108.48 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.5 m -126.3 106.84 9.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -71.43 130.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 164.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -121.89 133.27 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 165.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.2 139.57 37.54 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 119.145 0.884 . . . . 0.0 109.421 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.72 138.62 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.32 164.26 19.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 0.0 108.173 175.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -15.81 -71.8 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.934 2.207 . . . . 0.0 115.521 -175.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -123.98 23.48 8.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.998 1.719 . . . . 0.0 110.319 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.85 -178.75 6.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.273 1.029 . . . . 0.0 108.681 -152.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.04 134.25 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 172.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.2 tt -99.1 141.31 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.078 0.951 . . . . 0.0 108.554 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 133.52 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.689 1.596 . . . . 0.0 107.422 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -127.32 95.75 4.37 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.811 1.244 . . . . 0.0 109.071 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.28 82.7 7.68 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.677 0.791 . . . . 0.0 109.685 -174.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -74.92 72.9 2.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.627 0.771 . . . . 0.0 109.018 173.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.9 t -142.99 -68.55 0.35 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.067 1.747 . . . . 0.0 106.977 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.8 m -60.3 144.38 50.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.113 0.965 . . . . 0.0 110.279 175.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -48.55 135.69 14.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.944 0.498 . . . . 0.0 110.115 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 73.39 -4.73 2.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 0.0 113.458 -178.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.6 72.49 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 111.821 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.83 150.01 38.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.961 0.904 . . . . 0.0 112.623 -174.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -139.02 135.67 34.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.879 1.672 . . . . 0.0 107.863 -174.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 tp -159.45 159.42 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.535 0.607 . . . . 0.0 109.961 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.7 p -110.59 129.59 55.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.867 . . . . 0.0 109.834 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -131.16 179.87 5.75 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.476 0.71 . . . . 0.0 110.225 172.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -139.59 147.16 40.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.901 1.28 . . . . 0.0 107.864 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.54 68.7 1.64 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.007 0.523 . . . . 0.0 109.603 174.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.38 69.72 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -162.11 165.79 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.827 0.851 . . . . 0.0 108.908 175.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -156.85 166.95 31.92 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.771 0.829 . . . . 0.0 109.005 174.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -74.47 124.11 25.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.91 58.93 0.73 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 107.433 177.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.7 m -57.61 106.14 0.31 Allowed 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 165.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 t -147.64 134.6 20.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.895 0.478 . . . . 0.0 110.393 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.36 -36.19 41.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.526 1.13 . . . . 0.0 113.367 -174.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.43 1.07 23.36 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.669 1.188 . . . . 0.0 113.21 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -132.4 -57.05 0.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 109.7 174.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 128.64 -147.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 1 C-N-CA 132.553 4.341 . . . . 0.0 107.255 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -86.69 117.11 25.23 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 95' ' ' GLN . 7.2 p -151.85 148.0 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -169.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -95.61 141.1 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.8 p -121.06 87.76 2.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.513 1.125 . . . . 0.0 109.622 -166.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.1 105.34 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 175.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.59 139.92 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.835 0.854 . . . . 0.0 110.913 -172.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.35 171.0 19.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.23 1.812 . . . . 0.0 107.423 -152.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -142.16 131.53 23.65 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -136.7 150.81 48.66 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.182 0.993 . . . . 0.0 109.181 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.46 -80.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.61 1.1 . . . . 0.0 111.66 -177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.25 30.61 0.27 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.111 1.339 . . . . 0.0 110.651 171.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -132.1 141.55 49.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.111 1.364 . . . . 0.0 108.013 -176.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tt -96.78 112.32 24.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.632 1.173 . . . . 0.0 108.203 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.91 118.33 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 109.335 -174.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -111.35 99.43 8.23 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.601 2.36 . . . . 0.0 106.771 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 132.76 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 170.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HG3' HG21 ' A' ' 80' ' ' VAL . 8.2 tp60 -135.19 98.4 3.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -156.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -116.08 118.48 32.99 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.225 1.01 . . . . 0.0 111.232 -163.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -109.4 -26.16 10.15 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.235 0.614 . . . . 0.0 112.5 -176.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -144.61 -135.53 0.09 Allowed 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.54 66.85 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.287 0.949 . . . . 0.0 111.058 170.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -94.6 166.28 12.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.843 0.857 . . . . 0.0 111.643 -174.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.14 172.76 12.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.681 1.992 . . . . 0.0 110.597 173.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 t -113.67 154.2 27.66 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 153.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 p -112.9 106.52 14.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.652 1.181 . . . . 0.0 108.753 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 115' ' ' LEU . 2.1 mp -102.74 109.65 21.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.72 116.45 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.33 0.652 . . . . 0.0 109.403 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.472 ' CG ' HD23 ' A' ' 115' ' ' LEU . 12.0 mtt85 -95.93 131.58 42.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.836 1.654 . . . . 0.0 108.752 177.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -144.51 143.1 30.68 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -118.22 119.83 35.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.7 m -125.32 -169.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 159.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.26 -113.81 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.035 0.534 . . . . 0.0 109.649 176.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.32 20.68 3.15 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.095 1.807 . . . . 0.0 110.172 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -140.31 143.03 35.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.978 0.889 . . . . 0.0 109.895 -172.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.4 tt -97.01 99.61 11.14 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.23 125.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 106' ' ' ARG . 1.5 tm? -115.95 103.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -92.6 125.55 37.29 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.44 HD12 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -117.45 85.05 2.26 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.682 1.193 . . . . 0.0 108.383 -174.455 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.58 124.19 30.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -145.26 145.47 31.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 160.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -44.64 -36.07 4.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.1 1.333 . . . . 0.0 113.898 -175.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -54.8 -41.21 70.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.388 0.594 . . . . 0.0 111.623 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -171.2 128.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.196 0.599 . . . . 0.0 110.33 -175.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.82 128.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 166.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.467 ' SG ' ' OD2' ' A' ' 18' ' ' ASP . 24.2 m -145.1 153.07 41.03 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.086 -1.009 . . . . 0.0 108.436 -177.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.3 p -140.94 123.67 16.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.154 0.888 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -95.9 102.89 14.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.358 1.863 . . . . 0.0 107.559 175.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 110.04 18.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -92.92 147.99 22.38 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.54 0.686 . . . . 0.0 111.334 176.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -134.38 123.27 23.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.311 2.244 . . . . 0.0 107.148 -172.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -75.49 130.54 39.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.771 0.714 . . . . 0.0 109.782 -177.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.84 -21.42 11.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.137 0.426 . . . . 0.0 112.011 164.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 118.333 0.515 . . . . 0.0 111.171 -179.455 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.758 0.313 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.86 60.28 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 130.5 3.52 . . . . 0.0 111.174 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.07 -44.83 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.074 1.75 . . . . 0.0 107.884 -169.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -61.59 -39.86 92.71 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.534 0.734 . . . . 0.0 111.391 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -38.26 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.906 1.682 . . . . 0.0 111.753 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.19 -172.41 23.21 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.271 0.928 . . . . 0.0 113.172 170.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -84.24 116.98 23.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.64 1.576 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -99.99 161.21 13.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 166.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.17 135.42 22.82 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.85 135.42 52.51 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.981 -0.45 . . . . 0.0 109.846 -173.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.33 -39.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 175.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -141.6 162.72 34.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.8 t -174.38 148.89 1.29 Allowed 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 171.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -121.68 164.43 17.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.33 -22.86 0.21 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 166.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.09 -43.2 20.13 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -166.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -67.35 -61.82 1.72 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.245 0.93 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -40.8 -50.17 3.15 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.868 1.267 . . . . 0.0 111.92 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -50.36 -49.15 55.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.855 1.662 . . . . 0.0 111.876 177.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -37.17 70.76 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.501 -0.75 . . . . 0.0 110.256 176.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.95 48.82 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.914 2.486 . . . . 0.0 109.073 -169.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 p -172.96 -49.26 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.865 1.666 . . . . 0.0 107.26 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -66.16 33.82 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.226 1.411 . . . . 0.0 114.339 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.87 2.87 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 120.09 -1.631 . . . . 0.0 111.754 -178.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.61 54.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.299 2.64 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.82 145.39 17.84 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.916 1.246 . . . . 0.0 110.054 172.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -175.19 171.98 2.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.926 1.69 . . . . 0.0 106.568 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.25 44.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.845 0.748 . . . . 0.0 112.999 -175.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 -52.17 11.01 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.32 -0.863 . . . . 0.0 112.896 -167.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -63.87 -40.09 95.73 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -157.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -36.63 -43.31 0.4 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.686 1.595 . . . . 0.0 113.764 163.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.86 -50.04 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.75 -31.79 5.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.042 2.258 . . . . 0.0 115.702 -176.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -85.5 -37.51 19.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.36 1.08 . . . . 0.0 110.463 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -32.7 66.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.975 0.91 . . . . 0.0 109.885 -174.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -76.17 52.8 0.76 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.399 1.08 . . . . 0.0 111.763 -177.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 30.56 58.45 0.94 Allowed Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 127.599 2.36 . . . . 0.0 114.116 172.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.67 142.0 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.444 1.429 . . . . 0.0 112.023 -166.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.26 175.11 4.86 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.924 1.289 . . . . 0.0 109.825 172.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -159.29 112.15 2.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.486 1.914 . . . . 0.0 106.146 151.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.41 136.58 22.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 174.007 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.4 114.82 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 173.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -118.79 128.81 54.82 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.08 96.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 175.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -77.81 65.13 3.2 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.27 -87.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.453 1.502 . . . . 0.0 112.572 -179.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.42 -15.94 18.56 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.956 1.703 . . . . 0.0 111.621 -175.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.1 p -108.11 157.18 18.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.75 118.11 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 tt -101.35 137.89 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.794 0.837 . . . . 0.0 108.99 -174.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mp -117.44 131.72 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.416 1.487 . . . . 0.0 107.165 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -124.54 115.92 21.64 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m -64.89 -46.79 80.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.274 0.23 . . . . 0.0 110.475 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 56.5 78.52 0.21 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.59 0.756 . . . . 0.0 112.538 169.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -148.06 149.37 31.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 162.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.7 p -11.41 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 129.129 2.972 . . . . 0.0 114.363 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -118.24 46.48 1.78 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.98 1.312 . . . . 0.0 108.085 177.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -158.96 55.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -110.57 139.66 45.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.748 1.619 . . . . 0.0 108.892 177.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.8 p -146.41 160.83 41.55 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 173.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -138.99 128.14 23.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -144.12 132.67 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.596 0.758 . . . . 0.0 109.439 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.1 p -106.14 99.5 9.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.547 1.539 . . . . 0.0 109.98 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -84.91 110.22 18.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.424 0.556 . . . . 0.0 110.218 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -76.84 97.99 4.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 161.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.05 110.5 0.61 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 170.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.09 22.55 6.17 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.09 1.805 . . . . 0.0 113.11 175.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -149.11 159.95 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.905 1.352 . . . . 0.0 109.388 -177.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.14 121.81 42.94 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.593 1.557 . . . . 0.0 108.371 166.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -132.52 155.77 48.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.959 1.303 . . . . 0.0 109.401 -177.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.57 148.39 51.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.057 0.543 . . . . 0.0 109.867 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -141.39 158.01 44.43 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.044 1.337 . . . . 0.0 108.786 -167.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -130.18 119.42 22.93 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.969 0.508 . . . . 0.0 110.945 -175.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.82 150.44 20.41 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.123 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.68 14.68 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -166.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -106.41 11.58 30.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.569 1.948 . . . . 0.0 110.094 164.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 t0 58.96 26.26 14.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.26 1.824 . . . . 0.0 111.909 -170.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -68.75 100.88 1.22 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 156.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.92 125.59 19.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 151.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' HB3' ' A' ' 97' ' ' TRP . 11.6 m -135.45 -165.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -139.42 144.32 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.458 1.027 . . . . 0.0 110.935 171.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -110.16 118.5 36.53 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.701 2.0 . . . . 0.0 108.71 -175.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.7 tt -96.57 125.47 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 164.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.5 139.69 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 m -144.94 161.84 38.36 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 170.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 tt -123.33 115.02 20.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.03 130.73 53.89 Favored 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.88 -82.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.091 0.853 . . . . 0.0 113.705 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.35 25.45 1.1 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.353 1.454 . . . . 0.0 111.683 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.99 126.14 51.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 107.222 177.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 91' ' ' LEU . 5.6 tt -86.38 106.02 17.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 170.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.8 109.08 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -107.81 123.42 48.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -115.94 140.38 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.26 110.08 12.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.858 1.663 . . . . 0.0 107.907 -169.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.99 132.55 56.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.724 2.01 . . . . 0.0 108.233 -164.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.482 ' HB3' HG12 ' A' ' 80' ' ' VAL . 6.3 p90 -119.72 -65.01 1.2 Allowed 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.825 0.284 . . . . 0.0 111.443 177.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.49 -84.15 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.183 0.447 . . . . 0.0 111.11 -173.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.45 -30.22 74.91 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -175.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -171.75 3.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.557 0.694 . . . . 0.0 109.251 173.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.23 168.36 20.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.817 2.847 . . . . 0.0 104.767 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.5 t -144.26 147.79 34.02 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.9 m -109.74 143.99 38.77 Favored 'General case' 0 C--O 1.228 -0.075 0 C-N-CA 123.289 0.635 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.24 63.85 1.57 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.044 2.138 . . . . 0.0 107.322 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 p -74.02 128.94 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -110.82 114.64 28.15 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.904 1.282 . . . . 0.0 108.068 174.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -121.74 144.49 48.76 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 165.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.71 127.8 54.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.929 1.292 . . . . 0.0 108.393 169.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.59 -178.59 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.4 -110.78 0.58 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.3 21.0 2.25 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.866 1.698 . . . . 0.0 110.695 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -140.2 156.74 46.39 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -173.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -123.06 137.9 54.82 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.375 0.534 . . . . 0.0 109.776 173.898 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.63 106.97 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -176.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 115' ' ' LEU . 4.7 tt -88.12 103.72 16.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 170.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 m -85.91 93.66 8.99 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.84 95.63 9.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -121.07 131.61 54.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.66 0.784 . . . . 0.0 111.538 -174.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -113.97 -39.28 3.99 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.539 1.536 . . . . 0.0 110.224 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.84 -80.29 0.26 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 174.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.2 t -58.24 -39.86 80.21 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.45 141.38 40.4 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 108.766 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -146.22 112.02 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.634 1.574 . . . . 0.0 107.798 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.12 101.46 8.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.245 1.418 . . . . 0.0 110.33 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -56.59 129.83 42.58 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 150.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.94 108.55 10.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.1 113.55 26.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.893 1.277 . . . . 0.0 108.721 -156.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.56 147.57 35.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.946 1.298 . . . . 0.0 112.245 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -124.51 124.22 41.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.219 2.207 . . . . 0.0 106.501 -171.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -75.86 124.7 27.76 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -107.02 -28.51 9.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.387 0.275 . . . . 0.0 111.218 173.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 123.2 0.6 . . . . 0.0 110.705 -177.345 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.237 0.435 0 CA-C-O 119.764 -0.16 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.97 63.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.084 2.154 . . . . 0.0 110.53 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.18 -43.02 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.88 1.672 . . . . 0.0 108.084 -163.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.15 -43.66 21.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.257 0.623 . . . . 0.0 111.309 -177.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -43.97 102.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.75 1.62 . . . . 0.0 112.949 -169.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.86 -167.52 25.34 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.345 0.974 . . . . 0.0 113.224 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -76.34 110.58 10.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.301 1.441 . . . . 0.0 110.229 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.439 ' CE2' HG13 ' A' ' 42' ' ' ILE . 32.7 m0 -83.57 113.82 21.09 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 168.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -96.74 125.15 41.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.211 1.004 . . . . 0.0 109.073 174.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.52 141.64 58.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.491 0.587 . . . . 0.0 111.339 -175.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.81 25.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 174.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -161.41 158.11 26.26 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.856 1.662 . . . . 0.0 107.506 163.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 t -177.96 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.357 1.463 . . . . 0.0 109.7 -168.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -96.25 138.92 33.15 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 167.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 62.86 -3.69 0.3 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 167.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -59.16 -31.0 68.59 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.542 -1.348 . . . . 0.0 112.106 -173.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.72 -71.18 0.22 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -27.41 -61.24 0.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.458 2.303 . . . . 0.0 111.761 170.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -43.27 -61.12 1.43 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.912 1.285 . . . . 0.0 111.365 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.412 ' HB2' HG13 ' A' ' 25' ' ' VAL . 22.8 ptp -74.44 -31.56 62.32 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.859 -0.526 . . . . 0.0 111.718 -176.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.28 47.06 0.35 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.869 2.467 . . . . 0.0 109.29 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.2 m 177.47 -45.65 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 128.061 2.545 . . . . 0.0 107.691 -172.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.6 -45.09 66.39 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.204 -0.31 . . . . 0.0 110.93 172.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.95 -84.22 0.13 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 20' ' ' MET . 0.6 OUTLIER -9.01 -68.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.522 2.329 . . . . 0.0 115.549 167.014 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 38.04 39.61 0.7 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.418 1.009 . . . . 0.0 115.067 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 150.66 44.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 72.86 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.463 1.105 . . . . 0.0 108.929 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 57' ' ' PHE . 24.4 m -162.65 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.993 1.317 . . . . 0.0 109.454 -176.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -44.2 63.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.194 0.598 . . . . 0.0 110.651 -172.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -34.79 -41.26 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.637 2.375 . . . . 0.0 114.789 168.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.84 -30.24 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.307 1.443 . . . . 0.0 110.448 177.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.37 59.21 0.63 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 127.1 2.286 . . . . 0.0 111.668 174.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.93 -69.01 0.07 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 130.516 3.526 . . . . 0.0 104.886 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -61.53 -36.23 79.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.101 1.36 . . . . 0.0 110.457 -179.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -75.52 14.44 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.64 56.24 12.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.928 1.24 . . . . 0.0 111.773 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.61 153.24 73.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.581 2.188 . . . . 0.0 111.802 -165.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -109.48 165.45 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.216 1.006 . . . . 0.0 109.058 -176.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 m -151.55 106.69 3.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.14 121.07 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 8' ' ' TRP . 41.2 mm -111.1 123.08 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 164.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -123.79 145.53 48.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.9 m -105.15 110.33 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.7 56.97 3.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.06 -85.55 0.02 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.925 0.774 . . . . 0.0 112.33 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.12 -29.65 21.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.893 1.277 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 173.52 6.29 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.015 1.726 . . . . 0.0 107.95 -177.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.83 148.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -177.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.8 tt -129.84 129.29 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.639 0.776 . . . . 0.0 110.167 -173.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.62 135.9 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 125.354 1.461 . . . . 0.0 107.164 172.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -127.13 119.89 27.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.086 0.954 . . . . 0.0 109.361 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -94.25 84.11 4.36 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.16 0.984 . . . . 0.0 111.46 -166.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -88.07 95.7 10.24 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.442 1.019 . . . . 0.0 112.778 -168.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.9 p -108.12 154.34 21.84 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 164.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -76.17 61.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB3' HG23 ' A' ' 29' ' ' THR . 0.5 OUTLIER -177.93 -49.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.731 0.812 . . . . 0.0 110.148 -170.278 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -146.13 135.35 22.8 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -173.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -134.31 123.32 23.98 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.2 p -134.42 167.06 21.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.52 149.52 33.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.096 0.407 . . . . 0.0 110.544 168.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.2 pt -146.38 140.75 20.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.321 1.049 . . . . 0.0 109.106 177.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 p -105.03 153.97 20.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 110.335 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -158.9 160.62 36.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.345 0.658 . . . . 0.0 110.167 -178.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -84.48 131.87 34.61 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.94 54.89 1.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.079 0.854 . . . . 0.0 109.954 167.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.78 57.74 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.001 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -173.12 162.57 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.351 1.076 . . . . 0.0 111.037 169.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -100.44 126.22 46.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.063 2.545 . . . . 0.0 109.385 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.32 157.42 35.67 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.603 -0.685 . . . . 0.0 110.603 -176.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -70.57 150.7 45.8 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.512 0.725 . . . . 0.0 109.626 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -163.65 177.01 9.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.167 1.387 . . . . 0.0 107.276 -164.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.4 m -160.46 99.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 120.168 -1.583 . . . . 0.0 108.255 -163.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.544 HG22 ' HB2' ' A' ' 78' ' ' ARG . 5.5 t -82.62 174.76 10.74 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.354 -178.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.17 21.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.204 1.802 . . . . 0.0 115.585 -163.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -139.8 15.6 2.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.119 2.168 . . . . 0.0 111.37 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t0 50.34 40.12 21.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 111.576 -169.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.544 ' HB2' HG22 ' A' ' 74' ' ' THR . 10.4 mmt180 -68.2 111.08 4.32 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 149.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -74.58 71.54 1.88 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.03 154.42 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.802 -175.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.35 120.43 32.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 159.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.18 125.14 30.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 167.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.89 107.35 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 176.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.27 135.51 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.047 -169.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.7 p -145.85 -168.93 3.11 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.85 1.66 . . . . 0.0 107.413 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 pp -136.59 135.52 38.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 167.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.0 24.67 0.23 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.603 1.092 . . . . 0.0 112.602 -167.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -32.21 3.17 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.337 -163.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.36 -46.83 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.108 1.337 . . . . 0.0 113.143 -172.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -127.21 155.92 42.67 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.382 1.873 . . . . 0.0 109.039 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tt -81.49 121.56 26.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.85 104.57 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.893 1.277 . . . . 0.0 107.675 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -99.6 104.26 16.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 171.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.42 143.06 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 169.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.03 108.74 10.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -117.86 139.66 50.8 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.712 1.605 . . . . 0.0 107.66 -170.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.63 -78.76 0.58 Allowed 'General case' 0 C--N 1.337 0.064 0 CA-C-N 119.565 1.075 . . . . 0.0 110.717 172.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -149.23 -60.04 0.22 Allowed 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.57 0.07 20.2 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.402 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 153.36 38.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 172.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -125.79 170.15 11.89 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 108.233 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -143.57 149.75 37.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 110.269 165.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 p -109.57 138.03 46.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.512 1.125 . . . . 0.0 108.255 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.54 69.03 1.44 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.124 1.369 . . . . 0.0 107.997 -177.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 116' ' ' THR . 0.5 OUTLIER -77.21 146.35 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.566 -174.519 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.99 136.94 35.9 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.723 1.209 . . . . 0.0 110.254 176.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -161.25 147.71 14.59 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 157.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -93.0 102.6 14.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.478 1.511 . . . . 0.0 109.09 167.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.49 -173.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 158.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t70 50.99 -110.82 0.5 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.79 25.03 2.11 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.072 1.32 . . . . 0.0 110.803 174.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -150.74 153.45 35.54 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 118.3 1.05 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.7 120.62 31.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -89.0 133.52 30.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.9 tp -123.58 121.6 36.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.535 ' HB ' HG12 ' A' ' 105' ' ' VAL . 5.6 m -110.99 109.61 19.81 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.49 124.79 35.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 168.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.3 m -141.57 135.14 29.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.684 0.675 . . . . 0.0 110.723 173.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -137.71 154.7 49.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.376 2.27 . . . . 0.0 108.001 -177.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -30.6 -48.22 0.16 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.569 2.033 . . . . 0.0 115.627 -178.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 t -135.27 41.28 2.81 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.805 0.803 . . . . 0.0 110.6 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.6 126.07 4.44 Favored 'General case' 0 C--N 1.338 0.099 0 O-C-N 121.325 -0.86 . . . . 0.0 109.202 169.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 p -118.09 132.69 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.732 1.213 . . . . 0.0 107.774 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -139.24 112.56 8.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 p -67.12 143.48 56.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 158.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -139.14 162.28 35.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 160.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.73 145.64 26.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 170.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -125.48 162.82 24.03 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.416 1.486 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -124.87 103.22 7.94 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.045 2.138 . . . . 0.0 105.485 -175.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.53 108.71 12.11 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.43 -55.98 26.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.865 -173.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 O-C-N 121.93 -0.481 . . . . 0.0 110.939 -171.712 . . . . . . . . 0 0 . 1 stop_ save_